Citrus Sinensis ID: 042371
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 400 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S9M5 | 730 | Wall-associated receptor | yes | no | 0.915 | 0.501 | 0.559 | 1e-127 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.935 | 0.472 | 0.556 | 1e-126 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.8 | 0.438 | 0.636 | 1e-125 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.887 | 0.450 | 0.585 | 1e-125 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.827 | 0.442 | 0.616 | 1e-125 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.91 | 0.484 | 0.559 | 1e-124 | |
| Q9M092 | 786 | Wall-associated receptor | no | no | 0.922 | 0.469 | 0.553 | 1e-123 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.93 | 0.486 | 0.550 | 1e-123 | |
| Q9S9M1 | 731 | Wall-associated receptor | no | no | 0.905 | 0.495 | 0.546 | 1e-123 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.785 | 0.412 | 0.633 | 1e-122 |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 456 bits (1173), Expect = e-127, Method: Compositional matrix adjust.
Identities = 222/397 (55%), Positives = 295/397 (74%), Gaps = 31/397 (7%)
Query: 2 DECKDGTANCSENLLCENYEGGYRCITPKRKV---------------------------- 33
D C +G NC E+ C N G P K+
Sbjct: 317 DSC-EGNHNCGEDAHCVNMPGPMSMCRPNPKITKPTKPPVLQGILIGLSGLVFFVGLFWL 375
Query: 34 --YIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRIL 91
I KR +I +KFFKRNGGL+L+QQLT+ DG+++ K+F++KEL KATD+F+++R+L
Sbjct: 376 FKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVL 435
Query: 92 GQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLET 151
GQGGQGTVYKGML DG IVAVK+SK+V E K+EEFINE+V+LSQINHRN+VKLLGCCLET
Sbjct: 436 GQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLET 495
Query: 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDI 211
EVP+LVYE+I NG LF+ LHD+++++ +TWE+RLRIA E+AG+L+Y+HSAAS PI+HRDI
Sbjct: 496 EVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDI 555
Query: 212 KSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYS 271
K+TNILL+EKY AKV+DFGTS+ + +DQTH+TT V GTFGY+DPEYF S Q+T KSDVYS
Sbjct: 556 KTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYS 615
Query: 272 FGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIA 331
FGVVLVEL+TG+KP+ S+E GLA +F+ +M+ENR+ D +D ++ + E++M +A
Sbjct: 616 FGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVA 675
Query: 332 TLATRCLNLNGKRRPTMKEVAMELERIQALQKDINVK 368
LA +CLN GK RP MKEV+ ELERI++ +D++V+
Sbjct: 676 KLARKCLNRKGKNRPNMKEVSNELERIRSSPEDLDVR 712
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1159), Expect = e-126, Method: Compositional matrix adjust.
Identities = 223/401 (55%), Positives = 295/401 (73%), Gaps = 27/401 (6%)
Query: 1 IDECKD--GTANCSENLLCENYEGGYRCITPKRKV-----------------------YI 35
I+ECK+ G C N C N +G ++C+ + +I
Sbjct: 339 INECKEEEGMTYCGTNK-CVNLQGHFKCVYNNHRPLAIGLGASFGSLIFVVGIYLLYKFI 397
Query: 36 IKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGG 95
K+ + K+KFFKRNGGL+LQQQL S+ G +++ +F+++EL+KAT++F+ NRILGQGG
Sbjct: 398 KKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKATENFSSNRILGQGG 457
Query: 96 QGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155
QGTVYKGML DGRIVAVKKSK+V E KLEEFINEVVILSQINHRN+VKLLGCCLET+VP+
Sbjct: 458 QGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETKVPV 517
Query: 156 LVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKST 214
LVYEFI NG LF++LHD+ +E TW +RLRIA ++AG+LSYLHS+AS PIYHRD+KST
Sbjct: 518 LVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKST 577
Query: 215 NILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGV 274
NI+L+EKY AKV+DFGTS+ + +D TH+TT V GT GY+DPEYF+S QFTDKSDVYSFGV
Sbjct: 578 NIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGV 637
Query: 275 VLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLA 334
VLVEL+TG+K I S+E LA YFIL+M+EN+L+D +D ++ ++ A +A
Sbjct: 638 VLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDGCMLSQVTATAKVA 697
Query: 335 TRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIE 375
+CLNL G++RP+M+EV+MEL+ I+ D+ +++ E E
Sbjct: 698 RKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQECVSENE 738
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 448 bits (1153), Expect = e-125, Method: Compositional matrix adjust.
Identities = 205/322 (63%), Positives = 272/322 (84%), Gaps = 2/322 (0%)
Query: 46 KFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLA 105
KFFKRNGGL+L+QQLT+ DGS++ K+F+++EL+KATD+F+++R+LGQGGQGTVYK ML
Sbjct: 389 KFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRMLV 448
Query: 106 DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 165
DG IVAVK+SK+V E K+EEFINE+V+LSQINHRN+VKLLGCCLETEVP+LVYE+I NG
Sbjct: 449 DGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGD 508
Query: 166 LFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAK 225
LF+ LHD+ +++ +TWE+RLRIA E+AG+LSY+HSAAS PI+HRDIK+TNILL+EKY AK
Sbjct: 509 LFKRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAK 568
Query: 226 VADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
++DFGTS+ + DQTH+TT V GTFGY+DPEYF S Q+T KSDVYSFGVVLVEL+TG+KP
Sbjct: 569 ISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKP 628
Query: 286 IILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRR 345
+ S+E GLA YF+ +M+ENR D +D ++ + +++M +A LA RCLN G +R
Sbjct: 629 MSRVRSEEGIGLATYFLEAMKENRAVDIIDIRIKD--ESKQVMAVAKLARRCLNRKGNKR 686
Query: 346 PTMKEVAMELERIQALQKDINV 367
P M+EV+++LERI++ KD++V
Sbjct: 687 PNMREVSIKLERIRSSPKDLDV 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 447 bits (1150), Expect = e-125, Method: Compositional matrix adjust.
Identities = 222/379 (58%), Positives = 288/379 (75%), Gaps = 24/379 (6%)
Query: 10 NCSENLLCENYEGGYRCITPKRKVYII-----------------------KREDIKLKEK 46
NC E+ C N G + CI K +V +I KR K K K
Sbjct: 353 NCRESDTCVNLPGTFNCIGNKTRVTMIGVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRK 412
Query: 47 FFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLAD 106
FFKRNGGL+LQQQL ++ G++++ ++F+++EL+KATD+F+ +RILGQGGQGTVYKGML D
Sbjct: 413 FFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVD 472
Query: 107 GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166
GR VAVKKSK+V E KLEEFINEVVILSQINHR+VVKLLGCCLETEVP LVYEFI NG L
Sbjct: 473 GRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNL 532
Query: 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV 226
FQ++H++++++ TW MRLRIA ++AG+LSYLHSAAS PIYHRDIKSTNILL+EKY KV
Sbjct: 533 FQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKV 592
Query: 227 ADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
+DFGTS+ + ID TH TT + GT GY+DPEY+ S Q+TDKSDVYSFGVVLVEL+TG+KP+
Sbjct: 593 SDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPV 652
Query: 287 I-LTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRR 345
I ++ S+E GLA +F ++M+ENR ++ +D ++ + E++M +A LA RCLN GK+R
Sbjct: 653 ITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKR 712
Query: 346 PTMKEVAMELERIQALQKD 364
P M++V +LE+I A Q+D
Sbjct: 713 PCMRKVFTDLEKILASQED 731
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 447 bits (1150), Expect = e-125, Method: Compositional matrix adjust.
Identities = 204/331 (61%), Positives = 274/331 (82%)
Query: 34 YIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQ 93
++ KR + KFF+RNGG++L+QQL +G+++ ++F++ EL+KATD+FN NR+LGQ
Sbjct: 365 FVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQ 424
Query: 94 GGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153
GGQGTVYKGML DGRIVAVK+SK V E ++EEFINEVV+L+QINHRN+VKLLGCCLETEV
Sbjct: 425 GGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEV 484
Query: 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKS 213
P+LVYEF+ NG L + LHD+++++ +TWE+RL IA E+AG+LSYLHSAAS PIYHRDIK+
Sbjct: 485 PVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKT 544
Query: 214 TNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFG 273
TNILL+E+ AKV+DFGTS+ + IDQTH+TT+V GTFGY+DPEYF+S +FT+KSDVYSFG
Sbjct: 545 TNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFG 604
Query: 274 VVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATL 333
VVLVELLTG+KP S+E GLAA+F+ +++ENR+ D +DD++ +++M++A L
Sbjct: 605 VVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANL 664
Query: 334 ATRCLNLNGKRRPTMKEVAMELERIQALQKD 364
A RCLN GK+RP M+EV++ELE I++ D
Sbjct: 665 ARRCLNRKGKKRPNMREVSIELEMIRSSHYD 695
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 445 bits (1145), Expect = e-124, Method: Compositional matrix adjust.
Identities = 220/393 (55%), Positives = 296/393 (75%), Gaps = 29/393 (7%)
Query: 1 IDECKDGT--ANCSENLLCENYEGGYRC-------ITPKRK------------------- 32
IDEC++G ++C E L C N G +RC I P
Sbjct: 310 IDECEEGKGLSSCGE-LTCVNVPGSWRCELNGVGKIKPLFPGLVLGFPLLFLVLGIWGLI 368
Query: 33 VYIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILG 92
++ KR I K FFKRNGGL+L+QQLT+ G++ K+F++KEL+KATD+FN+NR+LG
Sbjct: 369 KFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLG 428
Query: 93 QGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE 152
QGGQGTVYKGML DGRIVAVK+SK++ E K+EEFINEV +LSQINHRN+VKL+GCCLETE
Sbjct: 429 QGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETE 488
Query: 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIK 212
VP+LVYE I NG LF+ LH ++++ +TW++RLRI+ E+AG+L+YLHSAAS P+YHRD+K
Sbjct: 489 VPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVK 548
Query: 213 STNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSF 272
+TNILL+EKY AKV+DFGTS+ I +DQTH+TT V GTFGYLDPEYF++ QFTDKSDVYSF
Sbjct: 549 TTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSF 608
Query: 273 GVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT 332
GVVLVEL+TG+KP + +E GL ++F +M++NR+ D +D ++ + E+++ +A
Sbjct: 609 GVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAK 668
Query: 333 LATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365
LA RCL+L GK+RP M+EV++ELERI++ +D+
Sbjct: 669 LARRCLSLKGKKRPNMREVSVELERIRSSPEDL 701
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 442 bits (1136), Expect = e-123, Method: Compositional matrix adjust.
Identities = 218/394 (55%), Positives = 285/394 (72%), Gaps = 25/394 (6%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRCITPKRKVYIIKRE----------DIKLKEKFF-- 48
IDECK+ C E C N+EGGYRC+ K K +I + KF
Sbjct: 337 IDECKENPKYCKETDTCVNFEGGYRCVGDKTKAIMIGAGTGFGVLVLVGGVWWLRKFLVK 396
Query: 49 -----------KRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQG 97
KRNGGL+LQQ+L + G +++ ++FT+KEL+KAT++F+ NR+LG GGQG
Sbjct: 397 RRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQG 456
Query: 98 TVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157
TVYKGML DGR VAVKKSK++ E KL+EFINEVVILSQINHR+VVKLLGCCLETEVP+LV
Sbjct: 457 TVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILV 516
Query: 158 YEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216
YEFI NG LF+++H++ +++ + W MRLRIA ++AG+LSYLHSAAS PIYHRDIKSTNI
Sbjct: 517 YEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNI 576
Query: 217 LLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVL 276
LL+EKY AKVADFGTS+ + IDQTH TT + GT GY+DPEY+RS Q+T+KSDVYSFGV+L
Sbjct: 577 LLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVIL 636
Query: 277 VELLTGQKPIILT-GSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLAT 335
EL+TG KP+I+ ++E LA +F ++M+E RL D +D ++ + E++M +A LA
Sbjct: 637 AELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVMAVANLAM 696
Query: 336 RCLNLNGKRRPTMKEVAMELERIQALQKDINVKQ 369
+CL+ G+ RP M+EV ELERI +D V+
Sbjct: 697 KCLSSRGRNRPNMREVFTELERICTSPEDSQVQN 730
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-123, Method: Compositional matrix adjust.
Identities = 222/403 (55%), Positives = 291/403 (72%), Gaps = 31/403 (7%)
Query: 1 IDECKDGTANCSENLL-----CENYEGGYRCI---TPK---------------------R 31
I+EC + C + + C N GG+RCI P+ R
Sbjct: 342 INECTEYKNPCGDTRILYRNTCINTSGGHRCIDYHIPEVMLGLGAGFFVLIVGGGIWWWR 401
Query: 32 KVYIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRIL 91
K+ + KR K KFFKRNGGL+LQQQL ++ G +++ KLF+++EL+KATD+FN NR++
Sbjct: 402 KL-LRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVI 460
Query: 92 GQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLET 151
GQGGQGTVYKGML DGR VAVKKS +V E KL+EFINEV+ILSQINHR+VVKLLGCCLET
Sbjct: 461 GQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLET 520
Query: 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDI 211
EVP+LVYEFI NG LFQ+LH++ +++ W +R+RIA +++G+ SYLH+AA PIYHRDI
Sbjct: 521 EVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDI 580
Query: 212 KSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYS 271
KSTNILL+EKY AKV+DFGTS+ + ID TH TT + GT GY+DPEY+ S FT+KSDVYS
Sbjct: 581 KSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYS 640
Query: 272 FGVVLVELLTGQKPII-LTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTI 330
FGVVLVEL+TG+KP+I L+ ++E TGLA YF L+M ENRL++ +D ++ + E+++ +
Sbjct: 641 FGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQVIAV 700
Query: 331 ATLATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDE 373
A LA RCL GK RP M+EV+ LERI + +D V+ DE
Sbjct: 701 ANLALRCLKKTGKTRPDMREVSTALERICSAPEDFQVQIQIDE 743
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-123, Method: Compositional matrix adjust.
Identities = 216/395 (54%), Positives = 296/395 (74%), Gaps = 33/395 (8%)
Query: 2 DECKDGTANCSENLLCENYEGGYRC------ITPKRK----------------------- 32
D+CK N E C N GGYRC I P +
Sbjct: 320 DDCKG--PNICEEGTCVNVPGGYRCDPKPKIIKPAKPLVLQGVLLGLMGLLFLVVGTLGL 377
Query: 33 -VYIIKREDIKLKEKFFKRNGGLVLQQQLTSS-DGSIDRCKLFTTKELDKATDHFNVNRI 90
++I KR I KFFKRNGGL+L+QQLT++ DG++D +LF+++EL KATD+F+V R+
Sbjct: 378 IIFIKKRRRIISSRKFFKRNGGLLLKQQLTTTNDGNVDMSRLFSSEELKKATDNFSVKRV 437
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE 150
LG+G QGTVYKGM+ DG+I+AVK+SK+V E KLE+FINE+++LSQINHRN+VKL+GCCLE
Sbjct: 438 LGKGSQGTVYKGMMVDGKIIAVKRSKVVDEDKLEKFINEIILLSQINHRNIVKLIGCCLE 497
Query: 151 TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRD 210
TEVP+LVYE+I NG +F+ LHD+++++ +TWE+RLRIA E+AG+L+Y+HSAAS PIYHRD
Sbjct: 498 TEVPILVYEYIPNGDMFKRLHDESDDYAMTWEVRLRIAIEIAGALTYMHSAASFPIYHRD 557
Query: 211 IKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVY 270
IK+TNILL+EKY AKV+DFGTS+ + IDQTH+TT V GTFGY+DPEYF S Q+TDKSDVY
Sbjct: 558 IKTTNILLDEKYGAKVSDFGTSRSVTIDQTHLTTMVAGTFGYMDPEYFLSSQYTDKSDVY 617
Query: 271 SFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTI 330
SFGVVLVEL+TG+KP+ S+E GLA +F+ +M+ENR+ D +D ++ + + +++M +
Sbjct: 618 SFGVVLVELITGEKPLSRIRSEEGRGLATHFLEAMKENRVIDIIDIRIKEESKLDQLMAV 677
Query: 331 ATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365
A LA +CL+ G +RP M+E ++ELERI++ +D+
Sbjct: 678 AKLARKCLSRKGIKRPNMREASLELERIRSSPEDL 712
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 438 bits (1126), Expect = e-122, Method: Compositional matrix adjust.
Identities = 199/314 (63%), Positives = 262/314 (83%)
Query: 47 FFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLAD 106
FF+RNGG++L+QQL +G+++ K+F++ EL+KATD+FN NR+LGQGGQGTVYKGML D
Sbjct: 386 FFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLVD 445
Query: 107 GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166
GRIVAVK+SK + E K+EEFINEVV+L+QINHRN+VKLLGCCLETEVP+LVYEF+ NG L
Sbjct: 446 GRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDL 505
Query: 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV 226
+ L D+ +++ +TWE+RL IA E+AG+LSYLHSAAS PIYHRDIK+TNILL+EKY KV
Sbjct: 506 CKRLRDECDDYIMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKV 565
Query: 227 ADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
+DFGTS+ + IDQTH+TT+V GTFGY+DPEYF+S +FTDKSDVYSFGVVLVEL+TG+ P
Sbjct: 566 SDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPS 625
Query: 287 ILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP 346
S+E G AA+F+ +++ENR D +D+++ +++M +A LA RCLN GK+RP
Sbjct: 626 SRVQSEENRGFAAHFVAAVKENRFLDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRP 685
Query: 347 TMKEVAMELERIQA 360
M+EV++ELERI++
Sbjct: 686 NMREVSVELERIRS 699
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 400 | ||||||
| 147852023 | 413 | hypothetical protein VITISV_028337 [Viti | 0.87 | 0.842 | 0.721 | 1e-149 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.885 | 0.408 | 0.700 | 1e-147 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.822 | 0.400 | 0.752 | 1e-145 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.885 | 0.521 | 0.693 | 1e-144 | |
| 224075820 | 626 | predicted protein [Populus trichocarpa] | 0.815 | 0.520 | 0.753 | 1e-142 | |
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.82 | 0.472 | 0.734 | 1e-142 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.882 | 0.491 | 0.695 | 1e-141 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.875 | 0.481 | 0.688 | 1e-141 | |
| 297734146 | 1029 | unnamed protein product [Vitis vinifera] | 0.882 | 0.343 | 0.695 | 1e-140 | |
| 224075946 | 729 | predicted protein [Populus trichocarpa] | 0.922 | 0.506 | 0.660 | 1e-140 |
| >gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1379), Expect = e-149, Method: Compositional matrix adjust.
Identities = 257/356 (72%), Positives = 306/356 (85%), Gaps = 8/356 (2%)
Query: 37 KREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQ 96
+R IK KEK FKRNGGL+L+QQL+SS+G++D+ KLFT+KEL+KATD +N NR++GQGGQ
Sbjct: 35 RRRKIKHKEKCFKRNGGLLLEQQLSSSEGNVDKTKLFTSKELEKATDRYNENRVIGQGGQ 94
Query: 97 GTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156
GTVYKGML DGRIVAVKK KIV +GKLE+FINEVVILSQINHRNVVKLLGCCLE EVPLL
Sbjct: 95 GTVYKGMLMDGRIVAVKKLKIVGDGKLEQFINEVVILSQINHRNVVKLLGCCLEIEVPLL 154
Query: 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216
VYE+I NGTL +++HDQNEEFP+TW+MRL+IATEVAG+LSYLHSAAS+PIYHRDIKSTNI
Sbjct: 155 VYEYIPNGTLSEHIHDQNEEFPITWKMRLQIATEVAGALSYLHSAASIPIYHRDIKSTNI 214
Query: 217 LLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVL 276
LL++KY AKVADFGTSK + IDQTH+TTKVQGTFGYLDPEYF+S QFT+KSDVYSFG+VL
Sbjct: 215 LLDDKYRAKVADFGTSKSVAIDQTHLTTKVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVL 274
Query: 277 VELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATR 336
+ELLTG+KPI+ GS E LA+YFI+SM+E+RL D LD +V+K G+KEEI IA LA R
Sbjct: 275 IELLTGKKPILSIGSGEGKSLASYFIMSMKEDRLSDLLDARVVKEGRKEEINAIAFLAKR 334
Query: 337 CLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIE--------SCDIVSTST 384
C+NLNGK+RPTM EVAMELERI+ + D N ++ DE+E D+ STST
Sbjct: 335 CINLNGKKRPTMMEVAMELERIRKCEGDFNAQENSDEVEYDTIELTRPWDVASTST 390
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 526 bits (1354), Expect = e-147, Method: Compositional matrix adjust.
Identities = 255/364 (70%), Positives = 307/364 (84%), Gaps = 10/364 (2%)
Query: 33 VYII--KREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRI 90
+YI+ +R+ IK KEK F RNGGL+L+QQL+S++G+ID+ KLFT+KEL+KATD +N NR+
Sbjct: 319 LYIVLKRRKKIKYKEKCFNRNGGLLLEQQLSSTEGNIDKTKLFTSKELEKATDRYNENRV 378
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE 150
+GQGG+GTVYKGML DGRIVAVKK KI+ + KLE+FINEVVIL QINHRNVVKLLGCCLE
Sbjct: 379 IGQGGEGTVYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCLE 438
Query: 151 TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRD 210
TEVPLLVYEFI NGTL +++H QNEEFP+TWE+RLRIATEVAG+LSYLHSAAS+PIYHRD
Sbjct: 439 TEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEIRLRIATEVAGALSYLHSAASVPIYHRD 498
Query: 211 IKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVY 270
IKSTNILL++KY AKVADFG SKF+ IDQTH+TT+VQGTFGYLDPEYF+S QFT+KSDVY
Sbjct: 499 IKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVY 558
Query: 271 SFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTI 330
SFG+VL+ELLTG+KPI+ T S+E LA+YFILSM E+RL D LD QV+K +KEEI I
Sbjct: 559 SFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAI 618
Query: 331 ATLATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIE--------SCDIVST 382
A LA RC+NLNGK+RPTM EVAMELERI+ Q D ++ +EIE D+ S
Sbjct: 619 AFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFGAQENSEEIEYNTIELIGPWDVTSI 678
Query: 383 STET 386
ST++
Sbjct: 679 STDS 682
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 249/331 (75%), Positives = 294/331 (88%), Gaps = 2/331 (0%)
Query: 37 KREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQ 96
+R+ IK KEK FKRNGGL+L+QQL+SS+G++D+ KLFT+KEL+KATD +N NR++GQGGQ
Sbjct: 481 RRQKIKYKEKCFKRNGGLLLEQQLSSSEGNVDKTKLFTSKELEKATDRYNENRVIGQGGQ 540
Query: 97 GTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156
GTVYKGML DGRIVAVKK KIV +GK+E+FINEVVILSQINHRNVVKLLGCCLET VPLL
Sbjct: 541 GTVYKGMLMDGRIVAVKKLKIVGDGKVEQFINEVVILSQINHRNVVKLLGCCLETAVPLL 600
Query: 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216
VYEFI NGTL +++HDQNEEFP+TWEMRLRIA EVAG+LSYLHSAAS+PIYHRDIKSTNI
Sbjct: 601 VYEFIPNGTLSEHIHDQNEEFPITWEMRLRIAIEVAGALSYLHSAASIPIYHRDIKSTNI 660
Query: 217 LLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVL 276
LL++KY AKVADFGTSK + IDQTH+TT+VQGTFGYLDPEYF+S QFT+KSDVYSFG+VL
Sbjct: 661 LLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVL 720
Query: 277 VELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATR 336
+ELLTG+KPI+ T S+E LA+YFILSM E+RL D LD QV+K G+KEEI IA LA R
Sbjct: 721 IELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKEGKKEEINAIAFLARR 780
Query: 337 CLNLNGKRRPTMKEVAMELE--RIQALQKDI 365
C+NLNGK+RPTM EVAMELE + + +QK +
Sbjct: 781 CINLNGKKRPTMMEVAMELEILKTKKMQKWV 811
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1336), Expect = e-144, Method: Compositional matrix adjust.
Identities = 251/362 (69%), Positives = 300/362 (82%), Gaps = 8/362 (2%)
Query: 33 VYIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILG 92
+ + +R+ IK KEK F RNGGL+L+QQL+SS+G+ID+ KLFT+KEL+KATD +N NR++G
Sbjct: 306 IXLKRRKKIKYKEKCFNRNGGLLLEQQLSSSEGNIDKTKLFTSKELEKATDRYNENRVIG 365
Query: 93 QGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE 152
QG QGT YKGML DGRIVAVKK KI+ + KLE+FINEVVIL QINHRNVVKLLGCCLETE
Sbjct: 366 QGXQGTXYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCLETE 425
Query: 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIK 212
VPLLVYEFI NGTL +++H QNEEFP+TWEMRLRIATEV G+LSYLHS AS+PIYHRDIK
Sbjct: 426 VPLLVYEFIPNGTLSEHIHGQNEEFPITWEMRLRIATEVXGALSYLHSXASIPIYHRDIK 485
Query: 213 STNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSF 272
STNILLB+KY AKVADFG SKF+ IDQTH+TT+VQGTFGYLDPEYF+S QFT+KSDVYSF
Sbjct: 486 STNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSF 545
Query: 273 GVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT 332
G+VL+ELLTG+KPI+ S+E LA+YFILSM E+RL D LD QV+K +KEEI IA
Sbjct: 546 GIVLIELLTGKKPILSIASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAF 605
Query: 333 LATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIE--------SCDIVSTST 384
LA RC+NLNGK+RPTM EVAMELERI+ Q D ++ +EIE D+ S ST
Sbjct: 606 LARRCINLNGKKRPTMMEVAMELERIRKCQGDFRAQENFEEIEYNTTELIGPWDVTSIST 665
Query: 385 ET 386
++
Sbjct: 666 DS 667
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075820|ref|XP_002335844.1| predicted protein [Populus trichocarpa] gi|222835559|gb|EEE73994.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 510 bits (1314), Expect = e-142, Method: Compositional matrix adjust.
Identities = 247/328 (75%), Positives = 286/328 (87%), Gaps = 2/328 (0%)
Query: 32 KVYIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRIL 91
KV+ KR + KLK+K+FKRNGGL+LQ+QL+S + ++++ K+F +KELDKATDH+NVNR L
Sbjct: 300 KVFKRKRSE-KLKKKYFKRNGGLLLQEQLSSGEVNVEKIKMFPSKELDKATDHYNVNRTL 358
Query: 92 GQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLET 151
GQGGQGTVYKGMLADG+IVAVKKSK++ EG L +FINEVV+LSQINHRNVVKLLGCCLET
Sbjct: 359 GQGGQGTVYKGMLADGKIVAVKKSKVIDEGNLRQFINEVVLLSQINHRNVVKLLGCCLET 418
Query: 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDI 211
EVPLLVYEFI NGTLFQ+LHD NEEFPLTWEMRLRIA EVAG+L YLHSAAS+PI+HRDI
Sbjct: 419 EVPLLVYEFIPNGTLFQFLHDPNEEFPLTWEMRLRIAAEVAGALFYLHSAASLPIFHRDI 478
Query: 212 KSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYS 271
KSTNILL+EKY AKVADFGTS+ + IDQTHVTT VQGTFGYLDPEYF+S QFTDKSDVYS
Sbjct: 479 KSTNILLDEKYRAKVADFGTSRSVSIDQTHVTTLVQGTFGYLDPEYFQSSQFTDKSDVYS 538
Query: 272 FGVVLVELLTGQKPIILTGSKE-ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTI 330
FGVVLVELLTGQK I T S+E LA YFI++ME N L+D LD QV+K G++EE++ +
Sbjct: 539 FGVVLVELLTGQKAISFTRSEEQGRSLATYFIMAMESNCLFDILDPQVVKQGEREEVLMV 598
Query: 331 ATLATRCLNLNGKRRPTMKEVAMELERI 358
A+LA CL LNGK RPTMKEV M LERI
Sbjct: 599 ASLARSCLRLNGKERPTMKEVTMVLERI 626
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1312), Expect = e-142, Method: Compositional matrix adjust.
Identities = 241/328 (73%), Positives = 290/328 (88%)
Query: 35 IIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQG 94
I +R +KLK+ FFKRNGGL+L+QQL+S++ +++ K+FT+KEL+KATD ++ NRILGQG
Sbjct: 350 IKRRRAMKLKQNFFKRNGGLLLEQQLSSTENYVEQTKVFTSKELEKATDDYHTNRILGQG 409
Query: 95 GQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154
GQGTVYKGML DGR+VA+KKSK+V E KL++FINEVVILSQINHRNVVKL+GCCLETEVP
Sbjct: 410 GQGTVYKGMLIDGRVVAIKKSKVVDEDKLDQFINEVVILSQINHRNVVKLIGCCLETEVP 469
Query: 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKST 214
LLVYEFI NGTL+QY+H+ NEEFP+TWEMRLRIATEVAG+L+YLH+AASMPIYHRDIKS+
Sbjct: 470 LLVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAGALAYLHAAASMPIYHRDIKSS 529
Query: 215 NILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGV 274
NILL+EKY AKVADFGTSK I IDQTHVTT+VQGTFGYLDPEYF+S QFT+KSDVYSFGV
Sbjct: 530 NILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYSFGV 589
Query: 275 VLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLA 334
VLVELLTGQKPI S E LA YF+++MEE+RL++ LD +VLK G +EEI+ +A LA
Sbjct: 590 VLVELLTGQKPISSYRSVEERSLATYFLMTMEESRLFEILDARVLKEGGREEIIAMAKLA 649
Query: 335 TRCLNLNGKRRPTMKEVAMELERIQALQ 362
+CLNLNGK+RP MK VA+ELE I++ Q
Sbjct: 650 EKCLNLNGKKRPKMKTVAIELEGIRSSQ 677
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1307), Expect = e-141, Method: Compositional matrix adjust.
Identities = 251/361 (69%), Positives = 299/361 (82%), Gaps = 8/361 (2%)
Query: 37 KREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQ 96
K+ DI++K++FFKRNGGL+LQQQ++S + ++ K+FT+ EL+KATD+FN NRILGQGGQ
Sbjct: 339 KQLDIRVKKRFFKRNGGLLLQQQISSDKIAFEKTKIFTSDELEKATDNFNKNRILGQGGQ 398
Query: 97 GTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156
GTVYKGML DGRIVAVKKSKIV E +LE FINE+VILSQINHRNVV +LGCCLETEVPLL
Sbjct: 399 GTVYKGMLNDGRIVAVKKSKIVDENQLEHFINEIVILSQINHRNVVGILGCCLETEVPLL 458
Query: 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216
VYEFISNGTLFQ +HDQN EFPL+WEMRLRIA EV+G+LSYLHSA S+PIYHRDIKSTNI
Sbjct: 459 VYEFISNGTLFQLIHDQNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRDIKSTNI 518
Query: 217 LLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVL 276
LL++KY AKV+DFGTS+ I IDQTH+TT VQGTFGYLDPEYF+S QFT+KSDVYSFGVVL
Sbjct: 519 LLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 578
Query: 277 VELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATR 336
VELLTGQKPI T S E LA +FILS++E+RL+D LD +V+K G+KE+IMT A LA R
Sbjct: 579 VELLTGQKPISSTRSPEEKSLATHFILSLQESRLFDILDARVVKEGRKEDIMTFAKLAGR 638
Query: 337 CLNLNGKRRPTMKEVAMELERIQALQKDINVKQ-------ICDEI-ESCDIVSTSTETST 388
CLNLNG++RPTMKEV E++ I+ +NV Q + EI E D+ TST +
Sbjct: 639 CLNLNGRKRPTMKEVTTEIDNIRVSALHLNVDQNFQENACVVTEITEFLDMDDTSTSRGS 698
Query: 389 C 389
C
Sbjct: 699 C 699
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 507 bits (1305), Expect = e-141, Method: Compositional matrix adjust.
Identities = 247/359 (68%), Positives = 302/359 (84%), Gaps = 9/359 (2%)
Query: 35 IIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQG 94
I +R KLK+KFFKRNGGL+L+QQL+S++ +++ K+FT+KEL+KATD+++ +RILGQG
Sbjct: 345 IKRRRATKLKQKFFKRNGGLLLEQQLSSTESHVEQTKVFTSKELEKATDNYHTSRILGQG 404
Query: 95 GQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154
GQGTVYKGML DGR+VA+KKSK+V E KL++FINEVVILSQINHRNVVKL GCCLETEVP
Sbjct: 405 GQGTVYKGMLTDGRVVAIKKSKLVDEDKLDQFINEVVILSQINHRNVVKLTGCCLETEVP 464
Query: 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKST 214
LLVYEFI NGTLFQY+ + N+EFP+TWEMRLRIATEVAG+L+YLHSAASMPIYHRDIKS+
Sbjct: 465 LLVYEFIPNGTLFQYIQNPNKEFPITWEMRLRIATEVAGALAYLHSAASMPIYHRDIKSS 524
Query: 215 NILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGV 274
NILL+EKY AKVADFGTSK I I+QTHVTT VQGTFGYLDPEYF+S QFT+KSDVYSFGV
Sbjct: 525 NILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEKSDVYSFGV 584
Query: 275 VLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLA 334
VLVELLTGQKPI S E LA YF+++MEENRL++ LD +VLK G +EEI+ +A +A
Sbjct: 585 VLVELLTGQKPISSLRSVEERSLATYFLMTMEENRLFEILDARVLKEGGREEIIAMAKMA 644
Query: 335 TRCLNLNGKRRPTMKEVAMELERIQALQK-DINVKQICDEIE--------SCDIVSTST 384
+CLNLNGK+RP MK VA+ELE I++ Q ++Q +E++ S D+ S+ST
Sbjct: 645 EKCLNLNGKKRPKMKTVAIELEGIRSSQGVSSTIQQDYEEVDYVVGDYTASWDVASSST 703
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734146|emb|CBI15393.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1302), Expect = e-140, Method: Compositional matrix adjust.
Identities = 251/361 (69%), Positives = 299/361 (82%), Gaps = 8/361 (2%)
Query: 37 KREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQ 96
K+ DI++K++FFKRNGGL+LQQQ++S + ++ K+FT+ EL+KATD+FN NRILGQGGQ
Sbjct: 219 KQLDIRVKKRFFKRNGGLLLQQQISSDKIAFEKTKIFTSDELEKATDNFNKNRILGQGGQ 278
Query: 97 GTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156
GTVYKGML DGRIVAVKKSKIV E +LE FINE+VILSQINHRNVV +LGCCLETEVPLL
Sbjct: 279 GTVYKGMLNDGRIVAVKKSKIVDENQLEHFINEIVILSQINHRNVVGILGCCLETEVPLL 338
Query: 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216
VYEFISNGTLFQ +HDQN EFPL+WEMRLRIA EV+G+LSYLHSA S+PIYHRDIKSTNI
Sbjct: 339 VYEFISNGTLFQLIHDQNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRDIKSTNI 398
Query: 217 LLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVL 276
LL++KY AKV+DFGTS+ I IDQTH+TT VQGTFGYLDPEYF+S QFT+KSDVYSFGVVL
Sbjct: 399 LLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 458
Query: 277 VELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATR 336
VELLTGQKPI T S E LA +FILS++E+RL+D LD +V+K G+KE+IMT A LA R
Sbjct: 459 VELLTGQKPISSTRSPEEKSLATHFILSLQESRLFDILDARVVKEGRKEDIMTFAKLAGR 518
Query: 337 CLNLNGKRRPTMKEVAMELERIQALQKDINVKQ-------ICDEI-ESCDIVSTSTETST 388
CLNLNG++RPTMKEV E++ I+ +NV Q + EI E D+ TST +
Sbjct: 519 CLNLNGRKRPTMKEVTTEIDNIRVSALHLNVDQNFQENACVVTEITEFLDMDDTSTSRGS 578
Query: 389 C 389
C
Sbjct: 579 C 579
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075946|ref|XP_002304841.1| predicted protein [Populus trichocarpa] gi|222842273|gb|EEE79820.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-140, Method: Compositional matrix adjust.
Identities = 261/395 (66%), Positives = 305/395 (77%), Gaps = 26/395 (6%)
Query: 1 IDECKDGTAN-CSENLLCENYEGGYRC------ITPKRKVYII----------------- 36
I+ECKD + C C N G Y+C I P V I
Sbjct: 286 INECKDPNRHSCLGITKCVNTLGSYKCEVNKYWIVPILVVVIAGILSLLAGISWLYKLAK 345
Query: 37 KREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQ 96
KR++I+LK KFFKRNGGL+LQQQL+S+ GS+ + K+FT+KEL+ ATD FN NRILGQGGQ
Sbjct: 346 KRKNIELKRKFFKRNGGLLLQQQLSSNHGSVQKTKIFTSKELETATDRFNENRILGQGGQ 405
Query: 97 GTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156
GTVYKGML DGRIVAVK+S IV E KLEEFINEVVILSQINHRNVVKL GCCLETEVPLL
Sbjct: 406 GTVYKGMLEDGRIVAVKRSTIVGEEKLEEFINEVVILSQINHRNVVKLFGCCLETEVPLL 465
Query: 157 VYEFISNGTLFQYLHD--QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKST 214
VYEFISNG LFQYLH+ QNE+F L+WEMRL+IA EVAG+LSYLHSAAS+PIYHRDIKS
Sbjct: 466 VYEFISNGNLFQYLHNFYQNEDFILSWEMRLQIAIEVAGALSYLHSAASIPIYHRDIKSA 525
Query: 215 NILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGV 274
NILL++KY AKV+DFG+S+ + IDQTH+TT VQGTFGYLDPEYF+S QFTDKSDVYSFGV
Sbjct: 526 NILLDDKYRAKVSDFGSSRSMAIDQTHLTTNVQGTFGYLDPEYFQSSQFTDKSDVYSFGV 585
Query: 275 VLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLA 334
VLVELL+G+KPII + S+E LA +FI+ MEENRL+D LD QV + +EEIM +A LA
Sbjct: 586 VLVELLSGKKPIISSTSQETRSLATHFIVLMEENRLFDILDVQVKEDCLEEEIMAVANLA 645
Query: 335 TRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQ 369
RCLN++ K RPTMKEV+ ELERI L + V+Q
Sbjct: 646 KRCLNVSRKHRPTMKEVSAELERIGLLHRKSIVQQ 680
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 400 | ||||||
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.892 | 0.454 | 0.594 | 1.3e-122 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.835 | 0.457 | 0.631 | 4e-121 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.9 | 0.479 | 0.580 | 3.2e-119 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.842 | 0.427 | 0.627 | 1.8e-118 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.86 | 0.433 | 0.593 | 2.2e-118 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.855 | 0.444 | 0.606 | 1.2e-117 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.855 | 0.431 | 0.618 | 2e-117 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.885 | 0.463 | 0.6 | 2.6e-115 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.86 | 0.459 | 0.602 | 9.4e-114 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.817 | 0.454 | 0.617 | 1.6e-113 |
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1123 (400.4 bits), Expect = 1.3e-122, Sum P(2) = 1.3e-122
Identities = 214/360 (59%), Positives = 280/360 (77%)
Query: 31 RKVYIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRI 90
RK +++KR K K+KFFKRNGGL+LQQ+L + G +++ ++FT+KEL+KAT++F+ NR+
Sbjct: 391 RK-FLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRV 449
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE 150
LG GGQGTVYKGML DGR VAVKKSK++ E KL+EFINEVVILSQINHR+VVKLLGCCLE
Sbjct: 450 LGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLE 509
Query: 151 TEVPLLVYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHR 209
TEVP+LVYEFI NG LF+++H++ +++ + W MRLRIA ++AG+LSYLHSAAS PIYHR
Sbjct: 510 TEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHR 569
Query: 210 DIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDV 269
DIKSTNILL+EKY AKVADFGTS+ + IDQTH TT + GT GY+DPEY+RS Q+T+KSDV
Sbjct: 570 DIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDV 629
Query: 270 YSFGVVLVELLTGQKPIILT-GSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIM 328
YSFGV+L EL+TG KP+I+ ++E LA +F ++M+E RL D +D ++ + E++M
Sbjct: 630 YSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVM 689
Query: 329 TIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIESCDIVSTSTETST 388
+A LA +CL+ G+ RP M+EV ELERI +D V+ DE E D V E T
Sbjct: 690 AVANLAMKCLSSRGRNRPNMREVFTELERICTSPEDSQVQNRIDEEEEEDGVEEEEEVVT 749
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 4.0e-121, Sum P(2) = 4.0e-121
Identities = 211/334 (63%), Positives = 281/334 (84%)
Query: 35 IIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQG 94
I KR +I +KFFKRNGGL+L+QQLT+ DG+++ K+F++KEL KATD+F+++R+LGQG
Sbjct: 379 IKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQG 438
Query: 95 GQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154
GQGTVYKGML DG IVAVK+SK+V E K+EEFINE+V+LSQINHRN+VKLLGCCLETEVP
Sbjct: 439 GQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVP 498
Query: 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKST 214
+LVYE+I NG LF+ LHD+++++ +TWE+RLRIA E+AG+L+Y+HSAAS PI+HRDIK+T
Sbjct: 499 ILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTT 558
Query: 215 NILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGV 274
NILL+EKY AKV+DFGTS+ + +DQTH+TT V GTFGY+DPEYF S Q+T KSDVYSFGV
Sbjct: 559 NILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGV 618
Query: 275 VLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLA 334
VLVEL+TG+KP+ S+E GLA +F+ +M+ENR+ D +D ++ + E++M +A LA
Sbjct: 619 VLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAKLA 678
Query: 335 TRCLNLNGKRRPTMKEVAMELERIQALQKDINVK 368
+CLN GK RP MKEV+ ELERI++ +D++V+
Sbjct: 679 RKCLNRKGKNRPNMKEVSNELERIRSSPEDLDVR 712
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1130 (402.8 bits), Expect = 3.2e-119, Sum P(2) = 3.2e-119
Identities = 209/360 (58%), Positives = 287/360 (79%)
Query: 34 YIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQ 93
++ KR I K FFKRNGGL+L+QQLT+ G++ K+F++KEL+KATD+FN+NR+LGQ
Sbjct: 370 FVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQ 429
Query: 94 GGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153
GGQGTVYKGML DGRIVAVK+SK++ E K+EEFINEV +LSQINHRN+VKL+GCCLETEV
Sbjct: 430 GGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEV 489
Query: 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKS 213
P+LVYE I NG LF+ LH ++++ +TW++RLRI+ E+AG+L+YLHSAAS P+YHRD+K+
Sbjct: 490 PILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKT 549
Query: 214 TNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFG 273
TNILL+EKY AKV+DFGTS+ I +DQTH+TT V GTFGYLDPEYF++ QFTDKSDVYSFG
Sbjct: 550 TNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFG 609
Query: 274 VVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATL 333
VVLVEL+TG+KP + +E GL ++F +M++NR+ D +D ++ + E+++ +A L
Sbjct: 610 VVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKL 669
Query: 334 ATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIESCDIVSTSTETSTCDSIA 393
A RCL+L GK+RP M+EV++ELERI++ +D+ + ++ E C + ++ + D A
Sbjct: 670 ARRCLSLKGKKRPNMREVSVELERIRSSPEDLELHIEEEDEEECAMEINMDDSWSVDMTA 729
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1132 (403.5 bits), Expect = 1.8e-118, Sum P(2) = 1.8e-118
Identities = 214/341 (62%), Positives = 281/341 (82%)
Query: 31 RKVYIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRI 90
RK ++ KR K K KFFKRNGGL+LQQQL ++ G++++ ++F+++EL+KATD+F+ +RI
Sbjct: 398 RK-FLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRI 456
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE 150
LGQGGQGTVYKGML DGR VAVKKSK+V E KLEEFINEVVILSQINHR+VVKLLGCCLE
Sbjct: 457 LGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLE 516
Query: 151 TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRD 210
TEVP LVYEFI NG LFQ++H++++++ TW MRLRIA ++AG+LSYLHSAAS PIYHRD
Sbjct: 517 TEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRD 576
Query: 211 IKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVY 270
IKSTNILL+EKY KV+DFGTS+ + ID TH TT + GT GY+DPEY+ S Q+TDKSDVY
Sbjct: 577 IKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVY 636
Query: 271 SFGVVLVELLTGQKPII-LTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMT 329
SFGVVLVEL+TG+KP+I ++ S+E GLA +F ++M+ENR ++ +D ++ + E++M
Sbjct: 637 SFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMA 696
Query: 330 IATLATRCLNLNGKRRPTMKEVAMELERIQALQKD--INVK 368
+A LA RCLN GK+RP M++V +LE+I A Q+D +N++
Sbjct: 697 VANLARRCLNSKGKKRPCMRKVFTDLEKILASQEDSLVNIE 737
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 2.2e-118, Sum P(2) = 2.2e-118
Identities = 206/347 (59%), Positives = 276/347 (79%)
Query: 31 RKVYIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRI 90
RK ++IKR K K+KFFKRNGGL+L Q+L + +G +++ ++F ++EL+KAT++F+ NR+
Sbjct: 400 RK-FLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEKTRVFNSRELEKATENFSENRV 458
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE 150
LG GGQGTVYKGML DGR VAVKKSK++ E KL+EFINEVVILSQINHR+VVKLLGCCLE
Sbjct: 459 LGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLE 518
Query: 151 TEVPLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHR 209
TEVP+LVYEFI NG LF+++H++ ++++ + W MRLRIA ++AG+LSYLHS+AS PIYHR
Sbjct: 519 TEVPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIAVDIAGALSYLHSSASSPIYHR 578
Query: 210 DIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDV 269
DIKSTNILL+EKY AKVADFGTS+ + IDQTH TT + GT GY+DPEY++S Q+T+KSDV
Sbjct: 579 DIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQYTEKSDV 638
Query: 270 YSFGVVLVELLTGQKPIILT-GSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIM 328
YSFGV+L EL+TG KP+I+ ++E LA +F ++M+E RL D +D ++ + E++M
Sbjct: 639 YSFGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEKRLTDIIDARIRNDCKPEQVM 698
Query: 329 TIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIE 375
+A +A +CL+ GK+RP M+EV ELERI +D V DE E
Sbjct: 699 AVAKVAMKCLSSKGKKRPNMREVFTELERICTSPEDSQVHNRIDEEE 745
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1133 (403.9 bits), Expect = 1.2e-117, Sum P(2) = 1.2e-117
Identities = 208/343 (60%), Positives = 281/343 (81%)
Query: 34 YIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQ 93
+I ++ + K+KFFKRNGGL+LQQQLT+++G++D ++F ++EL+KAT++F++ RILG+
Sbjct: 382 FIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILGE 441
Query: 94 GGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153
GGQGTVYKGML DGRIVAVKKSK+V E KLEEFINEVVILSQINHRN+VKLLGCCLET+V
Sbjct: 442 GGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDV 501
Query: 154 PLLVYEFISNGTLFQYLHDQNEEFPLT-WEMRLRIATEVAGSLSYLHSAASMPIYHRDIK 212
P+LVYEFI NG LF++LHD ++++ +T WE+RLRIA ++AG+LSYLHSAAS PIYHRDIK
Sbjct: 502 PILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIK 561
Query: 213 STNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSF 272
STNI+L+EK+ AKV+DFGTS+ + +D TH+TT V GT GY+DPEYF+S QFTDKSDVYSF
Sbjct: 562 STNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSF 621
Query: 273 GVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT 332
GVVL EL+TG+K + S+E LA YF L+M+ENRL D +D ++ + ++ A
Sbjct: 622 GVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKLNQVTAAAK 681
Query: 333 LATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIE 375
+A +CLN+ G++RP+M++V+MELE+I++ +D+ + E E
Sbjct: 682 IARKCLNMKGRKRPSMRQVSMELEKIRSYSEDMQPYEYASENE 724
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1121 (399.7 bits), Expect = 2.0e-117, Sum P(2) = 2.0e-117
Identities = 212/343 (61%), Positives = 277/343 (80%)
Query: 34 YIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQ 93
+I K+ + K+KFFKRNGGL+LQQQL S+ G +++ +F+++EL+KAT++F+ NRILGQ
Sbjct: 396 FIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKATENFSSNRILGQ 455
Query: 94 GGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153
GGQGTVYKGML DGRIVAVKKSK+V E KLEEFINEVVILSQINHRN+VKLLGCCLET+V
Sbjct: 456 GGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETKV 515
Query: 154 PLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIK 212
P+LVYEFI NG LF++LHD+ +E TW +RLRIA ++AG+LSYLHS+AS PIYHRD+K
Sbjct: 516 PVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVK 575
Query: 213 STNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSF 272
STNI+L+EKY AKV+DFGTS+ + +D TH+TT V GT GY+DPEYF+S QFTDKSDVYSF
Sbjct: 576 STNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSF 635
Query: 273 GVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT 332
GVVLVEL+TG+K I S+E LA YFIL+M+EN+L+D +D ++ ++ A
Sbjct: 636 GVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDGCMLSQVTATAK 695
Query: 333 LATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIE 375
+A +CLNL G++RP+M+EV+MEL+ I+ D+ +++ E E
Sbjct: 696 VARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQECVSENE 738
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 2.6e-115, Sum P(2) = 2.6e-115
Identities = 216/360 (60%), Positives = 282/360 (78%)
Query: 31 RKVYIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRI 90
RK+ + KR K KFFKRNGGL+LQQQL ++ G +++ KLF+++EL+KATD+FN NR+
Sbjct: 401 RKL-LRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRV 459
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE 150
+GQGGQGTVYKGML DGR VAVKKS +V E KL+EFINEV+ILSQINHR+VVKLLGCCLE
Sbjct: 460 IGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLE 519
Query: 151 TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRD 210
TEVP+LVYEFI NG LFQ+LH++ +++ W +R+RIA +++G+ SYLH+AA PIYHRD
Sbjct: 520 TEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRD 579
Query: 211 IKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVY 270
IKSTNILL+EKY AKV+DFGTS+ + ID TH TT + GT GY+DPEY+ S FT+KSDVY
Sbjct: 580 IKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVY 639
Query: 271 SFGVVLVELLTGQKPII-LTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMT 329
SFGVVLVEL+TG+KP+I L+ ++E TGLA YF L+M ENRL++ +D ++ + E+++
Sbjct: 640 SFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQVIA 699
Query: 330 IATLATRCLNLNGKRRPTMKEVAMELERIQALQKDINVK-QICDEIESCDIV---STSTE 385
+A LA RCL GK RP M+EV+ LERI + +D V+ QI +E E+ + S STE
Sbjct: 700 VANLALRCLKKTGKTRPDMREVSTALERICSAPEDFQVQIQIDEEDETTKLFRGYSGSTE 759
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1122 (400.0 bits), Expect = 9.4e-114, P = 9.4e-114
Identities = 208/345 (60%), Positives = 280/345 (81%)
Query: 34 YIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQ 93
++ KR + KFF+RNGG++L+QQL +G+++ ++F++ EL+KATD+FN NR+LGQ
Sbjct: 365 FVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQ 424
Query: 94 GGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153
GGQGTVYKGML DGRIVAVK+SK V E ++EEFINEVV+L+QINHRN+VKLLGCCLETEV
Sbjct: 425 GGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEV 484
Query: 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKS 213
P+LVYEF+ NG L + LHD+++++ +TWE+RL IA E+AG+LSYLHSAAS PIYHRDIK+
Sbjct: 485 PVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKT 544
Query: 214 TNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFG 273
TNILL+E+ AKV+DFGTS+ + IDQTH+TT+V GTFGY+DPEYF+S +FT+KSDVYSFG
Sbjct: 545 TNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFG 604
Query: 274 VVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATL 333
VVLVELLTG+KP S+E GLAA+F+ +++ENR+ D +DD++ +++M++A L
Sbjct: 605 VVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANL 664
Query: 334 ATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIESCD 378
A RCLN GK+RP M+EV++ELE I++ D + I D+ E D
Sbjct: 665 ARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGI-HIEDDDEEDD 708
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 1.6e-113, Sum P(2) = 1.6e-113
Identities = 202/327 (61%), Positives = 264/327 (80%)
Query: 37 KREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQ 96
KR+ K K KFF+RNGGL+LQQQ + GS++R K+F++ +L+ ATD FN +RILGQGGQ
Sbjct: 342 KRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQGGQ 401
Query: 97 GTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156
GTVYKGML DG IVAVKKSK + E LEEFINE+++LSQINHRNVVK+LGCCLETEVP+L
Sbjct: 402 GTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPIL 461
Query: 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216
VYEFI N LF +LH+ +E+FP++WE+RL IA EVA +LSYLHSA S+PIYHRD+KSTNI
Sbjct: 462 VYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNI 521
Query: 217 LLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVL 276
LL+EK+ AKV+DFG S+ + ID TH+TT VQGT GY+DPEY +S FT KSDVYSFGV+L
Sbjct: 522 LLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLL 581
Query: 277 VELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATR 336
+ELLTG+KP+ L +E L AYF+ +M +RL++ LD ++ + +EE++ +A LA R
Sbjct: 582 IELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAKLARR 641
Query: 337 CLNLNGKRRPTMKEVAMELERIQALQK 363
CL+LN + RPTM++V +EL+R+Q+ +K
Sbjct: 642 CLSLNSEHRPTMRDVFIELDRMQSKRK 668
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00005799001 | SubName- Full=Chromosome chr3 scaffold_158, whole genome shotgun sequence; (970 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 400 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-32 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-32 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-29 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-28 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-27 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-26 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-23 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-21 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-17 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| pfam07645 | 42 | pfam07645, EGF_CA, Calcium-binding EGF domain | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 9e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-04 | |
| smart00179 | 39 | smart00179, EGF_CA, Calcium-binding EGF-like domai | 5e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-04 | |
| cd00054 | 38 | cd00054, EGF_CA, Calcium-binding EGF-like domain, | 0.002 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 0.002 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 8e-55
Identities = 90/271 (33%), Positives = 132/271 (48%), Gaps = 21/271 (7%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHE--GKLEEFINEVVILSQINHRNV 141
+ + R LG G GTVYK G+IVAVK K E K + E+ IL +++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
V+L+ + + LV E+ G LF YL PL+ + +IA ++ L YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHS- 116
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
I HRD+K NILL+E K+ADFG +K ++ + +TT V GT Y+ PE G
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 262 Q-FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320
+ K DV+S GV+L ELLTG+ P +G L + + +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP--FSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ L +CLN + +RPT +E+
Sbjct: 232 EAKD--------LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-54
Identities = 85/276 (30%), Positives = 131/276 (47%), Gaps = 37/276 (13%)
Query: 88 NRILGQGGQGTVYKGML----ADGRI-VAVKKSKIVHEGK-LEEFINEVVILSQINHRNV 141
+ LG+G G VYKG L + VAVK K + +EEF+ E I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
VKLLG C E E ++V E++ G L YL N L+ L A ++A + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
S HRD+ + N L+ E K++DFG S+ + D + + ++ PE + G
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 262 QFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320
+FT KSDV+SFGV+L E+ T G++P Y +S E + + LK
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP--------------YPGMSNAE--VL-----EYLK 218
Query: 321 VGQKEEIMT-----IATLATRCLNLNGKRRPTMKEV 351
G + + L +C + + RPT E+
Sbjct: 219 KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 8e-53
Identities = 85/276 (30%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 88 NRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVHEGK-LEEFINEVVILSQINHRNV 141
+ LG+G G VYKG L VAVK K + +EEF+ E I+ +++H NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
VKLLG C E E +V E++ G L YL + L+ L A ++A + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE-- 119
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
S HRD+ + N L+ E K++DFG S+ + D + + ++ PE + G
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 262 QFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320
+FT KSDV+SFGV+L E+ T G++P Y +S EE + ++L +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQP--------------YPGMSNEE--VLEYLKN---- 218
Query: 321 VGQKEEIM-----TIATLATRCLNLNGKRRPTMKEV 351
G + + L +C + + RPT E+
Sbjct: 219 -GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 3e-52
Identities = 73/193 (37%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVILSQINHRNVVKLLGCC 148
LG+GG GTVY G+ VA+K K LEE + E+ IL ++NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
+ LV E+ G+L L + E L+ + LRI ++ L YLH S I H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 209 RDIKSTNILLNEK-YTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDK 266
RD+K NILL+ K+ADFG SK + + + GT Y+ PE G +++K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLL-TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 267 SDVYSFGVVLVEL 279
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 3e-51
Identities = 88/283 (31%), Positives = 136/283 (48%), Gaps = 43/283 (15%)
Query: 88 NRILGQGGQGTVYKGML-----ADGRIVAVKKSK-IVHEGKLEEFINEVVILSQINHRNV 141
+ LG+G G VYKG L VAVK K E + EEF+ E I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
V+LLG C + E +V E++ G L +L E LT + L++A ++A + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE--KLTLKDLLQMALQIAKGMEYLE-- 119
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFG---YLDPEYF 258
S HRD+ + N L+ E K++DFG S+ I D + G ++ PE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESL 176
Query: 259 RSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317
+ G+FT KSDV+SFGV+L E+ T G++P Y +S EE + + L+D
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP--------------YPGMSNEE--VLELLED- 219
Query: 318 VLKVGQKEEI-----MTIATLATRCLNLNGKRRPTMKEVAMEL 355
G + + L +C + + RPT E+ +L
Sbjct: 220 ----GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 1e-50
Identities = 92/285 (32%), Positives = 131/285 (45%), Gaps = 40/285 (14%)
Query: 89 RILGQGGQGTVYKGMLADG----RIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVK 143
+ LG+G G VYKG L VAVK K E + ++F+ E ++ ++ H NVV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFP------LTWEMRLRIATEVAGSLSY 197
LLG C E E LV E++ G L YL FP L+ + L A ++A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GYLDP 255
L S HRD+ + N L+ E K++DFG S+ + D + G ++ P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRWMAP 176
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314
E + G FT KSDV+SFGV+L E+ T G P Y LS EE + ++L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--------------YPGLSNEE--VLEYL 220
Query: 315 -DDQVLKVGQKEEIMT--IATLATRCLNLNGKRRPTMKEVAMELE 356
L K E + L C L+ + RPT E+ LE
Sbjct: 221 RKGYRLP---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-48
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVILSQINHRNVV 142
+ + LG+G G VY G++VA+K K + E + E+ IL ++ H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+L + + LV E+ G LF L + L+ + ++ +L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLH--- 114
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
S I HRD+K NILL+E K+ADFG ++ +D T GT Y+ PE
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEVLLGKG 172
Query: 263 FTDKSDVYSFGVVLVELLTGQKP 285
+ D++S GV+L ELLTG+ P
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-43
Identities = 84/285 (29%), Positives = 133/285 (46%), Gaps = 54/285 (18%)
Query: 89 RILGQGGQGTVYKGMLAD-GRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLL 145
+LG+G G+VY + D G ++AVK ++ E +LE E+ ILS + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 146 GCCL-ETEVPLLVY-EFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLHSAA 202
G E + L ++ E++S G+L L + + P E +R ++ L+YLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLP---EPVIRKYTRQILEGLAYLHSNG 121
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTTKVQGTFGYLDPEYFRSG 261
I HRDIK NIL++ K+ADFG +K + I+ T V+GT ++ PE R
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 262 QFTDKSDVYSFGVVLVELLTGQKP---------IIL--TGSKEATGLAAYFILSMEENRL 310
++ +D++S G ++E+ TG+ P + S E + + LS E
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH--LSEE---A 233
Query: 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355
DFL +CL + K+RPT A EL
Sbjct: 234 KDFLR--------------------KCLRRDPKKRPT----ADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-40
Identities = 69/199 (34%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
+G+GG G VYK G+ VA+K K+ + K E+ INE+ IL + H N+VK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 150 ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT---EVAGSLSYLHSAASMPI 206
+ + +V EF S G+L L N+ + IA E+ L YLH S I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLH---SNGI 119
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
HRDIK+ NILL K+ DFG S + T + GT ++ PE + K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQ--LSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 267 SDVYSFGVVLVELLTGQKP 285
+D++S G+ +EL G+ P
Sbjct: 178 ADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 80/272 (29%), Positives = 127/272 (46%), Gaps = 34/272 (12%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLL 145
+ +G+G G VY +DG++ +K+ + + E + E+ +NEV IL ++NH N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNEEF-PLTWEMRLRIATEVAGSLSYLHSAASM 204
E +V E+ G L Q + Q +E P E L ++ +L YLHS
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---R 122
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT 264
I HRDIK NI L K+ DFG SK ++ + V GT YL PE ++ +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYYLSPELCQNKPYN 181
Query: 265 DKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQK 324
KSD++S G VL EL T + P E ++ E L ++LK GQ
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPF------EGE--------NLLE------LALKILK-GQY 220
Query: 325 EEIMT-----IATLATRCLNLNGKRRPTMKEV 351
I + + L + L + + RP++ ++
Sbjct: 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 1e-33
Identities = 79/280 (28%), Positives = 119/280 (42%), Gaps = 22/280 (7%)
Query: 84 HFNVNRILGQGGQGTVYKGMLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH-R 139
+ + R LG+G G VY D ++VA+K K ++E F+ E+ IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
N+VKL + LV E++ G+L L + PL+ L I ++ +L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 200 SAASMPIYHRDIKSTNILLNEKYT-AKVADFGTSKFIVIDQTHV-----TTKVQGTFGYL 253
S I HRDIK NILL+ K+ DFG +K + + + GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 254 DPEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310
PE + SD++S G+ L ELLTG P + AT IL
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL----ELP 231
Query: 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKE 350
L + + + L + L + K R +
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 71/223 (31%), Positives = 107/223 (47%), Gaps = 35/223 (15%)
Query: 89 RILGQGGQGTVYKGMLA------DGRIVAVKKSKIVHEGKLEE-FINEVVILSQINHRNV 141
R LG+G G V+ G D +VAVK K + F E +L+ H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYL--HD---------QNEEFPLTWEMRLRIATE 190
VK G C E + P++V+E++ +G L ++L H + LT L+IA +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT---KVQ 247
+A + YL AS HRD+ + N L+ K+ DFG S+ + TT +V
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVG 181
Query: 248 GT----FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
G ++ PE +FT +SDV+SFGVVL E+ T G++P
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 12/206 (5%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRN 140
++ + ++G+G G VYKG+ L G VA+K+ + + E L+ + E+ +L + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLH 199
+VK +G ++ ++ E+ NG+L Q + + FP E + + +V L+YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFP---ESLVAVYVYQVLQGLAYLH 116
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
+ HRDIK+ NIL + K+ADFG + + D + V GT ++ PE
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKP 285
+ SD++S G ++ELLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 60/196 (30%), Positives = 107/196 (54%), Gaps = 10/196 (5%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLGCC 148
LG G G V+ G VA+K ++ EG + ++FI E ++ +++H N+V+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
+ +V E+++NG L YL ++ + E L + ++V ++ YL S + H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEAMEYLESNGFI---H 123
Query: 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSD 268
RD+ + N L+ E KV+DFG +++++ DQ + + + PE F +F+ KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 269 VYSFGVVLVELLTGQK 284
V+SFGV++ E+ + K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 87/298 (29%), Positives = 136/298 (45%), Gaps = 50/298 (16%)
Query: 85 FNVNRILGQGGQGTVYKGMLA--DGRI--VAVK--KSKIVHEGKLEEFINEVVILSQINH 138
+ +ILG+G G+V +G L+ DG VAVK K I ++EEF++E + +H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 139 RNVVKLLGCCLETE------VPLLVYEFISNGTLFQYL-----HDQNEEFPLTWEMRLRI 187
NV+KL+G C E P+++ F+ +G L +L E+ PL + L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKF 118
Query: 188 ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID----QTHVT 243
++A + YL ++ HRD+ + N +L E T VADFG SK I Q +
Sbjct: 119 MVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFI 302
+ ++ E +T KSDV++FGV + E+ T GQ P + E
Sbjct: 176 ---KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------- 223
Query: 303 LSMEENRLYDFL-DDQVLKVGQKEEIMT-IATLATRCLNLNGKRRPTMKEVAMELERI 358
+YD+L LK Q E+ + + L C + K RPT ++ LE I
Sbjct: 224 -------IYDYLRHGNRLK--QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 72/284 (25%), Positives = 128/284 (45%), Gaps = 44/284 (15%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
+ + +G+G G VYK A G+ VA+KK ++ + E INE++I+ H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPN 76
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+V L + +V E++ G+L + QN + + EV L YLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS 134
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
+ HRDIKS NILL++ + K+ADFG + + +++ + V GT ++ PE +
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM-------EENR---- 309
+ K D++S G++ +E+ G+ P + L A F+++ +
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYL-----REPPLRALFLITTKGIPPLKNPEKWSPE 245
Query: 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAM 353
DFL+ +CL + ++RP+ +E+
Sbjct: 246 FKDFLN--------------------KCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 63/202 (31%), Positives = 108/202 (53%), Gaps = 6/202 (2%)
Query: 85 FNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKL 144
F + R LG G G V++G+ + VA+K K K ++F EV L ++ H++++ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASM 204
C E ++ E + G+L +L E L + +A +VA ++YL S+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSI 126
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT 264
HRD+ + NIL+ E KVADFG ++ ++ + ++++ + + + PE G F+
Sbjct: 127 ---HRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 265 DKSDVYSFGVVLVELLT-GQKP 285
KSDV+SFG++L E+ T GQ P
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 76/265 (28%), Positives = 124/265 (46%), Gaps = 24/265 (9%)
Query: 85 FNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLE--EFINEVVILSQINHRNV 141
F + +G+G G V+K + AD R+ A+K+ + + E E I+E +L++++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
++ L+ +V E+ NG L + L Q PL + R ++ L++LHS
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSK 120
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
I HRDIKS N+ L+ K+ D G +K ++ D T+ + GT YL PE
Sbjct: 121 K---ILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 262 QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321
+ +KSDV++ GVVL E TG+ P +A A IL + V
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPF------DANNQGA-LILKIIRGVFP--------PV 221
Query: 322 GQKEEIMTIATLATRCLNLNGKRRP 346
Q +A L +CL + ++RP
Sbjct: 222 SQMYS-QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 66/198 (33%), Positives = 111/198 (56%), Gaps = 11/198 (5%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLGCC 148
+G G G V+ G + R VA+K + EG + E+FI E ++ +++H +V+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT---IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
E LV+EF+ +G L YL Q +F + E L + +V ++YL S+ + H
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSD 268
RD+ + N L+ E KV+DFG ++F++ DQ +T + + PE F +++ KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 269 VYSFGVVLVELLT-GQKP 285
V+SFGV++ E+ + G+ P
Sbjct: 184 VWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 75/283 (26%), Positives = 116/283 (40%), Gaps = 46/283 (16%)
Query: 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFI-NEVVILSQINHRN 140
++LGQG G VYK G+I A+KK + + + + + E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL-RIATEVAGSLSYLH 199
VVK G + +V E++ G+L L + + P E L IA ++ L YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIP---EPVLAYIARQILKGLDYLH 116
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI----VIDQTHVTTKVQGTFGYLDP 255
+ I HRDIK +N+L+N K K+ADFG SK + T V GT Y+ P
Sbjct: 117 TKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSP 169
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF----ILSMEENR-- 309
E + ++ +D++S G+ L+E G+ P + G L S+
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFS 229
Query: 310 --LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKE 350
DF+ CL + K+RP+ E
Sbjct: 230 PEFRDFIS--------------------ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-30
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG--KLEEFINEVVILSQINHRNVVKLL 145
R LG G G V+ G VAVK K G E F+ E I+ ++ H +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
C E E +V E++S G+L +L E L + +A ++A ++YL S
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYLES---RN 123
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GYLDPEYFRSGQF 263
HRD+ + NIL+ E K+ADFG ++ +I+ T + F + PE G+F
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 264 TDKSDVYSFGVVLVELLT-GQKP 285
T KSDV+SFG++L E++T G+ P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE 150
+G+G G V G G+ VAVK K + F+ E +++ + H N+V+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 151 TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRD 210
+V E+++ G+L YL + +T +L A +V + YL HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127
Query: 211 IKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVY 270
+ + N+L++E AKV+DFG +K Q V+ T PE R +F+ KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 271 SFGVVLVELLT-GQKPIILTGSKEATGLAAYFI--LSMEENRLYDFLDDQVLKVGQKEEI 327
SFG++L E+ + G+ P K+ + + ME + +V KV +
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKGYRMEAP---EGCPPEVYKVMKD--- 234
Query: 328 MTIATLATRCLNLNGKRRPTMKEVAMELERI 358
C L+ +RPT K++ +L I
Sbjct: 235 ---------CWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 9e-30
Identities = 71/200 (35%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNVVKLLG 146
LG+G G V G++ A+K K KI+ ++E + E ILS+INH +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 147 CCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
+TE L LV E+ G LF +L ++E + E A E+ +L YLHS +
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYLHS---LG 113
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTD 265
I +RD+K NILL+ K+ DFG +K + + T GT YL PE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 266 KSDVYSFGVVLVELLTGQKP 285
D +S GV+L E+LTG+ P
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-30
Identities = 71/206 (34%), Positives = 114/206 (55%), Gaps = 22/206 (10%)
Query: 89 RILGQGGQGTVYKGMLADG----RIVAVKK-SKIVHEGKLEEFINEVVILSQINHRNVVK 143
R++G+G G VY G L D AVK ++I ++E+F+ E +I+ +H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 144 LLGCCLETE-VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
LLG CL +E PL+V ++ +G L ++ ++E T + + +VA + YL A
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI-------VIDQTHVTTKVQGTFGYLDP 255
S HRD+ + N +L+E +T KVADFG ++ I V + T V+ ++
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMAL 171
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLT 281
E ++ +FT KSDV+SFGV+L EL+T
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 61/210 (29%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 87 VNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIVHEGKLE-EFINEVVILSQINHRNV 141
+ +++G G G V +G L VA+K K K +F+ E I+ Q +H N+
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
++L G ++ +++ E++ NG+L ++L + + +F T + + +A + YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYL--- 122
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK-----VQGTFGYLDPE 256
+ M HRD+ + NIL+N KV+DFG S+ + + TTK ++ T PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
+FT SDV+SFG+V+ E+++ G++P
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 76/268 (28%), Positives = 128/268 (47%), Gaps = 23/268 (8%)
Query: 91 LGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
LG G G VY+G+ VAVK K ++EEF+ E ++ +I H N+V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 150 ETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
E P ++ EF++ G L YL + N + + + L +AT+++ ++ YL + H
Sbjct: 73 R-EPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---H 127
Query: 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSD 268
RD+ + N L+ E + KVADFG S+ + D + + PE +F+ KSD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 269 VYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIM 328
V++FGV+L E+ T G++ Y ++ +++Y+ L+ +
Sbjct: 188 VWAFGVLLWEIAT-------------YGMSPY--PGIDLSQVYELLEKGYRMERPEGCPP 232
Query: 329 TIATLATRCLNLNGKRRPTMKEVAMELE 356
+ L C N RP+ E+ E
Sbjct: 233 KVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVK---KSKIVHEGKLEEFINEVVILSQIN- 137
D F +I+G+G TV + A+K K +++ E K++ E +L+++N
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLS 196
H ++KL + E V E+ NG L QY+ + + T R A E+ +L
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT---RF-YAAEILLALE 116
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ--------- 247
YLHS I HRD+K NILL++ K+ DFGT+K + + + + K
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 248 ----------GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
GT Y+ PE SD+++ G ++ ++LTG+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 85/296 (28%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 89 RILGQGGQGTVYKGMLAD------GRIVAVKKSKIVHE----GKLEEFINEVVILSQINH 138
R LGQG G VY+G+ VA+K V+E + EF+NE ++ + N
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIK---TVNENASMRERIEFLNEASVMKEFNC 68
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYL--HDQNEEF-----PLTWEMRLRIATEV 191
+VV+LLG + L+V E ++ G L YL E P T + +++A E+
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTTKVQGTF 250
A ++YL A+ HRD+ + N ++ E T K+ DFG ++ I D K
Sbjct: 129 ADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 251 GYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENR 309
++ PE + G FT KSDV+SFGVVL E+ T ++P GL+
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ--------GLS----------- 226
Query: 310 LYDFLDDQVLKVGQKEEIMT--------IATLATRCLNLNGKRRPTMKEVAMELER 357
+++VLK + + L C N K RPT E+ L+
Sbjct: 227 -----NEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 83/294 (28%), Positives = 135/294 (45%), Gaps = 55/294 (18%)
Query: 91 LGQGGQGTVYKGML------ADGRIVAVKKSKIVHEGKL-EEFINEVVILSQINHRNVVK 143
LG+G G VYKG L VA+K K E K+ +EF E ++S + H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYL-------------HDQNEEFPLTWEMRLRIATE 190
LLG C + + +++E++++G L ++L D+ + L L IA +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTTKVQGT 249
+A + YL +S HRD+ + N L+ E T K++DFG S+ I D V +K
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309
++ PE G+FT +SD++SFGVVL E+ + GL Y+ S +E
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS-------------YGLQPYYGFSNQE-- 234
Query: 310 LYDFLDDQVLKVGQKEEIM--------TIATLATRCLNLNGKRRPTMKEVAMEL 355
V+++ + +++ + L C N RRP K++ L
Sbjct: 235 --------VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 86/325 (26%), Positives = 138/325 (42%), Gaps = 75/325 (23%)
Query: 79 DKATDHFNVNRILGQGGQGTVY----------------KGMLADG-RIVAVKKSKI-VHE 120
+ N LG+G G V+ + AD +VAVK + +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 121 GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLH--------D 172
E+F+ EV ILS+++ N+ +LLG C ++ E++ NG L Q+L
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 173 QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232
L++ L +AT++A + YL S+ HRD+ + N L+ + YT K+ADFG S
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 233 KFIVIDQTHVTTKVQGT----FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIIL 288
+ + + +VQG ++ E G+FT KSDV++FGV L E IL
Sbjct: 178 RNLY---SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE--------IL 226
Query: 289 TGSKEATGLAAYFILSMEENRLYDFL-DDQVLK------VGQKEEIM---------TIAT 332
T +E + Y+ L D QV++ +I I
Sbjct: 227 TLCRE---------------QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYE 271
Query: 333 LATRCLNLNGKRRPTMKEVAMELER 357
L C + + RPT +E+ + L+R
Sbjct: 272 LMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-28
Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 43/282 (15%)
Query: 91 LGQGGQGTVYKG--MLADGRIVAVKKSKIVHEGKL----EEFINEVVILSQINHRNVVKL 144
LG G G+V KG ++ G+ V V K + + + +EF+ E +++Q++H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVA-VKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFP----LTWEMRLRIATEVAGSLSYLHS 200
+G C E +LV E G L +YL E P A +VA ++YL S
Sbjct: 62 IGVCKG-EPLMLVMELAPLGPLLKYLKK-RREIPVSDLKEL------AHQVAMGMAYLES 113
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GYLDPEYF 258
HRD+ + N+LL ++ AK++DFG S+ + + G + + PE
Sbjct: 114 KH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 259 RSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317
G+F+ KSDV+S+GV L E + G KP E G +++M E
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPY-----GEMKGAE---VIAMLE---------S 213
Query: 318 VLKVGQKEEI-MTIATLATRCLNLNGKRRPTMKEVAMELERI 358
++ + EE I ++ C + RPT E+ R
Sbjct: 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLG 146
R LG G G V++G+ + VAVK K G + ++F+ E I+ ++ H +++L
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
C E +V E + G+L +YL L + +A +VA ++YL +
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEA---QNY 124
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
HRD+ + N+L+ E KVADFG ++ I D + + PE +F+ K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 267 SDVYSFGVVLVELLT-GQKP 285
SDV+SFG++L E++T G+ P
Sbjct: 185 SDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 79/290 (27%), Positives = 136/290 (46%), Gaps = 44/290 (15%)
Query: 88 NRILGQGGQGTVYKGM---LADGRI-VAVKKSKIVHEGKL-EEFINEVVILSQINHRNVV 142
R +G+G G VY+G+ + +I VAVK K + E+F+ E I+ Q +H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 143 KLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
KL+G TE P+ +V E G L YL Q ++ L + + +++ +L+YL S
Sbjct: 71 KLIGVI--TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES- 125
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
HRDI + N+L++ K+ DFG S+++ + + +K + ++ PE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 262 QFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320
+FT SDV+ FGV + E+L G KP G+ +N D + +
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPF--------QGV---------KNN------DVIGR 220
Query: 321 VGQKEEI-------MTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363
+ E + T+ +L T+C + +RP E+ +L I +K
Sbjct: 221 IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEEK 270
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVK--KSKIVHEGKLEEFINEVVILSQINHRNVVKLLG 146
+G+G G VYKG+L VAVK +S + + K +F+ E IL Q +H N+VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
C++ + +V E + G+L +L + + +++ + + A + YL S +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLESKNCI-- 115
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSK------FIVIDQTHVTTKVQGTFGYLDPEYFRS 260
HRD+ + N L+ E K++DFG S+ + V D Q + PE
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK-----QIPIKWTAPEALNY 169
Query: 261 GQFTDKSDVYSFGVVLVELLTG 282
G++T +SDV+S+G++L E +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGK--LEEFINEVVILSQINHRNVVKLLGC 147
+G G G VY + L G ++AVK+ +I ++E +E+ +L + H N+VK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 148 CLETEVPLLVYEFISNGTLFQYL-HDQNEEFPLTWEMRLRIAT-EVAGSLSYLHSAASMP 205
+ E + E+ S GTL + L H + + E +R+ T ++ L+YLHS
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILD-----EHVIRVYTLQLLEGLAYLHSHG--- 119
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFG---YLDPEYFRSGQ 262
I HRDIK NI L+ K+ DFG + + + T + +VQ G Y+ PE G+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 263 FTDK---SDVYSFGVVLVELLTGQKP 285
+D++S G V++E+ TG++P
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-27
Identities = 86/291 (29%), Positives = 146/291 (50%), Gaps = 41/291 (14%)
Query: 87 VNRILGQGGQGTVYKGML-ADGRI--VAVKKSKIV--HEGKLEEFINEVVILSQINHRNV 141
+ + LG+G G+V +G L D I VAVK KI ++E+F++E V + + +H NV
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 142 VKLLGCCLETE------VPLLVYEFISNGTLFQY-----LHDQNEEFPLTWEMRLRIATE 190
++L+G CL+T P+++ F+ +G L + L D + P +M ++ T+
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTD 120
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV-QGT 249
+A + YL S + + HRD+ + N +LNE VADFG SK I + ++ +
Sbjct: 121 IASGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEEN 308
++ E +T KSDV+SFGV + E+ T GQ P +E +
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP----------------GVENS 221
Query: 309 RLYDFLDDQVLKVGQKEEIMT-IATLATRCLNLNGKRRPTMKEVAMELERI 358
+YD+L Q ++ Q + + + +L + C LN K RP+ + + ELE+
Sbjct: 222 EIYDYL-RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 85 FNVNRILGQGGQGTVYK-GMLADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRNV 141
F V + LG+G G+VYK L+D + A+K+ + + + + E+ +NE+ IL+ +NH N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 142 VK-----LLGCCLETEVPLLVYEFISNGTLFQYL-HDQNEEFPLTWEMRLRIATEVAGSL 195
+ L G L +V E+ G L + + + + + + RI ++ L
Sbjct: 62 ISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
LH I HRD+KS NILL K+ D G SK V+ + T++ GT Y+ P
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQI-GTPHYMAP 170
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
E ++ ++ KSD++S G +L E+ T P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 79/268 (29%), Positives = 131/268 (48%), Gaps = 28/268 (10%)
Query: 89 RILGQG--GQGTVYKGMLADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRNVVKL 144
R+LG+G G+ T+Y+ D +V K+ + + E + + +NE+VILS + H N++
Sbjct: 6 RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYL-HDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
++ L+ E+ + GTL+ + + + F EM L ++ ++SY+H A
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWYLFQIVSAVSYIHKAG- 121
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF 263
I HRDIK+ NI L + K+ DFG SK + + + T V GT Y+ PE + ++
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 264 TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323
KSD+++ G VL ELLT L + +AT + ++ N V+ V
Sbjct: 179 NFKSDIWALGCVLYELLT------LKRTFDATNPLNLVVKIVQGNY------TPVVSVYS 226
Query: 324 KEEIMTIATLATRCLNLNGKRRPTMKEV 351
E I L L + ++RPT EV
Sbjct: 227 SELIS----LVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 67/211 (31%), Positives = 116/211 (54%), Gaps = 15/211 (7%)
Query: 84 HFNVNRILGQGGQGTVYKGML-ADGR---IVAVKKSKIVH-EGKLEEFINEVVILSQINH 138
H +++G G G V++G+L GR VA+K K + E + ++F++E I+ Q +H
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEF-PLTWEMRLRIATEVAGSLSY 197
N+++L G + + +++ E++ NG L +YL D + EF LR +A + Y
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKY 122
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID--QTHVTTKVQGTFGYLDP 255
L + M HRD+ + NIL+N KV+DFG S+ + D T+ T+ + + P
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
E +FT SDV+SFG+V+ E+++ G++P
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 90 ILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF----INEVVILSQINHRNVVKL 144
LG+G G VYK G IVA+KK ++ +E E + E+ +L ++ H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKL 63
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASM 204
L LV+E+ L +YL + + I ++ L+Y HS
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP--NLIKSIMYQLLRGLAYCHS---H 117
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT 264
I HRD+K NIL+N K+ADFG ++ I T +V T Y PE +
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176
Query: 265 DKS-DVYSFGVVLVELLTGQKPI 286
+ D++S G + E++TG KP+
Sbjct: 177 STAVDIWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-25
Identities = 80/306 (26%), Positives = 136/306 (44%), Gaps = 57/306 (18%)
Query: 87 VNRILGQGGQGTVYKGM------LADGRIVAVKKSKI-VHEGKLEEFINEVVILSQINHR 139
+ + LG+G G V K A VAVK K +L + ++E +L Q+NH
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLH---------------------DQNEEFP 178
+V+KL G C + LL+ E+ G+L +L D +E
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 179 LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238
LT + A +++ + YL A M + HRD+ + N+L+ E K++DFG S+ + +
Sbjct: 124 LTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 239 QTHVT-TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGL 297
++V +K + ++ E +T +SDV+SFGV+L E++T G G+
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-------LGGNPYPGI 233
Query: 298 AAYFILSMEENRLYDFLDDQVLKVGQKEE-----IMTIATLATRCLNLNGKRRPTMKEVA 352
A RL++ +LK G + E + L C +RPT +++
Sbjct: 234 AP--------ERLFN-----LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280
Query: 353 MELERI 358
ELE++
Sbjct: 281 KELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 83 DHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVHEGK-LEEFINEVVILSQI 136
H + LG+G G V G VAVK E + +F E+ IL +
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 137 NHRNVVKLLGCCLET--EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
+H N+VK G C + L+ E++ +G+L YL ++ + + L ++++
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKG 121
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG---TFG 251
+ YL S HRD+ + NIL+ + K++DFG +K + D+ + K G F
Sbjct: 122 MDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281
Y PE R+ +F+ SDV+SFGV L EL T
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 90 ILGQGGQGTVYKGMLADGRIVAVKK------SKIVHEGKLEEFINEVVILSQINHRNVVK 143
+LG+G GTVY G+ G+++AVK+ + + E + E+ EV +L + H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
LG CL+ + EF+ G++ L N PL + + ++ ++YLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC- 122
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT-----TKVQGTFGYLDPEYF 258
+ HRDIK N++L K+ DFG ++ + H T + GT ++ PE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKPI 286
+ KSD++S G + E+ TG+ P+
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 23/224 (10%)
Query: 91 LGQGGQGTVYKGMLA------DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKL 144
LG+G G V+ D +VAVK K E ++F E +L+ + H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLH---------DQNEEFP---LTWEMRLRIATEVA 192
G C E L+V+E++ +G L ++L E+ LT L IA+++A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTTKVQGTFG 251
+ YL AS+ HRD+ + N L+ + K+ DFG S+ I D V +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEA 294
++ PE +FT +SD++SFGVVL E+ T G++P + EA
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 84 HFNVNRILGQGGQGTVYKGMLADGRIV-AVK---KSKIVHEGKLEEFINEVVILSQINHR 139
HF + R++G+G G V D + + A+K K K V +G + +NE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYL 198
+V L + E LV + + G L +Y Q +F E +++ E+ +L YL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFS---EEQVKFWICEIVLALEYL 116
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
HS I HRDIK NILL+E+ + DF + V T T+ GT GY+ PE
Sbjct: 117 HS---KGIIHRDIKPDNILLDEQGHVHITDFNIAT-KVTPDTLTTSTS-GTPGYMAPEVL 171
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKP 285
++ D +S GV E L G++P
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 89 RILGQGGQGTVYKGMLADGRI-------VAVKK-SKIVHEGKLEEFINEVVILSQINHRN 140
R LG G G VY+G L GR VAVK + E +F+ E +I+S+ NH+N
Sbjct: 12 RALGHGAFGEVYEG-LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQN 70
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHD----QNEEFPLTWEMRLRIATEVAGSLS 196
+V+L+G E ++ E ++ G L +L + LT + L A +VA
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 197 YLHSAASMPIYHRDIKSTNILLNEK---YTAKVADFGTSKFIV-IDQTHVTTKVQGTFGY 252
YL + HRDI + N LL K AK+ADFG ++ I + +
Sbjct: 131 YLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLT 281
+ PE F G FT K+DV+SFGV+L E+ +
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVK 143
F++ LG+G G+VYK + G++VA+K + E L+E I E+ IL Q + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS---LSYLHS 200
G + +V E+ G++ + N+ LT E IA + + L YLHS
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEE---EIAAILYQTLKGLEYLHS 117
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
HRDIK+ NILLNE+ AK+ADFG S + D V GT ++ PE +
Sbjct: 118 ---NKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKP 285
+ +K+D++S G+ +E+ G+ P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 82/221 (37%), Positives = 112/221 (50%), Gaps = 32/221 (14%)
Query: 89 RILGQGGQGTVYKGMLAD------GRI-VAVK---KSKIVHEGKLEEFINEVVILSQINH 138
LG G G VY+G D G I VAVK K E K EF+ E ++S NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHD-QNEEFP---LTWEMRLRIATEVAGS 194
N+VKLLG CL E ++ E + G L YL D + E F LT + L I +VA
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEK-YTA----KVADFGTSKFIVIDQTHVTTKVQG- 248
YL M HRD+ + N L++EK Y A K+ DFG ++ I + + +G
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGE 172
Query: 249 ---TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
++ PE G+FT +SDV+SFGV++ E+LT GQ+P
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 90 ILGQGGQGTVYKGMLA-DGRIVAVK---------KSKIVHEGKLEEFINEVVILSQINHR 139
++G G G+VY GM A G ++AVK SK L+ E+ +L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLR-IATEVAGSLSYL 198
N+V+ LG L+ + + E++ G++ L + F E +R ++ L+YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFE---ETLVRNFVRQILKGLNYL 122
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK-----VQGTFGYL 253
H+ I HRDIK NIL++ K K++DFG SK + + T +QG+ ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE + +T K+D++S G ++VE+LTG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 31/272 (11%)
Query: 90 ILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEE-----FINEVVILSQINHRNVVK 143
+G+G GTV K +DG+I+ K+ + G + E ++EV IL ++ H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKE---IDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 144 LLGCCL--ETEVPLLVYEFISNGTLFQYL-HDQNEEFPLTWEMRLRIATEVAGSLSYLH- 199
+ + +V E+ G L Q + + E + E RI T++ +L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 200 -SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
S + HRD+K NI L+ K+ DFG +K + D + T V GT Y+ PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQL 182
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318
+ +KSD++S G ++ EL P + I + R+ ++
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK----IKEGKFRRIPYRYSSEL 238
Query: 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKE 350
+V LN++ +RP+ +E
Sbjct: 239 NEV------------IKSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 77/281 (27%), Positives = 139/281 (49%), Gaps = 41/281 (14%)
Query: 84 HFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVK 143
+ I+G+G G V +G G+ VAVK K + + F+ E ++++++H+N+V+
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVR 63
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
LLG L + +V E +S G L +L + ++ L+ + +VA + YL S
Sbjct: 64 LLGVILHNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQL-LQFSLDVAEGMEYLESKK- 120
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKF--IVIDQTHVTTKVQGTFGYLDPEYFRSG 261
+ HRD+ + NIL++E AKV+DFG ++ + +D + + K + PE +
Sbjct: 121 --LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHK 172
Query: 262 QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321
+F+ KSDV+S+GV+L E+ + G A Y +S++E + + V K
Sbjct: 173 KFSSKSDVWSYGVLLWEVFS-------------YGRAPYPKMSLKE------VKECVEK- 212
Query: 322 GQKEEI-----MTIATLATRCLNLNGKRRPTMKEVAMELER 357
G + E + L T C K+RP+ ++ +LE+
Sbjct: 213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 40/274 (14%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGK-----LEEFINEVVILSQINHRNVV 142
+LG G G+VY+G+ L DG AVK+ + +G+ +++ E+ +LS++ H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 143 KLLGCCLETEVPLLVY-EFISNGTLFQYLHDQNEEFPLTWEMRLRIATE-VAGSLSYLHS 200
+ LG E + L ++ E + G+L +++ E +R+ T + L YLH
Sbjct: 66 QYLGTEREED-NLYIFLELVPGGSL----AKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK-VQGTFGYLDPEYFR 259
++ HRDIK NIL++ K+ADFG +K +V K +G+ ++ PE
Sbjct: 121 RNTV---HRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSFKGSPYWMAPEVIA 174
Query: 260 S-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL--SMEENRLYDFLDD 316
G + +D++S G ++E+ TG+ P + G+AA F + S E + D L D
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW-----SQLEGVAAVFKIGRSKELPPIPDHLSD 229
Query: 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKE 350
+ K+ I+ +CL + RPT E
Sbjct: 230 EA-----KDFIL-------KCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 91 LGQGGQGTVYKG--MLADGRI--VAVKKSK-IVHEGKLEEFINEVVILSQINHRNVVKLL 145
LG G G V +G + G++ VAVK K +++F+ E I+ ++H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHD-QNEEFPLTWEMRLRIATEVAGSLSYLHSAASM 204
G L T ++V E G+L L F ++ A ++A + YL S
Sbjct: 63 GVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESKR-- 117
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT--FGYLDPEYFRSGQ 262
HRD+ + NILL K+ DFG + + ++ H + F + PE R+
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 263 FTDKSDVYSFGVVLVELLT-GQKPII-LTGS 291
F+ SDV+ FGV L E+ T G++P L+GS
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 72/284 (25%), Positives = 133/284 (46%), Gaps = 44/284 (15%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKKS-KIVHEGK----LEEFINEVVILSQINHRNVV 142
++LG G GTVYKG+ + +G V + + K++ E +E ++E +++ ++H +VV
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+LLG CL + L+ + + G L Y+ + + + + L ++A +SYL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR 129
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG---TFGYLDPEYFR 259
+ HRD+ + N+L+ K+ DFG +K + +D+ +G ++ E
Sbjct: 130 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESIL 184
Query: 260 SGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318
+T KSDV+S+GV + EL+T G KP E + D +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP-------------------YEGIPAVEIPD--L 223
Query: 319 LKVGQKEEIMTIATL-----ATRCLNLNGKRRPTMKEVAMELER 357
L+ G++ I T+ +C ++ + RPT KE+ E +
Sbjct: 224 LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 69/221 (31%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK-----KSKIVHEGKLEEFINEVVILSQI 136
D + + ++G G VY + L + VA+K K + ++E EV +SQ
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT----SVDELRKEVQAMSQC 56
Query: 137 NHRNVVKLLGCCLETEVPLLVYEFISNGTL-----FQYLHDQNEEFPLTWEMRLRIAT-- 189
NH NVVK + + LV ++S G+L Y +E IAT
Sbjct: 57 NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI--------IATVL 108
Query: 190 -EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI---VIDQTHVTTK 245
EV L YLHS + HRDIK+ NILL E + K+ADFG S + V
Sbjct: 109 KEVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 246 VQGTFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKP 285
GT ++ PE + K+D++SFG+ +EL TG P
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 62/195 (31%), Positives = 107/195 (54%), Gaps = 10/195 (5%)
Query: 90 ILGQGGQGTVYKGMLADGRIVAVK--KSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
+LG+G G V+KG L D VAVK K + E K++ F++E IL Q +H N+VKL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
C + + +V E + G +L + +E L + ++ A + A ++YL S +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLESKNCI--- 115
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV-QGTFGYLDPEYFRSGQFTDK 266
HRD+ + N L+ E K++DFG S+ D + ++ + Q + PE G+++ +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 267 SDVYSFGVVLVELLT 281
SDV+S+G++L E +
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 59/200 (29%), Positives = 109/200 (54%), Gaps = 11/200 (5%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLG 146
+ LG G G V+ G VA+K ++EG + E+FI E ++ +++H +V+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
C + + +V EF+ NG L YL + + + +M L + +V + YL + +
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKL--SKDMLLSMCQDVCEGMEYLERNSFI-- 122
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
HRD+ + N L++ KV+DFG +++++ D+ ++ + + PE F +++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 267 SDVYSFGVVLVELLT-GQKP 285
SDV+SFGV++ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 1e-23
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD----GRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
D F + LG G G V ML G+ A+K K+KIV ++E +NE IL
Sbjct: 1 DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
I H +V L G + LV E++ G LF +L ++ FP A +V +L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFY--AAQVVLAL 114
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
YLH S+ I +RD+K N+LL+ K+ DFG +K + +T+ GT YL P
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYTLC---GTPEYLAP 167
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
E S + D ++ G+++ E+L G P
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 71/289 (24%), Positives = 125/289 (43%), Gaps = 48/289 (16%)
Query: 90 ILGQGGQGTVYKGML------ADGRIVAVKK-SKIVHEGKLEEFINEVVILSQINHRNVV 142
LG+G G V+ +V VK K E EF E+ + +++H+NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYL------HDQNEEFPLTWEMRLRIATEVAGSLS 196
+LLG C E E ++ E+ G L Q+L ++ + PL+ + ++ + T++A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
+L +A HRD+ + N L++ + KV+ SK + + + +L PE
Sbjct: 132 HLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316
+ F+ KSDV+SFGV++ E + + E Y D+
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWE-----------------------VFTQGELPFYGLSDE 225
Query: 317 QVL-KVGQKEEIMTIAT--------LATRCLNLNGKRRPTMKEVAMELE 356
+VL ++ + + + L TRC +N K RP+ E+ L
Sbjct: 226 EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-23
Identities = 72/280 (25%), Positives = 130/280 (46%), Gaps = 49/280 (17%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLGCC 148
LG G G V G VA+K ++ EG + +EFI E ++ +++H +V+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
+ +V E++SNG L YL + + F L + +V ++YL S + H
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMAYLESKQFI---H 123
Query: 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GYLDPEYFRSGQFTDK 266
RD+ + N L++++ KV+DFG S++++ D+ T+ V F + PE +F+ K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 267 SDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ--VLKVGQ 323
SDV++FGV++ E+ + G+ P Y+ ++ V KV Q
Sbjct: 182 SDVWAFGVLMWEVYSLGKMP-------------------------YERFNNSETVEKVSQ 216
Query: 324 KEEIM-------TIATLATRCLNLNGKRRPTMKEVAMELE 356
+ + + C + + RPT +++ +E
Sbjct: 217 GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 91 LGQGGQGTVYKGML--ADGRIVAVKKSKIVHEGKLEEF---INEVVILSQINHRNVVKLL 145
LG G G V K +L G+I+AVK I E + E+ IL + N +V
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKT--IRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 146 GCCL-ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL-RIATEVAGSLSYLHSAAS 203
G ++ + + E++ G+L + L + P E L +IA V L+YLH
Sbjct: 66 GAFYNNGDISICM-EYMDGGSLDKILKEVQGRIP---ERILGKIAVAVLKGLTYLHEKHK 121
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV--IDQTHVTTKVQGTFGYLDPEYFRSG 261
I HRD+K +NIL+N + K+ DFG S +V + +T V GT Y+ PE +
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGN 174
Query: 262 QFTDKSDVYSFGVVLVELLTGQKPI 286
++ KSD++S G+ L+EL TG+ P
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-23
Identities = 75/272 (27%), Positives = 132/272 (48%), Gaps = 29/272 (10%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCC 148
+ +G+G G V ML D R V I ++ + F+ E +++Q+ H N+V+LLG
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 149 LETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
+E + L +V E+++ G+L YL + L + L+ + +V ++ YL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKS 267
HRD+ + N+L++E AKV+DFG +K Q V+ T PE R +F+ KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 180
Query: 268 DVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE 326
DV+SFG++L E+ + G+ P K+ + +E+ D D G
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYKMDAPD------GCPPV 227
Query: 327 IMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
+ + +C +L+ RP+ ++ +LE I
Sbjct: 228 VYDV---MKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-23
Identities = 83/293 (28%), Positives = 136/293 (46%), Gaps = 40/293 (13%)
Query: 85 FNVNRILGQGGQGTVYKGML----ADGRIVAVK--KSKIVHEGKLEEFINEVVILSQINH 138
F + R+LG+G G+V + L + VAVK K+ I +EEF+ E + + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 139 RNVVKLLGCCLETE------VPLLVYEFISNGTLFQYL---HDQNEEFPLTWEMRLRIAT 189
NV+KL+G L + +P+++ F+ +G L +L E F L + +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI-DQTHVTTKVQG 248
++A + YL +S HRD+ + N +LNE T VADFG SK I D +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 249 TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEE 307
+L E +T SDV++FGV + E++T GQ P +E
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA----------------GVEN 221
Query: 308 NRLYDFL-DDQVLKVGQKEEIMT-IATLATRCLNLNGKRRPTMKEVAMELERI 358
+ +Y++L LK Q + + + L +C + K RP+ + + +LE I
Sbjct: 222 SEIYNYLIKGNRLK--QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-23
Identities = 84/303 (27%), Positives = 135/303 (44%), Gaps = 50/303 (16%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD-----GRI-VAVKKSKI-VHEGKLEEFINEVVILSQ 135
D + + LG+G G V K VAVK K E L + ++E+ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 136 I-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHD---QNEEF----------PLTW 181
I H+N++ LLG C + +V E+ ++G L +L E LT
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 182 EMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI-VIDQT 240
+ + A +VA + +L AS HRD+ + N+L+ E + K+ADFG ++ I ID
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAY 300
TT + ++ PE +T +SDV+SFGV+L E+ T L GS Y
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGS-------PY 235
Query: 301 FILSMEENRLYDFLDDQVLKVGQKEE-----IMTIATLATRCLNLNGKRRPTMKEVAMEL 355
+ +EE L+ LK G + E + L C + +RPT K++ +L
Sbjct: 236 PGIPVEE--LFKL-----LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
Query: 356 ERI 358
+R+
Sbjct: 289 DRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 5e-23
Identities = 82/289 (28%), Positives = 129/289 (44%), Gaps = 40/289 (13%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN-----EVVILSQINHRNVVKL 144
LG+G VYK GRIVA+KK K+ + ++ IN E+ +L ++ H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPL----TW-EMRLRIATEVAGSLSYLH 199
L LV+EF+ L + + D++ ++ M LR L YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR-------GLEYLH 119
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE-YF 258
S I HRD+K N+L+ K+ADFG ++ +T +V T Y PE F
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF 175
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAA-YFILSM--EEN-----RL 310
+ + D++S G + ELL + P L G + L + L EEN L
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLL-RVP-FLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233
Query: 311 YDFLDDQVLKVGQKEEIMTIAT-----LATRCLNLNGKRRPTMKEVAME 354
D+++ + ++I A+ L R L LN +R T ++ A+E
Sbjct: 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ-ALE 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 6e-23
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN--EVVILSQINHRNVVKLLGC 147
+G+G G VYK G IVA+KK K+ E + E+ +L ++NH N++KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFP------LTWEMRLRIATEVAGSLSYLHSA 201
LV+EF+ L++ + D+ P +++ L+ L++ HS
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQL-LQ-------GLAFCHSH 117
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE-YFRS 260
I HRD+K N+L+N + K+ADFG ++ T V T Y PE
Sbjct: 118 G---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGD 173
Query: 261 GQFTDKSDVYSFGVVLVELLTGQ 283
++ D++S G + ELL+ +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-23
Identities = 74/269 (27%), Positives = 124/269 (46%), Gaps = 25/269 (9%)
Query: 91 LGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLE-EFINEVVILSQINHRNVVKLLGCC 148
+G+G G V+ G L AD VAVK + L+ +F+ E IL Q +H N+V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
+ + +V E + G +L + E L + +++ A + YL S + H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKHCI---H 117
Query: 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK--VQGTFGYLDPEYFRSGQFTDK 266
RD+ + N L+ EK K++DFG S+ D + +T Q + PE G+++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 267 SDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE 326
SDV+SFG++L E + G Y LS ++ R + ++ V +
Sbjct: 177 SDVWSFGILLWEAFS-------------LGAVPYANLSNQQTR--EAIEQGVRLPCPELC 221
Query: 327 IMTIATLATRCLNLNGKRRPTMKEVAMEL 355
+ L RC + +RP+ V EL
Sbjct: 222 PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-22
Identities = 75/294 (25%), Positives = 134/294 (45%), Gaps = 55/294 (18%)
Query: 91 LGQGGQGTVYKGML-----ADGRIVAVKKSKIVHEGK-LEEFINEVVILSQINHRNVVKL 144
LG+ G +YKG L ++VA+K K ++ + EF E ++++++H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYL--------------HDQNEEFPLTWEMRLRIATE 190
LG + + +++E+++ G L ++L D + L L IA +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTTKVQGT 249
+A + YL +S H+D+ + NIL+ E+ K++D G S+ I D V K
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309
++ PE G+F+ SD++SFGVVL E+ + GL Y
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS-------------FGLQPY--------- 227
Query: 310 LYDFLDDQVLKVGQKEEIMT--------IATLATRCLNLNGKRRPTMKEVAMEL 355
Y F + +V+++ +K +++ + +L T C RRP K++ L
Sbjct: 228 -YGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-22
Identities = 76/285 (26%), Positives = 140/285 (49%), Gaps = 44/285 (15%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKKS-KIVHEGKLE----EFINEVVILSQINHRNVV 142
++LG G GTVYKG+ + +G V + + KI++E EF++E +I++ ++H ++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+LLG CL + LV + + +G L Y+H+ + + ++ L ++A + YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEERR 129
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT---KVQGTFGYLDPEYFR 259
+ HRD+ + N+L+ K+ DFG ++ + D+ K+ + L+ ++R
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 260 SGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318
+FT +SDV+S+GV + EL+T G KP ++E L
Sbjct: 187 --KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL--------------------- 223
Query: 319 LKVGQKEEIMTIATL-----ATRCLNLNGKRRPTMKEVAMELERI 358
L+ G++ I T+ +C ++ RP KE+A E R+
Sbjct: 224 LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-22
Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 12/194 (6%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLGCC 148
LG G G V+ G VA+K K +G + E F+ E ++ Q+ H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 149 LETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
T+ P+ ++ E++ NG+L +L E LT + +A ++A ++++ +
Sbjct: 71 --TQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI--- 124
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKS 267
HRD+++ NIL++E K+ADFG ++ I ++ + + PE G FT KS
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 268 DVYSFGVVLVELLT 281
DV+SFG++L E++T
Sbjct: 185 DVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 87 VNRILGQGGQGTVYKGML------ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
+ R LG+G G V+ D +VAVK K + ++F E +L+ + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLH----------DQNEEFPLTWEMRLRIATE 190
+VK G C+E + ++V+E++ +G L ++L + N LT L IA +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTTKVQGT 249
+A + YL AS HRD+ + N L+ E K+ DFG S+ + D V
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
++ PE +FT +SDV+S GVVL E+ T G++P
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-22
Identities = 62/198 (31%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLGCC 148
LGQG G V+ G VA+K K G + E F+ E ++ ++ H +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
E + +V E++S G+L +L + ++ L + +A ++A ++Y+ M H
Sbjct: 71 SEEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER---MNYVH 125
Query: 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSD 268
RD+++ NIL+ E KVADFG ++ I ++ + + PE G+FT KSD
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 269 VYSFGVVLVELLT-GQKP 285
V+SFG++L EL T G+ P
Sbjct: 186 VWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-22
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLGCC 148
LG G G V+ G VAVK K G + E F+ E I+ ++ H +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 149 LETEVPLLVYEFISNGTLFQYLHD---QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
E + +V E++S G+L +L D + + P +M A +VA ++Y+ M
Sbjct: 71 SEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM----AAQVAAGMAYIER---MN 122
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTD 265
HRD++S NIL+ + K+ADFG ++ I ++ + + PE G+FT
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 266 KSDVYSFGVVLVELLT-GQKP 285
KSDV+SFG++L EL+T G+ P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 85/296 (28%), Positives = 133/296 (44%), Gaps = 36/296 (12%)
Query: 84 HFNVNRILGQGGQGTVYK---GMLAD--GRIVAVKKSKIVHEGKLEEFINEVVILSQINH 138
H + LG+G G+V L D G +VAVKK + L +F E+ IL + H
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64
Query: 139 RNVVKLLGCCLETEVP--LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
N+VK G C LV E++ G+L YL Q L L A+++ +
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGME 122
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG---TFGYL 253
YL S HRD+ + NIL+ + K+ DFG +K + D+ + + G F Y
Sbjct: 123 YL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR---- 309
PE +F+ SDV+SFGVVL EL T S ++ A F+ M ++
Sbjct: 180 -PESLTESKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGNDKQGQM 230
Query: 310 -LYDFLDDQVLKVGQKEEI-----MTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359
+Y ++ +LK + I + C N + +RP+ E+A+++E I+
Sbjct: 231 IVYHLIE--LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
+GQG GTVY + +A G+ VA+K+ + + K E INE++++ + H N+V L L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 150 ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHR 209
+ +V E+++ G+L D E + + E +L +LHS + HR
Sbjct: 87 VGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 139
Query: 210 DIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDV 269
DIKS NILL + K+ DFG I +Q+ +T V GT ++ PE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 270 YSFGVVLVELLTGQKP 285
+S G++ +E++ G+ P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-22
Identities = 77/298 (25%), Positives = 133/298 (44%), Gaps = 49/298 (16%)
Query: 89 RILGQGGQGTVYK----GMLA--DGRIVAVKKSKIVHEGKLE---EFINEVVILSQINHR 139
R +GQG G V++ G+L +VAVK K E + +F E ++++ +H
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMAEFDHP 68
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQN-------------------EEFPLT 180
N+VKLLG C + L++E+++ G L ++L ++ PL+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 181 WEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI-VIDQ 239
+L IA +VA ++YL + HRD+ + N L+ E K+ADFG S+ I D
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAA 299
+ ++ PE ++T +SDV+++GVVL E+ + G+
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS-------------YGMQP 232
Query: 300 YFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357
Y+ ++ EE +Y D VL + + L C + RP+ + L+R
Sbjct: 233 YYGMAHEE-VIYYVRDGNVLSCPDNCP-LELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 4e-22
Identities = 62/209 (29%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 87 VNRILGQGGQGTVYKGML-ADGR---IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNV 141
+ ++G G G V +G L G+ VA+K K + E + +F++E I+ Q +H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
+ L G ++ +++ EF+ NG L +L + +F + + + +A + YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYL--- 122
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT-TKVQG---TFGYLDPEY 257
+ M HRD+ + NIL+N KV+DFG S+F+ D + T T G + PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 258 FRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 9/209 (4%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI---VHEGKLEEFINEVVILSQIN 137
+F + + +G+G VYK + L DGR+VA+KK +I + ++ + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYL-HDQNEEFPLTWEMRLRIATEVAGSLS 196
H NV+K L +E +V E G L + + H + ++ + + ++ +L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
++HS M HRDIK N+ + K+ D G +F T + V GT Y+ PE
Sbjct: 121 HMHSKRIM---HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ KSD++S G +L E+ Q P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 10/223 (4%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQ 135
E + D +LG+G G VY L+ +A+K+ ++ E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
+ HRN+V+ LG E + E + G+L L + + + ++ L
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTA--KVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
YLH I HRDIK N+L+N Y+ K++DFGTSK + T GT Y+
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYM 176
Query: 254 DPEYFRSGQ--FTDKSDVYSFGVVLVELLTGQKPIILTGSKEA 294
PE G + +D++S G +VE+ TG+ P I G +A
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA 219
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 6e-22
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKG-MLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV 141
+ + + + +G G G VYK +A G +VA+K K+ E E+ +L + H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
V G L + +V E+ G+L Q ++ PL+ + E L+YLH
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRG-PLSELQIAYVCRETLKGLAYLHET 120
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ---GTFGYLDPEYF 258
+ HRDIK NILL E K+ADFG S + T K + GT ++ PE
Sbjct: 121 GKI---HRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVA 173
Query: 259 ---RSGQFTDKSDVYSFGVVLVELLTGQKP 285
R G + K D+++ G+ +EL Q P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 7e-22
Identities = 69/227 (30%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF----INEVVILSQINHRNVVK 143
+G+G G VYK G +VA+KK ++ +E E F I E+ +L ++ H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62
Query: 144 LLGCCLETEVPLLVYEFISNGT--LFQYL-HD-----QNEEFPLTWEMRLRIATEVAGSL 195
L E+ V +F+Y+ HD + E T ++ L
Sbjct: 63 LK------EI---VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGL 113
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
YLHS I HRDIK +NIL+N K+ADFG ++ + T T Y P
Sbjct: 114 QYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 256 E-YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF 301
E + ++ + D++S G +L EL G KP I GS E L F
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLG-KP-IFQGSTELEQLEKIF 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 8e-22
Identities = 74/285 (25%), Positives = 131/285 (45%), Gaps = 41/285 (14%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRI-------VAVKKSK-IVHEGKLEEFINEVVILS 134
++ + + LG G G V + A G VAVK K H + E ++E+ I+S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 135 QI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
+ NH N+V LLG C L++ E+ G L +L + E F ++ L + +VA
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAK 152
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT---- 249
+++L AS HRD+ + N+LL K+ DFG ++ I+ D +V V+G
Sbjct: 153 GMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLP 206
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309
++ PE + +T +SDV+S+G++L E+ + G Y + ++
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS-------------LGSNPYPGMPVDSK- 252
Query: 310 LYDFLDD--QVLK-VGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
Y + + ++ + EI I C + + +RPT K++
Sbjct: 253 FYKLIKEGYRMAQPEHAPAEIYDI---MKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 24/219 (10%)
Query: 81 ATDHFNVNRILGQGGQGTVYKGMLADGRI-------VAVK---KSKIVHEGKLEEFINEV 130
A + ++R LGQG G VY+G +A G + VA+K ++ + E EF+NE
Sbjct: 4 AREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEA 60
Query: 131 VILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEF-------PLTWEM 183
++ + N +VV+LLG + + L++ E ++ G L YL E P + +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 184 RLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHV 242
+++A E+A ++YL++ HRD+ + N ++ E +T K+ DFG ++ I D
Sbjct: 121 MIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281
K ++ PE + G FT SDV+SFGVVL E+ T
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 82/310 (26%), Positives = 133/310 (42%), Gaps = 57/310 (18%)
Query: 81 ATDHFNVNRILGQGGQGTVYKGMLAD---GRIVAVKKSKIVHEG----KLEEFINEVVIL 133
+ + + R LGQG G VY+G D G K V+E + EF+NE ++
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 134 SQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYL--------HDQNEEFPLTWEMRL 185
+VV+LLG + + L+V E +++G L YL ++ P EM +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM-I 122
Query: 186 RIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTT 244
++A E+A ++YL++ HRD+ + N ++ +T K+ DFG ++ I D
Sbjct: 123 QMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 245 KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS 304
K ++ PE + G FT SD++SFGVVL E I S
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-----------------------ITS 216
Query: 305 MEENRLYDFLDDQVLK-------VGQKEEI-MTIATLATRCLNLNGKRRPTMKEVAMELE 356
+ E ++QVLK + Q + + L C N K RPT E+
Sbjct: 217 LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI----- 271
Query: 357 RIQALQKDIN 366
+ L+ D++
Sbjct: 272 -VNLLKDDLH 280
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-21
Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF--INEVVILSQINHRNVVKLL 145
R++G+G G V+ AD ++V +K+ + K E NE +L ++H N+++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
LE + ++V E+ GTL +Y+ + L + L ++ +L ++H+
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTKL--- 121
Query: 206 IYHRDIKSTNILLNEKYT-AKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT 264
I HRD+K+ NILL++ K+ DFG SK + T V GT Y+ PE +
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYN 179
Query: 265 DKSDVYSFGVVLVELLT 281
KSD+++ G VL EL +
Sbjct: 180 QKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 7e-21
Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLGCC 148
LGQG G V+ G VA+K K G + E F+ E I+ ++ H +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
E + +V EF+ G+L +L + + ++ L + +A ++A ++Y+ M H
Sbjct: 71 SEEPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIER---MNYIH 125
Query: 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSD 268
RD+++ NIL+ + K+ADFG ++ I ++ + + PE G+FT KSD
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 269 VYSFGVVLVELLT-GQKP 285
V+SFG++L EL+T G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 69/219 (31%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 85 FNVNRILGQGGQGTVY----KGMLADGRIVAVK---KSKIVHEGK-LEEFINEVVILSQI 136
F + R+LG G G V+ G G++ A+K K+ IV + K E E +L +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 137 NHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
+ L +T+ L L+ ++++ G LF +L+ Q E F + E+R+ IA E+ +L
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTES-EVRVYIA-EIVLAL 118
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
+LH + I +RDIK NILL+ + + DFG SK + ++ GT Y+ P
Sbjct: 119 DHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 256 EYFRSGQ--FTDKSDVYSFGVVLVELLTGQKPIILTGSK 292
E R G D +S GV+ ELLTG P + G +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 15/203 (7%)
Query: 91 LGQGGQGTVYKG---MLADGRIVAVK--KSKIVHEGKLEEFINEVVILSQINHRNVVKLL 145
LG G GTV KG M + VAVK K+ +E + E ++ Q+++ +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
G C E E +LV E G L ++L +N+ +T + + +V+ + YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ-KNKH--VTEKNITELVHQVSMGMKYLEETN--- 115
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GYLDPEYFRSGQF 263
HRD+ + N+LL ++ AK++DFG SK + D+ + K G + + PE +F
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 264 TDKSDVYSFGVVLVELLT-GQKP 285
+ KSDV+SFGV++ E + GQKP
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-20
Identities = 61/207 (29%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 87 VNRILGQGGQGTVYKGMLA-DGR---IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNV 141
+ +++G G G V G L G+ VA+K K + E + +F++E I+ Q +H N+
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
+ L G +++ ++V E++ NG+L +L + +F T + + +A + YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF--TVIQLVGMLRGIASGMKYL--- 122
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFG--YLDPEYFR 259
+ M HRD+ + NIL+N KV+DFG S+ + D T G + PE
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 260 SGQFTDKSDVYSFGVVLVELLT-GQKP 285
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 2e-20
Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 27/264 (10%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
+GQG GTVY + +A G+ VA+K+ + + K E INE++++ + + N+V L L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 150 ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHR 209
+ +V E+++ G+L D E + + E +L +LHS + HR
Sbjct: 87 VGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHR 139
Query: 210 DIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDV 269
DIKS NILL + K+ DFG I +Q+ +T V GT ++ PE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 270 YSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMT 329
+S G++ +E++ G+ P + E A Y I + L Q E ++
Sbjct: 199 WSLGIMAIEMVEGEPPYL----NENPLRALYLIATNGTPEL------------QNPERLS 242
Query: 330 IA--TLATRCLNLNGKRRPTMKEV 351
RCL ++ RR + KE+
Sbjct: 243 AVFRDFLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 57/187 (30%), Positives = 98/187 (52%), Gaps = 20/187 (10%)
Query: 109 IVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLF 167
+VAVK + V + +F+ E+ I+S++ + N+++LLG C+ + ++ E++ NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 168 QYLHDQNEEFPLT---------WEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL 218
Q+L + E T L +A ++A + YL AS+ HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 219 NEKYTAKVADFGTSKFIVIDQTHVTTKVQG----TFGYLDPEYFRSGQFTDKSDVYSFGV 274
YT K+ADFG S+ + + ++QG ++ E G+FT SDV++FGV
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 275 VLVELLT 281
L E+ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 91 LGQGGQGTVYKGM--LADGRI-VAVKKSKIVHEGKL-EEFINEVVILSQINHRNVVKLLG 146
LG G G V KG+ + +I VA+K K +E + +E + E I+ Q+++ +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
C E E +LV E S G L ++L + +E + + + +V+ + YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLEGKN---F 116
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GYLDPEYFRSGQFT 264
HRD+ + N+LL ++ AK++DFG SK + D ++ + G + + PE +F+
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 265 DKSDVYSFGVVLVELLT-GQKP 285
+SDV+S+G+ + E + GQKP
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 66/204 (32%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 89 RILGQGGQGTV--YKGMLAD---GRIVAVKKSKIVHEGKLEE-FINEVVILSQINHRNVV 142
R+LG+G G V Y A+ G +VAVK K + + E+ IL + H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 143 KLLGCCLET--EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
K GCC E + L+ E++ G+L YL L L A ++ ++YLHS
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHS 125
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG---TFGYLDPEY 257
+ HRD+ + N+LL+ K+ DFG +K + + + G F Y E
Sbjct: 126 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VEC 181
Query: 258 FRSGQFTDKSDVYSFGVVLVELLT 281
+ +F+ SDV+SFGV L ELLT
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLGC 147
+G+G G V K A G IVA+KK K + + + + EV +L Q+ H N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFP--LTWEMRLRIATEVAGSLSYLHSAASMP 205
LV+E++ TL + L E P L + ++ +++Y HS
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCHS---HN 120
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTD 265
I HRDIK NIL++E K+ DFG ++ + T T Y PE
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 266 KS-DVYSFGVVLVELLTGQ 283
K DV++ G ++ ELL G+
Sbjct: 181 KPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 90/313 (28%), Positives = 147/313 (46%), Gaps = 52/313 (16%)
Query: 81 ATDHFNVNRILGQG--GQGTVYKGMLAD----GRI--VAVKKSKI-VHEGKLEEFINEVV 131
D + + LG+G GQ + + + D R+ VAVK K E L + I+E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 132 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLH-------------DQNEEF 177
++ I H+N++ LLG C + ++ E+ S G L +YL Q E
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 178 PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI-V 236
L+++ + A +VA + YL AS HRD+ + N+L+ E K+ADFG ++ I
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
Query: 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATG 296
ID TT + ++ PE +T +SDV+SFGV+L E+ T L GS
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGS----- 241
Query: 297 LAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT-----LATRCLNLNGKRRPTMKEV 351
Y + +EE L+ ++LK G + + + T + C + +RPT K++
Sbjct: 242 --PYPGVPVEE--LF-----KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292
Query: 352 AMELERIQALQKD 364
+L+RI AL +
Sbjct: 293 VEDLDRILALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-20
Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLE---EFINEVVILSQINHRNVVKLLGC 147
LG G G+V K V KK + K + + E+ I+ + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHI-GAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
L + EF+ G+L + + P+ E+ +IA V L+YL++ I
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IM 126
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIV--IDQTHVTTKVQGTFGYLDPEYFRSGQFTD 265
HRDIK +NIL+N + K+ DFG S ++ I T V GT Y+ PE + G++T
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTV 181
Query: 266 KSDVYSFGVVLVELLTGQKP 285
KSDV+S G+ ++EL G+ P
Sbjct: 182 KSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 6e-20
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 90 ILGQGGQGTVYKGM-LADGRIVAVKKSKIVH----EGKLEEFINEVVILSQINH---RNV 141
++G+G G VY+G + GR+VA+K I++ + + + EV +LSQ+ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALK---IINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
K G L+ ++ E+ G++ + P+ + I EV +L Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV 120
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
+ HRDIK+ NIL+ K+ DFG + + + + +T V GT ++ PE G
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEG 176
Query: 262 QFTD-KSDVYSFGVVLVELLTGQKP 285
++ D K+D++S G+ + E+ TG P
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 7e-20
Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 25/263 (9%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
+GQG GTVY M +A G+ VA+++ + + K E INE++++ + + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 150 ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHR 209
+ +V E+++ G+L D E + + E +L +LHS + HR
Sbjct: 88 VGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 210 DIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDV 269
DIKS NILL + K+ DFG I +Q+ +T V GT ++ PE + K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 270 YSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMT 329
+S G++ +E++ G+ P + A LY + ++ E++
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRA---------------LYLIATNGTPELQNPEKLSA 244
Query: 330 I-ATLATRCLNLNGKRRPTMKEV 351
I RCL+++ ++R + KE+
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN--EVVILSQIN-HRN 140
+ V + LG G G+VY G +VA+KK K EE +N EV L ++N H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNEHPN 59
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLR-IATEVAGSLSYLH 199
+VKL E + V+E++ G L+Q + D+ + P + E +R I ++ L+++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK-PFS-ESVIRSIIYQILQGLAHIH 116
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF- 258
HRD+K N+L++ K+ADFG ++ I + T V T Y PE
Sbjct: 117 KHGFF---HRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYV-STRWYRAPEILL 171
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKPI 286
RS ++ D+++ G ++ EL T +P+
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTL-RPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCC 148
+G+G G VYK + ++VA+K + E ++E+ E+ LSQ + K G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
L+ ++ E+ G+ L + L I EV L YLH + H
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEEGKI---H 121
Query: 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSD 268
RDIK+ NILL+E+ K+ADFG S + + T V GT ++ PE + + +K+D
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKAD 180
Query: 269 VYSFGVVLVELLTGQKP 285
++S G+ +EL G+ P
Sbjct: 181 IWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 8e-20
Identities = 57/213 (26%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 90 ILGQGGQGTVYKGMLAD-GRIVAVKKSKI----------VHEGKLEEFINEVVILSQINH 138
++G+G G VY + G ++AVK+ ++ + ++ +E+ L ++H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 139 RNVVKLLGCCLETEVPLLVY-EFISNGTLFQYL--HDQNEEFPLTWEMRLRIATEVAGSL 195
N+V+ LG TE L ++ E++ G++ L + + EE ++ +V L
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----QLVRFFTEQVLEGL 121
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTTKVQGTFGYLD 254
+YLHS I HRD+K+ N+L++ K++DFG SK I +QG+ ++
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 255 PEYFRSGQ--FTDKSDVYSFGVVLVELLTGQKP 285
PE S ++ K D++S G V++E+ G++P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 89 RILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGK-----LEEFINEVVILSQINHRNVV 142
++LGQG G VY D GR +AVK+ + + E+ +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEF-PLTWEMRLRIATEVAGSLSYLHSA 201
+ GC + E + E++ G++ DQ + + LT + + ++ + YLHS
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSK---FIVIDQTHVTTKVQGTFGYLDPEYF 258
I HRDIK NIL + K+ DFG SK I T + + V GT ++ PE
Sbjct: 124 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVI 179
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ K+DV+S G +VE+LT + P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVH----EGKLEEFINEVVILSQINHRNVVKLLG 146
+G+G G V+KG+ D R V KI+ E ++E+ E+ +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
L+ ++ E++ G+ L E PL I E+ L YLHS +
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKKI-- 123
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
HRDIK+ N+LL+E K+ADFG + + Q T V GT ++ PE + + K
Sbjct: 124 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 181
Query: 267 SDVYSFGVVLVELLTGQKP 285
+D++S G+ +EL G+ P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 51/176 (28%), Positives = 92/176 (52%), Gaps = 26/176 (14%)
Query: 125 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYL-HDQNEE------- 176
+F+ EV ILS++ N+++LLG C++ + ++ E++ NG L Q+L ++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 177 --------FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVAD 228
+++ L +A ++A + YL +S+ HRD+ + N L+ E T K+AD
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 229 FGTSKFIVIDQTHVTTKVQG----TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELL 280
FG S+ + + ++QG ++ E G+FT SDV++FGV L E+L
Sbjct: 182 FGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 2e-19
Identities = 58/198 (29%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
+GQG GTV+ + +A G+ VA+K+ + + K E INE++++ ++ + N+V L L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 150 ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHR 209
+ +V E+++ G+ L D E + + E +L +LH+ + HR
Sbjct: 87 VGDELFVVMEYLAGGS----LTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHR 139
Query: 210 DIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDV 269
DIKS N+LL + K+ DFG I +Q+ +T V GT ++ PE + K D+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 270 YSFGVVLVELLTGQKPII 287
+S G++ +E++ G+ P +
Sbjct: 199 WSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 28/230 (12%)
Query: 87 VNRILGQGGQGTVYKGM------LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
+ R LG+G G V+ D +VAVK K ++F E +L+ + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLH---------------DQNEEFPLTWEMRL 185
+VK G C + + ++V+E++ +G L ++L E L+ L
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QML 126
Query: 186 RIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTT 244
IA+++A + YL AS HRD+ + N L+ K+ DFG S+ + D V
Sbjct: 127 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 245 KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKE 293
++ PE +FT +SDV+SFGV+L E+ T G++P + E
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVH----EGKLEEFINEVVILSQINHRNVVKLLG 146
+G+G G VYKG+ D R V KI+ E ++E+ E+ +LSQ + + + G
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
L+ ++ E++ G+ L + PL I E+ L YLHS +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERKI-- 123
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
HRDIK+ N+LL+E+ K+ADFG + + Q T V GT ++ PE + + K
Sbjct: 124 -HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 267 SDVYSFGVVLVELLTGQKP 285
+D++S G+ +EL G+ P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 60/231 (25%), Positives = 113/231 (48%), Gaps = 10/231 (4%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCC 148
+ LG G G V+ G + VAVK K ++ F+ E ++ + H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
+ E ++ E+++ G+L +L E + + + ++A ++Y+ + H
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYI---H 126
Query: 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSD 268
RD+++ N+L++E K+ADFG ++ I ++ + + PE G FT KSD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 269 VYSFGVVLVELLT-GQKPII-LTGSKEATGLAAYFILSMEEN---RLYDFL 314
V+SFG++L E++T G+ P ++ S + L + + EN LYD +
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 91 LGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNVVK 143
+ +G G V+ LA G I A+K K+ ++ + ++++ + E ILSQ VVK
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 144 LLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
L + + L LV E++ G L L + R+ IA E+ +L YLHS
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDV-ARIYIA-EIVLALEYLHSNG 113
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV-------TTKVQGTFGYLDP 255
I HRD+K NIL++ K+ DFG SK ++ + ++ GT Y+ P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
E + D +S G +L E L G P
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 4e-19
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVH----EGKLEEFINEVVILSQINHRNVVKLLG 146
+G+G G V+KG+ D R V KI+ E ++E+ E+ +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
L+ ++ E++ G+ L +EF + ++ E+ L YLHS +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHSEKKI- 123
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTD 265
HRDIK+ N+LL+E+ K+ADFG + + Q T V GT ++ PE + +
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180
Query: 266 KSDVYSFGVVLVELLTGQKP 285
K+D++S G+ +EL G+ P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-19
Identities = 51/213 (23%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVKK------SKIVHEGKLEEFINEVVILSQI 136
+ + LG G + Y+ + G ++AVK+ + E +E E+ +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 137 NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
NH +++++LG E L E+++ G++ L + + ++ LS
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLS 117
Query: 197 YLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSKFIVIDQT---HVTTKVQGTFGY 252
YLH I HRD+K N+L++ ++ADFG + + T ++ GT +
Sbjct: 118 YLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ PE R Q+ DV+S G V++E+ T + P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
+G+G G V + GR VAVKK + + + E NEVVI+ H N+V++ L
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 150 ETEVPLLVYEFISNGTLFQYL-HDQ-NEEFPLTWEMRLRIAT---EVAGSLSYLHSAASM 204
+ +V EF+ G L + H + NEE +IAT V +LS+LH+
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEE---------QIATVCLAVLKALSFLHAQG-- 135
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT 264
+ HRDIKS +ILL K++DFG + + + V GT ++ PE +
Sbjct: 136 -VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYG 193
Query: 265 DKSDVYSFGVVLVELLTGQKP 285
+ D++S G++++E++ G+ P
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 76/287 (26%), Positives = 137/287 (47%), Gaps = 40/287 (13%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADG---RI-VAVKKSKIVHEGKL-EEFINEVVILSQINH 138
F ++LG G GTVYKG+ + +G +I VA+K+ + K +E ++E +++ +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+V +LLG CL + V L + + + G L Y+ + + + L ++A ++YL
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT---KVQGTFGYLDP 255
+ HRD+ + N+L+ K+ DFG +K + D+ KV + L+
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN--RLYDF 313
R +T +SDV+S+GV + EL+T GSK G+ A I S+ E RL
Sbjct: 183 ILHRI--YTHQSDVWSYGVTVWELMT-------FGSKPYDGIPASEISSILEKGERL--- 230
Query: 314 LDDQVLKVGQKEEIMTIAT--LATRCLNLNGKRRPTMKEVAMELERI 358
+ I TI + +C ++ RP +E+ +E ++
Sbjct: 231 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 91 LGQGGQGTVYK-GMLADGRIVAVKK--SKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
+G+G G V+K G VA+KK + + G + + E+ L H VVKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
+LV E++ L + L D EE PL + ++Y+H+ M
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANGIM--- 121
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKS 267
HRD+K N+L++ K+ADFG ++ ++ + + T Y PE + D
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 268 -DVYSFGVVLVELLTGQ 283
D+++ G + ELL G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKK----SKIVHEGKLEEFINEVVILSQINHRNVVK 143
R +G G G VY + +VA+KK K +E K ++ I EV L Q+ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQQLRHPNTIE 79
Query: 144 LLGCCLETEVPLLVYEF-ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
GC L LV E+ + + + +H + PL + IA G+L L
Sbjct: 80 YKGCYLREHTAWLVMEYCLGSASDILEVHKK----PL---QEVEIAAICHGALQGLAYLH 132
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS-- 260
S HRDIK+ NILL E T K+ADFG++ + + V GT ++ PE +
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMD 187
Query: 261 -GQFTDKSDVYSFGVVLVELLTGQKPI 286
GQ+ K DV+S G+ +EL + P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 9e-19
Identities = 71/223 (31%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEF----INEVVILSQIN 137
D F++ +G+G G VYK D G +VA+KK ++ +E E F I E+ IL Q+N
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 138 HRNVVKLLGCCLETEVPL----------LVYEFISN---GTLFQYLHDQNEEFPLTWEMR 184
HRN+V L + + L LV+E++ + G L L +E+ +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS---- 120
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT 244
++ L+Y H + HRDIK +NILLN K K+ADFG ++ +++ T
Sbjct: 121 --FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 245 KVQGTFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPI 286
T Y PE + + DV+S G +L EL T +KPI
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 68/201 (33%), Positives = 101/201 (50%), Gaps = 21/201 (10%)
Query: 90 ILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLE-EFINEVVILSQINHRNVVKLLGC 147
ILG G GTVYK L RI+AVK + +L+ + ++E+ IL + + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL-RIATEVAGSLSYLHSAASMPI 206
+ EF+ G+L D + P E L RIA V L+YL S + I
Sbjct: 68 FFVENRISICTEFMDGGSL-----DVYRKIP---EHVLGRIAVAVVKGLTYLWS---LKI 116
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIV--IDQTHVTTKVQGTFGYLDPEYFRSGQFT 264
HRD+K +N+L+N + K+ DFG S +V I +T+V GT Y+ PE Q+
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYG 171
Query: 265 DKSDVYSFGVVLVELLTGQKP 285
SDV+S G+ +EL G+ P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 24/274 (8%)
Query: 88 NRILGQGGQGTVYKG-MLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLG 146
++ +G +G YKG + +G VK+ V+ +E+ + ++ H N+VKL+G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIG 750
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
C + L++E+I L + L + L+WE R +IA +A +L +LH S +
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
++ I+++ K + + D + Y+ PE + T+K
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEK 858
Query: 267 SDVYSFGVVLVELLTGQKPI-ILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG--- 322
SD+Y FG++L+ELLTG+ P G + A + S + D D ++
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS---DCHLDMWIDPSIRGDVSV 915
Query: 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356
+ EI+ + LA C + RP +V LE
Sbjct: 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 82 TDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
D + + LG G G VYK + G A K +I E +LE+F+ E+ ILS+ H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLR-IATEVAGSLSYLH 199
+V L ++ EF G L + + E LT E ++R + ++ +L++LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGAL-DSIMLELER-GLT-EPQIRYVCRQMLEALNFLH 120
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTS-KFIVIDQTHVTTKVQGTFGYLDPEY- 257
S + HRD+K+ NILL K+ADFG S K Q T GT ++ PE
Sbjct: 121 SHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVV 175
Query: 258 ----FRSGQFTDKSDVYSFGVVLVELLTGQKP 285
F+ + K+D++S G+ L+EL + P
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 74/217 (34%), Positives = 108/217 (49%), Gaps = 41/217 (18%)
Query: 87 VNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFI-NEVVILSQINHRNVVKL 144
VNRI G G GTVYK + GR+ A+K HE + I E+ IL +NH NVVK
Sbjct: 79 VNRI-GSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK- 136
Query: 145 LGCCLET-----EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
C + E+ +L+ EF+ G+L + H +E+F L +A ++ ++YLH
Sbjct: 137 ---CHDMFDHNGEIQVLL-EFMDGGSL-EGTHIADEQF-LA-----DVARQILSGIAYLH 185
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH--VTTKVQGTFGYLDPEY 257
I HRDIK +N+L+N K+ADFG S+ ++ QT + V GT Y+ PE
Sbjct: 186 RRH---IVHRDIKPSNLLINSAKNVKIADFGVSR--ILAQTMDPCNSSV-GTIAYMSPER 239
Query: 258 FRSGQFTD---------KSDVYSFGVVLVELLTGQKP 285
TD D++S GV ++E G+ P
Sbjct: 240 IN----TDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 89 RILGQGGQGTVYKGMLA-DGRIVAVKKS-KIVHEGKL----EEFINEVVILSQINHRNVV 142
++LG G GTVYKG+ DG V + + K++ E +E ++E +++ + V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNE----EFPLTWEMRLRIATEVAGSLSYL 198
+LLG CL + V L V + + G L Y+ + + + L W ++A +SYL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT---KVQGTFGYLDP 255
+ + HRD+ + N+L+ K+ DFG ++ + ID+T KV + L+
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
R +FT +SDV+S+GV + EL+T G KP
Sbjct: 183 ILHR--RFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-18
Identities = 67/300 (22%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 71 KLFTTKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGK-----LE 124
++ EL K ++LG G GTV+KG+ + +G + + + + + +
Sbjct: 2 RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54
Query: 125 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMR 184
E + ++ + ++H +V+LLG C + L V + G+L ++ + L +
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS--LDPQRL 111
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI-DQTHVT 243
L ++A + YL + HR++ + NILL ++ADFG + + D+ +
Sbjct: 112 LNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY 168
Query: 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL 303
++ + ++ E G++T +SDV+S+GV + E+++ G++ G+
Sbjct: 169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS-------YGAEPYAGM------ 215
Query: 304 SMEENRLYDFLDDQVLKVGQK---EEIMTIAT--LATRCLNLNGKRRPTMKEVAMELERI 358
R ++ D +L+ G++ +I TI + +C ++ RPT KE+A E R+
Sbjct: 216 -----RPHEVPD--LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 9e-18
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 91 LGQGGQGTVYKGMLA----DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLG 146
+G+G G V +A GR VAVK + + + E NEVVI+ H+NVV++
Sbjct: 29 IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
L E ++ EF+ G L D + L E + V +L YLHS +
Sbjct: 86 SYLVGEELWVLMEFLQGGA----LTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---V 138
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
HRDIKS +ILL K++DFG I D + V GT ++ PE + +
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTE 197
Query: 267 SDVYSFGVVLVELLTGQKP 285
D++S G++++E++ G+ P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 78 LDKATDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQI 136
L T F + ++G+G G VYK G++VA+K I+ + + EE E IL +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 137 -NHRNVVKLLGCCLETEVPL------LVYEFISNGT---LFQYLHDQNEEFPLTWEMRLR 186
NH N+ G ++ P LV E G+ L + L + + L E
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--RLKEEWIAY 117
Query: 187 IATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV 246
I E L+YLH + HRDIK NILL + K+ DFG S + + +
Sbjct: 118 ILRETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSA-------QLDSTL 167
Query: 247 Q------GTFGYLDPEYFRSGQFTD-----KSDVYSFGVVLVELLTGQKP 285
GT ++ PE + D +SDV+S G+ +EL G+ P
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 91 LGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
+G+G G V + + G++VAVKK + + + E NEVVI+ H NVV++ L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 150 ETEVPLLVYEFISNGTLFQYL-HDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208
+ +V EF+ G L + H + E E + V +LS LH+ + H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ------GTFGYLDPEYFRSGQ 262
RDIKS +ILL K++DFG V+ +V GT ++ PE
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC-------AQVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 263 FTDKSDVYSFGVVLVELLTGQKP 285
+ + D++S G++++E++ G+ P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 82/308 (26%), Positives = 138/308 (44%), Gaps = 52/308 (16%)
Query: 83 DHFNVNRILGQGGQGTVY--------KGMLADGRIVAVKKSKI-VHEGKLEEFINEVVIL 133
D + + LG+G G V K + VAVK K E L + ++E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 134 SQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQN-------------EEFPL 179
I H+N++ LLG C + ++ E+ S G L +YL + + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 180 TWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI-VID 238
T++ + +VA + YL AS HRD+ + N+L+ E K+ADFG ++ + ID
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLA 298
TT + ++ PE +T +SDV+SFGV++ E+ T L GS
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGS------- 238
Query: 299 AYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT-----LATRCLNLNGKRRPTMKEVAM 353
Y + +EE L+ ++LK G + + T + C + RPT K++
Sbjct: 239 PYPGIPVEE--LF-----KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
Query: 354 ELERIQAL 361
+L+RI L
Sbjct: 292 DLDRILTL 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 74/267 (27%), Positives = 112/267 (41%), Gaps = 22/267 (8%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLG 146
LG+G G+V K L + ++ K+ ++ + E+ I +VK G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 147 CCL---ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL-RIATEVAGSLSYLHSAA 202
L + + + + E+ G+L + E L +IA V LSYLHS
Sbjct: 67 AFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
I HRDIK +NILL K K+ DFG S +V T GT Y+ PE +
Sbjct: 126 ---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKP 179
Query: 263 FTDKSDVYSFGVVLVELLTGQKPIILTGSKEA--TGLAAYFILSMEENRLYDFLDDQVLK 320
++ SDV+S G+ L+E+ + P G L +Y I++M L D+
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPEL---KDEPGNG 235
Query: 321 VGQKEEIMTIATLATRCLNLNGKRRPT 347
+ EE +CL + RRPT
Sbjct: 236 IKWSEE---FKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 71/234 (30%), Positives = 109/234 (46%), Gaps = 17/234 (7%)
Query: 84 HFNVNRILGQGGQGTVYKGMLADGR-------IVAVKKSKIVHEGKLEEFI-NEVVILSQ 135
+F + ++LG G G V+ G + +KK+ IV + K E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
I + L +T+ L L+ ++I+ G LF +L Q E F E+++ E+ +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK-EQEVQIYSG-EIVLA 117
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
L +LH + I +RDIK NILL+ + DFG SK D+ GT Y+
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 255 PEYFRSGQFT-DKS-DVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306
P+ R G DK+ D +S GV++ ELLTG P + G K + + IL E
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 18/233 (7%)
Query: 85 FNVNRILGQGGQGTVY---KGMLAD-GRIVAVK---KSKIVHEGKLEEFI-NEVVILSQI 136
F + ++LG G G V+ K D G++ A+K K+ +V + K E E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 137 NHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGS 194
+ L +TE L L+ +++S G +F +L+ Q + F E +R + E+ +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFS---EDEVRFYSGEIILA 117
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
L +LH + I +RDIK NILL+ + + DFG SK + ++ T GT Y+
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 255 PEYFRSGQFTDKS-DVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306
PE R K+ D +S G+++ ELLTG P L G + + IL +
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 49/169 (28%), Positives = 95/169 (56%), Gaps = 18/169 (10%)
Query: 125 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLH--------DQNEE 176
+F+ E+ I+S++ N+++LL C+ ++ ++ E++ NG L Q+L ++ +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 177 FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236
+++ + +AT++A + YL +S+ HRD+ + N L+ + YT K+ADFG S+ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 237 IDQTHVTTKVQG----TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281
+ ++QG ++ E G+FT SDV++FGV L E+LT
Sbjct: 182 SGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRN 140
F + + +G+G VY+ L D + VA+KK +I + ++ + E+ +L Q+NH N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQ---YLHDQNEEFP--LTWEMRLRIATEVAGSL 195
V+K L +E +V E G L Q Y Q P W+ +++ + ++
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS----AV 119
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
++HS M HRDIK N+ + K+ D G +F T + V GT Y+ P
Sbjct: 120 EHMHSRRVM---HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
E + KSD++S G +L E+ Q P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 71/239 (29%), Positives = 109/239 (45%), Gaps = 38/239 (15%)
Query: 69 RCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHE--GKLEE 125
RC+ + E +K +NRI G+G G VY+ G IVA+KK ++ +E G
Sbjct: 2 RCR--SVTEFEK------LNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPIS 52
Query: 126 FINEVVILSQINHRNVVKLL----GCCLETEVPLLVYEFISNGTLFQYLHD-----QNEE 176
+ E+ +L + H N+V+L G L++ LV E+ D N
Sbjct: 53 SLREITLLLNLRHPNIVELKEVVVGKHLDS--IFLVMEYCE--------QDLASLLDNMP 102
Query: 177 FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236
P + + ++ L YLH I HRD+K +N+LL +K K+ADFG ++
Sbjct: 103 TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
Query: 237 IDQTHVTTKVQGTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA 294
+ +T KV T Y PE +T D+++ G +L ELL KP +L G E
Sbjct: 160 LPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KP-LLPGKSEI 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 9/207 (4%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHR 139
+F + + +G+G VY+ L DG VA+KK +I + + I E+ +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL-RIATEVAGSLSYL 198
NV+K +E +V E G L + + ++ L E + + ++ +L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
HS M HRDIK N+ + K+ D G +F +T + GT Y+ PE
Sbjct: 123 HSRRVM---HRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ KSD++S G +L E+ Q P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 89 RILGQGGQGTVYKGMLADGR-------IVAVKKSKIVHEGKLEEFINEVVILSQINHRNV 141
++LG+G G V +LA+ + + +KK I+ + +E + E +L+
Sbjct: 1 KVLGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 142 VKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLH 199
+ L C +T+ L V E+++ G L ++ ++ F E R R A E+ L +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFD---EPRARFYAAEIVLGLQFLH 113
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK-FIVIDQTHVTTKVQGTFGYLDPEYF 258
I +RD+K N+LL+ + K+ADFG K I+ T T+ GT Y+ PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ D ++ GV+L E+L GQ P
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 59/180 (32%), Positives = 90/180 (50%), Gaps = 10/180 (5%)
Query: 107 GRIVAVKKSKIVHEGK-LEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVYEFISN 163
G VAVK K G + + E+ IL + H N+VK G C E L+ EF+ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223
G+L +YL + L + +L+ A ++ + YL S HRD+ + N+L+ ++
Sbjct: 93 GSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQ 147
Query: 224 AKVADFGTSKFIVIDQTHVTTK--VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281
K+ DFG +K I D+ + T K + + PE +F SDV+SFGV L ELLT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 74/201 (36%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 95 GQGTVYKGMLA----DGRIVAVK--KSKIVHEGKLEEFI--NEVVILSQINHRNVVKLLG 146
G+G+ K +LA DG+ AVK + KIV K ++ I V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHY 63
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEE-FPLTWEMRLRI-ATEVAGSLSYLHSAASM 204
TE V +F++ G LF H Q E FP E R R A E+A +L YLHS +
Sbjct: 64 SFQTTEKLYFVLDFVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS---I 115
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT 264
I +RD+K NILL+ + + DFG K I Q+ TT GT YL PE R +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 265 DKSDVYSFGVVLVELLTGQKP 285
+ D + G VL E+L G P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 91 LGQGGQGTVYKGMLA-DGRIVAVKK----SKIVHEGKLEEFINEVVILSQINHRNVVKLL 145
+G G G VY + +VAVKK K +E K ++ I EV L Q+ H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 146 GCCLETEVPLLVYEF-ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL---SYLHSA 201
GC L+ LV E+ + + + +H + PL + IA G+L +YLHS
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKK----PL---QEVEIAAITHGALQGLAYLHSH 140
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS- 260
+ HRDIK+ NILL E K+ADFG++ + V GT ++ PE +
Sbjct: 141 NMI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 261 --GQFTDKSDVYSFGVVLVELLTGQKPI 286
GQ+ K DV+S G+ +EL + P+
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-17
Identities = 75/273 (27%), Positives = 131/273 (47%), Gaps = 46/273 (16%)
Query: 110 VAVKKSKIVHEGK-LEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLV-YEFISNGTL 166
VAVK K K L + I+E+ ++ I H+N++ LLG C + E PL V E+ + G L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGNL 105
Query: 167 FQYLHDQN-------------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKS 213
++L + E L+++ + A +VA + YL S + HRD+ +
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLAA 162
Query: 214 TNILLNEKYTAKVADFGTSKFI-VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSF 272
N+L+ E K+ADFG ++ + ID T+ + ++ PE +T +SDV+SF
Sbjct: 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 273 GVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT 332
G+++ E+ T L GS Y + +EE L+ ++L+ G + + + T
Sbjct: 223 GILMWEIFT------LGGS-------PYPGIPVEE--LF-----KLLREGHRMDKPSNCT 262
Query: 333 -----LATRCLNLNGKRRPTMKEVAMELERIQA 360
L C + +RPT K++ L+++ A
Sbjct: 263 HELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 72/205 (35%), Positives = 107/205 (52%), Gaps = 17/205 (8%)
Query: 89 RILGQGGQGTVY---KGMLAD-GRIVAVK--KSKIVHEGKLEEFINEVVILSQINHRNVV 142
++LGQG G V+ K D G++ A+K K + E IL+++NH +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 143 KLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWE-MRLRIATEVAGSLSYLHS 200
KL +TE L L+ +F+ G LF L ++E T E ++ +A E+A +L +LHS
Sbjct: 62 KL-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLA-ELALALDHLHS 116
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
+ I +RD+K NILL+E+ K+ DFG SK ID GT Y+ PE
Sbjct: 117 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKP 285
T +D +SFGV++ E+LTG P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 85 FNVNRILGQGGQGTVYKGMLADGR-------IVAVKKSKIVHEGKLEEFINEVVILSQIN 137
+ + + +G+G G +Y LA + I + +K+ + K E EV++L+++
Sbjct: 2 YEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMK 57
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQ-----NEEFPLTWEMRLRIATEVA 192
H N+V E +V E+ G L + ++ Q +E+ L+W +++
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQIS 111
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSKFIVIDQTHVTTKVQGTFG 251
L ++H I HRDIKS NI L++ AK+ DFG ++ + D + GT
Sbjct: 112 LGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPY 167
Query: 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
YL PE ++ + +K+D++S G VL EL T + P
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 89 RILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNV 141
R+LG+G G V MLA GR+ AVK K I+ + +E + E ILS +
Sbjct: 1 RVLGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 142 VKLLGCCLET-EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLH 199
+ L CC +T + V EF++ G L ++ ++ F E R R A E+ +L +LH
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEITSALMFLH 113
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
I +RD+K N+LL+ + K+ADFG K + + T+ GT Y+ PE +
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTFCGTPDYIAPEILQ 169
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKP 285
+ D ++ GV+L E+L G P
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 13/215 (6%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLA-DGR---IVAVKKSKIVHEGKLEE-FINEVV 131
ELD + + RILG G G + +G L + VA+ + K F+ E +
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 132 ILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEV 191
L Q +H N+V+L G ++V E++SNG L +L + E L + + +
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGL 116
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFG 251
A + YL + M H+ + + +L+N K++ F + + + T +
Sbjct: 117 ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173
Query: 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
+ PE + F+ SDV+SFG+V+ E+++ G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 39/279 (13%)
Query: 91 LGQGGQGTVYKGMLADG--RIVAVK----------KSKIVHEGKLEEFINEVVIL-SQIN 137
LG G G VYK + ++A+K K K + + + ++EV I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISN---GTLFQYLHDQNEEFPLTWEMRL-RIATEVAG 193
H N+V+ LE + +V + I G F L ++ + F E R+ I ++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMVL 124
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
+L YLH I HRD+ NI+L E + DFG +K T V GT Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYS 180
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313
PE ++ + +K+DV++FG +L ++ T Q P S LA + +Y+
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY---STNMLSLATKIV-----EAVYEP 232
Query: 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVA 352
L + + + + T CL + + RP + +V+
Sbjct: 233 LPEGMYS-------EDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 87 VNRILGQGGQGTVYKGM-LADGRIVAVKKSKIV--HEGKLEEFINEVVILSQI---NHRN 140
+ I G+G GTVYK L GR VA+KK ++ EG + E+ +L Q+ H N
Sbjct: 4 LAEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 141 VVKLLGCC----LETEVPL-LVYEFISNGTLFQYLHDQNEEFP---LTWEMRLRIATEVA 192
+V+LL C + E+ L LV+E + Q L + P L E + ++
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
+ +LHS I HRD+K NIL+ K+ADFG ++ + T V T Y
Sbjct: 118 RGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR--IYSFEMALTSVVVTLWY 172
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVEL 279
PE + D++S G + EL
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 85 FNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKL 144
+ + LG G G V+ VAVK K +E F+ E ++ + H +VKL
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLH-DQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
+ E ++ EF++ G+L +L D+ + PL + + ++A ++++
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRNY 123
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF 263
+ HRD+++ NIL++ K+ADFG ++ I ++ + + PE G F
Sbjct: 124 I---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 264 TDKSDVYSFGVVLVELLT-GQKP 285
T KSDV+SFG++L+E++T G+ P
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 76/242 (31%), Positives = 114/242 (47%), Gaps = 36/242 (14%)
Query: 61 TSSDGSI---DRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLADGR---IVAVKK 114
TS GS+ + +LF ++ +K F R +G G G VY D R +VA+KK
Sbjct: 3 TSRAGSLKDPEIAELFFKEDPEKL---FTDLREIGHGSFGAVY--FARDVRTNEVVAIKK 57
Query: 115 ---SKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF-ISNGTLFQYL 170
S K ++ I EV L +I H N ++ GC L LV E+ + + + +
Sbjct: 58 MSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEV 117
Query: 171 HDQNEEFPLTWEMRLRIATEVAGSL---SYLHSAASMPIYHRDIKSTNILLNEKYTAKVA 227
H + PL + IA G+L +YLHS + HRDIK+ NILL E K+A
Sbjct: 118 HKK----PL---QEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLA 167
Query: 228 DFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS---GQFTDKSDVYSFGVVLVELLTGQK 284
DFG++ + V GT ++ PE + GQ+ K DV+S G+ +EL +
Sbjct: 168 DFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222
Query: 285 PI 286
P+
Sbjct: 223 PL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 9/204 (4%)
Query: 85 FNVNRILGQG--GQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
+NV R++G+G G+ + + + +D + + +E+ E V+L+++ H N+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 143 KLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
E + L +V E+ G L Q + Q + + L+ ++ + ++H
Sbjct: 62 AFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHEK 119
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
+ HRDIKS NI L + K+ DFG+++ + + T V GT Y+ PE + +
Sbjct: 120 R---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 262 QFTDKSDVYSFGVVLVELLTGQKP 285
+ +KSD++S G +L EL T + P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 91 LGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
+G+G G V G+ VAVKK + + + E NEVVI+ +H NVV + L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 150 ETEVPLLVYEFISNGTLFQYL-HDQ-NEEFPLTWEMRLRIAT---EVAGSLSYLHSAASM 204
+ +V EF+ G L + H + NEE +IAT V +LSYLH+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEE---------QIATVCLSVLRALSYLHNQG-- 138
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT 264
+ HRDIKS +ILL K++DFG V + + GT ++ PE +
Sbjct: 139 -VIHRDIKSDSILLTSDGRIKLSDFGFCA-QVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 265 DKSDVYSFGVVLVELLTGQKP 285
+ D++S G++++E++ G+ P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 44/270 (16%)
Query: 110 VAVKKSKIVHEGK-LEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLF 167
VAVK K K L + ++E+ ++ I H+N++ LLG C + ++ E+ S G L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 168 QYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKST 214
+YL + E LT++ + A +VA + YL AS HRD+ +
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 215 NILLNEKYTAKVADFGTSKFI-VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFG 273
N+L+ E K+ADFG ++ + ID TT + ++ PE +T +SDV+SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 274 VVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT- 332
V+L E+ T G + Y + +EE L+ ++LK G + + T
Sbjct: 224 VLLWEIFT-------------LGGSPYPGIPVEE--LF-----KLLKEGHRMDKPANCTH 263
Query: 333 ----LATRCLNLNGKRRPTMKEVAMELERI 358
+ C + +RPT K++ +L+R+
Sbjct: 264 ELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 84 HFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEG-----KLEEFINEVVILSQIN 137
++ + ++LGQG G VY AD GR +AVK+ + E ++ E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 138 HRNVVKLLGCCLET-EVPLLVY-EFISNGTLFQYLHDQNEEF-PLTWEMRLRIATEVAGS 194
H +V+ GC + E L ++ E + G++ DQ + + LT + + ++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSI----KDQLKSYGALTENVTRKYTRQILEG 118
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK---FIVIDQTHVTTKVQGTFG 251
+SYLHS I HRDIK NIL + K+ DFG SK I + T + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174
Query: 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
++ PE + K+D++S G +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 78/289 (26%), Positives = 134/289 (46%), Gaps = 45/289 (15%)
Query: 91 LGQGGQGTVYKGML---ADG---RIVAVKKSKIVHEGKL-EEFINEVVILSQINHRNVVK 143
LG+ G VYKG L A G + VA+K K EG L EEF +E ++ S++ H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYL-----------HDQNEEFPLTWEMR--LRIATE 190
LLG + + +++ + S+ L ++L D ++ T E + I T+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT- 249
+A + +L +S + H+D+ + N+L+ +K K++D G + + + K+ G
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGNS 186
Query: 250 ---FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306
++ PE G+F+ SD++S+GVVL E+ + G + G + ++ M
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS-------YGLQPYCGYSNQDVIEMI 239
Query: 307 ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355
NR QVL + + TL C N RRP K++ L
Sbjct: 240 RNR-------QVLPC-PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 89 RILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEG-----KLEEFINEVVILSQINHRNVV 142
++LGQG G VY D GR +A K+ + E ++ E+ +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 143 KLLGCCLE-TEVPLLVY-EFISNGTLFQYLHDQNEEF-PLTWEMRLRIATEVAGSLSYLH 199
+ GC + E L ++ E++ G++ DQ + + LT + + ++ +SYLH
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSV----KDQLKAYGALTESVTRKYTRQILEGMSYLH 123
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK---FIVIDQTHVTTKVQGTFGYLDPE 256
S I HRDIK NIL + K+ DFG SK I + T + + V GT ++ PE
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPE 179
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ K+DV+S G +VE+LT + P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 85 FNVNRILGQGGQGTVYKGML-ADGRIVAVKK--SKIVHEGKLEEF-INEVVILSQINHRN 140
F R+LG+GG G V + A G++ A KK K + + K E +NE IL ++N R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTL-FQYLHDQNEEFPLTWEMR-LRIATEVAGSLSYL 198
VV L + LV ++ G L F H F E R + A E+ L L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFYAAEICCGLEDL 118
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
H I +RD+K NILL++ +++D G + + QT + +V GT GY+ PE
Sbjct: 119 HQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVV 173
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKP 285
++ ++T D ++ G +L E++ GQ P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 25/193 (12%)
Query: 107 GRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLL--GCCLETEVPLL--VYE 159
G VA+K + E + F E + +++ H N+V LL G E LL V+E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAVFE 59
Query: 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN 219
++ TL + L L R+ +V +L+ H+ I HRD+K NI+++
Sbjct: 60 YVPGRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVS 113
Query: 220 E---KYTAKVADFGTSKFI----VIDQTHVT--TKVQGTFGYLDPEYFRSGQFTDKSDVY 270
+ + AKV DFG + D +T T+V GT Y PE R T SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 271 SFGVVLVELLTGQ 283
++G++ +E LTGQ
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI--VHEGKLEEFI-NEVVILSQINH 138
D + +G G G V+ A+K I V K E+ + NE +L +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+++L + ++ E++ G LF YL + + L A+E+ +L YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYL 117
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
HS I +RD+K NILL+++ K+ DFG +K + D+T + GT YL PE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWT---LCGTPEYLAPEVI 170
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKP 285
+S D ++ G+++ E+L G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKK----SKIVHEGKLEEFINEVVILSQINHRNVVK 143
R +G G G VY + + +VA+KK K +E K ++ I EV L ++ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHPNTIQ 79
Query: 144 LLGCCLETEVPLLVYEF-ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVA-GSLSYLHSA 201
GC L LV E+ + + + +H + PL E+ + T A L+YLHS
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQ-EVEIAAVTHGALQGLAYLHSH 134
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS- 260
+ HRD+K+ NILL+E K+ DFG++ + V GT ++ PE +
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186
Query: 261 --GQFTDKSDVYSFGVVLVELLTGQKPI 286
GQ+ K DV+S G+ +EL + P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 75/296 (25%), Positives = 133/296 (44%), Gaps = 46/296 (15%)
Query: 90 ILGQGGQGTVYKGMLA-DGRIV--AVKKSK-IVHEGKLEEFINEVVILSQI-NHRNVVKL 144
++G+G G V + M+ DG + A+K K E +F E+ +L ++ +H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQN--EEFP-----------LTWEMRLRIATEV 191
LG C + E+ G L +L E P LT + L+ A++V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF--IVIDQTHVTTKVQGT 249
A + YL + HRD+ + N+L+ E +K+ADFG S+ + + +T V+
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR-- 183
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPII-LTGSKEATGLAAYFILSMEE 307
++ E +T KSDV+SFGV+L E+++ G P +T ++ L + +
Sbjct: 184 --WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPR 241
Query: 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363
N DD+V + L +C RP +++++L R+ +K
Sbjct: 242 N-----CDDEVYE------------LMRQCWRDRPYERPPFAQISVQLSRMLEARK 280
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 67/240 (27%), Positives = 102/240 (42%), Gaps = 40/240 (16%)
Query: 81 ATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF----INEVVILSQ 135
+ + LG+G G VYK + GR+VA+KK ++H K + F + E+ IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEK-DGFPITALREIKILKK 63
Query: 136 INHRNVVKLLGCCLE-----TEVPLLVYEFISNGTLFQYL-HD-----QNEEFPLTWEMR 184
+ H NVV L+ +E VY + Y+ HD +N LT
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVY------MVTPYMDHDLSGLLENPSVKLTESQI 117
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG----------TSKF 234
++ ++YLH I HRDIK+ NIL++ + K+ADFG K
Sbjct: 118 KCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 235 IVIDQTHVTTKVQGTFGYLDPEY-FRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
T T + T Y PE ++T D++ G V E+ T +P IL G +
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RP-ILQGKSD 232
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 23/199 (11%)
Query: 95 GQGTVYKGMLA----DGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRNVVKLLGCC 148
G+G+ K +L DG+ +K+ I + + EE EV +LS + H N+V+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQN-----EEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
E +V ++ G L++ ++ Q E+ L W +++ +A L ++H
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK- 121
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQ 262
I HRDIKS NI L + T K+ DFG ++ V++ T + GT YL PE +
Sbjct: 122 --ILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICENRP 177
Query: 263 FTDKSDVYSFGVVLVELLT 281
+ +KSD+++ G VL E+ T
Sbjct: 178 YNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 14/221 (6%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVH----EGKLEEFINEVVILSQINHRNVVKLLG 146
LG G G V K ++ +K ++H + I E+ +L + N +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARK--LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
+ E + G+L Q L + + E+ +++ V L+YL I
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQ--I 125
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
HRD+K +NIL+N + K+ DFG S ++ + GT Y+ PE + ++ +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 267 SDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307
SD++S G+ LVEL G+ PI +KE + ++ EE
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEE 223
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 91 LGQGGQGTVYKGMLA-DGRIVAVK--KSKIVHEGKLEEFI-NEVVILSQINHRNVVKLLG 146
LG GG G V + R A+K K + + E +E I +E IL + NH +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
+ + ++ E+ G L+ L D+ F + R IA V YLH+ I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-FD-EYTARFYIACVVLA-FEYLHNRG---I 114
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
+RD+K N+LL+ K+ DFG +K + T GT Y+ PE + +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 267 SDVYSFGVVLVELLTGQKP 285
D +S G++L ELLTG+ P
Sbjct: 173 VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 62/272 (22%), Positives = 120/272 (44%), Gaps = 32/272 (11%)
Query: 93 QGGQGTVYKGMLADGRIV--AVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE 150
+ Q ++YKG+ + ++ KK H+ ++ NE+ L +I+ N++K+ G ++
Sbjct: 30 ENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89
Query: 151 TEVPL----LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
L L+ E+ + G L + L ++E L+++ +L +A + L L+ + P
Sbjct: 90 IVDDLPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS--GQFT 264
++++ S + L+ E Y K+ G K + + K Y + ++T
Sbjct: 146 -YKNLTSVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLNDIFSEYT 200
Query: 265 DKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQK 324
K D+YS GVVL E+ TG+ P + T Y ++ + N L LD +
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPF-----ENLTTKEIYDLIINKNNSLKLPLDCPLE----- 250
Query: 325 EEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356
I + C + + +RP +KE+ L
Sbjct: 251 -----IKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 74 TTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRI--VAVK---KSKIVHEGKLEEFIN 128
++ + FN R LG G G V + VA+K KSKI+ + +++ +
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
E IL+ INH V L G + LV EF+ G F +L +N+ FP ++ A
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPN--DVGCFYA 137
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG 248
++ YL S+ I +RD+K N+LL++ K+ DFG +K V+D T + G
Sbjct: 138 AQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTR--TYTLCG 190
Query: 249 TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
T Y+ PE + +D ++ G+ + E+L G P
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 84 HFNVNRILGQGGQGTVYKGMLAD-GRIVAVKK----------SKIVHEGKLEEFINEVVI 132
++ + ++LG+G G VY AD GR +AVK+ SK V+ LE E+ +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVN--ALE---CEIQL 57
Query: 133 LSQINHRNVVKLLGCCLE-TEVPLLVY-EFISNGTLFQYLHDQNEEF-PLTWEMRLRIAT 189
L + H +V+ GC + E L ++ E++ G++ DQ + + LT + R
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI----KDQLKAYGALTENVTRRYTR 113
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK---FIVIDQTHVTTKV 246
++ +SYLHS I HRDIK NIL + K+ DFG SK I + T + + V
Sbjct: 114 QILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-V 169
Query: 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
GT ++ PE + K+DV+S +VE+LT + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCC 148
LG+G G+VYK + G +A+K+ ++ + E K + I E+ IL + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL-RIATEVAGSLSYLHSAASMPIY 207
+ E++ G+L L+ E L RI V L +L I
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIV--IDQTHVTTKVQGTFGYLDPEYFRSG---- 261
HRD+K TN+L+N K+ DFG S +V + +T++ G Y+ PE +SG
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQ 180
Query: 262 --QFTDKSDVYSFGVVLVELLTGQKP 285
+T +SDV+S G+ ++E+ G+ P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 67/204 (32%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINE-VVILSQINHRNVVK 143
+++G+G G V ADG+ AVK K I+ + + + + E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNEE-FPLTWEMRLRI-ATEVAGSLSYLHSA 201
L + V ++++ G LF H Q E FP E R R A E+A +L YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS- 114
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
+ I +RD+K NILL+ + + DFG K I+ + T+ GT YL PE R
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 262 QFTDKSDVYSFGVVLVELLTGQKP 285
+ D + G VL E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 11/208 (5%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV 141
+ F + + +G G G VYK + G + A+K K+ E++++ H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
V G L + + EF G+L H PL+ ++ E L YLHS
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK 125
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF--- 258
M HRDIK NILL + K+ADFG S I + + GT ++ PE
Sbjct: 126 GKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVE 181
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKPI 286
R G + D+++ G+ +EL Q P+
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 11/200 (5%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
+G G G VYK L G + AVK K+ E+ ++ + H N+V G L
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 150 ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHR 209
E + E+ G+L H PL+ + E L+YLHS M HR
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKGKM---HR 130
Query: 210 DIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF---RSGQFTDK 266
DIK NILL + K+ADFG + I + + GT ++ PE ++G +
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYNQL 189
Query: 267 SDVYSFGVVLVELLTGQKPI 286
D+++ G+ +EL Q P+
Sbjct: 190 CDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 91 LGQGGQGTVYK------GMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKL 144
LG G G VYK G LA +++ K E +LE+++ E+ IL+ NH +VKL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKL 74
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLR-IATEVAGSLSYLHSAAS 203
LG ++ EF G + + + + E +++ I ++ +L YLHS
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS--- 128
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF 263
M I HRD+K+ N+LL K+ADFG S V + + GT ++ PE
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETM 187
Query: 264 TD-----KSDVYSFGVVLVELLTGQKP 285
D K+D++S G+ L+E+ + P
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 90 ILGQGGQGTVYKGML-ADG-RI-VAVKKSK-IVHEGKLEEFINEVVILSQIN-HRNVVKL 144
++G+G G V K + DG R+ A+K+ K + +F E+ +L ++ H N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQN--EEFP-----------LTWEMRLRIATEV 191
LG C L E+ +G L +L E P L+ + L A +V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFG 251
A + YL + HRD+ + NIL+ E Y AK+ADFG S+ Q K G
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLP 186
Query: 252 --YLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281
++ E +T SDV+S+GV+L E+++
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 89 RILGQGGQGTVYKGMLADGR-----IVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVK 143
++LG+G G V L G+ + A+KK ++ + +E + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 144 LLGCCLETEVPLL-VYEFISNGTLFQYLHDQN--EEFPLTWEMRLRIATEVAGSLSYLHS 200
L C +T+ L V EF++ G L ++ D+ + + T+ A E+ L +LHS
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHS 114
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
I +RD+K N++L+ K+ADFG K V +T GT Y+ PE +
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG 170
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKP 285
++T D +SFGV+L E+L GQ P
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN-----EVVILSQINHRNVVKL 144
+G G G VYK G ++AVK+ + G EE +VV+ S + +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQ--MRRTGNKEENKRILMDLDVVLKSH-DCPYIVKC 79
Query: 145 LGCCL-ETEVPLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMRL-RIATEVAGSLSYLHSA 201
G + +++V + E +S T L + P E L ++ + +L YL
Sbjct: 80 YGYFITDSDV-FICMELMS--TCLDKLLKRIQGPIP---EDILGKMTVAIVKALHYLKEK 133
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
+ HRD+K +NILL+ K+ DFG S +V + T+ G Y+ PE
Sbjct: 134 HG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPP 189
Query: 262 QFTDK----SDVYSFGVVLVELLTGQKP 285
K +DV+S G+ LVEL TGQ P
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 91 LGQGGQGTVYKGMLAD-GRIVAVKK-SKIVHEGKLEEFINEV-VILSQINHRNVVKLLGC 147
+G+G GTV K + G I+AVK+ V E + + + ++ V++ + +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 148 CLETEVPLLVYEF--ISNGTLFQYLHD-QNEEFPLTWEMRLRIATEVAGSLSYLHSAASM 204
+ E IS ++Y+++ P E+ +IA +L+YL +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIP--EEILGKIAVATVKALNYLKE--EL 127
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIV--IDQTHVTTKVQGTFGYLDPEYFRSGQ 262
I HRD+K +NILL+ K+ DFG S +V I +T G Y+ PE
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPERIDPSA 183
Query: 263 ---FTDKSDVYSFGVVLVELLTGQKP 285
+ +SDV+S G+ L E+ TG+ P
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKL--EEFINEVVILSQINHR 139
+++ R++G+GG G VY R VA+KK + + E L + F+ E I + + H
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHD--QNEEFPLTWEMR------LRIATEV 191
+V + C + + +I TL L Q E + L I ++
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH---------- 241
++ Y+HS + HRD+K NILL + D+G + F +++
Sbjct: 123 CATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 242 -------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281
+ K+ GT Y+ PE ++ +D+Y+ GV+L ++LT
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGC 147
+G+G G VYK G IVA+KK ++ EG I E+ +L ++NH N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
LV+EF+ + L +Y+ D + L + ++ ++Y HS +
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VL 121
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDK 266
HRD+K N+L++ + K+ADFG ++ + T +V T Y PE Q++
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTP 180
Query: 267 SDVYSFGVVLVELLTGQKPI 286
D++S G + E++ ++P+
Sbjct: 181 VDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
E ++L +NH +V+++ + + +V + L+ YL PL + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYL--TKRSRPLPIDQALIIE 163
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG 248
++ L YLH+ I HRD+K+ NI +N+ + D G ++F V+ + + G
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--GLAG 218
Query: 249 TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELL 280
T PE ++ K+D++S G+VL E+L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 85 FNVNRILGQGGQGTVYKGMLADGR-------IVAVKKSKIVHEGKLEEFINEVVILSQIN 137
F +LG+G G V +LA+ + I A+KK I+ ++E + E I N
Sbjct: 1 FRCLAVLGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 138 ---HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAG 193
H +V L C + V E+ + G L +H + F E R A V
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLM--MHIHTDVFS---EPRAVFYAACVVL 112
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK-FIVIDQTHVTTKVQGTFGY 252
L YLH I +RD+K N+LL+ + K+ADFG K + T+ GT +
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEF 167
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
L PE +T D + GV++ E+L G+ P
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGC 147
+G+G G VYKG G+IVA+KK ++ EG I E+ +L ++ H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS------- 200
++ L++EF+S L +YL + P M + SYL+
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYL----DSLPKGQYMDAELVK------SYLYQILQGILF 116
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
S + HRD+K N+L++ K K+ADFG ++ I V T T Y PE
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLG 175
Query: 261 GQ-FTDKSDVYSFGVVLVELLTGQKPI 286
++ D++S G + E+ T +KP+
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 66/239 (27%), Positives = 99/239 (41%), Gaps = 46/239 (19%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
D F V +++G+G G V+ L G++ A+K KS ++ ++ E IL+
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
+ +VKL + E L LV E++ G L L ++ FP R IA E+ +
Sbjct: 58 ADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEET-ARFYIA-ELVLA 113
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK-------------------FI 235
L +H + HRDIK NIL++ K+ADFG K F
Sbjct: 114 LDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 236 VIDQTHVTTKVQ---------GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Q GT Y+ PE R + + D +S GV+L E+L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 6e-14
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 21/216 (9%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH-RNVV 142
F + ++G G G VYKG + G++ A+K + + + EE E+ +L + +H RN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 143 KLLGCCLETEVP------LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
G ++ P LV EF G++ + + L E I E+ LS
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLS 125
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDP 255
+LH + HRDIK N+LL E K+ DFG S +D+T GT ++ P
Sbjct: 126 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAP 180
Query: 256 EYFRSGQFTD-----KSDVYSFGVVLVELLTGQKPI 286
E + D KSD++S G+ +E+ G P+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 6e-14
Identities = 75/291 (25%), Positives = 127/291 (43%), Gaps = 46/291 (15%)
Query: 90 ILGQGGQGTVYKGMLA-DGRIV--AVKKSK-IVHEGKLEEFINEVVILSQINHR-NVVKL 144
++G+G G V K + DG + A+K+ K + +F E+ +L ++ H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQN--EEFP-----------LTWEMRLRIATEV 191
LG C L E+ +G L +L E P L+ + L A +V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF--IVIDQTHVTTKVQGT 249
A + YL + HRD+ + NIL+ E Y AK+ADFG S+ + + +T V+
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPII-LTGSKEATGLAAYFILSMEE 307
++ E +T SDV+S+GV+L E+++ G P +T ++ L + L
Sbjct: 177 --WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234
Query: 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
N DD+V L +C RP+ ++ + L R+
Sbjct: 235 N-----CDDEVYD------------LMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 90 ILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFI--NEVVILSQINHRNVVKLLG 146
++G+G G V K + G+IVA+KK + K+ + I E+ +L Q+ H N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFP--LTWEMRLRIATEVAGSLSYLHSAASM 204
+ LV+EF+ + L D E++P L + ++ + + HS
Sbjct: 68 VFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF-RSGQF 263
I HRDIK NIL+++ K+ DFG ++ + T V T Y PE ++
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKY 178
Query: 264 TDKSDVYSFGVVLVELLTGQ 283
D+++ G ++ E+LTG+
Sbjct: 179 GRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 67/200 (33%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 95 GQGTVYKGMLA----DGRIVAVK--KSKIVHEGKLEEFI--NEVVILSQINHRNVVKLLG 146
G+G+ K +LA DG AVK + K + + K + I V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLHSAASMP 205
E V ++++ G LF H Q E L E R R A EVA ++ YLHS +
Sbjct: 64 SFQTAEKLYFVLDYVNGGELF--FHLQRERCFL--EPRARFYAAEVASAIGYLHS---LN 116
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTD 265
I +RD+K NILL+ + + DFG K V + T+ GT YL PE R +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGV-EPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 266 KSDVYSFGVVLVELLTGQKP 285
D + G VL E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 84 HFNVNRILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINHR 139
F + +GQGG G V+ D G IVA+K KS + ++ + E IL+
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 140 NVVKLLGCCLETEVPLLVYEFISNG---TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
+VKLL + E L E++ G TL L +E+ R +A E+ ++
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYMA-EMFEAVD 115
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
LH + HRD+K N L++ K+ DFG SK IV T+ + V G+ Y+ PE
Sbjct: 116 ALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPE 168
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
R + D +S G +L E L G P
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 20/218 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLE-------EFINEVVILSQ 135
D F LG G G V+K ++ +K ++H LE + I E+ +L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARK--LIH---LEIKPAIRNQIIRELQVLHE 59
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
N +V G + E + G+L Q L + ++ +++ V L
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 116
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
+YL I HRD+K +NIL+N + K+ DFG S ++ + GT Y+ P
Sbjct: 117 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 171
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
E + ++ +SD++S G+ LVE+ G+ PI +KE
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 67/248 (27%), Positives = 105/248 (42%), Gaps = 42/248 (16%)
Query: 87 VNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF---------------INEV 130
LG+G G V K G+IVA+KK KI+ E + + E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 131 VILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATE 190
I+++I H N++ L+ +E + LV + I L + + + + LT I +
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVV---DRKIRLTESQVKCILLQ 127
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID------------ 238
+ L+ LH M HRD+ NI +N K K+ADFG ++
Sbjct: 128 ILNGLNVLHKWYFM---HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 239 --QTHVTTKVQGTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEAT 295
+ +T+KV T Y PE + ++ D++S G + ELLTG KP + G E
Sbjct: 185 QRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KP-LFPGENEID 241
Query: 296 GLAAYFIL 303
L F L
Sbjct: 242 QLGRIFEL 249
|
Length = 335 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRNVVKLLGC 147
+G+G G VYK G +VA+KK ++ EG I E+ +L ++NH N+VKLL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 148 CLETEVPL-LVYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
+ TE L LV+EF+ + L +++ PL + ++ L++ HS
Sbjct: 68 -IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLP--LIKSYLFQLLQGLAFCHSHR--- 120
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSK-FIVIDQTHVTTKVQGTFGYLDPEYFRSGQF- 263
+ HRD+K N+L+N + K+ADFG ++ F V +T+ V T Y PE ++
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYY 178
Query: 264 TDKSDVYSFGVVLVELLT 281
+ D++S G + E++T
Sbjct: 179 STAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKS-KIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149
LG G G VYK + ++A K E +LE+++ E+ IL+ +H N+VKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 150 ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHR 209
++ EF + G + + + E PLT + + +L+YLH I HR
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHR 127
Query: 210 DIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ------GTFGYLDPEYFRSGQF 263
D+K+ NIL K+ADFG S T +Q GT ++ PE
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS-------AKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 264 TD-----KSDVYSFGVVLVELLTGQKP 285
D K+DV+S G+ L+E+ + P
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 85 FNVNRILGQGGQGTVYKGML-ADGRIVAVKK--SKIVHEGKLEEF-INEVVILSQINHRN 140
F R+LG+GG G V + A G++ A K+ K + + K E +NE IL ++N +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMR-LRIATEVAGSLSYLH 199
VV L ET+ L + I NG ++ H N P E R L A E+ L LH
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
+RD+K NILL++ +++D G + + I + GT GY+ PE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKP 285
+ ++T D + G ++ E++ GQ P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 91 LGQGGQGTVYK-GMLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNVVKLLG 146
LG+GG G V + A G++ A K K ++ + +NE IL +++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 147 CCLETEVPL-LVYEFISNGTLFQYLHDQNEE-FPLTWEMRLRI-ATEVAGSLSYLHSAAS 203
ET+ L LV ++ G L ++++ E FP E R A ++ L +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIICGLEHLHQRR- 115
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF 263
I +RD+K N+LL++ +++D G + + + + GT GY+ PE + +
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGEVY 171
Query: 264 TDKSDVYSFGVVLVELLTGQKP 285
D ++ G L E++ G+ P
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 89 RILGQGGQGTVYKGMLADGR-------IVAVKKSKIVHEGKLEEFINEVVILSQINHRNV 141
++LG+G G V MLA+ + I A+KK ++ + +E + E +L+
Sbjct: 1 KVLGKGSFGKV---MLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 142 VKLLGCCLETEVPLL-VYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLH 199
+ L C +T+ L V E+++ G L ++ F E R R A E+ L +LH
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FD---EARARFYAAEIICGLQFLH 113
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
I +RD+K N+LL++ K+ADFG K + + +T GT Y+ PE +
Sbjct: 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILK 169
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKP 285
++ + D +SFGV+L E+L GQ P
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 66/201 (32%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 91 LGQGGQGTVYKGMLADG-RIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNVVKLLG 146
+G+G G V + D RI A+K K+ IV ++ + E +L+Q+N +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
E LV FI+ G LF +L Q E R A E+ +L LH +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRARFYTA-ELLCALENLHK---FNV 114
Query: 207 YHRDIKSTNILLNEKYTAKVA--DFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT 264
+RD+K NILL+ Y +A DFG K + D T GT YL PE +T
Sbjct: 115 IYRDLKPENILLD--YQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 265 DKSDVYSFGVVLVELLTGQKP 285
D ++ GV+L E+LTG P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 85 FNVNRILGQGGQGTVYKGML-ADGRIVAVKK--SKIVHEGKLEEF-INEVVILSQINHRN 140
F R+LG+GG G V + A G++ A KK K + + K E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 141 VVKLLGCCLETEVPL-LVYEFISNGTL-FQYLHDQNEEFPLTWEMR-LRIATEVAGSLSY 197
VV L ET+ L LV ++ G L F + N F E R + A E+ L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITCGLED 117
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
LH I +RD+K NILL++ +++D G + I +T + +V GT GY+ PE
Sbjct: 118 LHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEV 172
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKP 285
++ ++T D + G ++ E++ G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 66/227 (29%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIV--HEGKLEEFINEVVIL---SQINHRNVVKL 144
+G G GTVYK G VA+K ++ +G + EV +L +H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 145 LGCCL------ETEVPLLVYEFISNGTLFQYLHDQNEEFP---LTWEMRLRIATEVAGSL 195
+ C ET+V L V+E + L YL ++ P L E + + L
Sbjct: 68 MDVCATSRTDRETKVTL-VFEHVDQ-DLRTYL----DKVPPPGLPAETIKDLMRQFLRGL 121
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT-TKVQGTFGYLD 254
+LH+ I HRD+K NIL+ K+ADFG ++ I + T V T Y
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRA 175
Query: 255 PEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF 301
PE + D++S G + E+ +KP + G+ EA L F
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFR-RKP-LFCGNSEADQLGKIF 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 29/225 (12%)
Query: 76 KELDKATDHFNVNRILGQGGQGTV----YKGMLADGRIVAVK---KSKIVHEGKLEEFIN 128
++L + ++V +++G+G G V +K + ++ A+K K +++ F
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI 187
E I++ N VV+L C + + L +V E++ G L + N + P W
Sbjct: 93 ERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFY-- 147
Query: 188 ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT---HVTT 244
EV +L +HS M + HRD+K N+LL++ K+ADFGT + +D+T T
Sbjct: 148 TAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDT 202
Query: 245 KVQGTFGYLDPEYFRS----GQFTDKSDVYSFGVVLVELLTGQKP 285
V GT Y+ PE +S G + + D +S GV L E+L G P
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVK--KSKIVHEGKLEEFI--NEVVILSQINHRNVVK 143
+++G+G G V A+ + AVK + K + + K E+ I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLHSAA 202
L + V ++I+ G LF +L Q E L E R R A E+A +L YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL--QRERCFL--EPRARFYAAEIASALGYLHS-- 114
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
+ I +RD+K NILL+ + + DFG K I+ T+ GT YL PE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 263 FTDKSDVYSFGVVLVELLTGQKP 285
+ D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 89 RILGQGGQGTVY----KGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKL 144
++LG+G G V+ KG I A+KK ++ + +E + E +LS +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 145 LGCCLETEVPLL-VYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAA 202
L C +T+ L V E+++ G L H Q+ +F L A E+ L +LHS
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLM--FHIQSCHKFDLPRATFY--AAEIICGLQFLHSKG 116
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
I +RD+K NILL+ K+ADFG K ++ T GT Y+ PE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQK 172
Query: 263 FTDKSDVYSFGVVLVELLTGQKP 285
+ D +SFGV+L E+L GQ P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 80/266 (30%), Positives = 107/266 (40%), Gaps = 67/266 (25%)
Query: 62 SSDGSIDR-CKLFT-TKELDKATDH-----FNVNRILGQGGQGTV-YKGMLADGRIVAVK 113
S D I R C+ F T D+AT + ++R+LG G GTV ++DG AVK
Sbjct: 4 SGDAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVK 63
Query: 114 KSKIVHEGKLEEFIN----EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQY 169
+ EG E N EV L + ++VK C E F
Sbjct: 64 VVDM--EGMSEADKNRAQAEVCCLLNCDFFSIVK----CHED---------------FAK 102
Query: 170 LHDQNEEFPLTWEMRLRIATEVAGSLSY---------------------------LHSAA 202
+N E L + L A AG L +H
Sbjct: 103 KDPRNPENVLMIALVLDYAN--AGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH 160
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKF---IVIDQTHVTTKVQGTFGYLDPEYFR 259
S + HRDIKS NILL K+ DFG SK V D V GT Y+ PE +R
Sbjct: 161 SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD--VGRTFCGTPYYVAPEIWR 218
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKP 285
++ K+D++S GV+L ELLT ++P
Sbjct: 219 RKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 5/101 (4%)
Query: 186 RIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK 245
+I+ V L+YL I HRD+K +NIL+N + K+ DFG S + ID +
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANS 157
Query: 246 VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
GT Y+ PE + +T +SD++S G+ LVE+ G+ PI
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 28/203 (13%)
Query: 96 QGTVYKGMLADGRIVA--VKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153
G ++GM + R+V ++ S E L F+ EV ++NH NV++ LG C+E+
Sbjct: 13 LGEAHRGM-SKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVLQCLGQCIESIP 69
Query: 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL--RIATEVAGSLSYLHSAASMPIYHRDI 211
LLV EF G L YL + + R+A EVA L +LH A + H D+
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI---HSDL 126
Query: 212 KSTNILLNEKYTAKVADFGTS------KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ--- 262
N L + K+ D+G + + + H +L PE
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-----PLRWLAPELVEIRGQDL 181
Query: 263 ----FTDKSDVYSFGVVLVELLT 281
T KS+++S GV + EL T
Sbjct: 182 LPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEF-INEVV-------ILSQINHRNVV 142
LG+G GTVY ++ D + VA ++ K++ E + E NE V +LS+++H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 143 KLLGCCLETEVPLLVYEFISNGTL---FQYLHDQNEEFP----LTWEMRLRIATEVAGSL 195
K LE + ++ E+ L + L + W ++L + +
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG------V 119
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
Y+H I HRD+K+ NI L + K+ DFG S+ + + + T GT Y+ P
Sbjct: 120 HYMHQRR---ILHRDLKAKNIFL-KNNLLKIGDFGVSRLL-MGSCDLATTFTGTPYYMSP 174
Query: 256 EYFRSGQFTDKSDVYSFGVVLVEL 279
E + + KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 55/196 (28%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCC 148
LG+G TVYKG G IVA+K+ + EG I E+ ++ ++ H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66
Query: 149 LETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
+ TE L LV+E++ L +Y+ L ++ +++ H +
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR-SGQFTDK 266
HRD+K N+L+N++ K+ADFG ++ I + +V T Y P+ S ++
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181
Query: 267 SDVYSFGVVLVELLTG 282
D++S G ++ E++TG
Sbjct: 182 IDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 89 RILGQGGQGTVYKGMLADGR-------IVAVKKSKIVHEGKLEEFINEVVILSQINHRNV 141
++LG+G G V MLA+ + I +KK I+ + ++ + E IL+
Sbjct: 1 KVLGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 142 VKLLGCCLETEVPLL-VYEFISNGTL-FQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYL 198
+ L CC +T+ L V E+++ G L FQ + + E R R A EV +L +L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTLALMFL 112
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
H + +RD+K NILL+ + K+ADFG K I TT GT Y+ PE
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEIL 168
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ ++ D ++ GV++ E++ GQ P
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 85 FNVNRILGQGGQGTVYKGMLADGR-------IVAVKKSKIVHEGKLEEFINEVVILSQIN 137
FN +LG+G G V MLA+ + I +KK ++ + +E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG 58
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
+ L C +T L V E+++ G L + + A E+A L
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLF 115
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV-QGTFGYLDP 255
+LHS I +RD+K N++L+ + K+ADFG K + D VTTK GT Y+ P
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAP 170
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
E + D ++FGV+L E+L GQ P
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 71 KLFTTKELDKATDHFNVNRILGQGGQGTVYKG--MLADGRIVAVKKSKIVHE-GKLEEFI 127
KL T +LDK LG+G TVYKG L D +VA+K+ ++ HE G I
Sbjct: 4 KLETYIKLDK----------LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAI 52
Query: 128 NEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI 187
EV +L + H N+V L + LV+E++ + L QYL D + ++L +
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFL 110
Query: 188 ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ 247
+ G L+Y H + HRD+K N+L+NE+ K+ADFG ++ I + +V
Sbjct: 111 FQLLRG-LNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166
Query: 248 GTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQ 283
T Y P+ S ++ + D++ G + E+ TG+
Sbjct: 167 -TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 6e-13
Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 51/230 (22%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF----INEVVILSQINH 138
+ + + +G G G V + GR VA+KK I + + E+ +L + H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKK--ISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 139 RNVVKLLGCCLETEVPL-----------LVYEF--------ISNGTLFQYLHDQNEEFPL 179
N++ LL ++ +V E I + Q L D + ++
Sbjct: 59 ENIIGLL------DILRPPSPEDFNDVYIVTELMETDLHKVIKSP---QPLTDDHIQY-F 108
Query: 180 TWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239
+++ LR L YLHSA + HRD+K +NIL+N K+ DFG ++ + D+
Sbjct: 109 LYQI-LR-------GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
Query: 240 THVTTKVQG--TFGYLDPEYFRSGQFTDKS-DVYSFGVVLVELLTGQKPI 286
+ T Y PE S K+ D++S G + ELLT KP+
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 85 FNVNRILGQGGQGTVYKGMLADGR-------IVAVKKSKIVHEGKLEEFINEVVILSQIN 137
FN +LG+G G V MLA+ + I +KK I+ + +E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG 58
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEF--PLTWEMRLRIATEVAGS 194
+ L C +T L V E+++ G L Y Q +F P + A E+A
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-YHIQQVGKFKEPHA----VFYAAEIAIG 113
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV-QGTFGYL 253
L +LHS I +RD+K N++L+ + K+ADFG K + TT+ GT Y+
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYI 168
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE + D ++FGV+L E+L GQ P
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 85 FNVNRILGQGGQGTVYKGML-ADGRIVAVKK--SKIVHEGKLEEF-INEVVILSQINHRN 140
F R+LG+GG G V + A G++ A KK K + + K E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMR-LRIATEVAGSLSYLH 199
VV L ET+ L + I NG ++ H N P E R + A E+ L L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
I +RD+K NILL+++ +++D G + I +T V +V GT GY+ PE
Sbjct: 120 RER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVIN 174
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKP 285
+ ++T D + G ++ E++ GQ P
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 89 RILGQGGQGTVYKGMLADG----RIVAVK---KSKIVHEGKLEEFIN-EVVILSQINHRN 140
++LG+GG G V++ G +I A+K K+ IV K E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 141 VVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
+V L+ +T L L+ E++S G LF +L + T L +E++ +L +LH
Sbjct: 62 IVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL---SEISLALEHLH 117
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF- 258
I +RD+K NILL+ + K+ DFG K + + T VT GT Y+ PE
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILM 173
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKP 285
RSG D +S G ++ ++LTG P
Sbjct: 174 RSGHGKA-VDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH-RNVV 142
F + ++G G G VYKG + G++ A+K V E + EE E+ +L + +H RN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 143 KLLGCCLETEVP------LLVYEFISNGTLFQYLHD-QNEEFPLTWEMRLRIATEVAGSL 195
G ++ P LV EF G++ + + + W I E+ L
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLD 254
++LH+ + HRDIK N+LL E K+ DFG S +D+T GT ++
Sbjct: 135 AHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 189
Query: 255 PEYFRSGQFTD-----KSDVYSFGVVLVELLTGQKPI 286
PE + D +SD++S G+ +E+ G P+
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 44/234 (18%)
Query: 73 FTTKELDKAT----DHFNVNRILGQGGQGTVYKGMLADGRI-VAVKK-----SKIVHEGK 122
F +EL+K D + +G G G V VA+KK +H +
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR 60
Query: 123 LEEFINEVVILSQINHRNVVKLLGCCLETEVPL-------LVYEFI----SNGTLFQYLH 171
E+ +L ++H NV+ LL L LV + +N Q L
Sbjct: 61 T---YRELRLLKHMDHENVIGLLDVFTPAS-SLEDFQDVYLVTHLMGADLNNIVKCQKLS 116
Query: 172 DQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231
D + +F L +++ LR L Y+HSA I HRD+K +NI +NE K+ DFG
Sbjct: 117 DDHIQF-LVYQI-LR-------GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164
Query: 232 SKFIVIDQT-HVTTKVQGTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQ 283
++ + T +V T+ Y PE + D++S G ++ ELLTG+
Sbjct: 165 ARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 91 LGQGGQGTVYKG--MLADGRIVAVKKSKI--VHEGKLEEFINEVVILSQIN---HRNVVK 143
+G+G G V+K + GR VA+K+ ++ EG I EV +L + H NVV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 144 LLGCCL------ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
L C ET++ L V+E + L YL D+ E + E + ++ L +
Sbjct: 69 LFDVCTVSRTDRETKLTL-VFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
LHS + HRD+K NIL+ K+ADFG ++ T V T Y PE
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEV 180
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF 301
+ D++S G + E+ +KP + GS + L
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR-RKP-LFRGSSDVDQLGKIL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 91 LGQGGQGTVYKGMLAD-GRIVAVKKSKIV-------HEGKLEEFINEVVILSQINHRNVV 142
LGQG ++KG+ + G + K++++ H E F ++SQ++H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
G C+ + ++V E++ G+L YL ++W +L +A ++A +L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD------PE 256
+ H ++ + N+LL + K G FI + ++ V L+ PE
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKT---GNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 257 YFRSGQ-FTDKSDVYSFGVVLVELLTG-QKPI 286
+ Q + +D +SFG L E+ +G KP+
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 89 RILGQGGQGTV-YKGMLADGRIVAVKKSKIVHEGKLEEFI--NEVVILSQINHRNVVKLL 145
R++G+G G V DG+ +KK + + + E E +LSQ+ H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 146 GCCLETEVPLL--VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
E E LL V F G L+ L +Q + L + ++A +L YLH
Sbjct: 66 ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH- 122
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF 263
I HRD+K+ N+ L KV D G ++ ++ +Q + + + GT Y+ PE F + +
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 264 TDKSDVYSFGVVLVELLT 281
KSDV++ G + E+ T
Sbjct: 180 NYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 68/228 (29%), Positives = 102/228 (44%), Gaps = 35/228 (15%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEE---------- 125
+L + F+V +++G+G G V ++V K SK V+ KL
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEV--------QLVRHKSSKQVYAMKLLSKFEMIKRSDS 87
Query: 126 --FINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWE 182
F E I++ N +V+L + + L +V E++ G L + N + P W
Sbjct: 88 AFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWA 144
Query: 183 MRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS-KFIVIDQTH 241
R A EV +L +HS M HRD+K N+LL++ K+ADFGT K
Sbjct: 145 -RFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199
Query: 242 VTTKVQGTFGYLDPEYFRS----GQFTDKSDVYSFGVVLVELLTGQKP 285
T V GT Y+ PE +S G + + D +S GV L E+L G P
Sbjct: 200 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 81 ATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVILSQINH 138
AT + N+ + LG+G TVYKG+ +G++VA+K S EG I E +L + H
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQY-------LHDQNEEFPLTWEMRLRIATEV 191
N+V L E V+E++ L QY LH N +RL + +
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYN--------VRLFMFQLL 113
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI-DQTHVTTKVQGTF 250
G L+Y+H I HRD+K N+L++ K+ADFG ++ I QT+ + V T
Sbjct: 114 RG-LAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TL 167
Query: 251 GYLDPEYFR-SGQFTDKSDVYSFGVVLVELLTGQ 283
Y P+ + ++ D++ G + +E+L GQ
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 71 KLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFIN 128
KL T +LDK LG+G TV+KG +VA+K+ ++ H EG I
Sbjct: 3 KLETYVKLDK----------LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR 52
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI 187
EV +L + H N+V L + TE L LV+E++ + L QYL D +++ +
Sbjct: 53 EVSLLKNLKHANIVTLHDI-IHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFM 109
Query: 188 ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ 247
+ G LSY H I HRD+K N+L+NEK K+ADFG ++ + + +V
Sbjct: 110 FQLLRG-LSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV 165
Query: 248 GTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQ 283
T Y P+ S +++ D++ G +L E+ TG+
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 91 LGQGGQGTVYK-GMLADGRIVAVKK---SKIVHEGKLEEFINEVVILSQINHRNVVKLLG 146
LG+GG G V M A G++ A KK ++ E + E IL++++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 147 CCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMR-LRIATEVAGSLSYLHSAASM 204
+T+ L LV ++ G L ++++ +EE P E R ++ L +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT 264
I +RD+K N+LL+ +++D G + + Q+ T GT G++ PE + ++
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 265 DKSDVYSFGVVLVELLTGQKPIILTGSK 292
D ++ GV L E++ + P G K
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 14/205 (6%)
Query: 85 FNVNRILGQGGQGTVYKGML-ADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRN 140
F + LG G G V G A+K K +I+ +++ E IL +++H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+V ++ + + EF+ G LF +L FP ++ E+ + YLHS
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPN--DVAKFYHAELVLAFEYLHS 136
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
I +RD+K N+LL+ K KV DFG +K + T + GT YL PE +S
Sbjct: 137 KD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQS 189
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKP 285
D ++ GV+L E + G P
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 89 RILGQGGQGT---VYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN------- 137
+ILG+ G+GT V K G+ A+K K + + +V L +I
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-----LEQVNNLREIQALRRLSP 56
Query: 138 HRNVVKLLGCCLE--TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLR-IATEVAGS 194
H N+++L+ + T LV+E + + L++ + + P E R++ ++ S
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLP---EKRVKSYMYQLLKS 112
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
L ++H I+HRDIK NIL+ K+ADFG+ + I T+ T Y
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCR--GIYSKPPYTEYISTRWYRA 166
Query: 255 PE-YFRSGQFTDKSDVYSFGVVLVELLT 281
PE G + K D+++ G V E+L+
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 60/240 (25%), Positives = 111/240 (46%), Gaps = 44/240 (18%)
Query: 67 IDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLADG-----RIVAVKKSKI-VHE 120
I R + T +L + +G G ++ G+L D V VK K E
Sbjct: 3 ISRDR-VTLSDLLQ------------EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE 49
Query: 121 GKLEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLVYEFISNGTLFQYLH-----DQN 174
++ + E +L ++H+N++ +L C+E E P ++Y +++ G L +L + N
Sbjct: 50 IQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN 109
Query: 175 EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234
L+ + + +A ++A +SYLH + H+DI + N +++E+ K+ D S+
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRD 166
Query: 235 IVIDQTHVTTKVQGTFG--------YLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
+ H G ++ E + +++ SDV+SFGV+L EL+T GQ P
Sbjct: 167 LFPMDYH-------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 85 FNVNRILGQGGQGTVYKGMLADGR-------IVAVKKSKIVHEGKLEEFINEVVILSQIN 137
FN +LG+G G V MLA+ + I +KK ++ + +E + E +L+ +
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
+ L C +T L V E+++ G L ++ + + A E++ L
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLF 115
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV-QGTFGYLDP 255
+LH I +RD+K N++L+ + K+ADFG K ++D VTT+ GT Y+ P
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAP 170
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
E + D +++GV+L E+L GQ P
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 93 QGGQGTVYKGMLADGR-------IVAVKKSKIVHEGKLEEFINEVVIL-SQINHRNVVKL 144
+G G+VY LA R I +KKS ++ + ++ E I+ Q V KL
Sbjct: 6 KGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 145 LGCCLETEVPLLVYEFISNG---TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
+ LV E+++ G +L + L E++ + EV + LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY------IAEVVLGVEDLHQR 116
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
I HRDIK N+L+++ K+ DFG S+ + ++ K GT YL PE
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGV 168
Query: 262 QFTDKSDVYSFGVVLVELLTGQKP 285
SD +S G V+ E L G P
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 90 ILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF----INEVVILSQINHRNVVKL 144
+GQG G V+K +IVA+KK ++ E + E F + E+ IL + H NVV L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 145 LGCCLETEVP--------LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
+ C P LV+EF + L L ++N +F L+ E++ ++ + L
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS-EIK-KVMKMLLNGLY 133
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI----DQTHVTTKVQGTFGY 252
Y+H I HRD+K+ NIL+ + K+ADFG ++ + T +V T Y
Sbjct: 134 YIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWY 189
Query: 253 LDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGL 297
PE + D++ G ++ E+ T I+ G+ E L
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP--IMQGNTEQHQL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 89 RILGQGGQGTVYKGMLAD-GRIVAVK--KSKIVHEGKLEEFIN-EVVILSQINHRNVVKL 144
R++G+G V L RI A+K K ++V++ + +++ E + Q ++ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 145 LGCCLETEVPLL-VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
L C +TE L V E+++ G L ++ Q + L E + E++ +L+YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG- 116
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF 263
I +RD+K N+LL+ + K+ D+G K + T+ GT Y+ PE R +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 264 TDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
D ++ GV++ E++ G+ P + GS +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 5e-12
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 91 LGQGGQGTVYKGML-ADGRIVAVKKSKIVHE-GKLEEFINEVVILSQINHRNVVKLLGCC 148
LG+G TVYKG +G++VA+K ++ E G I E +L + H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 149 LETEVPLLVYEFISNGTLFQY-------LHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
E LV+E++ L QY LH +N + L +R LSY+H
Sbjct: 73 HTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLR---------GLSYIHQR 122
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE-YFRS 260
I HRD+K N+L+++ K+ADFG ++ + +H + T Y P+ S
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGS 178
Query: 261 GQFTDKSDVYSFGVVLVELLTG 282
+++ D++ G + VE++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 90 ILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNV--VK 143
I+G+GG G VY AD G++ A+K K +I + +NE ++LS ++ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
+ T L + NG Y Q+ F EMR ATE+ L ++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK-EMRF-YATEIILGLEHMHNRF- 117
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF 263
+ +RD+K NILL+E +++D G + + H + GT GY+ PE + G
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTA 172
Query: 264 TDKS-DVYSFGVVLVELLTGQKP 285
D S D +S G +L +LL G P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 45/283 (15%)
Query: 91 LGQGGQGTVYKGML---ADGRIVAVKKS-----KIVHEGK--LEEFINEVVILSQINHRN 140
LGQG +YKG+L +D IV + K++ F ++SQ++H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+VKL G C+ E ++V E++ G L +LH + L W +L +A ++A +L YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE- 118
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV------QGTFGYLD 254
+ H ++ NIL+ + G FI + + V ++
Sbjct: 119 --DKKLVHGNVCGKNILV----ARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIA 172
Query: 255 PEYFRSGQ--FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312
PE R+GQ T +D +SFG L+E I + +E L+ S E+ R Y
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLE--------ICSNGEEP--LSTL--SSSEKERFYQ 220
Query: 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355
D L + + +A L +C + +RP+ + + +L
Sbjct: 221 --DQHRLPM---PDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 90 ILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNV--VK 143
I+G+GG G VY AD G++ A+K K +I + +NE ++LS ++ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
+ T L + NG Y Q+ F EMR A E+ L ++H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-EMRF-YAAEIILGLEHMHNRF- 117
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF 263
+ +RD+K NILL+E +++D G + + H + GT GY+ PE + G
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVA 172
Query: 264 TDKS-DVYSFGVVLVELLTGQKP 285
D S D +S G +L +LL G P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 89 RILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
R LG G G V+ + +D + VAVKK + ++ + E+ I+ +++H N+VK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 148 CLETEVPLLVYEFISNGTLF------QYLHDQN-----EEFPLTWEMRLRIATEVAGSLS 196
+ L E + + T Q + + E+ PL+ E ++ L
Sbjct: 71 LGPSGSDL--TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLK 128
Query: 197 YLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIVIDQTHVTTKVQG--TFGYL 253
Y+HSA + HRD+K N+ +N E K+ DFG ++ + +H +G T Y
Sbjct: 129 YIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 254 DPEYFRS-GQFTDKSDVYSFGVVLVELLTGQ 283
P S +T D+++ G + E+LTG+
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 74/286 (25%), Positives = 114/286 (39%), Gaps = 25/286 (8%)
Query: 76 KELDKATDHFNVNRILGQGGQGTV----YKGMLADGRIVAVKKSKIVHEGKLEEFINEVV 131
++L + + V +++G+G G V +K + + K +++ F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 132 ILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEV 191
I++ N VV+L + +V E++ G L + N + P W R A EV
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWA-RFYTA-EV 151
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFG 251
+L +HS M HRD+K N+LL++ K+ADFGT + + GT
Sbjct: 152 VLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 252 YLDPEYFRS----GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307
Y+ PE +S G + + D +S GV L E+L G P A L + M
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY------ADSLVGTYSKIMNH 262
Query: 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNG----KRRPTMK 349
F DD + K I T L NG KR K
Sbjct: 263 KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 128 NEVVILSQINHRNVVKL---LGCCLETEVPLLVYEFISNGTLFQYLHD---QNEEFPLTW 181
NE++ L ++NH N++K+ L T + Y+F L+ +++D ++ PL
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLK 267
Query: 182 EMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241
+ R I ++ ++ Y+H + HRDIK NI LN + DFGT+ ++
Sbjct: 268 QTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281
GT PE + + +D++S G++L+++L+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 55/197 (27%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 91 LGQGGQGTVYKG--MLADGRIVAVKKSKIVHE-GKLEEFINEVVILSQINHRNVVKLLGC 147
LG+G TV+KG L + +VA+K+ ++ HE G I EV +L + H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
+ LV+E++ + L QY+ D + +++ + + G L+Y H +
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH-NVKIFLYQILRG-LAYCHRRK---VL 126
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR-SGQFTDK 266
HRD+K N+L+NE+ K+ADFG ++ + + +V T Y P+ S +++ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQ 185
Query: 267 SDVYSFGVVLVELLTGQ 283
D++ G + E+ +G+
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 95 GQGTVYKGML----ADGRIVA---VKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
G+GT K +L A G+ A +KK I+ + ++ + E +L H + L
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLHSAASMPI 206
+ V E+++ G LF +L + + E R R E+ +L YLHS I
Sbjct: 64 FQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---I 116
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
+RD+K N++L++ K+ DFG K + D + T GT YL PE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 267 SDVYSFGVVLVELLTGQKP 285
D + GVV+ E++ G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 37/104 (35%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 186 RIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK 245
+IA + +L YLHS S + HRD+K +N+L+N K+ DFG S ++V + T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV--DSVAKTI 162
Query: 246 VQGTFGYLDPEYF----RSGQFTDKSDVYSFGVVLVELLTGQKP 285
G Y+ PE + KSDV+S G+ ++EL TG+ P
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 22/226 (9%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYK-GMLADGRIVAVKKSKIVHEGKLEEFINEVVILS 134
+ L TD + + +G+G G VYK DG + AVK + + EE E IL
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQ 73
Query: 135 QI-NHRNVVKLLGCCLETEVPL-----LVYEFISNGTLFQYLHDQNEEFPLTWEMRLR-- 186
+ NH NVVK G + + + LV E + G++ + + L RL
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL-----LICGQRLDEA 128
Query: 187 -IATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK 245
I+ + G+L L + I HRD+K NILL + K+ DFG S + + T
Sbjct: 129 MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 246 VQGTFGYLDPEYFRSGQFTDKS-----DVYSFGVVLVELLTGQKPI 286
V GT ++ PE Q D S DV+S G+ +EL G P+
Sbjct: 189 V-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 58/189 (30%), Positives = 90/189 (47%), Gaps = 26/189 (13%)
Query: 103 MLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162
ML D R A +S E+ L+ +H +VK + LL+ E+ S
Sbjct: 102 MLNDERQAAYARS-------------ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148
Query: 163 NGTLFQYLHDQ-NEEFPLT-WEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE 220
G L + + + E P +E+ L + ++ +L +HS M HRD+KS NI L
Sbjct: 149 GGDLNKQIKQRLKEHLPFQEYEVGL-LFYQIVLALDEVHSRKMM---HRDLKSANIFLMP 204
Query: 221 KYTAKVADFGTSK----FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVL 276
K+ DFG SK + +D V + GT YL PE + +++ K+D++S GV+L
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 277 VELLTGQKP 285
ELLT +P
Sbjct: 262 YELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN------EVVILSQINHRNV 141
+G G G V + G+ VA+KK I H + E+ IL H N+
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKK--IPH--AFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 142 VKLLGCCLETEVPL-----LVYEFISNGTLFQYLHDQNEEFPLTWE-MR------LRIAT 189
+ + L +V + + + L +H PLT E +R LR
Sbjct: 67 IAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQ---PLTEEHIRYFLYQLLR--- 118
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV---IDQTHVTTKV 246
L Y+HSA + HRD+K +N+L+NE ++ DFG ++ + + + T+
Sbjct: 119 ----GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 247 QGTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
T Y PE ++T D++S G + E+L G++ +
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHR 139
+D + + +G+G G V+K + +G AVK +H+ EE E IL + +H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75
Query: 140 NVVKLLGCCLETEVP-----LLVYEFISNGTL------FQYLHDQNEEFPLTWEMRLRIA 188
NVVK G + +V LV E + G++ F ++ EE + + I
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----IL 130
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG 248
E L +LH ++ HRD+K NILL + K+ DFG S + + T V G
Sbjct: 131 HEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-G 186
Query: 249 TFGYLDPEYFRSGQFTDKS-----DVYSFGVVLVELLTGQKPI 286
T ++ PE Q D + DV+S G+ +EL G P+
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 89 RILGQGGQGTVYKGML-ADGRIVAVK--KSKIVHEGKLEEFINEV-----VILSQINHRN 140
R++G+G V L RI A+K K ++V++ +E I+ V V + NH
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND---DEDIDWVQTEKHVFETASNHPF 57
Query: 141 VVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
+V L C +TE L V EF+S G L ++ Q + L E + E++ +L++LH
Sbjct: 58 LVGL-HSCFQTESRLFFVIEFVSGGDLMFHMQRQRK---LPEEHARFYSAEISLALNFLH 113
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
I +RD+K N+LL+ + K+ D+G K I T+ GT Y+ PE R
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILR 169
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
+ D ++ GV++ E++ G+ P + G +
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 91 LGQGGQGTVYKGMLAD-GRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRNVVKLLGC 147
+G+G GTV+K + IVA+K+ ++ EG + E+ +L ++ H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS--------LSYLH 199
+ LV+E+ L +Y N + I E+ S L++ H
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGD----------IDPEIVKSFMFQLLKGLAFCH 116
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
S + HRD+K N+L+N+ K+ADFG ++ I + +V T Y P+
Sbjct: 117 SHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 172
Query: 260 SGQFTDKS-DVYSFGVVLVELLTGQKPI 286
+ S D++S G + EL +P+
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 89 RILGQGGQGTVYKGMLA-DGRIVAVK--KSKIVHEGKLEEFIN-EVVILSQINHRNVVKL 144
R++G+G V L + +I A+K K ++VH+ + +++ E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 145 LGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
L C +T L LV E+++ G L ++ Q + L E A E+ +L++LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK---LPEEHARFYAAEICIALNFLHERG- 116
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF 263
I +RD+K N+LL+ K+ D+G K + T+ GT Y+ PE R ++
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 264 TDKSDVYSFGVVLVELLTGQKP 285
D ++ GV++ E++ G+ P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 32/221 (14%)
Query: 87 VNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF----INEVVILSQINHRNV 141
+NRI +G G VY+ G IVA+KK K+ E + E F + E+ IL ++ H N+
Sbjct: 10 LNRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKLQHPNI 66
Query: 142 VKLLGCCLETEVPL--------LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
V + EV + +V E++ + L + + F L E++ + ++G
Sbjct: 67 VTV------KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPF-LQSEVKCLMLQLLSG 118
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
+++LH I HRD+K++N+LLN + K+ DFG ++ T++ T Y
Sbjct: 119 -VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE-YGSPLKPYTQLVVTLWYR 173
Query: 254 DPE-YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
PE + +++ D++S G + ELLT +KP + G E
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT-KKP-LFPGKSE 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 90 ILGQGGQGT---VYKGML---ADGRIVAVKK---SKIVHEGKLEEFINEVVILSQINHRN 140
I G G+GT VYK DG+ A+KK K + G + E+ +L ++ H N
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN 63
Query: 141 VVKLLGCCLETEVPL--LVYEFISNGTLFQYLHD--QNEEFPLTWEMRLRIATEVAGSLS 196
VV L+ LE L++++ + L+Q + Q + + M + ++ +
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 197 YLHSAASMPIYHRDIKSTNILL----NEKYTAKVADFGTSKFIV--IDQTHVTTKVQGTF 250
YLHS + HRD+K NIL+ E+ K+ D G ++ + V T
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 251 GYLDPEYFR-SGQFTDKSDVYSFGVVLVELLTGQKPI 286
Y PE + +T D+++ G + ELLT +PI
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 90 ILGQGGQGTVYKGM-LADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRN-VVKLL 145
+G+G G VYK G++VA+KK+++ EG + E+ +L ++ +V+LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 146 GCCLETEVPL------LVYEFISNGTLFQYL--HDQNEEFPLTWEMRLRIATEVAGSLSY 197
E LV+E++ + L +++ + + PL + ++ +++
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 198 LHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
H M HRD+K N+L++ +K K+AD G + I T ++ T Y PE
Sbjct: 126 CHKHGVM---HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPE 181
Query: 257 -YFRSGQFTDKSDVYSFGVVLVELLTGQ 283
S ++ D++S G + E+ Q
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHE--GKLEEFINEVVILSQINHRNVVKLLGC 147
+G+G G VYK +A+KK ++ E G I E+ +L ++ H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
+ LV+E++ + L +++ D + +F + ++ ++Y HS +
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VL 124
Query: 208 HRDIKSTNILLNEKYTA-KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE-YFRSGQFTD 265
HRD+K N+L++ + A K+ADFG ++ I T +V T Y PE S ++
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYST 183
Query: 266 KSDVYSFGVVLVELLTGQKPI 286
D++S G + E++ QKP+
Sbjct: 184 PVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 71 KLFTTKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVH-EGKLEEFIN 128
KL T K+LDK LG+G TVYKG G++VA+K+ ++ H EG I
Sbjct: 3 KLETYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR 52
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
E +L + H N+V L + LV+E++ L QY+ D + +RL +
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRLFLF 110
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF-IVIDQTHVTTKVQ 247
+ G L+Y H + HRD+K N+L++E+ K+ADFG ++ V +T+ V
Sbjct: 111 QLLRG-LAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV- 165
Query: 248 GTFGYLDPEYFR-SGQFTDKSDVYSFGVVLVELLTGQ 283
T Y P+ S +++ D++ G + E+ TG+
Sbjct: 166 -TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 64/243 (26%), Positives = 100/243 (41%), Gaps = 52/243 (21%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
HF ++LG+G G V+ L G++ A+K K +++ K++ + E IL+ ++H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEE-FPLTWEMRLRI-ATEVAGSL 195
+ L +TE L LV ++ G LF+ L Q + E R A EV +L
Sbjct: 61 PFLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS---EEVARFYAAEVLLAL 116
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ-------- 247
YLH + I +RD+K NILL+E ++DF SK Q+ V
Sbjct: 117 EYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSK-----QSDVEPPPVSKALRKGS 168
Query: 248 -------------------------GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTG 282
GT Y+ PE D ++ G++L E+L G
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
Query: 283 QKP 285
P
Sbjct: 229 TTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 95 GQGTVYKGML----ADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
G+GT K +L A GR A+K K I+ + ++ + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 63
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
+ V E+ + G LF +L + E T E E+ +L YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VV 117
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKS 267
+RDIK N++L++ K+ DFG K + D + T GT YL PE +
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 268 DVYSFGVVLVELLTGQKP 285
D + GVV+ E++ G+ P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 83 DHFNVNRILGQGGQGTVY----KGMLADGRIVA---VKKSKIVHEGKLEEFINEVVILSQ 135
F+V ++G+G G V K A G I A +KKS ++ + + F E ILS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLH---DQNEEFPLTWEM-RLRIATEV 191
N + +L + + LV E+ G L L+ DQ +E +M + +A V
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE-----DMAQFYLAELV 112
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFG 251
+HS M HRDIK N+L++ K+ADFG++ + ++ + GT
Sbjct: 113 LA----IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168
Query: 252 YLDPEYFRS------GQFTDKSDVYSFGVVLVELLTGQKP 285
Y+ PE + G + + D +S GV+ E++ G+ P
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 30/193 (15%)
Query: 172 DQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231
D + +PL + LR +++VA + +L AS HRD+ + N+LL + AK+ DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 232 SKFIVIDQTHVTTKVQGT----FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQK--- 284
++ I+ D +V V+G ++ PE +T +SDV+S+G++L E+ + K
Sbjct: 259 ARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
Query: 285 PIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKR 344
P IL SK + + +S DF EI +I + C NL
Sbjct: 316 PGILVNSKFYKMVKRGYQMSRP-----DF---------APPEIYSIMKM---CWNLEPTE 358
Query: 345 RPTMKEVAMELER 357
RPT +++ ++R
Sbjct: 359 RPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 47/228 (20%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVILSQINHRN 140
+ +G+G G V G VA+KK S H+ + + E+ IL + H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 141 VVKLLG-----------------CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEM 183
++ +L +ET++ L+ Q+L + + ++ L +
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT--------QHLSNDHIQYFLYQIL 116
Query: 184 RLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243
R L Y+HSA + HRD+K +N+LLN K+ DFG ++ + D H
Sbjct: 117 R---------GLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHDH 162
Query: 244 ----TKVQGTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
T+ T Y PE S +T D++S G +L E+L+ +P+
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 60/298 (20%)
Query: 91 LGQGGQGTVYKGML-----------------------ADGR--IVAVKKSKIVHEGKLEE 125
LGQG + +Y G L +GR V +K H
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 126 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL 185
F ++SQ++H ++ + G C+ ++V EF+ +G L L + P+ W++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI-- 120
Query: 186 RIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK 245
+A ++A +LSYL + H ++ + NILL A+ GTS FI + V+
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE----GTSPFIKLSDPGVSFT 173
Query: 246 VQG------TFGYLDPEYFRSG-QFTDKSDVYSFGVVLVEL-LTGQKPIILTGSKEATGL 297
++ PE G + +D +SFG L+E+ G+ P+ KE T
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL-----KERT-- 226
Query: 298 AAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355
E+ R Y ++ ++ + +ATL ++CL +RP+ + + +L
Sbjct: 227 ------PSEKERFY----EKKHRL-PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 95 GQGTVYKGML----ADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
G+GT K +L A G+ A+K K I+ + ++ + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLHSAASMPI 206
+ V E+ + G LF +L + E + E R R E+ +L YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHL---SRERVFS-EDRARFYGAEIVSALGYLHSCD---V 116
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
+RD+K N++L++ K+ DFG K + D + T GT YL PE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 267 SDVYSFGVVLVELLTGQKP 285
D + GVV+ E++ G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 12/184 (6%)
Query: 105 ADGRIVAVKKSK-----IVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159
A+G A +K ++ G+ E IL INH ++++L G + L+
Sbjct: 104 AEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163
Query: 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN 219
L+ YL + + ++ L I V ++ YLH I HRDIK+ NI +N
Sbjct: 164 RYKT-DLYCYLAAK-RNIAIC-DI-LAIERSVLRAIQYLHENR---IIHRDIKAENIFIN 216
Query: 220 EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVEL 279
+ DFG + F V + GT PE + D++S G+VL E+
Sbjct: 217 HPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
Query: 280 LTGQ 283
T
Sbjct: 277 ATCH 280
|
Length = 391 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 40/126 (31%), Positives = 58/126 (46%), Gaps = 37/126 (29%)
Query: 178 PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237
PLT E + + +VA + +L AS HRD+ + NILL+E K+ DFG ++ I
Sbjct: 169 PLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI-- 223
Query: 238 DQTHVTTKVQGTFGYLDPEYFRSGQ-----------------FTDKSDVYSFGVVLVELL 280
Y DP+Y R G +T +SDV+SFGV+L E+
Sbjct: 224 --------------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 269
Query: 281 T-GQKP 285
+ G P
Sbjct: 270 SLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 91 LGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFI--NEVVILSQINHRNVVKLLGC 147
+G+G G V+K + G+IVA+KK + + + I E+ +L Q+ H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
LV+E+ + T+ L ++N + + +I + ++++ H +
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNEL-EKNPR-GVPEHLIKKIIWQTLQAVNFCHKHNCI--- 122
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDK 266
HRD+K NIL+ ++ K+ DFG ++ + T V T Y PE Q+
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGPP 181
Query: 267 SDVYSFGVVLVELLTGQ 283
DV++ G V ELLTGQ
Sbjct: 182 VDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 62/218 (28%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 91 LGQGGQGTVYKGMLADGRIVA--VKKSKIVHEGKLEE--FINEVVILSQINHRNVVKLLG 146
+G G G V G + G A V K V E+ F+ E + H N+++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL--RIATEVAGSLSYLHSAASM 204
C E LLV EF G L YL + +T + R+A E+A L +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSK-------FIVIDQTHVTTK---------VQG 248
H D+ N LL T K+ D+G S ++ DQ V + V G
Sbjct: 123 ---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 249 TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
+D T +S+V+S GV + EL G +P
Sbjct: 180 NLLVVDQ--------TKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 84 HFNVNRILGQGGQGTV----YKGMLADGRIVAVKKSKIVHEGKL--EEFINEVVILSQI- 136
+ + + LGQG G V ++ VA+KK V K+ + + E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 137 NHRNVVKLLGCCLETEVP-------LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT 189
H+N+ C + ++ L +YE + L Q + PLT
Sbjct: 60 GHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIR---SGQPLTDAHFQSFIY 112
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG- 248
++ L Y+HSA + HRD+K N+L+N K+ DFG ++ + +
Sbjct: 113 QILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 249 --TFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPI 286
T Y PE S Q +T DV+S G +L ELL G+KP+
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 91 LGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNVVKLLG 146
+G+G G VY+ D RI A+K K +IV + ++ I E IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 147 CCLETEVP---LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLHSAA 202
+ LV +++S G LF +L + F E R + E+ +L +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FS---EDRAKFYIAELVLALEHLHK-- 114
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
I +RD+K NILL+ + DFG SK + D T GT YL PE +
Sbjct: 115 -YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEK 172
Query: 263 -FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAY 300
+T D +S GV++ E+ G P +++ A+
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 27/166 (16%)
Query: 129 EVVILSQINHRNVVKLLGCCLE-TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI 187
E+ +L + H N++ L + E V E + LH PL +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTD-----LHRLLTSRPLEKQFIQYF 113
Query: 188 ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ 247
++ L Y+HSA + HRD+K +NIL+NE K+ DFG ++ I +T
Sbjct: 114 LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMT---- 163
Query: 248 GTFGYLDPEYFRSGQ-------FTDKSDVYSFGVVLVELLTGQKPI 286
GY+ Y+R+ + + + D++S G + E+L G KP+
Sbjct: 164 ---GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 38/110 (34%), Positives = 59/110 (53%), Gaps = 5/110 (4%)
Query: 178 PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237
PLT E + + +VA + +L AS HRD+ + NILL+E K+ DFG ++ I
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 238 DQTHVTT-KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
D +V + ++ PE +T +SDV+SFGV+L E+ + G P
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 83 DHFNVNRILGQG--GQGTVYKGMLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQIN 137
D F + +++G+G G+ V K M G++ A+K K +++ + F E +L +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVK-MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD 59
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEM-RLRIATEVAGSLS 196
R + L + LV ++ G L L + P +M R +A V
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE--DMARFYLAEMVLA--- 114
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
+ S + HRDIK N+LL++ ++ADFG+ ++ D T + GT Y+ PE
Sbjct: 115 -IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
Query: 257 YFRS-----GQFTDKSDVYSFGVVLVELLTGQKP 285
++ G++ + D +S GV + E+L G+ P
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 95 GQGTVYKGML----ADGRIVA---VKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
G+GT K +L A GR A +KK IV + ++ + E +L H + L
Sbjct: 4 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 63
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLSYLHSAASMPI 206
+ V E+ + G LF +L + F E R R E+ +L YLHS + +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHL-SRERVFS---EDRARFYGAEIVSALDYLHSEKN--V 117
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK 266
+RD+K N++L++ K+ DFG K + D + T GT YL PE +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRA 176
Query: 267 SDVYSFGVVLVELLTGQKP 285
D + GVV+ E++ G+ P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 18/157 (11%)
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL-RIATEVAGS 194
+ H N+++ LG C+E LLV+E+ G L YL + + + L R+A E+A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT--KVQGTFGY 252
++++H H D+ N L T KV D+G + ++ T +
Sbjct: 112 VTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRW 167
Query: 253 LDPEYFRSGQFTDK---------SDVYSFGVVLVELL 280
L PE G+F S+V++ GV L EL
Sbjct: 168 LAPELV--GEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKK--SKIVHEGKLEEFINEVVILSQINHRNVVKLL 145
+ +G G QG V G VAVKK ++ + E+V+L +NH+N++ LL
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 146 GC-----CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
LE + + + + L Q +H L E + ++ + +LHS
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMDANLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS 141
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
A I HRD+K +NI++ T K+ DFG ++ + T T Y PE
Sbjct: 142 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILG 196
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKPIILTGS 291
+ + D++S G ++ EL+ G +I G+
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGS--VIFQGT 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 29/214 (13%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLL 145
+ + K +VAVKK + E L+ E++ Q+ H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKE-DLKLLQQEIITSRQLQHPNILPYV 65
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLR-IATEVAGSLSYLHSAAS 203
+ +V ++ G+ L E P E+ + I +V +L Y+HS
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIHS--- 119
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADF---------GTSKFIVIDQTHVTTKVQGTFGYLD 254
HR +K+++ILL+ ++ G + +V D + K +L
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WLS 176
Query: 255 PEYFR---SGQFTDKSDVYSFGVVLVELLTGQKP 285
PE + G + +KSD+YS G+ EL G P
Sbjct: 177 PEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 85 FNVNRILGQGGQGTVY---KGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV 141
+N+ L G +G V+ K + V VK V GK E+ IL I+HR +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVK---AVTGGKTPG--REIDILKTISHRAI 148
Query: 142 VKLLGCCLETEVPLLV---YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+ L+ +V Y+ LF Y+ D++ PL E + I + +L+YL
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKC----DLFTYV-DRSGPLPL--EQAITIQRRLLEALAYL 201
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD---P 255
H I HRD+K+ NI L+E A + DFG + +D T + G G L+ P
Sbjct: 202 HGRG---IIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAHPDTPQCYGWSGTLETNSP 256
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
E + K+D++S G+VL E+ +
Sbjct: 257 ELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 30/224 (13%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGR----IVAVKKSKIVHEGKLEEFINEVVILSQINH 138
+ F +++ G G VY + R + + K ++ ++++ E IL+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEM-RLRIATEVAGSLS 196
VV + C ET+ L +V E++ G L + L +M R+ A E +L
Sbjct: 61 PFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFA-ETVLALE 115
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT--------------HV 242
YLH+ I HRD+K N+L+ K+ DFG SK ++ T +
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 243 TTKVQGTFGYLDPEY-FRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+V GT Y+ PE R G + D ++ G++L E L G P
Sbjct: 173 DKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 5/110 (4%)
Query: 178 PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237
LT E + + +VA + +L AS HRD+ + NILL+E K+ DFG ++ I
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 238 DQTHVTT-KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
D +V + ++ PE +T +SDV+SFGV+L E+ + G P
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 9e-09
Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 62/234 (26%)
Query: 85 FNVNRILGQGGQGTVYKGMLAD---GRIVAVKKSKIVHEGKLEEFIN---------EVVI 132
+ + + LG+G G V+K + D +VA+KK + F N E++
Sbjct: 9 YEILQKLGKGAYGIVWKAI--DRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59
Query: 133 LSQI-NHRNVVKLLGC--------------CLETEVPLLVYEFISNGTLFQYLHDQNEEF 177
L ++ +H N+VKLL +ET++ + I L + +H +
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDL----HAVIRANIL-EDVHKR---- 110
Query: 178 PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV- 236
I ++ +L Y+HS + HRD+K +NILLN K+ADFG ++ +
Sbjct: 111 --------YIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 237 ---IDQTHVTTKVQGTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
+ V T T Y PE S ++T D++S G +L E+L G KP+
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 44/151 (29%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 137 NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
++ N +KL + +L+ ++I +G LF L + E E++ I ++ +L+
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKK-IIRQLVEALN 123
Query: 197 YLHSAASMPIYHRDIKSTNILLNE-KYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
LH I H DIK N+L + K + D+G K I + GT Y P
Sbjct: 124 DLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYDGTLDYFSP 175
Query: 256 EYFRSGQFTDKS-DVYSFGVVLVELLTGQKP 285
E + G D S D ++ GV+ ELLTG+ P
Sbjct: 176 EKIK-GHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 62/252 (24%), Positives = 123/252 (48%), Gaps = 29/252 (11%)
Query: 48 FKRNGGLVLQQQLTSSD---GSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGML 104
F+ N + +++ + ++ D K+ + + I+G G G VY+ +
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 105 AD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKL-----LGCCLETEVPL--- 155
D VA+KK ++ + + + E++I+ +NH N++ L C + E +
Sbjct: 88 IDTSEKVAIKK--VLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143
Query: 156 LVYEFISNGTLFQYLH---DQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIK 212
+V EFI T+ +Y+ N PL + ++L + ++ +L+Y+HS I HRD+K
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPL-FLVKL-YSYQLCRALAYIHSKF---ICHRDLK 197
Query: 213 STNILLNEK-YTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE-YFRSGQFTDKSDVY 270
N+L++ +T K+ DFG++K ++ Q V+ + F Y PE + +T D++
Sbjct: 198 PQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPELMLGATNYTTHIDLW 255
Query: 271 SFGVVLVELLTG 282
S G ++ E++ G
Sbjct: 256 SLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 91 LGQGGQGTV---YKGMLADGRIVAVKK--SKIVHEGKLEEFINEVVILSQINHRNVVKLL 145
+G G QG V Y +L R VA+KK ++ + E+V++ +NH+N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNE----EFPLTWEMRLRIATEVAGSLSYLHSA 201
P E + L L D N + L E + ++ + +LHSA
Sbjct: 83 ----NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
I HRD+K +NI++ T K+ DFG ++ + + T T Y PE
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 262 QFTDKSDVYSFGVVLVELL 280
+ + D++S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 28/192 (14%)
Query: 120 EGKLEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVYEFISNGTLFQYLHDQNEEF 177
E + + + EV ++ ++ H+N+V+ + L + ++ EF G L + + + F
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 178 PLTWEMRL-RIATEVAGSLSYLHSAASMP----IYHRDIKSTNILL-------------- 218
E + I ++ +L+Y H+ P + HRD+K NI L
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 219 ---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF--RSGQFTDKSDVYSFG 273
N + AK+ DFG SK I I+ + GT Y PE + + DKSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 274 VVLVELLTGQKP 285
++ EL +G+ P
Sbjct: 231 CIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYL 253
L YLHSA I HRDIK N+L+N K+ DFG ++ D++ H+T +V + Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 254 DPEYFR-SGQFTDKSDVYSFGVVLVELLTGQ 283
PE S +T D++S G + ELL +
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 83 DHFNVNRILGQGGQGTV-YKGMLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
D F + +++G+G G V M RI A+K K +++ + F E +L +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+ + L + LV ++ G L L + P R IA V +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYIAEMVLA----I 115
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
HS + HRDIK N+LL+ ++ADFG+ + D T ++ GT Y+ PE
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 259 RS-----GQFTDKSDVYSFGVVLVELLTGQKP 285
++ G++ + D +S GV + E+L G+ P
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 9/204 (4%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGR-IVAVKKSKIVHEGK--LEEFINEVVILSQINHR 139
+ F V ++G+G G V K + + IVA+KK K E + E + E+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
N+V+L LV+E++ L + EE P ++ + + + +H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNML-----ELLEEMP-NGVPPEKVRSYIYQLIKAIH 114
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
I HRDIK N+L++ K+ DFG ++ + T+ T Y PE
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQ 283
+ D++S G +L EL GQ
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 38/118 (32%), Positives = 62/118 (52%), Gaps = 11/118 (9%)
Query: 173 QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232
+ +E L E L + +VA +S+L AS HRD+ + NILL K+ DFG +
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 261
Query: 233 KFIVIDQTHVTTKVQGT----FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
+ I D +V V+G ++ PE + +T +SDV+S+G++L E+ + G P
Sbjct: 262 RDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 60/253 (23%), Positives = 101/253 (39%), Gaps = 65/253 (25%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
D F +++G+G G V D G I A+K KS+++ + ++ E IL++ ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATE------V 191
VVKL + E L L+ E++ G + L M+ TE +
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLL------------MKKDTFTEEETRFYI 107
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ---- 247
A ++ + S + HRDIK N+LL+ K K++DFG + ++H T +
Sbjct: 108 AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG--LKKSHRTEFYRILSH 165
Query: 248 -----------------------------------GTFGYLDPEYFRSGQFTDKSDVYSF 272
GT Y+ PE F + + D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 273 GVVLVELLTGQKP 285
GV++ E+L G P
Sbjct: 226 GVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADG-RIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
+ F + +++G+G G V L + ++ A+K K +++ + F E +L ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+ + L + LV ++ G L L + P R +A V +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYLAEMVIA----I 115
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
S + HRDIK NIL++ ++ADFG+ ++ D T ++ GT Y+ PE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 259 RS-----GQFTDKSDVYSFGVVLVELLTGQKP 285
++ G++ + D +S GV + E+L G+ P
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 48/216 (22%)
Query: 91 LGQGGQGTVYKGMLAD-GRIVAVKK-----SKIVHEGKLEEFINEVVILSQINHRNVVKL 144
+G G G+V G VAVKK I+H + E+ +L + H NV+ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 81
Query: 145 L-----GCCLE--TEVPLLVYEF---ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
L LE +V L+ + ++N Q L D + +F + +R
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------G 132
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
L Y+HSA I HRD+K +N+ +NE K+ DFG ++ + T GY+
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 179
Query: 255 PEYFRSGQ-------FTDKSDVYSFGVVLVELLTGQ 283
++R+ + + D++S G ++ ELLTG+
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNV 141
+ + ++G+G G V + G VA+KK V H + E+ +L + H ++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 142 VKLLGCCL-----ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
V++ L E + +V+E + + L Q + ++ LT E ++ +L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD---LTPEHHQFFLYQLLRALK 117
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT--TKVQGTFGYLD 254
Y+H+A ++HRD+K NIL N K+ DFG ++ D T T Y
Sbjct: 118 YIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 255 PEYFRS--GQFTDKSDVYSFGVVLVELLTGQKPI 286
PE S ++T D++S G + E+LTG KP+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 8/111 (7%)
Query: 174 NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233
NE L++ + + +VA + +L AS HRD+ + N+L+ E K+ DFG ++
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 234 FIVIDQTHVTTKVQGTF---GYLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281
I+ D +++ TF ++ PE + +T SDV+SFG++L E+ T
Sbjct: 288 DIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 68/287 (23%), Positives = 127/287 (44%), Gaps = 50/287 (17%)
Query: 91 LGQGGQGTVYKGMLA------DGRIVAVKKSKIV-------HEGKLEEFINEVVILSQIN 137
LG+G + +Y G+L D K+ K++ H F ++ Q++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
H+++V L G C+ ++V EF+ G L ++H +++ LT + ++A ++A +LSY
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSY 120
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYT-------AKVADFGTSKFIVIDQTHVTTKVQGTF 250
L + H ++ + NILL + K++D G ++ Q V
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----RI 172
Query: 251 GYLDPEYFR-SGQFTDKSDVYSFGVVLVEL-LTGQKPIILTGSKEATGLAAYFILSMEEN 308
++ PE S + +D +SFG L E+ G+ P+ K+ T LA E+
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL-----KDKT-LA-------EKE 219
Query: 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355
R Y+ ++ KE +A L T C+N + +RP + + ++
Sbjct: 220 RFYE-GQCMLVTPSCKE----LADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 46/217 (21%)
Query: 89 RILGQGGQGTV---YKGMLADGRIVAVKKSKIVHEGKLEEFIN---------EVVILSQI 136
+ +G G QG V Y + G+ VA+KK F N E+V++ +
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKLV 72
Query: 137 NHRNVVKLLGC-----CLET--EVPLLVYEFISNGTLFQYLH---DQNEEFPLTWEMRLR 186
NH+N++ LL LE +V LV E + + L Q + D L ++M
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDHERMSYLLYQMLCG 130
Query: 187 IATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV 246
I +LHSA I HRD+K +NI++ T K+ DFG ++ +T V
Sbjct: 131 I--------KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYV 178
Query: 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQ 283
T Y PE + + D++S G ++ E++ G
Sbjct: 179 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 91 LGQGGQGTV---YKGMLADGRIVAVKK--SKIVHEGKLEEFINEVVILSQINHRNVVKLL 145
+G G QG V Y +L R VA+KK ++ + E+V++ +NH+N++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 146 GC-----CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
LE + + + + L Q + + L E + ++ + +LHS
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHS 144
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
A I HRD+K +NI++ T K+ DFG ++ + + T T Y PE
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 261 GQFTDKSDVYSFGVVLVELLTGQ 283
+ + D++S G ++ E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 37/127 (29%), Positives = 63/127 (49%), Gaps = 9/127 (7%)
Query: 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNIL 217
Y+ ++ + L D E LT L +VA + +L AS HRD+ + N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSE-GLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVL 269
Query: 218 LNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF---GYLDPEYFRSGQFTDKSDVYSFGV 274
L + K+ DFG ++ I+ D +V+ TF ++ PE +T SDV+S+G+
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 275 VLVELLT 281
+L E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 85 FNVNRILGQGGQGTVYKGMLAD--GRIVAVKK---SKIVHEGKLEEFINEVVILSQINHR 139
F ++R L G +G V++ D R+V VK + VHE +L ++ +L+ ++ R
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVV-VKAGWYASSVHEARLLRRLSHPAVLALLDVR 229
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
VV L C L++ ++ S+ L+ YL + PL +A ++ ++ Y+H
Sbjct: 230 -VVGGLTC-------LVLPKYRSD--LYTYLGARLR--PLGLAQVTAVARQLLSAIDYIH 277
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID-QTHVTTKVQGTFGYLDPEYF 258
I HRDIK+ N+L+N + DFG + F T + GT PE
Sbjct: 278 GEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVL 334
Query: 259 RSGQFTDKSDVYSFGVVLVE 278
+T D++S G+V+ E
Sbjct: 335 AGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 52/238 (21%)
Query: 73 FTTKELDKAT----DHFNVNRILGQGGQGTVYKGMLADGR-IVAVKK-----SKIVHEGK 122
F +EL+K + + +G G G+V R VAVKK ++H +
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR 60
Query: 123 LEEFINEVVILSQINHRNVVKLL-----GCCLE--TEVPL---LVYEFISNGTLFQYLHD 172
E+ +L + H NV+ LL +E EV L L+ ++N Q L D
Sbjct: 61 T---YRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSD 117
Query: 173 QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232
++ +F + +R L Y+HSA I HRD+K +N+ +NE ++ DFG +
Sbjct: 118 EHVQFLIYQLLR---------GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165
Query: 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ-------FTDKSDVYSFGVVLVELLTGQ 283
+ + T GY+ ++R+ + + D++S G ++ ELL G+
Sbjct: 166 RQADDEMT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
L Y+HSA + HRD+K +N+LLN K+ DFG ++ +T V T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRA 176
Query: 255 PE-YFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
PE ++T DV+S G + ELL G+KP+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 50/200 (25%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 91 LGQGGQGTVYKGMLAD-GRIVAVKK---SKIVHEGKLEEFINEVVILSQINHRNVVKLLG 146
LG+GG G V + + G++ A KK ++ + + + E IL ++N +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 147 CCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
E++ L LV ++ G L ++++ E L E + + ++ + +LHS M
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGER-GLEMERVIHYSAQITCGILHLHS---MD 115
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTD 265
I +RD+K N+LL+++ +++D G + + + T+ GT GY+ PE + ++
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 266 KSDVYSFGVVLVELLTGQKP 285
D ++ G + E++ G+ P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|219496 pfam07645, EGF_CA, Calcium-binding EGF domain | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-06
Identities = 14/29 (48%), Positives = 18/29 (62%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRCITP 29
+DEC DGT NC N +C N G + C+ P
Sbjct: 2 VDECADGTHNCPANTVCVNTIGSFECVCP 30
|
Length = 42 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLGC 147
+G G G+V + G VA+KK + ++ + E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80
Query: 148 CLETEVPLLVYEFISNGTLFQ-YLHDQNEEF---PLTWEMRLRIATEVAGSLSYLHSAAS 203
+ + + + L Y+ ++ PL+ + + ++ L Y+HSA
Sbjct: 81 --DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG- 137
Query: 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSG- 261
I HRD+K N+ +NE K+ DFG ++ + T +V T+ Y PE +
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILNWM 190
Query: 262 QFTDKSDVYSFGVVLVELLTGQ 283
+ D++S G ++ E+LTG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 40/212 (18%)
Query: 91 LGQGGQGTVYKGMLADGRI---VAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLL 145
+G G GTV + D R VA+KK + +L + E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 146 GCCLETEVP------LLVYEFISN--GTLFQY--LHDQNEEFPLTWEMRLRIATEVAGSL 195
LV F+ G L ++ L + +F L ++M L+ L
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-LVYQM-LK-------GL 131
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG---TFGY 252
Y+H+A I HRD+K N+ +NE K+ DFG ++ +++ G T Y
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRWY 181
Query: 253 LDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQ 283
PE + +T D++S G ++ E+LTG+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRN 140
F + + + +G G VY G + ++ AVK K+ ++++ + + E L+
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLH-----DQNEEFPLTWEMRLRIATEVAGSL 195
+V L LV E++ G + LH D+ EM ++ +EVA +L
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKYISEVALAL 117
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233
YLH I HRD+K N+L++ + K+ DFG SK
Sbjct: 118 DYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 63/262 (24%), Positives = 96/262 (36%), Gaps = 86/262 (32%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVHEGKLEEFINEVVILSQI 136
D F + + LG+G G VYK L +G+ V +KK+ G +E ++NE V +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKAT--EYGAVEIWMNERV---RR 185
Query: 137 NHRN-VVKLLGCCLET-----EVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRL---- 185
N + LE E LV+ + TL + Q++EFP E L
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLM--QSKEFPYNVEPYLLGKV 243
Query: 186 ---------------RIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230
I ++ +L LHS I HRD+K NI+ +E G
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSE---------G 291
Query: 231 TSKFIVIDQTHVTTKVQGTFGY------LDP------EYFRSGQ---------------- 262
+ F +ID G Y LDP +Y S Q
Sbjct: 292 SGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 350
Query: 263 -----FTDKSDVYSFGVVLVEL 279
D+ D+YS G++ +++
Sbjct: 351 LWQLNLPDRFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 56/241 (23%), Positives = 94/241 (39%), Gaps = 44/241 (18%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
D F +++G+G G V D G I A+K K+ ++ + ++ E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
VVK+ + L+ EF+ G + L ++ L+ E E ++ +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAI 117
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFG---------------------TSKFIV- 236
H + HRDIK N+LL+ K K++DFG S F
Sbjct: 118 HQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 237 ------------IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQK 284
++ + GT Y+ PE F + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 285 P 285
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 57/248 (22%), Positives = 89/248 (35%), Gaps = 52/248 (20%)
Query: 84 HFNVNRILGQGGQGTVYKGMLADGRIV-AVK---KSKIVHEGKLEEFINEVVILSQINHR 139
F + +G G G V D + A+K K+ ++ + E IL++ ++
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
VVKL + + V ++I G + L + F R IA E+ ++ +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-IRLGIFEEDLA-RFYIA-ELTCAIESVH 118
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFG---------TSKFI--------------- 235
M HRDIK NIL++ K+ DFG SK+
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 236 -----------------VIDQTHVTT-KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLV 277
+ GT Y+ PE +T D +S GV+L
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 278 ELLTGQKP 285
E+L GQ P
Sbjct: 236 EMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 57/259 (22%), Positives = 100/259 (38%), Gaps = 68/259 (26%)
Query: 83 DHFNVNRILGQGGQGTV-YKGMLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
+ F+ +++G+G G V G+I A+K KS++ + +L E +L++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEM------RLRIATEVA 192
VV L + + L+ EF+ G L L + ++ R +A E
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECV 111
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS-------------------- 232
++ +H + HRDIK NIL++ K++DFG S
Sbjct: 112 LAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 233 --------KFIVIDQTHVT--TKVQ----------------GTFGYLDPEYFRSGQFTDK 266
+ +D ++T +K Q GT Y+ PE F + +
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 267 SDVYSFGVVLVELLTGQKP 285
D +S G ++ E L G P
Sbjct: 229 CDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 91 LGQGGQGTVYKGMLADGRI---VAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
+G+G G VYK DG+ A+K+ I G E+ +L ++ H NV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQ--IEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 148 CL---ETEVPLLVYEFISNGTL----FQYLHDQNEE-FPLTWEMRLRIATEVAGSLSYLH 199
L + +V LL +++ + F N++ L M + ++ + YLH
Sbjct: 67 FLSHSDRKVWLL-FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 200 SAASMPIYHRDIKSTNILL----NEKYTAKVADFGTSKFI--VIDQTHVTTKVQGTFGYL 253
+ + HRD+K NIL+ E+ K+AD G ++ + V TF Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 254 DPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPI 286
PE + +T D+++ G + ELLT + PI
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 8/103 (7%)
Query: 83 DHFNVNRILGQGGQG-----TVYKGMLADGRI-VAVKKSK-IVHEGKLEEFINEVVILSQ 135
+ + + LG G G T Y +D + VAVK K H + E ++E+ +LS
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94
Query: 136 I-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEF 177
+ NH N+V LLG C L++ E+ G L +L + + F
Sbjct: 95 LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 44/241 (18%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
+ F +++G+G G V D G + A+K K+ ++ + ++ E IL + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
VVK+ + L+ EF+ G + L ++ LT E E ++ +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT---LTEEETQFYIAETVLAIDSI 117
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFG---------------------TSKFIVI 237
H + HRDIK N+LL+ K K++DFG S F
Sbjct: 118 HQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 238 -------------DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQK 284
++ + GT Y+ PE F + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 285 P 285
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 34/123 (27%), Positives = 54/123 (43%), Gaps = 11/123 (8%)
Query: 83 DHFNVNRILGQGGQGTVYK----GMLADGRI--VAVKKSKI-VHEGKLEEFINEVVILSQ 135
D+ + LG G G V + G+ + + VAVK K H + E ++E+ ILS
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 136 I-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
+ H+N+V LLG C L++ E+ G L +L + E F + + S
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF---LNFVMALPEISETS 154
Query: 195 LSY 197
Y
Sbjct: 155 SDY 157
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 32/148 (21%), Positives = 59/148 (39%), Gaps = 15/148 (10%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV--KLLG 146
++L G VY D V +K K + EV IL + + + K+L
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYV-LKI--NPSREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
L+ E+I TL + ++ E+ IA ++A L+ LH + +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVL 110
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKF 234
H D+ NIL+++ + D+ + +
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 91 LGQGGQGTVYKGMLADGRI---VAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
+G+G G VYK DG+ A+K+ I G E+ +L ++ H NV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQ--IEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 148 CL---ETEVPLLVYEFISNGTL----FQYLHDQNEE-FPLTWEMRLRIATEVAGSLSYLH 199
L + +V LL +++ + F N++ L M + ++ + YLH
Sbjct: 67 FLSHADRKVWLL-FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 200 SAASMPIYHRDIKSTNILL----NEKYTAKVADFGTSKFI--VIDQTHVTTKVQGTFGYL 253
+ + HRD+K NIL+ E+ K+AD G ++ + V TF Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 254 DPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPI 286
PE + +T D+++ G + ELLT + PI
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 62/249 (24%), Positives = 96/249 (38%), Gaps = 56/249 (22%)
Query: 89 RILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINHRNVVKL 144
+ LG G G V D + A+K K +++ ++ E IL++ ++ VVKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASM 204
+ + V ++I G + L + E FP R IA E+ ++ +H M
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL-IRMEVFPEVLA-RFYIA-ELTLAIESVHK---M 120
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFG---------TSKF------IVID----------- 238
HRDIK NIL++ K+ DFG SK+ I D
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 239 --------------------QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVE 278
Q + + GT Y+ PE +T D +S GV+L E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 279 LLTGQKPII 287
+L GQ P +
Sbjct: 241 MLVGQPPFL 249
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 8/103 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGM---LADGR---IVAVKKSK-IVHEGKLEEFINEVVILSQ 135
D + RILG G G V +G L+ + VAVK K + + ++E+ I++
Sbjct: 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTH 96
Query: 136 IN-HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEF 177
+ H N+V LLG C ++ ++ E+ G L YLH + F
Sbjct: 97 LGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 16/146 (10%)
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQ---NEEFPLTWEMRLRIATEVAGSLS 196
N+V L + + LV + G L+ ++ EE W A E+ +L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRW------AAEMVVALD 99
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
LH I RD+ NILL+++ ++ F ++ ++ + V+ Y PE
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPE 152
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTG 282
+ T+ D +S G +L ELLTG
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|214542 smart00179, EGF_CA, Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 5e-04
Identities = 12/27 (44%), Positives = 12/27 (44%), Gaps = 1/27 (3%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRCI 27
IDEC G C C N G YRC
Sbjct: 2 IDECASG-NPCQNGGTCVNTVGSYRCE 27
|
Length = 39 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 17/102 (16%)
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADF---------GTSKFIVIDQTHVTTK 245
L+YLH + HR+IK+++IL++ ++ G +V D +T
Sbjct: 114 LNYLHQNGYI---HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 246 VQGTFGYLDPEYFRSG--QFTDKSDVYSFGVVLVELLTGQKP 285
V +L PE R + KSD+YS G+ EL TG+ P
Sbjct: 171 VLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
Score = 35.3 bits (82), Expect = 0.002
Identities = 12/27 (44%), Positives = 12/27 (44%), Gaps = 1/27 (3%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRCI 27
IDEC G C C N G YRC
Sbjct: 2 IDECASGN-PCQNGGTCVNTVGSYRCS 27
|
Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. Length = 38 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 22/115 (19%), Positives = 43/115 (37%), Gaps = 13/115 (11%)
Query: 175 EEFPL-TWEMRLRIATEVAGSLSYLHSAASMPIYHR-DIKSTNILLNEKYTAKVADFGTS 232
+ +P W+ LR+A +A + + LH + D+ + L+++ +KV +
Sbjct: 109 QSYPHCAWDFLLRVARNLASAFATLHEHG----HVVGDVNQNSFLVSD--DSKVVLVDSD 162
Query: 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTD-----KSDVYSFGVVLVELLTG 282
F + + G + PE F D + V++ LL G
Sbjct: 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217
|
Length = 637 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 400 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.81 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.57 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.51 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.44 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.32 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.23 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.04 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.03 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.02 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.96 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.93 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.86 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.85 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.78 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.64 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.6 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 97.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.47 | |
| PLN02236 | 344 | choline kinase | 97.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.25 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.15 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.04 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.98 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.93 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.84 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.74 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.6 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.58 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.52 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.23 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.07 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.93 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.77 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.55 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.4 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.3 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.99 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=400.01 Aligned_cols=290 Identities=46% Similarity=0.737 Sum_probs=253.0
Q ss_pred cccccChHHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEE
Q 042371 69 RCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCC 148 (400)
Q Consensus 69 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 148 (400)
....|+..++..++++|.-.+.||+|+||.||+|...++..||||++.........+|.+|+.++.+++|||+|+++|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999998899999977654433145599999999999999999999999
Q ss_pred eeCCc-ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEE
Q 042371 149 LETEV-PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVA 227 (400)
Q Consensus 149 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~ 227 (400)
.+.+. .+||+||+++|+|.+.+...... +++|..+++|+.++|.||+|||....++||||||||.|||+|++.++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99984 99999999999999999886654 79999999999999999999999888889999999999999999999999
Q ss_pred ecCCccccccCCceeeecc-cccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh
Q 042371 228 DFGTSKFIVIDQTHVTTKV-QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 228 Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
|||+|+..... ....... .||.+|+|||++..+..+.++||||||++|+||+||+.|...........+..|......
T Consensus 220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999654321 1111112 799999999999999999999999999999999999999877665556668888877788
Q ss_pred hcccccccchhhh-ccCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 307 ENRLYDFLDDQVL-KVGQK-EEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 307 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
...+.+++|+.+. ..... .....+..++.+|++.+|..||+|.+|+++|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 8899999999987 44443 577789999999999999999999999999965544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=371.29 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=211.7
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc-cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc-ceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV-PLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e 159 (400)
.+++..+.||+|..|+||++..+ +++.+|+|.+.. ......+++.+|+++++..+|||||.+|+.|...+. +.|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45677889999999999999975 688999998854 345567899999999999999999999999999995 999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||++|+|++++...+ .+++...-+++.+|++||.|||. .+ ||||||||+|||++.+|.|||+|||.+..+...
T Consensus 159 YMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999998764 59999999999999999999996 66 999999999999999999999999999876433
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||......... ..... ..+++...
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-~~~Ll---------~~Iv~~pp 299 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-IFELL---------CAIVDEPP 299 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-HHHHH---------HHHhcCCC
Confidence 556688999999999999999999999999999999999999999665211111 11111 11111111
Q ss_pred hccCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 319 LKVGQK-EEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 319 ~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
. ..+. .+++++++|+..||+.||.+|||+.++++|=.
T Consensus 300 P-~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 300 P-RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred C-CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 1 1122 47788999999999999999999999999733
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=386.19 Aligned_cols=329 Identities=26% Similarity=0.387 Sum_probs=256.4
Q ss_pred CCCCceeEeccC------c---eee-ecCCchhh--hhhHHH----HHHHHHHHhhcCCccchhhhccC--CCCCCcccc
Q 042371 11 CSENLLCENYEG------G---YRC-ITPKRKVY--IIKRED----IKLKEKFFKRNGGLVLQQQLTSS--DGSIDRCKL 72 (400)
Q Consensus 11 ~~~~~~c~~~~~------~---y~~-~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 72 (400)
=|+.++|+.... . |++ ..+.+..+ +..+.. .++.+.+..++.|+...-..... .........
T Consensus 116 ~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~~~~~~~~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~~~p~~~~ 195 (468)
T KOG0197|consen 116 KGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYPYIDERELFSSLQQLVNYYSKNADGLCTRLRDPCSKQGHTKPQTPD 195 (468)
T ss_pred cCCeeEEEEeccccCCccceeeeeeeEcCCCCeecCCCHHHhhhhHHHHHhhhhccCcchhhcccCchhccCCCCCCCCc
Confidence 356667766643 1 888 44444333 655554 34555555555555433211111 001111122
Q ss_pred cChHHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC
Q 042371 73 FTTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE 152 (400)
Q Consensus 73 ~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 152 (400)
+..+.|+...+.+++.+.||+|-||.||.|.+++..+||+|.++.. .-..+.|.+|+.+|++|+|++||+++++|..+.
T Consensus 196 ~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 196 LARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 3355566677778899999999999999999988889999987754 334578889999999999999999999999988
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
.++||||||+.|+|.++|+.... ..+.....+.++.|||+||+||++++ +|||||.+.||||++++.+||+|||+|
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~-~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREG-GLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCC-CccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence 99999999999999999998333 35899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
+....+.........-+..|.|||++..+.++.+||||||||+||||+| |+.|+...... .+.
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~ 414 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVL 414 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHH
Confidence 9655555445555555778999999999999999999999999999999 99998544332 223
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
+.++.+.+-..+..++..+.+++..||+.+|++|||++.+...|+++..
T Consensus 415 ~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 415 ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 3344455555677788999999999999999999999999999988765
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=388.33 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=214.5
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.+|...+.||+|||+.||.++. ..|..||+|.+.. ......+...+|++|.++|+|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999997 6799999997754 35667889999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
|+|..++|..+++++. ++++.+++.++.||+.||.|||+.+ |+|||||..|+|++++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999998544 6999999999999999999999999 999999999999999999999999999987543
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.....+.+|||.|.|||++.....+..+||||+||+||.||.|++||......+... .....+-
T Consensus 172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~-----~Ik~~~Y---------- 235 (592)
T KOG0575|consen 172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN-----KIKLNEY---------- 235 (592)
T ss_pred -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH-----HHHhcCc----------
Confidence 344566889999999999999999999999999999999999999996543332111 1111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+.+..+||.++|++||.+|||+++|+.+
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1233555678899999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=374.96 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=208.5
Q ss_pred HHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC-------chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH-------EGKLEEFINEVVILSQINHRNVVKLLGCCLET 151 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 151 (400)
...+.|.+.+.||+|+||.|-+|.. ++|+.||||++.... ........+|+++|++++|||||+++++|...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3567889999999999999999995 469999999765321 12234467999999999999999999999999
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CcEEEEe
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK---YTAKVAD 228 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~D 228 (400)
+..||||||++||+|.+.+..++ .+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ -.+||+|
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999998766 3777778889999999999999999 9999999999999866 6899999
Q ss_pred cCCccccccCCceeeecccccCCCCCccccccCCC---CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF---TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 305 (400)
||+|++.. ....+.+.+|||.|.|||++.+..+ ..++||||+||+||-+++|.+||........ + ...+
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l----~eQI 394 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--L----KEQI 394 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--H----HHHH
Confidence 99999864 5667788999999999999987643 3478999999999999999999954332210 0 1111
Q ss_pred hhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 EENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...- -...+...+++..+||.+||..||++|||+.|++++
T Consensus 395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1221110 012245567889999999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=366.74 Aligned_cols=201 Identities=31% Similarity=0.537 Sum_probs=183.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.++|.+.+.||+|+||+||+|+.+ ++..||||.+... .....+.+..|+.+|+.++|||||.+++++...+.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467999999999999999999965 5789999987765 5666788899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC------CcEEEEecCCc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK------YTAKVADFGTS 232 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~------~~~kl~Dfgla 232 (400)
|||+||+|.++++.++ .+++..+..++.||+.||++||+++ ||||||||+|||++.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999876 4999999999999999999999999 9999999999999865 46899999999
Q ss_pred cccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCC
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTG 290 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 290 (400)
+.+. ......+.+|+|-|||||++...+|+.|+|+||+|+++|++++|+.||....
T Consensus 163 R~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9874 5556677899999999999999999999999999999999999999996443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=376.83 Aligned_cols=267 Identities=36% Similarity=0.530 Sum_probs=217.1
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCch--hHHHHHHHHHHHHhCCCCcceeeeeEEeeCC-cceE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG--KLEEFINEVVILSQINHRNVVKLLGCCLETE-VPLL 156 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l 156 (400)
.....+.+.+.||+|+||+||+|.+++...||+|++...... ....|.+|+.+|.+++|||||+++|++.+.. ..+|
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 334555666779999999999999976666999987754322 2569999999999999999999999999887 7899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-cEEEEecCCcccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKFI 235 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~Dfgla~~~ 235 (400)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+. ||||||||+|||++.++ ++||+|||+++..
T Consensus 118 VtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceee
Confidence 99999999999999874 22369999999999999999999999885 89999999999999998 9999999999875
Q ss_pred ccCCceeeecccccCCCCCccccc--cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFR--SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.... ...+...||+.|||||++. ...|+.++||||||+++|||+||+.||...... .........
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~------ 261 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVG------ 261 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhc------
Confidence 4322 3334467999999999999 569999999999999999999999999543321 111111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhcc
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~ 365 (400)
..+...+...+..+..++.+||+.||..||++.+++..|+.+.......
T Consensus 262 ---~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 262 ---GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred ---CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 1112223336677999999999999999999999999999998765543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=352.60 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=209.6
Q ss_pred cCCcccceeeecCcEEEEEEE-ecCCcEEEEEEccc--cCchhHHHHHHHHHHHHhCCCCcceeeee-EEeeCCc-ceEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRNVVKLLG-CCLETEV-PLLV 157 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~-~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~-~~lv 157 (400)
..|.++++||+|.||.||++. ..+|..+|.|.+.- .+....+....|+.+|++|+|||||++++ .+.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 568999999999999999998 46899999998763 34556788999999999999999999998 5555555 8899
Q ss_pred EEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 158 YEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAAS-MPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
||||.+|+|..+++..+ ....+++..+|+++.|++.||..+|+.-. ..|+||||||.||+++.+|.+||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999998743 34469999999999999999999999321 23899999999999999999999999999987
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
... .......+|||.||+||.+...+|+.+|||||+||++|||..-++||... ++... -..+..+....+
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L-~~KI~qgd~~~~-- 248 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSL-CKKIEQGDYPPL-- 248 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHH-HHHHHcCCCCCC--
Confidence 543 34455688999999999999999999999999999999999999999533 22111 112222221111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
....++..+..+|..|+.+||..||+...+++-+.
T Consensus 249 ------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 249 ------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 12567788999999999999999999655554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=358.55 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=208.9
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
...++|++.++||+|+||.||.++.+ .++.+|+|.++. ...........|..+|..++||+||+++-.|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34578999999999999999999965 488999997653 34566788999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
||+||+.||.|...|++.+ .+++..+..++.+|+.||.|||+.| ||||||||+|||+|.+|+++|+|||+++..
T Consensus 102 lVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999998766 4899999999999999999999999 999999999999999999999999999854
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
. .....+.+.+||+.|||||++.+..|+.++|+||||+++|+|++|.+||....... . ...+..++
T Consensus 176 ~-~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~-~~~I~~~k------ 241 (357)
T KOG0598|consen 176 L-KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------M-YDKILKGK------ 241 (357)
T ss_pred c-cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------H-HHHHhcCc------
Confidence 3 33445566899999999999999999999999999999999999999995443221 1 11111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRP----TMKEVAM 353 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~ell~ 353 (400)
....+.-.+...++++.++|..||++|. ++.+|-.
T Consensus 242 ---~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 242 ---LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ---CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1112223456688999999999999995 4555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=337.88 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=210.2
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
+.|+.+.++|+|+||+||+++.+ .|+.||||++.... +...+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999976 48999999876543 3345677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
||+..-| +-+..... .++...+.+++.|++.|+.|+|+++ +|||||||+|||++.+|.+||+|||+|+.+.. +
T Consensus 82 ~~dhTvL-~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVL-HELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHH-HHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 9987444 44555443 3899999999999999999999999 99999999999999999999999999998764 5
Q ss_pred ceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH--------HHHhhhc--
Q 042371 240 THVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF--------ILSMEEN-- 308 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~-- 308 (400)
....+.++.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|...+.-+........ ...+...
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 666778889999999999887 78999999999999999999999887443322211111111 1111111
Q ss_pred ----ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 309 ----RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 309 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+.+.-+...++...+..+.-+.+|+..||+.||.+|++.++++.+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1222222222333344556678999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=349.39 Aligned_cols=262 Identities=29% Similarity=0.417 Sum_probs=209.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC--cceEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE--VPLLVY 158 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 158 (400)
..+|...+.||+|+||.||++... +|...|+|.+........+.+.+|+.+|.+++|||||+++|...... ..+++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 456888999999999999999965 48999999877654344677899999999999999999999744444 588999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCcEEEEecCCcccccc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-KYTAKVADFGTSKFIVI 237 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~Dfgla~~~~~ 237 (400)
||+++|+|.+++...+. .+++..+..+.+||++||.|||++| |+||||||+|||++. ++.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999988664 4999999999999999999999999 999999999999999 79999999999986642
Q ss_pred --CCceeeecccccCCCCCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 238 --DQTHVTTKVQGTFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 238 --~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
..........||+.|||||++.++. ...++|||||||++.||+||++||... ..............
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------ 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------ 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC------
Confidence 1222334577999999999999643 345999999999999999999998532 01111111111111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.....+...+....+|+.+|++.||++|||+.+++++.-..+...
T Consensus 240 ---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 240 ---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 111334456677899999999999999999999999866554433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=355.22 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=208.7
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
...++|.+++.||+|+||.||+|+.+ .|..+|+|+++. ....++..+..|-++|...++|+||++|-.|.+...+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35688999999999999999999965 589999998775 34567889999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
|||||++||++..+|.+.+ .|++..++.++.+++.|+..||+.| ||||||||+|+|||..|++||+||||+..+
T Consensus 218 LiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999998766 6999999999999999999999999 999999999999999999999999998543
Q ss_pred ccC----------------------Cce-----ee-------------------ecccccCCCCCccccccCCCCCcchh
Q 042371 236 VID----------------------QTH-----VT-------------------TKVQGTFGYLDPEYFRSGQFTDKSDV 269 (400)
Q Consensus 236 ~~~----------------------~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~Di 269 (400)
... ... .. -..+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 210 000 00 01459999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCC---
Q 042371 270 YSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP--- 346 (400)
Q Consensus 270 wSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--- 346 (400)
|||||||||||.|.+||....+.+...-..... ..+ ........+.+..+||.+||. ||++|.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-----~~l--------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR-----ETL--------KFPEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-----hhc--------cCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999997655544322222211 111 111122333668899999999 999995
Q ss_pred CHHHHHHH
Q 042371 347 TMKEVAME 354 (400)
Q Consensus 347 t~~ell~~ 354 (400)
.++||.++
T Consensus 438 G~~EIK~H 445 (550)
T KOG0605|consen 438 GAEEIKKH 445 (550)
T ss_pred cHHHHhcC
Confidence 46666554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=359.68 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=214.5
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
..|....+||+|+.|.||.|.. ..++.||||++........+-+++|+.+|+..+|+|||.+++.|...+.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 5677888999999999999985 467889999998888888889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
+||+|.+.+.... +++.++..|+.++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999987553 899999999999999999999999 99999999999999999999999999988765444
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
...+.+|||.|||||++....|++++||||||++++||+-|.+||..... ....|....... ....
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lrAlyLIa~ng~----------P~lk 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLIATNGT----------PKLK 490 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----HHHHHHHhhcCC----------CCcC
Confidence 34456799999999999999999999999999999999999999964221 111111111111 1122
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...+..+++|+.+||+.||.+|||+.|||++
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 345667889999999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=352.87 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=211.5
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCc
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEV 153 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 153 (400)
.....+|.+++.||.|+|++|++|+.. .++.||||++.. ..+.....+..|-.+|.+| .||.|++++..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345678999999999999999999965 588999997653 3345566777899999999 79999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
+|+|+||+++|+|.++|.+.+ .+++.-++.++.+|+.||.|||+.| ||||||||+|||+|.++++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999999875 5999999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCce------------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH
Q 042371 234 FIVIDQTH------------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF 301 (400)
Q Consensus 234 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 301 (400)
.+...... .....+||..|.+||++..+..++.+|||+||||||+|+.|.+||..... .....
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----yliFq 297 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----YLIFQ 297 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----HHHHH
Confidence 87532211 11457899999999999999999999999999999999999999954321 11111
Q ss_pred HHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 302 ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...- +.-..+++.++.+.+||.++|..||.+|+|+++|.++
T Consensus 298 kI~~------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 KIQA------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHH------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 0000 1112234445678999999999999999999999887
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=326.98 Aligned_cols=237 Identities=27% Similarity=0.366 Sum_probs=203.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|+..+.||.|+||.|.+++.+ +|..+|+|.+.. ....+.++..+|..+|+.+.||+++++++.+.+.+.+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357899999999999999999965 588999997754 3445678889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||.+||.|..++++.. ++++..++.++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+.+.
T Consensus 123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 99999999999998765 4999999999999999999999999 9999999999999999999999999998753
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
..+-+.+|||.|+|||++...+|..++|+|||||++|||+.|.+||..... +..|.......-.
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY~KI~~~~v~-------- 259 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIYEKILEGKVK-------- 259 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHHHHHHhCccc--------
Confidence 235678999999999999999999999999999999999999999965443 2222211111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCC
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRR 345 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~R 345 (400)
.+.-.+..+++|+..+|+.|-.+|
T Consensus 260 ----fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 ----FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----CCcccCHHHHHHHHHHHhhhhHhh
Confidence 233445668999999999999999
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=341.31 Aligned_cols=267 Identities=24% Similarity=0.376 Sum_probs=213.9
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
++......|++...||.|..++||+|.. +.+..||||++.... ....+.+.+|+..|+.++||||++++..|..+..+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 3445568899999999999999999994 567999999987644 33368999999999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
|+||+||.+|++.+++...-.. .+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeee
Confidence 9999999999999999886544 3999999999999999999999999 99999999999999999999999998876
Q ss_pred cccCCcee---eecccccCCCCCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 235 IVIDQTHV---TTKVQGTFGYLDPEYFRS--GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 235 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
+....... ....+||++|||||++.. ..|+.|+||||||++..||.+|..||....+- ........+ .
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn-~ 248 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQN-D 248 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcC-C
Confidence 65433221 145689999999999653 36999999999999999999999999433221 111111111 1
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...............+..++.++..||+.||.+|||+++++++
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111111122234455689999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=350.49 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=208.7
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhH-HHHHHHHHHHHhCC-CCcceeeeeEEeeCC-cceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKL-EEFINEVVILSQIN-HRNVVKLLGCCLETE-VPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~-~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~l 156 (400)
..++|.+.++||.|+||.||+|+. ..|..||||+++.....+. -.-++|+..|++|+ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 457899999999999999999995 4688999998875433322 23468999999998 999999999999888 8999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
|||||+. +|.++++.++ .++++..++.|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 88 VfE~Md~-NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999965 9999998874 37999999999999999999999999 9999999999999988899999999999764
Q ss_pred cCCceeeecccccCCCCCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH-HHH----------
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYF-RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF-ILS---------- 304 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~---------- 304 (400)
.....+.++.|.+|+|||++ ..+-|+.+.|||++|||++|+.+-++-|.... +.+++-... ...
T Consensus 162 --SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s--E~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 162 --SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS--EIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred --cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc--HHHHHHHHHHHhCCCccccchhH
Confidence 45566778899999999986 56789999999999999999999998884332 211111111 000
Q ss_pred -----hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 305 -----MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 305 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+-.+.+.....+....+ ..+.+..+++.+|+++||.+|||+++.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0011111111111111122 266788999999999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=349.85 Aligned_cols=266 Identities=27% Similarity=0.370 Sum_probs=213.3
Q ss_pred HHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--Ccc
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVP 154 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 154 (400)
...+.|+.+++||+|.||.||+|+. .+|+.||+|++.... +.......+||.||++|+||||+++.+...+. ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3446788899999999999999995 579999999987654 55677788999999999999999999998876 689
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
|||+|||+. +|..++....- .+++.++..++.||+.||.|+|.+| |+|||||..|||||.+|.+||+|||||++
T Consensus 194 YlVFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence 999999976 89988876433 4899999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh-h-hcccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM-E-ENRLY 311 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~-~~~~~ 311 (400)
+........+..+-|.+|+|||.+.+. .|+.++|+||.||||.||+.|++.|... .+..++...+...- + +..+.
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~--tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR--TEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc--cHHHHHHHHHHHhCCCChhccc
Confidence 877666667777889999999998875 7999999999999999999999988432 23333333332211 1 11111
Q ss_pred --cccc----------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042371 312 --DFLD----------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAM 353 (400)
Q Consensus 312 --~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 353 (400)
.+.. .+...+.....++...+|+..+|..||.+|.|+.++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1110 01111112334566789999999999999999998886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=348.59 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=210.5
Q ss_pred HHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc----Cc-hhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCC
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV----HE-GKLEEFINEVVILSQIN-HRNVVKLLGCCLETE 152 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 152 (400)
...+.|.+.+.||+|+||.|+.|.. ..+..||+|.+... .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999985 46899999965432 11 34556778999999998 999999999999999
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CcEEEEecCC
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGT 231 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~Dfgl 231 (400)
..++||||+.||+|.+++...+ ++.+..+.+++.|++.|+.|+|+.| |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998844 5889999999999999999999999 9999999999999999 9999999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCC-CC-CcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ-FT-DKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..... ... ...+..+.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l--~~ki~~~~ 239 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNL--YRKIRKGE 239 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHH--HHHHhcCC
Confidence 98763 3344566788999999999999987 86 789999999999999999999964211 111 11111111
Q ss_pred cccccchhhhccCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEE-IMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
+ ..+... +..+.+++.+||..||.+|+|+.+++ .-..++.
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1 111122 56789999999999999999999999 5566665
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=319.53 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=207.3
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.+|...+.||+|.||.||+|++ ..|+.||||+++... +.......+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688899999999999999995 579999999987643 3335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|++. +|+..++.... .++...+..++.+++.||+|||.+. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9974 99999987654 6899999999999999999999999 9999999999999999999999999999876433
Q ss_pred ceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH--Hhhhccccc---c
Q 042371 240 THVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL--SMEENRLYD---F 313 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~---~ 313 (400)
. ..+..+-|.+|+|||.+.+. .|+..+||||.|||+.||+-|.+-|... .+.+++...+.. ......+.+ +
T Consensus 156 ~-~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~--sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 156 R-IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD--SDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c-ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC--chHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 22333679999999998765 6999999999999999999877655322 222222222211 111111111 1
Q ss_pred cc--------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LD--------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.| .......-...+....+|+.+||..||.+|+|+++.+++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 111112334455667999999999999999999999886
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=350.17 Aligned_cols=263 Identities=29% Similarity=0.430 Sum_probs=206.1
Q ss_pred HHhcCCcccceeeecCcEEEEEEEe------cCCcEEEEEEccccC-chhHHHHHHHHHHHHhC-CCCcceeeeeEEeeC
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGML------ADGRIVAVKKSKIVH-EGKLEEFINEVVILSQI-NHRNVVKLLGCCLET 151 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 151 (400)
...++|++.+.||+|+||.||+|.. ..++.||+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3456899999999999999999973 235679999876432 33456789999999999 899999999988764
Q ss_pred C-cceEEEEccCCCCHHHHHhhcCC-------------------------------------------------------
Q 042371 152 E-VPLLVYEFISNGTLFQYLHDQNE------------------------------------------------------- 175 (400)
Q Consensus 152 ~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 175 (400)
+ ..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 57899999999999999875321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce-eeecccccC
Q 042371 176 ----EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTF 250 (400)
Q Consensus 176 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~ 250 (400)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 124778889999999999999999999 999999999999999999999999999765322221 122234567
Q ss_pred CCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHH
Q 042371 251 GYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMT 329 (400)
Q Consensus 251 ~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (400)
.|+|||++.+..++.++|||||||++|+|++ |..||....... ........+.. ...+...++.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~ 305 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR---------MRAPENATPE 305 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC---------CCCCCCCCHH
Confidence 8999999999999999999999999999997 999985432211 01111111111 1112234456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 330 IATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 330 l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=339.96 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=212.1
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..|+....||+|.||.||+|.+. .++.||+|.+... ....++.+.+|+.+|.+++++||.++|+.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35777789999999999999964 5889999998764 455678999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
|.||++.+++.... .+.+..+.-++++++.|+.|||..+ .+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999997654 3577778889999999999999999 99999999999999999999999999987755444
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
.. .+.+|||.|||||++....|+.++||||||++.+||++|.+|+....+ -++.-++......
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~PP 229 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAPP 229 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCCC
Confidence 43 667899999999999988999999999999999999999999843222 1122222222223
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....++..+++|+..||+.||+.|||+.+++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3334667789999999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=344.03 Aligned_cols=247 Identities=30% Similarity=0.429 Sum_probs=210.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.... +.+...+.+|+++++.++||||+.++++|.....+|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999965 57899999876543 4457789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+.| +|..++...+ .+++..+..++.++..||.|||+.+ |.|||+||.|||++.+|.+|++|||+|+.... .
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9977 9999998755 4999999999999999999999999 99999999999999999999999999997654 4
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
....+...|||-|||||++.+.+|+..+|+||+||++||+++|++||..... ....... ..+..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I---------~~d~v- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSI---------LKDPV- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHH---------hcCCC-
Confidence 4556778899999999999999999999999999999999999999942211 1111111 11111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.++...+..+.+|+...|..||.+|.|..+++.+
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1233667789999999999999999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=345.95 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=212.6
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
+-|++++.||.|+.|.|.+|+. ..|+.+|||.+... .......+.+|+.+|+.+.|||++++|+++.+...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5589999999999999999995 47999999987543 3445677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||++||.|++++..++ ++++..+.+++.||+.|+.|+|..+ |+||||||+|+|+|.++++||+|||+|..- .
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe--~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE--V 163 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc--c
Confidence 9999999999998776 5999999999999999999999999 999999999999999999999999999753 3
Q ss_pred CceeeecccccCCCCCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFT-DKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.+....+.+|.|.|.|||++.+.+|. .++||||.|||||.||+|+.||...+ ..........+.+
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlKV~~G~f------- 229 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLKVQRGVF------- 229 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCcc-------
Confidence 45556678899999999999999995 68999999999999999999995221 2222233333221
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
..+...+.+..+|+.+||.+||.+|.|++||++|-.
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 233445567899999999999999999999998743
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=329.45 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=199.5
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEccccCchh---HHHHHHHHHHHHhCCCCcceeeeeEEee----CCcceEEEEcc
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGK---LEEFINEVVILSQINHRNVVKLLGCCLE----TEVPLLVYEFI 161 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 161 (400)
..||+|++|.||+|.. +|+.||+|.+....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999887543332 5778899999999999999999999877 34678999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
++|+|.+++.... .+++...+.++.+++.||.|||.. + ++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999997643 488999999999999999999985 6 8899999999999999999999999987643211
Q ss_pred eeeecccccCCCCCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 241 HVTTKVQGTFGYLDPEYFRS--GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..........
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~~~--------- 239 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINKNN--------- 239 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCC---------
Confidence 23457899999999976 689999999999999999999999996432211 1111111100
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
....+...+..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 011122345679999999999999999999999999998864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=359.26 Aligned_cols=263 Identities=30% Similarity=0.489 Sum_probs=221.3
Q ss_pred HhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
...+....+.||+|+||.||+|... +...||||.++..... ..++|.+|++.+..++|||||+++|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3456677889999999999999843 2457999999876666 67899999999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 042371 154 PLLVYEFISNGTLFQYLHDQNE-----------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY 222 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 222 (400)
.++|+|||..|||.++|+.+.. ..+++..+.+.|+.|||.||.||-++. +|||||...|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 9999999999999999986532 123889999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCccccccCCceeee-cccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHH
Q 042371 223 TAKVADFGTSKFIVIDQTHVTT-KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAY 300 (400)
Q Consensus 223 ~~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 300 (400)
.|||+|||+++........... ...-..+|||||.+..++||++||||||||+|||+++ |..|+.....++
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------- 713 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------- 713 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence 9999999999987654443322 2234679999999999999999999999999999999 999985444332
Q ss_pred HHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 301 FILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
+-+.+..+.....++.++.++++|+..||+.+|.+||+++||-..|+......
T Consensus 714 ---------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 ---------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ---------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 22222233335567788889999999999999999999999999999876543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=308.07 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=214.2
Q ss_pred HHHhcCCcccceeeecCcEEEEEEE-ecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC-----
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE----- 152 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 152 (400)
-.+..+|++.+.||.|||+-||++. ..+++.+|+|++......+.+..++|++..++++|||+++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3456789999999999999999998 5678899999998888888999999999999999999999998765443
Q ss_pred cceEEEEccCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEE-FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
..||+++|...|+|.+.++..... ..+++...+.|+.+|+.||.+||... .+++||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 489999999999999999875433 26899999999999999999999988 4799999999999999999999999999
Q ss_pred ccccccCCcee--------eecccccCCCCCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHH
Q 042371 232 SKFIVIDQTHV--------TTKVQGTFGYLDPEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAY 300 (400)
Q Consensus 232 a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 300 (400)
++.....-... -..-..|..|+|||.+.- ...++++|||||||++|.|+.|..||...-..
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------- 247 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------- 247 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------
Confidence 97643111000 011235889999999864 45789999999999999999999999432211
Q ss_pred HHHHhhhcccc-cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 301 FILSMEENRLY-DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 301 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
.+.+. .+............+++.+.++|++||++||.+||++.+++..++.+.
T Consensus 248 ------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 111222222233347888999999999999999999999999988764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=325.55 Aligned_cols=250 Identities=24% Similarity=0.409 Sum_probs=211.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
...+|++.+.||+|.||.|-+|.. ..|+.||||.++. .++.+.-.+.+|++||..|+||||+.+|.+|.+.+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 346799999999999999999995 6799999996653 456667789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||..+|.|++++.... .+++..++.+++||..|+.|+|+++ ++|||||.+|||+|.|+++||+|||++..+.
T Consensus 131 vMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999998766 4999999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCceeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
......+++|+|-|.+||++.+.+| ++.+|-||||++||.|+.|..||...+-. .....+..+...+
T Consensus 205 --~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrE--- 272 (668)
T KOG0611|consen 205 --DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYRE--- 272 (668)
T ss_pred --cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccC---
Confidence 4455677899999999999999998 47899999999999999999999533211 1122222222111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
+..+....-||++||.+||++|.|+.+|+.+-+
T Consensus 273 --------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 --------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 112233567999999999999999999988754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.51 Aligned_cols=266 Identities=22% Similarity=0.232 Sum_probs=202.1
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|++.+.||+|+||.||++..+ +++.+|+|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46999999999999999999975 57889999876432 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|++++++..+.... ..+++..++.++.|++.||.|||..+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99987766554322 24899999999999999999999999 9999999999999999999999999998754333
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH---------HHhhhccc
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI---------LSMEENRL 310 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~ 310 (400)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||................ ........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 333334568999999999998899999999999999999999999996433211100000000 00000000
Q ss_pred ccccchh------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFLDDQ------VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....+. .........+..+.+|+.+||+.||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000111245679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=325.30 Aligned_cols=256 Identities=22% Similarity=0.386 Sum_probs=204.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec----CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..+|++.+.||+|+||.||+|.++ .+..||+|.++... ......+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356899999999999999999753 35689999877543 3345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999976432 5899999999999999999999999 9999999999999999999999999876532
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
...........++..|+|||.+.+..++.++|||||||++|++++ |..||....... . ........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~------ 225 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---V----IKAVEDGF------ 225 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHCCC------
Confidence 221111112334678999999999999999999999999999775 999995433211 0 11111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
....+...+..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus 226 ---~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1112233456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=333.76 Aligned_cols=264 Identities=27% Similarity=0.400 Sum_probs=205.9
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999965 57889999876542 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+. |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999997654 48999999999999999999998532 999999999999999999999999998765321
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh---c--------
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE---N-------- 308 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~-------- 308 (400)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||....... +.......... .
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 2233568999999999999999999999999999999999999995432211 00000000000 0
Q ss_pred -------------------ccccccc----hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 309 -------------------RLYDFLD----DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 309 -------------------~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
......+ ...........+..+.+|+.+||+.||++|||+.+++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000000 00000011234567999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=325.91 Aligned_cols=252 Identities=24% Similarity=0.294 Sum_probs=201.2
Q ss_pred CCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999986 468999999765322 2233467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~-- 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE-- 154 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC--
Confidence 9999999988865432 25899999999999999999999999 99999999999999999999999999976432
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ... ...... ..
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~-~~~~~~----------~~ 221 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEV-DRRVKE----------DQ 221 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHH-HHHhhc----------cc
Confidence 12223456899999999999999999999999999999999999999643321100 000 000000 00
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
...+...+..+.+|+.+||+.||.+||+ +++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1122334567899999999999999997 7888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=336.12 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=215.4
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc-ceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEV-PLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 158 (400)
++|..++.+|+|+||.+++++.+ +++.+++|++.... ....+...+|+.+++++.|||||.+.+.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57999999999999999998854 57899999877644 3344578899999999999999999999999988 99999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
+||+||+|.+.+...+. ..+++..++.|+.|++.|+.|||+.. |+|||||+.||+++.++.|+|+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k~-~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG-VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999988763 35899999999999999999999888 999999999999999999999999999987543
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
. ....++.|||.|+.||.+.+.+|..++|||||||++|||++-+++|...+..+ ... .+. ...
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~-ki~---------~~~ 222 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LIL-KIN---------RGL 222 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHH-HHh---------hcc
Confidence 3 34566889999999999999999999999999999999999999996544322 111 111 112
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+..++.++..+|..||+.+|..||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 334566778889999999999999999999999998
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=350.21 Aligned_cols=270 Identities=23% Similarity=0.336 Sum_probs=222.1
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecCC-cEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeE-Eee---C-
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLADG-RIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGC-CLE---T- 151 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-~~~---~- 151 (400)
.....++++.+.|.+|||+.||+|....+ ..||+|++-..++...+.+.+|+++|++|. |+|||.+++. ... .
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34556788999999999999999997665 999999988888888999999999999996 9999999993 221 1
Q ss_pred --CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEec
Q 042371 152 --EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADF 229 (400)
Q Consensus 152 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Df 229 (400)
-.++|.||||.||.|-+++..+... .|++..+++|+.++++|+.+||... .+|||||||-+||||+.+|+.|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 2457999999999999999876554 3999999999999999999999988 77999999999999999999999999
Q ss_pred CCccccccCCceee--------ecccccCCCCCcccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchH
Q 042371 230 GTSKFIVIDQTHVT--------TKVQGTFGYLDPEYF---RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLA 298 (400)
Q Consensus 230 gla~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 298 (400)
|.+.-......... ....-|+.|+|||++ .+.++++|+|||+|||+||-|+....||...+.-
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------ 264 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------ 264 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence 99975433321110 112359999999975 5778999999999999999999999999654332
Q ss_pred HHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhcccccc
Q 042371 299 AYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQ 369 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~ 369 (400)
.++.........+.++..+.+||..||+.||.+||++-+|+..+-.++...-.....+
T Consensus 265 -------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 265 -------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 2333333333446778889999999999999999999999999999887666554444
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=330.55 Aligned_cols=262 Identities=26% Similarity=0.338 Sum_probs=208.3
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--------------chhHHHHHHHHHHHHhCCCCcc
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--------------EGKLEEFINEVVILSQINHRNV 141 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~~i 141 (400)
+-....++|++.+.||+|.||.|-+|+.. +++.||||++.... ....+...+|+.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 33456689999999999999999999954 68999999764311 1124688999999999999999
Q ss_pred eeeeeEEeeC--CcceEEEEccCCCCHHHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 042371 142 VKLLGCCLET--EVPLLVYEFISNGTLFQYLHDQNEEFP-LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL 218 (400)
Q Consensus 142 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 218 (400)
|+++++..+. +.+|||+|||..|.+...- ...+ +++.+++++++++..||.|||.+| ||||||||+|+|+
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl 243 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL 243 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence 9999998764 5789999999988764321 2224 899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCccccccC----CceeeecccccCCCCCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCcCC
Q 042371 219 NEKYTAKVADFGTSKFIVID----QTHVTTKVQGTFGYLDPEYFRSGQ----FTDKSDVYSFGVVLVELLTGQKPIILTG 290 (400)
Q Consensus 219 ~~~~~~kl~Dfgla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~ 290 (400)
+++|++||+|||.+...... .........|||.|+|||...++. -+.+.||||+||+||.|+.|+.||....
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 99999999999999765321 111223367999999999987643 2568899999999999999999994321
Q ss_pred CccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 291 SKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
. -.....++...+.....++..+.+.+||.+||..||++|.+..+|..+..-.+.
T Consensus 324 ~---------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 E---------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred H---------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1 112223344444444555677889999999999999999999999988776554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=328.14 Aligned_cols=263 Identities=25% Similarity=0.402 Sum_probs=201.4
Q ss_pred hcCCcccceeeecCcEEEEEEEecC-----------------CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCccee
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD-----------------GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVK 143 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~ 143 (400)
.++|.+.+.||+|+||.||++.+++ +..||+|.+.... ......+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3579999999999999999997532 3369999876532 334567889999999999999999
Q ss_pred eeeEEeeCCcceEEEEccCCCCHHHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 042371 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNE----------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207 (400)
Q Consensus 144 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 207 (400)
+++++.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999865321 124678889999999999999999999 99
Q ss_pred ecCCCCCCeEEcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh--CCC
Q 042371 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT--GQK 284 (400)
Q Consensus 208 HrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~ 284 (400)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999765332221 1222345788999999998899999999999999999997 456
Q ss_pred CCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 285 PIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 285 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
||....... .............. ......+...+..+.+++.+||+.||.+|||+.+|.+.|+
T Consensus 241 p~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQ---VIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHH---HHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 664322111 11111110000000 0001112234467899999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=341.32 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=204.6
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEe------cCCcEEEEEEccccC-chhHHHHHHHHHHHHhC-CCCcceeeeeEEee
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGML------ADGRIVAVKKSKIVH-EGKLEEFINEVVILSQI-NHRNVVKLLGCCLE 150 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 150 (400)
....++|++.+.||+|+||.||+|.. ..+..||+|.++... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34456799999999999999999973 235689999876432 33456788999999999 89999999999999
Q ss_pred CCcceEEEEccCCCCHHHHHhhcCC-------------------------------------------------------
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQNE------------------------------------------------------- 175 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 175 (400)
.+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999865321
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 176 -----------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 176 -----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788889999999999999999999 999999999999999999999999999765432
Q ss_pred Ccee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 239 QTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 239 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
.... .....++..|+|||++.+..++.++|||||||++|+|++ |..||....... .. ......+.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~----~~~~~~~~------- 334 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KF----YKMIKEGY------- 334 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HH----HHHHHhCc-------
Confidence 2211 112334667999999999999999999999999999998 889985332111 00 01111110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
....+...+..+.+++.+||+.||++|||+.+|++.|++
T Consensus 335 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 --RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 001111224568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=324.13 Aligned_cols=256 Identities=22% Similarity=0.416 Sum_probs=207.6
Q ss_pred HhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..++|++.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 34679999999999999999999878888999986543 23457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++...... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999999764322 5888999999999999999999998 99999999999999999999999999986543222
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ......... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~ 222 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGY---------R 222 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCC---------C
Confidence 22233345678999999998899999999999999999998 999985432211 011111110 0
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
.......+..+.+++.+||+.+|++|||++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=341.86 Aligned_cols=245 Identities=27% Similarity=0.367 Sum_probs=204.6
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCc
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEV 153 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 153 (400)
....++|.++++||+|.||+|+++..+ +++.+|||.++. ...++++..+.|.+|+.... ||+++.++.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345688999999999999999999976 578999997764 45677899999999998885 9999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
+|+||||+.||++..+.+.. .+++..+..++..|+.||.|||.+| ||+||||.+|||+|.+|.+||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954333322 4999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.... ....+.+.+|||.|+|||++.+..|+.++|+|||||+||||+.|..||...+.++ .+.....+.
T Consensus 517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d~----- 584 (694)
T KOG0694|consen 517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVNDE----- 584 (694)
T ss_pred ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCC-----
Confidence 6432 3446678999999999999999999999999999999999999999995443222 111111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTM 348 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 348 (400)
..++...+.+..++++++|..||++|.-+
T Consensus 585 ------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12344556678899999999999999655
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=339.77 Aligned_cols=273 Identities=28% Similarity=0.502 Sum_probs=219.7
Q ss_pred ChHHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC
Q 042371 74 TTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET 151 (400)
Q Consensus 74 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 151 (400)
+..+|++..+.+.+...||+|.||+||+|.+-+ .||||++... .+...+.|.+|+.++++-+|.||+-+.|++...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 446788888999999999999999999999853 4999987764 455788999999999999999999999999988
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
.. .||+-+|+|.+|+.+++.... .+.....+.|++||++||.|||.++ |||||||..||++.++++|||+|||+
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 77 899999999999999987654 4888999999999999999999999 99999999999999999999999999
Q ss_pred cccccc-CCceeeecccccCCCCCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh
Q 042371 232 SKFIVI-DQTHVTTKVQGTFGYLDPEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307 (400)
Q Consensus 232 a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 307 (400)
+..... ..........|...|||||++.. .+|++.+||||||+++|||++|..||.. ...+.. .....+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqI------ifmVGr 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQI------IFMVGR 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhhe------EEEecc
Confidence 975321 11222223446778999999863 4799999999999999999999999962 221111 111111
Q ss_pred cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhccc
Q 042371 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDIN 366 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~ 366 (400)
+.+. .+ ........+.++.+|+..||..++++||.+.+|+..|+.+....++++
T Consensus 608 G~l~--pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~ 661 (678)
T KOG0193|consen 608 GYLM--PD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN 661 (678)
T ss_pred cccC--cc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence 1110 00 111234556789999999999999999999999999998887655444
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=335.39 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=204.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999975 5889999987643 2234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997644 4889999999999999999999999 99999999999999999999999999975432
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ....... .+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-----~i~~~~~----~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-----NLKYWKE----TLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH-----HHHhccc----cccCCC
Confidence 2334568999999999999999999999999999999999999995433221100 0000000 000000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........+..+.+++.+||..+|.+|||+.+++++
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000012345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=327.65 Aligned_cols=265 Identities=25% Similarity=0.315 Sum_probs=200.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|.+.+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999865 58899999876433 23345678999999999999999999999998899999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++ +|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 975 89998876443 4788999999999999999999999 9999999999999999999999999987543221
Q ss_pred eeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc-------
Q 042371 241 HVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD------- 312 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------- 312 (400)
.......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.......................+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 12233457999999999865 5689999999999999999999999965433221111110000000000000
Q ss_pred --ccchhhh----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 --FLDDQVL----KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 --~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+... .......+..+.+|+.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=338.68 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=208.5
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
|+...+....++-||+|+-|.||+|++. ++.||||+++...+ .+|.-|++|+||||+.|.|+|.....++||
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 3333444455677999999999999985 67899998764333 457779999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
||||..|-|.++|+... ++.......|..+|+.||.|||.+. |||||||.-||||+.+..|||+|||.++....
T Consensus 191 MEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999999999998765 5888889999999999999999999 99999999999999999999999999986643
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
......+.||..|||||++.+.+.++|+|||||||+|||||||..||........ +..+-...
T Consensus 265 --~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------IwGVGsNs 327 (904)
T KOG4721|consen 265 --KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IWGVGSNS 327 (904)
T ss_pred --hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EEeccCCc
Confidence 2445568899999999999999999999999999999999999999853332210 11111122
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
+....+..++..|.-|+++||+-.|.+||++++++.+|+-..
T Consensus 328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 333445667778999999999999999999999999987543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=339.71 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=204.9
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeC
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLET 151 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 151 (400)
...++|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34467999999999999999998742 2357999988643 333456788999999999 899999999999999
Q ss_pred CcceEEEEccCCCCHHHHHhhcCC--------------------------------------------------------
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNE-------------------------------------------------------- 175 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 175 (400)
+..++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999864311
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee-e
Q 042371 176 -----------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV-T 243 (400)
Q Consensus 176 -----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~ 243 (400)
..++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 124788889999999999999999999 9999999999999999999999999997653322211 1
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (400)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... . . ....... . ....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~---~-~~~~~~~-~--------~~~~ 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K---F-YKMVKRG-Y--------QMSR 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H---H-HHHHHcc-c--------CccC
Confidence 22334668999999998999999999999999999997 999985432111 0 0 0000000 0 0001
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
+...+..+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1122456899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=326.85 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=201.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46899999999999999999965 68899999875422 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999999765321
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... . ........
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~-~~~i~~~~--------- 214 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------I-YEKILAGK--------- 214 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhCC---------
Confidence 223468999999999999899999999999999999999999995432211 0 01111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
...+...+..+.+++.+||+.||.+||+ +++++++
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0112223456889999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.60 Aligned_cols=246 Identities=25% Similarity=0.329 Sum_probs=201.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367999999999999999999975 5889999987542 223456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999997654 4889999999999999999999999 99999999999999999999999999976532
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+ ........
T Consensus 171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~--~~i~~~~~------- 232 (329)
T PTZ00263 171 R----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RIY--EKILAGRL------- 232 (329)
T ss_pred C----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HHH--HHHhcCCc-------
Confidence 1 22356899999999999999999999999999999999999999532211 001 11111110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
..+...+..+.+|+.+||+.||.+||+ +.+++.+
T Consensus 233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011123456889999999999999987 6887766
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=314.14 Aligned_cols=264 Identities=23% Similarity=0.281 Sum_probs=206.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc--hhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--CcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE--GKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 156 (400)
.+.|+.+..|++|+||.||+|+++ +++.||+|+++...+ .-.-..++|+.+|.+.+|||||.+-.+.... +.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356888999999999999999964 689999999887543 2345668999999999999999999887644 46899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
|||||+. +|..++..... ++...++..++.|++.|++|||... |+||||||+|+|++..|.+||+|||+|+.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999986 99999987663 5889999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH--hhhcccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS--MEENRLYDF 313 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 313 (400)
.. ....+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++-|...+ +..++...+... ..+.-+..+
T Consensus 229 sp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s--E~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 229 SP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS--EIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred CC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc--hHHHHHHHHHHhCCCccccCCCc
Confidence 43 4445667789999999998765 69999999999999999999998874433 223333322211 111111111
Q ss_pred cchhhh--------------ccCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LDDQVL--------------KVGQ-KEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~--------------~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...... .... ...++.-.+|+..+|..||.+|.|+.+.+++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111100 0000 0134667899999999999999999998875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=321.77 Aligned_cols=255 Identities=26% Similarity=0.318 Sum_probs=213.5
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC-CcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|++.+.||.|.-|+||++..++ +..+|+|.+.. .......+...|-+||+.++||.++.+|..|..+...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 44678999999999999999999765 58999998764 234556778889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
|||||+||+|..+++++... .+++..++.++.+++-||+|||..| ||+|||||+||||-++|++.|+||.|+....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999887655 6999999999999999999999999 9999999999999999999999999864331
Q ss_pred cC----------------------------------C---------------------ceeeecccccCCCCCccccccC
Q 042371 237 ID----------------------------------Q---------------------THVTTKVQGTFGYLDPEYFRSG 261 (400)
Q Consensus 237 ~~----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~ 261 (400)
.. . .......+||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 0 0011225699999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccC
Q 042371 262 QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLN 341 (400)
Q Consensus 262 ~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 341 (400)
..+.++|+|+||+++|||+.|.-||...+.. .++..++-..+........+..+++||+++|..|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 9999999999999999999999999655443 3344444444444444466778999999999999
Q ss_pred CCCCCC----HHHHHHH
Q 042371 342 GKRRPT----MKEVAME 354 (400)
Q Consensus 342 P~~RPt----~~ell~~ 354 (400)
|.+|.. +.||.++
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999988 7777665
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.25 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=202.6
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
+.|++.+.||+|+||.||++..+++..+|+|.+... ......+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458889999999999999999888888999976532 3334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999875432 4889999999999999999999999 9999999999999999999999999987653322222
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ ......... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-------~~~i~~~~~---------~~ 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-------VEMISRGFR---------LY 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCC---------CC
Confidence 223335668999999998899999999999999999999 8999854322110 011111100 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
.+...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1112345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=323.01 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=210.8
Q ss_pred HhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
...+|++.+.||.|+||.||+|...++..+|+|.+..........+..|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45679999999999999999999888899999988766665677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 84 MEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred cccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 999999999976543 35899999999999999999999999 9999999999999999999999999997653221
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+ . . ...... ..
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~---~-~~~~~~---------~~ 222 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---V---Y-DQITAG---------YR 222 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---H---H-HHHHhC---------Cc
Confidence 11223345678999999998899999999999999999998 899985432111 0 0 001110 01
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
...+...++.+.+++.+||+.||.+|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11123445678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=329.67 Aligned_cols=242 Identities=24% Similarity=0.321 Sum_probs=197.4
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
+.||+|+||.||++... +|+.||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 6889999987642 2344567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeee
Q 042371 165 TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT 244 (400)
Q Consensus 165 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 244 (400)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~ 153 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccc
Confidence 9999987644 5899999999999999999999999 999999999999999999999999998753221 22233
Q ss_pred cccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCH
Q 042371 245 KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQK 324 (400)
Q Consensus 245 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (400)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .... ..... ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~-~~~~~----------~~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFEL-ILMEE----------IRFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HHHH-HHcCC----------CCCCC
Confidence 4569999999999999999999999999999999999999995322111 0000 00000 01122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 325 EEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 325 ~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
..+..+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3456689999999999999999 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=359.03 Aligned_cols=266 Identities=29% Similarity=0.492 Sum_probs=219.2
Q ss_pred hcCCcccceeeecCcEEEEEEEecC--Cc----EEEEEEccc-cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD--GR----IVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~--~~----~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
..+.++.+.||+|.||.||.|...+ +. .||+|.+.. .+.....+|++|..+|+.++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4567788999999999999999643 33 489998765 4567789999999999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 155 LLVYEFISNGTLFQYLHDQN----EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
+|++|||+||+|..+|+... ....++....+.++.+||+|+.||++++ +|||||..+|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998751 1235899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeecc-cccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 231 TSKFIVIDQTHVTTKV-QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 231 la~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
+|+.+........... .-...|||||.+..+.++.++|||||||++||++| |..||....+.+. ...
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~----- 916 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLD----- 916 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHH-----
Confidence 9996654333332222 23568999999999999999999999999999999 9999854433221 011
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhccc
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDIN 366 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~ 366 (400)
+...+ +-..+..+++.+++++.+||+.+|++||++..|++.+..+..-.....
T Consensus 917 ----~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 917 ----VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred ----HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 11111 334566777889999999999999999999999998888876655544
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=320.17 Aligned_cols=256 Identities=29% Similarity=0.455 Sum_probs=206.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
...|.+.+.||+|+||.||+|... .++.+|+|..... ......+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345888999999999999999965 4788999987643 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++..... ..+++..++.++.|++.||.|||..+ ++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999876443 24899999999999999999999998 99999999999999999999999999976543222
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ...... ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~-~~~~~~---------~~ 223 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VY-ELLEKG---------YR 223 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HH-HHHHCC---------CC
Confidence 22222334668999999999999999999999999999998 999985332111 11 111110 01
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
...+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112233456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=320.31 Aligned_cols=273 Identities=24% Similarity=0.326 Sum_probs=210.6
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcc--ccCchhHHHHHHHHHHHHhCCCCcceeeeeEEee-----CC
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSK--IVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE-----TE 152 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 152 (400)
....|...+.||+|+||.|+.+... +|..||||++. -......++..+|+.+|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456777899999999999999964 68999999987 3455667889999999999999999999998865 35
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
.+|+|+|+| +.+|...++.+. .++...+..++.|++.||+|+|+.+ ++||||||.|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 789999999 569999997654 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccC-CceeeecccccCCCCCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 233 KFIVID-QTHVTTKVQGTFGYLDPEYFR-SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 233 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
+..... .....+.++.|.+|.|||++. ...|+.+.||||+|||+.||++|++-|.....-....+............+
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 976432 233346677899999999865 568999999999999999999999988544432222222211111111111
Q ss_pred ccccchhh--------------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHH
Q 042371 311 YDFLDDQV--------------LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERIQA 360 (400)
Q Consensus 311 ~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~~~ 360 (400)
..+-.+.. .....+...+...+|+.+||..||.+|+|++|.+++ |....+
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 11110000 001112334567899999999999999999999987 665554
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=319.92 Aligned_cols=256 Identities=26% Similarity=0.415 Sum_probs=206.5
Q ss_pred HhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456799999999999999999998777889999876433 3356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++.... ...+++..++.++.|++.||.+||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999997654 235899999999999999999999999 99999999999999999999999999987642221
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
........+..|+|||++.+..++.++||||||+++|+|++ |+.||....... ......... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~---------~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGY---------R 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC---------C
Confidence 11122223457999999998899999999999999999999 999985332111 011111110 0
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
...+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01122344678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=334.19 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=198.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..+|++.+.||+|+||.||++... .++.||+|... ...+.+|+.+++.++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999964 58899999643 24567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+. ++|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 68888886543 4889999999999999999999999 99999999999999999999999999975432222
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccc----cchHHHHHHHhhh--ccc----
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA----TGLAAYFILSMEE--NRL---- 310 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~--~~~---- 310 (400)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ............. ..+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 333446799999999999999999999999999999999999988743221110 0000000000000 000
Q ss_pred ----cccc-----------chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 ----YDFL-----------DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ----~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.... ............+..+.+|+.+||+.||.+|||+.|++++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 0000000111345678999999999999999999999974
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=330.10 Aligned_cols=246 Identities=25% Similarity=0.342 Sum_probs=201.7
Q ss_pred hcCCcccceeeecCcEEEEEEEecC--CcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD--GRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~--~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.++|++.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4579999999999999999998543 368999976532 23445678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997654 4899999999999999999999999 9999999999999999999999999997653
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+ ........
T Consensus 183 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~--~~i~~~~~------ 245 (340)
T PTZ00426 183 T----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LIY--QKILEGII------ 245 (340)
T ss_pred C----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HHH--HHHhcCCC------
Confidence 2 123456899999999999889999999999999999999999999543211 111 11111100
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+|+ |+++++++
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11222345688999999999999995 89998876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=339.11 Aligned_cols=271 Identities=29% Similarity=0.460 Sum_probs=219.2
Q ss_pred ccChHHHHHHhcCCcccceeeecCcEEEEEEEec--CC--cE-EEEEEccc---cCchhHHHHHHHHHHHHhCCCCccee
Q 042371 72 LFTTKELDKATDHFNVNRILGQGGQGTVYKGMLA--DG--RI-VAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVK 143 (400)
Q Consensus 72 ~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~--~~--~~-vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~ 143 (400)
......|....++..+.++||+|+||.||+|... ++ .. ||+|..+. .......++++|+++|++++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 3445566777788888899999999999999954 22 23 89998774 44667889999999999999999999
Q ss_pred eeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 042371 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223 (400)
Q Consensus 144 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 223 (400)
+||++.....++||||+|+||+|.++|+.... .++..+...++.+.+.||+|||+.+ ++||||.++|+|++.++.
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGV 300 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCe
Confidence 99999999999999999999999999998764 4899999999999999999999999 999999999999999999
Q ss_pred EEEEecCCccccccCCceeee-cccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHH
Q 042371 224 AKVADFGTSKFIVIDQTHVTT-KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYF 301 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 301 (400)
+||+|||+++... ...... ...-...|+|||.+..+.|++++|||||||++||+++ |..||........ .
T Consensus 301 vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------~ 372 (474)
T KOG0194|consen 301 VKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------K 372 (474)
T ss_pred EEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH------H
Confidence 9999999987542 111111 1234679999999999999999999999999999999 8889854433211 0
Q ss_pred HHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 302 ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
...... ......+...+..+..++.+||..+|++||||.++.+.|+.+......
T Consensus 373 ~kI~~~---------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 373 AKIVKN---------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHhc---------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111011 111122234456688999999999999999999999999998876553
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.28 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=203.4
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
++|++.+.||+|+||.||+|...++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688999999999999999988777779999876432 234678999999999999999999999998888999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999976433 4899999999999999999999999 9999999999999999999999999987654332222
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .......... ..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLR---------LY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCC---------CC
Confidence 222335678999999998889999999999999999998 999985433211 0111111110 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11123467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=322.73 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=195.9
Q ss_pred cCCcccceeeecCcEEEEEEEec--CCcEEEEEEccccC--chhHHHHHHHHHHHHhC---CCCcceeeeeEEee-----
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA--DGRIVAVKKSKIVH--EGKLEEFINEVVILSQI---NHRNVVKLLGCCLE----- 150 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~----- 150 (400)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999863 46789999876432 22344566777777665 69999999998852
Q ss_pred CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
....++||||++ ++|.+++...... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346789999996 5899988764332 4899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|++||......+................+
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99765322 2233456899999999999889999999999999999999999999654322111000000000000000
Q ss_pred cc---ccchh-------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YD---FLDDQ-------VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~---~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. +.... .........+..+.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 00000 0001112344668899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=328.25 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=200.2
Q ss_pred CCcccceeeecCcEEEEEEEec----CCcEEEEEEcccc----CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIV----HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 154 (400)
+|++.+.||+|+||.||++... .++.||+|.+... .....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999998752 5789999987532 223356678899999999 599999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987644 4899999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... .........
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~----- 226 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKC----- 226 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhcC-----
Confidence 543333333446799999999998865 47899999999999999999999996433221111 011111000
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
+ ...+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 227 -~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 -D----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -C----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0 011223345688999999999999999 77788775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=321.62 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=206.0
Q ss_pred cCCcccceeeecCcEEEEEEEecC------CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLAD------GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
++|++.+.||+|+||.||+|.... ...+|+|.+.... ......+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468899999999999999998542 2579999876433 334567889999999999999999999999888999
Q ss_pred EEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 042371 156 LVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY 222 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 222 (400)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||..+ ++|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999976421 135788999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHH
Q 042371 223 TAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAY 300 (400)
Q Consensus 223 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 300 (400)
.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999976432221 12233446788999999998899999999999999999998 999985432211
Q ss_pred HHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 301 FILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
....... ......+...+..+.+|+.+||+.||.+|||+++|+++|+.
T Consensus 235 ~~~~i~~---------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRS---------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHc---------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 0111111 11112234556789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=302.08 Aligned_cols=250 Identities=27% Similarity=0.353 Sum_probs=209.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|++++.||+|-||.||.|+.+ ++..||+|.+.. .......++.+|++|-..|+||||+++|++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4578999999999999999999964 577899997653 223445678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
++||..+|.|...++.+... .+++.....++.|++.|+.|+|..+ ++||||||+|+|++..+.+||+|||-+....
T Consensus 100 ilEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999865443 4889999999999999999999999 9999999999999999999999999986542
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
.....+.+||..|.|||...+..++..+|+|++|++.||++.|.+||......+ .|....-
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-----tYkrI~k----------- 236 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-----TYKRIRK----------- 236 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-----HHHHHHH-----------
Confidence 444556789999999999999999999999999999999999999995433111 1111000
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+....+...+....++|.+|+..+|.+|.+..+++++
T Consensus 237 -~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 -VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 0111223445668899999999999999999999886
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.29 Aligned_cols=264 Identities=24% Similarity=0.385 Sum_probs=196.6
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC-----cce
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 155 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 155 (400)
+|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999964 6889999987642 2334557889999999999999999999876432 479
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68998887543 4899999999999999999999999 999999999999999999999999999754
Q ss_pred ccCCc--eeeecccccCCCCCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH--------H
Q 042371 236 VIDQT--HVTTKVQGTFGYLDPEYFRS--GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI--------L 303 (400)
Q Consensus 236 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~ 303 (400)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................ .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 11234568999999999876 678999999999999999999999995433211100000000 0
Q ss_pred Hhhhcccccccc---hh---hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 304 SMEENRLYDFLD---DQ---VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 304 ~~~~~~~~~~~~---~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
............ .. .........++.+.+++.+||+.||.+|||+++++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000 00 0000001234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=320.29 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=209.3
Q ss_pred hcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
..+|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457899999999999999999742 24568999877655566778999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEE
Q 042371 156 LVYEFISNGTLFQYLHDQNE----------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAK 225 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~k 225 (400)
+||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999975431 124899999999999999999999999 99999999999999999999
Q ss_pred EEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHH
Q 042371 226 VADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 226 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 303 (400)
|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 9999999755322211 1122335778999999998899999999999999999998 999985332211 011
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
....+.... .+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 234 ~i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111111111 1112345689999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=321.60 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=198.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 68899999876433 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|++ ++|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 156 (303)
T cd07869 84 YVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP- 156 (303)
T ss_pred CCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC-
Confidence 996 588888765433 4888999999999999999999999 999999999999999999999999998754322
Q ss_pred ceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh---ccc-----
Q 042371 240 THVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE---NRL----- 310 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~----- 310 (400)
........+++.|+|||++.+ ..++.++||||+||++|+|++|..||........ ........... ..+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhh
Confidence 222234567999999999865 4588999999999999999999999964322110 00000000000 000
Q ss_pred -ccccchhhhccCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 -YDFLDDQVLKVGQ---------KEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 -~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+.........+ ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000000000 0123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=320.90 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=206.0
Q ss_pred hcCCcccceeeecCcEEEEEEEecC------CcEEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD------GRIVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|.+.+.||+|+||.||+|...+ +..+|+|.+...... ..+.+.+|+.+++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568999999999999999998532 478999987654444 457889999999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 042371 155 LLVYEFISNGTLFQYLHDQNE-----------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 223 (400)
++||||+++++|.+++..... ...+++..+..++.|++.|+.|||..+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 999999999999999976431 234788899999999999999999999 999999999999999999
Q ss_pred EEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHH
Q 042371 224 AKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYF 301 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 301 (400)
++|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~------- 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV------- 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------
Confidence 99999999875432211 11223345788999999999999999999999999999998 9999854332210
Q ss_pred HHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 302 ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
......+.. ...+...+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 IECITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111111 1112234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=315.77 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=206.0
Q ss_pred hcCCcccceeeecCcEEEEEEEecC----CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.++|++.+.||+|+||.||+|.++. ...+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3579999999999999999998642 3579999876433 3345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
+|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999976543 5899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 237 IDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 237 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .........
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~----- 225 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGY----- 225 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCC-----
Confidence 22221 1122334678999999999999999999999999999998 999984332111 011111110
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
....+...+..+.+++.+||+.+|++||++.+|+++|..+
T Consensus 226 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=316.39 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=204.3
Q ss_pred HhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3467999999999999999999988888899998764332 3467889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++..... ..+++..++.++.+++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999999876432 24899999999999999999999999 99999999999999999999999999976543222
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . ....... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~-~~~~~~~---------~~ 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------V-LEQVERG---------YR 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------H-HHHHHcC---------CC
Confidence 22222335668999999988899999999999999999999 899985332111 0 1111110 01
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
...+...+..+.+++.+||..+|.+|||+.++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223445679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=334.76 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=207.1
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccC-chhHHHHHHHHHHHHhCC-CCcceeeeeEEee
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVH-EGKLEEFINEVVILSQIN-HRNVVKLLGCCLE 150 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 150 (400)
....++|.+.+.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.++..+. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 344678999999999999999999852 23479999886433 334567899999999996 9999999999999
Q ss_pred CCcceEEEEccCCCCHHHHHhhcCC-------------------------------------------------------
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQNE------------------------------------------------------- 175 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 175 (400)
.+..+|||||+++|+|.+++.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998865310
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 042371 176 --------------------------------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNIL 217 (400)
Q Consensus 176 --------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 217 (400)
...+++..+..++.|++.||.|||+.+ |+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 124778888999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCcccc
Q 042371 218 LNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEAT 295 (400)
Q Consensus 218 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~ 295 (400)
++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~- 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST- 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-
Confidence 999999999999999765322221 1222346788999999998999999999999999999997 9999853321110
Q ss_pred chHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 296 GLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
........ .....+...+..+.+++.+||+.+|.+|||+.+|+++|+++.
T Consensus 349 -----~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 -----FYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -----HHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 00111111 011122344567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=304.78 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=208.5
Q ss_pred HHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCc--------hhHHHHHHHHHHHHhC-CCCcceeeeeEEe
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHE--------GKLEEFINEVVILSQI-NHRNVVKLLGCCL 149 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 149 (400)
..-+.|...+.||+|..++|.++.. .+|..+|+|++..... ...+.-.+|+.||+++ .||+|+.+.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4456788889999999999998875 4678899997664321 1234556899999998 6999999999999
Q ss_pred eCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEec
Q 042371 150 ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADF 229 (400)
Q Consensus 150 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Df 229 (400)
.+..+++|+|.|+.|.|.+++...- .++++...+|++|+++|++|||..+ |+||||||+|||++++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 9999999999999999999998765 5999999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCceeeecccccCCCCCcccccc------CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH
Q 042371 230 GTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS------GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 230 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 303 (400)
|+++.+ ......+..+|||+|+|||.+.. ..|+..+|+|++|||||.|+.|.+||.... +++ ...
T Consensus 168 GFa~~l--~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Qml--MLR 238 (411)
T KOG0599|consen 168 GFACQL--EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QML--MLR 238 (411)
T ss_pred ceeecc--CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHH--HHH
Confidence 999876 35566677899999999998753 358889999999999999999999994321 111 111
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+..+. +++ ....+.+.+....+||.+||+.||.+|.|+.|.+++
T Consensus 239 ~ImeGk-yqF-----~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIMEGK-YQF-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHhcc-ccc-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 112221 122 223355677789999999999999999999999987
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=343.01 Aligned_cols=253 Identities=24% Similarity=0.298 Sum_probs=204.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-C-CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-D-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..|.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34999999999999999999854 3 678899977655555566788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
+++|+|.+++... ....++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988653 22346899999999999999999999999 9999999999999999999999999998654322
Q ss_pred c-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 240 T-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 240 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. .....+..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~-~~~~~~~~-------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IM-QQVLYGKY-------- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCCC--------
Confidence 1 12344569999999999999999999999999999999999999995332111 00 00001110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...+..+.+++.+||+.||.+|||+.+++.+
T Consensus 289 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 -DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01122334568999999999999999999999764
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=316.11 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=206.0
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
...++|++.++||+|+||.||+|...+++.+|+|.+.... .....+.+|+.+++.++|+|++++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 3457899999999999999999998888999999876433 33567889999999999999999999864 456899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999999876443 35899999999999999999999998 9999999999999999999999999997654222
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||....... . ........
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~--------- 220 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---V----IQNLERGY--------- 220 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---H----HHHHHcCC---------
Confidence 222223345678999999998899999999999999999999 999995332211 0 01111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
....+...+..+.+++.+||+.+|++|||+++++..|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011122234569999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=327.56 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=202.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999975 5788999977653 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
|+++++|.+++.... .+++..+..++.+++.||.|||.. + |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997644 488999999999999999999974 5 999999999999999999999999998754321
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH-H-------------
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL-S------------- 304 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~------------- 304 (400)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||................. .
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 22334689999999999988999999999999999999999999854322110000000000 0
Q ss_pred ------h--hh---cccccccchhh----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 305 ------M--EE---NRLYDFLDDQV----LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 305 ------~--~~---~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. .. .....+.+... ........+..+.+|+.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0 00 00000000000 000011234568999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=334.64 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=204.3
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|.+.+.||+|+||.||+|... +++.||+|.+... .......+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999965 6889999987642 2245567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++.... .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999998653 5899999999999999999999999 999999999999999999999999999765432
Q ss_pred C----------------------------ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCC
Q 042371 239 Q----------------------------THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTG 290 (400)
Q Consensus 239 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 290 (400)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234568999999999999999999999999999999999999995433
Q ss_pred CccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 042371 291 SKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT-MKEVAME 354 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ell~~ 354 (400)
... .+. .... .. ...........++.+.+++.+||. ||.+||+ +.+++++
T Consensus 235 ~~~-----~~~--~i~~-----~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE-----TYN--KIIN-----WK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH-----HHH--HHhc-----cC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211 010 0000 00 000000111145678899999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.86 Aligned_cols=265 Identities=24% Similarity=0.443 Sum_probs=227.2
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC----CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
......+.++||.|.||.|++|.++- ...||||.++... +....+|+.|+.||.+++||||+++.|+......+.
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 34567889999999999999999652 3579999988744 556789999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
||.|||++|+|+.+|+.+..+ +...++..+++.|+.||+||.+.+ +|||||.+.|||++.+..+|++|||+++.+
T Consensus 707 IiTEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999988765 788888899999999999999988 999999999999999999999999999988
Q ss_pred ccCCceeeecccc--cCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 236 VIDQTHVTTKVQG--TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 236 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.++.....++.-| ...|.|||.+....++.+|||||||++|||.++ |..||..+.+++ +..
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VIk 845 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VIK 845 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HHH
Confidence 6665444444333 568999999999999999999999999999988 999986554432 333
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhccc
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDIN 366 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~ 366 (400)
-++...+-..+.+++..|.+|+..||+.|-.+||.+.+|+.+|+++...-....
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 344455556677889999999999999999999999999999999886444333
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=327.87 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=214.5
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecC-CcEEEEEEccccCc---hhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcc
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHE---GKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVP 154 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 154 (400)
.....|.+.+.||+|.||.||+++.+. |+.+|+|.+..... .....+.+|+.+|+++. ||||+.+++++.+...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345679999999999999999999764 99999997764322 34578999999999998 99999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC----CcEEEEecC
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK----YTAKVADFG 230 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~----~~~kl~Dfg 230 (400)
++|||++.||.|.+.+... . +++..+..++.|++.++.|||+.| |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999876 2 899999999999999999999999 9999999999999643 479999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... .+....+
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF 255 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence 9987654 556677889999999999999999999999999999999999999996555333211 1111111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..........+..+.+++.+||..||.+|+|+.+++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 12233445667789999999999999999999999996
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=333.09 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=198.0
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5889999999999999999864 5789999987542 23446678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++|+|.+++.... .+++..+..++.||+.||.|||..+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987654 4889999999999999999999999 9999999999999999999999999975431100
Q ss_pred c----------------------------------------------eeeecccccCCCCCccccccCCCCCcchhHHHH
Q 042371 240 T----------------------------------------------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFG 273 (400)
Q Consensus 240 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 273 (400)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001235699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhc--ccCCCCCCCHHHH
Q 042371 274 VVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCL--NLNGKRRPTMKEV 351 (400)
Q Consensus 274 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dP~~RPt~~el 351 (400)
|++|+|++|..||........ .......... .........+..+.+++.+|+ ..+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET------QLKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH------HHHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999954332110 0000000000 000111123456888998854 5566669999999
Q ss_pred HHH
Q 042371 352 AME 354 (400)
Q Consensus 352 l~~ 354 (400)
+.+
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=323.13 Aligned_cols=240 Identities=25% Similarity=0.318 Sum_probs=194.3
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 91 LGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 91 lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
||+|+||.||++... +++.||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 5788999987532 334456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecc
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV 246 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 246 (400)
.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++..... .......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 153 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTF 153 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccc
Confidence 99997643 4899999999999999999999999 999999999999999999999999999753222 2223345
Q ss_pred cccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHH
Q 042371 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE 326 (400)
Q Consensus 247 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (400)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....... ... ...+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~-~~~----------~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKIL-QEP----------LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHH-cCC----------CCCCCcC
Confidence 6899999999999999999999999999999999999999533211 1111111 100 0112234
Q ss_pred HHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 042371 327 IMTIATLATRCLNLNGKRRPT---MKEVAME 354 (400)
Q Consensus 327 ~~~l~~li~~cl~~dP~~RPt---~~ell~~ 354 (400)
+..+.+++.+||+.||.+||+ +.+++.+
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 566889999999999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=331.16 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=200.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|... +++.||||.+... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999965 5889999987642 2334566788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cce-------------------------------------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh
Q 042371 239 QTH-------------------------------------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281 (400)
Q Consensus 239 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 281 (400)
... ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112458999999999999999999999999999999999
Q ss_pred CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 042371 282 GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT---MKEVAME 354 (400)
Q Consensus 282 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~~ 354 (400)
|..||....... .............+. .....++.+.+++.+|+. +|.+|++ +.+++++
T Consensus 235 G~~Pf~~~~~~~------~~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQE------TYRKIINWKETLQFP-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHH------HHHHHHcCCCccCCC-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999995432211 000111000000000 111234568899999996 9999997 9998885
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=323.97 Aligned_cols=242 Identities=25% Similarity=0.327 Sum_probs=196.5
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
+.||+|+||.||++... +|..||+|.+... .......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 6889999987642 2344567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeee
Q 042371 165 TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT 244 (400)
Q Consensus 165 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 244 (400)
+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~ 153 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccc
Confidence 9998887644 4899999999999999999999999 999999999999999999999999998753221 22223
Q ss_pred cccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCH
Q 042371 245 KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQK 324 (400)
Q Consensus 245 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (400)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... ... ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~-~~~----------~~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELIL-MEE----------IRFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCC----------CCCCC
Confidence 4568999999999999999999999999999999999999995332211 000000 000 01122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 325 EEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 325 ~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
..+..+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 3456688999999999999998 88888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=314.83 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=204.0
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.++|++.+.||+|+||.||+|...+...+|+|.+.... .....+.+|+.+++.++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 46799999999999999999998776789999876432 23467889999999999999999999874 45679999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999976432 24789999999999999999999999 999999999999999999999999999765433222
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......++..|+|||+..+..++.++||||||+++|+|++ |..||........ ....... ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-------~~~~~~~---------~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERG---------YRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-------HHHHhcC---------CCC
Confidence 2223345678999999998899999999999999999999 8888854322110 0011000 001
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
......+..+.+++.+||+.+|.+|||+.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11234556789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.84 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=209.6
Q ss_pred cCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
++|.+.+.||+|+||.||+|... ++..+++|............+.+|+.+++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888999999999999999742 345688998776555556788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 042371 157 VYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 223 (400)
||||+++++|.+++..... ...+++..++.++.||+.||.|||..+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999976431 124789999999999999999999999 999999999999999999
Q ss_pred EEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHH
Q 042371 224 AKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYF 301 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 301 (400)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976533221 11223446788999999999999999999999999999999 999985433211 0
Q ss_pred HHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 302 ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
.......... ..+...+..+.+++.+||+.+|.+|||+.+|++.|.++.+.
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111111111 11222345689999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=327.98 Aligned_cols=262 Identities=30% Similarity=0.440 Sum_probs=205.0
Q ss_pred HhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccC-chhHHHHHHHHHHHHhC-CCCcceeeeeEEeeC-
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVH-EGKLEEFINEVVILSQI-NHRNVVKLLGCCLET- 151 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~- 151 (400)
..++|++.+.||+|+||.||+|... .++.||+|++.... ......+..|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3467999999999999999999632 24789999876432 33456778899999999 799999999987654
Q ss_pred CcceEEEEccCCCCHHHHHhhcCC--------------------------------------------------------
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNE-------------------------------------------------------- 175 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 175 (400)
...+++|||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 467899999999999999865321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee-eecccccCCC
Q 042371 176 --EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV-TTKVQGTFGY 252 (400)
Q Consensus 176 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y 252 (400)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++..+....... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 125789999999999999999999999 9999999999999999999999999998654322211 2234456789
Q ss_pred CCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHH
Q 042371 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIA 331 (400)
Q Consensus 253 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 331 (400)
+|||++.+..++.++|||||||++|+|++ |..||......+ .......... ....+...++.+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGT---------RMRAPEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccC---------CCCCCccCCHHHH
Confidence 99999999999999999999999999998 999985422211 0111111111 0111223346689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 332 TLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 332 ~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
+++.+||+.+|.+|||+.+++++|+++..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=313.79 Aligned_cols=251 Identities=27% Similarity=0.462 Sum_probs=201.6
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
.+|++.+.||+|+||.||++.++++..+|+|..... ......+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 358899999999999999999877778999986532 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999976443 5899999999999999999999999 9999999999999999999999999987653222211
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . ....... ....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~---------~~~~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V----VESVSAG---------YRLY 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H----HHHHHcC---------CcCC
Confidence 122223457999999999999999999999999999999 899985332211 0 0111111 0011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
.+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1223456799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=313.48 Aligned_cols=270 Identities=24% Similarity=0.342 Sum_probs=207.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc--hhHHHHHHHHHHHHhCCCCc-ceeeeeEEeeCC-----
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE--GKLEEFINEVVILSQINHRN-VVKLLGCCLETE----- 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~----- 152 (400)
...|...++||+|+||+||+|+.+ +|+.||+|++....+ .......+|+.+|+.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777788999999999999954 689999999887544 45677889999999999999 999999998877
Q ss_pred -cceEEEEccCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 153 -VPLLVYEFISNGTLFQYLHDQNEE-FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 153 -~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
.+++|+||++ .+|..++...... ..++...+..++.||+.||.|||+++ |+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7889999995 5999999876531 24777899999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH-HHhh-h
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI-LSME-E 307 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~-~ 307 (400)
+|+....+ ....+..++|..|+|||++.+. .|+...||||+|||++||+++++-|..... ..++...+. ...+ .
T Consensus 166 lAra~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNE 242 (323)
T ss_pred hHHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCc
Confidence 99865432 3334556789999999998876 799999999999999999998888754433 222222221 1111 1
Q ss_pred ccccccc---chh----------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 042371 308 NRLYDFL---DDQ----------VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERI 358 (400)
Q Consensus 308 ~~~~~~~---~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~ 358 (400)
..+.... +.. ......+.......+++.+||+.+|.+|.|+...+++ +..+
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1111111 110 0000111111467899999999999999999999987 5554
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=333.77 Aligned_cols=254 Identities=23% Similarity=0.312 Sum_probs=201.8
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467999999999999999999965 5889999987532 22344567789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998653 3788889999999999999999999 9999999999999999999999999997654
Q ss_pred cCCceeeecccccCCCCCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSG----QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+ ...........
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~-~~i~~~~~~~~ 267 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TY-SKIMDHKNSLT 267 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-----HH-HHHHcCCCcCC
Confidence 3222223346799999999998653 47899999999999999999999995433211 01 11111000000
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKR--RPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~ 354 (400)
.......+..+.+++.+||+.+|.+ |||+.+++++
T Consensus 268 -------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 -------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111124567889999999999988 9999999886
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.44 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=197.0
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 6889999987642 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeee
Q 042371 165 TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT 244 (400)
Q Consensus 165 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 244 (400)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 153 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMK 153 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccc
Confidence 9998886543 4899999999999999999999999 999999999999999999999999998753221 12223
Q ss_pred cccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCH
Q 042371 245 KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQK 324 (400)
Q Consensus 245 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (400)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .... ..... ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~-~~~~~----------~~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFEL-ILMED----------IKFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHH-hccCC----------ccCCC
Confidence 4568999999999999999999999999999999999999995432211 0000 00000 01122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 325 EEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 325 ~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
..+..+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3455688999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=329.66 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=197.0
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||++... +++.||+|.+... .......+..|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46899999999999999999865 5889999987542 2334467788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997654 5899999999999999999999999 999999999999999999999999998754211
Q ss_pred Cc----------------------------------eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 042371 239 QT----------------------------------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQK 284 (400)
Q Consensus 239 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 284 (400)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 01123569999999999999999999999999999999999999
Q ss_pred CCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 042371 285 PIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLN--LNGKRRPTMKEVAME 354 (400)
Q Consensus 285 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~ell~~ 354 (400)
||....... .+ ...........+. .....++.+.+++.+++. .++..||++.+++++
T Consensus 235 Pf~~~~~~~-----~~-~~i~~~~~~~~~p-------~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQE-----TY-KKVMNWKETLIFP-------PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHH-----HH-HHHHcCcCcccCC-------CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 995432211 00 0000000000000 011234557788888664 233456899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=329.65 Aligned_cols=326 Identities=26% Similarity=0.431 Sum_probs=259.4
Q ss_pred CCceeEeccCc---eee-ecCCchhhhhhHHH----HHHHHHHHhhcCCccchhhhccCCCCCCccc--ccChHHHHHHh
Q 042371 13 ENLLCENYEGG---YRC-ITPKRKVYIIKRED----IKLKEKFFKRNGGLVLQQQLTSSDGSIDRCK--LFTTKELDKAT 82 (400)
Q Consensus 13 ~~~~c~~~~~~---y~~-~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 82 (400)
-.+..+-|+|. ||| ....+|||+..... ..+..++--..+|++.--.-+.......... .-..+.|+-..
T Consensus 187 Q~sISlRyeGRVyHYRINt~~dgK~yvt~EsrF~TLaELVHHHStvADGLittLhYPApK~nKptvygvSPn~DkWEmeR 266 (1157)
T KOG4278|consen 187 QYSISLRYEGRVYHYRINTDNDGKMYVTQESRFRTLAELVHHHSTVADGLITTLHYPAPKKNKPTVYGVSPNADKWEMER 266 (1157)
T ss_pred ceeEEEEecceEEEEEeeccCCccEEEeehhhhhHHHHHHhhccccccceeEeeeccCccCCCCceeeecCCcchhhccc
Confidence 33455677887 999 56677898875544 2445555555666653211111111111111 11236788778
Q ss_pred cCCcccceeeecCcEEEEEEEecC-CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.+.....+||-|.||.||.|.|+. ...||||.++. +.-.+++|+.|+.+|+.++|||+|+++++|..+..+|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 888889999999999999999875 56799998764 3445789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
..|+|.++|+..+.. .++.-..+.++.||..||.||..++ +|||||...|.|+.++..+|++|||+++++..+...
T Consensus 346 ~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999999987654 4777788899999999999999999 999999999999999999999999999988665555
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......-...|.|||-+....++.++|||+|||+|||+.| |-.||..- ....++.+++...+-
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi----------------dlSqVY~LLEkgyRM 485 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYGLLEKGYRM 485 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc----------------cHHHHHHHHhccccc
Confidence 5455555778999999999999999999999999999999 77777321 122345556666666
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
..+..+++.+++|++.||+++|.+||++.|+-+.++.+-
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 778888999999999999999999999999999988764
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.24 Aligned_cols=271 Identities=28% Similarity=0.408 Sum_probs=202.5
Q ss_pred cCCcccceeeecCcEEEEEEEe-----cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--Ccce
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPL 155 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 155 (400)
.+|++.+.||+|+||.||++.. .++..||+|.+..........+.+|+.+++.++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4789999999999999999874 24788999998766666677889999999999999999999987543 4578
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+++++|.+++..... .+++..++.++.|++.||.|||..+ |+||||||+||+++.++.++|+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999975432 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCceee--ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 236 VIDQTHVT--TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 236 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
........ ....++..|+|||++.+..++.++||||||+++|+|++|..|+.......................+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43222111 1122344699999999889999999999999999999987765322110000000000000000000000
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
+............+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111111223456799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=317.55 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=202.4
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE 152 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 152 (400)
...++|++.+.||+|+||.||+|... .+..+|+|..... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999998753 2467999987532 2234567889999999999999999999999889
Q ss_pred cceEEEEccCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEE
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNE-------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAK 225 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~k 225 (400)
..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999999875321 124678889999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHH
Q 042371 226 VADFGTSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 226 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 303 (400)
|+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||....... . ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~-~~ 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------V-LR 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------H-HH
Confidence 99999987543222111 112335778999999998899999999999999999999 788885332211 0 11
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
........ ..+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 233 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 FVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111111 111223456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.17 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=200.3
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC-----cceEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE-----VPLLV 157 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv 157 (400)
.|.-.+++|+|+||.||+|... ++..||||+.-.... .--+|+.+|+.++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5778899999999999999964 578999998654332 2246899999999999999988876432 23489
Q ss_pred EEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CcEEEEecCCcccc
Q 042371 158 YEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSKFI 235 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~Dfgla~~~ 235 (400)
|||++. +|.++++.. ..+..++.-.+.-+..||+.||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 999998852 12235788888889999999999999999 9999999999999976 89999999999987
Q ss_pred ccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH----------
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS---------- 304 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------- 304 (400)
..+ .....+.-|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|..... ..++.......
T Consensus 177 ~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHhh
Confidence 543 333556679999999998765 799999999999999999999999855333 22333222110
Q ss_pred hhh----cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHHH
Q 042371 305 MEE----NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERIQAL 361 (400)
Q Consensus 305 ~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~~~~ 361 (400)
+.. ....++.............+++..+|+.++|+.+|.+|.++.+++.+ ++.++..
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000 11111111111111233455678999999999999999999999976 5555554
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=306.41 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=205.8
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccc--cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
..+.|.+.+.||+|.|+.|+++.. ..|+.+|+|.+.. ......+.+.+|++|.+.|+||||+++.+.+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356789999999999999999875 4688899886543 3445678899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CcEEEEecCCccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK---YTAKVADFGTSKF 234 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~Dfgla~~ 234 (400)
+|+++|++|..-|-.+. ..++..+-..++||++||.|+|.++ |||||+||+|+|+.+. .-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999988776553 4788889999999999999999999 9999999999999543 4699999999987
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
+. ....--...|||.|+|||++...+|+..+|||+.||+||-|+.|++||...... . ....+..+. .++
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----r--lye~I~~g~-yd~- 231 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----R--LYEQIKAGA-YDY- 231 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----H--HHHHHhccc-cCC-
Confidence 75 444445677999999999999999999999999999999999999999542211 1 111111111 111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....+..+++.++|+++||..||.+|.|+.|.+.+
T Consensus 232 ----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 ----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 111234456778999999999999999999987754
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=311.59 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=208.4
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|... +++.||+|.+.. ........+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999964 688999997653 22344567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 159 EFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 2235789999999999999999999999 99999999999999999999999999876532
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....... .... ........
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~-~~~~~~~~------- 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLC-QKIEQCDY------- 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHH-HHHhcCCC-------
Confidence 221 1223457889999999998889999999999999999999999984332111 1111 11111010
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
........+..+.+++.+||+.+|.+|||+.++++.|++++
T Consensus 226 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 -PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01112345567999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=316.74 Aligned_cols=250 Identities=36% Similarity=0.581 Sum_probs=194.0
Q ss_pred cccceeeecCcEEEEEEEec-----CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 86 NVNRILGQGGQGTVYKGMLA-----DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 86 ~~~~~lg~G~fg~V~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++.+.||.|.||.||+|.+. .+..|+||.++... ....+.+.+|+..+.+++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999976 25689999886533 3347899999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ ++|+||+++||+++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999988722 25899999999999999999999999 9999999999999999999999999998652221
Q ss_pred c-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 240 T-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 240 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. ...........|+|||.+.+..++.++||||||+++|||++ |+.||....... ..........
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~------- 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQR------- 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEE-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccc-------
Confidence 1 22233446778999999999899999999999999999999 788874332111 1111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
...+...+..+.+++.+||+.+|.+|||++++++.|
T Consensus 224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111223355688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=332.11 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=199.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||++... +++.+|+|.+.. ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999965 578999998753 2233445677899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999998653 3788999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccCCCCCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSG----QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
..........||+.|+|||++.+. .++.++||||+||++|+|++|+.||....... .............+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~ 268 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHKNSLNF 268 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCcccCC
Confidence 322233456799999999998754 37889999999999999999999995432211 11111111000011
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKR--RPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~ 354 (400)
......+..+.+++.+||..+|.+ |+|+.+++++
T Consensus 269 -------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 -------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111233556889999999865544 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=321.66 Aligned_cols=258 Identities=24% Similarity=0.460 Sum_probs=203.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCc----EEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGR----IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.+|++.+.||+|+||.||+|.+. ++. .||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56999999999999999999853 333 48999876432 34467888999999999999999999998764 5689
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
+++|+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999986543 4788999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCceee-ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 237 IDQTHVT-TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 237 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
....... ....++..|+|||++.+..++.++||||||+++|+|++ |..||....... . ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~-~~~~~~~~----- 228 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------I-SSILEKGE----- 228 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------H-HHHHhCCC-----
Confidence 3322211 22234678999999999999999999999999999998 999985322111 0 01111110
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
....+...+..+.+++.+||+.+|.+|||+.+++..|.++....
T Consensus 229 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00111223356889999999999999999999999988876533
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=322.80 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=196.8
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||++... +++.||+|.++.. .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 5889999987642 233456678899999888 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc-CCCcc
Confidence 99999886543 5899999999999999999999999 99999999999999999999999999874321 12223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccc--cchHHHHHHHhhhcccccccchhhhcc
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA--TGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.... .....+.......... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 346789999999999999999999999999999999999999964332221 1111111111111100 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPT------MKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt------~~ell~~ 354 (400)
.+...+..+.+++.+||+.||.+||| +.+++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 12233456889999999999999997 6677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=313.35 Aligned_cols=257 Identities=29% Similarity=0.450 Sum_probs=207.2
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
...++|++.+.||+|+||.||+|..+++..+|+|.+.... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3457899999999999999999998778889999876432 345678899999999999999999999998889999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++..... ..+++..++.++.+++.|+.|||..+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999976542 25899999999999999999999999 9999999999999999999999999987654322
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
........++..|+|||.+.+..++.++||||+|+++|+|++ |+.||....... . ....... .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~----~~~~~~~-~-------- 221 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---V----LEQVERG-Y-------- 221 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcC-C--------
Confidence 222222334668999999998899999999999999999999 999984332111 0 0011000 0
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
....+...+..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001112235568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=315.70 Aligned_cols=267 Identities=28% Similarity=0.398 Sum_probs=201.4
Q ss_pred CcccceeeecCcEEEEEEEe-----cCCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--CcceE
Q 042371 85 FNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 156 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 156 (400)
|.+.+.||+|+||.||++.. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48899999999999988652 357789999876532 23456788999999999999999999987654 35789
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
+|||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999998654 3899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCce--eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 237 IDQTH--VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 237 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ..............+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhh
Confidence 32211 11122356679999999988999999999999999999999999854321100 0000000000000111111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
+.......+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111122334567999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.03 Aligned_cols=242 Identities=24% Similarity=0.322 Sum_probs=195.5
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
+.||+|+||.||++... ++..||+|.+... .......+..|+.++..++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 6889999987642 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 165 TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 165 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
+|..++.... .+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATM 153 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccc
Confidence 9999887543 48999999999999999999997 67 999999999999999999999999998753222 2222
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .... ..... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~-i~~~~----------~~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFEL-ILMEE----------IRFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHH-HhcCC----------CCCC
Confidence 34568999999999999999999999999999999999999995332111 0000 00000 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
...+..+.+++.+||+.||.+|+ ++.+++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 22345688999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=328.09 Aligned_cols=253 Identities=24% Similarity=0.316 Sum_probs=202.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|.+.+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999964 6889999987643 2234566788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999987533 5899999999999999999999999 999999999999999999999999999866443
Q ss_pred CceeeecccccCCCCCccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFR------SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||....... .............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLK 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccC
Confidence 333334456899999999986 4567899999999999999999999995432211 1111111111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+. .....+..+.+++.+||+ +|.+|||+.+++.+
T Consensus 230 ~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 FP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11 112245668899999998 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=331.96 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=196.9
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.|++.+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999964 5789999987542 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987653 4889999999999999999999999 9999999999999999999999999975321000
Q ss_pred ----------------------------------------------ceeeecccccCCCCCccccccCCCCCcchhHHHH
Q 042371 240 ----------------------------------------------THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFG 273 (400)
Q Consensus 240 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 273 (400)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 042371 274 VVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT---MKE 350 (400)
Q Consensus 274 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~e 350 (400)
|++|+|++|+.||........ . ........ ..........++.+.+++.+|+ .+|.+|++ +.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~-----~-~~i~~~~~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLET-----Q-MKVINWQT-------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHH-----H-HHHHccCC-------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999954322110 0 00000000 0001111223456788888876 59999987 888
Q ss_pred HHHH
Q 042371 351 VAME 354 (400)
Q Consensus 351 ll~~ 354 (400)
++.+
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 7765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=308.72 Aligned_cols=260 Identities=25% Similarity=0.426 Sum_probs=209.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|... +++.+|+|.++. ........+.+|+.++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999976 788999997653 22334678889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 159 EFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2335899999999999999999999999 99999999999999999999999999876533
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... .... ..........
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~~------ 226 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEKCDYP------ 226 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHH-HhhhhcCCCC------
Confidence 221 123345788999999999889999999999999999999999998433211 0000 0011111100
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
.......+..+.+++.+||..+|.+|||+.+|++.|+++.
T Consensus 227 --~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 --PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0111245567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=319.17 Aligned_cols=245 Identities=26% Similarity=0.350 Sum_probs=194.7
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHH---HhCCCCcceeeeeEEeeCCcceEE
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVIL---SQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999865 5889999987642 233445667776665 456799999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++++|..++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999887542 4899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.........|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .. .......
T Consensus 154 -~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~-~~i~~~~-------- 217 (324)
T cd05589 154 -FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VF-DSIVNDE-------- 217 (324)
T ss_pred -CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCC--------
Confidence 1222334668999999999999999999999999999999999999995432211 00 0111100
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
...+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 011222345688999999999999999 57777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=320.19 Aligned_cols=242 Identities=26% Similarity=0.348 Sum_probs=195.2
Q ss_pred ceeeecCcEEEEEEEe----cCCcEEEEEEcccc----CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 89 RILGQGGQGTVYKGML----ADGRIVAVKKSKIV----HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~----~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+.||+|+||.||++.. ..++.||+|.+... .......+..|+.+++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 25788999987642 223345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 154 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-G 154 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-C
Confidence 99999999987654 4788889999999999999999999 999999999999999999999999998753222 2
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... . ........ .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~-~~~~~~~~----------~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------T-IDKILKGK----------L 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------H-HHHHHcCC----------C
Confidence 22334568999999999998899999999999999999999999995432211 0 11111111 0
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
..+...+..+.+++.+||+.+|.+|| ++.+++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11222345688999999999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.49 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=202.5
Q ss_pred cCCcccceeeecCcEEEEEEEe-----cCCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..|++.+.||+|+||.||+|.. ..+..+++|.+.... ......+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688899999999999999984 245789999876433 3344678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 042371 157 VYEFISNGTLFQYLHDQNE--------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY 222 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 222 (400)
||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999864321 124788899999999999999999999 99999999999999999
Q ss_pred cEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHH
Q 042371 223 TAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAY 300 (400)
Q Consensus 223 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 300 (400)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999976532221 12223345678999999998899999999999999999998 999984332111
Q ss_pred HHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 301 FILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
.......... ...+...+..+.+++.+||+.||.+||++.+++++|..
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0111111111 11122344668999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=310.75 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=202.8
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.++|.+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35689999999999999999998777789999765432 33467889999999999999999998875 45679999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999976432 24789999999999999999999999 999999999999999999999999999765332222
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......++..|+|||...+..++.++||||||+++|+|++ |..||....... . ........ ..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~---------~~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---V----LEQVERGY---------RM 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCC---------CC
Confidence 2222345678999999998899999999999999999999 899985332111 0 11111110 01
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
..+...+..+.+++.+||+.||.+||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=311.60 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=202.9
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..+|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++++++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999996 46789999988765555566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++.... ++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 99999999987543 4899999999999999999999998 9999999999999999999999999997653221
Q ss_pred eeeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 241 HVTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.......|++.|+|||.+. ...++.++|+||+|+++|+|++|+.||......... ....... +..+.
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-------~~~~~~~---~~~~~ 230 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLMSKSN---FQPPK 230 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-------eeeecCC---CCCCC
Confidence 1123345889999999874 345788999999999999999999998432211100 0000000 00000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
.......+..+.+++.+||+.+|++|||+++++++|
T Consensus 231 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 --LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 011123456789999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.59 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=197.7
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|.+.+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46899999999999999999864 6889999987532 2334567888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987643 4889999999999999999999999 999999999999999999999999998632110
Q ss_pred Cc----------------------------------------------eeeecccccCCCCCccccccCCCCCcchhHHH
Q 042371 239 QT----------------------------------------------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSF 272 (400)
Q Consensus 239 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 272 (400)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 00012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCC---CCHH
Q 042371 273 GVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRR---PTMK 349 (400)
Q Consensus 273 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ 349 (400)
||++|+|++|..||....... .+ ...........+ ......+..+.+++.+||. +|.+| +|+.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~-----~~-~~i~~~~~~~~~-------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE-----TY-RKIINWRETLYF-------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH-----HH-HHHHccCCccCC-------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999995432211 00 000000000000 0111234568899999997 66665 6999
Q ss_pred HHHHH
Q 042371 350 EVAME 354 (400)
Q Consensus 350 ell~~ 354 (400)
+++.+
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 99987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=331.64 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=198.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
+.|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999964 5889999987532 2234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999997654 4889999999999999999999999 999999999999999999999999997532100
Q ss_pred C------------------------------------------ceeeecccccCCCCCccccccCCCCCcchhHHHHHHH
Q 042371 239 Q------------------------------------------THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVL 276 (400)
Q Consensus 239 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 276 (400)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001234699999999999999999999999999999
Q ss_pred HHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 042371 277 VELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP---TMKEVAM 353 (400)
Q Consensus 277 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~ell~ 353 (400)
|+|++|+.||......... ......... .........+..+.+++.+|+ .+|.+|+ |+.++++
T Consensus 235 yell~G~~Pf~~~~~~~~~------~~i~~~~~~-------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQ------LKVINWETT-------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHH------HHHhccCcc-------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999999544321110 000000000 000111123456788998876 5999999 8999998
Q ss_pred H
Q 042371 354 E 354 (400)
Q Consensus 354 ~ 354 (400)
+
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=326.94 Aligned_cols=261 Identities=24% Similarity=0.303 Sum_probs=198.9
Q ss_pred CCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC-----cce
Q 042371 84 HFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 155 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 155 (400)
+|++.+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999996 46899999987543 2234567889999999999999999999988766 789
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+. ++|.+.+.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 58888775433 5899999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc---
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY--- 311 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 311 (400)
............+++.|+|||++.+. .++.++||||+||++|+|++|+.||............. .........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT---DLLGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH---HHcCCCCHHHHH
Confidence 43333333445678999999998764 57999999999999999999999996443221110000 000000000
Q ss_pred ---------------cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 312 ---------------DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 312 ---------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...............++.+.+|+.+||+.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000001112235668899999999999999999999886
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=318.93 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=197.5
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCC-CcceeeeeEEeeCCcceEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 158 (400)
+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+..|..++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4889999999999999999965 4788999987642 23456678889999999976 56888999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999987654 4889999999999999999999999 999999999999999999999999998643221
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
........||+.|+|||++.+..++.++||||+||++|+|++|+.||....... . ........
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~----~~~i~~~~--------- 217 (324)
T cd05587 155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L----FQSIMEHN--------- 217 (324)
T ss_pred -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H----HHHHHcCC---------
Confidence 222334568999999999999999999999999999999999999995332111 0 00111100
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTM-----KEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~~ 354 (400)
...+...+..+.+++.+||..||.+|++. .+++++
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01122334568899999999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=311.06 Aligned_cols=256 Identities=24% Similarity=0.416 Sum_probs=205.6
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
...++|++.+.||+|+||.||++...++..+|+|..... ......+.+|+.+++.++|+||+++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 345789999999999999999999777788999977643 3345678899999999999999999999887 77899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999976432 24788899999999999999999998 9999999999999999999999999997654322
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
........++..|+|||++....++.++|+||||+++|++++ |+.||....... . ........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~~~--------- 220 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V----IRALERGY--------- 220 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhCCC---------
Confidence 222223345678999999998889999999999999999999 999985332111 0 01111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011122344568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=309.68 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=202.1
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-----chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-----EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
++|.+.+.||+|++|.||.+... +++.+|+|.+.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999864 58899999765432 1234578889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
|+||+++++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987654 4889999999999999999999999 9999999999999999999999999987543
Q ss_pred cCCceee--ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 237 IDQTHVT--TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 237 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
....... ....++..|+|||++.+..++.++||||||+++|+|++|+.||...... ..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~--~~~~------ 222 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAIFK--IATQ------ 222 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHHHH--Hhcc------
Confidence 2211111 2345788999999999989999999999999999999999998532111 11100 0000
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 --PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00111223345568999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=313.86 Aligned_cols=252 Identities=24% Similarity=0.297 Sum_probs=201.2
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
+|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999964 68899999875422 2223456789999999999999999999999899999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988865432 25899999999999999999999999 9999999999999999999999999987643221
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ .......... ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~----------~~ 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKE----------DQ 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhh----------cc
Confidence 22334689999999999988999999999999999999999999954322110 0000000000 01
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
...+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112234556789999999999999999 88888776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=315.81 Aligned_cols=260 Identities=25% Similarity=0.431 Sum_probs=204.1
Q ss_pred cCCcccceeeecCcEEEEEEEecC-C--cEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLAD-G--RIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~-~--~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 157 (400)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998653 3 34788877642 334456788999999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcE
Q 042371 158 YEFISNGTLFQYLHDQN-------------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTA 224 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~ 224 (400)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 1124889999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHH
Q 042371 225 KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 225 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 303 (400)
||+|||++..... .........+..|+|||++.+..++.++|||||||++|+|++ |..||....... . ..
T Consensus 159 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~-~~ 229 (297)
T cd05089 159 KIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------L-YE 229 (297)
T ss_pred EECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------H-HH
Confidence 9999999864211 111111223557999999998899999999999999999998 999985432211 0 00
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
..... .....+...+..+.+++.+||+.+|.+|||+.++++.|..+....+
T Consensus 230 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11110 0111122345668999999999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=310.02 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=208.6
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||++.. .++..+|+|.+... .......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688999999999999999995 47889999976542 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 159 EFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987522 2335899999999999999999999999 99999999999999999999999999876533
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.. .......++..|+|||++.+..++.++|+||||+++|+|++|..||....... .... .......
T Consensus 159 ~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~-~~~~~~~-------- 224 (267)
T cd08229 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLC-KKIEQCD-------- 224 (267)
T ss_pred CC-cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHh-hhhhcCC--------
Confidence 22 11223458899999999998899999999999999999999999985322110 0000 0000000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
.........+..+.+++.+||+.+|.+|||+.+|++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 001112245667999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=320.76 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=195.7
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||++... +++.+|+|.+... .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999987642 233456677888888776 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~-~~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC-CCCcc
Confidence 99998886543 4899999999999999999999999 99999999999999999999999999875322 12223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCcccc--chHHHHHHHhhhcccccccchhhhcc
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEAT--GLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... ....+......... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CC
Confidence 3456899999999999999999999999999999999999999643322111 11111111111110 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTM------KEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~------~ell~~ 354 (400)
.+...+..+.+++.+||+.||.+|||+ .+++++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 122344568899999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=310.50 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=211.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
+-|.++.+||+|+||.||+|..+ .|+.+|||++.. +.+.+++..|+.+|+++++|++|++||.+.....+|||||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34778899999999999999865 699999998764 566889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
..|++.++++.++. +++++.+..+++..+.||+|||... -+|||||+.|||++.+|..||+|||.|-.+.+ ...
T Consensus 111 GAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMA 184 (502)
T KOG0574|consen 111 GAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMA 184 (502)
T ss_pred CCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh-hHH
Confidence 99999999987654 6999999999999999999999988 89999999999999999999999999976542 223
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
...++.|||.|||||++..-.|+.++||||||++..||.-|++||..-.+- .....++. .+.....
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-------RAIFMIPT-------~PPPTF~ 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-------RAIFMIPT-------KPPPTFK 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-------ceeEeccC-------CCCCCCC
Confidence 344578999999999999999999999999999999999999998422111 11111111 1122234
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...+..+.+|+++||..+|++|.|+-+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 566778889999999999999999999999875
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=316.96 Aligned_cols=263 Identities=28% Similarity=0.420 Sum_probs=207.4
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEe
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCL 149 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 149 (400)
+....++|++.+.||+|+||.||++... +...+|+|.+... .......+.+|+.++..+ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3445678999999999999999999853 2367999987643 233456788999999999 7999999999999
Q ss_pred eCCcceEEEEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042371 150 ETEVPLLVYEFISNGTLFQYLHDQN-------------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216 (400)
Q Consensus 150 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NI 216 (400)
..+..+++|||+++|+|..++.... ....+++..++.++.|++.||.|||..+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 9999999999999999999996531 2235889999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccc
Q 042371 217 LLNEKYTAKVADFGTSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEA 294 (400)
Q Consensus 217 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 294 (400)
+++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 99999999999999998654322111 122234678999999998899999999999999999998 999984322111
Q ss_pred cchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 295 TGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
. ........ ....+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 243 -----~-~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -----L-FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----H-HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 01111111 11112233456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=310.55 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=200.6
Q ss_pred CcccceeeecCcEEEEEEEecC----CcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc-----
Q 042371 85 FNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV----- 153 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 153 (400)
|.+.+.||+|+||.||+|.... +..+|+|.+... .......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5788999999999999998642 367999987643 23445788999999999999999999998866543
Q ss_pred -ceEEEEccCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEec
Q 042371 154 -PLLVYEFISNGTLFQYLHDQN---EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADF 229 (400)
Q Consensus 154 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Df 229 (400)
.+++|||+++++|..++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999985532 2235899999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhh
Q 042371 230 GTSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEE 307 (400)
Q Consensus 230 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 307 (400)
|+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~----~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I----YDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHc
Confidence 9997654322211 112234678999999998899999999999999999999 889985332211 1 011111
Q ss_pred cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
... ...+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 231 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=334.03 Aligned_cols=266 Identities=22% Similarity=0.342 Sum_probs=195.6
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--------
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLET-------- 151 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-------- 151 (400)
...+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999964 57899999774322 2345799999999999999998876432
Q ss_pred CcceEEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-cEEEEec
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADF 229 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~Df 229 (400)
..+++||||+++ +|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999975 777776542 22335899999999999999999999999 99999999999999664 7999999
Q ss_pred CCccccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh--
Q 042371 230 GTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME-- 306 (400)
Q Consensus 230 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-- 306 (400)
|+++..... .......||+.|+|||++.+. .|+.++|||||||++|+|++|.+||........ +.... ....
T Consensus 216 Gla~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~-~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRII-QVLGTP 290 (440)
T ss_pred ccchhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH-HHhCCC
Confidence 999865322 222345689999999998654 699999999999999999999999954332211 11100 0000
Q ss_pred -------------hcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 042371 307 -------------ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERIQ 359 (400)
Q Consensus 307 -------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~~ 359 (400)
...+.......+....+...+..+.+|+.+||+.||.+|||+.+++++ ++.+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000011111111111222344678999999999999999999999976 44443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=325.00 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=195.0
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
..+|+..+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 356788899999999999999964 68899999875432 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+.. ...+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~- 221 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT- 221 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc-
Confidence 99999986421 3567788899999999999999999 999999999999999999999999999765322
Q ss_pred ceeeecccccCCCCCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 240 THVTTKVQGTFGYLDPEYFRS-----GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
........||..|+|||++.. ...+.++|||||||++|+|++|+.||............ .... ..
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~-~~------ 291 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM---CAIC-MS------ 291 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHHh-cc------
Confidence 122234568999999998743 23456899999999999999999999632221110000 0000 00
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.........+..+.+|+.+||+.||++|||+.+++++
T Consensus 292 ---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 ---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122345678999999999999999999999986
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=309.30 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=205.3
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.++|++.+.||.|+||.||+|... |+.+|+|....... ..+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457899999999999999999875 78899998875443 5678899999999999999999999999888999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++...... .+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 999999999765432 4899999999999999999999999 9999999999999999999999999997652211
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
.....+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ......... ..
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 218 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGY---------RM 218 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCC---------CC
Confidence 12334668999999998899999999999999999997 999985432211 011111110 01
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
..+...++.+.+++.+||+.+|.+|||+.+++++|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1122335678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=318.41 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=194.1
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|..+ +++.||+|.+... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999987532 234456777888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTT 153 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcc
Confidence 99999887654 4899999999999999999999999 999999999999999999999999998753222 2223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. ........ ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~-~~i~~~~~----------~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LF-EAILNDEV----------VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HH-HHHhcCCC----------CCC
Confidence 34568999999999999999999999999999999999999995432211 10 11111100 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTM------KEVAME 354 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~------~ell~~ 354 (400)
...+..+.+++.+||+.||.+||++ ++++.+
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 2234568899999999999999998 555554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=317.34 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=191.1
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|... +++.||+|.++.. .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5788999987642 233445566677777654 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999987644 4899999999999999999999999 9999999999999999999999999997543222 233
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. ...... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~-~~i~~~----------~~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LF-DSILND----------RPHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHcC----------CCCCC
Confidence 34568999999999999999999999999999999999999995432211 00 011000 01112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMK-EVAM 353 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~-ell~ 353 (400)
...+..+.+++.+||+.||.+||++. ++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 22345688999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=338.60 Aligned_cols=257 Identities=26% Similarity=0.326 Sum_probs=204.7
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC---
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE--- 152 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 152 (400)
....++|.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++..++|+|+++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 44567999999999999999999985 46899999987543 3445567889999999999999999988765432
Q ss_pred -----cceEEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEE
Q 042371 153 -----VPLLVYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV 226 (400)
Q Consensus 153 -----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl 226 (400)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 2579999999999999987532 2346899999999999999999999999 999999999999999999999
Q ss_pred EecCCccccccCC-ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh
Q 042371 227 ADFGTSKFIVIDQ-THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305 (400)
Q Consensus 227 ~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 305 (400)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... ..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~-~~ 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMH-KT 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHH-HH
Confidence 9999997654221 12233466999999999999999999999999999999999999999533211 1111 11
Q ss_pred hhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 EENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..... ...+...++.+.+++.+||+.||.+|||+.+++.+
T Consensus 258 ~~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11110 11223345678999999999999999999999875
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=312.32 Aligned_cols=261 Identities=24% Similarity=0.419 Sum_probs=207.7
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC-----CcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEee-CCc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD-----GRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLE-TEV 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 153 (400)
..++|.+.+.||+|+||.||+|...+ +..|++|.+... .......+.+|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999755 678999987643 34456778899999999999999999998766 467
Q ss_pred ceEEEEccCCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEe
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEE-----FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVAD 228 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D 228 (400)
.+++++|+++++|.+++...... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998764322 45899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhh
Q 042371 229 FGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 229 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
||+++.+...... ......++..|+|||++.+..++.++||||||+++|++++ |+.||....... .... ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~-~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------MAAY-LK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH------HHHH-HH
Confidence 9999765322221 1122345678999999998899999999999999999999 999985432211 1110 10
Q ss_pred hcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 307 ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.. .........++.+.+++.+||+.+|++|||+.++++.|..+..
T Consensus 234 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 10 0001112234568999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=307.09 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=195.7
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
+.||+|+||.||+|... +++.+|+|..... .......+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999964 6889999976543 234456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee-ec
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT-TK 245 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 245 (400)
.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999875432 4889999999999999999999999 99999999999999999999999999875432111110 11
Q ss_pred ccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCH
Q 042371 246 VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQK 324 (400)
Q Consensus 246 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (400)
...+..|+|||.+.++.++.++||||||+++|+|++ |..||....... ........ .....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQG---------VRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcC---------CCCCCcc
Confidence 123457999999999999999999999999999998 888884332211 00111000 0011122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 325 EEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 325 ~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
..+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 33567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=317.53 Aligned_cols=265 Identities=29% Similarity=0.415 Sum_probs=208.2
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec--------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEe
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA--------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCL 149 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 149 (400)
...++|.+.+.||+|+||.||++... .+..+|+|.+... .......+..|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33467999999999999999999742 2346999987643 234456788899999999 7999999999999
Q ss_pred eCCcceEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042371 150 ETEVPLLVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216 (400)
Q Consensus 150 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NI 216 (400)
..+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 99999999999999999999976431 124788999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccc
Q 042371 217 LLNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEA 294 (400)
Q Consensus 217 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 294 (400)
+++.++.++|+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-- 249 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 249 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--
Confidence 9999999999999998755321111 1112224568999999998899999999999999999998 88888432211
Q ss_pred cchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 295 TGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
.. ........ ....+...+..+.+++.+||+.+|.+|||+.++++.|+.+.....
T Consensus 250 ----~~-~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 ----EL-FKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ----HH-HHHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 11 11111111 111122345678899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=313.05 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=204.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
..+|.+.++||+|+||.||++... ++..+|+|............+.+|+.+++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356888999999999999999632 35678999877666666788999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 042371 156 LVYEFISNGTLFQYLHDQNE------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 223 (400)
++|||+++++|.+++..... ...+++..++.++.|++.|+.|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999976432 124789999999999999999999999 999999999999999999
Q ss_pred EEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHH
Q 042371 224 AKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYF 301 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 301 (400)
++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||........
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------- 233 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------- 233 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------
Confidence 99999999875432221 11122335678999999999999999999999999999998 9999843322110
Q ss_pred HHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 302 ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
........ ....+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 IECITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00010100 01111233456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=324.88 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=201.1
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
....++|++.+.||+|+||.||++... +++.+|+|.+.. ........+.+|+.+++.++||||+++++.+.+.+..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 344578999999999999999999965 578899998753 2233445677899999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 9999999999999998653 3788889999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeecccccCCCCCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSG----QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
.............||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ............
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~ 265 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNS 265 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCc
Confidence 543332233456799999999998754 3789999999999999999999999543221 111111111000
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKR--RPTMKEVAMEL 355 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~L 355 (400)
..+ ......+..+.+++.+||..++.+ ||++.+++++.
T Consensus 266 ~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 LTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111 111234566889999999844433 78999998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=309.18 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=193.9
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 91 LGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 91 lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
||+|+||.||++..+ +|+.+|+|.+.... ......+..|+.++++++||||+++++.+......++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 58999999875321 22234556799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecc
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV 246 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 246 (400)
.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQR 154 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeecc
Confidence 988865432 24889999999999999999999999 999999999999999999999999998765322 222345
Q ss_pred cccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHH
Q 042371 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE 326 (400)
Q Consensus 247 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (400)
.|++.|+|||++.+..++.++||||+||++|+|++|+.||......... ... ........ + .......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~-~~~~~~~~----~-----~~~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EEL-KRRTLEDE----V-----KFEHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHH-HHHhhccc----c-----ccccccC
Confidence 6899999999999889999999999999999999999998543221110 000 00000000 0 0011234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 327 IMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 327 ~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
+..+.+++.+||+.||.+||++.|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 566899999999999999999987764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=315.51 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=205.9
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccC-chhHHHHHHHHHHHHhC-CCCcceeeeeEEeeC
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVH-EGKLEEFINEVVILSQI-NHRNVVKLLGCCLET 151 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 151 (400)
...++|.+.+.||+|+||.||++... .+..+|+|.++... ....+.+.+|+.+++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34467999999999999999999741 24579999876433 33456788999999999 799999999999999
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
+..++||||+++|+|.+++...... .+++..++.++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRES-FLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999999764322 3899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 232 SKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 232 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
+......... ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||........ ........
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~- 260 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEG- 260 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcC-
Confidence 9865432221 1222345778999999998999999999999999999998 9999854322110 00111111
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
.....+...+..+.+++.+||+.+|++|||+.++++.|.++
T Consensus 261 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 --------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00111122345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=307.69 Aligned_cols=245 Identities=29% Similarity=0.413 Sum_probs=195.3
Q ss_pred eeeecCcEEEEEEEec---CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCC
Q 042371 90 ILGQGGQGTVYKGMLA---DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
.||+|+||.||+|.++ ++..+|+|.+.... ....+.+..|+.+++.++||||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999743 57889999876433 2345678899999999999999999998754 4678999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee-
Q 042371 165 TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT- 243 (400)
Q Consensus 165 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~- 243 (400)
+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||.||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999997543 4899999999999999999999999 99999999999999999999999999986543322211
Q ss_pred -ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 244 -TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 244 -~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . ........ ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~-~~~i~~~~---------~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------V-TQMIESGE---------RME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------H-HHHHHCCC---------CCC
Confidence 12234578999999988889999999999999999998 999995432211 0 11111111 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
.+...+..+.++|.+||+.||.+||++++|.+.|+.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 222345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=305.53 Aligned_cols=247 Identities=28% Similarity=0.443 Sum_probs=197.5
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCHH
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLF 167 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 167 (400)
+.||+|+||.||+|...++..+|+|...... ......+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998788899999876543 233457889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeeccc
Q 042371 168 QYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ 247 (400)
Q Consensus 168 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 247 (400)
+++..... .+++..++.++.+++.||.|||..+ ++|+||||+||+++.++.++|+|||++...............
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99875433 4789999999999999999999999 999999999999999999999999998754322211112223
Q ss_pred ccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHH
Q 042371 248 GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE 326 (400)
Q Consensus 248 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (400)
++..|+|||++.+..++.++||||||+++|++++ |..||....... .......... ...+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYR---------MSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCC---------CCCCCCC
Confidence 4667999999998899999999999999999998 999985332111 0011111100 0111223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 327 IMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 327 ~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=315.77 Aligned_cols=264 Identities=27% Similarity=0.419 Sum_probs=208.4
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec--------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEe
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA--------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCL 149 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 149 (400)
...++|.+.+.||+|+||.||+|... ++..+|+|..... .......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44677899999999999999999731 2457999987643 234467788999999999 7999999999999
Q ss_pred eCCcceEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042371 150 ETEVPLLVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216 (400)
Q Consensus 150 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NI 216 (400)
.....+++|||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999976421 124788889999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccc
Q 042371 217 LLNEKYTAKVADFGTSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEA 294 (400)
Q Consensus 217 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 294 (400)
+++.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 99999999999999997654322221 222345678999999998899999999999999999998 78887432211
Q ss_pred cchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 295 TGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.... ...... ....+...+..+.+++.+||+.+|.+|||+.++++.|+++....
T Consensus 247 ----~~~~-~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 247 ----ELFK-LLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ----HHHH-HHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 1111 111111 01112234567899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=317.95 Aligned_cols=242 Identities=23% Similarity=0.346 Sum_probs=195.0
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|... +++.||+|.+... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 4789999987642 234456677888888866 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
++|...+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTT 153 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-Cccc
Confidence 99999887654 4889999999999999999999999 999999999999999999999999998753222 2223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ... ....... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~-~i~~~~~----------~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFE-SILHDDV----------LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHH-HHHcCCC----------CCC
Confidence 34568999999999999999999999999999999999999995433211 111 1111100 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRP-------TMKEVAME 354 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RP-------t~~ell~~ 354 (400)
...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 12345688999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=315.95 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=205.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCc--EEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGR--IVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 157 (400)
++|++.+.||+|+||.||+|... ++. .+|+|..... .......+.+|+.++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57899999999999999999964 343 4677765532 334456788999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcE
Q 042371 158 YEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTA 224 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~ 224 (400)
|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999975421 225789999999999999999999999 9999999999999999999
Q ss_pred EEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHH
Q 042371 225 KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 225 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 303 (400)
||+|||++..... ........++..|+|||++.+..++.++||||||+++|+|++ |..||....... . ..
T Consensus 164 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~-~~ 234 (303)
T cd05088 164 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------L-YE 234 (303)
T ss_pred EeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------H-HH
Confidence 9999999863211 111111224567999999988889999999999999999998 999985332211 0 01
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhccc
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDIN 366 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~ 366 (400)
..... .....+...+..+.+++.+||+.+|.+|||+.++++.|..+....+...
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~ 288 (303)
T cd05088 235 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 288 (303)
T ss_pred HHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhh
Confidence 11110 0001112234568899999999999999999999999998877665433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=311.10 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=195.3
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 91 LGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 91 lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.+++.++|+||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 68899999875422 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeec
Q 042371 167 FQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK 245 (400)
Q Consensus 167 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 245 (400)
.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccc
Confidence 9887542 22335899999999999999999999999 9999999999999999999999999997653322 22234
Q ss_pred ccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHH
Q 042371 246 VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKE 325 (400)
Q Consensus 246 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (400)
..||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ... .... .... ...+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~-~~~~--------~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KEL-KQRI--------LNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHH-HHhh--------cccC--CCCccc
Confidence 56899999999999999999999999999999999999999643321110 000 0000 0000 112234
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 326 EIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 326 ~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
.+..+.+++.+||+.||.+|| |+++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 556789999999999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=316.26 Aligned_cols=241 Identities=26% Similarity=0.339 Sum_probs=191.8
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|... ++..||+|.++.. .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999975 5789999987642 133455667788888754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++.... .....
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc-CCCce
Confidence 99999987643 4889999999999999999999999 99999999999999999999999999864321 12223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. ...... . ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~----~~~~~~-~---------~~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LF----ESIRVD-T---------PHYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhC-C---------CCCC
Confidence 44668999999999999999999999999999999999999995332111 00 000000 0 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMK-EVAM 353 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~-ell~ 353 (400)
...+..+.+++.+||+.||.+||++. ++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12345688999999999999999984 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=310.01 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=205.4
Q ss_pred hcCCcccceeeecCcEEEEEEEecC----CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..+|.+.+.||+|+||.||+|...+ ...+|+|...... ....+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568899999999999999998543 2468999766543 4456788999999999999999999998875 45789
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++..... .+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999976432 4899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
...........++..|+|||.+....++.++||||||+++|+|++ |..||........ .........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~~----- 226 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------IGRIENGER----- 226 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCCc-----
Confidence 332222223334568999999988889999999999999999996 9999854332110 011111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
...+...+..+.+++.+||..+|.+|||+.++++.|+.+...
T Consensus 227 ----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 ----LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011223456799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=312.44 Aligned_cols=258 Identities=27% Similarity=0.428 Sum_probs=203.7
Q ss_pred CCcccceeeecCcEEEEEEEec------CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999853 23568888765433 3345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042371 157 VYEFISNGTLFQYLHDQN---------------------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTN 215 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~N 215 (400)
++||+.+++|.+++.... ...++++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 1124788999999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEEecCCccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCcc
Q 042371 216 ILLNEKYTAKVADFGTSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKE 293 (400)
Q Consensus 216 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 293 (400)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997653222211 122345678999999988889999999999999999998 999984322111
Q ss_pred ccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 294 ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.. ..... ......+...+..+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 238 ------~~-~~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ------LF-NLLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ------HH-HHHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 00 01111 01111122344578999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=313.75 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=203.9
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLET 151 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 151 (400)
+...++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345678999999999999999998743 24579999765432 23345678899999999999999999999999
Q ss_pred CcceEEEEccCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcE
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNE-------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTA 224 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~ 224 (400)
+..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 224567788899999999999999999 9999999999999999999
Q ss_pred EEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHH
Q 042371 225 KVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 225 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 302 (400)
+|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~~~ 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------VLK 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence 99999998754322211 1122234678999999998899999999999999999998 788885322211 111
Q ss_pred HHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 303 LSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
... ..... ..+...+..+.+++.+||+.+|.+|||+.++++.|+...
T Consensus 233 ~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVM-DGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHH-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111 11110 111223467999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.88 Aligned_cols=255 Identities=31% Similarity=0.500 Sum_probs=197.8
Q ss_pred CcccceeeecCcEEEEEEEecC-Cc--EEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC------Cc
Q 042371 85 FNVNRILGQGGQGTVYKGMLAD-GR--IVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET------EV 153 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~~-~~--~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~ 153 (400)
|.+.+.||+|+||.||+|.+.+ +. .+|+|..+.. .....+.+..|+.+++.++|+||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999754 32 6899976643 345567888999999999999999999987432 24
Q ss_pred ceEEEEccCCCCHHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 154 PLLVYEFISNGTLFQYLHDQ---NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
.+++|||+++|+|.+++... .....+++..++.++.|++.||.|||..+ |+||||||+|||++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 12234889999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 231 TSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 231 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... . .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I----YDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcC
Confidence 998654322111 122345778999999999999999999999999999999 889985322111 1 1111111
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
... ..+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 231 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 11123345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=317.39 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=199.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999965 57889999876433 22344677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++ +|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 975 88888765433 4788999999999999999999999 9999999999999999999999999987543221
Q ss_pred eeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc----
Q 042371 241 HVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD---- 315 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 315 (400)
.......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+................+..+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 12223457899999998865 4689999999999999999999999965433221111110000000000000000
Q ss_pred --hhh-------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 --DQV-------LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 --~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... ........+..+.+++.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000 000112245568899999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.20 Aligned_cols=256 Identities=25% Similarity=0.455 Sum_probs=204.4
Q ss_pred hcCCcccceeeecCcEEEEEEEec-C---CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-D---GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~---~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.++|++.+.||+|+||.||+|... + +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357889999999999999999853 2 3479999876432 3345688899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999976543 4789999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCceeeec--ccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 237 IDQTHVTTK--VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 237 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
......... ..++..|+|||.+.+..++.++|+||||+++|++++ |..||....... . ........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~--~- 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V----IKAIEEGY--R- 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H----HHHHhCCC--c-
Confidence 333222221 223567999999998899999999999999999887 999985432211 0 01111110 0
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
...+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011223355689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=317.81 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=196.7
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||++... +++.+|+|.+... .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999964 5788999987642 233456788899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-~~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG-PGDTT 153 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC-CCCce
Confidence 99999887544 4899999999999999999999999 99999999999999999999999999875321 12223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||........................ ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence 4466999999999999999999999999999999999999999643332222222221111111110 112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTM------KEVAME 354 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~------~ell~~ 354 (400)
...+..+.+++.+||+.||.+|+++ .+++++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 2234568899999999999999985 466554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=307.18 Aligned_cols=253 Identities=33% Similarity=0.521 Sum_probs=199.8
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhH--HHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKL--EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
|++.+.||+|+||+||++... +++.+|+|.+........ ....+|+.+++.++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999975 467899998876543332 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++.... .+++..++.++.|++.||.+||+.+ |+|+||||+||+++.++.++|+|||.+... .....
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNE 153 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc-ccccc
Confidence 9999999998433 4899999999999999999999999 999999999999999999999999999753 12233
Q ss_pred eeecccccCCCCCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFR-SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......+++.|+|||++. +..++.++||||+|+++|+|++|..||............. ...... .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~-----~~~~~-- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKRP-----LPSSS-- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHTH-----HHHHT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccccc-----ccccc--
Confidence 444566899999999998 8889999999999999999999999996441111111100 000000 00000
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.........+.+++.+||+.||++|||+.+++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112679999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.51 Aligned_cols=256 Identities=24% Similarity=0.424 Sum_probs=200.4
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCc----EEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGR----IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
++|++.+.||+|+||.||+|.+. +++ ++++|...... ......+..|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46888999999999999999864 343 47788765332 2334677788889999999999999998754 45789
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
++||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999976443 4899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 237 IDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 237 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
.... .......++..|+|||.+.++.++.++||||||+++|+|++ |..||........ .........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~---- 229 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGER---- 229 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCc----
Confidence 3222 12233456778999999998999999999999999999998 9999854322110 111111110
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
...+...+..+.+++.+||..||.+|||+.++++.|..+..
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 -----LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 00111223457889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=307.78 Aligned_cols=256 Identities=26% Similarity=0.486 Sum_probs=204.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CC---cEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DG---RIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+... .....+.+..|+.+++.++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888999999999999999864 23 37999987654 23446778899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999876432 4899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCceeeec--ccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 237 IDQTHVTTK--VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 237 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
......... ...++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~----- 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDG----- 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcC-----
Confidence 322221111 223457999999998899999999999999999998 999985432211 01111110
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
.........+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=312.16 Aligned_cols=257 Identities=30% Similarity=0.436 Sum_probs=204.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC------CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD------GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
..++|++.+.||+|+||.||+|...+ +..+|+|...... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45679999999999999999998642 3679999876432 3445678899999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEE
Q 042371 154 PLLVYEFISNGTLFQYLHDQNE-------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV 226 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl 226 (400)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 9999999999999999975321 124788899999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHH
Q 042371 227 ADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILS 304 (400)
Q Consensus 227 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 304 (400)
+|||+++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. . .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~---~-~ 233 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VL---K-F 233 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HH---H-H
Confidence 99999876543221 11223346788999999998899999999999999999998 999985332211 11 1 1
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
....... ..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 VIDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111 111223567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=310.49 Aligned_cols=256 Identities=30% Similarity=0.437 Sum_probs=201.1
Q ss_pred hcCCcccceeeecCcEEEEEEEecC------CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD------GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|.+.+.||+|+||.||+|...+ +..||+|...... ......+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999998653 4678999776433 33346788999999999999999999999998899
Q ss_pred eEEEEccCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---cEEEE
Q 042371 155 LLVYEFISNGTLFQYLHDQNE----EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY---TAKVA 227 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl~ 227 (400)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999876432 124889999999999999999999999 99999999999998764 69999
Q ss_pred ecCCccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHh
Q 042371 228 DFGTSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSM 305 (400)
Q Consensus 228 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 305 (400)
|||+++......... ......+..|+|||++.+..++.++|||||||++|+|++ |..||....... . .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~---~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V---MEFVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHHHH
Confidence 999998653211111 111223567999999998999999999999999999997 999985432211 0 00110
Q ss_pred hhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 306 EENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.... ...+...+..+.+++.+||+.+|.+|||+.+|+++|.
T Consensus 236 ~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0100 1112233466899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=314.31 Aligned_cols=241 Identities=27% Similarity=0.371 Sum_probs=191.9
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|... +++.||+|.+... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 4789999987642 233445667788888764 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKT 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCce
Confidence 99999987643 4889999999999999999999999 999999999999999999999999998753221 1223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++||||+||++|+|++|..||....... . . ....... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~---~-~~i~~~~----------~~~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---L---F-QSIRMDN----------PCYP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---H---H-HHHHhCC----------CCCC
Confidence 34568999999999999999999999999999999999999995432211 0 0 0000000 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMK-EVAM 353 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~-ell~ 353 (400)
...+..+.+++.+||+.||.+||++. ++++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 22345688999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.74 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=204.6
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|++.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999965 5889999986542 345567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++..... ..+++..++.++.+++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 81 AENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence 999999999986532 35899999999999999999999998 9999999999999999999999999987654322
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
.......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....... .......... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 219 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRGVF---------P 219 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence 22233468899999999999999999999999999999999999995433110 0111111111 1
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.27 Aligned_cols=260 Identities=26% Similarity=0.457 Sum_probs=203.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCc----EEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGR----IVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
..+|++.+.||+|+||.||+|.+. ++. +||+|..... .......+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356889999999999999999853 343 4899987643 33445678899999999999999999999875 4568
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
++++|+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999876433 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 236 VIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 236 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||....... .. .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~---- 228 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP----DLLEKGE---- 228 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCC----
Confidence 4322211 112234678999999998899999999999999999998 999985332111 00 0011100
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
....+...+..+.+++.+||+.||++|||+.++++.|..+.....
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 229 -----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred -----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 011122344568899999999999999999999999888765443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=312.12 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=193.8
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhC---CCCcceeeeeEEeeC-----C
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQI---NHRNVVKLLGCCLET-----E 152 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~-----~ 152 (400)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999965 58899999876432 22234455677766655 799999999987642 3
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..+++|||+++ +|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999975 88888876433 24899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH--hhhccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS--MEENRL 310 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~ 310 (400)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|++||....... ......... .....+
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhhC
Confidence 765322 22234567999999999998899999999999999999999999985433211 111110000 000000
Q ss_pred cccc-------ch---hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFL-------DD---QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~-------~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.... .. .......+..+..+.+++.+||+.||.+|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00 00001112345668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=316.49 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=198.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||++... +++.||+|.+.. ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999965 588999998753 22334566888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999976432 4889999999999999999999999 999999999999999999999999998765433
Q ss_pred CceeeecccccCCCCCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRS-----GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.........||+.|+|||++.. ..++.++|||||||++|+|++|+.||....... .............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcccC
Confidence 3222333468999999999863 457889999999999999999999995332111 11111111100011
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGK--RRPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~ell~~ 354 (400)
. ......+..+.+++.+||..++. .||++.+++++
T Consensus 230 ~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 P------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 11112456688999998865444 37899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=326.62 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=207.4
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccC-chhHHHHHHHHHHHHhCC-CCcceeeeeEEe
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVH-EGKLEEFINEVVILSQIN-HRNVVKLLGCCL 149 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 149 (400)
+....++|.+.+.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.+|..+. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4555667899999999999999999853 24679999887542 333457889999999997 999999999999
Q ss_pred eCCcceEEEEccCCCCHHHHHhhcCC------------------------------------------------------
Q 042371 150 ETEVPLLVYEFISNGTLFQYLHDQNE------------------------------------------------------ 175 (400)
Q Consensus 150 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 175 (400)
..+..++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999965321
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 042371 176 -----------------------------------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKST 214 (400)
Q Consensus 176 -----------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~ 214 (400)
...+++..++.++.||+.||.|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 123677788899999999999999998 999999999
Q ss_pred CeEEcCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCc
Q 042371 215 NILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSK 292 (400)
Q Consensus 215 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~ 292 (400)
|||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999976432221 11223346788999999998899999999999999999998 88998543221
Q ss_pred cccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 293 EATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
+. .......+. ....+...+..+.+++.+||+.+|.+||++++|++.|+.+.
T Consensus 349 ~~------~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQ------FYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH------HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 10 001111110 01112233567899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=305.42 Aligned_cols=247 Identities=26% Similarity=0.418 Sum_probs=194.6
Q ss_pred eeeecCcEEEEEEEec---CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCC
Q 042371 90 ILGQGGQGTVYKGMLA---DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 165 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 165 (400)
.||+|+||.||+|.+. .+..+|+|...... ....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 35579999876543 233567889999999999999999999875 456799999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee--
Q 042371 166 LFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT-- 243 (400)
Q Consensus 166 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-- 243 (400)
|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999875432 5899999999999999999999999 99999999999999999999999999976543322211
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (400)
....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ......... ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGK---------RLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCC---------CCCC
Confidence 11223578999999988889999999999999999996 999985432211 001111111 1112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
+...++.+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 223456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.09 Aligned_cols=242 Identities=25% Similarity=0.353 Sum_probs=195.1
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|... ++..||+|.+... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 4789999987642 234456677888999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTT 153 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcc
Confidence 99999887654 4899999999999999999999999 999999999999999999999999998653221 1222
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... .. ....... ...+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~-~~i~~~~----------~~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LF-QSILEDE----------VRYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HH-HHHHcCC----------CCCC
Confidence 33568999999999999999999999999999999999999995332111 10 1111100 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTM-----KEVAME 354 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~~ 354 (400)
...+..+.+++.+||+.||.+|||+ .+++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2334568999999999999999999 777765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=306.89 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=199.0
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|++.+.||+|+||.||+|.. .+++.+|+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999985 46889999987543 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999986542 3788889999999999999999999 999999999999999999999999999754321
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||....................... ...
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 219 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------PPV 219 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--------CCC
Confidence 22335689999999999988999999999999999999999999954322211111100000000000 000
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
......+..+.+++.+||+.+|.+||++++++++-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 01122345689999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=315.08 Aligned_cols=247 Identities=25% Similarity=0.338 Sum_probs=196.8
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
+|.+.+.||+|+||.||+|... +++.||+|.+... .......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999865 5789999987642 233345667788888777 5899999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999887654 4889999999999999999999999 999999999999999999999999998753221
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... . ........
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~----~~~i~~~~--------- 217 (323)
T cd05616 155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L----FQSIMEHN--------- 217 (323)
T ss_pred -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCC---------
Confidence 222334568999999999999999999999999999999999999995432211 0 01111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTM-----KEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~~ 354 (400)
...+...+..+.+++.+||+.+|.+|++. .+++++
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 01122345668899999999999999985 555543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=312.38 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=202.3
Q ss_pred cCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccCc-hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVHE-GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
..|.+.+.||+|+||.||+|... .+..||+|.+..... ...+.+..|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45788899999999999999853 246899998875433 23467889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 042371 156 LVYEFISNGTLFQYLHDQN-------------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY 222 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 222 (400)
+++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1224788889999999999999999999 99999999999999999
Q ss_pred cEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHH
Q 042371 223 TAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAY 300 (400)
Q Consensus 223 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 300 (400)
.+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|+|++ |..||....... .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------V 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------H
Confidence 999999999876532221 11223345778999999988899999999999999999998 888874322111 1
Q ss_pred HHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 301 FILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
......... ...+.+.+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 236 -~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 -IEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111111 11223455668999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.95 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=198.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||++... +++.||+|.+... .......+..|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 5788999987532 2334456778999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||++||+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999976432 4889999999999999999999999 999999999999999999999999999765433
Q ss_pred CceeeecccccCCCCCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRS-----GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.........||+.|+|||++.+ +.++.++||||||+++|+|++|+.||....... .............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 229 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQF 229 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCcccC
Confidence 3323334569999999999875 568899999999999999999999995332211 11111110000000
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKR--RPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~ 354 (400)
.......++.+.+++.+||...+.+ |+++++++++
T Consensus 230 ------p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 ------PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ------CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0111224567889999999876554 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=317.04 Aligned_cols=238 Identities=29% Similarity=0.313 Sum_probs=192.0
Q ss_pred ceeeecCcEEEEEEEe----cCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 89 RILGQGGQGTVYKGML----ADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
+.||+|+||.||++.. .+++.+|+|.+.... ......+..|+.++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999876432 2234566789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKK 154 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCc
Confidence 999999986543 5899999999999999999999999 999999999999999999999999998764322 122
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccC
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (400)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... . ........ ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~-~~~i~~~~----------~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------T-MTMILKAK----------LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------H-HHHHHcCC----------CCC
Confidence 334568999999999998889999999999999999999999995332111 0 01111110 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 042371 323 QKEEIMTIATLATRCLNLNGKRRPTMKE 350 (400)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dP~~RPt~~e 350 (400)
+...+..+.+++.+||+.||.+|||+.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2233456889999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.82 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=202.9
Q ss_pred cCCcccceeeecCcEEEEEEEe-----cCCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--Ccc
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVP 154 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 154 (400)
..|++.+.||+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578999999999999999973 347789999876443 33456788999999999999999999998775 567
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999865432 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce--eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCc--------cccchHHHHHHH
Q 042371 235 IVIDQTH--VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSK--------EATGLAAYFILS 304 (400)
Q Consensus 235 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~--------~~~~~~~~~~~~ 304 (400)
....... ......++..|+|||++.+..++.++||||||+++|+|++++.|+...... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5432221 122344677899999998889999999999999999999987764221100 000000000000
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
.... .....+...+..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 01111223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.90 Aligned_cols=267 Identities=23% Similarity=0.369 Sum_probs=207.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999965 58899999876422 233567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 159 EFISNGTLFQYLHDQNE--------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
||++|++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999865211 123567788899999999999999999 9999999999999999999999999
Q ss_pred CccccccCCc-----------------eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCcc
Q 042371 231 TSKFIVIDQT-----------------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293 (400)
Q Consensus 231 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 293 (400)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521110 01112468999999999999999999999999999999999999995422110
Q ss_pred ccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHHHhhccc
Q 042371 294 ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRR-PTMKEVAMELERIQALQKDIN 366 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~ell~~L~~~~~~~~~~~ 366 (400)
. ... ... ..+ .........+..+.+++.+||+.||++| ++++++++.|+........+.
T Consensus 239 ---i-~~~------~~i---~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~ 298 (932)
T PRK13184 239 ---I-SYR------DVI---LSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWT 298 (932)
T ss_pred ---h-hhh------hhc---cCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcccc
Confidence 0 000 000 000 0001112345668899999999999999 567888888888766554443
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.28 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=204.3
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.+|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|+.+++.++|+|++++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57999999999999999999854 68899999887655556678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++... .+++..+..++.|++.||.|||..+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~ 171 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-c
Confidence 999999998643 3788999999999999999999999 9999999999999999999999999987643222 1
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ . ....... .. ...
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~----~~~~~~~-~~-------~~~ 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L----YLIATNG-TP-------ELQ 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--H----HHHhcCC-CC-------CCC
Confidence 12234588999999999988899999999999999999999999954332110 0 0000000 00 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...+..+.+++.+||..+|.+|||+.+++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 123445668999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.46 Aligned_cols=263 Identities=26% Similarity=0.402 Sum_probs=205.7
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec--------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEe
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA--------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCL 149 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 149 (400)
...++|.+.+.||+|+||.||++... ....+|+|.+... .......+..|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34467899999999999999999742 2456899987643 234456788999999999 6999999999999
Q ss_pred eCCcceEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042371 150 ETEVPLLVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216 (400)
Q Consensus 150 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NI 216 (400)
..+..+++|||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 98899999999999999999976421 134889999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccc
Q 042371 217 LLNEKYTAKVADFGTSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEA 294 (400)
Q Consensus 217 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 294 (400)
|++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~- 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE- 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 99999999999999997653211111 111224467999999998899999999999999999999 889984332111
Q ss_pred cchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 295 TGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
. ......... ...+...+..+.+++.+||+.+|.+|||+.++++.|.++...
T Consensus 245 -----~-~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 245 -----L-FKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -----H-HHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 0 011111110 011223345688999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=305.03 Aligned_cols=251 Identities=27% Similarity=0.500 Sum_probs=201.8
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
..|++.+.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688899999999999999998777889999876432 234578899999999999999999999999899999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+++|.+++..... .+++..++.++.+++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999876443 4789999999999999999999999 9999999999999999999999999987653322222
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
.....++..|+|||.+.++.++.++||||||+++|+|++ |+.||....... ........ ... .
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~--~~~-------~ 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAG--FRL-------Y 221 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCC--CCC-------C
Confidence 222334678999999998899999999999999999998 999985332211 01111110 000 0
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
.+...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1112346699999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=315.23 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=212.5
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.+-|.+.+.||+|.|+.|-+|+. -.|.+||||++.... .-...++.+|++-|+.++|||||++|++...+..+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45689999999999999999984 379999999876543 334567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCcEEEEecCCcccccc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~~kl~Dfgla~~~~~ 237 (400)
|.-++|+|++||-.+..+ +.+..+.+++.||+.|+.|+|+.. +|||||||+||.+- .-|-|||+|||++..+
T Consensus 97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf-- 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF-- 169 (864)
T ss_pred EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC--
Confidence 999999999999887764 899999999999999999999999 99999999998775 5689999999999765
Q ss_pred CCceeeecccccCCCCCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFT-DKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
.+.....+.+|...|.|||++.+..|+ +++||||||||||.|++|++||......+. +..++|-
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDC 234 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDC 234 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcc
Confidence 355566778899999999999999996 679999999999999999999965544332 2222222
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.-..+...+.++++||..||..||.+|.|.++|+..
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 223466778889999999999999999999998764
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=307.57 Aligned_cols=255 Identities=26% Similarity=0.487 Sum_probs=202.5
Q ss_pred cCCcccceeeecCcEEEEEEEecC-C---cEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLAD-G---RIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~-~---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
..|++.+.||+|+||.||+|.... + ..||+|.+... .......+..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 458899999999999999999643 3 36999987653 344567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999876543 4889999999999999999999999 99999999999999999999999999876543
Q ss_pred CCcee--eeccc--ccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 238 DQTHV--TTKVQ--GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 238 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
..... ..... .+..|+|||.+.+..++.++||||||+++|+|++ |..||....... . ....... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~----~~~i~~~--~- 228 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---V----INAIEQD--Y- 228 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---H----HHHHHcC--C-
Confidence 22211 11111 1357999999999999999999999999999886 999985432211 0 0001000 0
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
....+.+.+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 229 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111223456688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=320.44 Aligned_cols=263 Identities=27% Similarity=0.469 Sum_probs=220.8
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecC---C--cEEEEEEccc-cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLAD---G--RIVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~---~--~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
...+..++.++||.|-||.||.|.+-+ | -.||||.-+. ...+..+.|+.|+.+|++++||||++++|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 334445567789999999999999532 3 3588886654 4556689999999999999999999999999875 5
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.|||||.++-|.|..+++..+. .++......++.||+.||.|||+.. +|||||...|||+.+...+||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 6999999999999999998765 4888999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.+..+.....+...-...|||||.+.-..++.+||||.|||.|||+++ |..||....+. .+-.
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~ 603 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIG 603 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEE
Confidence 887655555554555778999999999999999999999999999998 99999543322 2223
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
.++.+-+...++.+++.++.+..+||..+|.+||++.++...|.++....+.
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 3344445556778888999999999999999999999999999998875444
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=313.13 Aligned_cols=263 Identities=28% Similarity=0.416 Sum_probs=203.2
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36899999999999999999865 5788999977643 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+ ++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997653 48999999999999999999997 46 999999999999999999999999998654221
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc----------
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR---------- 309 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---------- 309 (400)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........ ............
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccC
Confidence 22345688999999999888899999999999999999999999853321110 000000000000
Q ss_pred ----------cccccc----hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 310 ----------LYDFLD----DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 310 ----------~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
.....+ ...........+..+.+++.+||+.+|++|||+.+++++-.-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 000000 000000111245678999999999999999999999998544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=309.99 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=200.8
Q ss_pred hcCCcccceeeecCcEEEEEEEecC---------------CcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeee
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD---------------GRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLL 145 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~---------------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~ 145 (400)
.++|++.+.||+|+||.||++...+ ...||+|..... .......+.+|+.++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3579999999999999999987532 235899987643 233456788999999999999999999
Q ss_pred eEEeeCCcceEEEEccCCCCHHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042371 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNE---------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216 (400)
Q Consensus 146 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NI 216 (400)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999865321 123688899999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCcCCCcc
Q 042371 217 LLNEKYTAKVADFGTSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT--GQKPIILTGSKE 293 (400)
Q Consensus 217 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~~ 293 (400)
+++.++.+||+|||++.......... .....++..|+|||++.++.++.++||||||+++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999997653222111 122334678999999998899999999999999999998 566774332211
Q ss_pred ccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 294 ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
. ........... ........+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 241 ~---~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 V---IENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H---HHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1 00000000000 000001112223467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.99 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=200.1
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEe-eCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL-ETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 160 (400)
..+|.+.+.||+|+||.||++... +..+|+|..... ...+.+.+|+.++++++|+|++++++++. ..+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 357899999999999999999764 778999987532 33567889999999999999999999765 44578999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++...... .+++..++.++.|++.||.|||..+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999998765432 4889999999999999999999999 9999999999999999999999999987543211
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... . ....... ..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~------~-~~~~~~~---------~~ 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------V-VPRVEKG---------YK 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------H-HHHHhcC---------CC
Confidence 22334668999999998899999999999999999998 999985322111 0 0111110 00
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
.......+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111223456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=307.68 Aligned_cols=252 Identities=26% Similarity=0.318 Sum_probs=199.8
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++|+|++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999965 58899999765422 2223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999998865433 24899999999999999999999999 9999999999999999999999999987543221
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
......|++.|+|||++.+..++.++||||+|+++|+|++|+.||............ ...... ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~----------~~ 221 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKE----------VQ 221 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhh----------hh
Confidence 122346899999999999999999999999999999999999999543221100000 000000 00
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
.......+..+.+|+.+||+.||.+||| +.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1112234456889999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=307.61 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=203.4
Q ss_pred cCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
.+|.+.+.||+|+||.||+|..+ +...+++|........ ....+.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999853 2457899976543333 4678899999999999999999999999988999
Q ss_pred EEEEccCCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEec
Q 042371 156 LVYEFISNGTLFQYLHDQNEE------FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADF 229 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Df 229 (400)
+||||+++++|.+++...... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999765422 15899999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 230 GTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 230 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~-~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------V-LNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------H-HHHHHcC
Confidence 9987543222222233346778999999988889999999999999999999 888884322110 0 1111111
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
... .......+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 110 1112234457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=303.90 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=202.7
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
+|++.+.||.|+||.||++... ++..+|+|.+... .....+.+..|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999965 5889999987542 3345677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GA 155 (255)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc-cc
Confidence 99999998865432 25789999999999999999999999 999999999999999999999999998765322 22
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||....... . .......... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~-~~~~~~~~~~---------~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------L-ILKVCQGSYK---------P 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------H-HHHHhcCCCC---------C
Confidence 2234568899999999998899999999999999999999999995322110 0 1111111111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...+..+.+++.+||+.||.+|||+.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=323.66 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=198.0
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||++... +++.||+|.+... .......+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999965 5889999987532 2334567888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999987654 4899999999999999999999999 999999999999999999999999998754211
Q ss_pred Cc----------------------------------eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 042371 239 QT----------------------------------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQK 284 (400)
Q Consensus 239 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 284 (400)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 00123468999999999999999999999999999999999999
Q ss_pred CCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 042371 285 PIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT---MKEVAME 354 (400)
Q Consensus 285 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~~ 354 (400)
||........ + ...........+. .....+..+.+++.+++ .||.+|++ +.+++++
T Consensus 235 Pf~~~~~~~~-----~-~~i~~~~~~~~~p-------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQET-----Y-RKVMNWKETLVFP-------PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHH-----H-HHHHcCCCceecC-------CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9954332211 0 0000000000000 01113456888999977 49999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=308.51 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=199.6
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788999999999999999965 68899999876432 33356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
++ ++|.+++........+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 589888876544446899999999999999999999999 9999999999999999999999999987543221
Q ss_pred eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH--hhhc---------
Q 042371 241 HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS--MEEN--------- 308 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~--------- 308 (400)
.......+++.|+|||++.+. .++.++||||||+++|+|++|+.||........ ........ ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhH
Confidence 222233568899999988654 578999999999999999999999954322110 00000000 0000
Q ss_pred ----ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 309 ----RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 309 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........ .........+.++.+++.+||+.||.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKG-SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcc-hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 0000111245668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.97 Aligned_cols=262 Identities=29% Similarity=0.407 Sum_probs=202.5
Q ss_pred HhcCCcccceeeecCcEEEEEEEe------cCCcEEEEEEccccC-chhHHHHHHHHHHHHhC-CCCcceeeeeEEeeC-
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML------ADGRIVAVKKSKIVH-EGKLEEFINEVVILSQI-NHRNVVKLLGCCLET- 151 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~- 151 (400)
..++|++.+.||+|+||.||+|.+ .+++.||||.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346899999999999999999973 246789999886532 33456788999999999 689999999987654
Q ss_pred CcceEEEEccCCCCHHHHHhhcCC--------------------------------------------------------
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNE-------------------------------------------------------- 175 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 175 (400)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999999865321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce-eeecc
Q 042371 176 --------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH-VTTKV 246 (400)
Q Consensus 176 --------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~ 246 (400)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 113678888999999999999999999 999999999999999999999999999765322211 11223
Q ss_pred cccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHH
Q 042371 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKE 325 (400)
Q Consensus 247 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (400)
.+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ........... ..+..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRM---------RAPDY 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCC---------CCCCC
Confidence 35678999999998899999999999999999997 9999854322110 01111111110 01111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 326 EIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 326 ~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.++.+.+++.+||+.+|.+|||+.+|+++|+.+..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=320.03 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=197.3
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC-----
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE----- 152 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 152 (400)
..++|++.+.||+|+||.||++... .+..||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 5889999987542 3344567889999999999999999999886543
Q ss_pred -cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 153 -VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 153 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
..++||||+++ +|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 56666532 3788889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchH---------HHH-
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLA---------AYF- 301 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~---------~~~- 301 (400)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .+.
T Consensus 170 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 975422 22233456899999999999999999999999999999999999999644321100000 000
Q ss_pred ------HHHh-hhcccc-----cccchhh---hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 302 ------ILSM-EENRLY-----DFLDDQV---LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 302 ------~~~~-~~~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
.... ...... +...... ........+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000 000000 0000000 0001112245689999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=307.94 Aligned_cols=263 Identities=29% Similarity=0.428 Sum_probs=203.7
Q ss_pred hcCCcccceeeecCcEEEEEEEecC-----------------CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCccee
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD-----------------GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVK 143 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~ 143 (400)
.++|++.+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4679999999999999999987542 2458999876432 345678889999999999999999
Q ss_pred eeeEEeeCCcceEEEEccCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042371 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNE--------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTN 215 (400)
Q Consensus 144 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~N 215 (400)
+++++...+..+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999976431 125899999999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCcCCCc
Q 042371 216 ILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT--GQKPIILTGSK 292 (400)
Q Consensus 216 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~ 292 (400)
|+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876432221 12223446778999999998899999999999999999998 67777433211
Q ss_pred cccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 293 EATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
. ............. .......+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 241 ~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q---VIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 1111111100000 00001112233467999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=315.33 Aligned_cols=268 Identities=26% Similarity=0.406 Sum_probs=208.8
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEecC--------CcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeE
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLAD--------GRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGC 147 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~--------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 147 (400)
++....+|++.+.||+|+||.||++...+ +..+|+|..... .......+.+|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 34455679999999999999999997421 236899977643 233467889999999999 79999999999
Q ss_pred EeeCCcceEEEEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 042371 148 CLETEVPLLVYEFISNGTLFQYLHDQN-------------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKST 214 (400)
Q Consensus 148 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~ 214 (400)
+...+..+++|||+++|+|.+++.... ....+++..++.++.|++.||.|||..+ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999999999999997532 1224788899999999999999999999 999999999
Q ss_pred CeEEcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCc
Q 042371 215 NILLNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSK 292 (400)
Q Consensus 215 NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~ 292 (400)
|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999765322111 1122234567999999999999999999999999999998 88888433211
Q ss_pred cccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 293 EATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
. . ........ ....+...+..+.+++.+||+.+|.+|||+.++++.|+.+......
T Consensus 244 ~------~-~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 244 E------L-FKLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred H------H-HHHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 1 1 11111111 0111223345688999999999999999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=302.63 Aligned_cols=247 Identities=30% Similarity=0.463 Sum_probs=195.8
Q ss_pred ceeeecCcEEEEEEEecC----CcEEEEEEccccCc-hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLAD----GRIVAVKKSKIVHE-GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
++||+|+||.||+|.+.. +..+|+|....... .....+.+|+.+++.++|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 26899998764433 34567889999999999999999999876 4467999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
++|.+++.... .+++..++.++.|++.||.|||..+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999997654 4899999999999999999999999 99999999999999999999999999986643322211
Q ss_pred e--cccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 244 T--KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 244 ~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
. ...++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ...... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~----~~~~~~---------~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIA----MLESGE---------RL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----HHHcCC---------cC
Confidence 1 1223467999999998899999999999999999998 999985432211 111 111110 01
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
..+...+..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 12223446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=307.40 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=201.7
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
++|.+.+.||+|+||.||+|... +++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57889999999999999999864 58899999887655555667888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++.... .+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++...... ..
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IA 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-cc
Confidence 9999999987654 4899999999999999999999999 999999999999999999999999998755322 12
Q ss_pred eeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 242 VTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
......|++.|+|||++. ...++.++|+|||||++|+|++|..||........ ... ...... .....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-----~~~--~~~~~~---~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----LFL--MTKSNF---QPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-----HHh--hhccCC---CCCcc
Confidence 223356899999999874 45688999999999999999999999854322110 000 000000 00000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+..+.+++.+||+.+|++|||+++++++
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 --KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0011234568899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=314.19 Aligned_cols=237 Identities=26% Similarity=0.371 Sum_probs=188.5
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHH-HHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|... +++.||+|.+... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 6889999987542 1223345555655 45778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~ 153 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTT 153 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCcc
Confidence 99999887643 5889999999999999999999999 99999999999999999999999999875322 12223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ........ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~-~~i~~~~~----------~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MY-DNILNKPL----------RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HH-HHHHcCCC----------CCC
Confidence 34568999999999999999999999999999999999999995432111 00 01111100 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMK 349 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~ 349 (400)
...+..+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 22356688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=303.30 Aligned_cols=249 Identities=33% Similarity=0.505 Sum_probs=202.2
Q ss_pred ceeeecCcEEEEEEEecC----CcEEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLAD----GRIVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|.... +..+++|.+...... ....+.+|+..+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 788999987754433 367889999999999999999999999998899999999999
Q ss_pred CCHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 164 GTLFQYLHDQNE------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 164 g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 236899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 238 DQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 238 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
... .......+++.|+|||.+....++.++||||+|+++|+|++ |..||....... . .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~-~~~~~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------V-LEYLRKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------H-HHHHHcC-------
Confidence 221 12233457889999999998899999999999999999999 699985442111 0 1111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.....+...+..+.+++.+||+.+|.+|||+.+++++|+
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122334567999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=306.35 Aligned_cols=252 Identities=24% Similarity=0.288 Sum_probs=199.1
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++|+|++++++.+...+..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999864 68899999875422 2234557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG- 155 (285)
T ss_pred eccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence 9999999988865432 25899999999999999999999999 999999999999999999999999998654321
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......|+..|+|||++.+..++.++|+||+|+++|+|++|..||........... ........ .
T Consensus 156 -~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~----------~ 221 (285)
T cd05632 156 -ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLET----------E 221 (285)
T ss_pred -CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhcc----------c
Confidence 122345689999999999988999999999999999999999999954322111000 00000000 0
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
.......+..+.+|+.+||+.||.+||| +.+++.+
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0112234456889999999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=307.85 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=201.0
Q ss_pred cCCcccceeeecCcEEEEEEEec-----------------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceee
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-----------------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKL 144 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-----------------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~ 144 (400)
++|++.+.||+|+||.||++... ++..+|+|..... .......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56999999999999999998532 2346899987643 33345688999999999999999999
Q ss_pred eeEEeeCCcceEEEEccCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042371 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNE--------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216 (400)
Q Consensus 145 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NI 216 (400)
++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999876431 123678889999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCcCCCcc
Q 042371 217 LLNEKYTAKVADFGTSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT--GQKPIILTGSKE 293 (400)
Q Consensus 217 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~~ 293 (400)
|++.++.++|+|||++..+....... .....+++.|+|||...++.++.++|||||||++|+|++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999997653222111 122334678999999888899999999999999999998 678875332211
Q ss_pred ccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 294 ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
. ............... ....+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 242 ~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 V---IENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 110001010000000 01112223467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=321.20 Aligned_cols=196 Identities=30% Similarity=0.435 Sum_probs=170.7
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCC-C-----CcceeeeeEEeeCCc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-H-----RNVVKLLGCCLETEV 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~~~~~~~~~~~ 153 (400)
...+|.+.+.||+|+||.|.+|.+. +++.||||+++.. ..-..+...|+.+|..|+ | -|+|+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3458999999999999999999964 5899999998754 444567788999999996 3 489999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC--CcEEEEecCC
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK--YTAKVADFGT 231 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~--~~~kl~Dfgl 231 (400)
.|||+|.+. .+|.++++.+.-. .++...++.++.||+.||.+||..+ |||+||||+|||+..- ..+||+|||+
T Consensus 263 lciVfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence 999999994 6999999876544 5999999999999999999999999 9999999999999753 4899999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 286 (400)
+++.. .... ++..+..|+|||++.+.+|+.+.||||||||++||++|.+-|
T Consensus 338 Sc~~~---q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 338 SCFES---QRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred ccccC---Ccce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 98753 2222 566789999999999999999999999999999999996665
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.68 Aligned_cols=266 Identities=24% Similarity=0.356 Sum_probs=199.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|.+.+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357999999999999999999865 57899999876433 2334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|++ ++|.+++..... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 589888876433 4889999999999999999999999 9999999999999999999999999987543221
Q ss_pred ceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch--
Q 042371 240 THVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD-- 316 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 316 (400)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.......................+..+...
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 122234568899999988654 5788999999999999999999999644322110000000000000011100000
Q ss_pred -------hh----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 -------QV----LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 -------~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. ........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 000111234568899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=300.13 Aligned_cols=247 Identities=29% Similarity=0.467 Sum_probs=198.1
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCHH
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLF 167 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 167 (400)
++||.|+||.||++...+++.||+|........ ....+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877899999987654333 5678899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee-ecc
Q 042371 168 QYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT-TKV 246 (400)
Q Consensus 168 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~ 246 (400)
+++..... .+++..++.++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........... ...
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99876433 4789999999999999999999999 99999999999999999999999999875432111111 112
Q ss_pred cccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHH
Q 042371 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKE 325 (400)
Q Consensus 247 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (400)
.++..|+|||.+.++.++.++|+||||+++|+|++ |..||........ ....... .....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-------~~~~~~~---------~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-------RERIESG---------YRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-------HHHHhcC---------CCCCCCcc
Confidence 23567999999998899999999999999999999 8888844322110 0000000 00111233
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 326 EIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 326 ~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=303.88 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=194.7
Q ss_pred ceeeecCcEEEEEEEecC-Cc--EEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLAD-GR--IVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|...+ +. .+++|..... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999753 43 4688877643 344556888999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 164 GTLFQYLHDQN-------------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 164 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 1124789999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
++..... .........+..|+|||++.+..++.++||||||+++|+|++ |..||....... . ........
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~-~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------L-YEKLPQGY 228 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------H-HHHHhCCC
Confidence 9853211 111111223567999999988899999999999999999997 999984322111 0 01111110
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
....+...+..+.+++.+||+.+|.+|||+.++++.|.++.
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00111223456889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=314.00 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=198.8
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||++..+ +++.+|+|.+.. ........+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46899999999999999999965 477899998753 12333455788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976433 4899999999999999999999999 999999999999999999999999998765433
Q ss_pred CceeeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.........||+.|+|||++. ...++.++|||||||++|+|++|+.||....... .............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 229 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQF 229 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCccccC
Confidence 333333456999999999986 3468899999999999999999999995432111 11111111000000
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKR--RPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~ 354 (400)
.......+..+.+++.+||..+|.+ |+++.+++++
T Consensus 230 ------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 ------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0111234567889999998665444 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=308.80 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=204.5
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6799999999999999999996 468999999887655556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....... .
T Consensus 99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~ 170 (297)
T cd06656 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 170 (297)
T ss_pred CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc-c
Confidence 999999998643 3788999999999999999999999 9999999999999999999999999987643222 1
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......... ..... ......
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------~~~~~-------~~~~~~ 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATN-------GTPELQ 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------eeccC-------CCCCCC
Confidence 2233457899999999999899999999999999999999999995432211000 00000 000011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123345668899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=311.40 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=193.4
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 158 (400)
+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999865 6889999987642 2334566778889988885 577888999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999987654 4899999999999999999999999 999999999999999999999999998753222
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
........||+.|+|||++.+..++.++||||+||++|+|++|+.||....... . ........
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~----~~~i~~~~--------- 217 (323)
T cd05615 155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---L----FQSIMEHN--------- 217 (323)
T ss_pred -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCC---------
Confidence 122334568999999999999999999999999999999999999995432111 0 00111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTM 348 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 348 (400)
...+...+..+.+++.+||+.+|.+|++.
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122334568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=303.89 Aligned_cols=250 Identities=26% Similarity=0.480 Sum_probs=201.3
Q ss_pred CCcccceeeecCcEEEEEEEecCCcEEEEEEccccC------chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH------EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478899999999999999998788999999776432 12345688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
+||+++++|.+++.... ++++..++.++.|++.||.|||..+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997654 4789999999999999999999999 99999999999999999999999999875431
Q ss_pred CC-----ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 238 DQ-----THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 238 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.. ........|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~--- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRGL--- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccCC---
Confidence 11 111233458899999999998899999999999999999999999995322111 00000000000
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAM 353 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 353 (400)
....+...+..+.+++.+||+.+|.+|||+.+++.
T Consensus 227 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11122234566899999999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=318.49 Aligned_cols=264 Identities=22% Similarity=0.290 Sum_probs=197.6
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC----
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE---- 152 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 152 (400)
...++|++.+.||+|+||.||++... .++.+|+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 5789999987643 2344567888999999999999999999886433
Q ss_pred --cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 153 --VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 153 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999975 66666642 3788889999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHH---------H-
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAA---------Y- 300 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~---------~- 300 (400)
+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .
T Consensus 165 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9975432 222334568999999999999999999999999999999999999995432111000000 0
Q ss_pred ------HHHHhhh-cccc-----cccchhhh---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 301 ------FILSMEE-NRLY-----DFLDDQVL---KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 301 ------~~~~~~~-~~~~-----~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....... .... ........ ..........+.+|+.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 0000 00000000 00111234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=300.72 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=205.8
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
++|++.+.||.|+||.||+|... ++..+++|............+.+|+.+++.++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57999999999999999999964 57889999887665556788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++..... .+++..++.++.|++.||.|||..+ |+|+||+|+||+++.++.++|+|||++...... ..
T Consensus 83 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IA 156 (262)
T ss_pred CCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh-hh
Confidence 99999999876522 4899999999999999999999999 999999999999999999999999998765322 11
Q ss_pred eeecccccCCCCCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 242 VTTKVQGTFGYLDPEYFRSG---QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ . .......+ ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~-----~~~~~~~~---~~~-- 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--L-----FLISKSNF---PPP-- 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--H-----HHHHhccC---CCc--
Confidence 22335678899999998776 889999999999999999999999854322110 0 00001000 000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........+..+.+++.+||..+|.+|||+.+++.+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011123456679999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=306.33 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=198.3
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeC------C
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLET------E 152 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~------~ 152 (400)
..+.|++.+.||+|+||.||+|... +++.+|+|...... .....+.+|+.++..+ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567899999999999999999865 57889999876443 3346788899999998 699999999998753 3
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 57899999999999999876432 25899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCceeeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 307 (400)
....... .......|++.|+|||++. +..++.++||||+||++|+|++|..||...... .... ....
T Consensus 159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~--~~~~ 230 (272)
T cd06637 159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALF--LIPR 230 (272)
T ss_pred eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHH--HHhc
Confidence 7543221 2223456899999999986 346888999999999999999999998432211 1110 0011
Q ss_pred cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... ........+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 231 ~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000 011112334568999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=302.18 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=198.9
Q ss_pred ceeeecCcEEEEEEEecC--C--cEEEEEEccccCc-hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLAD--G--RIVAVKKSKIVHE-GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~--~--~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689998876555 567789999999999999999999999888 888999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce--
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH-- 241 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 241 (400)
++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999977543 35899999999999999999999999 999999999999999999999999999876432221
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .... ... .. ...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~-~~~--~~---------~~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKK-IDK--EG---------ERL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-HHh--cC---------CcC
Confidence 1122446788999999998899999999999999999999 999985332211 0000 000 00 001
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
..+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=299.84 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=203.8
Q ss_pred cCCcccceeeecCcEEEEEEEecC-CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
++|++.+.||+|+||.||+|...+ +..+++|.+..... .+.+.+|+.+++.++|+||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 579999999999999999999764 78999998764322 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++..... .+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999875443 5899999999999999999999999 99999999999999999999999999986543221
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........ ......... ....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~-------~~~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IFMIPNKPP-------PTLS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hhhhccCCC-------CCCC
Confidence 22334578899999999988999999999999999999999999853322110 000000000 0011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 123345678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=317.54 Aligned_cols=259 Identities=22% Similarity=0.274 Sum_probs=194.8
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC------
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLET------ 151 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 151 (400)
..++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999864 67899999876432 22345677899999999999999999887543
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
...+++++++ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 77998887542 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH------
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS------ 304 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------ 304 (400)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.......
T Consensus 165 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 976432 2234568999999999876 568999999999999999999999995432211 000000000
Q ss_pred ----hhhc-------ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 305 ----MEEN-------RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 305 ----~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.... .+........ ........+.+.+|+.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDL-KKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhH-HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000000 00001123457899999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.97 Aligned_cols=192 Identities=27% Similarity=0.467 Sum_probs=164.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
...+|++.+.||+|+||.||+|... .+..||+|..... ....|+.++++++|+||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999975 4678999964321 23468999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
++. ++|.+++..... .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||++.....
T Consensus 138 ~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 209 (357)
T PHA03209 138 HYS-SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-- 209 (357)
T ss_pred ccC-CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence 995 588888865433 5899999999999999999999999 99999999999999999999999999975322
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 286 (400)
........||+.|+|||++.+..++.++|||||||++|+|+++..|+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 12223456899999999999999999999999999999999865554
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=310.38 Aligned_cols=196 Identities=26% Similarity=0.400 Sum_probs=159.7
Q ss_pred cceeeecCcEEEEEEEec---CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEee--CCcceEEEEccC
Q 042371 88 NRILGQGGQGTVYKGMLA---DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIS 162 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 162 (400)
.++||+|+||.||+|... +++.+|+|.+... .....+.+|+.+++.++||||+++++.+.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 4678999987543 223457789999999999999999998864 345789999996
Q ss_pred CCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCcEEEEecCCc
Q 042371 163 NGTLFQYLHDQN------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL----NEKYTAKVADFGTS 232 (400)
Q Consensus 163 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll----~~~~~~kl~Dfgla 232 (400)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888875421 1225889999999999999999999999 9999999999999 45678999999999
Q ss_pred cccccCCc--eeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcC
Q 042371 233 KFIVIDQT--HVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILT 289 (400)
Q Consensus 233 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~ 289 (400)
........ .......||+.|+|||++.+ ..++.++||||+||++|+|++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 76543221 12234568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=320.13 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=199.1
Q ss_pred HhcCCcccceeeecCcEEEEEEEec---CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA---DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
...+|.+.+.||+|+||.||++... .+..||+|.+... ....+|+.++++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4567999999999999999999753 3578999976532 2345799999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
||++. ++|.+++.... .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||++.....
T Consensus 165 ~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99995 68888884332 5899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc--cc--
Q 042371 238 DQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL--YD-- 312 (400)
Q Consensus 238 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~-- 312 (400)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........................ ..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 222 1223456899999999999999999999999999999999999999654432211111111111100000 00
Q ss_pred ---c------cchhhhc--cC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 ---F------LDDQVLK--VG-----QKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ---~------~~~~~~~--~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+ ....... .. ....+..+.++|.+||..||.+|||+.+++.+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000000 00 01224567899999999999999999999987
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=306.68 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=202.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
+.|++.+.||.|+||.||+|... ++..+++|..........+.+.+|+.+++.++|+|++++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56999999999999999999975 47899999887666666788899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|..++..... .+++..++.++.|++.+|.|||..+ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 92 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 92 PGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred CCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 99999988765433 4899999999999999999999998 999999999999999999999999998653221 12
Q ss_pred eeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 242 VTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
......+++.|+|||++. ...++.++|||||||++|+|++|..||...... .. ...........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~-~~~~~~~~~~~---- 234 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RV-LLKIAKSEPPT---- 234 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HH-HHHHhcCCCcc----
Confidence 223345788999999984 345788999999999999999999998432211 00 01111110000
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 235 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 ---LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 01122344568899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=306.22 Aligned_cols=270 Identities=26% Similarity=0.401 Sum_probs=205.0
Q ss_pred cCCcccceeeecCcEEEEEEEec-----CCcEEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEee--CCcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-----DGRIVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLE--TEVP 154 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 154 (400)
+.|++.+.||+|+||.||++... .+..+|+|.+...... ....+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 3678999987754443 56789999999999999999999999877 5578
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
+++|||+++++|.+++..... .+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999976543 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcee--eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 235 IVIDQTHV--TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 235 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|..|+............. .........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHH
Confidence 64222211 112234567999999988899999999999999999999999974432211000000 000000000000
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
.+........+...+..+.+++.+||+.+|.+|||+.+|+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000111111223446799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=307.68 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=202.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457999999999999999999853 36789999876433 23356788999999999999999999999998899
Q ss_pred eEEEEccCCCCHHHHHhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042371 155 LLVYEFISNGTLFQYLHDQNE-------------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTN 215 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~N 215 (400)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||..+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999975321 124788899999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCcc
Q 042371 216 ILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKE 293 (400)
Q Consensus 216 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 293 (400)
|+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432211 11122234667999999998899999999999999999998 888884322111
Q ss_pred ccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 294 ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
. .......... ..+...+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 241 ------~-~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ------V-IYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------H-HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0 1111111110 1122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=312.33 Aligned_cols=240 Identities=25% Similarity=0.331 Sum_probs=188.4
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHH-HHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|... +++.+|+|.+.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 57789999875321 222334444544 46778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
++|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~ 153 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTT 153 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCc
Confidence 99999987643 4788888999999999999999999 999999999999999999999999998754221 2223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+ ........ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~--~~i~~~~~----------~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MY--DNILNKPL----------QLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HH--HHHHhCCc----------CCC
Confidence 44569999999999999999999999999999999999999995332211 00 00101100 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMKEVA 352 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~ell 352 (400)
...+..+.+++.+||+.||.+||++.+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 23445688999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=301.53 Aligned_cols=251 Identities=29% Similarity=0.469 Sum_probs=193.3
Q ss_pred ceeeecCcEEEEEEEec----CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEe-eCCcceEEEEccC
Q 042371 89 RILGQGGQGTVYKGMLA----DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCL-ETEVPLLVYEFIS 162 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 162 (400)
+.||+|+||.||+|... +...+|+|.+... .......+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999987532 3345678889999999999999999999775 4556889999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce-
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH- 241 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 241 (400)
+++|.+++..... .+++..++.++.|++.||.|||..+ ++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999976433 3677888899999999999999998 999999999999999999999999999754322111
Q ss_pred --eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 242 --VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTG-QKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 242 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
......+++.|+|||.+.+..++.++||||||+++|+|++| .+||....... ... ......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~----~~~~~~--------- 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITV----YLLQGR--------- 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhcCC---------
Confidence 11233457789999999888999999999999999999995 55663321110 110 010100
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
....+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 001112234568899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=329.10 Aligned_cols=265 Identities=19% Similarity=0.254 Sum_probs=192.2
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCC------CcceeeeeEEee
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINH------RNVVKLLGCCLE 150 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~ 150 (400)
++...++|++.+.||+|+||.||+|... .++.||||+++... .....+..|+.++..++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999864 57889999876432 223445567777766654 458888888876
Q ss_pred C-CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCC------
Q 042371 151 T-EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKY------ 222 (400)
Q Consensus 151 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~------ 222 (400)
. ...++||+++ +++|.+++.... .+++..+..++.||+.||.|||. .+ |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 4 4678999988 678988887653 58999999999999999999998 48 99999999999998765
Q ss_pred ----------cEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCc
Q 042371 223 ----------TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSK 292 (400)
Q Consensus 223 ----------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 292 (400)
.+||+|||++... ........||+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDE----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccC----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 4999999988642 22234567999999999999999999999999999999999999999654322
Q ss_pred cccchHHHHHHHhhh------------------cccccccchhhh----c-c--CCHHHHHHHHHHHHHhcccCCCCCCC
Q 042371 293 EATGLAAYFILSMEE------------------NRLYDFLDDQVL----K-V--GQKEEIMTIATLATRCLNLNGKRRPT 347 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~----~-~--~~~~~~~~l~~li~~cl~~dP~~RPt 347 (400)
+.............. ..+....+.... . . ........+.+||.+||+.||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 111111000000000 000000000000 0 0 00012345789999999999999999
Q ss_pred HHHHHHH
Q 042371 348 MKEVAME 354 (400)
Q Consensus 348 ~~ell~~ 354 (400)
+.|++++
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999985
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=301.68 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=203.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..|+..+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35788899999999999999965 57899999876432 34567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++... ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 9999999988643 4788999999999999999999998 9999999999999999999999999997653222
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||........ .... ......
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~---------~~~~~~ 219 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFLI---------PKNNPP 219 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhhh---------hcCCCC
Confidence 222334578899999999988899999999999999999999999853321110 0000 001112
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+..+.+++.+||+.+|.+||++.+++.+
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2234566779999999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=300.09 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=201.2
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEee-CCcceEEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLVYE 159 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 159 (400)
.|++.+.||+|++|.||++... +++.+|+|++... .....+.+.+|+.++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999964 5788999987643 23445678899999999999999999988764 345789999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++..... .++++..++.++.+++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999876432 25899999999999999999999999 9999999999999999999999999997653322
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......+++.|+|||++.+..++.++||||+|+++|+|++|+.||...... .. .........
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~-~~~~~~~~~--------- 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SL-VYRIIEGKL--------- 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HH-HHHHHhcCC---------
Confidence 2233456889999999999999999999999999999999999998532211 11 011111111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223455679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.61 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=201.2
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
...+++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34455556678999999999999954 57889999877666666778999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCcEEEEecCCcccccc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-KYTAKVADFGTSKFIVI 237 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~Dfgla~~~~~ 237 (400)
||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999976432211278888899999999999999999 999999999999986 67999999999876532
Q ss_pred CCceeeecccccCCCCCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQ--FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.. .......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+.....
T Consensus 162 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~---------- 227 (268)
T cd06624 162 IN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF---------- 227 (268)
T ss_pred CC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh----------
Confidence 21 1222345789999999987644 78899999999999999999999853322110 00000000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+....+.+.+++.+||+.+|.+|||+.+++++
T Consensus 228 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 -KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111223345668999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=302.33 Aligned_cols=249 Identities=27% Similarity=0.482 Sum_probs=200.1
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCch---------hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEG---------KLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
+|.+...||.|+||.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999864 5788999976543221 23567889999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997653 4889999999999999999999998 9999999999999999999999999988
Q ss_pred ccccCCce-----eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 234 FIVIDQTH-----VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 234 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
........ ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~--~~~~~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAI--FKIGEN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHH--HHHhcc
Confidence 66422111 112245788999999999889999999999999999999999999532211 000 000000
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 ---------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0111223345678999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.61 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=201.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36889999999999999999975 6889999977643 334457888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
+++++|..++........+++..+..++.+++.||.|||. .+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-- 155 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-- 155 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC--
Confidence 9999999988764323358999999999999999999997 46 99999999999999999999999999875422
Q ss_pred ceeeecccccCCCCCccccccC------CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 240 THVTTKVQGTFGYLDPEYFRSG------QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||....... .... ........
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~-~~~~~~~~---- 226 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQ-LSAIVDGD---- 226 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHH-HHHHhhcC----
Confidence 122334578899999998544 35889999999999999999999995322111 0000 00000100
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 -----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111233456778999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=316.85 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=197.5
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC------
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET------ 151 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 151 (400)
..++|.+.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999964 5788999987643 234456788999999999999999999987543
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346899999965 77776643 3788889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHH-----------
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAY----------- 300 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~----------- 300 (400)
++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus 173 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCC--CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 976432 2223345689999999999999999999999999999999999999954432111000000
Q ss_pred -----HHHHhhh-cccc-----cccchhh---hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 301 -----FILSMEE-NRLY-----DFLDDQV---LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 301 -----~~~~~~~-~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....... .... ....... ...........+.+++.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0000 0000000 000111123568899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=299.63 Aligned_cols=251 Identities=28% Similarity=0.402 Sum_probs=204.6
Q ss_pred CCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|++.+.||.|+||.||.+.. .++..+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999999999885 45888999986543 345567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997653 235899999999999999999999999 99999999999999999999999999976543221
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ..... ..... .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~-~~~~~---------~ 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKI-VQGNY---------T 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HcCCC---------C
Confidence 2234568999999999988889999999999999999999999985322111 11111 11111 1
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
......+..+.+++.+||+.+|.+|||+.++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11233456688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=304.23 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=199.9
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
|++.+.||.|+||.||+|... ++..+++|.+..........+.+|+.+++.++|||++++++.+...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 678899999999999999975 4778899987665556677889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
++|..++..... ++++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ....
T Consensus 87 ~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 160 (282)
T cd06643 87 GAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 160 (282)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc-cccc
Confidence 999988765332 5899999999999999999999999 999999999999999999999999998754321 1222
Q ss_pred ecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 244 TKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
....+++.|+|||++. +..++.++||||+||++|+|++|+.||....... . ...........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~--~~~~~~~~~~~------ 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-----V--LLKIAKSEPPT------ 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-----H--HHHHhhcCCCC------
Confidence 3345889999999974 3457889999999999999999999985322110 0 00000000000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 -LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122345678999999999999999999998875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=303.80 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=203.3
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|++.+.||.|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+|++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46889999999999999999965 58899999876543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++... ++++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998754 5899999999999999999999999 9999999999999999999999999997764322
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ............+
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~~------- 218 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNNPPSL------- 218 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhcCCCCC-------
Confidence 22233457889999999998889999999999999999999999995332110 0011111100000
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....+..+.+++.+||..+|++|||+++++++
T Consensus 219 -~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 -EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011145668999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=306.98 Aligned_cols=250 Identities=25% Similarity=0.439 Sum_probs=204.3
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.+|++.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++|||++++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999985 468899999887655556678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|..++... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 999999988643 3899999999999999999999999 99999999999999999999999999876533221
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ ....... .... ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~-~~~~-------~~ 236 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATN-GTPE-------LQ 236 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc-CCcc-------cC
Confidence 12234588899999999988899999999999999999999999954332110 0000000 0000 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...+..+.+++.+||..+|.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 122345568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.16 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=196.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
...|.+.+.||+|+||.||++... .++.||+|... ...+.+|+.+|++++|+||+++++++...+..++||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999975 47889999532 23456899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+. ++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 688888865432 5899999999999999999999999 99999999999999999999999999976532221
Q ss_pred e-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCc-cccchHHHHHHHhhh-----cccccc
Q 042371 241 H-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSK-EATGLAAYFILSMEE-----NRLYDF 313 (400)
Q Consensus 241 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~ 313 (400)
. ......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ............+.. ..+...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 223456999999999999999999999999999999999988765332211 111111101111100 000000
Q ss_pred cchhhh-------------------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LDDQVL-------------------KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+. +.........+.+||.+||+.||.+|||+.|++++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 00000123468899999999999999999999986
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=321.41 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=207.4
Q ss_pred cCCcccceeeecCcEEEEEEEecCC-cEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADG-RIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
+.|.|+..||.|+||.||+|..++. -..|.|.+........+.++-|++||..++||+||++++.|..++.+||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4578888999999999999997754 345677777778888999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
.||-...++-.-+. ++.+..+..++.|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+.... ....
T Consensus 112 ~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQ 185 (1187)
T ss_pred CCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch-hHHh
Confidence 99999988876544 5999999999999999999999999 9999999999999999999999999875422 2333
Q ss_pred eeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 242 VTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
....+.|||+|||||+.. ..+|+.++||||||++|.+|..+.+|-.... .+.....+....
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVllKiaKSe------- 251 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSE------- 251 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHHHHhhcC-------
Confidence 445688999999999864 5689999999999999999999999963211 111112211111
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+..++..+.+|+.+||..||..||++.+++++
T Consensus 252 PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11112345667789999999999999999999999875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=311.92 Aligned_cols=238 Identities=29% Similarity=0.397 Sum_probs=188.4
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHH-HHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|... +|+.+|+|.+... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 6889999987532 2233445556655 46778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|..++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~ 153 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTT 153 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC-CCCCc
Confidence 99998887543 5899999999999999999999999 99999999999999999999999999875321 12223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. ........ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~-~~~~~~~~----------~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MY-DNILHKPL----------VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HH-HHHHcCCc----------cCC
Confidence 34568999999999999999999999999999999999999995432111 00 11111100 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMKE 350 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~e 350 (400)
...+..+.+++.+||+.+|.+||++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 123456889999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=304.18 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=205.0
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|++.+.||.|+||.||++... ++..+|+|..........+.+..|+.+++.++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356999999999999999999964 5789999988766666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...... .
T Consensus 84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~ 157 (280)
T cd06611 84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-L 157 (280)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc-c
Confidence 999999999876443 5899999999999999999999999 999999999999999999999999998654322 2
Q ss_pred eeeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 241 HVTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||....... . ..........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~~~~---- 226 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------V-LLKILKSEPP---- 226 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------H-HHHHhcCCCC----
Confidence 2223355899999999875 3457889999999999999999999985432111 0 0111111000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 ---TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001122345568899999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=298.47 Aligned_cols=251 Identities=32% Similarity=0.515 Sum_probs=201.2
Q ss_pred CcccceeeecCcEEEEEEEecC-----CcEEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 85 FNVNRILGQGGQGTVYKGMLAD-----GRIVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
+++.+.||.|+||.||++...+ +..+|+|.+...... ....+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4577899999999999999653 378999988654433 5678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++...... .+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999765432 2899999999999999999999999 999999999999999999999999999766433
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.........+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...... ... ........
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------~~~-~~~~~~~~------- 222 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------EVL-EYLKKGYR------- 222 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHhcCCC-------
Confidence 2222212336789999999988889999999999999999998 88888532111 110 11111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
...+...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111122456789999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=319.33 Aligned_cols=245 Identities=29% Similarity=0.439 Sum_probs=202.4
Q ss_pred CCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCch---hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEG---KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.|.-++.||.|+||.||.|++ .+...||||++...... ..+.++.|+..|++++|||++.+-++|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 356678999999999999995 46789999998765433 45788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
||- |+-.|++.-+.. ++-+..+..|..+.+.||.|||+.+ .||||||+.|||+++.|.|||+|||.|....
T Consensus 107 YCl-GSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred HHh-ccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 995 588888876654 5889999999999999999999999 9999999999999999999999999996542
Q ss_pred ceeeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 240 THVTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
....++|||.|||||++. .+.|+.++||||||++..||.-.++|+..++.-. ....+..+.-
T Consensus 178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQNes------ 242 (948)
T KOG0577|consen 178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNES------ 242 (948)
T ss_pred --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhcCC------
Confidence 234567999999999864 5789999999999999999999999974433211 1111111110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.-....+++..+.+|+..||+.-|.+|||..+++.+
T Consensus 243 --PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 --PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111245677889999999999999999999988764
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=307.87 Aligned_cols=257 Identities=18% Similarity=0.265 Sum_probs=194.9
Q ss_pred ccceeeec--CcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 87 VNRILGQG--GQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 87 ~~~~lg~G--~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
+.++||+| +|++||++..+ +|+.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 78999999864 68999999876532 334566778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++|+|.+++...... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999764322 4899999999999999999999999 999999999999999999999999875433211110
Q ss_pred ------eeecccccCCCCCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 242 ------VTTKVQGTFGYLDPEYFRS--GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 242 ------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ... .........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-----~~~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLE-----KLNGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHH-----HhcCCcccc
Confidence 0112346778999999876 4689999999999999999999999954322110 000 000000000
Q ss_pred cc------------------------------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LD------------------------------------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~------------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+ ...........+..+.+|+.+||+.||++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 000001122345678999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=298.83 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=201.1
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-----chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-----EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
+|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999976 78899999765433 23457788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
+||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997653 4889999999999999999999999 99999999999999999999999999876533
Q ss_pred CCceeeecccccCCCCCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
.. ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||...... ............
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~------ 220 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKEL------ 220 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccC------
Confidence 22 233456889999999987766 899999999999999999999998543210 000000000000
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11122345668899999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=308.62 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=201.8
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc---hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE---GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||++... +++.+|+|.+..... .....+..|+.+++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999975 488999998764322 24567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+.+++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999999875432 35899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cce----------------------------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCC
Q 042371 239 QTH----------------------------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTG 290 (400)
Q Consensus 239 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 290 (400)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 0112357889999999998899999999999999999999999995332
Q ss_pred CccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 042371 291 SKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT----MKEVAME 354 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ell~~ 354 (400)
... .+ .. ..............+..+.+++.+||+.+|.+||| +.+++.+
T Consensus 237 ~~~-----~~-~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDE-----TF-SN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHH-----HH-HH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 211 00 00 01111111111225667999999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=296.22 Aligned_cols=239 Identities=24% Similarity=0.416 Sum_probs=188.4
Q ss_pred ceeeecCcEEEEEEEecC-------------CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 89 RILGQGGQGTVYKGMLAD-------------GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
+.||+|+||.||+|...+ ...+++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998432 2358888876655555667888999999999999999999999988999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-------EEEEe
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT-------AKVAD 228 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-------~kl~D 228 (400)
+||||+++++|..++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988865432 4899999999999999999999999 999999999999987654 89999
Q ss_pred cCCccccccCCceeeecccccCCCCCccccc-cCCCCCcchhHHHHHHHHHHH-hCCCCCCcCCCccccchHHHHHHHhh
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR-SGQFTDKSDVYSFGVVLVELL-TGQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+. ....
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--------~~~~ 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--------ERFY 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------HHHH
Confidence 9998654221 2234788899999887 467899999999999999998 58888743221110 0000
Q ss_pred hcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 307 ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
.... . ........+.+++.+||+.||.+||++.+|++.|
T Consensus 223 ~~~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcCc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1100 0 0111235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=299.61 Aligned_cols=246 Identities=29% Similarity=0.485 Sum_probs=197.9
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
++|++.+.||+|+||.||++.. .++.+|+|..... .....+.+|+.+++.++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4689999999999999999875 5778999987543 2346788999999999999999999998764 4799999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999976543 24889999999999999999999998 999999999999999999999999998653211
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||....... . ........ ...
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~---------~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------V-KECVEKGY---------RME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------H-HHHHhCCC---------CCC
Confidence 122234568999999998899999999999999999998 999985433211 0 11111110 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.....+..+.+++.+||+.+|.+|||++++++.|+
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 12234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.20 Aligned_cols=237 Identities=26% Similarity=0.347 Sum_probs=187.0
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHH-HHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|... +++.||+|.+... .......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5889999987532 1223344555554 57888999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
++|...+.... .+++..+..++.||+.||.|||..+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETT 153 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcc
Confidence 99998886543 4888899999999999999999999 999999999999999999999999998753221 2223
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ....... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~-~~i~~~~----------~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMY-DNILHKP----------LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHH-HHHhcCC----------CCCC
Confidence 3456899999999999989999999999999999999999999543211 111 1111110 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMK 349 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~ 349 (400)
...+..+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23345688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=302.57 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=199.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46899999999999999999975 58899999765432 2234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|..++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988887765433 4899999999999999999999999 9999999999999999999999999997654322
Q ss_pred ceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH--------hhhccc
Q 042371 240 THVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS--------MEENRL 310 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~ 310 (400)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+........... ......
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1 2223457889999999876 46889999999999999999999999543322110000000000 000000
Q ss_pred c---cccchhhh---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 Y---DFLDDQVL---KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~---~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ........ .......+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 00000000 00011235678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.32 Aligned_cols=265 Identities=26% Similarity=0.408 Sum_probs=206.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357899999999999999999964 58889999765432 3345788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
|+++++|.+++.... ++++..+..++.+++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999887643 58999999999999999999997 46 999999999999999999999999998654221
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||................... +........
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 230 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL----LQQIVQEPP 230 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH----HHHHhhccC
Confidence 1223468999999999988899999999999999999999999996543321100000000000 000000000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
........+..+.+++.+||+.||.+|||+.|++++..-++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01111224567899999999999999999999999754444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=301.19 Aligned_cols=256 Identities=26% Similarity=0.459 Sum_probs=203.1
Q ss_pred cCCcccceeeecCcEEEEEEEecC-Cc----EEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLAD-GR----IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~-~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.+|++.+.||+|+||.||+|..++ +. .+|+|...... ......+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568899999999999999998642 32 58999766443 3445778899999999999999999999887 77899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999976543 4899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCceee-ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 237 IDQTHVT-TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 237 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
....... ....++..|+|||.+....++.++|+||||+++|++++ |..||....... . ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~----- 228 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------I-PDLLEKGE----- 228 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------H-HHHHhCCC-----
Confidence 3222111 11223568999999988899999999999999999998 999985432211 1 11111110
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
....+...+..+.+++.+||..+|.+|||+.++++.|.++..
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 ----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011111233458899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=320.01 Aligned_cols=256 Identities=24% Similarity=0.415 Sum_probs=214.0
Q ss_pred cCCcccceeeecCcEEEEEEEec--CCc--EEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA--DGR--IVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~--~~~--~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
+..++.++||+|.||.|++|.|. +|+ .||||.++..... ....|++|+.+|.+|+|+|++++||+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 44567789999999999999975 344 5899998876554 67899999999999999999999999988 667899
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
||.++.|+|.+.|+. .....+.......++.||+.||.||..++ +|||||...|+|+-....|||+|||+.+.+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999998 33446889999999999999999999999 99999999999999999999999999998875
Q ss_pred CCceeeec--ccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 238 DQTHVTTK--VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 238 ~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
+....... ..-...|+|||.+....++.++|||+|||++|||++ |..||..-.. ..+.+.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQILKNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHHHhc
Confidence 54443221 224668999999999999999999999999999999 8889832211 1223344
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
|.+-+...+..+++.+++++.+||..+|.+|||+..|.+.+-...
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 555555667788999999999999999999999999986554433
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=303.30 Aligned_cols=247 Identities=27% Similarity=0.432 Sum_probs=200.3
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4677888999999999999864 57889999876432 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++... .+++..++.++.|++.|+.|||..+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-h
Confidence 999999988642 4889999999999999999999998 9999999999999999999999999997654221 1
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ....... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~---------~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFLIPKN---------SPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------HhhhhcC---------CCCC
Confidence 12234578899999999988999999999999999999999999853221110 0000000 0111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....+..+.+++.+||+.+|.+|||+.+++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 122345668999999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=302.37 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=201.9
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|++.+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5889999999999999999964 68899999876543 34457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+ +++|.+++.... .++++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987644 35899999999999999999999999 99999999999999999999999999986643332
Q ss_pred eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc---cc---ccc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN---RL---YDF 313 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~---~~~ 313 (400)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||........ ........... .+ ...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence 223345689999999998654 468999999999999999999888743322110 00000000000 00 000
Q ss_pred cc--------h--hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LD--------D--QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~--------~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+ . ..........+..+.+++.+||+.+|++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0 00001112234778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=299.39 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=200.6
Q ss_pred CCcccceeeecCcEEEEEEEecC--CcEEEEEEcccc----------CchhHHHHHHHHHHHHh-CCCCcceeeeeEEee
Q 042371 84 HFNVNRILGQGGQGTVYKGMLAD--GRIVAVKKSKIV----------HEGKLEEFINEVVILSQ-INHRNVVKLLGCCLE 150 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~~--~~~vaiK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~ 150 (400)
+|++.+.||+|+||.||+|.... ++.+|+|.+... .......+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999754 678999976432 22344567788888865 799999999999999
Q ss_pred CCcceEEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCcEEEEe
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKYTAKVAD 228 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~D 228 (400)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||. .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 223358999999999999999999996 66 99999999999999999999999
Q ss_pred cCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... . .......
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~-~~~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------L-ATKIVEA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------H-HHHHhhc
Confidence 99997654322 3344568899999999998889999999999999999999999985332111 0 0111111
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
... .......+..+.+++.+||+.||++|||+.|+.++|.
T Consensus 229 ~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 110 0011123456899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=295.82 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=205.4
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|++.+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++|+|++++++.+......++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46899999999999999999964 57889999876432 23567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++........+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999987543335899999999999999999999999 99999999999999999999999999876653322
Q ss_pred e---eeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 241 H---VTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 241 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
. ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||....... .... ..... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~-~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----VLML-TLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----hHHH-HhcCC------CC
Confidence 2 22334588999999998876 78999999999999999999999985332211 0000 00000 00
Q ss_pred hhhcc-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKV-GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..... .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 112455678999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=298.15 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=195.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-----chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--Ccc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-----EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVP 154 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 154 (400)
.+|+..+.||+|+||.||+|... .+..+|+|.+.... ......+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46899999999999999999864 58899999765322 22356788899999999999999999988753 567
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++++||+++++|.+++.... .+++...+.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997644 4789999999999999999999998 99999999999999999999999999875
Q ss_pred cccCC--ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 235 IVIDQ--THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 235 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
..... ........++..|+|||.+.+..++.++||||+||++|+|++|+.||....... .. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~--~~~~~~---- 224 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AI--FKIATQ---- 224 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HH--HHHhcC----
Confidence 43211 111123457889999999998889999999999999999999999995321110 00 000000
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+....+.+.+++ +||..+|.+|||+.+++.+
T Consensus 225 ----~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 225 ----PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ----CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 001111233445577787 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=311.63 Aligned_cols=266 Identities=24% Similarity=0.375 Sum_probs=215.6
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchh-HHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGK-LEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
...+...+.++||+|-||.|.++...++.+||+|.++...... ...|.+|+.+|.+++||||++++++|..++.+++++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3456778899999999999999998888999999988765444 489999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|..++.++.... +.-.....|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+|||+++.+...
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999875432 344456679999999999999999 999999999999999999999999999976554
Q ss_pred Cceee-ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 239 QTHVT-TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT--GQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 239 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
..... ...+-...|||||.+..++++.+||+|+||+++||+++ ...||.....+. ........... ..
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~------~~ 761 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRD------QG 761 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCC------CC
Confidence 44332 23345779999999999999999999999999999887 677874333221 11111111111 11
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
.......+..++..+.+++.+||+.+-.+|||++++...|.+.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1222344667778899999999999999999999999988764
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=334.56 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=199.2
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--Ccc
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVP 154 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 154 (400)
...++|.+.+.||+|+||.||++... .+..+|+|.+... .......+..|+.++..++||||++++++|.+. ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44578999999999999999999965 4678999977643 344567788999999999999999999988654 468
Q ss_pred eEEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCCeEEcC---------
Q 042371 155 LLVYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAAS----MPIYHRDIKSTNILLNE--------- 220 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~iiHrDikp~NIll~~--------- 220 (400)
||||||+++++|.++|.... ....+++..++.|+.||+.||.|||..+. .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997632 22359999999999999999999998541 23999999999999964
Q ss_pred --------CCcEEEEecCCccccccCCceeeecccccCCCCCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCcCC
Q 042371 221 --------KYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS--GQFTDKSDVYSFGVVLVELLTGQKPIILTG 290 (400)
Q Consensus 221 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~ 290 (400)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||+||+|++|..||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 235899999999765322 22234568999999999854 458999999999999999999999995332
Q ss_pred CccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 291 SKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. ... ........ . ......+..+.+||.+||+.+|.+|||+.+++.+
T Consensus 248 ~~-----~ql-i~~lk~~p--~--------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 NF-----SQL-ISELKRGP--D--------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cH-----HHH-HHHHhcCC--C--------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 21 111 11111110 0 0011234568999999999999999999999964
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.83 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=199.8
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEee----
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLE---- 150 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~---- 150 (400)
+.....+.|++.+.||.|+||.||+|... +++.+|+|..... ......+..|+.+++.+ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 33445678999999999999999999964 5788999977543 23445678899999998 69999999999853
Q ss_pred --CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEe
Q 042371 151 --TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVAD 228 (400)
Q Consensus 151 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D 228 (400)
....+++|||+++|+|.+++...... .+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEee
Confidence 34678999999999999998764432 4788889999999999999999999 99999999999999999999999
Q ss_pred cCCccccccCCceeeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 303 (400)
||++....... .......|++.|+|||.+. ...++.++|||||||++|+|++|..||........ ..
T Consensus 165 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-----~~-- 236 (282)
T cd06636 165 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-----LF-- 236 (282)
T ss_pred Ccchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-----hh--
Confidence 99987543211 1223355889999999875 34688899999999999999999999853321110 00
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.... ...........+..+.+++.+||+.||.+|||+.+++++
T Consensus 237 ~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 LIPR--------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hHhh--------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0000 000111122345679999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=296.57 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=190.5
Q ss_pred ceeeecCcEEEEEEEecC---CcEEEEEEccccCc-hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCC
Q 042371 89 RILGQGGQGTVYKGMLAD---GRIVAVKKSKIVHE-GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
+.||+|+||.||+|...+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998543 45789998765432 33457888999999999999999999999988999999999999
Q ss_pred CHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 165 TLFQYLHDQNE--EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 165 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+|.+++..... ....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 224567788889999999999999999 9999999999999999999999999987543221111
Q ss_pred -eecccccCCCCCccccccC-------CCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 243 -TTKVQGTFGYLDPEYFRSG-------QFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 243 -~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.....++..|+|||++.+. .++.++||||||+++|+|++ |+.||........ ... .. ......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TV-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hh-hcccCCC
Confidence 1234467889999998642 35789999999999999996 9999954322111 000 00 0111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
..+.. ....+..+.+++.+|| .+|.+|||+++|+..|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1123345788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=297.38 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=197.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-----chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--Ccc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-----EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVP 154 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 154 (400)
.+|++.+.||+|+||.||.|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999965 58899999765321 23356788899999999999999999988764 457
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987653 4788889999999999999999999 99999999999999999999999999875
Q ss_pred cccCCc--eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 235 IVIDQT--HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 235 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .. .. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~-~~-~~~~---- 224 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AI-FK-IATQ---- 224 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HH-HH-HhcC----
Confidence 432111 11223458889999999988889999999999999999999999985321110 00 00 0000
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+...+..+.+++.+||. +|.+|||+++++++
T Consensus 225 ----~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 ----PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 01112234556678899999994 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=318.45 Aligned_cols=244 Identities=29% Similarity=0.453 Sum_probs=206.2
Q ss_pred eeeecCcEEEEEEEecC-CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCHHH
Q 042371 90 ILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQ 168 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 168 (400)
+||+|.||+||.|++.+ ...+|||.+...+....+-+..|+..-++++|.|||+++|.+.+++.+-|.||-.+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999765 55689998887777778889999999999999999999999999998889999999999999
Q ss_pred HHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCcEEEEecCCccccccCCceeeec
Q 042371 169 YLHDQNEEFPL--TWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIVIDQTHVTTK 245 (400)
Q Consensus 169 ~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~ 245 (400)
+++..=+ |+ .+...-.+.+||++||.|||.+. |||||||-+||||+ -.|.+||+|||.++.+.. -...+.+
T Consensus 662 LLrskWG--PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 662 LLRSKWG--PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHHhccC--CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 9987432 45 77888889999999999999999 99999999999997 578999999999987642 2344556
Q ss_pred ccccCCCCCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 246 VQGTFGYLDPEYFRSGQ--FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 246 ~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
+.||.-|||||++..++ |+.++|||||||++.||.||++||...+.... .+. ..+ --..-...+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMF-----kVG------myKvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMF-----KVG------MYKVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhh-----hhc------ceecCCCCc
Confidence 77999999999998764 88999999999999999999999966554321 111 111 112234567
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMKEVAM 353 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 353 (400)
...+++.+.||.+|+.++|.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 788899999999999999999999999986
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=302.86 Aligned_cols=262 Identities=22% Similarity=0.322 Sum_probs=197.0
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|++.+.||+|+||.||+|... +|..+|+|.+.... ......+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888999999999999999975 58899999876432 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
++ ++|.+++..... .+++..++.++.||+.||.|||..+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 97 478887765432 4899999999999999999999999 9999999999999999999999999997653222
Q ss_pred eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh-------------
Q 042371 241 HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME------------- 306 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------- 306 (400)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..|+........ .+.. ......
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKR-IFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHH-HHHHhCCCChHHhHHhhhc
Confidence 122334578899999998764 478999999999999999999998643322111 0000 000000
Q ss_pred -hc-ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 307 -EN-RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 307 -~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. ..................++.+.+++.+||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 0000000000011112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=302.47 Aligned_cols=266 Identities=24% Similarity=0.306 Sum_probs=201.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999975 5789999977643 23345788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|++++.+..+..... .+++..++.++.+|+.||.|||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877766554332 4899999999999999999999999 9999999999999999999999999998765433
Q ss_pred ceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh---------hc-
Q 042371 240 THVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME---------EN- 308 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------~~- 308 (400)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+............. ..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3233445678899999999888 889999999999999999999999854322110000000000000 00
Q ss_pred ----ccccccchh-hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 309 ----RLYDFLDDQ-VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 309 ----~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......... .....+...+..+.+++.+||+.+|.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000000 0001122236779999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=304.61 Aligned_cols=257 Identities=27% Similarity=0.496 Sum_probs=200.1
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCc----EEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGR----IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
++|+..+.||+|+||.||+|.+. ++. .+|+|.+.... ......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56788899999999999999864 343 57888765432 23345688999999999999999999988654 4679
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
+++|+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999876543 4789999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 237 IDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 237 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~---- 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IP----DLLEKGER---- 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHCCCC----
Confidence 22221 1122335678999999998999999999999999999997 899984332111 10 11111100
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
...+...+..+.+++.+||..+|++||++.++++.|+.+...
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 -----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001112334688999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=296.76 Aligned_cols=253 Identities=24% Similarity=0.424 Sum_probs=201.8
Q ss_pred CCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC------chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 84 HFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH------EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
+|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999985 468899999876432 1235678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-cEEEEecCCcccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKFI 235 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~Dfgla~~~ 235 (400)
||||+++++|.+++.... ++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997644 5889999999999999999999999 99999999999998776 6999999998765
Q ss_pred ccCCc---eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 236 VIDQT---HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 236 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
..... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||........ .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~------ 225 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIAS------ 225 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhc------
Confidence 43211 112234578899999999888899999999999999999999999853322111 110000000
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+...+..+.+++.+||..+|.+|||+.+++.+
T Consensus 226 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 226 ---ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 001122334456778999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=315.08 Aligned_cols=241 Identities=26% Similarity=0.320 Sum_probs=187.1
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC---CCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 91 LGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI---NHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 91 lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
||+|+||.||+|... +++.||+|.+... ..........|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 5889999987532 122334455677776655 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~ 153 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTT 153 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCc
Confidence 99999887643 4899999999999999999999999 999999999999999999999999998753222 2223
Q ss_pred ecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccC
Q 042371 244 TKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (400)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+ ........ .+ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----~~--~~i~~~~~-~~--------~ 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MY--RNIAFGKV-RF--------P 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-----HH--HHHHcCCC-CC--------C
Confidence 345689999999998754 48999999999999999999999995432111 00 11111100 00 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 042371 323 QKEEIMTIATLATRCLNLNGKRRP----TMKEVAME 354 (400)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dP~~RP----t~~ell~~ 354 (400)
....+..+.+++.+||+.||.+|| ++.+++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 112345688999999999999998 56666664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=304.55 Aligned_cols=196 Identities=25% Similarity=0.405 Sum_probs=158.8
Q ss_pred cceeeecCcEEEEEEEec---CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEee--CCcceEEEEccC
Q 042371 88 NRILGQGGQGTVYKGMLA---DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIS 162 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 162 (400)
..+||+|+||.||+|... .+..+|+|.+... .....+.+|+.+++.++||||+++++++.. ....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999964 3578999977543 223467789999999999999999998854 456789999996
Q ss_pred CCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCcEEEEecCCc
Q 042371 163 NGTLFQYLHDQN------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL----NEKYTAKVADFGTS 232 (400)
Q Consensus 163 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll----~~~~~~kl~Dfgla 232 (400)
+ +|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7877775321 1234889999999999999999999999 9999999999999 55679999999999
Q ss_pred cccccCCc--eeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcC
Q 042371 233 KFIVIDQT--HVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILT 289 (400)
Q Consensus 233 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~ 289 (400)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 86543221 12234568999999999876 45899999999999999999999999543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=300.00 Aligned_cols=239 Identities=24% Similarity=0.405 Sum_probs=186.7
Q ss_pred eeeecCcEEEEEEEecC-------------------------CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceee
Q 042371 90 ILGQGGQGTVYKGMLAD-------------------------GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKL 144 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 144 (400)
.||+|+||.||+|.... ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999987421 13588888765545555678889999999999999999
Q ss_pred eeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC--
Q 042371 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-- 222 (400)
Q Consensus 145 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-- 222 (400)
++++......++||||+++|+|..++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998875433 4889999999999999999999998 99999999999997643
Q ss_pred -----cEEEEecCCccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHH-hCCCCCCcCCCcccc
Q 042371 223 -----TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELL-TGQKPIILTGSKEAT 295 (400)
Q Consensus 223 -----~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell-tg~~pf~~~~~~~~~ 295 (400)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|+|+ +|..||........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 4899999988643211 12346788999998875 56899999999999999985 69999854322111
Q ss_pred chHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 296 GLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
... .... ...+......+.+++.+||+.+|.+|||+.++++.|.
T Consensus 231 --~~~----~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ERF----YEKK-----------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHH----HHhc-----------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 000 0000 0001112245889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=309.63 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=200.7
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccc--cCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcce
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKI--VHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 155 (400)
......|++.+.||+||.+.||++...+.+.+|+|++.. .+.....-|.+|+..|.+| .|.+|++++++-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 345678999999999999999999988888899987654 4556688999999999999 4999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||- ..+|..+|+..... ++.-.++.+..||+.|+.++|..| |||.||||.|+|+-.. .+||+|||.|..+
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAI 509 (677)
T ss_pred EEeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhccc
Confidence 999987 46999999876643 332367788999999999999999 9999999999999864 9999999999887
Q ss_pred ccCCce-eeecccccCCCCCccccccCC-----------CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH
Q 042371 236 VIDQTH-VTTKVQGTFGYLDPEYFRSGQ-----------FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 236 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 303 (400)
..+... .....+||+.||+||++.... .+.++||||||||||+|+.|+.||..-.. .+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~--- 579 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QI--- 579 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HH---
Confidence 654433 344578999999999985432 45789999999999999999999932111 11
Q ss_pred HhhhcccccccchhhhccCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 304 SMEENRLYDFLDDQVLKVGQK-EEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.++..+.++....+.+. ....++.++++.||++||.+|||+.+||++
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12222222211111110 001128899999999999999999999986
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=295.38 Aligned_cols=237 Identities=26% Similarity=0.492 Sum_probs=188.1
Q ss_pred ceeeecCcEEEEEEEecCCc-----------EEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 89 RILGQGGQGTVYKGMLADGR-----------IVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~-----------~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
+.||+|+||.||+|...+.. .+++|........ ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999975432 5777765543332 6788899999999999999999999888 778999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-------cEEEEecC
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-------TAKVADFG 230 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-------~~kl~Dfg 230 (400)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999986543 4889999999999999999999999 99999999999999887 79999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccC--CCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhh
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG--QFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEE 307 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 307 (400)
++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||........ ... ....
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~---~~~~ 222 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERF---YQDQ 222 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHH---HhcC
Confidence 9976432 2233467789999998876 78999999999999999999 5777744321110 000 0000
Q ss_pred cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
... +......+.+++.+||..+|.+|||+.++++.|
T Consensus 223 ~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 223 HRL------------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCC------------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 000115688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=296.00 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=202.4
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999854 6889999987643 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999999876432 24789999999999999999999998 9999999999999999999999999997653221
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
.......|++.|+|||++.+..++.++|+||||+++|+|++|+.||......+ . ......+.. .
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~-~~~~~~~~~---------~ 219 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------L-VLKIIRGSY---------P 219 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------H-HHHHhcCCC---------C
Confidence 11223457889999999998899999999999999999999999985332111 0 011111111 1
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122345668999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=298.25 Aligned_cols=249 Identities=32% Similarity=0.478 Sum_probs=195.8
Q ss_pred ceeeecCcEEEEEEEecC-------CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 89 RILGQGGQGTVYKGMLAD-------GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2578999765432 34466788999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-----cEEEEecCC
Q 042371 161 ISNGTLFQYLHDQN----EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-----TAKVADFGT 231 (400)
Q Consensus 161 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-----~~kl~Dfgl 231 (400)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 1224788999999999999999999998 99999999999999877 899999999
Q ss_pred ccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 232 SKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 232 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
+......... ......++..|+|||++.++.++.++||||||+++|+|++ |..||....... ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQ----HVTAG- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHH----HHhcC-
Confidence 8765322111 1112335678999999999999999999999999999998 999985332111 100 00010
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.....+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 011122334567899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=300.62 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=196.9
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc-hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE-GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367999999999999999999965 688999998764322 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+.+ +|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9975 99998876543 4889999999999999999999999 9999999999999999999999999987543211
Q ss_pred ceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh---hccccc---
Q 042371 240 THVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME---ENRLYD--- 312 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 312 (400)
.......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||........ .... ...... ...+..
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHK-IFRVLGTPTEETWPGVSS 234 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHH-HHHhcCCCChhhhhhhhh
Confidence 11122346889999999875 4689999999999999999999999954331110 0000 000000 000000
Q ss_pred ----------ccchhhhccCCHHH--HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 ----------FLDDQVLKVGQKEE--IMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ----------~~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.............. ...+.+++.+||+.+|.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000000011 2567899999999999999999998863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=295.76 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=201.3
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEee--CCcceEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVY 158 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 158 (400)
+|++.+.||.|+||.||++... ++..+|+|.+... .....+.+..|+.+++.++|+||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788999999999999999854 6788999977542 34445678899999999999999999998764 34578999
Q ss_pred EccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 159 EFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLH-----SAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 159 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
||+++++|.+++... ....++++..++.++.||+.||.||| ..+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999763 22336899999999999999999999 666 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... . .........
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~--- 226 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---Q----LASKIKEGK--- 226 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---H----HHHHHhcCC---
Confidence 87643221 123456899999999999888999999999999999999999998543211 0 011111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+...+..+.+++.+||+.+|.+|||+.+|+++
T Consensus 227 ------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112233445678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=299.63 Aligned_cols=240 Identities=24% Similarity=0.430 Sum_probs=188.8
Q ss_pred ceeeecCcEEEEEEEecC--------CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 89 RILGQGGQGTVYKGMLAD--------GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+.||+|+||.||+|.... ...+|+|..........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998542 234888876554455567888999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--------EEEEecCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT--------AKVADFGTS 232 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~--------~kl~Dfgla 232 (400)
+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999976543 4889999999999999999999999 999999999999987764 699999988
Q ss_pred cccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCC-CCCCcCCCccccchHHHHHHHhhhccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQ-KPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
..... .....++..|+|||++.+. .++.++||||||+++|+|++|. .||....... . .......
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~--~~~~~~~- 221 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------K--LQFYEDR- 221 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------H--HHHHHcc-
Confidence 65421 2234578899999999864 5899999999999999999985 5553221111 0 0000000
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
...+......+.+++.+||+.||.+|||++++++.|+
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111122356889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=295.24 Aligned_cols=253 Identities=26% Similarity=0.321 Sum_probs=188.8
Q ss_pred ceeeecCcEEEEEEEecC---CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCC
Q 042371 89 RILGQGGQGTVYKGMLAD---GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 3568888765432 333567789999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce-
Q 042371 165 TLFQYLHDQNE--EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH- 241 (400)
Q Consensus 165 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 241 (400)
+|.+++..... ....++...+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 123467788899999999999999999 999999999999999999999999998653222111
Q ss_pred eeecccccCCCCCcccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 242 VTTKVQGTFGYLDPEYFRS-------GQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
......+++.|+|||++.. ..++.++|||||||++|+|++ |..||....... . ...... .....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~-~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V---LKQVVR-EQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHhh-ccCccC
Confidence 1122345678999998743 356889999999999999999 788885332111 0 000011 111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
..+ ......+..+.+++..|| .||.+|||+++|++.|.
T Consensus 231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 112234456778999998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=297.76 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=200.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46899999999999999999965 5889999976532 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999997653 5899999999999999999999999 999999999999999999999999999865432
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||...... .... ......
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~--~~~~~~--------- 214 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-----QIYE--KILEGK--------- 214 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH--HHhcCC---------
Confidence 23446899999999998888999999999999999999999998543311 0000 000100
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
...+...+..+.+++.+||..||.+|+ ++.+++++
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 011122346688999999999999998 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=301.84 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=199.3
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|++.+.||+|+||.||+|... +++.+|+|...... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999975 58899999765422 2235667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|..+..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999998888765432 4899999999999999999999998 9999999999999999999999999987653322
Q ss_pred ceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH--------HHHhhhc--
Q 042371 240 THVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF--------ILSMEEN-- 308 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~-- 308 (400)
.......++..|+|||++.+ ..++.++||||||+++|+|++|++||............... .......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22233457889999999875 45788999999999999999999998533221100000000 0000000
Q ss_pred ----ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 309 ----RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 309 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..................+..+.+++.+||+.+|.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000001112345679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=299.99 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=204.1
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67999999999999999999854 67889999876555555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999998653 3788899999999999999999999 99999999999999999999999998875543222
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
......+++.|+|||.+....++.++|+||||+++|++++|+.||........... .... ......
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-------~~~~-------~~~~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATN-------GTPELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-------hhcC-------CCCCCC
Confidence 22234578899999999888899999999999999999999999954322110000 0000 000011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122345668899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=300.61 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=200.4
Q ss_pred HHHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEe----
Q 042371 76 KELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCL---- 149 (400)
Q Consensus 76 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~---- 149 (400)
+.+....++|++.+.||+|+||.||++... +++.+|+|...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 344556789999999999999999999864 57899999765422 2235677899999999 6999999999874
Q ss_pred -eCCcceEEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEE
Q 042371 150 -ETEVPLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVA 227 (400)
Q Consensus 150 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~ 227 (400)
..+..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 334689999999999999988642 22235889999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCceeeecccccCCCCCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH
Q 042371 228 DFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS-----GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 228 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 302 (400)
|||++....... .......|++.|+|||++.. ..++.++||||+||++|+|++|+.||....... ..
T Consensus 167 dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~~-- 238 (286)
T cd06638 167 DFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----AL-- 238 (286)
T ss_pred cCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----HH--
Confidence 999987653221 12233468999999998753 457889999999999999999999985432111 00
Q ss_pred HHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 303 LSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
........... ..+...+..+.+++.+||+.||.+|||+.++++++
T Consensus 239 ~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FKIPRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hhccccCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000000000 01112345688999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=297.58 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=203.7
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|++.+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999975 58899999876543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997653 258999999999999999999999 88 9999999999999999999999999987653221
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|..||......... ......... ... .
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~-~~~---------~ 221 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIV-NEP---------P 221 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHh-cCC---------C
Confidence 11 156889999999999989999999999999999999999998544321111 111111110 000 0
Q ss_pred ccCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 320 KVGQK-EEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 320 ~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+. ..+..+.++|.+||..+|.+|||+.+++.+
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01111 156679999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=295.50 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=201.3
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc--hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE--GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|.+.+.||+|+||.||+|... +++.+++|.+..... .....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 688999998765444 3678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++.... .+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999987643 4788999999999999999999999 99999999999999999999999999987643322
Q ss_pred eee---ecccccCCCCCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 241 HVT---TKVQGTFGYLDPEYFRSGQ---FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 241 ~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
... ....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...+. ........+
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~---~~~~~~~~~- 227 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFH---VGAGHKPPI- 227 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHH---HhcCCCCCC-
Confidence 211 1345788999999998766 8899999999999999999999995332111 00000 000100000
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAM 353 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 353 (400)
......+..+.+++.+||+.+|.+|||+.+++.
T Consensus 228 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 ------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011123556889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=298.45 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=200.2
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCC------
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETE------ 152 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~------ 152 (400)
..++|++.+.||+|+||.||+|..+ +++.+++|....... ..+.+.+|+.+++.+ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999975 578899998765433 346788999999999 6999999999987654
Q ss_pred cceEEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 153 VPLLVYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 3799999999999999987532 1235899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccCCCCCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRS-----GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
+....... .......|++.|+|||.+.. ..++.++||||||+++|+|++|+.||....... . .....
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~--~~~~~ 231 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-----A--LFKIP 231 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-----H--HHHhh
Confidence 87643222 22233558899999998754 347789999999999999999999995322110 0 01111
Q ss_pred hcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 307 ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...... ...+...+..+.+++.+||..||++|||+.+++++
T Consensus 232 ~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RNPPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ccCCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111100 11122356679999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.70 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=206.7
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc-hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE-GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|++.+.||+|++|.||+|... +++.+++|++..... .....+.+|+.++..++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36889999999999999999976 489999998765443 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
+++++|.+++.... ++++..++.++.|++.||.|||. .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999997653 58999999999999999999999 99 9999999999999999999999999998654322
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ....... .
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~~~~~~---------~ 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QAICDGP---------P 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HHHhcCC---------C
Confidence 22 22445789999999999989999999999999999999999998554321111111 1111110 0
Q ss_pred ccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 320 KVGQKE-EIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 320 ~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+.. .+..+.+++.+||+.+|.+|||+.+++++
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111222 55679999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=293.45 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=200.7
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.+++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 5788999987543 334567888999999999999999999999988999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CcEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~Dfgla~~~~~~~ 239 (400)
+++++|.+++..... ..+++..++.++.+++.+|.|||+.+ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999976432 24899999999999999999999999 9999999999999865 468999999998654322
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .. .........
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~-~~~~~~~~~-------- 219 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LV-LKIMSGTFA-------- 219 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HH-HHHHhcCCC--------
Confidence 2223457889999999998889999999999999999999999985432211 00 111111111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 220 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 -PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112245568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=332.27 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=214.0
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE 152 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 152 (400)
++....++|.+.++||+|+||.|..++.+ .++.||+|++.. ........|..|-++|..-+.+.|+.++-.|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 44556689999999999999999999965 588999997764 44556678889999999999999999999999999
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
.+|+||||++||+|..++.... ++++..+..++..|..||..||+.| +|||||||+|||+|..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999998766 5999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCccccc----c-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFR----S-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 307 (400)
-.+..+..-.....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||.... ++.-....+..
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~h 296 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNH 296 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhch
Confidence 887766666777788999999999985 2 579999999999999999999999994332 22222222222
Q ss_pred cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 042371 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT---MKEVAME 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~~ 354 (400)
.....+++ ..+.++...+||.+.+ -+|+.|.. ++++..|
T Consensus 297 k~~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 297 KESLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhhcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 22222221 2346777899998888 67778877 7777665
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=296.46 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=199.0
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc----------hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE----------GKLEEFINEVVILSQINHRNVVKLLGCCLETE 152 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 152 (400)
+|.+.+.||.|+||.||+|... +++.+|+|.+..... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788899999999999999864 588999997653211 12346788999999999999999999999999
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999997653 5899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCc-eeeecccccCCCCCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 233 KFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQ--FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 233 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
........ .......|+..|+|||.+.... ++.++|+||||+++|+|++|..||...... ..... .. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~-~~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFK-LG-NKR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHH-hh-ccc
Confidence 75432111 1123355788999999987654 889999999999999999999998432211 11110 00 000
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+. .......+..+.+++.+||+.+|.+|||+.+++++
T Consensus 229 ~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000011 11122345679999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=297.30 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=194.2
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHH-HHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVI-LSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|++.+.||+|+||.||++... +|+.||+|.+.... ......+..|+.+ ++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999965 58999999876432 2233455566665 566789999999999999999999999
Q ss_pred ccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 160 FISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 160 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|++ ++|.+++... .....+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888887653 2234689999999999999999999987 7 99999999999999999999999999876532
Q ss_pred CCceeeecccccCCCCCcccccc----CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRS----GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... .... .... ......
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~-~~~~-~~~~~~- 227 (283)
T cd06617 157 S--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQL-KQVV-EEPSPQ- 227 (283)
T ss_pred c--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHH-HHHH-hcCCCC-
Confidence 1 12223457889999998865 45788999999999999999999998532211 0000 0000 000000
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+..+.+++.+||+.+|.+|||+.+++++
T Consensus 228 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 -------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112245678999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=300.97 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=199.8
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
.|.....||.|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999864 588999998766555566778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ..
T Consensus 103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 174 (292)
T cd06658 103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PK 174 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-cc
Confidence 99999988543 3789999999999999999999999 9999999999999999999999999987543222 12
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccC
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (400)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .. .... ... .... ..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~--~~~~-~~~----~~~~--~~ 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AM--RRIR-DNL----PPRV--KD 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HH--HHHH-hcC----CCcc--cc
Confidence 233458899999999998899999999999999999999999985332111 00 0000 000 0000 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+..+.+++.+||..||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=293.33 Aligned_cols=263 Identities=25% Similarity=0.309 Sum_probs=202.7
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--CcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 158 (400)
++|...+.||.|++|.||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36888999999999999999975 57889999876432 23456789999999999999999999988654 3689999
Q ss_pred EccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 159 EFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 159 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
||+++++|.+++... .....+++..+..++.||+.||.|||..+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987642 22335889999999999999999999999 99999999999999999999999999875432
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......... .... ..........+.+.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~- 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP-IELL-SYIVNMPNPELKDE- 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh-HHHH-HHHhcCCchhhccC-
Confidence 11 123457889999999999999999999999999999999999996553311111 1111 11111011111100
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.......++.+.+++.+||+.+|.+|||+.|++++-.
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 232 --PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred --CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0111234567899999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=301.46 Aligned_cols=248 Identities=26% Similarity=0.387 Sum_probs=199.3
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
|.....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|||++++++.+...+..+++|||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344557999999999999864 6889999987655555567788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
++|..++... .+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....... ...
T Consensus 103 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 103 GALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 9999987542 3889999999999999999999999 9999999999999999999999999987543222 222
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ........ .. .....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~-~~------~~~~~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLRDSP-PP------KLKNA 240 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhccC-CC------Ccccc
Confidence 335689999999999988999999999999999999999999854322110 00110000 00 00011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1234568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.24 Aligned_cols=255 Identities=30% Similarity=0.490 Sum_probs=197.6
Q ss_pred CcccceeeecCcEEEEEEEec----CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC------
Q 042371 85 FNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE------ 152 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 152 (400)
|.+.+.||+|+||.||+|... .+..+|+|.+... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999853 3678999977643 3345677889999999999999999999886532
Q ss_pred cceEEEEccCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEec
Q 042371 153 VPLLVYEFISNGTLFQYLHDQN---EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADF 229 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Df 229 (400)
..+++++|+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2468899999999998875321 2234788999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhh
Q 042371 230 GTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEE 307 (400)
Q Consensus 230 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 307 (400)
|+++........ ......+++.|++||.+.+..++.++||||||+++|+|++ |++||....... . ... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~---~~~-~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I---YNY-LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H---HHH-HHc
Confidence 999865332211 1122335678999999998899999999999999999999 889985332211 0 000 001
Q ss_pred cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
... ...+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 231 ~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 001123345799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=295.01 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=200.2
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
-|++.+.||+|+||.||+|... ++..+|+|...... ......+.+|+.++..++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4778899999999999999864 67899999765432 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++... .+++..+..++.+++.|+.+||..+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-h
Confidence 999999988643 4889999999999999999999999 9999999999999999999999999987653221 1
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ......... ...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNN---------PPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCC---------CCC
Confidence 2223457889999999988889999999999999999999999984322110 001111110 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....+..+.+++.+||+.+|.+||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122345668899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=291.13 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=188.0
Q ss_pred ceeeecCcEEEEEEEecCC---cEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCC
Q 042371 89 RILGQGGQGTVYKGMLADG---RIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
+.||+|+||.||++...++ ..+++|...... ......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 346677655432 344678899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC-cee
Q 042371 165 TLFQYLHDQNE-EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ-THV 242 (400)
Q Consensus 165 ~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~-~~~ 242 (400)
+|.+++..... ...++...++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 224677778899999999999999999 9999999999999999999999999986432111 112
Q ss_pred eecccccCCCCCcccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 243 TTKVQGTFGYLDPEYFRS-------GQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
.....++..|+|||++.. ..++.++||||||+++|+|++ |..||......+ ...... ........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~-~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVI-KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-hhcccccC
Confidence 233457889999998753 245789999999999999997 567874322111 001111 11111122
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
++.. ....+..+.+++..|| .+|.+|||+++|++.|.
T Consensus 231 ~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2211 1124456888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.41 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=199.2
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||++... .++.|++|.+.... ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999965 47889999776432 234567789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||++|++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997653 5899999999999999999999998 999999999999999999999999998642110
Q ss_pred C--------------ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH
Q 042371 239 Q--------------THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS 304 (400)
Q Consensus 239 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 304 (400)
. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence 0 00111245788999999998889999999999999999999999998532211 011110
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
. ..... . .......+..+.+++.+||+.+|.+||+..++.+.|+.
T Consensus 229 ~-~~~~~-~------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 I-SDDIE-W------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred H-hcccC-C------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 00000 0 00111345568999999999999999997666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=298.39 Aligned_cols=261 Identities=26% Similarity=0.312 Sum_probs=198.3
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCch-----hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEG-----KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
+|++.+.||+|+||.||+|... +++.||+|.+...... ....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999965 6889999987654322 345667899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||..+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889999997644 25899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh---------
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE--------- 307 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------- 307 (400)
.. .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||........ .... ......
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKI-FEALGTPTEENWPGV 230 (298)
T ss_pred CC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHH-HHHcCCCchhhhhhc
Confidence 22 22223346788999998854 4678999999999999999999877753322110 0000 000000
Q ss_pred cccccccchhh-----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 NRLYDFLDDQV-----LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 ~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........... ........+..+.+++.+||+.+|.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 000112235678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=297.40 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=196.1
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCc-----
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEV----- 153 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~----- 153 (400)
++|++.+.||+|+||.||+|... +++.||+|...... ......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999965 68899999765432 233467888999999995 6999999999887665
Q ss_pred ceEEEEccCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCcEEEEecC
Q 042371 154 PLLVYEFISNGTLFQYLHDQNE--EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-KYTAKVADFG 230 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~Dfg 230 (400)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.|||..+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 88888765432 235899999999999999999999999 999999999999998 8899999999
Q ss_pred CccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc-
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN- 308 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 308 (400)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........ ..... ......
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~-~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIF-KLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHH-HHhCCCC
Confidence 9875432211 1222346888999998865 4579999999999999999999999954322111 00000 000000
Q ss_pred --cccccc-----------chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 309 --RLYDFL-----------DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 309 --~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+.... .........+..+..+.++|.+||+.||.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 0000001112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=301.82 Aligned_cols=246 Identities=24% Similarity=0.320 Sum_probs=204.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.+.|+.-++||+||||.|+-++.+ .|+.+|.|++... ........++|-.+|.+++.++||.+--.|...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 467888999999999999998854 6899999976432 122345677899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
+..|+||+|.-.|.+.+.. .+++..+..++.+|+.||.+||..+ ||.||+||+|||+|+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~~-gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNP-GFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCCC-CCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999998876653 5999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
....+..+||.+|||||++.++.|+...|+||+||++|+|+.|+.||........ .. -++.+
T Consensus 340 --g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------------~e----Evdrr 401 (591)
T KOG0986|consen 340 --GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------------RE----EVDRR 401 (591)
T ss_pred --CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh------------HH----HHHHH
Confidence 3444445799999999999999999999999999999999999999954332211 10 11111
Q ss_pred hh---ccCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 042371 318 VL---KVGQKEEIMTIATLATRCLNLNGKRRPTMK 349 (400)
Q Consensus 318 ~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 349 (400)
.+ ...+...+++.+++.+..|..||++|....
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11 234567788899999999999999996543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=299.87 Aligned_cols=267 Identities=22% Similarity=0.320 Sum_probs=197.6
Q ss_pred CCcccceeeecCcEEEEEEEec---CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--Ccce
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA---DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPL 155 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 155 (400)
+|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999876532 44456778899999999999999999999988 7899
Q ss_pred EEEEccCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC----CCcEEEEec
Q 042371 156 LVYEFISNGTLFQYLHDQNE--EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE----KYTAKVADF 229 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~----~~~~kl~Df 229 (400)
+||||+++ +|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 77777654321 235899999999999999999999999 999999999999999 899999999
Q ss_pred CCccccccCCc--eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH-----
Q 042371 230 GTSKFIVIDQT--HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF----- 301 (400)
Q Consensus 230 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~----- 301 (400)
|++........ .......+++.|+|||.+.+. .++.++||||||+++|+|++|++||...............
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543222 112234578899999987664 5889999999999999999999999654432210000000
Q ss_pred -HHHhhh------------ccccc---------ccchhhhccCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 302 -ILSMEE------------NRLYD---------FLDDQVLKVGQ--KEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 302 -~~~~~~------------~~~~~---------~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+.. ..... +....+..... ...+..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 00000 00000000000 0234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.19 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=199.1
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--CcceEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLV 157 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 157 (400)
++|++.+.||.|+||.||+|..+ +++.+|+|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999975 57899999876433 22334567899999999999999999998877 789999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++ +|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 99998876543 5899999999999999999999999 99999999999999999999999999886543
Q ss_pred CCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHH----------HHHH-Hh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAA----------YFIL-SM 305 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~----------~~~~-~~ 305 (400)
.. .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||............. |... ..
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Cc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 22 222334578899999998754 46899999999999999999999996433221100000 0000 00
Q ss_pred h--h-cccccccchhhhccCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 E--E-NRLYDFLDDQVLKVGQKE-EIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 ~--~-~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. . ..........+....+.. .+..+.+++.+||+.+|++|||+.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0 000000000111111111 35668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=296.49 Aligned_cols=266 Identities=24% Similarity=0.340 Sum_probs=196.0
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
..+|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++|+||+++++++......++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467999999999999999999864 58899999876432 2333467789999999999999999999999889999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+. ++|.+.+..... .+++..+..++.|++.||.|||..+ |+|+||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 677777654332 4788888899999999999999999 9999999999999999999999999987543221
Q ss_pred ceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc-------ccc
Q 042371 240 THVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN-------RLY 311 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~ 311 (400)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.............+........ ...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 112234468899999998754 57889999999999999999999996443221110000000000000 000
Q ss_pred cccch-------hhhcc--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 312 DFLDD-------QVLKV--GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 312 ~~~~~-------~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..... ..... .....+..+.+++.+|++.||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000 00000 000124568899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=294.59 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=200.7
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
+|++.+.||.|++|.||+|... ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999975 58899999876543 334567778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++ +|.+++........+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888876554446899999999999999999999999 99999999999999999999999999975532211
Q ss_pred eeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH--------HHhh-h----
Q 042371 242 VTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI--------LSME-E---- 307 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~-~---- 307 (400)
......+++.|+|||++.+. .++.++||||||+++|+|++|+.||......+......... .... .
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22234568899999988654 57899999999999999999999986443221100000000 0000 0
Q ss_pred cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+ .......+..+..+.+++.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPP-QDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCCh-HHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 00011112335678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=298.56 Aligned_cols=247 Identities=29% Similarity=0.436 Sum_probs=197.3
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
..|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|||++++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45889999999999999999965 68899999875332 234467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||++ |+|.+++..... .+++..+..++.|++.||.|||..+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~- 167 (307)
T cd06607 95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP- 167 (307)
T ss_pred HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC-
Confidence 9997 577777754332 4899999999999999999999999 99999999999999999999999999875422
Q ss_pred CceeeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.....+++.|+|||++. ...++.++||||||+++|+|++|+.||....... .. ........
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~--~~~~~~~~----- 231 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----AL--YHIAQNDS----- 231 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HH--HHHhcCCC-----
Confidence 12345788999999874 4568899999999999999999999985332111 00 00000000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
........+..+.+++.+||+.+|.+||++.+++.+.
T Consensus 232 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 ---PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0111223556799999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.26 Aligned_cols=243 Identities=26% Similarity=0.451 Sum_probs=194.6
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccc----cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc--ceEE
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI----VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV--PLLV 157 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 157 (400)
.+...+||+|+|-+||+|.+. .|-.||--.++. ..+...+++..|+.+|+.|+||||+++|+++.+... +-+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 345668999999999999964 465666332221 234556899999999999999999999999988765 6789
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CcEEEEecCCccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSKFIV 236 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~Dfgla~~~~ 236 (400)
+|.+..|+|..|+.+.+ .++...+..|++||+.||.|||++. +||||||||-+||+|+.+ |.|||+|+|||+...
T Consensus 122 TEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999998876 4889999999999999999999988 789999999999999865 899999999998763
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh----ccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE----NRLYD 312 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~ 312 (400)
. .. ...+.|||.|||||++. ..|+..+||||||+.|+||+|+.+||.. ............. ..+..
T Consensus 198 ~--s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE------C~n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 198 K--SH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE------CTNPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred c--cc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh------hCCHHHHHHHHHcCCCHHHhhc
Confidence 2 22 23378999999999988 8999999999999999999999999831 1111111111111 11111
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+- .+++++||.+||.. ...|||+.|+|+.
T Consensus 268 V~------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 VK------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cC------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11 24588999999999 9999999999874
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=296.41 Aligned_cols=260 Identities=26% Similarity=0.360 Sum_probs=200.3
Q ss_pred HHHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeC--
Q 042371 76 KELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLET-- 151 (400)
Q Consensus 76 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-- 151 (400)
..+....++|.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++.+ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 344455788999999999999999999964 6889999987543 22345677899999998 799999999998754
Q ss_pred ---CcceEEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEE
Q 042371 152 ---EVPLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVA 227 (400)
Q Consensus 152 ---~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~ 227 (400)
+..++||||+++++|.+++... .....+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 3579999999999999988642 12235899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCceeeecccccCCCCCccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH
Q 042371 228 DFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-----QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 228 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 302 (400)
|||++........ ......|+..|+|||.+... .++.++|||||||++|+|++|+.||....... . .
T Consensus 171 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-----~--~ 242 (291)
T cd06639 171 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-----T--L 242 (291)
T ss_pred ecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----H--H
Confidence 9999876532221 12234578999999997644 36889999999999999999999985332111 0 0
Q ss_pred HHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 303 LSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..........+ ..+......+.+++.+||+.+|.+||++.+++++
T Consensus 243 ~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FKIPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111110 1122344568999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=294.96 Aligned_cols=248 Identities=24% Similarity=0.450 Sum_probs=199.0
Q ss_pred CCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc-CchhHHHHHHHHHHHHhCC---CCcceeeeeEEeeCCcceEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV-HEGKLEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.|++.+.||+|+||.||+|.. .++..+|+|.+... .......+.+|+.+++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 478889999999999999996 46889999987543 3345567888999999986 999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++... .+++..++.++.|++.||.|||..+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998653 4899999999999999999999999 999999999999999999999999999866433
Q ss_pred CceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. .......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||........ ........ .+.
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~~~~~~~-----~~~ 221 (277)
T cd06917 155 S-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------MMLIPKSK-----PPR 221 (277)
T ss_pred c-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------hhccccCC-----CCC
Confidence 2 222334688999999988654 578999999999999999999999953321110 00000000 000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+ .....+..+.+++.+||+.||.+|||+.+++.+
T Consensus 222 ~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 L---EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred C---CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0 011144568999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.73 Aligned_cols=270 Identities=20% Similarity=0.272 Sum_probs=190.7
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecC--CcEEEEE------------------EccccCchhHHHHHHHHHHHHhCCCC
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLAD--GRIVAVK------------------KSKIVHEGKLEEFINEVVILSQINHR 139 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~--~~~vaiK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ 139 (400)
...++|++.+.||+|+||.||++..+. +...+.| .+. ........+.+|+.+|+.++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987432 2222211 111 1122345678999999999999
Q ss_pred cceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 042371 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNE--EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNIL 217 (400)
Q Consensus 140 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 217 (400)
||+++++++...+..++|++++. ++|.+++..... ........++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999995 577777654321 112345667789999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCC-CCcCCCccccc
Q 042371 218 LNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP-IILTGSKEATG 296 (400)
Q Consensus 218 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p-f~~~~~~~~~~ 296 (400)
++.++.+||+|||++..+............||+.|+|||++.+..++.++|||||||++|+|++|..+ +..........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999987643333333446799999999999999999999999999999999998754 43222221111
Q ss_pred hHHHHHHH-hhhcc-------cccccchhhhccC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 297 LAAYFILS-MEENR-------LYDFLDDQVLKVG---------QKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 297 ~~~~~~~~-~~~~~-------~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+....... ..... +.++++....... ....+..+.+++.+||+.||.+|||+.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111000 00000 0001000000000 00123457788999999999999999999875
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.34 Aligned_cols=250 Identities=31% Similarity=0.469 Sum_probs=204.7
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
.|.+.+.||+|++|.||++... ++..+++|+...........+.+|+.+++.++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3788899999999999999975 688999998876555567889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+++|.+++.... ..+++..+..++.+++.||.+||..+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999987653 25899999999999999999999988 99999999999999999999999999976543221
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccC
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (400)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ............. .
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~-------~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-------LFKIATNGPPGLR-------N 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHHhcCCCCcC-------c
Confidence 3345688999999999988899999999999999999999999854321110 0001111111110 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+..+.+++.+||+.||.+|||+.+++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11125668999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=296.19 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=199.9
Q ss_pred CcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 85 FNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999985 46889999987655555567788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
++|.+++... .+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........ ..
T Consensus 101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 9999998762 4889999999999999999999999 99999999999999999999999998875432221 22
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ....... ... ....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~--~~~~~~~-~~~------~~~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAM--KRIRDNL-PPK------LKNL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHH--HHHHhcC-CCC------Cccc
Confidence 3345889999999999889999999999999999999999998532211 000 0010000 000 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1244679999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=295.02 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=197.6
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|++.+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999865 68899999876432 33346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+. ++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 589888865433 25899999999999999999999999 9999999999999999999999999987543221
Q ss_pred eeeecccccCCCCCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH-hh------------
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS-ME------------ 306 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~------------ 306 (400)
.......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ......... ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHH
Confidence 1122334688999999887644 6889999999999999999999995432211 110000000 00
Q ss_pred --hcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 307 --ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 307 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+........ .......+..+.++|.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 00111234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=295.34 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=204.9
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
..+.|++.+.||+|+||.||+|..+ ++..+++|.+..... ....+.+|+.+++.++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3456888999999999999999976 688999998765444 56778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++.... ..+++..++.++.+++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999998754 25899999999999999999999998 9999999999999999999999999986543222
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....... .. ..........
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-----~~--~~~~~~~~~~------- 235 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-----AL--FLITTKGIPP------- 235 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-----HH--HHHHhcCCCC-------
Confidence 12223457889999999998889999999999999999999999985332211 00 0000111100
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+..+.+++.+||+.+|.+|||+.+++++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01112245678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=294.65 Aligned_cols=264 Identities=24% Similarity=0.314 Sum_probs=199.2
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--CcceEEEE
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVYE 159 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 159 (400)
|++.+.||.|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999976 47899999877542 34456788999999999999999999999888 78999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++ +|.+++.... ..+++..++.++.||+.||.|||..+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888886543 25899999999999999999999999 9999999999999999999999999998664433
Q ss_pred ceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc-----
Q 042371 240 THVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF----- 313 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 313 (400)
........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......................+..+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 222334456889999998765 46889999999999999999999998544322110000000000000000000
Q ss_pred ---------cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 ---------LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.............+..+.+++.+||+.+|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000011125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.58 Aligned_cols=273 Identities=27% Similarity=0.407 Sum_probs=211.8
Q ss_pred CCcccceeeecCcEEEEEEEe-cCCcEEEEEEccc-cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC------cce
Q 042371 84 HFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE------VPL 155 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~ 155 (400)
.|...+.||+|+||.||+|+. ..|+.||||.... ......+...+|+++|++++|+|||+++++=.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 455667899999999999994 5799999997664 34556788899999999999999999998754433 467
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc----CCCcEEEEecCC
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN----EKYTAKVADFGT 231 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~----~~~~~kl~Dfgl 231 (400)
+|||||.||+|...++.-.+...+++.+.+.++.++..||.|||.++ |+||||||.||++- .....||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998666667999999999999999999999999 99999999999994 233689999999
Q ss_pred ccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
|+.+. .....+.+.||+.|.+||.+.. +.|+..+|.|||||++|+.+||..||.............|....-+...+
T Consensus 171 Arel~--d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 171 ARELD--DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccCC--CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 99764 4447778899999999999984 88999999999999999999999999877665433333343322211111
Q ss_pred ccccc------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHHHHH
Q 042371 311 YDFLD------------DQVLKVGQKEEIMTIATLATRCLNLNGKRRP--TMKEVAMELERIQAL 361 (400)
Q Consensus 311 ~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~ell~~L~~~~~~ 361 (400)
.-... -+......+.....+-..+..+|..+|.+|- ...+.-..+.+|...
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 10000 0001122344445667788889999999998 666666666666543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=298.58 Aligned_cols=266 Identities=25% Similarity=0.326 Sum_probs=196.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--CcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 156 (400)
.++|++.+.||+|+||.||+|... +|..||+|.+.... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999965 58899999876432 22234566899999999999999999998765 46799
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999964 8888887543 25899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc-----
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL----- 310 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 310 (400)
... .......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......................+
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 160 LPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred Ccc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 322 12222345788999999865 56899999999999999999999999643322111100000000000000
Q ss_pred ------ccccchhh--hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 ------YDFLDDQV--LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ------~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........ ........+..+.++|.+||+.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 000001135668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.96 Aligned_cols=267 Identities=22% Similarity=0.326 Sum_probs=197.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC-----cc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE-----VP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 154 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999854 6889999987642 2334567788999999999999999998866443 47
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++|+||+.+ +|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999964 888777543 4899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCce--eeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh---c
Q 042371 235 IVIDQTH--VTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE---N 308 (400)
Q Consensus 235 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~ 308 (400)
....... ......|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||........ .......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHH
Confidence 5322111 1123467899999998754 5689999999999999999999999954321110 0000000000 0
Q ss_pred ccccccc-----------hhh---hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 042371 309 RLYDFLD-----------DQV---LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERIQ 359 (400)
Q Consensus 309 ~~~~~~~-----------~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~~ 359 (400)
.+..+.. ... .....+..+..+.+++.+||+.+|.+|||+.+++++ +++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000000 000 000011235668999999999999999999999997 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=297.51 Aligned_cols=253 Identities=28% Similarity=0.421 Sum_probs=199.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
..|...+.||+|+||.||++... ++..+|+|.+... .......+.+|+.+++.++|||++++++++.+....++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34788899999999999999964 6889999987543 2234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+.+ +|.+++..... ++++..+..++.+++.||.|||..+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99975 78777755432 5899999999999999999999999 99999999999999999999999999865422
Q ss_pred CceeeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.....|++.|+|||++. .+.++.++||||||+++|+|++|+.||....... .. .......
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~--~~~~~~~------ 240 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----AL--YHIAQNE------ 240 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-----HH--HHHHhcc------
Confidence 22345788999999873 4578999999999999999999999985322111 00 0010100
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
.........+..+.+++.+||+.+|.+||++.++++++..+...
T Consensus 241 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 241 --SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred --CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 01111223455689999999999999999999999987655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=291.04 Aligned_cols=248 Identities=26% Similarity=0.338 Sum_probs=201.8
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
+|++.+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999975 58899999876422 2456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+.+++|.+++.... ++++..+..++.|+++||.|||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999987652 5899999999999999999999999 9999999999999999999999999987653321
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........... ...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc----------cc
Confidence 22345688899999999988899999999999999999999999965443211111 000000 01
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTM--KEVAM 353 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~ell~ 353 (400)
...+...+..+.+++.+||+.||.+||++ +++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11222344678999999999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.84 Aligned_cols=242 Identities=25% Similarity=0.350 Sum_probs=202.2
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|..+++||+|.||.|.+++.+ .++.+|+|+++. ...+.+.+-+.|-++|+..+||.+..+.-.|...+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3478999999999999999999964 689999998764 345667778899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||++||.|.-.+.+.. .+++...+.+-..|..||.|||+++ ||.||||.+|+|+|.+|++||+|||+++.-.
T Consensus 246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999998887644 5889989999999999999999999 9999999999999999999999999998543
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
.....+.+.+|||.|+|||++....|+.++|+|.+||+||||++|+.||..... ...+.......
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh------~kLFeLIl~ed-------- 384 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH------EKLFELILMED-------- 384 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch------hHHHHHHHhhh--------
Confidence 234456678999999999999999999999999999999999999999943322 22222111110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCC
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRP 346 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 346 (400)
...+...+++...|+..+|..||.+|.
T Consensus 385 ---~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 ---LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 011333455688999999999999993
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.98 Aligned_cols=265 Identities=25% Similarity=0.419 Sum_probs=206.9
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
....|...+.||+|+||.||+|.. .++..||+|++...... ...|+.++++++||||+++++++.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345678888999999999999996 47889999987643222 1345888999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++|+|.++++ .+++..+..++.|++.||.|||.....+|+||||||+||+++.++..++. ||.+.....
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999999999995 27899999999999999999996544459999999999999999888775 665543211
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||..... .......+............++++...
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 1223578999999999999999999999999999999999999843322 223344444333333333333443332
Q ss_pred c--cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 320 K--VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 320 ~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
. ........++.+++.+||+.||.+||||.++++.|+.+....
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 2 223455667889999999999999999999999999876633
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=289.12 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=198.2
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-----CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--Ccc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-----HEGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVP 154 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 154 (400)
.+|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999964 5889999976432 223456788999999999999999999998764 457
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++++||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987644 4788999999999999999999999 99999999999999999999999999976
Q ss_pred cccCC--ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 235 IVIDQ--THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 235 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
..... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .. .. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~-~~-~~~~----- 223 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AA-IF-KIAT----- 223 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HH-HH-HHHc-----
Confidence 43211 11123355889999999999888999999999999999999999998532111 00 00 0000
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+...+..+.+++.+||+ +|..|||+.+++.+
T Consensus 224 ---~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 224 ---QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 011122344456679999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=301.72 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=197.9
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC------
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET------ 151 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 151 (400)
..++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 6889999987532 334456778899999999999999999987643
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
...++||||+. ++|.+.+... ++...+..++.|++.||.|||..+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34689999996 4888877532 788889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchH---------HHH-
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLA---------AYF- 301 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~---------~~~- 301 (400)
+...... .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||............ .+.
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9765322 2223345788999999999999999999999999999999999999544321100000 000
Q ss_pred ------HHHhhhc------ccccccchhhh----ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 302 ------ILSMEEN------RLYDFLDDQVL----KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 302 ------~~~~~~~------~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....... .+......... .......+..+.+++.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00000000000 00012345668899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=290.51 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=192.4
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCC-CCcceeeeeEEeeC--CcceEEEE
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQIN-HRNVVKLLGCCLET--EVPLLVYE 159 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 159 (400)
|++.+.||+|+||.||+|... +++.+|+|...... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999964 68899999876432 222234457888888885 99999999999887 88999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|++ ++|.+.+..... .+++..++.++.|++.||.|||..+ ++||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 588888765432 5899999999999999999999999 999999999999999 999999999997653221
Q ss_pred ceeeecccccCCCCCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH-----------Hhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFR-SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL-----------SMEE 307 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------~~~~ 307 (400)
......++..|+|||.+. +..++.++||||+||++|+|++|..||......+. ...... ....
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcc
Confidence 222345788999999765 45678899999999999999999999954332110 000000 0000
Q ss_pred cccccccchhh----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 NRLYDFLDDQV----LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 ~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....+..+.. ........+..+.+++.+||+.+|.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 000112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=289.75 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=200.4
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|.+.+.||+|+||.||++..+ ++..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999975 5788999987543 223456778999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-cEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~Dfgla~~~~~~~ 239 (400)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++ .++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999876433 24799999999999999999999999 99999999999999886 46999999987654322
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... .... ......+.
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~-------- 220 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVL-KICQGYFA-------- 220 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH-HHhcccCC--------
Confidence 2223345889999999998888999999999999999999999998432211 1111 11111111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+..+.+++.+||+.+|.+|||+.+++++
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112334568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=284.40 Aligned_cols=251 Identities=28% Similarity=0.441 Sum_probs=205.0
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--CcceEEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVY 158 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 158 (400)
+|.+.+.||+|++|.||+|... ++..+++|...... ....+.+.+|+.++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 68899999876543 24567889999999999999999999999988 7899999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++.... .+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999998654 5899999999999999999999998 999999999999999999999999999876433
Q ss_pred Cce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 239 QTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 239 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||..... ..... ..... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~-~~~~~--------~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAAL-YKIGS--------SG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHH-Hhccc--------cC
Confidence 221 12345688999999999988899999999999999999999999854431 11110 00000 01
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1112223336679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=293.02 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=197.4
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
|++.+.||.|++|.||+|... +|..||+|++.... ......+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677899999999999999964 68999999876433 233467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
+ ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 689998876542 24899999999999999999999998 99999999999999999999999999975432211
Q ss_pred eeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh-hh------------
Q 042371 242 VTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM-EE------------ 307 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~------------ 307 (400)
......+++.|+|||++.+. .++.++||||||+++|+|++|+.||........ ......... ..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence 12223468899999987654 578999999999999999999999854332110 000000000 00
Q ss_pred --cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 --NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......... .........+..+.+++.+||+.+|.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQ-DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhccccccc-chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 0001122334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=291.81 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=200.2
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc--hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE--GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
|++.+.||.|++|.||++... +++.+++|.+..... .....+..|+.+++.++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999964 688999998764332 34567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++ +|.+++.... ..+++..++.++.|++.||.|||..+ |+|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 75 8888887644 25899999999999999999999999 9999999999999999999999999987664332 1
Q ss_pred eeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc-----
Q 042371 242 VTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD----- 315 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 315 (400)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+................+..+..
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 22334578899999998776 789999999999999999999999854332111000000000000000000000
Q ss_pred ------h--hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 ------D--QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ------~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ..........+..+.+++.+||+.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 00011123456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=287.04 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=205.3
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc--hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE--GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|.+.+.||+|+||.||++... ++..+++|.+..... .....+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999965 588999998765433 5567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
+++++|.+++.... ....+++..++.++.+++.||.+||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997642 1236899999999999999999999998 9999999999999999999999999997654332
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ..... ......
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~--------- 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALK-ILKGQY--------- 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHH-HhcCCC---------
Confidence 2333456889999999999889999999999999999999999998543311 11111 111111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122345668999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.06 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=196.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999965 68899999875432 2334678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCcEEEEecCCccccccC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-KYTAKVADFGTSKFIVID 238 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~Dfgla~~~~~~ 238 (400)
|++ ++|.+++..... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 588887765432 24688888999999999999999999 999999999999985 567999999999754322
Q ss_pred CceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh---cccccc-
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE---NRLYDF- 313 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 313 (400)
........+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+. .... ...... ..+..+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKI-FRILGTPNEETWPGVT 232 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HHHhCCCChhhccccc
Confidence 112233456889999998865 4578999999999999999999999954332111 0000 000000 000000
Q ss_pred --cc---------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 --LD---------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 --~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+ ...........+..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000000112234568899999999999999999999974
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=290.93 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=187.0
Q ss_pred eeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHh---CCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 90 ILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQ---INHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+|||++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 58899999765321 1222334445444433 479999999999999899999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... .
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~ 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---C
Confidence 999999887654 4899999999999999999999999 999999999999999999999999998654321 1
Q ss_pred eecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 243 TTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
.....|++.|+|||.+.+ ..++.++||||+||++|+|++|..||......... ....... .....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~-----------~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL-----------TVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhh-----------cCCcC
Confidence 223458999999999864 56899999999999999999999999644322111 0000000 00111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
.+...+..+.+++.+||+.||.+|| |+++++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2334556789999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=294.20 Aligned_cols=266 Identities=27% Similarity=0.352 Sum_probs=198.0
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC----
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETE---- 152 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 152 (400)
...++|++.+.||.|+||.||+|..+ +++.||+|.+.... ......+.+|+.+++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 57899999876532 233456778999999999999999999887654
Q ss_pred ------cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEE
Q 042371 153 ------VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV 226 (400)
Q Consensus 153 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl 226 (400)
..++|+||+++ +|..++.... ..+++..++.++.|++.||.|||..+ |+|+||+|+||+++.++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 68899999976 7777776542 25899999999999999999999999 999999999999999999999
Q ss_pred EecCCccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh
Q 042371 227 ADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305 (400)
Q Consensus 227 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 305 (400)
+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|++||....... .+.. .....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~-~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLEL-ISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHh
Confidence 9999997654332222223346788999998865 457899999999999999999999995432211 1100 00000
Q ss_pred hh---cccccccchh-------------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 EE---NRLYDFLDDQ-------------VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 ~~---~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. ..+..+.... .........+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000000000 0000011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=287.57 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=203.7
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|++.+.||.|+||.||++... ++..+|+|.+... .......+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4888999999999999999854 6789999987643 334466788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987632 1235899999999999999999999999 999999999999999999999999999766433
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....... . .........
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~-~~~~~~~~~--------- 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------L-RYKVQRGKY--------- 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHhcCCC---------
Confidence 2233457899999999999899999999999999999999999995433211 0 111111111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223455679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=300.99 Aligned_cols=271 Identities=22% Similarity=0.289 Sum_probs=201.0
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC-----Cc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET-----EV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 153 (400)
.++|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357999999999999999999964 6889999987642 233355677899999999999999999987654 24
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++|+||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68988886543 5899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......................+..
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 653321 22234457889999998765 4689999999999999999999999954321110000000000000000000
Q ss_pred ccch--------------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHH
Q 042371 313 FLDD--------------QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERIQA 360 (400)
Q Consensus 313 ~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~~~ 360 (400)
+.+. ..........+..+.+++.+||+.+|++|||+.+++++ +..+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0000 00001112345678999999999999999999999998 665544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=301.52 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=198.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEee----CCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLE----TEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 154 (400)
.++|++.+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999964 58899999876432 2345677889999999999999999988753 3467
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+. ++|.+++.... .+++..++.++.||+.||.|||..+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999996 58988886543 4899999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCc---eeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH------
Q 042371 235 IVIDQT---HVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS------ 304 (400)
Q Consensus 235 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------ 304 (400)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 532221 11233468899999999865 46899999999999999999999999543321110000000000
Q ss_pred --hhhcccccccch------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 305 --MEENRLYDFLDD------QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 305 --~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
............ ..........+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000 00000112346779999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=290.75 Aligned_cols=259 Identities=17% Similarity=0.245 Sum_probs=185.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC----CcEEEEEEccccCchhH-----------HHHHHHHHHHHhCCCCcceeee
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIVHEGKL-----------EEFINEVVILSQINHRNVVKLL 145 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~ 145 (400)
...+|++.+.||+|+||.||+|...+ +..+|+|.......... .....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 44689999999999999999999654 34566665433222111 1122334455667899999999
Q ss_pred eEEeeCC----cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 042371 146 GCCLETE----VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK 221 (400)
Q Consensus 146 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~ 221 (400)
+.+.... ..+++++++. .++.+++.... ..++..+..++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 8765543 2367888774 36766665432 3578888999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCccccccCCc------eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCcccc
Q 042371 222 YTAKVADFGTSKFIVIDQT------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEAT 295 (400)
Q Consensus 222 ~~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 295 (400)
+.++|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 9999999999986542221 1112346899999999999999999999999999999999999999654322211
Q ss_pred chHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 296 GLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
........ +..+..... .....+..+.+++..|++.+|.+||++.++++.|
T Consensus 243 --~~~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 --IHAAKCDF----IKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred --HHHhHHHH----HHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10000000 000000000 0112245689999999999999999999999876
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.86 Aligned_cols=267 Identities=23% Similarity=0.306 Sum_probs=194.4
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc-----
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEV----- 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 153 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999965 58899999875432 2233456789999999999999999998876543
Q ss_pred ---ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 154 ---PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 154 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
.++||||+. ++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 489999996 488888765432 4899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCce---eeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh
Q 042371 231 TSKFIVIDQTH---VTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 231 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
++......... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99765432211 11234467889999988664 478899999999999999999999854332211111111000000
Q ss_pred hcccccc-----------cc---hhhhc-cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 307 ENRLYDF-----------LD---DQVLK-VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 307 ~~~~~~~-----------~~---~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+... .. ..... .........+.+++.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 00 00000 0000113457799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=288.87 Aligned_cols=245 Identities=22% Similarity=0.284 Sum_probs=193.2
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 91 LGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 91 lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
||+|+||.||++... +++.+|+|.+.... ......+..|+.+++.++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 58899999765321 22345667899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecc
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV 246 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 246 (400)
.+++..... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++..... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccc
Confidence 999876543 25899999999999999999999999 99999999999999999999999999876532 2222334
Q ss_pred cccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHH
Q 042371 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE 326 (400)
Q Consensus 247 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (400)
.++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......... ........ .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------ELKRRTLE------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------HHHhcccc------ccccCCccC
Confidence 57889999999988889999999999999999999999995433211000 00000000 011122234
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 327 IMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 327 ~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
++.+.+++.+||+.+|.+|| ++.+++.+
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 56789999999999999999 66666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=292.31 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=194.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667789999999999999965 57899999876432 344567889999999996 9999999999998889999999
Q ss_pred ccCCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 160 FISNGTLFQYLHD--QNEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 160 ~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
|+.. +|.++... ......+++..+..++.+++.||.|||+. + ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 66554322 11123589999999999999999999975 7 9999999999999999999999999997653
Q ss_pred cCCceeeecccccCCCCCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSG---QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
... ......|++.|+|||.+.+. .++.++||||+|+++|+|++|+.||..... ....... ......
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~-~~~~~~--- 228 (288)
T cd06616 160 DSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQ-VVKGDP--- 228 (288)
T ss_pred cCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhh-hcCCCC---
Confidence 221 12233578899999998876 689999999999999999999999853320 0000000 000000
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...........+..+.+|+.+||+.+|.+|||+.+|+.+
T Consensus 229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111123356679999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=302.65 Aligned_cols=255 Identities=27% Similarity=0.353 Sum_probs=211.6
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.....|.+.+.||+|.|+.|.+|+.. .+..||||.+.... ....+.+.+|+.+|+.++|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34578999999999999999999964 58899999876532 3334668899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+.+|.+++++.+++. +.+..+..++.|+..|++|||+++ |+|||||++|||++.+.++||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999998764 666888899999999999999999 9999999999999999999999999999874
Q ss_pred cCCceeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
......+.+|++.|.|||++.+..| ++++|+||+|+++|.|+.|..||+.....+....... +
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-------g------- 270 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-------G------- 270 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-------e-------
Confidence 5556677899999999999999887 5789999999999999999999964433221111000 0
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
....+.-.+..+.++++++|..+|.+|++++++.+.-+--.
T Consensus 271 ---k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 271 ---KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred ---eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 00112223345789999999999999999999988744433
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=300.21 Aligned_cols=270 Identities=24% Similarity=0.346 Sum_probs=204.1
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC-----cce
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 155 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 155 (400)
+|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999975 48899999876533 344578889999999999999999999987765 789
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
++|+|++ ++|.+++.... ++++..++.++.+|+.||.+||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 48888886543 5899999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCc--eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH--------
Q 042371 236 VIDQT--HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS-------- 304 (400)
Q Consensus 236 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------- 304 (400)
..... .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 43321 122334578899999999887 8899999999999999999999999554322110000000000
Q ss_pred hhhcccccccch------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHH
Q 042371 305 MEENRLYDFLDD------QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERIQA 360 (400)
Q Consensus 305 ~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~~~ 360 (400)
.........+.. ..........+..+.+++.+||+.+|.+|||+.+++.+ ++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000000 00000112245678999999999999999999999986 555444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=288.63 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=201.2
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecC-CcEEEEEEccc---cCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCc
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKI---VHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEV 153 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 153 (400)
.....+|..+.+||+|+||.|.+|..++ .+.+|||+++. ...++++--+.|-++|... +-|.+++++.+|..-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3445679999999999999999998764 56799997764 2345566677788888877 47899999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
+|+||||+.||+|...++..+ .+-+..+..++..|+-||-+||++| |+.||||.+|||+|.+|++||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999999998766 3777888899999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.-. -....+.+.+|||.|+|||++...+|+.++|+||+||+||||+.|++||......+ .+...+..
T Consensus 499 Eni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------lF~aI~eh------ 565 (683)
T KOG0696|consen 499 ENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQAIMEH------ 565 (683)
T ss_pred ccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHHc------
Confidence 532 23445667899999999999999999999999999999999999999995433221 11111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCC
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP 346 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 346 (400)
...++...+.+..+++...|..+|.+|.
T Consensus 566 -----nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 -----NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -----cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1234556667788999999999999994
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=285.43 Aligned_cols=242 Identities=27% Similarity=0.314 Sum_probs=194.5
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 91 LGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 91 lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
||.|+||.||++... ++..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48899999875422 23456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecc
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV 246 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 246 (400)
.+++.... .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 99997653 4889999999999999999999999 9999999999999999999999999998654322 22334
Q ss_pred cccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHH
Q 042371 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE 326 (400)
Q Consensus 247 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (400)
.+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ........... .....+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~---------~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGN---------GKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccC---------CCCCCCccc
Confidence 67899999999988889999999999999999999999995443211 01001100000 001112222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 042371 327 IMTIATLATRCLNLNGKRRPT-----MKEVAM 353 (400)
Q Consensus 327 ~~~l~~li~~cl~~dP~~RPt-----~~ell~ 353 (400)
+..+.+++.+||+.+|.+||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 567999999999999999999 777766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=289.03 Aligned_cols=252 Identities=26% Similarity=0.344 Sum_probs=197.3
Q ss_pred CCcccceeeecCcEEEEEEEe----cCCcEEEEEEccccC----chhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcc
Q 042371 84 HFNVNRILGQGGQGTVYKGML----ADGRIVAVKKSKIVH----EGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 154 (400)
+|++.+.||.|+||.||.+.. .+|..||+|.+.... ....+.+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999985 367899999875422 22346678899999999 599999999999998899
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++++|.+++.... ++++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999987654 4889999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCceeeecccccCCCCCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSG--QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.............|+..|+|||.+... .++.++||||||+++|+|++|..||...+.... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE---- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC----
Confidence 543322222345588999999998753 478899999999999999999999854322111 111111100000
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
...+...+..+.+++.+||+.+|.+|| ++.+++.+
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011223445688999999999999997 67777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=290.34 Aligned_cols=262 Identities=19% Similarity=0.245 Sum_probs=194.7
Q ss_pred cccceeeecCcEEEEEEEecCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 86 NVNRILGQGGQGTVYKGMLADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 86 ~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
.+.+.+|.|+++.|+++.. +++.||+|++... .......+.+|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 4455556666666666555 6889999987643 345567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc---
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT--- 240 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~--- 240 (400)
++|.+++...... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+........
T Consensus 84 ~~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999999865332 4889999999999999999999999 99999999999999999999999998865432111
Q ss_pred ---eeeecccccCCCCCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh----------
Q 042371 241 ---HVTTKVQGTFGYLDPEYFRS--GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM---------- 305 (400)
Q Consensus 241 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---------- 305 (400)
.......++..|+|||++.. ..++.++|||||||++|+|++|..||....... ..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence 11123346778999999876 358899999999999999999999995432111 0000000000
Q ss_pred -hhccccc----c----cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 -EENRLYD----F----LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 -~~~~~~~----~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....... . .............+..+.+++.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 0 00001111233455678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=279.57 Aligned_cols=247 Identities=27% Similarity=0.451 Sum_probs=202.6
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc--hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE--GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|++.+.||+|++|.||++... +++.+++|....... .....+.+|+.++..++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999865 578899998765443 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++.... .+++..++.++.|++.||.+||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999987653 5899999999999999999999999 99999999999999999999999999986643222
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ...... ...... .
T Consensus 155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~--~~~~~~---------~ 217 (254)
T cd06627 155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFR--IVQDDH---------P 217 (254)
T ss_pred -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH--HhccCC---------C
Confidence 12335678899999999888899999999999999999999999853321 111111 001100 1
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAM 353 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 353 (400)
..+...+..+.+++.+||..+|++|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112233567899999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=282.80 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=190.2
Q ss_pred HHhcCCccccee--eecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcce
Q 042371 80 KATDHFNVNRIL--GQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 80 ~~~~~y~~~~~l--g~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 155 (400)
...++|.+.+.+ |+|+||.||++... ++..+|+|......... .|+.....+ +|||++++++.+...+..+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 344677777776 99999999999964 57889999765332111 122233223 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-cEEEEecCCccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKF 234 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~Dfgla~~ 234 (400)
+||||+++++|.+++.... ++++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||++..
T Consensus 86 iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999997654 5899999999999999999999999 99999999999999998 999999999875
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
.... ....++..|+|||++.+..++.++||||+|+++|+|++|+.||....... .....+.... . .
T Consensus 160 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~-~----- 225 (267)
T PHA03390 160 IGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--Q-K----- 225 (267)
T ss_pred cCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--c-c-----
Confidence 4321 22457899999999999899999999999999999999999996332211 1111111000 0 0
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT-MKEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ell~~ 354 (400)
........++.+.+++.+||+.+|.+||+ +++++++
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 ----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00112245567899999999999999996 5888753
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=290.60 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=197.0
Q ss_pred cceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 88 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
...||+|+||.||++... ++..+|+|++..........+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999864 6889999987655555667788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecc
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV 246 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 246 (400)
.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 9987543 3789999999999999999999999 9999999999999999999999999987553322 122335
Q ss_pred cccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHH
Q 042371 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE 326 (400)
Q Consensus 247 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (400)
.|++.|+|||.+.+..++.++|+||+|+++|+|++|..||........ ... . ..... ... ......
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~----~-~~~~~----~~~--~~~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKM----I-RDNLP----PKL--KNLHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----H-HhhCC----ccc--CCcccC
Confidence 578999999999888899999999999999999999999853221110 000 0 00000 000 011123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 327 IMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 327 ~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+..+.+++.+||+.+|.+||++.+++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 4568899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=288.24 Aligned_cols=245 Identities=26% Similarity=0.376 Sum_probs=194.9
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEEccccCc---hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 91 LGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE---GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 91 lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
||.|+||.||++... +++.+++|.+..... .....+.+|+.+++.++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999998754332 4567788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc------
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT------ 240 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~------ 240 (400)
.+++.... .+++..++.++.||+.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997654 5899999999999999999999999 99999999999999999999999999876432211
Q ss_pred -eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 241 -HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 241 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......++..|+|||.+....++.++|+||||+++|+|++|..||....... .. ........ .+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~-~~~~~~~~-~~------ 220 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IF-QNILNGKI-EW------ 220 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhcCCc-CC------
Confidence 12233457889999999988889999999999999999999999985433111 11 11111110 00
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
......+..+.+++.+||+.+|.+|||+..+.+.|+
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 -PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000112566899999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=288.22 Aligned_cols=256 Identities=24% Similarity=0.310 Sum_probs=200.3
Q ss_pred CCcccceeeecCcEEEEEEEec----CCcEEEEEEccccC----chhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIVH----EGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 154 (400)
+|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999998842 46789999765321 22345678899999999 599999999999998899
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++++|.+++.... .+++..+..++.|++.+|.|||..+ ++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999987543 4889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCceeeecccccCCCCCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQ--FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.............|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.... ......... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~-~~---- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRIL-KS---- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHH-cc----
Confidence 5433322233345889999999987665 78899999999999999999999854322110 011100000 00
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
....+...+..+.+++.+||+.+|++|||+.++.+.|...
T Consensus 228 ------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0111223445688999999999999999998887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=294.00 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=193.5
Q ss_pred ceeeec--CcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQG--GQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G--~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
..||+| +||+||++... +++.||+|..... .....+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999964 6899999987643 233457788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee-
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV- 242 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 242 (400)
++|.+++...... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999998765432 4899999999999999999999999 9999999999999999999999998654322111110
Q ss_pred -----eecccccCCCCCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH-------------
Q 042371 243 -----TTKVQGTFGYLDPEYFRSG--QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI------------- 302 (400)
Q Consensus 243 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~------------- 302 (400)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||........ ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 0112245679999998764 478999999999999999999999954322110 000000
Q ss_pred ---HHh-----------hhcc-----cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 303 ---LSM-----------EENR-----LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 303 ---~~~-----------~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
... .... .................+..+.+|+.+||+.||++|||+.+++++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 000 0000 00000011111223446678999999999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=285.70 Aligned_cols=260 Identities=27% Similarity=0.369 Sum_probs=194.8
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhC---CCCcceeeeeEEeeCCc-----
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQI---NHRNVVKLLGCCLETEV----- 153 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~----- 153 (400)
|++.+.||+|+||.||+|..+ +++.+|+|.+.... ......+.+|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999976 48899999876432 22344566787777666 59999999999988776
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.+++|||+++ +|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 89888876433 24899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh---ccc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE---NRL 310 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~ 310 (400)
...... ......++..|+|||++.+..++.++|+||||+++|+|++|++||......+. ..... ..... ..+
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIF-DVIGLPSEEEW 230 (287)
T ss_pred eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHH-HHcCCCChHhc
Confidence 653221 12233478899999999999999999999999999999999999854332111 11000 00000 000
Q ss_pred cc-------ccch---hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YD-------FLDD---QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~-------~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. .... ..........+..+.+++.+||+.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 0000 00011112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=279.92 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=200.7
Q ss_pred HhcCCccc-ceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEee----CCc
Q 042371 81 ATDHFNVN-RILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLE----TEV 153 (400)
Q Consensus 81 ~~~~y~~~-~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~ 153 (400)
.+++|.+. ++||-|--|.|..+..+ .|+++|+|.+... ....+|++.--.. .|||||.+++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667664 57999999999988854 6899999987643 3456777765444 69999999998754 346
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CcEEEEecC
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK---YTAKVADFG 230 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~Dfg 230 (400)
+.+|||.++||.|+..++.++.. .+++..+..|+.||..|+.|||+.+ |.||||||+|+|...+ ..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 78999999999999999987654 6999999999999999999999999 9999999999999754 479999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
+|+... ......+.+-||.|.|||++....|+...|+||+||+||-|++|.+||........ .......+..+.
T Consensus 210 FAK~t~--~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gq- 283 (400)
T KOG0604|consen 210 FAKETQ--EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQ- 283 (400)
T ss_pred cccccC--CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccC-
Confidence 998643 23344556789999999999999999999999999999999999999954433221 111111221111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+.|.+ ..+...++..+++|+.+|+.+|.+|.|+.+++.+
T Consensus 284 y~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 YEFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 12222 2345678889999999999999999999999875
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.08 Aligned_cols=266 Identities=25% Similarity=0.338 Sum_probs=197.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCC--cc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETE--VP 154 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~--~~ 154 (400)
..++|++.+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +||||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3568999999999999999999965 5789999977432 233455677899999999 9999999999886543 57
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||++ ++|..++... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5998888653 4788899999999999999999999 99999999999999999999999999976
Q ss_pred cccCCc----eeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH-------
Q 042371 235 IVIDQT----HVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI------- 302 (400)
Q Consensus 235 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~------- 302 (400)
...... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543221 12233568899999998765 567899999999999999999999995433221100000000
Q ss_pred -HHhh---hccccc-ccch--hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 303 -LSME---ENRLYD-FLDD--QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 303 -~~~~---~~~~~~-~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.... ...+.. .... ..........+..+.+++.+||+.+|.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 000000 0000 00001111245678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=290.93 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=197.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
..|...+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999965 5788999987532 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+. |+|.+++..... ++++..++.++.|++.||.|||..+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 95 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 9996 588777754432 4889999999999999999999998 99999999999999999999999999875432
Q ss_pred CceeeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.....+++.|+|||.+. ...++.++|||||||++|+|++|..||........ .........
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~----- 231 (308)
T cd06634 168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQNES----- 231 (308)
T ss_pred ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-------HHHHhhcCC-----
Confidence 12345788999999874 35688999999999999999999999843221110 000111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
........+..+.+++.+||+.+|.+||++.+++.+-....
T Consensus 232 ---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ---CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 01112234566899999999999999999999998755433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=282.68 Aligned_cols=244 Identities=24% Similarity=0.278 Sum_probs=188.0
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHH-HhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVIL-SQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||.|+||.||+|... +++.||+|.+.... ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999864 57899999875432 12223344555444 445899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999997654 4899999999999999999999999 99999999999999999999999999875432 2
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
....+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ... ........ . .....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~-~-----~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFD-NILSRRIN-W-----PEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHH-HHHhcccC-C-----CCccc
Confidence 23457889999999988889999999999999999999999995332211 000 01110000 0 00111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 324 KEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 324 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
...+..+.+++.+||+.+|.+|||+.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 234566899999999999999998765555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=285.56 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=202.1
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 157 (400)
++|.+.+.||+|+||.||++... ++..+|+|..... .......+..|+.+++.++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36899999999999999999965 6889999976542 2334567888999999998 99999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++++|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999998654 5899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCc-------------------eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchH
Q 042371 238 DQT-------------------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLA 298 (400)
Q Consensus 238 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 298 (400)
... .......++..|+|||.+....++.++|+||||++++++++|+.||...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~ 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----L 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----H
Confidence 221 1122345788999999998888999999999999999999999999543311 0
Q ss_pred HHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 042371 299 AYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTM----KEVAME 354 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~ell~~ 354 (400)
.. .... . .....+...++.+.+++.+||+.+|.+|||+ .+++++
T Consensus 230 ~~-~~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 TF-QKIL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HH-HHHH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 00 0000 0 0111222335668999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=289.60 Aligned_cols=244 Identities=30% Similarity=0.432 Sum_probs=193.4
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
|...+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999964 58899999876432 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+. ++|.+++..... ++++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 578777765432 5899999999999999999999999 9999999999999999999999999986432
Q ss_pred eeeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 241 HVTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
......|+..|+|||++. ...++.++||||||+++|+|++|..||........ . .........
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-----~--~~~~~~~~~------ 238 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----L--YHIAQNDSP------ 238 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----H--HHHHhcCCC------
Confidence 122356889999999974 45688999999999999999999999854321110 0 000011000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+..+.+++.+||+.+|.+||++.+++.+
T Consensus 239 --~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 --TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112234568899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=319.20 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=189.9
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC------
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLET------ 151 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 151 (400)
....+|+....||+||||.||+++.+ ||+.||||++... .......+.+|+..|.+|+|||||++|..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45577899999999999999999976 8999999998764 344567889999999999999999988543200
Q ss_pred --------------------------------------------------------------------------------
Q 042371 152 -------------------------------------------------------------------------------- 151 (400)
Q Consensus 152 -------------------------------------------------------------------------------- 151 (400)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 042371 152 ---------------------------------EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198 (400)
Q Consensus 152 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L 198 (400)
..+||-||||+..+|.+++..+... -.....|+++++|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 0136789999987777777654421 14677899999999999999
Q ss_pred HhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc------c-----------CCceeeecccccCCCCCccccccC
Q 042371 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV------I-----------DQTHVTTKVQGTFGYLDPEYFRSG 261 (400)
Q Consensus 199 H~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~ 261 (400)
|..| ||||||||.||++++++.|||+|||+|+... . ......+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998721 0 011123556799999999998765
Q ss_pred C---CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH-HHHhhhcccccccchhhhccCCHHHHHHHHHHHHHh
Q 042371 262 Q---FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF-ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRC 337 (400)
Q Consensus 262 ~---~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 337 (400)
. |+.|+||||||++++||+. ||.... .... ......+.+... ........+.-+.+|++|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-------ERa~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-------ERASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH-------HHHHHHHhcccCCCCCC------cccccccchHHHHHHHHH
Confidence 4 9999999999999999985 452211 1111 111112222111 111222233456899999
Q ss_pred cccCCCCCCCHHHHHH
Q 042371 338 LNLNGKRRPTMKEVAM 353 (400)
Q Consensus 338 l~~dP~~RPt~~ell~ 353 (400)
++.||.+|||+.|+|.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999985
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=294.82 Aligned_cols=264 Identities=23% Similarity=0.279 Sum_probs=196.6
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLET-- 151 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 151 (400)
++....++|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 3445678999999999999999999985 468899999876432 22346678899999999999999999987643
Q ss_pred ----CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEE
Q 042371 152 ----EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVA 227 (400)
Q Consensus 152 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~ 227 (400)
...+++++++ +++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence 3467888877 78998887643 3889999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH-h
Q 042371 228 DFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS-M 305 (400)
Q Consensus 228 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~ 305 (400)
|||++..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ........ .
T Consensus 163 dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 236 (345)
T cd07877 163 DFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGT 236 (345)
T ss_pred cccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCC
Confidence 9999875421 2233467889999999866 5688999999999999999999999954332110 00000000 0
Q ss_pred hhcccc-cccch---h-----------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 EENRLY-DFLDD---Q-----------VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 ~~~~~~-~~~~~---~-----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+. .+.+. . .........+..+.+++.+||+.||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 00000 0 0000001134568899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=328.29 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=200.6
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.-++.-...||.|.||.||.|.. .+|...|+|.+... .......+.+|..++..++|||+|++||+=.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34566677899999999999995 46888999966542 2334567789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
|||++|+|.+++.... ..++.....+..|++.|+.|||+.| ||||||||+||+++.+|.+|++|||.|..+..+
T Consensus 1314 EyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999998654 3566667778899999999999999 999999999999999999999999999876543
Q ss_pred Cce---eeecccccCCCCCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 239 QTH---VTTKVQGTFGYLDPEYFRSGQ---FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 239 ~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
... ......||+.|||||++.+.. -..+.||||+||++.||+||+.||........ .+ .....+..+
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---IM---y~V~~gh~P- 1460 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---IM---YHVAAGHKP- 1460 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---HH---hHHhccCCC-
Confidence 211 122456999999999997643 45689999999999999999999954443321 11 111112222
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+.+-.+|+.+||..||.+|.++.+++++
T Consensus 1461 --------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 --------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2233366778899999999999999888877664
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=274.32 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=199.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc-cCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI-VHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.+..+.+..||+|+.|.|++++.+ .|...|||.+.. .+..+..+++..++++..-+ +|+||+.+|+|..+..+++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 345566778999999999999965 588999998764 44566778888888877664 999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
|.|. ..+..++..... ++++..+-++...+..||.||..+.+ |+|||+||+|||+|+.|++||+|||.+-++.+
T Consensus 171 elMs-~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvd- 244 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVD- 244 (391)
T ss_pred HHHH-HHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeec-
Confidence 9984 477777766443 69999999999999999999988654 99999999999999999999999999977643
Q ss_pred CceeeecccccCCCCCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
....+...|.+.|||||.+.- ..|+..+||||||++++||.||+.||..-..+ .... ....+ ..
T Consensus 245 -SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----Fe~l--tkvln-~e----- 311 (391)
T KOG0983|consen 245 -SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----FEVL--TKVLN-EE----- 311 (391)
T ss_pred -ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----HHHH--HHHHh-cC-----
Confidence 334455679999999999864 46899999999999999999999999543221 0000 00101 00
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+.. .......++.+.+|+..||..|+.+||...+++++
T Consensus 312 PP~-L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPL-LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCC-CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 011 11122367789999999999999999999999886
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=284.50 Aligned_cols=242 Identities=22% Similarity=0.287 Sum_probs=185.8
Q ss_pred eeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHH---HHHhCCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 90 ILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVV---ILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~---~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
.||+|+||.||++... +++.||+|.+.... ......+..|.. .++...||+|+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 58899999765422 111122333433 3444579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
|++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~ 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---C
Confidence 999999886543 5899999999999999999999999 999999999999999999999999998754322 1
Q ss_pred eecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 243 TTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
.....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||.......... . ...... ....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---~-~~~~~~----------~~~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---I-DRMTLT----------MAVE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---H-HHHhhc----------cCCC
Confidence 2234689999999998754 68999999999999999999999995442211100 0 000000 0011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
.+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1222356799999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=290.64 Aligned_cols=266 Identities=24% Similarity=0.301 Sum_probs=193.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETE------ 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 152 (400)
.++|++.+.||.|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++.+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 58899999775432 222346678999999999999999998875443
Q ss_pred --cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 153 --VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 153 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
..++||+|+.+ +|...+.... ..+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999965 6777765433 25899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCce----------eeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHH
Q 042371 231 TSKFIVIDQTH----------VTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAA 299 (400)
Q Consensus 231 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 299 (400)
++......... ..+...+++.|+|||.+.+. .++.++||||||+++|+|++|++||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99765322111 11234568889999987654 58999999999999999999999985433221111000
Q ss_pred HHHHHhhhc------cccccc--------chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 300 YFILSMEEN------RLYDFL--------DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 300 ~~~~~~~~~------~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......... .+.... ...+ ........+.+.+++.+||+.||.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL-EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccH-HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000000 000000 0000 00011223568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=284.64 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=195.1
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc-hhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEEEcc
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE-GKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
|++.+.||+|+||.||+|... +++.++||.+..... .......+|+..++.++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999975 478899998654322 22234567899999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
+++|.+++..... ..+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 7899998876542 25899999999999999999999999 9999999999999999999999999997653221
Q ss_pred eeecccccCCCCCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchH----------HHHHHHhhhccc
Q 042371 242 VTTKVQGTFGYLDPEYFR-SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLA----------AYFILSMEENRL 310 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~----------~~~~~~~~~~~~ 310 (400)
......++..|+|||++. +..++.++|+||||+++|+|++|++||............ .+.........+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 223345788999999875 456899999999999999999999998544321110000 000000000000
Q ss_pred ccccchhh---hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFLDDQV---LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+.... ........+..+.+++.+||+.+|.+|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 000001114668999999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=297.07 Aligned_cols=264 Identities=24% Similarity=0.335 Sum_probs=194.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC---------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLET--------- 151 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------- 151 (400)
..+|.+.+.||.|+||.||+|... ++..||+|++........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999964 5889999988766666667888999999999999999999776543
Q ss_pred -----CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCcEE
Q 042371 152 -----EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-KYTAK 225 (400)
Q Consensus 152 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~~k 225 (400)
...++||||++ ++|.+++... .+++..++.++.||+.||.|||..+ |+||||||+||+++. ++.++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34689999997 5888887542 4889999999999999999999999 999999999999974 56789
Q ss_pred EEecCCccccccCCce--eeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH
Q 042371 226 VADFGTSKFIVIDQTH--VTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 226 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 302 (400)
|+|||++......... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...............
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~- 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES- 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-
Confidence 9999999764321111 1122357889999998654 56888999999999999999999999543321110000000
Q ss_pred HHhh----hcccccccchhh----------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 303 LSME----ENRLYDFLDDQV----------LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 303 ~~~~----~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.... ...+........ ........+..+.+++.+||+.||.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 000000000000 000011234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=292.39 Aligned_cols=263 Identities=24% Similarity=0.291 Sum_probs=195.2
Q ss_pred hcCCc-ccceeeecCcEEEEEEEec-CCcEEEEEEccccCchh--------------HHHHHHHHHHHHhCCCCcceeee
Q 042371 82 TDHFN-VNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGK--------------LEEFINEVVILSQINHRNVVKLL 145 (400)
Q Consensus 82 ~~~y~-~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~~iv~~~ 145 (400)
.++|. +.+.||.|+||.||+|... +++.||+|.+....... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 4578999999999999965 68899999875432211 12467899999999999999999
Q ss_pred eEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEE
Q 042371 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAK 225 (400)
Q Consensus 146 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~k 225 (400)
+++...+..++||||+. ++|.+++.... .+++.....++.|++.||.|||..+ ++|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 58999886543 4899999999999999999999999 99999999999999999999
Q ss_pred EEecCCccccccCC-------------ceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCC
Q 042371 226 VADFGTSKFIVIDQ-------------THVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGS 291 (400)
Q Consensus 226 l~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~ 291 (400)
|+|||++....... ........+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999987653110 1111223467889999998764 478999999999999999999999964432
Q ss_pred ccccchHHHHHHHhhhc---ccccccc-----------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 292 KEATGLAAYFILSMEEN---RLYDFLD-----------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~---~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... ........... .+..... +..........+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 240 ~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 211 10000000000 0000000 000000111234668899999999999999999999974
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=286.90 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=195.5
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC-CcEEEEEEccccC-chhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVH-EGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 157 (400)
..++|++.+.||+|+||.||+|...+ ++.+|+|.+.... ......+..|+.++... +||||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 44678999999999999999999764 8899999876432 23445666777777666 499999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
|||+. ++|.+++..... ++++..+..++.|++.||.|||. .+ |+||||+|+||+++.++.++|+|||++....
T Consensus 93 ~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 578887765433 58999999999999999999997 47 9999999999999999999999999987653
Q ss_pred cCCceeeecccccCCCCCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQ----FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .... ....... ...
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~-~~~~~~~-~~~ 238 (296)
T cd06618 167 DSK--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVL-TKILQEE-PPS 238 (296)
T ss_pred CCC--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHH-HHHhcCC-CCC
Confidence 221 122234788999999987553 889999999999999999999998432111 0000 0111110 000
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.......+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 239 -------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 239 -------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0011124566899999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=292.84 Aligned_cols=264 Identities=23% Similarity=0.305 Sum_probs=197.1
Q ss_pred HHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC----
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE---- 152 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 152 (400)
...++|++.+.||+|+||.||++.. .++..||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999985 46889999987532 2223456789999999999999999999887554
Q ss_pred --cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 153 --VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 153 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
..++||+|+ +++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 348999999 77998887642 4899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH------
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL------ 303 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------ 303 (400)
++..... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... ........
T Consensus 164 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCH
Confidence 9875432 1223457889999999876 458899999999999999999999995432211 00000000
Q ss_pred ----Hhhhcc-------cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 042371 304 ----SMEENR-------LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERI 358 (400)
Q Consensus 304 ----~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~ 358 (400)
...... +..+.... ........+..+.+++.+||+.||.+|||+.+++.+ ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKD-FRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcch-HHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000 00000000 000112234568899999999999999999999954 4444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=290.92 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=196.1
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc--cCchhHHHHHHHHHHHHhCCCCcceeeeeEEee-CCcce
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRNVVKLLGCCLE-TEVPL 155 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 155 (400)
...++|++.+.||.|+||.||++... +++.+|+|++.. ........+..|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35678999999999999999999855 688999997653 223345678899999999999999999999875 45788
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+++||+ +++|.+++... ++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 56898887642 4788888899999999999999999 999999999999999999999999998753
Q ss_pred ccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH--------HHHhh
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF--------ILSME 306 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~ 306 (400)
.. ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||............... .....
T Consensus 159 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 159 DP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred CC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 21 1223457889999998766 56899999999999999999999999543321100000000 00000
Q ss_pred hcccccccchhh-hcc-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 307 ENRLYDFLDDQV-LKV-----GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 307 ~~~~~~~~~~~~-~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....+++.... ... .....+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 000 011234678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=273.98 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=200.9
Q ss_pred ceeeecCcEEEEEEE-ecCCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 89 RILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
+.||+|+++.|-.+. ..+|..||||++.........++.+|++++.+. .|+||++++++|.++..+|||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999999887 568999999998877777788999999999999 599999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---cEEEEecCCccccccCC----
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY---TAKVADFGTSKFIVIDQ---- 239 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl~Dfgla~~~~~~~---- 239 (400)
...|+.+. .+++..+..+..+|+.||.+||.+| |.|||+||+|||..... -+||+||.++.-...+.
T Consensus 164 LshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99998776 4899999999999999999999999 99999999999997654 58999999875433211
Q ss_pred --ceeeecccccCCCCCccccc---c--CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCcc-------ccchHHHH-HHH
Q 042371 240 --THVTTKVQGTFGYLDPEYFR---S--GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE-------ATGLAAYF-ILS 304 (400)
Q Consensus 240 --~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-------~~~~~~~~-~~~ 304 (400)
.....+.+|+..|||||+.. + .-|+.+.|.||||+|+|-|++|++||...-..+ ....-... ...
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 12233467888999999753 2 358899999999999999999999995443211 01010011 111
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAM 353 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 353 (400)
+. +..+++++. .+...+.+..+++..+|..++.+|.++..++.
T Consensus 318 IQ-EGkYeFPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQ-EGKYEFPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred Hh-ccCCcCChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 12 222333333 23456677899999999999999999988877
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=283.07 Aligned_cols=262 Identities=26% Similarity=0.355 Sum_probs=198.5
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
|++.+.||+|+||.||+|... +++.+|+|...... ......+..|+.+++.++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999965 48999999876542 344567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
+ ++|.+++..... .+++..++.++.+++.||.+||..+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRPG--PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 589999987532 4899999999999999999999999 99999999999999999999999999976543221
Q ss_pred eeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh-------------h
Q 042371 242 VTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME-------------E 307 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------------~ 307 (400)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.................... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 22233457789999998766 789999999999999999999999854332111000000000000 0
Q ss_pred cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+........ ....+..+..+.+++.+||+.+|.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000 00111225679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.58 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=194.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE------ 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 152 (400)
.++|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999964 6889999987542 2233456789999999999999999999886543
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..++|+||+.. +|..++. ..+++..+..++.|++.||.|||..+ ++||||||+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999964 7766542 14889999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH-HHhhhccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI-LSMEENRL 310 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 310 (400)
..... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .+..... .......+
T Consensus 165 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 165 RHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPEF 238 (342)
T ss_pred cCCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHH
Confidence 75421 1223457889999999876 468999999999999999999999996432111 0000000 00000000
Q ss_pred c---------ccc-------chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHH
Q 042371 311 Y---------DFL-------DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERIQA 360 (400)
Q Consensus 311 ~---------~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~~~ 360 (400)
. ... .... ....+..+..+.+++.+||+.||.+|||+.+++.+ ++.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchH-HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 000 0000 00001234568899999999999999999999976 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=290.01 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=191.9
Q ss_pred CCcccceeeecCcEEEEEEEec-C--CcEEEEEEcccc--CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeC----Cc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-D--GRIVAVKKSKIV--HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLET----EV 153 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~--~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----~~ 153 (400)
+|++.+.||+|+||.||++... . +..+|+|.+... .....+.+.+|+.+++.+ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999964 3 678999987642 223356778899999999 599999999875432 35
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.+++++|+. ++|.+++.... .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688999986 68988886543 5899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCce---eeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHH--------H
Q 042371 234 FIVIDQTH---VTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAY--------F 301 (400)
Q Consensus 234 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~--------~ 301 (400)
........ ......|++.|+|||.+.+ ..++.++||||+|+++|+|++|..||.............. .
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65422111 1223468999999998765 4689999999999999999999999854332110000000 0
Q ss_pred HHHhhhcccccc------cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 302 ILSMEENRLYDF------LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 302 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
............ .............+..+.+++.+||+.||.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 00000000111124568999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=274.23 Aligned_cols=203 Identities=25% Similarity=0.369 Sum_probs=170.3
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC-----CcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEee-CC
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD-----GRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLE-TE 152 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 152 (400)
....|++.+.||+|.||.||+|..++ ...+|||+++... ........+|+..++.++|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34579999999999999999997432 2378999887543 3345677899999999999999999999877 77
Q ss_pred cceEEEEccCCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC----CcEEE
Q 042371 153 VPLLVYEFISNGTLFQYLHDQN--EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK----YTAKV 226 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~----~~~kl 226 (400)
.+++++||++. +|..+|+.+. ....++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999986 9999886542 2346899999999999999999999998 9999999999999877 89999
Q ss_pred EecCCccccccCCc--eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCC
Q 042371 227 ADFGTSKFIVIDQT--HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPII 287 (400)
Q Consensus 227 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~ 287 (400)
+|||+++.+...-. .....++-|..|+|||.+.+. .||.+.|||++|||+.||++-.+-|.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 99999998754322 223446679999999998775 69999999999999999999887763
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=294.49 Aligned_cols=260 Identities=25% Similarity=0.325 Sum_probs=196.2
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc----
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV---- 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 153 (400)
..++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++|||++++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999975 5789999987542 23344667789999999999999999988765544
Q ss_pred --ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 154 --PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 154 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
.++|+||+ +++|.+++... .+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 79999999 67999988652 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH-Hhhhcc
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL-SMEENR 309 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 309 (400)
+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ....... ......
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~i~~~~~~~~~~ 238 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCCHH
Confidence 9765322 233457889999999865 3678999999999999999999999954322110 0000000 000000
Q ss_pred -cccccchh-------h-------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 -LYDFLDDQ-------V-------LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 -~~~~~~~~-------~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+.... . ........+..+.+++.+||+.+|.+|||+.+|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 0 000011235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.69 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=194.4
Q ss_pred CCcccceeeecCcEEEEEEEecC-CcEEEEEEccc-----cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKI-----VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
+|.+.+.||+|+||.||++.... +..+++|..+. ........+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999998643 34444444332 1223345667889999999999999999999988899999
Q ss_pred EEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 158 YEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988652 22335899999999999999999999999 999999999999986 579999999987653
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... ....
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~-~~~~------- 221 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRI-VEGP------- 221 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-HcCC-------
Confidence 322 222345578899999999888899999999999999999999999843211 1111111 0110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111233556678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=278.69 Aligned_cols=272 Identities=24% Similarity=0.344 Sum_probs=203.4
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHh--CCCCcceeeeeEEeeCC----c
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQ--INHRNVVKLLGCCLETE----V 153 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~----~ 153 (400)
...++..+.+.||+|.||.||+|.++ |..||||++... +...+.+|.+|.+. |+|+||+.+++.-..++ .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 44678899999999999999999996 788999987643 33556777787766 59999999998765433 5
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCCeEEcCCCcEEEEe
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-----AASMPIYHRDIKSTNILLNEKYTAKVAD 228 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~iiHrDikp~NIll~~~~~~kl~D 228 (400)
+|||.+|.+.|+|.|+|.+. .++....++++..++.||++||. +|++.|.|||||..|||+..+|.+-|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 78999999999999999874 48999999999999999999995 5678899999999999999999999999
Q ss_pred cCCccccccCCce---eeecccccCCCCCccccccCC----C-C-CcchhHHHHHHHHHHHhC----------CCCCCcC
Q 042371 229 FGTSKFIVIDQTH---VTTKVQGTFGYLDPEYFRSGQ----F-T-DKSDVYSFGVVLVELLTG----------QKPIILT 289 (400)
Q Consensus 229 fgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~-~-~~~DiwSlG~il~elltg----------~~pf~~~ 289 (400)
+|||......... .....+||.+|||||++...- + + ..+||||||.++||+... +.||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999754433222 223467999999999986532 1 1 258999999999999873 4676444
Q ss_pred CCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 290 GSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
.+.+.....+. +.-.+.++-..-.......+....+.++++.||..||.-|-|+--+.+.|.++..+.++
T Consensus 440 Vp~DPs~eeMr-----kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 440 VPSDPSFEEMR-----KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK 509 (513)
T ss_pred CCCCCCHHHHh-----cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence 33222111100 00011111111111122345556788999999999999999999999999998764433
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=306.28 Aligned_cols=265 Identities=28% Similarity=0.436 Sum_probs=215.4
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEec----C----CcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeee
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLA----D----GRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLG 146 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~----~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 146 (400)
.|+...++..+.+.||+|.||.|++|... . ...||+|.++.. ...+.+.+..|+.+|+.+ .|+||+.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56666777788889999999999999832 1 356999987753 345678899999999999 5999999999
Q ss_pred EEeeCCcceEEEEccCCCCHHHHHhhcC------CC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 042371 147 CCLETEVPLLVYEFISNGTLFQYLHDQN------EE-------FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKS 213 (400)
Q Consensus 147 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp 213 (400)
++...+..++|+||+..|+|.++++... .. ..++....+.++.||+.|++||++.. ++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998765 00 13888999999999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEEecCCccccccCCceeeecccc--cCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCC
Q 042371 214 TNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG--TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTG 290 (400)
Q Consensus 214 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~ 290 (400)
.|||+..+..+||+|||+|+..............+ ...|||||.+....|+.++||||||++|||+++ |..|+....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999998654433333232222 446999999999999999999999999999999 888984311
Q ss_pred CccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 291 SKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
.. ..+.+.+.++.+...+..++.+++++++.||+.+|.+||++.++.+.|..+.
T Consensus 527 ~~---------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PT---------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cH---------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 00 1111223333344455566788999999999999999999999999999954
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.37 Aligned_cols=256 Identities=27% Similarity=0.477 Sum_probs=212.9
Q ss_pred CcccceeeecCcEEEEEEEe-cCC----cEEEEEEccc-cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 85 FNVNRILGQGGQGTVYKGML-ADG----RIVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~-~~~----~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.+..++||+|+||+||+|.+ +.| -+||||.+.. .......+++.|+.+|..++|||++++++++.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45567999999999999985 333 4789997653 34555788999999999999999999999998776 77999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
+|+++|+|.++++.+.. .+..+..+.|..||++||.|||.+. ++||||...||||.....+||+|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999988655 4888999999999999999999999 999999999999999999999999999987655
Q ss_pred Cceeeec-ccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 239 QTHVTTK-VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 239 ~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
....... ..-.+.|||-|.+....|+.++|||||||++||++| |..|+...... .+.++++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----------------eI~dlle~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----------------EIPDLLEK 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------------HhhHHHhc
Confidence 4443322 223567999999999999999999999999999999 99998543332 23344444
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
+.+-..++..+..+..++.+||..|+..||+++++...+......-
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 4445556677778999999999999999999999999998876543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=288.78 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=210.1
Q ss_pred cceeeecCcEEEEEEEe-cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCC
Q 042371 88 NRILGQGGQGTVYKGML-ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
.+.||+|.||+||-|.. ++|+.||||.+... .......+.+|+.||+++.||.||.+...|...+.+++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 57899999999999995 57999999977642 34445788899999999999999999999999999999999995 5
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CcEEEEecCCccccccCCce
Q 042371 165 TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK---YTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 165 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~Dfgla~~~~~~~~~ 241 (400)
++.+.|-....+ .+++..-..++.||+.||.|||.++ |+|+||||+|||+.+. ..+||+|||+|+++. ...
T Consensus 648 DMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--Eks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKG-RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKS 721 (888)
T ss_pred hHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc--hhh
Confidence 777766554433 5999999999999999999999999 9999999999999754 489999999999874 444
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
....++|||.|+|||++.+..|...-|+||+|||+|--++|..||..... . ...+.+..++ - ...
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----I----ndQIQNAaFM---y---Pp~ 786 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----I----NDQIQNAAFM---Y---PPN 786 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----h----hHHhhccccc---c---CCC
Confidence 55678899999999999999999999999999999999999999943211 0 1111121111 1 112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--------HHHHHHHhhcccccccccc
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--------LERIQALQKDINVKQICDE 373 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--------L~~~~~~~~~~~~~~~~~~ 373 (400)
.+.+.+....+||..+|+..-.+|-|...-+.+ -.++++...+.+...+..|
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThe 846 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHE 846 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCc
Confidence 234556678899999999999999998877655 3356666666665555444
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=268.68 Aligned_cols=236 Identities=30% Similarity=0.347 Sum_probs=191.1
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 91 LGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 91 lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
||.|+||.||++... +++.+|+|.+.... ......+..|+.+++.++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 58899999765432 23456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecc
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV 246 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 246 (400)
.+++.... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 99997654 4899999999999999999999999 9999999999999999999999999997653321 223345
Q ss_pred cccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHH
Q 042371 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE 326 (400)
Q Consensus 247 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (400)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .. ....... ....+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~-~~~~~~~----------~~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EI-YEKILKD----------PLRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHhcC----------CCCCCCCC
Confidence 6788999999998888999999999999999999999999433210 00 0000000 01112222
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHH
Q 042371 327 IMTIATLATRCLNLNGKRRPTMKE 350 (400)
Q Consensus 327 ~~~l~~li~~cl~~dP~~RPt~~e 350 (400)
+..+.+++.+||..||.+|||+.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 566889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=278.28 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=205.5
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCC--CC----cceeeeeEEeeC
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQIN--HR----NVVKLLGCCLET 151 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--h~----~iv~~~~~~~~~ 151 (400)
+....+|.+...+|+|.||.|-.+.+. .+..||||+++..... .+..+-|+++|.++. -| -++.+.++|...
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 445889999999999999999998864 3688999988765333 356677999999994 23 378888999999
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----------
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE----------- 220 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~----------- 220 (400)
+..+||+|.+ |-++.+++..++.. +++...++.++.|+++++++||+.+ ++|.||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~-~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYI-PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCcc-ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCC
Confidence 9999999988 67999999876544 6999999999999999999999999 999999999999932
Q ss_pred ---------CCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCC
Q 042371 221 ---------KYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGS 291 (400)
Q Consensus 221 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 291 (400)
+..++|+|||.|++..... ..++.|..|+|||++.+-.++..+||||+||||+|+.+|..-|....+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 2368999999998753222 456689999999999999999999999999999999999999876664
Q ss_pred ccccchHHHHHHHhhhcccc-------------cccch---h-------------hhccCCHHHHHHHHHHHHHhcccCC
Q 042371 292 KEATGLAAYFILSMEENRLY-------------DFLDD---Q-------------VLKVGQKEEIMTIATLATRCLNLNG 342 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~-------------~~~~~---~-------------~~~~~~~~~~~~l~~li~~cl~~dP 342 (400)
.+-..++.....+++...+. ++.+. + ........+...|.+|+.+||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 44333333222211111000 00000 0 0001123344569999999999999
Q ss_pred CCCCCHHHHHHH
Q 042371 343 KRRPTMKEVAME 354 (400)
Q Consensus 343 ~~RPt~~ell~~ 354 (400)
.+|+|+.|++.+
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=291.15 Aligned_cols=243 Identities=21% Similarity=0.276 Sum_probs=195.5
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
..+.|.+...+|.|+|+.|..+.. ..++..++|++... .....+|+.++... +||||+++.+.+.+....|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467899999999999999998885 45788999987654 12234566666655 7999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE-cCCCcEEEEecCCcccccc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL-NEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll-~~~~~~kl~Dfgla~~~~~ 237 (400)
|.+.|+-|.+.+.... .....+..|+.+|+.|+.|||.+| ++||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998888876654 233677789999999999999999 9999999999999 5889999999999986543
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. ..+.+-|..|.|||++....|++++||||||++||+||+|+.||.....+ .. ....+..+++
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~e--i~~~i~~~~~------- 531 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IE--IHTRIQMPKF------- 531 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HH--HHHhhcCCcc-------
Confidence 3 33344588999999999999999999999999999999999999655443 00 1111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
....+...++|+.+||++||.+||++.++..+=.
T Consensus 532 -----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 532 -----SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred -----ccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 1445667899999999999999999999987633
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=247.20 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=201.6
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|.-.++||+|.||+||+|+.. .++.||+|.++.. ++......++|+-+++.+.|.|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666789999999999999955 5789999987654 455678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
|.. +|..+...-++ .++...+..++.|++.||.++|+.+ +.|||+||+|+||+.+|.+|++|||+++.+.....
T Consensus 83 cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 964 89888877554 4889999999999999999999999 99999999999999999999999999998754433
Q ss_pred eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHH-Hh-hhc---ccccc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFIL-SM-EEN---RLYDF 313 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~-~~-~~~---~~~~~ 313 (400)
.. ..-+-|..|.+|.++.+. -|+++.|+||.||++.|+.. |++-|. +.+-.+++...+.. .. .+. .+..+
T Consensus 157 cy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp--g~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 CY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC--CCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 33 334469999999998876 58999999999999999998 444442 22222333332221 11 111 22222
Q ss_pred cchhhhccCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LDDQVLKVGQ---------KEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.|-......+ +.....=++++.+.|.-+|.+|.+++..+++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2322222111 2222344789999999999999999988764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.50 Aligned_cols=146 Identities=29% Similarity=0.406 Sum_probs=131.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|.+.+.||+|+||.||+|... +++.||||++... .......+..|+.++..++||||+++++++...+..+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999975 6889999987542 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
|||+.+++|.+++.... .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997644 4788999999999999999999998 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=269.92 Aligned_cols=219 Identities=21% Similarity=0.179 Sum_probs=175.6
Q ss_pred cCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCHHHHHhh
Q 042371 94 GGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHD 172 (400)
Q Consensus 94 G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 172 (400)
|.||.||++... +++.+|+|.+.... ....|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 68899999876432 223455555566799999999999999999999999999999999876
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCC
Q 042371 173 QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252 (400)
Q Consensus 173 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 252 (400)
.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 53 4899999999999999999999999 999999999999999999999999987654321 1223457789
Q ss_pred CCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHH
Q 042371 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT 332 (400)
Q Consensus 253 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 332 (400)
+|||.+.+..++.++|+||+|+++|+|++|+.|+....... .. ......+...+..+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~---------~~~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT---------HTTLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc---------ccccCCcccCCHHHHH
Confidence 99999988889999999999999999999998874221100 00 0000112234556889
Q ss_pred HHHHhcccCCCCCCCH
Q 042371 333 LATRCLNLNGKRRPTM 348 (400)
Q Consensus 333 li~~cl~~dP~~RPt~ 348 (400)
++.+||+.||.+|||+
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=275.20 Aligned_cols=270 Identities=27% Similarity=0.390 Sum_probs=202.2
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhC--CCCcceeeeeEEeeCC----cce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQI--NHRNVVKLLGCCLETE----VPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~----~~~ 155 (400)
....++.++||+|.||.||+|.+. ++.||||++. ....+.|.+|-+|.+.. .|+||+++++.-...+ .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345677889999999999999985 5899999765 55667888888887764 7999999998865544 789
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeEEcCCCcEEEEec
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA------SMPIYHRDIKSTNILLNEKYTAKVADF 229 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~iiHrDikp~NIll~~~~~~kl~Df 229 (400)
||++|.+.|+|.++|..+. ++|....+++..++.||+|||..- +++|+|||||..||||.++++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999998764 899999999999999999999743 467999999999999999999999999
Q ss_pred CCccccccCCc-eeeecccccCCCCCccccccCC-CC-----CcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHH--
Q 042371 230 GTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQ-FT-----DKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAY-- 300 (400)
Q Consensus 230 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~-- 300 (400)
|+|..+..... ......+||.+|||||++.+.- +. .+.||||+|.+||||++...-+.. +......+.-.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAE 439 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHH
Confidence 99987753322 2233467999999999998652 22 358999999999999996543321 11111111100
Q ss_pred ----------HHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 301 ----------FILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 301 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
............+.+ ... ......-+.+.+..||..||+-|.|+.=+.+.+..+......
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~-~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPD-AWR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChh-hhh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 000111111111111 111 113345688999999999999999999999999998876544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=286.18 Aligned_cols=251 Identities=23% Similarity=0.275 Sum_probs=205.2
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCc-EEEEEEcc---ccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGR-IVAVKKSK---IVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~-~vaiK~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
..+++....||-||||.|=++..++.. .+|+|.++ .......+++..|-.||...++|+||++|..|.+...+|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 356677778999999999998876543 37777544 45667788999999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
||-|-||.|+..++.++ .+.......++..+++|+.|||++| ||.|||||+|+|++.+|-+||.|||+|+.+.
T Consensus 499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~- 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG- 571 (732)
T ss_pred HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc-
Confidence 99999999999998876 4888899999999999999999999 9999999999999999999999999999875
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
....+-+.+|||.|.|||++.+...+.++|.||||+++|||++|.+||...++ +..|..... .-.
T Consensus 572 -~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-----mktYn~ILk-Gid-------- 636 (732)
T KOG0614|consen 572 -SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-----MKTYNLILK-GID-------- 636 (732)
T ss_pred -cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-----HHHHHHHHh-hhh--------
Confidence 34455678999999999999999999999999999999999999999965433 222221110 000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAMEL 355 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~L 355 (400)
....+........++++++...+|.+|.. +.++.+|-
T Consensus 637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 637 -KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred -hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 01122333445779999999999999965 55555553
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.15 Aligned_cols=266 Identities=21% Similarity=0.314 Sum_probs=200.0
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEee--------C
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLE--------T 151 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~ 151 (400)
+.|.-..+||+|.||.||+|+.+ .|++||+|++-.. ...-....++|+.+|..+.|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666789999999999999965 5788999975543 34445677899999999999999999887653 2
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
..+|+||++|+. +|..++....- .++...+.+++.++..||.|+|... |+|||+||+|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999976 89999876543 4889999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCc---eeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh
Q 042371 232 SKFIVIDQT---HVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307 (400)
Q Consensus 232 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 307 (400)
++.+..... ...+..+-|..|++||.+.+ ..|+++.|||+.||+|.+|+||.+-|..........+....-..+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987653322 22344456999999998775 57999999999999999999999887544433322222222222222
Q ss_pred cccccccchhhhccC---------CHH---------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 NRLYDFLDDQVLKVG---------QKE---------EIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~---------~~~---------~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+.+.....-.+.... ... ......+|+.++|..||.+|+++++++.+
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 223222221111111 000 11356799999999999999999998865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=278.80 Aligned_cols=259 Identities=29% Similarity=0.420 Sum_probs=202.0
Q ss_pred HHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC-------chhHHHHHHHHHHHHhCCCCcceeeeeEEee-
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH-------EGKLEEFINEVVILSQINHRNVVKLLGCCLE- 150 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 150 (400)
...++|-++.+||+|||+.||+|.+ ..++.||+|+-.... ..-.....+|.+|-+.|+||.||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4457899999999999999999994 467889999654322 1224567899999999999999999999864
Q ss_pred CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCcEEEE
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE---KYTAKVA 227 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~ 227 (400)
.+.++-|+|||+|.+|.-+|..+. .+++..++.|+.||+.||.||.... .+|||-||||.|||+.. .|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 557789999999999999998766 5899999999999999999999876 77999999999999954 4789999
Q ss_pred ecCCccccccCCc------eeeecccccCCCCCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccch
Q 042371 228 DFGTSKFIVIDQT------HVTTKVQGTFGYLDPEYFRSG----QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGL 297 (400)
Q Consensus 228 Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 297 (400)
|||+++.+..+.. ..+....||.+|++||.+.-+ ..+.++||||+|||+|..+.|+.||....... ..
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HH
Confidence 9999998754322 223446799999999987533 47889999999999999999999996544322 11
Q ss_pred HHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042371 298 AAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAM 353 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 353 (400)
.....+... ..+.....+..+.+..+||++||+..-++|....+++.
T Consensus 694 -------LqeNTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 -------LQENTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------Hhhhchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111 01111222345567889999999999999988777764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=281.70 Aligned_cols=207 Identities=24% Similarity=0.366 Sum_probs=177.7
Q ss_pred hcCCcccceeeecCcEEEEEEEecC-CcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
..-|..++.||-|+||.|.++...| ...||+|.+.. .....+.....|.+||..-+.+.||+||-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3567788999999999999998544 56789996653 3355677888999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|+|++||++..+|.+.+ .+++..++.++.++..|+.+.|+-| +|||||||+|||||.+|++||+||||++-+.-
T Consensus 708 MdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999998766 4899999999999999999999999 99999999999999999999999999865431
Q ss_pred CC--------cee---------------------------------eecccccCCCCCccccccCCCCCcchhHHHHHHH
Q 042371 238 DQ--------THV---------------------------------TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVL 276 (400)
Q Consensus 238 ~~--------~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 276 (400)
.. ... .-..+||+.|+|||++....|+..+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00 000 0114599999999999999999999999999999
Q ss_pred HHHHhCCCCCCcCCCccc
Q 042371 277 VELLTGQKPIILTGSKEA 294 (400)
Q Consensus 277 ~elltg~~pf~~~~~~~~ 294 (400)
|||+.|++||......+.
T Consensus 862 ~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHhhCCCCccCCCCCcc
Confidence 999999999977665544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=264.55 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=205.0
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 155 (400)
..++|.++++||+|+|+.|..+..+ ..+.+|+|.++. ....+++....|-.+..+- +||.+|.++.+|..+.+++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3478999999999999999999864 578899997664 3455677788888888776 6999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+|.||.+||+|.-.++++. .+++..++.+...|..||.|||+.| ||.||||.+|||+|..|++||+|+|+++.-
T Consensus 328 fvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999987777654 4999999999999999999999999 999999999999999999999999999753
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccc-hHHHHHHHhhhccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATG-LAAYFILSMEENRLYDFL 314 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 314 (400)
......+.+.+|||.|.|||++.+..|..++|+|+||++|+||+.|+.||...+.+.... ...|....+.+.
T Consensus 402 -l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek------ 474 (593)
T KOG0695|consen 402 -LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK------ 474 (593)
T ss_pred -CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh------
Confidence 345566678999999999999999999999999999999999999999998777554332 222322222221
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT 347 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 347 (400)
++ ..+...+-....+++.-|+.||.+|..
T Consensus 475 --qi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 475 --QI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --cc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11 122333344567889999999999843
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=289.34 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=207.0
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEee-----CCc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLE-----TEV 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-----~~~ 153 (400)
.++.|++...||.|.+|.||++.. ++++..|+|+.... .+.-+++..|.++|+.. .|||++.+++++.. .+.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 356799999999999999999994 46888999977654 33346677889999888 69999999999863 457
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
+|||||||.||+..|+++... +..+.|..+..|+..++.|+.+||... ++|||||-.|||++.++.|||.|||.+.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 899999999999999998866 446999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceeeecccccCCCCCccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSG-----QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
.+..... ...+..|||.|||||++... .|+..+|+||||++..||.-|.+|+..+-+ ..+...+++
T Consensus 172 QldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------mraLF~IpR- 242 (953)
T KOG0587|consen 172 QLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFLIPR- 242 (953)
T ss_pred eeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------hhhhccCCC-
Confidence 7643332 33446799999999998653 477899999999999999999999843221 111111111
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.++.....+...++++.++|..||..|-.+||++.+++++
T Consensus 243 ------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 ------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1222333467788899999999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=292.49 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=169.9
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-C----CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeE------Ee
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-D----GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC------CL 149 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~------~~ 149 (400)
..++|.+.+.||+|+||.||+|... + +..||+|++..... .+....+ .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999965 4 68999998653222 1211211 1222222222222211 23
Q ss_pred eCCcceEEEEccCCCCHHHHHhhcCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 042371 150 ETEVPLLVYEFISNGTLFQYLHDQNEEF-----------------PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIK 212 (400)
Q Consensus 150 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik 212 (400)
.....++||||+.+++|.+++....... ......+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 4567899999999999999987543110 1123345679999999999999999 9999999
Q ss_pred CCCeEEcC-CCcEEEEecCCccccccCCceeeecccccCCCCCccccccC----------------------CCCCcchh
Q 042371 213 STNILLNE-KYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG----------------------QFTDKSDV 269 (400)
Q Consensus 213 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Di 269 (400)
|+|||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986544333344456789999999965322 23446799
Q ss_pred HHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh--c---ccccccchhhhc------cCCHHHHHHHHHHHHHhc
Q 042371 270 YSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE--N---RLYDFLDDQVLK------VGQKEEIMTIATLATRCL 338 (400)
Q Consensus 270 wSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl 338 (400)
|||||++|+|+++..|+... .... ...+.. . .+.......... ...........+|+.+||
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999977664211 1100 000000 0 000000000000 000011223558999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042371 339 NLNGKRRPTMKEVAME 354 (400)
Q Consensus 339 ~~dP~~RPt~~ell~~ 354 (400)
+.||.+|||+.+++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=264.86 Aligned_cols=257 Identities=23% Similarity=0.300 Sum_probs=194.3
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCc-hhHHHHHHHHHHHHh-CCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHE-GKLEEFINEVVILSQ-INHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++.+-+..||.|+||+|++-.. +.|+..|||+++.... ....+++.|.+...+ -+.||||++||.+..++..||.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3445567899999999999775 4689999999886543 556778888876544 579999999999999999999999
Q ss_pred ccCCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 160 FISNGTLFQYLHDQ--NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 160 ~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
.|+ .+|..+.... .....+++..+-.|......||.||...- .|||||+||+|||++..|.+||+|||.+-.+.
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv- 219 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV- 219 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH-
Confidence 995 5777665431 11225899988899999999999998754 39999999999999999999999999987653
Q ss_pred CCceeeecccccCCCCCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSG--QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.+...+...|...|||||.+... .|+.+||+||||++|||+.||..|+....+. +... ...-.+....+..
T Consensus 220 -~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----feql--~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 220 -DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----FEQL--CQVVIGDPPILLF 292 (361)
T ss_pred -HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----HHHH--HHHHcCCCCeecC
Confidence 23334455688899999998643 5899999999999999999999998543321 1000 0000111111100
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+..+..+|.-||..|-+.||.+.+++++
T Consensus 293 ----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 ----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11123466789999999999999999999998875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=258.12 Aligned_cols=238 Identities=29% Similarity=0.392 Sum_probs=192.1
Q ss_pred CcEEEEEEEec-CCcEEEEEEccccCchh-HHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCHHHHHhh
Q 042371 95 GQGTVYKGMLA-DGRIVAVKKSKIVHEGK-LEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHD 172 (400)
Q Consensus 95 ~fg~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 172 (400)
+||.||+|... +++.+|+|......... .+.+.+|+..++.++|+|++++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48899999877654444 68899999999999999999999999998999999999999999999876
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCC
Q 042371 173 QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252 (400)
Q Consensus 173 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 252 (400)
.. .+++..++.++.+++.++.+||..+ ++|+||+|.||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 44 2789999999999999999999998 9999999999999999999999999998654321 33345578899
Q ss_pred CCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHH
Q 042371 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT 332 (400)
Q Consensus 253 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 332 (400)
+|||.+.+..++.++||||||+++|+|++|..||....... ............. .......+..+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPF-------PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------HHHHHHhccCCCC-------ccccccCCHHHHH
Confidence 99999998889999999999999999999999985421110 0011111110000 0000014467899
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 042371 333 LATRCLNLNGKRRPTMKEVAM 353 (400)
Q Consensus 333 li~~cl~~dP~~RPt~~ell~ 353 (400)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=278.22 Aligned_cols=267 Identities=21% Similarity=0.263 Sum_probs=180.6
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-----------------cCCcEEEEEEccccCchhHHHH--------------HHH
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-----------------ADGRIVAVKKSKIVHEGKLEEF--------------INE 129 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-----------------~~~~~vaiK~~~~~~~~~~~~~--------------~~E 129 (400)
..++|.+.++||+|+||.||+|.. ..++.||||++........+.| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999863 2356799998865443333333 346
Q ss_pred HHHHHhCCCCcc-----eeeeeEEee--------CCcceEEEEccCCCCHHHHHhhcCC---------------------
Q 042371 130 VVILSQINHRNV-----VKLLGCCLE--------TEVPLLVYEFISNGTLFQYLHDQNE--------------------- 175 (400)
Q Consensus 130 ~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 175 (400)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 566676643 3467999999999999999875321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCCCCc
Q 042371 176 EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255 (400)
Q Consensus 176 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP 255 (400)
...+++..+..++.|++.+|.|||..+ |+||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 112456778899999999999999999 99999999999999999999999999975432221111222348899999
Q ss_pred cccccCC--------------------C--CCcchhHHHHHHHHHHHhCCC-CCCcCCCccccchHHHHHHHhhhccccc
Q 042371 256 EYFRSGQ--------------------F--TDKSDVYSFGVVLVELLTGQK-PIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 256 E~~~~~~--------------------~--~~~~DiwSlG~il~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
|.+.... | ..+.||||+||++|+|++|.. ||........ ....+. .. ...+..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~~~-~~--~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQYD-ND--LNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhhcc-ch--HHHHHh
Confidence 9875432 1 124799999999999999875 6632111100 000000 00 000000
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNG---KRRPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~ell~~ 354 (400)
..............++...+|+.+||..+| .+|+|++++++|
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000000111122345668899999999766 689999999876
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=242.41 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=196.8
Q ss_pred HhcCCcccceeeecCcEEEEEEE-ecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCC--cceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETE--VPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--~~~l 156 (400)
..++|++.+++|+|.++.||.|. ..++.+++||.++.. ....+.+|+.||..|. ||||+++++...+.. .+.|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35789999999999999999998 456889999988743 4567889999999996 999999999987654 5679
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CcEEEEecCCcccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSKFI 235 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~Dfgla~~~ 235 (400)
++||+++.+...+.. .++...+..++.+++.||.|+|+.| |+|||+||.|+|||.. ..++|+|||+|.+.
T Consensus 113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999887766553 3677788899999999999999999 9999999999999964 57999999999987
Q ss_pred ccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh---------
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM--------- 305 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------- 305 (400)
..... ....+.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||..... ..+++.......-
T Consensus 184 Hp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHH
Confidence 54332 222345778899998765 4689999999999999999999999955443 3333333321110
Q ss_pred -----hhcccccccchhhh--------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 -----EENRLYDFLDDQVL--------KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 -----~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
-+..+..++..... .......+++..+|+.+.|..|-.+|+|++|.+.+
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00111111111000 01111234678899999999999999999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=237.59 Aligned_cols=209 Identities=25% Similarity=0.387 Sum_probs=171.7
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcc
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 154 (400)
++...+.......||+|++|.|-+-+. .+|...|+|.+... +.....+.++|+++.... .+|++|.+||.......+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 455556667778999999999987774 57999999987653 344556778888886554 799999999999999999
Q ss_pred eEEEEccCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 155 LLVYEFISNGTLFQYLHD-QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
||.||.|. .+|..+-.. -..+..+++..+-+|+..+..||.|||++-+ ++|||+||+|||++.+|++|++|||.+-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 99999995 588887654 2334469999999999999999999999654 9999999999999999999999999997
Q ss_pred ccccCCceeeecccccCCCCCcccccc----CCCCCcchhHHHHHHHHHHHhCCCCCCcCCC
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRS----GQFTDKSDVYSFGVVLVELLTGQKPIILTGS 291 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 291 (400)
.+.+ +-..+...|...|+|||.+.. ..|+-++||||||+++.||.++++||...+.
T Consensus 198 ~L~d--SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVD--SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehh--hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 6632 223333568889999998753 3699999999999999999999999965543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=278.80 Aligned_cols=266 Identities=26% Similarity=0.378 Sum_probs=199.6
Q ss_pred CcccceeeecCcEE-EEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEccC
Q 042371 85 FNVNRILGQGGQGT-VYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 85 y~~~~~lg~G~fg~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
|.-.+.+|.|+-|+ ||+|.. +++.||||.+- ......+.+|+..|+.- +||||+++|+.-.+.+..||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 33456789998886 799998 57899999764 33345667899999888 59999999999999999999999996
Q ss_pred CCCHHHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---C--CcEEEEecCCccccc
Q 042371 163 NGTLFQYLHDQNEEFP-LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE---K--YTAKVADFGTSKFIV 236 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~--~~~kl~Dfgla~~~~ 236 (400)
. +|.+++........ ...-..+.++.|++.||++||+.+ ||||||||+||||+. + .+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 4 99999987411111 111345678899999999999999 999999999999976 2 479999999999886
Q ss_pred cCCcee--eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 237 IDQTHV--TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTG-QKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 237 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.+.... ..+..||.+|+|||++....-+.++||||+||++|+.++| .+||...-..+. ........+..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-------NIl~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-------NILTGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-------hhhcCccceeee
Confidence 554433 3457799999999999988888899999999999999995 999953322111 011111111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH---------HHHHHHHhhccccccccccc
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME---------LERIQALQKDINVKQICDEI 374 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~---------L~~~~~~~~~~~~~~~~~~~ 374 (400)
- ...++ +..+||.+|++++|..||++.+|+.+ |+-+++...+.++.+...+.
T Consensus 736 ~-------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~s 796 (903)
T KOG1027|consen 736 E-------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSPS 796 (903)
T ss_pred c-------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCch
Confidence 1 11111 57899999999999999999999854 77777777666654444443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=254.60 Aligned_cols=266 Identities=23% Similarity=0.376 Sum_probs=212.2
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEecC------CcEEEEEEccc-cCchhHHHHHHHHHHHHhCCCCcceeeeeEEe
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLAD------GRIVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCCL 149 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~------~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 149 (400)
++.....++++..++-+|.||.||.|.+.+ .+.|.+|.++. .++-+...++.|...+..+.|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 444556778888899999999999997543 34566675543 34556778889999999999999999999876
Q ss_pred eC-CcceEEEEccCCCCHHHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 042371 150 ET-EVPLLVYEFISNGTLFQYLH-----DQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223 (400)
Q Consensus 150 ~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 223 (400)
++ ..+++++.++.-|+|..++. ..+....+...+...++.|++.|+.|||+.+ +||.||...|.+||+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 54 57789999999999999998 3333446778888899999999999999999 999999999999999999
Q ss_pred EEEEecCCccccccCCceeee-cccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHH
Q 042371 224 AKVADFGTSKFIVIDQTHVTT-KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYF 301 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 301 (400)
+||+|=.+++.+-........ .-..+..||+||.+.+..|+.++|+||||++||||+| |+.|+..-++.+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------- 506 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------- 506 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--------
Confidence 999999999876433322221 1223568999999999999999999999999999999 999984333221
Q ss_pred HHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 302 ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
+...+.++.+...+-.++.++..++.-||...|++||++++++.-|+.+...
T Consensus 507 --------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 --------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred --------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 2222333334445666778899999999999999999999999999987654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=248.57 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=197.8
Q ss_pred CCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCc--hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC-----cce
Q 042371 84 HFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHE--GKLEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 155 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 155 (400)
+.+..+.||-|+||.||.+++ ++|+.||+|++..... .....+.+|+.+|..++|.|++..++...-.. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345577899999999999996 4799999998765433 34578889999999999999999888765432 457
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+++|.+. .+|..+|-.- .+++.+.+.-++.||+.||+|||+.+ |.||||||.|+|+++|..+||+|||+++..
T Consensus 134 V~TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 8889885 4888877543 25888888889999999999999999 999999999999999999999999999987
Q ss_pred ccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh--------
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME-------- 306 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------- 306 (400)
..+....++.-+-|-.|+|||++.+. .|+.+.||||+|||+.||+..+.-|...++-...++.........
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 65555555555678899999999875 699999999999999999999888866554332222221110000
Q ss_pred hcccccccchh--------hhc-cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 307 ENRLYDFLDDQ--------VLK-VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 307 ~~~~~~~~~~~--------~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
++....++... +.. ..+.....+...+...++.+||.+|.+..+.+.++.
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00000011100 000 111222334567888999999999999888877653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-33 Score=262.18 Aligned_cols=265 Identities=22% Similarity=0.261 Sum_probs=204.7
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCC------CCcceeeeeEEeeC
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQIN------HRNVVKLLGCCLET 151 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 151 (400)
+....+|.+....|+|-|++|-+|.+. .|..||||++.. ++.....=+.|+++|++|+ --++++++..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 456678888999999999999999864 477999998864 3444556678999999995 34789999999999
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CcEEEEecC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFG 230 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~Dfg 230 (400)
+++|||+|-+ ..+|.++|...+....|...++..++.|++-||..|...| |+|.||||+|||+++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999988 4699999998877777999999999999999999999999 9999999999999865 578999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH---HHhhh
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI---LSMEE 307 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~ 307 (400)
.|.+...+.. +.+.-+..|.|||++.+-+|+...|+||+||+||||.||+.-|...... ++..++. ..++.
T Consensus 583 SA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN---~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 583 SASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN---QMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH---HHHHHHHHhcCCCcH
Confidence 9987654332 3334466899999999999999999999999999999999988433322 2222221 11110
Q ss_pred ----------c----------------------ccccccch------hh-----hccCCHHHHHHHHHHHHHhcccCCCC
Q 042371 308 ----------N----------------------RLYDFLDD------QV-----LKVGQKEEIMTIATLATRCLNLNGKR 344 (400)
Q Consensus 308 ----------~----------------------~~~~~~~~------~~-----~~~~~~~~~~~l~~li~~cl~~dP~~ 344 (400)
. .+...+.+ .+ +..........|.+|+..||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0 00000000 00 11122334567899999999999999
Q ss_pred CCCHHHHHHH
Q 042371 345 RPTMKEVAME 354 (400)
Q Consensus 345 RPt~~ell~~ 354 (400)
|.|..+.|++
T Consensus 737 Rit~nqAL~H 746 (752)
T KOG0670|consen 737 RITVNQALKH 746 (752)
T ss_pred cCCHHHHhcC
Confidence 9999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=248.86 Aligned_cols=131 Identities=29% Similarity=0.424 Sum_probs=112.4
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-----C---CcceeeeeEEeeC--
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-----H---RNVVKLLGCCLET-- 151 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~~~~~~~~~-- 151 (400)
++|.+.++||.|-|++||++.+ .+.+.||+|+.+. ...-.+..+.||.+|++++ | ..||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 7899999999999999999995 4678899998763 3444577889999999983 3 4699999998754
Q ss_pred --CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 042371 152 --EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL 218 (400)
Q Consensus 152 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 218 (400)
.++++|+|++ |-+|..+|.....+ .++...+..|+.||+.||.|||.... |||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 4789999999 67999999887665 49999999999999999999999764 9999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=228.90 Aligned_cols=211 Identities=37% Similarity=0.592 Sum_probs=182.9
Q ss_pred eeecCcEEEEEEEecC-CcEEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCHHH
Q 042371 91 LGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQ 168 (400)
Q Consensus 91 lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 168 (400)
||+|++|.||++...+ ++.+++|........ ....+.+|+..++.+.|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999987654332 45788999999999999999999999999889999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCcEEEEecCCccccccCCceeeeccc
Q 042371 169 YLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-KYTAKVADFGTSKFIVIDQTHVTTKVQ 247 (400)
Q Consensus 169 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~ 247 (400)
++.... ..++...++.++.+++.++.+||..+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 987653 24889999999999999999999998 999999999999999 89999999999976533221 223345
Q ss_pred ccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHH
Q 042371 248 GTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE 326 (400)
Q Consensus 248 gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (400)
+...|++||.+... .++.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999877 888999999999999999
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 327 IMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 327 ~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
..+.+++.+|++.+|.+||++.++++.+
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3478999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=255.24 Aligned_cols=196 Identities=23% Similarity=0.383 Sum_probs=169.0
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--------chhHHHHHHHHHHHHhCC---CCcceeeeeEEe
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--------EGKLEEFINEVVILSQIN---HRNVVKLLGCCL 149 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~ 149 (400)
...|...+.+|.|+||.|++|.++ +...|+||.+.... +...-.+..|+.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 456899999999999999999976 45678888654311 112234567999999997 999999999999
Q ss_pred eCCcceEEEEcc-CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEe
Q 042371 150 ETEVPLLVYEFI-SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVAD 228 (400)
Q Consensus 150 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D 228 (400)
+++..||+||.. +|.+|.++|..+. .+++..+..|+.|++.|+++||++| |||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999975 5779999998765 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccccCCceeeecccccCCCCCccccccCCCC-CcchhHHHHHHHHHHHhCCCCC
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT-DKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf 286 (400)
||.+.... .......+||..|.|||++.+.+|- ..-|||++|++||.++....||
T Consensus 714 fgsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 714 FGSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ccchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99997653 3344557799999999999999984 5689999999999999988887
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=262.16 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=207.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|.+...+|+|.+|.||++++. .++..|+|.++.....+..-+.+|+-+++..+||||+.+++.+...+..|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 468999999999999999999964 6889999999998888888999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
|.||+|.+.-+..+ ++++.++..+.+..++++.|||+.+ -+|||||-.|||+++.|.+|++|||.+-.+.. ..
T Consensus 94 cgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-ti 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-TI 166 (829)
T ss_pred cCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh-hh
Confidence 99999999876554 6999999999999999999999999 89999999999999999999999999865432 22
Q ss_pred eeeecccccCCCCCcccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 241 HVTTKVQGTFGYLDPEYF---RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.......||+.|||||+. ..+.|...+|||++|++..|+--.++|... .+.......+ ....++-
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd-------lhpmr~l~Lm-TkS~~qp---- 234 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD-------LHPMRALFLM-TKSGFQP---- 234 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc-------cchHHHHHHh-hccCCCC----
Confidence 233457799999999985 356799999999999999999888888521 1111111111 1111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..........+.+.+|++.+|-.+|.+|||+.-++++
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 1111223455678999999999999999999887763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=238.12 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=192.1
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC------Cc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET------EV 153 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~ 153 (400)
.+|.-.+.+|.|.- .|-.+.+. .++.||+|++... ......+..+|+..+..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777778888888 55555543 5789999986543 233456778999999999999999999998744 35
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
+|+|||+|. .+|...+.. .++-.....++.|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 789999995 589988872 2667778889999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh----hh--
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM----EE-- 307 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~-- 307 (400)
.. +.....+.++.|..|.|||++.+..|.+.+||||+||++.||++|+.-|... .....|....- ..
T Consensus 167 ~e--~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-----d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TE--DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-----DHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cc--CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-----hHHHHHHHHHHHhcCCCHH
Confidence 54 3335667788999999999999888999999999999999999999887421 11222211000 00
Q ss_pred ---------------------cccccccchhhh---ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 ---------------------NRLYDFLDDQVL---KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 ---------------------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+.+.+.+... .+.+.....-+++++.+||..||++|.|++++|.+
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 011111111110 01112223457899999999999999999999986
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=242.52 Aligned_cols=264 Identities=23% Similarity=0.351 Sum_probs=197.1
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec----CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCc
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEV 153 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 153 (400)
......|.++++||.|.|++||++... ..+.||+|.+.. ......+.+|+++|..+ .+.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR--TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc--ccCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 445567999999999999999999853 367899997654 34456789999999999 59999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCcEEEEecCCc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-KYTAKVADFGTS 232 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~Dfgla 232 (400)
+.+|+||++..+..++... ++...+..++..++.||.++|..| ||||||||.|+|.+. .+.-.|+|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999998888763 677889999999999999999999 999999999999985 468899999998
Q ss_pred ccccc-C--------------C----------------------------ceeeecccccCCCCCcccccc-CCCCCcch
Q 042371 233 KFIVI-D--------------Q----------------------------THVTTKVQGTFGYLDPEYFRS-GQFTDKSD 268 (400)
Q Consensus 233 ~~~~~-~--------------~----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 268 (400)
..... . . ........||++|.|||++.. ...++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 72100 0 0 000012459999999999764 56799999
Q ss_pred hHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh---------hhcc--ccc------ccc----------hhh---
Q 042371 269 VYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM---------EENR--LYD------FLD----------DQV--- 318 (400)
Q Consensus 269 iwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---------~~~~--~~~------~~~----------~~~--- 318 (400)
|||.|+|+..++++++||.....+-. .+.......- ..+. +.+ +.+ ..+
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred eeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999954443322 1111111000 0001 000 000 000
Q ss_pred -----h-ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 -----L-KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 -----~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. .......+..+.+|+.+||..||.+|.|+++.|++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 01112223468999999999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=225.14 Aligned_cols=198 Identities=37% Similarity=0.582 Sum_probs=172.3
Q ss_pred CcccceeeecCcEEEEEEEecC-CcEEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccC
Q 042371 85 FNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
|.+.+.||.|++|.||++...+ ++.+|+|........ ....+.+|+..++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999765 889999988765444 67788899999999999999999999998899999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+++|.+++...... +++..++.++.+++.++.+||..+ ++|+||+|.||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999998765421 788999999999999999999998 9999999999999999999999999998764332112
Q ss_pred eecccccCCCCCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 042371 243 TTKVQGTFGYLDPEYF-RSGQFTDKSDVYSFGVVLVELLTGQKPII 287 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~pf~ 287 (400)
.....++..|++||.+ ....++.++|+||||+++++|++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2334578899999998 66778889999999999999999999993
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=221.35 Aligned_cols=254 Identities=17% Similarity=0.251 Sum_probs=186.5
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeE-EeeCCcceEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGC-CLETEVPLLV 157 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv 157 (400)
..+.|.+.+.||+|.||.+.++..+ .++.+++|-+.. ......+|.+|...--.| .|.||+..|+. |...+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467999999999999999999976 467788886643 344567889998876666 48999998875 5566677789
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCCcEEEEecCCcccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN--EKYTAKVADFGTSKFI 235 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~--~~~~~kl~Dfgla~~~ 235 (400)
+||++.|+|..-+...+ +.+....+++.|++.|+.|+|+.+ +||||||.+||||- +..++||+|||+.+..
T Consensus 101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999998876643 778888899999999999999999 99999999999994 3348999999998754
Q ss_pred ccCCceeeecccccCCCCCcccccc---C--CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRS---G--QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
.. ......-+..|.|||.... + ...+.+|+|.||+++|..+||++||....... .....|... ..+..
T Consensus 174 g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w--~~rk~ 246 (378)
T KOG1345|consen 174 GT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQW--LKRKN 246 (378)
T ss_pred Cc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHH--hcccC
Confidence 22 1112224667999997643 2 24678999999999999999999996333222 222222111 11111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
... ...-...++.+..+.++-|.++|++|--..++.++-
T Consensus 247 ~~~------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PAL------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccC------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 111 111223456678899999999999996666665543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=265.40 Aligned_cols=196 Identities=20% Similarity=0.208 Sum_probs=137.9
Q ss_pred hCCC-CcceeeeeEE-------eeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 042371 135 QINH-RNVVKLLGCC-------LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206 (400)
Q Consensus 135 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 206 (400)
.++| +||.+++++| .....+++++||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5777777776 2334567889987 569999997533 25899999999999999999999999 9
Q ss_pred EecCCCCCCeEEcCCC-------------------cEEEEecCCccccccCC---------------ceeeecccccCCC
Q 042371 207 YHRDIKSTNILLNEKY-------------------TAKVADFGTSKFIVIDQ---------------THVTTKVQGTFGY 252 (400)
Q Consensus 207 iHrDikp~NIll~~~~-------------------~~kl~Dfgla~~~~~~~---------------~~~~~~~~gt~~y 252 (400)
+||||||+||||+..+ .+|++|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 45555666554321000 0001123578899
Q ss_pred CCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHH
Q 042371 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT 332 (400)
Q Consensus 253 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 332 (400)
+|||++.+..|+.++|||||||+||||++|..|+..... .. ...... ...+.. ........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~----~~~~~~----~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TM----SSLRHR----VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HH----HHHHHh----hcChhh-----hhcCHHHHH
Confidence 999999999999999999999999999999888631110 00 000000 011110 111234568
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 042371 333 LATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 333 li~~cl~~dP~~RPt~~ell~~ 354 (400)
++.+||+++|.+|||+.+++++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=208.15 Aligned_cols=171 Identities=22% Similarity=0.248 Sum_probs=128.2
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
|+|.+++...+. ++++..++.++.|++.||.|||+.+ ||+|||++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 689999976433 5999999999999999999999865 999999999999999 9998765322
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (400)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ............. .... ....
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~----~~~~---~~~~ 132 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD----DPRD---RSNL 132 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC----Cccc---cccH
Confidence 1258999999999999999999999999999999999999985332111 0111111110000 0000 0111
Q ss_pred HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 324 KEEIM--TIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 324 ~~~~~--~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
..... .+.+++.+||+.+|.+|||+.++++++..+....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 22333 5899999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-25 Score=210.84 Aligned_cols=262 Identities=20% Similarity=0.221 Sum_probs=196.6
Q ss_pred CCcccceeeecCcEEEEEEEecCC--cEEEEEEccccCchhHHHHHHHHHHHHhCC----CCcceeeeeEE-eeCCcceE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLADG--RIVAVKKSKIVHEGKLEEFINEVVILSQIN----HRNVVKLLGCC-LETEVPLL 156 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~----h~~iv~~~~~~-~~~~~~~l 156 (400)
+|.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+. .+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 478888665443333236777888888886 36889999888 46777899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-----CcEEEEecCC
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-----YTAKVADFGT 231 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-----~~~kl~Dfgl 231 (400)
||+.+ |.+|.++..... ...++...++.++.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 789999886655 346999999999999999999999999 9999999999999755 4699999999
Q ss_pred ccccc--cCCce------e-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH
Q 042371 232 SKFIV--IDQTH------V-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 232 a~~~~--~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 302 (400)
++... ..... . .....||..|+++.+..+...+.+.|+||++.++.+++.|..||........ .....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~- 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFE- 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHH-
Confidence 98322 11111 1 2335599999999999999999999999999999999999999844332211 00000
Q ss_pred HHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 303 LSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
..... ..... .....+..+.++...+-..+...+|....+...|++.....
T Consensus 251 ~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00000 00000 11122344666666666789999999999999998887765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=214.21 Aligned_cols=169 Identities=20% Similarity=0.161 Sum_probs=131.2
Q ss_pred HHHHHHhcCCcccceeeecCcEEEEEEEec--CCcEEEEEEcccc-----CchhHHHHHHHHHHHHhCCCCccee-eeeE
Q 042371 76 KELDKATDHFNVNRILGQGGQGTVYKGMLA--DGRIVAVKKSKIV-----HEGKLEEFINEVVILSQINHRNVVK-LLGC 147 (400)
Q Consensus 76 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~ 147 (400)
+......++|.+.+.||+|+||+||+|... +++.+|||++... .......+.+|+.+|++++|+|+++ +++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 344556788999999999999999999864 5777899975422 1223567889999999999999985 443
Q ss_pred EeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeEEcCCCcEEE
Q 042371 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDI-KSTNILLNEKYTAKV 226 (400)
Q Consensus 148 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi-kp~NIll~~~~~~kl 226 (400)
.+..+|||||++|++|.. +. . .. ...++.+++.+|.|||+.| |+|||| ||+|||++.++.+||
T Consensus 90 ---~~~~~LVmE~~~G~~L~~-~~--~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHL-AR--P----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred ---cCCcEEEEEccCCCCHHH-hC--c----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence 245799999999999963 21 1 11 1467889999999999999 999999 999999999999999
Q ss_pred EecCCccccccCCce-------eeecccccCCCCCccccccC
Q 042371 227 ADFGTSKFIVIDQTH-------VTTKVQGTFGYLDPEYFRSG 261 (400)
Q Consensus 227 ~Dfgla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 261 (400)
+|||+++.+...... ..+...+++.|+|||.+...
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999876432211 11345688899999988643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-23 Score=195.10 Aligned_cols=261 Identities=29% Similarity=0.397 Sum_probs=196.7
Q ss_pred CcccceeeecCcEEEEEEEecCCcEEEEEEccccCch---hHHHHHHHHHHHHhCCCC-cceeeeeEEeeCCcceEEEEc
Q 042371 85 FNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG---KLEEFINEVVILSQINHR-NVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~ 160 (400)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++++.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 678889999999999999976 77888977654332 467889999999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-cEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~Dfgla~~~~~~~ 239 (400)
+.++++.+++........++......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977665431124888999999999999999999999 99999999999999988 79999999997554322
Q ss_pred ce-----eeecccccCCCCCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 240 TH-----VTTKVQGTFGYLDPEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 240 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
.. ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 21 3456779999999999987 57889999999999999999999997544321 0000001111110000
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.................+.+++..++..+|..|.+..+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002223568899999999999999999887775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-26 Score=228.18 Aligned_cols=253 Identities=22% Similarity=0.273 Sum_probs=187.6
Q ss_pred cccceeeecCcEEEEEEEec-CCcEEEEEEcc-----ccCchhH-HHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 86 NVNRILGQGGQGTVYKGMLA-DGRIVAVKKSK-----IVHEGKL-EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 86 ~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~-----~~~~~~~-~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.....+|.|++|.|+..... ....++.|... ....... ..+..|+-+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45778999999988877643 33334444321 1111111 22666777788889999988777766655555559
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
|||++ +|..++.... .+....+..++.|++.|+.|+|..| |.|||+||+|++++.+|.+||+|||.+......
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999987653 3778888899999999999999999 999999999999999999999999999876543
Q ss_pred Cc---eeeecccccCCCCCccccccCCCCC-cchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 239 QT---HVTTKVQGTFGYLDPEYFRSGQFTD-KSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 239 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
.. .......|+..|+|||++.+..|++ ..||||.|+++..|++|+.||.......... .......++-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccccc
Confidence 33 3456678999999999999999986 5899999999999999999996655443221 0000000111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAM 353 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 353 (400)
...-........+..-+.++.+||+++|.+|.|+++|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111112223455667889999999999999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=187.89 Aligned_cols=265 Identities=19% Similarity=0.239 Sum_probs=201.7
Q ss_pred HHhcCCcccceeeecCcEEEEEEE-ecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCC-CcceeeeeEEeeCCcceEE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 157 (400)
...+.|.+.+.||+|+||.+|.|. ..+|..||||.-+. .....++..|..+...+++ ..|+.+..+..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345789999999999999999998 46799999996543 2333567788999999964 7888888888888888999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CcEEEEecCCccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK---YTAKVADFGTSKF 234 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~Dfgla~~ 234 (400)
|+.. |-+|.++.+-... .++...++-++-|++.-++|+|.++ ++||||||+|+|+.-+ ..+.++|||+|+.
T Consensus 90 MdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 9988 7899999887655 3788999999999999999999999 9999999999999633 4799999999987
Q ss_pred cccCCc------eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 235 IVIDQT------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 235 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
..+... .......||..|.+--+..+...+...|+-|+|.+|.++..|..||.........+-. ..+.+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy----EkI~Ek 239 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY----EKISEK 239 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH----HHHHHh
Confidence 654322 2234567999999988888778888999999999999999999999654433221111 111111
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
+..- ..+......+.++.-.+.-|=..--++-|+..-+-+.++-+-..
T Consensus 240 K~s~-----~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 240 KMST-----PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred hcCC-----CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 1111 11122334456677788888888888888888877776665543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-24 Score=190.54 Aligned_cols=266 Identities=17% Similarity=0.225 Sum_probs=205.4
Q ss_pred hcCCcccceeeecCcEEEEEEE-ecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.-+|++.++||.|.||.++.|. .-++++||||.-.. .....++..|.+..+.|. .++|+..|-+..+.-.-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4579999999999999999999 45789999996443 344567778999998885 7999999988777777789999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-----CcEEEEecCCccc
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-----YTAKVADFGTSKF 234 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-----~~~kl~Dfgla~~ 234 (400)
.+ |-+|+|+..-.++ .++.+.+..++.|++.-++|+|.+. +|.|||||+|+||... ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 88 7899999877665 4899999999999999999999999 9999999999999643 3689999999998
Q ss_pred cccCCce------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 235 IVIDQTH------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 235 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
..+.... ......||..||+--...+.+.+...|+=|||-+++++|.|..||....... +-..|.. +.+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t--nK~kYeK--IGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT--NKEKYEK--IGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc--hHHHHHH--hccc
Confidence 7654332 2344679999999998889899999999999999999999999996544332 1111111 1111
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
+-. ..........+.++..-+.-.=+.+-.+-|..+-+...+.++.+....
T Consensus 255 Kr~-----T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 255 KRS-----TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred ccc-----CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 100 011112234556677777766677888889999999888888765544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-25 Score=191.07 Aligned_cols=253 Identities=20% Similarity=0.329 Sum_probs=193.7
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccc--cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.+..+..+|.....|..|+|+++++. ++.|++.. ......+.|..|.-.|+-+.||||+++++.|.....+.++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 44566778999999999999997544 44565443 2333446788888999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
|+.|+|+.+++..... ..+..++.+++.+++.|++|||+... -|.---|....+++|++.+.+|+- +-.++.
T Consensus 269 mp~gslynvlhe~t~v-vvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfs----- 340 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSV-VVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFS----- 340 (448)
T ss_pred ccchHHHHHHhcCccE-EEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceee-----
Confidence 9999999999876543 46778899999999999999999874 244457889999999998777642 111111
Q ss_pred eeeecccccCCCCCccccccCCCC---CcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFT---DKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.......-.|.|++||.+...+-+ .++|+|||++++|||.|...||....+-+. -..+--++
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec---------------gmkialeg 405 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------------GMKIALEG 405 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------------hhhhhhcc
Confidence 111112237899999999877643 479999999999999999999965443221 11122234
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
++...++..+..+..++.-|++.||.+||.++.++-.|++++
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 555667777888999999999999999999999999998764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-24 Score=217.99 Aligned_cols=250 Identities=21% Similarity=0.236 Sum_probs=183.8
Q ss_pred CCcccceeeecCcEEEEEEEecCCcEEEEEEccc-cCchhHHHHHHHHHH--HHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKI-VHEGKLEEFINEVVI--LSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~E~~~--l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+|...+.||++.|=.|.+|....|. |+||..-. ...-..+.+.+++.- ...+++||.+++..+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778899999999999999988777 77786433 223334444444333 4556899999998887777788999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
..+ +|+|.+..+. -+..-+...|+.|++.||.-+|..| |+|||||.+||||+.-+-+.|+||...+.......
T Consensus 103 vkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 965 9999887654 3677778889999999999999999 99999999999999999999999988765432221
Q ss_pred ------eeeecccccCCCCCccccccC----------C-CCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHH
Q 042371 241 ------HVTTKVQGTFGYLDPEYFRSG----------Q-FTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 241 ------~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 302 (400)
....+-....+|.|||.+... . .+++.||||+||+++||++ |++||.. .++..|..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhc
Confidence 122333446689999987431 1 5678999999999999999 7898842 22222221
Q ss_pred HHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 303 LSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
. . ....+.+++..+. ..+++++..|++.||.+|.++++.++.-+.
T Consensus 250 ~-----~--~~~~e~~Le~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 250 G-----N--ADDPEQLLEKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred c-----C--ccCHHHHHHhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1 0 1111112222211 248899999999999999999999987433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=184.50 Aligned_cols=174 Identities=11% Similarity=0.121 Sum_probs=133.9
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhH---HH------HHHHHHHHHhCCCCcceeeeeEEe
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL---EE------FINEVVILSQINHRNVVKLLGCCL 149 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~---~~------~~~E~~~l~~l~h~~iv~~~~~~~ 149 (400)
+...++|++.++||.|+||.||++.. ++..+|+|.+........ .. +.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34568999999999999999999766 567899998764332222 22 578999999999999999988865
Q ss_pred eC--------CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 042371 150 ET--------EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK 221 (400)
Q Consensus 150 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~ 221 (400)
.. +..+|+|||++|.+|.++.. ++. ....+++.+|..+|..| ++|||++|+||+++.+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 43 35789999999999987631 332 24568999999999999 9999999999999998
Q ss_pred CcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh
Q 042371 222 YTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281 (400)
Q Consensus 222 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 281 (400)
| ++|+|||........... .-++....|..++|+||||+++..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 999999988643211100 013344557789999999999877643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-24 Score=206.04 Aligned_cols=243 Identities=27% Similarity=0.269 Sum_probs=187.0
Q ss_pred eeeecCcEEEEEEEe----cCCcEEEEEEccccC--chhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEEEccC
Q 042371 90 ILGQGGQGTVYKGML----ADGRIVAVKKSKIVH--EGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 162 (400)
.+|.|+||.|+++.. ..+..+|+|.++... .........|..++...+ ||.++++.-.+..++..++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998652 236678888654322 111225567778888886 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
||+|...+.... .+.+.....+...++-++..+|+.+ |+|||+|++||+++.+|.+++.|||+++........
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988776544 3677777788899999999999999 999999999999999999999999999875433222
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccC
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (400)
+||..|||||++. ....++|+||||+++++|++|..||.. + . + ..++ ......
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~---~-------~-----~~Il--~~~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D---T-------M-----KRIL--KAELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H---H-------H-----HHHh--hhccCC
Confidence 7999999999998 567899999999999999999999943 0 0 0 0000 111234
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHHHHHHHHhhccc
Q 042371 323 QKEEIMTIATLATRCLNLNGKRRPTM--KEVAMELERIQALQKDIN 366 (400)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dP~~RPt~--~ell~~L~~~~~~~~~~~ 366 (400)
+...+....+++.+++..+|.+|.-. ..+.++.+.---....|+
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 56667778999999999999999655 455555554444444444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=176.56 Aligned_cols=139 Identities=19% Similarity=0.155 Sum_probs=107.5
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCch--h------------------------HHHHHHHHHHHHhCCCCcc
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG--K------------------------LEEFINEVVILSQINHRNV 141 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~~i 141 (400)
...||+|+||.||+|...+|+.||+|.++..... . ......|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999987643211 0 1122358999999987776
Q ss_pred eeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCeEEcC
Q 042371 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL-HSAASMPIYHRDIKSTNILLNE 220 (400)
Q Consensus 142 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiHrDikp~NIll~~ 220 (400)
........ ...+|||||++|+++....... .+++...+..++.|++.+|.++ |..| |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 2348999999988776543322 2588999999999999999999 6888 99999999999998
Q ss_pred CCcEEEEecCCcccc
Q 042371 221 KYTAKVADFGTSKFI 235 (400)
Q Consensus 221 ~~~~kl~Dfgla~~~ 235 (400)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=205.73 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=185.7
Q ss_pred HHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC---CCcceeeeeEEeeCC
Q 042371 76 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN---HRNVVKLLGCCLETE 152 (400)
Q Consensus 76 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~ 152 (400)
.+.+.....|.|.+.||.|+||.||.|...+|+.||||.-+...... |.--..++.+|+ -+.|+.+...+...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 34556678899999999999999999998889999999766544332 111112233333 355666666667777
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-------CCcEE
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-------KYTAK 225 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-------~~~~k 225 (400)
.-+||++|.+.|+|.++++..+ .+++..++.++.|++..+..||..+ |||+||||+|+||.. .-.++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 7899999999999999998433 5899999999999999999999999 999999999999942 34699
Q ss_pred EEecCCccccccCC-ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH
Q 042371 226 VADFGTSKFIVIDQ-THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS 304 (400)
Q Consensus 226 l~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 304 (400)
|+|||.+..+..-. .......++|-.+-.+|+..|.++++.+|.|.++.+++-||.|++-=
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------ 903 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------ 903 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------
Confidence 99999998765433 33566778899999999999999999999999999999999997531
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
..++.... +.......... ..+.+|+..+|+.|-..=|...+|...|+..-.
T Consensus 904 ~~~g~~~~-~~~~~~Ry~~~---~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 904 VKNGSSWM-VKTNFPRYWKR---DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred hcCCccee-ccccchhhhhH---HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 11111111 11111111112 225577888888444444666666666665544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=179.79 Aligned_cols=234 Identities=20% Similarity=0.253 Sum_probs=148.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCC----------CcceeeeeEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINH----------RNVVKLLGCC 148 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~~iv~~~~~~ 148 (400)
..+...+.||.|+|+.||.+++. .++.+|+|...... ....+.+.+|......+.+ -.++.-++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 34567789999999999999976 48999999754432 3345666666554444322 1222222221
Q ss_pred e---------eC---C-----cceEEEEccCCCCHHHHHhh---cCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 042371 149 L---------ET---E-----VPLLVYEFISNGTLFQYLHD---QNE-EFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207 (400)
Q Consensus 149 ~---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 207 (400)
. .. + ..+++|+-+. ++|.+++.. ... ...+....++.+..|+++.+++||+.| ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 11 1 2367888774 588888653 221 122445566677799999999999999 99
Q ss_pred ecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCCCCcccccc--------CCCCCcchhHHHHHHHHHH
Q 042371 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS--------GQFTDKSDVYSFGVVLVEL 279 (400)
Q Consensus 208 HrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el 279 (400)
|+||+|+|++++.+|.++|+||+...... ........+..|.|||.... -.++.+.|.|+||+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g----~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAG----TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETT----EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecC----ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999998775432 12221335678999997643 2578899999999999999
Q ss_pred HhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCC
Q 042371 280 LTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRR 345 (400)
Q Consensus 280 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 345 (400)
++|..||........... ...... +.++.+..||..+|++||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999965433221111 111222 778889999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=169.80 Aligned_cols=141 Identities=22% Similarity=0.209 Sum_probs=109.6
Q ss_pred ccceeeecCcEEEEEEEecCCcEEEEEEccccCch---------------------h-----HHHHHHHHHHHHhCCCCc
Q 042371 87 VNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG---------------------K-----LEEFINEVVILSQINHRN 140 (400)
Q Consensus 87 ~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~~ 140 (400)
+.+.||+|+||.||+|...+|+.||||........ . ......|...+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999778999999987643211 0 122357889999999988
Q ss_pred ceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEc
Q 042371 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLN 219 (400)
Q Consensus 141 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~ 219 (400)
+.....+... ..+|||||++|+++....... ..++...+..++.+++.++.++|+ .| |+||||||+|||++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 7544433332 248999999988554432222 147788899999999999999999 88 99999999999999
Q ss_pred CCCcEEEEecCCccccc
Q 042371 220 EKYTAKVADFGTSKFIV 236 (400)
Q Consensus 220 ~~~~~kl~Dfgla~~~~ 236 (400)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-21 Score=166.91 Aligned_cols=186 Identities=17% Similarity=0.067 Sum_probs=138.2
Q ss_pred cccceeeecCcEEEEEEEecCCcEEEEEEccccCchh----HHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEEEc
Q 042371 86 NVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGK----LEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 86 ~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.+...|++|+||+|+.+.. ++.+++.+.+....... ...+.+|+.+|+++. ++++++++++ +..+++|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997766 67788877665433311 125789999999995 5889999886 346999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDI-KSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi-kp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
+.|.+|...+.. . ...++.|++.+|.++|..| |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999988654311 1 1357889999999999999 999999 7999999999999999999998543222
Q ss_pred ce----ee--------ecccccCCCCCccccccC-CCC-CcchhHHHHHHHHHHHhCCCCCCcC
Q 042371 240 TH----VT--------TKVQGTFGYLDPEYFRSG-QFT-DKSDVYSFGVVLVELLTGQKPIILT 289 (400)
Q Consensus 240 ~~----~~--------~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il~elltg~~pf~~~ 289 (400)
.. .. .-...++.|++|+...-- ..+ ...++++-|..+|.++|+..|+...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 00 012257788888753321 223 5679999999999999999987443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-20 Score=162.65 Aligned_cols=136 Identities=17% Similarity=0.203 Sum_probs=105.4
Q ss_pred cccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhC-----CCCcceeeeeEEeeCC---cce-E
Q 042371 86 NVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-----NHRNVVKLLGCCLETE---VPL-L 156 (400)
Q Consensus 86 ~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~~~-l 156 (400)
.-.+.||+|+||.||. ...++. .+||+.........+.+.+|+.+++.+ +||||+++++++.++. .++ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 322334 478987665445567899999999999 5799999999998864 333 7
Q ss_pred EEEc--cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCeEEcC----CCcEEEEec
Q 042371 157 VYEF--ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL-SYLHSAASMPIYHRDIKSTNILLNE----KYTAKVADF 229 (400)
Q Consensus 157 v~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~iiHrDikp~NIll~~----~~~~kl~Df 229 (400)
|+|| +.+++|.+++... .+++. ..++.+++.++ .|||+.+ |+||||||+|||++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999653 25555 34577777777 9999999 999999999999974 348999995
Q ss_pred CCc
Q 042371 230 GTS 232 (400)
Q Consensus 230 gla 232 (400)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=177.94 Aligned_cols=219 Identities=24% Similarity=0.454 Sum_probs=163.8
Q ss_pred HHhCCCCcceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCC
Q 042371 133 LSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI-YHRDI 211 (400)
Q Consensus 133 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-iHrDi 211 (400)
|+.+.|.|+.++++.+.+....++|.+||..|+|.+.+..... .+++.-...+.++|+.||.|||... | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 4578899999999999999999999999999999999987443 4788888889999999999999977 5 99999
Q ss_pred CCCCeEEcCCCcEEEEecCCccccccC-CceeeecccccCCCCCccccccCC-------CCCcchhHHHHHHHHHHHhCC
Q 042371 212 KSTNILLNEKYTAKVADFGTSKFIVID-QTHVTTKVQGTFGYLDPEYFRSGQ-------FTDKSDVYSFGVVLVELLTGQ 283 (400)
Q Consensus 212 kp~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~elltg~ 283 (400)
++.|.++|....+||+|||+....... .........-..-|.|||.+.... .+.+.||||||++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998765320 001111112345699999987642 466799999999999999999
Q ss_pred CCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 284 KPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 284 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.||..........-............+ .+.+... .+..+.+..++.+||..+|.+||++..+-..++.+....
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~----rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPF----RPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCc----Ccchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 999765544433111111111011111 1111100 134446899999999999999999999999888877754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-18 Score=155.52 Aligned_cols=134 Identities=22% Similarity=0.329 Sum_probs=112.0
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEccccCc--------hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHE--------GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
+.||+|++|.||+|.. ++..+++|+...... .....+.+|+.++..+.|++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 567889996543221 1124577899999999999988777777777888999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++|++|.+++.... . .+..++.+++.+|.++|..+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 67889999999999999999 99999999999999 78999999998863
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=166.14 Aligned_cols=198 Identities=21% Similarity=0.256 Sum_probs=141.5
Q ss_pred CCCcceeeeeEEeeC---------------------------CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHH
Q 042371 137 NHRNVVKLLGCCLET---------------------------EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT 189 (400)
Q Consensus 137 ~h~~iv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 189 (400)
.|||||++.++|.+. ..+|+||...+. +|..++-.+. .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 599999999887532 235889988864 8999987654 56666777899
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CC--CcEEEEecCCccccccC-----CceeeecccccCCCCCcccccc
Q 042371 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLN--EK--YTAKVADFGTSKFIVID-----QTHVTTKVQGTFGYLDPEYFRS 260 (400)
Q Consensus 190 ~i~~~l~~LH~~~~~~iiHrDikp~NIll~--~~--~~~kl~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~ 260 (400)
|+++|+.|||++| |.|||+|.+|||+. ++ ..+.|+|||++-..... -........|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999993 33 36899999987532211 1111223457888999999764
Q ss_pred CC------CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHH
Q 042371 261 GQ------FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLA 334 (400)
Q Consensus 261 ~~------~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 334 (400)
.+ --.++|.|+.|.+.||+++...||...+... .. .....+ ..+...+..++..+++++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~-----~r~Yqe---------~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LD-----TRTYQE---------SQLPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ec-----hhhhhh---------hhCCCCcccCChHHHHHH
Confidence 33 1358999999999999999999995422110 00 011111 122333445566789999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHH
Q 042371 335 TRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 335 ~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
...|++||++|++..=....|.-
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHhcCCccccCCccHHHhHHHH
Confidence 99999999999997766555543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.5e-20 Score=176.52 Aligned_cols=174 Identities=24% Similarity=0.384 Sum_probs=130.7
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
.++|.|++|...+|.+++......-..++...+.++.|++.|+.| ++ .+|+|+||.||++..+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999865544457888889999999999999 67 999999999999999999999999998
Q ss_pred cccccCC-----ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhh
Q 042371 233 KFIVIDQ-----THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 233 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
....... ....+...||..||+||.+.+..|+.++||||||++|+||+. -.-+|..... ...+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----------~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT----------LTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----------hhhhh
Confidence 7665433 223455679999999999999999999999999999999998 2323211100 11111
Q ss_pred hcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 042371 307 ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~el 351 (400)
.+.+ ++..+...+ .-+.|+.+++.+.|.+||++.+.
T Consensus 474 ~g~i----p~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGII----PPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCC----ChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 1111 111111122 23479999999999999955443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=157.28 Aligned_cols=144 Identities=18% Similarity=0.144 Sum_probs=110.8
Q ss_pred hcCCcccceeeecCcEEEEEEE--ecCCcEEEEEEccccCch------------------------hHHHHHHHHHHHHh
Q 042371 82 TDHFNVNRILGQGGQGTVYKGM--LADGRIVAVKKSKIVHEG------------------------KLEEFINEVVILSQ 135 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~--~~~~~~vaiK~~~~~~~~------------------------~~~~~~~E~~~l~~ 135 (400)
..-|.+.+.||+|+||.||+|. ..+|+.||+|........ ....+..|+.++..
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999998 567999999987643210 11235679999999
Q ss_pred CCCC--cceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 042371 136 INHR--NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKS 213 (400)
Q Consensus 136 l~h~--~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp 213 (400)
+.+. .++++++. ...++||||++|.+|........ .+....+..++.|++.++.+||..|. ++||||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp 177 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSE 177 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCCh
Confidence 9753 34444443 23589999999988766542221 35666678899999999999999774 99999999
Q ss_pred CCeEEcCCCcEEEEecCCcccc
Q 042371 214 TNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 214 ~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 789999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=184.83 Aligned_cols=206 Identities=26% Similarity=0.372 Sum_probs=141.8
Q ss_pred hcCCcccceeeecCcEEEEEEEecC-CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
...|..++.|..|++|.||.++.+. .+.+|+|.-+ ... +.+- ++.....|.+ |
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk---q~l---ilRn--ilt~a~npfv---------------v--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK---QNL---ILRN--ILTFAGNPFV---------------V--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc---cch---hhhc--cccccCCcce---------------e---
Confidence 4679999999999999999998764 5678885322 110 0000 2222233333 2
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC-
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ- 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~- 239 (400)
|+=.+++...+ +++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++......
T Consensus 136 ---gDc~tllk~~g---~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG---PLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcccCC---CCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 34444444322 34433 378899999999 9999999999999999999999999986532110
Q ss_pred -------------ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh
Q 042371 240 -------------THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 240 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
......++|||.|+|||++....|+..+|+|++|+|+|+++-|..||.....++-
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------------ 266 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------------ 266 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------------
Confidence 0112346799999999999999999999999999999999999999954433221
Q ss_pred hcccccccchhhh-ccCCHHHHHHHHHHHHHhcccCCCCC
Q 042371 307 ENRLYDFLDDQVL-KVGQKEEIMTIATLATRCLNLNGKRR 345 (400)
Q Consensus 307 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~R 345 (400)
+..++.+... .+.....+.+.++++.++|+.+|..|
T Consensus 267 ---fg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 267 ---FGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred ---HhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 1111111111 11233445678999999999999999
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.1e-18 Score=149.79 Aligned_cols=137 Identities=19% Similarity=0.200 Sum_probs=107.9
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCch----------------------hHHHHHHHHHHHHhCCCC-
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG----------------------KLEEFINEVVILSQINHR- 139 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~- 139 (400)
..|.+.+.||+|+||.||++...+|+.+|||........ .......|+.++..+.++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 348888999999999999999888999999975432210 112356788888888776
Q ss_pred -cceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 042371 140 -NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL 218 (400)
Q Consensus 140 -~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 218 (400)
.++..++ ....++||||++|++|..+... .....++.+++.++.++|..+ ++||||+|+||++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 4444443 2456899999999998765421 234568899999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCcccc
Q 042371 219 NEKYTAKVADFGTSKFI 235 (400)
Q Consensus 219 ~~~~~~kl~Dfgla~~~ 235 (400)
+.++.++|+|||++...
T Consensus 159 ~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 159 DDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCcEEEEECCccccC
Confidence 99999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.9e-18 Score=148.60 Aligned_cols=130 Identities=22% Similarity=0.345 Sum_probs=105.0
Q ss_pred eeeecCcEEEEEEEecCCcEEEEEEccccC--c------hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 90 ILGQGGQGTVYKGMLADGRIVAVKKSKIVH--E------GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~--~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.||+|+||.||+|.. ++..+++|...... . .....+.+|+.++..+.|+++....-++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 56789999743221 1 12356778999999998887655555555666779999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
+|++|.+++.... . .++.+++.+|.+||..+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875422 1 68899999999999999 99999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=169.05 Aligned_cols=137 Identities=20% Similarity=0.295 Sum_probs=110.5
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEE-ccc-cC------chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKK-SKI-VH------EGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~-~~~-~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
...|...+.||+|+||.||++.+.+.. +++|+ ... .. ....+.+.+|+.++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567889999999999999875443 33332 211 11 1123567899999999999999887777777777
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998875 24568999999999999999 9999999999999 57799999999996
Q ss_pred c
Q 042371 234 F 234 (400)
Q Consensus 234 ~ 234 (400)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 4
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-18 Score=176.49 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=191.9
Q ss_pred hcCCcccceeeecCcEEEEEEEecC--CcEEEEEEccccC--chhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD--GRIVAVKKSKIVH--EGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 156 (400)
...|.+.+.||+|+|+.|-...... ...+|.|.+.... ......+..|..+-..+. |+|++.+++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3568888899999999998877533 4456777655443 334556666888877786 9999999999999999999
Q ss_pred EEEccCCCCHHHHHh-hcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCeEEcCCC-cEEEEecCCcc
Q 042371 157 VYEFISNGTLFQYLH-DQNEEFPLTWEMRLRIATEVAGSLSYLH-SAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSK 233 (400)
Q Consensus 157 v~e~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiHrDikp~NIll~~~~-~~kl~Dfgla~ 233 (400)
+++|..|+++.+.+. .... ..+...+-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999998883 3221 2555667778999999999999 888 99999999999999999 99999999998
Q ss_pred cccc--CCceeeecccc-cCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 234 FIVI--DQTHVTTKVQG-TFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 234 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
.... ..........| ++.|+|||...+. -.....|+||.|+++..+++|..|+....... ..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--------------~~ 239 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--------------GR 239 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--------------cc
Confidence 7765 22333344567 9999999998875 44678999999999999999999986554332 11
Q ss_pred cccccchhh--hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 LYDFLDDQV--LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+..... .............+++.+++..+|..|.+.+++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 240 YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ceeecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 111111110 011222333457789999999999999998877553
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-16 Score=137.91 Aligned_cols=135 Identities=24% Similarity=0.264 Sum_probs=96.3
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCch--hHHH----------------------HHHHHHHHHhCCCC--cc
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG--KLEE----------------------FINEVVILSQINHR--NV 141 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--~i 141 (400)
.+.||+|+||.||+|...+++.||||........ .... ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5689999999999999878999999976542211 1111 12455555555433 24
Q ss_pred eeeeeEEeeCCcceEEEEccCCCCHHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEc
Q 042371 142 VKLLGCCLETEVPLLVYEFISNGTLFQY-LHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLN 219 (400)
Q Consensus 142 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~ 219 (400)
++.++. ...++||||++++.+... +.... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 444443 245899999998543221 11111 11 5577899999999999999 88 99999999999999
Q ss_pred CCCcEEEEecCCcccc
Q 042371 220 EKYTAKVADFGTSKFI 235 (400)
Q Consensus 220 ~~~~~kl~Dfgla~~~ 235 (400)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 889999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.5e-16 Score=130.22 Aligned_cols=135 Identities=23% Similarity=0.236 Sum_probs=112.1
Q ss_pred ccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCC--CcceeeeeEEeeCCcceEEEEccCCC
Q 042371 87 VNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH--RNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 87 ~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
+.+.||.|.++.||++...+ ..+++|....... ...+..|+.++..+++ .++++++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999754 7799997654333 4678889999999976 58999998888778899999999987
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 165 TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 165 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
.+..+ +......++.+++.++.++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 4455667889999999999996444499999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.6e-15 Score=137.44 Aligned_cols=134 Identities=20% Similarity=0.300 Sum_probs=102.3
Q ss_pred ceee-ecCcEEEEEEEecCCcEEEEEEcccc-------------CchhHHHHHHHHHHHHhCCCCcc--eeeeeEEeeCC
Q 042371 89 RILG-QGGQGTVYKGMLADGRIVAVKKSKIV-------------HEGKLEEFINEVVILSQINHRNV--VKLLGCCLETE 152 (400)
Q Consensus 89 ~~lg-~G~fg~V~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~ 152 (400)
..|| .||.|+||.+... +..++||..... .......+.+|+.++..+.|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 8888889888774 667888855321 01234567889999999988775 66666644322
Q ss_pred ----cceEEEEccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEE
Q 042371 153 ----VPLLVYEFISN-GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVA 227 (400)
Q Consensus 153 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~ 227 (400)
..++|||+++| .+|.+++... +++.. .+.+++.+|.+||..| |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 6998887542 25543 3578999999999999 9999999999999998899999
Q ss_pred ecCCccc
Q 042371 228 DFGTSKF 234 (400)
Q Consensus 228 Dfgla~~ 234 (400)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999865
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.1e-14 Score=138.42 Aligned_cols=141 Identities=21% Similarity=0.218 Sum_probs=97.5
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCchhH----------------------------------------HHHH
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKL----------------------------------------EEFI 127 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~~ 127 (400)
.+.||+|++|.||+|+..+|+.||||+......... -.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999997653211110 0234
Q ss_pred HHHHHHHhCC----CCcceeeeeEE-eeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 042371 128 NEVVILSQIN----HRNVVKLLGCC-LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG-SLSYLHSA 201 (400)
Q Consensus 128 ~E~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~ 201 (400)
+|+..+..+. +.+-+.+-..+ ...+..+|||||++|++|.++....... .. ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555542 22222222222 2234568999999999998876542211 22 3345666655 46788998
Q ss_pred CCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 202 ~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-14 Score=140.42 Aligned_cols=251 Identities=22% Similarity=0.259 Sum_probs=184.3
Q ss_pred HhcCCcccceeee--cCcEEEEEEEe---cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCC
Q 042371 81 ATDHFNVNRILGQ--GGQGTVYKGML---ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETE 152 (400)
Q Consensus 81 ~~~~y~~~~~lg~--G~fg~V~~~~~---~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 152 (400)
....+.+...+|. |.+|.||.+.. .++..+|+|+-+.. .......-.+|+...+.++ |+|.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456777889999 99999999885 35788999974432 2233344456777666664 999999999999999
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCeEEcCC-CcEEEE
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG----SLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVA 227 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~ 227 (400)
..++-+|++. .+|..+...... .++...++..+.+... ||..+|..+ ++|-|+||.||++..+ ...+++
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence 9999999995 688887765433 3777888888888888 999999999 9999999999999999 899999
Q ss_pred ecCCccccccCCce----eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH
Q 042371 228 DFGTSKFIVIDQTH----VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 228 Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 303 (400)
|||+...+...... ......|...|++||... +.++...|+|++|.++.+..++..+.......
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----------- 333 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS----------- 333 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-----------
Confidence 99999877543311 112235788999999876 57889999999999999999987665322111
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+.++....+..+.....+.++...+..|++.+|..|++.+.+..+
T Consensus 334 -----~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 334 -----SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred -----CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1111111001111112223345669999999999999998877664
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.6e-14 Score=128.13 Aligned_cols=205 Identities=21% Similarity=0.268 Sum_probs=141.7
Q ss_pred HHHHHhCCCCcceeeeeEEeeC-----CcceEEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 042371 130 VVILSQINHRNVVKLLGCCLET-----EVPLLVYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAAS 203 (400)
Q Consensus 130 ~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 203 (400)
+.-|.++.|.||++++.++.+. ....++.||+..|+|..+|++.. .+..+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 4456667899999999887654 35678999999999999998743 3446888889999999999999999987
Q ss_pred CCeEecCCCCCCeEEcCCCcEEEEecCCccccccC----CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHH
Q 042371 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID----QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVEL 279 (400)
Q Consensus 204 ~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 279 (400)
++|+|+++.-+.|++..+|-+|+.-- ........ .........+-++|.|||.=.....+.++|||+||....+|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 67999999999999999888877431 11111000 00111123367899999986666778899999999999999
Q ss_pred HhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 280 LTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 280 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
..|..--... +......... ...+ ...+. ..-+.++..|++..|+.||+|.+++-+.
T Consensus 276 ailEiq~tns---eS~~~~ee~i----a~~i-~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNS---ESKVEVEENI----ANVI-IGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCC---cceeehhhhh----hhhe-eeccC-----------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 8876531110 0000000000 0000 00000 1124688999999999999999988763
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.7e-13 Score=134.03 Aligned_cols=143 Identities=18% Similarity=0.168 Sum_probs=92.3
Q ss_pred cCCcccceeeecCcEEEEEEEecC-CcEEEEEEccccCch------------------------------h----HH---
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEG------------------------------K----LE--- 124 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~~~------------------------------~----~~--- 124 (400)
..|.. +.||+|++|.||+|+.++ |+.||||.....-.. . .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999877 999999977532110 0 11
Q ss_pred ---HHHHHHHHHHhCC----CCcceeeeeEEee-CCcceEEEEccCCCCHHHHH--hhcCC-CCCCCHHHHHHHHHHHHH
Q 042371 125 ---EFINEVVILSQIN----HRNVVKLLGCCLE-TEVPLLVYEFISNGTLFQYL--HDQNE-EFPLTWEMRLRIATEVAG 193 (400)
Q Consensus 125 ---~~~~E~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~-~~~l~~~~~~~i~~~i~~ 193 (400)
.+.+|+..+.++. +.+.+.+-.++.+ .+..+|||||++|+.+.++. ...+. ...+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1234444444442 3333333233322 34567999999999998753 22211 0013333333444444
Q ss_pred HHHHHHhcCCCCeEecCCCCCCeEEcCCC----cEEEEecCCccccc
Q 042371 194 SLSYLHSAASMPIYHRDIKSTNILLNEKY----TAKVADFGTSKFIV 236 (400)
Q Consensus 194 ~l~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~Dfgla~~~~ 236 (400)
...| ++|+|++|.||+++.+| .++++|||++..+.
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3466 99999999999999888 99999999987664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=112.37 Aligned_cols=130 Identities=22% Similarity=0.180 Sum_probs=94.9
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcc-eeeeeEEeeCCcceEEEEccCCCCH
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
.+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.++ ++++... ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999998874 67899997643321 12345678888888865444 4455443 3345899999999887
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA--SMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
... . .. ...++.+++.+|..||..+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~----~----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE----D----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc----c----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 543 0 11 1235678999999999987 22359999999999999 6689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.7e-12 Score=122.88 Aligned_cols=165 Identities=21% Similarity=0.190 Sum_probs=125.9
Q ss_pred cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHH
Q 042371 105 ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMR 184 (400)
Q Consensus 105 ~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~ 184 (400)
.++.+|.+...+.......+...+-+..|+.++||||+++++.+...+..|||+|.+. .|..++.... ...+
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------KEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------HHHH
Confidence 3577777777666555556677788899999999999999999999999999999884 7777776533 4456
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCC
Q 042371 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT 264 (400)
Q Consensus 185 ~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 264 (400)
..-+.||+.||.+||..++ ++|++|.-+.|+|+..|..||++|.++........ .......--.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 6678999999999986554 99999999999999999999999998754321111 111111223456666544322
Q ss_pred CcchhHHHHHHHHHHHhC
Q 042371 265 DKSDVYSFGVVLVELLTG 282 (400)
Q Consensus 265 ~~~DiwSlG~il~elltg 282 (400)
...|.|.||+++++++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.7e-11 Score=105.37 Aligned_cols=136 Identities=18% Similarity=0.126 Sum_probs=97.6
Q ss_pred cceeeecCcEEEEEEEecC-------CcEEEEEEccccC----------------------chhHHH----HHHHHHHHH
Q 042371 88 NRILGQGGQGTVYKGMLAD-------GRIVAVKKSKIVH----------------------EGKLEE----FINEVVILS 134 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~-------~~~vaiK~~~~~~----------------------~~~~~~----~~~E~~~l~ 134 (400)
...||.|--+.||.|...+ +..+|||..+... .+.... ..+|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 4789999433211 011222 237999999
Q ss_pred hCCC--CcceeeeeEEeeCCcceEEEEccCCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 042371 135 QINH--RNVVKLLGCCLETEVPLLVYEFISNGTLFQ-YLHDQNEEFPLTWEMRLRIATEVAGSLSYL-HSAASMPIYHRD 210 (400)
Q Consensus 135 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiHrD 210 (400)
++.. -+++..+++ ...+|||||+.+..+.. .+... .++......+..+++.+|..| |..+ ++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9853 466667754 45689999997653322 22211 245556677889999999998 8888 99999
Q ss_pred CCCCCeEEcCCCcEEEEecCCcccc
Q 042371 211 IKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 211 ikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
|++.|||++. +.+.|+|||.+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 68999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-12 Score=126.12 Aligned_cols=252 Identities=19% Similarity=0.207 Sum_probs=178.1
Q ss_pred HhcCCcccceeeecCcEEEEEEEec--CCcEEEEEEccccCchhHH--HHHHHHHHHHhC-CCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA--DGRIVAVKKSKIVHEGKLE--EFINEVVILSQI-NHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~--~~~~vaiK~~~~~~~~~~~--~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 155 (400)
...+|..+..||.|.|+.|+....+ ++..|++|.+......... .-+.|+.+...+ .|.+++.++..+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3467888999999999999987743 5788999865543332222 234566666666 4888888888877777778
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CcEEEEecCCccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSKF 234 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~Dfgla~~ 234 (400)
+-.|||+++++...+.... .+.+..++.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 9999999998877663222 3677788899999999999999988 9999999999999986 7889999999864
Q ss_pred cccCCceeeecccccCCC-CCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 235 IVIDQTHVTTKVQGTFGY-LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
+.. ........+..| .+|.......+-.+.|++|||..+.+.+++..--. .+. .+..+
T Consensus 417 ~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~~-----------------~~~~i 475 (524)
T KOG0601|consen 417 LAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SGV-----------------QSLTI 475 (524)
T ss_pred cce---ecccccccccccccchhhccccccccccccccccccccccccCcccCc-ccc-----------------cceee
Confidence 211 111111123334 36666677788899999999999999999865311 000 00111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
. .+.....+. ....+..+...+...++..||.+.++..+..-.++.
T Consensus 476 ~-~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 476 R-SGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred e-cccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 1 111111111 225577888999999999999999988877666553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.6e-13 Score=136.50 Aligned_cols=250 Identities=24% Similarity=0.284 Sum_probs=174.4
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
....+.+.+.+-+-+|.|+.++.+.-. .|...++|.... ......+....+-.++-...+|.++...-.+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345677888889999999999987743 344444443221 2222333333443444444567777665555566778
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
+|+++|..+++|...++... ..+.......+..+..++.+||... +.|+|++|.|+++..++..+++|||....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 99999999999999987654 3555566677788999999999988 89999999999999999999999984322
Q ss_pred ccc------C--C----------------------ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 042371 235 IVI------D--Q----------------------THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQK 284 (400)
Q Consensus 235 ~~~------~--~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 284 (400)
... . . ........||+.|.+||.+.+......+|+|++|+++++.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 210 0 0 001122458999999999999999999999999999999999999
Q ss_pred CCCcCCCccccchHHHHHHHhhhcccccccchhh-hccCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 042371 285 PIILTGSKEATGLAAYFILSMEENRLYDFLDDQV-LKVGQKEEIMTIATLATRCLNLNGKRRPTMK 349 (400)
Q Consensus 285 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 349 (400)
||........ +..+..... +...+...+....+++.+.+..+|.+|-.+.
T Consensus 1034 p~na~tpq~~---------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI---------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhh---------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9955433221 011111111 1122334455678899999999999997765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.5e-11 Score=100.20 Aligned_cols=131 Identities=24% Similarity=0.318 Sum_probs=98.6
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEcc-ccC--c-----hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSK-IVH--E-----GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~-~~~--~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..+++|+-+.++.+.+. |.++++|.-. ... + -...+-.+|+.++.++.--.|....=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999764 3446666321 111 1 1234556899999988655555444456667777899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++|..|.+++.... ..++..+-..+.-||..| |+|+||.++||++... .+.++|||++.+
T Consensus 81 I~G~~lkd~l~~~~----------~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEAR----------PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcc----------hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCC-cEEEEECCcccc
Confidence 99999988887541 346777888889999999 9999999999999987 499999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.7e-11 Score=105.09 Aligned_cols=142 Identities=23% Similarity=0.276 Sum_probs=107.3
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEccccCc-hhHHHHHHHHHHHHhCCC--CcceeeeeEEeeC---CcceEEEEccC
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHE-GKLEEFINEVVILSQINH--RNVVKLLGCCLET---EVPLLVYEFIS 162 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~~~ 162 (400)
+.|+.|.++.||++...+|..+++|....... .....+..|+.++..+.+ .++++++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999876678899997654322 134577889999999975 3456777776553 25689999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA---------------------------------------- 202 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 202 (400)
|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765431 13667777778888888888888531
Q ss_pred -------------CCCeEecCCCCCCeEEcC--CCcEEEEecCCccc
Q 042371 203 -------------SMPIYHRDIKSTNILLNE--KYTAKVADFGTSKF 234 (400)
Q Consensus 203 -------------~~~iiHrDikp~NIll~~--~~~~kl~Dfgla~~ 234 (400)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.3e-10 Score=96.13 Aligned_cols=143 Identities=21% Similarity=0.248 Sum_probs=105.4
Q ss_pred ccceeeecCcEEEEEEEecCCcEEEEEEccccC--------chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 87 VNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH--------EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 87 ~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
....|-+|+-+.|+++.+. |+..+||.-.... .-...+-.+|++.|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999884 7778888422111 112356678999998886444443333456666678999
Q ss_pred EccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---cEEEEecCCccc
Q 042371 159 EFISN-GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY---TAKVADFGTSKF 234 (400)
Q Consensus 159 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl~Dfgla~~ 234 (400)
||++| .++.+++....... ........++..|-+.+.-||..+ |+|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 48888887654432 333334678899999999999999 99999999999997655 468999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=6e-10 Score=106.93 Aligned_cols=215 Identities=19% Similarity=0.247 Sum_probs=153.4
Q ss_pred EEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEe----eCCcceEEEEccCC-CCHHHHH
Q 042371 97 GTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL----ETEVPLLVYEFISN-GTLFQYL 170 (400)
Q Consensus 97 g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-g~L~~~l 170 (400)
.+.|++.. .+|..|++|++.............-+++++++.|+|+|++.+++. .+..+++|++|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 46788884 489999999884433333334455678899999999999998876 34467899999875 5777765
Q ss_pred hhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 171 HDQN------------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 171 ~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
.... .+...++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4322 1224678999999999999999999999 888999999999999999999988877654322
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.. +-+.. -.+-|.=.||.+++.|.||...-...... ....
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~----------------------~~s~ 486 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST----------------------QSSH 486 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccch----------------------HHHH
Confidence 20 11111 23579999999999999996542111100 0000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
.......++..+++++.-....++++ -++.+++.++
T Consensus 487 ~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 12223455666888888888888887 6788887763
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.9e-10 Score=103.34 Aligned_cols=271 Identities=16% Similarity=0.148 Sum_probs=165.8
Q ss_pred CcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCccee--------eeeEEeeCCcce
Q 042371 85 FNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVK--------LLGCCLETEVPL 155 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~--------~~~~~~~~~~~~ 155 (400)
....+.||+|+.+.+|-.-.-.+ .+.|+..........+ .+..|... .||-+-. ++|- ......-
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iG 86 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIG 86 (637)
T ss_pred cCCCccccCCccceeeecchhhc--hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCC-CccceeE
Confidence 34567899999999996432111 2334433222222122 12223332 4553322 1111 1111245
Q ss_pred EEEEccCCC-CHHHHHhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 156 LVYEFISNG-TLFQYLHD---QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 156 lv~e~~~~g-~L~~~l~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
++|+.+.|. .+..+++. +..-....|.-.++.++.++.+...||..| .+-+|++++|+|+++++.+.|.|=..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccc
Confidence 778877654 22333322 222234689999999999999999999999 89999999999999999999999665
Q ss_pred ccccccCCceeeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhC-CCCCCcCCCc--cccchH-HHHH
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTG-QKPIILTGSK--EATGLA-AYFI 302 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~--~~~~~~-~~~~ 302 (400)
-..- .........+|.+.|.+||.-. +..-+...|-|.||+++++++.| ++||..-... ...... ....
T Consensus 164 fqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 164 FQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 4332 3344455567899999999744 44567889999999999999996 9998433211 111111 0000
Q ss_pred HHhhhcccccc-cchhhhccCCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHhhccc
Q 042371 303 LSMEENRLYDF-LDDQVLKVGQKEEIMTIATLATRCLNL--NGKRRPTMKEVAMELERIQALQKDIN 366 (400)
Q Consensus 303 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~ell~~L~~~~~~~~~~~ 366 (400)
..+....-... ..+..........++.+..+..+|+.. ++.-|||++-++..|..+.++.++..
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 11100000000 001111122234456788899999965 36789999999999999999887754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.9e-09 Score=93.38 Aligned_cols=125 Identities=26% Similarity=0.252 Sum_probs=82.2
Q ss_pred EEEEEEecCCcEEEEEEccccCc--------------------------hhHHHHHHHHHHHHhCCCC--cceeeeeEEe
Q 042371 98 TVYKGMLADGRIVAVKKSKIVHE--------------------------GKLEEFINEVVILSQINHR--NVVKLLGCCL 149 (400)
Q Consensus 98 ~V~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~ 149 (400)
.||.|...+|..+|+|..+.... .......+|.+.|..+... ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988899999995332110 0124566899999999755 566776542
Q ss_pred eCCcceEEEEccC--CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCCeEEcCCCcEEE
Q 042371 150 ETEVPLLVYEFIS--NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY-LHSAASMPIYHRDIKSTNILLNEKYTAKV 226 (400)
Q Consensus 150 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~iiHrDikp~NIll~~~~~~kl 226 (400)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 65555543322 1122345677778775555 57888 9999999999999988 9999
Q ss_pred EecCCcccc
Q 042371 227 ADFGTSKFI 235 (400)
Q Consensus 227 ~Dfgla~~~ 235 (400)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.5e-09 Score=95.59 Aligned_cols=135 Identities=22% Similarity=0.238 Sum_probs=99.8
Q ss_pred CcccceeeecCcEEEEEEEecCCcEEEEEEccccCc------------------h----hHHHHHHHHHHHHhCCCC--c
Q 042371 85 FNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHE------------------G----KLEEFINEVVILSQINHR--N 140 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~------------------~----~~~~~~~E~~~l~~l~h~--~ 140 (400)
..+...||-|--+.||.|..+.|.++|||.-+.... + ......+|..+|..|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999994332111 0 123456899999999654 6
Q ss_pred ceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 042371 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE 220 (400)
Q Consensus 141 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~ 220 (400)
+++.+++ +...+||||++|..|...- +.....-.++..|++-+.-+-..| |||+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777654 5568999999987665432 122233445555666666566777 999999999999999
Q ss_pred CCcEEEEecCCccc
Q 042371 221 KYTAKVADFGTSKF 234 (400)
Q Consensus 221 ~~~~kl~Dfgla~~ 234 (400)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=7.8e-09 Score=94.90 Aligned_cols=139 Identities=17% Similarity=0.148 Sum_probs=96.4
Q ss_pred eeeecCcEEEEEEEecCCcEEEEEEccccCch-----------hHHHHHHHHHHHHhCCCCc--ceeeeeEEee-----C
Q 042371 90 ILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG-----------KLEEFINEVVILSQINHRN--VVKLLGCCLE-----T 151 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~-----~ 151 (400)
.+-......|.+... +|+.+.||........ ....+.+|...+..+...+ .+..+.+... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333444666555 5778999955322211 1114778888888874333 3334444432 2
Q ss_pred CcceEEEEccCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-------CCc
Q 042371 152 EVPLLVYEFISNG-TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-------KYT 223 (400)
Q Consensus 152 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-------~~~ 223 (400)
...+||+|++++. +|.+++..... .+.+......++.+++..+.-||..| |+|+|+++.|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 2468999999886 89998864321 13566777889999999999999999 999999999999975 468
Q ss_pred EEEEecCCcc
Q 042371 224 AKVADFGTSK 233 (400)
Q Consensus 224 ~kl~Dfgla~ 233 (400)
+.|+||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999885
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.3e-09 Score=108.18 Aligned_cols=150 Identities=24% Similarity=0.280 Sum_probs=105.3
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeee--------cccccCCCCCcccccc
Q 042371 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT--------KVQGTFGYLDPEYFRS 260 (400)
Q Consensus 189 ~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~ 260 (400)
.+++.|+.|+|...+ +||++|.|++|.++.++..||+.|+++............ -..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 445599999998664 999999999999999999999999988654332211111 1224568999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHhCCCC-CCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcc
Q 042371 261 GQFTDKSDVYSFGVVLVELLTGQKP-IILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLN 339 (400)
Q Consensus 261 ~~~~~~~DiwSlG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 339 (400)
...+.++|+||+|+++|.+..|..+ +...+... .+. .....+...........++++++=+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~--------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYS--------FSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhh--------hhhcccccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999999955444 32222111 110 111111112222335667789999999999
Q ss_pred cCCCCCCCHHHHHH
Q 042371 340 LNGKRRPTMKEVAM 353 (400)
Q Consensus 340 ~dP~~RPt~~ell~ 353 (400)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.5e-07 Score=82.29 Aligned_cols=139 Identities=18% Similarity=0.129 Sum_probs=101.3
Q ss_pred eeecCcEEEEEEEecCCcEEEEEEcccc------CchhHHHHHHHHHHHHhCCCC--cceeeeeEEeeC----CcceEEE
Q 042371 91 LGQGGQGTVYKGMLADGRIVAVKKSKIV------HEGKLEEFINEVVILSQINHR--NVVKLLGCCLET----EVPLLVY 158 (400)
Q Consensus 91 lg~G~fg~V~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~----~~~~lv~ 158 (400)
-|+||.+.|++.... |..+-+|..... .+.-...|.+|+..+..+..- .+++....-... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999987764 447888965421 133457889999999988532 244444221111 1357999
Q ss_pred EccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--EEEEecCCccc
Q 042371 159 EFISN-GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT--AKVADFGTSKF 234 (400)
Q Consensus 159 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~--~kl~Dfgla~~ 234 (400)
|-++| -+|.+++...... +.+......++.+++.++.-||..| +.|+|+.+.||+++.++. +.++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 4888887654322 4677778889999999999999999 999999999999986677 99999987754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.8e-08 Score=85.23 Aligned_cols=106 Identities=20% Similarity=0.249 Sum_probs=82.4
Q ss_pred HHHHHHHHHHHHhCCC--CcceeeeeEEeeCC----cceEEEEccCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 042371 123 LEEFINEVVILSQINH--RNVVKLLGCCLETE----VPLLVYEFISNG-TLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195 (400)
Q Consensus 123 ~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l 195 (400)
.....+|...+..+.. -..++.+++..... ..+||+|++++. +|.+++..... .+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 4567788888777743 23445555554422 347999999874 79998876432 55666778999999999
Q ss_pred HHHHhcCCCCeEecCCCCCCeEEcCCC---cEEEEecCCccc
Q 042371 196 SYLHSAASMPIYHRDIKSTNILLNEKY---TAKVADFGTSKF 234 (400)
Q Consensus 196 ~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl~Dfgla~~ 234 (400)
.-||..| |+|+|++|.|||++.++ .+.++||+.+..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.5e-08 Score=95.00 Aligned_cols=139 Identities=17% Similarity=0.189 Sum_probs=89.6
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEccccCchh------------------------------HH----------HHHH
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGK------------------------------LE----------EFIN 128 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~------------------------------~~----------~~~~ 128 (400)
.-|+.++-|.||+|+.++|+.||||+....-... .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999654321110 01 1334
Q ss_pred HHHHHHhCC-----CCcceeeeeEE-eeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHH-HHHHHhc
Q 042371 129 EVVILSQIN-----HRNVVKLLGCC-LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS-LSYLHSA 201 (400)
Q Consensus 129 E~~~l~~l~-----h~~iv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l~~LH~~ 201 (400)
|+..+.+++ .+++ .+=.++ .-.+.-.|+|||++|..+.+.......+ ++.+.+ +..++.+ +.-+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~i---a~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKEL---AELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHH---HHHHHHHHHHHHHhc
Confidence 555444442 2322 111222 2235568999999999998885333222 443333 2222222 2223334
Q ss_pred CCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 202 ~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
| +.|.|..|.||+++.+|++.+.|||+...+.
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 5 9999999999999999999999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.59 E-value=7.6e-07 Score=78.18 Aligned_cols=138 Identities=14% Similarity=0.197 Sum_probs=90.9
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHH---------HHHHHHHHHhC---CCCcceeeeeE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEE---------FINEVVILSQI---NHRNVVKLLGC 147 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~E~~~l~~l---~h~~iv~~~~~ 147 (400)
....+|.+.+++-......|.+-.. +|..+++|..........+. ..+.+..+..+ .-.....++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4457788888888888888887666 57889999654432221111 22333333333 22223332222
Q ss_pred Ee-----eCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 042371 148 CL-----ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY 222 (400)
Q Consensus 148 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 222 (400)
.. .....+++|||++|..|.++.. +++ .++..+.+++.-||..| +.|+|..|.|++++.+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 21 2234468999999988766532 222 24566788899999999 9999999999999966
Q ss_pred cEEEEecCCcc
Q 042371 223 TAKVADFGTSK 233 (400)
Q Consensus 223 ~~kl~Dfgla~ 233 (400)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 59999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-06 Score=78.44 Aligned_cols=139 Identities=14% Similarity=0.119 Sum_probs=83.3
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCc--ceeeeeEEeeCCcceEEEEccCCCC-
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN--VVKLLGCCLETEVPLLVYEFISNGT- 165 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~g~- 165 (400)
..||+|..+.||+. .+..+++|..... .......+|.++++.+..-. +++.+.+....+...+||++++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 2446778865432 23455688999999886433 4667777777777789999999863
Q ss_pred HHHHHh--------------h-----cCC-CCCCCHHHHHH-HHHH----------HHH-HHHHHHh-cCCCCeEecCCC
Q 042371 166 LFQYLH--------------D-----QNE-EFPLTWEMRLR-IATE----------VAG-SLSYLHS-AASMPIYHRDIK 212 (400)
Q Consensus 166 L~~~l~--------------~-----~~~-~~~l~~~~~~~-i~~~----------i~~-~l~~LH~-~~~~~iiHrDik 212 (400)
+...+. . +.- ....+...... +..+ +.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211111 0 000 00011111000 0000 001 1112211 112347899999
Q ss_pred CCCeEEcCCCcEEEEecCCcc
Q 042371 213 STNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 213 p~NIll~~~~~~kl~Dfgla~ 233 (400)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.9e-06 Score=76.55 Aligned_cols=147 Identities=22% Similarity=0.242 Sum_probs=97.3
Q ss_pred HHHHHhcCCcccc---eeeecCcEEEEEEEecCCcEEEEEEccccCch------------------------hHHHHHHH
Q 042371 77 ELDKATDHFNVNR---ILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG------------------------KLEEFINE 129 (400)
Q Consensus 77 ~~~~~~~~y~~~~---~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~E 129 (400)
.+....++..+.. .|++|--+.||+|...++..+|+|+.+..... .......|
T Consensus 39 ~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kE 118 (268)
T COG1718 39 TLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKE 118 (268)
T ss_pred HHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHH
Confidence 3444445555544 56677778999999888999999965542211 01233467
Q ss_pred HHHHHhCC--CCcceeeeeEEeeCCcceEEEEccCCCC-HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCC
Q 042371 130 VVILSQIN--HRNVVKLLGCCLETEVPLLVYEFISNGT-LFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMP 205 (400)
Q Consensus 130 ~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ 205 (400)
+..|.++. +-.+++-+.+. .-.|||||+.... -.-.|. ..++.......+..++++.+.-|-. .+
T Consensus 119 f~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~--- 187 (268)
T COG1718 119 FRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEAG--- 187 (268)
T ss_pred HHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhcC---
Confidence 77777763 33444555443 2369999985431 000111 1123333577778889888888877 67
Q ss_pred eEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 206 iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||+||+.-|||+. ++.+.|+|||-|...
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 779999999988654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.7e-06 Score=75.46 Aligned_cols=143 Identities=21% Similarity=0.203 Sum_probs=82.8
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCC--cceeeeeEEee---CCcceEEEEccC
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHR--NVVKLLGCCLE---TEVPLLVYEFIS 162 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~---~~~~~lv~e~~~ 162 (400)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+++++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999876 68999975433 4566777888888888532 35666664432 234689999999
Q ss_pred CCCHHH----------------HHh---hc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 042371 163 NGTLFQ----------------YLH---DQ-NEEFPLTWEM---------RLRI------------ATEVAG-SLSYLHS 200 (400)
Q Consensus 163 ~g~L~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH~ 200 (400)
|..+.. .+. .. ....+..... .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 111 11 0111111100 0000 011111 2233332
Q ss_pred ----cCCCCeEecCCCCCCeEEc-CCCcEEEEecCCcc
Q 042371 201 ----AASMPIYHRDIKSTNILLN-EKYTAKVADFGTSK 233 (400)
Q Consensus 201 ----~~~~~iiHrDikp~NIll~-~~~~~kl~Dfgla~ 233 (400)
.....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234499999999999999 66667899999874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.44 E-value=4.6e-06 Score=75.88 Aligned_cols=140 Identities=15% Similarity=0.098 Sum_probs=84.4
Q ss_pred eeeecCc-EEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEEEccCCCCHH
Q 042371 90 ILGQGGQ-GTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFISNGTLF 167 (400)
Q Consensus 90 ~lg~G~f-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 167 (400)
.|..|.. +.||+.... +..+++|...... ...+.+|+.+++.+. +--+++++++....+..++||++++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 789998764 4678888765332 345667888888874 444667787776666789999999998776
Q ss_pred HHHh-------------------hcCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----c
Q 042371 168 QYLH-------------------DQNE-EFPLTWE--MRLRIAT--------------------EVAGSLSYLHS----A 201 (400)
Q Consensus 168 ~~l~-------------------~~~~-~~~l~~~--~~~~i~~--------------------~i~~~l~~LH~----~ 201 (400)
.... .... ..++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 0011100 0000000 01111222211 1
Q ss_pred CCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 202 ~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12448999999999999998778899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.5e-05 Score=69.41 Aligned_cols=104 Identities=24% Similarity=0.356 Sum_probs=81.8
Q ss_pred HHHHHHHhCCC-CcceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 042371 128 NEVVILSQINH-RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206 (400)
Q Consensus 128 ~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 206 (400)
.|..+++.+.+ +++++++|+|- .++|.||...+++...-..-......+|..+.+|+.++++.+.+|+......+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57788888865 69999999983 36899999877664321110111236899999999999999999998665558
Q ss_pred EecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 207 YHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 207 iHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
...|++|+|+-++++|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 89999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.8e-06 Score=83.46 Aligned_cols=140 Identities=17% Similarity=0.141 Sum_probs=88.5
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCchh-------------------------------HH------HHHHHH
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGK-------------------------------LE------EFINEV 130 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~------~~~~E~ 130 (400)
.+.||.-+.|.||+|+.++|+.||||.....-+.. .+ .|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 35799999999999999999999999654321110 00 133444
Q ss_pred HHHHh----CCCCc------ceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 042371 131 VILSQ----INHRN------VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200 (400)
Q Consensus 131 ~~l~~----l~h~~------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 200 (400)
.-..+ +.|-+ |+++|-.+ .....|+|||++|..+.++-.-... .++...+..-+.+...-+ +-.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~q--If~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQ--IFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHH--HHh
Confidence 33333 33444 33333222 2356899999999877766432222 255554443333332222 223
Q ss_pred cCCCCeEecCCCCCCeEEcC----CCcEEEEecCCccccc
Q 042371 201 AASMPIYHRDIKSTNILLNE----KYTAKVADFGTSKFIV 236 (400)
Q Consensus 201 ~~~~~iiHrDikp~NIll~~----~~~~kl~Dfgla~~~~ 236 (400)
.| ++|+|=.|.||+++. ++.+.+.|||+...+.
T Consensus 320 ~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 34 999999999999984 6689999999987664
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.6e-06 Score=70.23 Aligned_cols=131 Identities=18% Similarity=0.211 Sum_probs=92.7
Q ss_pred CCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcce-eeeeEEeeCCcceEEEEccC
Q 042371 84 HFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV-KLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~ 162 (400)
.....+.|++|.+|.||++.+.+ ..+|+|.... +.....+..|+.+|..+...++- ++|.+.. .++.|||+.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~ 95 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRG-GEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID 95 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccC-ceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence 34567889999999999999864 4788886553 44456788899999998765554 4555433 345699999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCCeEEcCCCcEEEEecCCccc
Q 042371 163 NGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIK-STNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 163 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik-p~NIll~~~~~~kl~Dfgla~~ 234 (400)
|-.|.+.-... .. +-...++++---|...| |-|..|. |...++..++.+.|+||..|+.
T Consensus 96 G~~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98887765422 11 22344666666677777 9999997 5555555555999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.2e-07 Score=93.62 Aligned_cols=185 Identities=19% Similarity=0.142 Sum_probs=130.4
Q ss_pred CcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCc-ceeeeeEEeeCCcceEEEEccCC
Q 042371 85 FNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN-VVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.....+++|+++.+++.+..-.+....+.+... ....-++++|.+++||| .+..++.+..+...+++++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 4445568899999999877432333334433322 44556788999999999 77777777778888999999987
Q ss_pred C-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee
Q 042371 164 G-TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 164 g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 242 (400)
+ +-........ -.+..-....+.+.-..+++++|+.. -+|+| ||+..+ +..+..||+....+.. ...
T Consensus 319 ~rs~~~~~~~se--~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~--~~~ 386 (829)
T KOG0576|consen 319 GRSSALEMTVSE--IALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTR--TMK 386 (829)
T ss_pred CccccccCChhh--Hhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCc--ccc
Confidence 6 2111111110 01223334445566677889999865 48998 887776 5899999999876532 223
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 286 (400)
.....+|+.++|||+.....+....|.|++|+-..+|--|-+|-
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 45567899999999999999999999999998877777777664
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.1e-05 Score=67.02 Aligned_cols=128 Identities=21% Similarity=0.295 Sum_probs=90.4
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccC----------------chhHHHHHHHHHHHHhCC------CCcceeee
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVH----------------EGKLEEFINEVVILSQIN------HRNVVKLL 145 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~~iv~~~ 145 (400)
...||+|+.-.||. .+++...+||...... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999986 4445567788765444 223456667776665555 78899999
Q ss_pred eEEeeCCcceEEEEccCC------CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 042371 146 GCCLETEVPLLVYEFISN------GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN 219 (400)
Q Consensus 146 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 219 (400)
|+...+-..-+|+|.+.+ -+|.+++.... ++. . +...+-+-..||-..+ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999998888899987642 37888885433 444 2 3344445566777777 99999999999996
Q ss_pred CCC----cEEEEe
Q 042371 220 EKY----TAKVAD 228 (400)
Q Consensus 220 ~~~----~~kl~D 228 (400)
.+. .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.5e-05 Score=81.54 Aligned_cols=78 Identities=14% Similarity=0.276 Sum_probs=56.1
Q ss_pred cceeeecCcEEEEEEEecCC---cEEEEEEccccC-chhHHHHHHHHHHHHhCC-CCcc--eeeeeEEeeC---CcceEE
Q 042371 88 NRILGQGGQGTVYKGMLADG---RIVAVKKSKIVH-EGKLEEFINEVVILSQIN-HRNV--VKLLGCCLET---EVPLLV 157 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv 157 (400)
.+.++.|.++.+|+....++ ..+++|+..... ......+.+|+.+|+.+. |.++ ++++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876543 467777654321 123356789999999995 6654 7778777654 467899
Q ss_pred EEccCCCC
Q 042371 158 YEFISNGT 165 (400)
Q Consensus 158 ~e~~~~g~ 165 (400)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.9e-05 Score=82.01 Aligned_cols=198 Identities=18% Similarity=0.189 Sum_probs=138.4
Q ss_pred HHHHHHHHHHHhCCCCcceeeeeEEeeCCcc----eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 042371 124 EEFINEVVILSQINHRNVVKLLGCCLETEVP----LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199 (400)
Q Consensus 124 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 199 (400)
.....|+..+....|+|++.++.+....... .+..+++...++...+.... .++....+.+..++..|+.|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHH
Confidence 3344566778888999999999987654322 24567888888888887655 5888889999999999999999
Q ss_pred hcCCCCeEecCCCCC---CeEEcCCCcEEEE--ecCCccccccCCceeeecccccCCCCCccccccCCCCCc--chhHHH
Q 042371 200 SAASMPIYHRDIKST---NILLNEKYTAKVA--DFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDK--SDVYSF 272 (400)
Q Consensus 200 ~~~~~~iiHrDikp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwSl 272 (400)
+.. ..|.-+... +-..+..+.+.++ ||+.+......... ....-+..+.|||......+..+ .|+|.+
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHH
Confidence 986 555555544 5555666777777 99988766433222 22334667888888776665554 799999
Q ss_pred HHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 042371 273 GVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVA 352 (400)
Q Consensus 273 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell 352 (400)
|.....+..|..+-.... ....+. ..... ....+...+|+..++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~~~------------------~~~~~l-----~~~~~---~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA------------------VPVSLL-----DVLST---SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc------------------chhhhh-----ccccc---hhhhhhhhhhcchhhhhccchhhhh
Confidence 999999999866521100 000000 00111 1467889999999999999999998
Q ss_pred HHH
Q 042371 353 MEL 355 (400)
Q Consensus 353 ~~L 355 (400)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.03 E-value=7.6e-05 Score=67.38 Aligned_cols=73 Identities=22% Similarity=0.172 Sum_probs=46.9
Q ss_pred ceeeecCcEEEEEEEecC--CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCc-ceeeeeEEeeCCcceEEEEccCCCC
Q 042371 89 RILGQGGQGTVYKGMLAD--GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN-VVKLLGCCLETEVPLLVYEFISNGT 165 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~g~ 165 (400)
+.|..|-...+|+....+ +..+++|........ .....+|+.++..+...+ .++++..+. -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999988664 678889865432221 122346888888885333 444544332 248999999876
Q ss_pred H
Q 042371 166 L 166 (400)
Q Consensus 166 L 166 (400)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.8e-05 Score=68.26 Aligned_cols=73 Identities=19% Similarity=0.251 Sum_probs=45.1
Q ss_pred ceeeecCcE-EEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCC---cceeeeeEEeeC---CcceEEEEcc
Q 042371 89 RILGQGGQG-TVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHR---NVVKLLGCCLET---EVPLLVYEFI 161 (400)
Q Consensus 89 ~~lg~G~fg-~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~~ 161 (400)
+.|+.|+.. .||+. +..+++|.... ......+.+|..++..+... .++..+...... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 48875 23467775432 22345788899999887532 344445443322 2358899999
Q ss_pred CCCCHH
Q 042371 162 SNGTLF 167 (400)
Q Consensus 162 ~~g~L~ 167 (400)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.4e-05 Score=69.40 Aligned_cols=138 Identities=16% Similarity=0.149 Sum_probs=76.4
Q ss_pred eeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcc-eeeeeEEeeCCcceEEEEccCCCCHHH
Q 042371 90 ILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFISNGTLFQ 168 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g~L~~ 168 (400)
.+..|-.+.+|+... ++..+++|..........-...+|..+++.+....+ ++++.... .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355677788998774 566788886443222110134678888888854333 34444322 368999999866532
Q ss_pred H--------------Hh---hcC-CCCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCeEecCCCCCC
Q 042371 169 Y--------------LH---DQN-EEFPLTWEM-RLRIATEV---------AGSLSYLHSA-----ASMPIYHRDIKSTN 215 (400)
Q Consensus 169 ~--------------l~---~~~-~~~~l~~~~-~~~i~~~i---------~~~l~~LH~~-----~~~~iiHrDikp~N 215 (400)
. +. ... ...+++... ...+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11 111 011122211 11111111 1112222111 12348999999999
Q ss_pred eEEcCCCcEEEEecCCcc
Q 042371 216 ILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 216 Ill~~~~~~kl~Dfgla~ 233 (400)
|++++++ +.|+||+.+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999876 7899999885
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00021 Score=66.99 Aligned_cols=78 Identities=9% Similarity=0.014 Sum_probs=56.3
Q ss_pred cccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCC---CcceeeeeEEee---CCcceEEEE
Q 042371 86 NVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH---RNVVKLLGCCLE---TEVPLLVYE 159 (400)
Q Consensus 86 ~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e 159 (400)
.-.+.||.|..+.||.....++ .+++|..+. ......+..|...|+.+.- -.++++++++.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3356799999999999876555 466665332 1133578889999988853 367888887754 356899999
Q ss_pred ccCCCCH
Q 042371 160 FISNGTL 166 (400)
Q Consensus 160 ~~~~g~L 166 (400)
+++|+++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=2.4e-05 Score=72.08 Aligned_cols=136 Identities=17% Similarity=0.196 Sum_probs=96.8
Q ss_pred CCcccceeeecCcEEEEEEEecCCcEEEEEEccccCch------------------h----HHHHHHHHHHHHhCC-C-C
Q 042371 84 HFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG------------------K----LEEFINEVVILSQIN-H-R 139 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~------------------~----~~~~~~E~~~l~~l~-h-~ 139 (400)
-+.+.+.||-|--+.||.+...+|++.++|.-...... + .-...+|+..|+.|. | -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 46788999999999999999999999999943221100 0 122456777888774 3 2
Q ss_pred cceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 042371 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN 219 (400)
Q Consensus 140 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 219 (400)
-+++.++. ++.++|||++.|..|...-+-.. .-.+...+...+--|...| +||+|.+-=||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d---------~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVED---------PPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCC---------hHHHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 34444443 45689999999888765432221 2234555666677788888 99999999999999
Q ss_pred CCCcEEEEecCCcccc
Q 042371 220 EKYTAKVADFGTSKFI 235 (400)
Q Consensus 220 ~~~~~kl~Dfgla~~~ 235 (400)
+++.++++||--+...
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999765443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0003 Score=61.28 Aligned_cols=125 Identities=30% Similarity=0.467 Sum_probs=88.4
Q ss_pred cCCcccceeeecCc-EEEEEEEecCCcEEEEEEccc---cCc------------------hhHHHHHHHHHHHHhCC---
Q 042371 83 DHFNVNRILGQGGQ-GTVYKGMLADGRIVAVKKSKI---VHE------------------GKLEEFINEVVILSQIN--- 137 (400)
Q Consensus 83 ~~y~~~~~lg~G~f-g~V~~~~~~~~~~vaiK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 137 (400)
..++..+.||.|.- |.||++.. +|+.+|+|.... ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999998 467999997221 111 11235677888777664
Q ss_pred CCcc--eeeeeEEeeCC------------------cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 042371 138 HRNV--VKLLGCCLETE------------------VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197 (400)
Q Consensus 138 h~~i--v~~~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 197 (400)
+.++ ++.+|+..-.. ...||.||.+... .+.. .-+.+|..-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4566 88888863220 1247888776533 1222 235667777888
Q ss_pred HHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 198 LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99999 999999999986 3589999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00068 Score=65.76 Aligned_cols=75 Identities=23% Similarity=0.214 Sum_probs=54.1
Q ss_pred ceeeecCcEEEEEEEecCC-cEEEEEEcccc----C---chhHHHHHHHHHHHHhCC---CCcceeeeeEEeeCCcceEE
Q 042371 89 RILGQGGQGTVYKGMLADG-RIVAVKKSKIV----H---EGKLEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~-~~vaiK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv 157 (400)
+.||.|.+..||++...+| +.++||..... . .-..++...|.+.|..+. ..++++++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 58999974311 1 124567777888888763 3456777766 34557899
Q ss_pred EEccCCCC
Q 042371 158 YEFISNGT 165 (400)
Q Consensus 158 ~e~~~~g~ 165 (400)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.001 Score=62.96 Aligned_cols=156 Identities=16% Similarity=0.183 Sum_probs=81.3
Q ss_pred ChHHHHHHhcCCcc-----cceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCC--cceeeee
Q 042371 74 TTKELDKATDHFNV-----NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHR--NVVKLLG 146 (400)
Q Consensus 74 ~~~~~~~~~~~y~~-----~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~ 146 (400)
+..++......|.+ .+.|+.|....+|+....+| .+++|.... ........|+.++..|... .+++.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 34444444445544 34567777789999876555 688887542 1223334455555554211 1333332
Q ss_pred ------EEeeCCcceEEEEccCCCCHH-----------HHH---hhcCCCC--------CC-CHHHHHH-----------
Q 042371 147 ------CCLETEVPLLVYEFISNGTLF-----------QYL---HDQNEEF--------PL-TWEMRLR----------- 186 (400)
Q Consensus 147 ------~~~~~~~~~lv~e~~~~g~L~-----------~~l---~~~~~~~--------~l-~~~~~~~----------- 186 (400)
+....+..+++++|++|..+. ..+ +...... .+ .+.....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 122345678999999886431 111 1111110 01 1111111
Q ss_pred -HHHH-HHHHHHHHHhc----CCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 187 -IATE-VAGSLSYLHSA----ASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 187 -i~~~-i~~~l~~LH~~----~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.+.+ +...+..+... -..+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122233211 12359999999999999976556899999885
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00044 Score=64.98 Aligned_cols=74 Identities=28% Similarity=0.277 Sum_probs=46.9
Q ss_pred ceeeecCcEEEEEEEecC-------CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCc-ceeeeeEEeeCCcceEEEEc
Q 042371 89 RILGQGGQGTVYKGMLAD-------GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN-VVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~ 160 (400)
+.|..|-...+|+....+ ++.+++|...... .......+|..++..+.... .++++.++. -.+|++|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456667777899887654 5788999754332 22234567888888875332 344555543 2368999
Q ss_pred cCCCCHH
Q 042371 161 ISNGTLF 167 (400)
Q Consensus 161 ~~~g~L~ 167 (400)
++|..+.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 8887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00089 Score=63.14 Aligned_cols=143 Identities=19% Similarity=0.243 Sum_probs=79.5
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCC--cceeeeeE------EeeCCcceEEEE
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHR--NVVKLLGC------CLETEVPLLVYE 159 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~------~~~~~~~~lv~e 159 (400)
.+.++.|....+|+....++ .+++|...... ....+..|..++..|... .+++++.. ....+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789998876444 57788654321 233455666777666322 23444332 122355689999
Q ss_pred ccCCCCHH-----------HH---HhhcCCCCCC---------CHHHHH------------HHHHHHHHHHHHHHh----
Q 042371 160 FISNGTLF-----------QY---LHDQNEEFPL---------TWEMRL------------RIATEVAGSLSYLHS---- 200 (400)
Q Consensus 160 ~~~~g~L~-----------~~---l~~~~~~~~l---------~~~~~~------------~i~~~i~~~l~~LH~---- 200 (400)
|++|..+. .. ++......+. .|.... .....+...+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885432 11 1111111100 011000 001123334555532
Q ss_pred cCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 201 ~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.-..+++|+|+.+.||+++.++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112459999999999999998777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0018 Score=60.53 Aligned_cols=142 Identities=19% Similarity=0.181 Sum_probs=82.8
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCC--cceeeeeE------EeeCCcceEEEE
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHR--NVVKLLGC------CLETEVPLLVYE 159 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~------~~~~~~~~lv~e 159 (400)
.+.|..|....+|+....+ ..+++|.... .....+..|+.++..+... .+++++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4467778778999887544 4688887653 2345566778777777432 24444332 223456689999
Q ss_pred ccCCCCHHH--------H------HhhcCCCC--------CCCHHHHH----------HHHHHHHHHHHHHHhc----CC
Q 042371 160 FISNGTLFQ--------Y------LHDQNEEF--------PLTWEMRL----------RIATEVAGSLSYLHSA----AS 203 (400)
Q Consensus 160 ~~~~g~L~~--------~------l~~~~~~~--------~l~~~~~~----------~i~~~i~~~l~~LH~~----~~ 203 (400)
|++|..+.. + ++...... ...|.... .....+..++.++... -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876432 0 01100000 01111110 0111233344454431 12
Q ss_pred CCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 204 ~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 349999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00016 Score=46.21 Aligned_cols=33 Identities=48% Similarity=0.912 Sum_probs=30.4
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCchh
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRKV 33 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~~ 33 (400)
||||......|..+..|++..|+|.|..+.+..
T Consensus 2 idEC~~~~~~C~~~~~C~N~~Gsy~C~C~~Gy~ 34 (42)
T PF07645_consen 2 IDECAEGPHNCPENGTCVNTEGSYSCSCPPGYE 34 (42)
T ss_dssp SSTTTTTSSSSSTTSEEEEETTEEEEEESTTEE
T ss_pred ccccCCCCCcCCCCCEEEcCCCCEEeeCCCCcE
Confidence 899999999999999999999999998887753
|
Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A .... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.47 E-value=1.6e-05 Score=85.82 Aligned_cols=160 Identities=14% Similarity=0.010 Sum_probs=112.9
Q ss_pred HHHHHHHHHhCCCCcceeeeeEEee--CCcceEEEEccCCCCHHHHHhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhcC
Q 042371 126 FINEVVILSQINHRNVVKLLGCCLE--TEVPLLVYEFISNGTLFQYLHDQNEEF-PLTWEMRLRIATEVAGSLSYLHSAA 202 (400)
Q Consensus 126 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ 202 (400)
...|.+-++...|+++...+.-... ....+.+++|+.+|.+.+.|.+..... ++...-+.....+...+..-.|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3444445555678888776655432 235688999999999999987654332 2333223222333244444444433
Q ss_pred --CCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHH
Q 042371 203 --SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELL 280 (400)
Q Consensus 203 --~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 280 (400)
+...+|+++|+-|.+|..+.+++++++|+.+... +.........+++.|++|+....-.++.++|+|..|+.+|..-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 3457899999999999999999999999998332 2223333455788999999988888999999999999999998
Q ss_pred hCCCCC
Q 042371 281 TGQKPI 286 (400)
Q Consensus 281 tg~~pf 286 (400)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888876
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0021 Score=61.61 Aligned_cols=140 Identities=20% Similarity=0.240 Sum_probs=78.5
Q ss_pred ceeeecCcEEEEEEEecC-----CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcc-eeeeeEEeeCCcceEEEEccC
Q 042371 89 RILGQGGQGTVYKGMLAD-----GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFIS 162 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~ 162 (400)
..|..|-...+|+....+ ++.+++|.........+.+ .+|..+++.+...++ +++++.+.. + .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345567788899987432 3678888665433322222 578888888854333 345555432 2 5789988
Q ss_pred CCCHHHH-----------------HhhcCC---CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 042371 163 NGTLFQY-----------------LHDQNE---EFPLTWEMRLRIATEV-----------------AGSLSYL----HS- 200 (400)
Q Consensus 163 ~g~L~~~-----------------l~~~~~---~~~l~~~~~~~i~~~i-----------------~~~l~~L----H~- 200 (400)
+.+|... ++.... ..+..+..+..+..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 111110 0011122222332221 1111112 11
Q ss_pred cCCCCeEecCCCCCCeEEcC-CCcEEEEecCCcc
Q 042371 201 AASMPIYHRDIKSTNILLNE-KYTAKVADFGTSK 233 (400)
Q Consensus 201 ~~~~~iiHrDikp~NIll~~-~~~~kl~Dfgla~ 233 (400)
.....++|+|+++.|||+++ ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11235899999999999986 4689999999885
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0043 Score=58.21 Aligned_cols=139 Identities=17% Similarity=0.228 Sum_probs=83.2
Q ss_pred ccceeeecCcEEEEEEEecCCcEEEEEEcc-ccCchhHHHHHHHHHHHHhCCC--CcceeeeeEEeeCC--cceEEEEcc
Q 042371 87 VNRILGQGGQGTVYKGMLADGRIVAVKKSK-IVHEGKLEEFINEVVILSQINH--RNVVKLLGCCLETE--VPLLVYEFI 161 (400)
Q Consensus 87 ~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~e~~ 161 (400)
+.+.+..|....+|..... ++++++.+-. ...........+|+.+++.+.- --+...++.|.++. ..|.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 3444444444445555443 6778877221 1223345566678888887753 33445666676655 779999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHH-HHHHHHHHHHHhcC--------------------------------------
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIA-TEVAGSLSYLHSAA-------------------------------------- 202 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~-~~i~~~l~~LH~~~-------------------------------------- 202 (400)
+|..+.+.+.. .+.. ..++ ..++..|.-||+-.
T Consensus 108 eGe~~~~~~~~------~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPP------ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCc------ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 88533222111 0111 1112 24444455554321
Q ss_pred -----------------CCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 203 -----------------SMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 203 -----------------~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
...++|+|+.+.||+++.++-+=|.||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 23489999999999999988899999999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0039 Score=57.78 Aligned_cols=30 Identities=23% Similarity=0.448 Sum_probs=25.3
Q ss_pred CeEecCCCCCCeEEcCCCc-EEEEecCCccc
Q 042371 205 PIYHRDIKSTNILLNEKYT-AKVADFGTSKF 234 (400)
Q Consensus 205 ~iiHrDikp~NIll~~~~~-~kl~Dfgla~~ 234 (400)
.++|+|+.|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998853
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0078 Score=55.98 Aligned_cols=74 Identities=22% Similarity=0.223 Sum_probs=47.3
Q ss_pred ccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC---CCcceeeeeEEeeCCcceEEEEccCC
Q 042371 87 VNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 87 ~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
-.+.|+.|....+|+.. .+++.+.+|... ......+..|+.-|+.|. .-.+++.+++....+..+|+|||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34578999999999977 467789999655 333356677888887773 45677888888877778999999876
Q ss_pred C
Q 042371 164 G 164 (400)
Q Consensus 164 g 164 (400)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 5
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0092 Score=56.88 Aligned_cols=79 Identities=23% Similarity=0.216 Sum_probs=51.0
Q ss_pred eeeecCcEEEEEEEecCC-cEEEEEEcc----ccC---chhHHHHHHHHHHHHhCC--CC-cceeeeeEEeeCCcceEEE
Q 042371 90 ILGQGGQGTVYKGMLADG-RIVAVKKSK----IVH---EGKLEEFINEVVILSQIN--HR-NVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~~~-~~vaiK~~~----~~~---~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv~ 158 (400)
.||.|....||++..++| +.++||... ... +-..++..-|...|+... .| .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 689999532 111 334556667888887764 34 45555543 444557899
Q ss_pred EccCCC-CHHHHH
Q 042371 159 EFISNG-TLFQYL 170 (400)
Q Consensus 159 e~~~~g-~L~~~l 170 (400)
|+++.. .|.+.+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998543 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.014 Score=56.60 Aligned_cols=80 Identities=16% Similarity=0.125 Sum_probs=53.6
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccc----cCc---hhHHHHHHHHHHHHhCC---CCcceeeeeEEeeCCcceEE
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKI----VHE---GKLEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~----~~~---~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv 157 (400)
.+.||.|....||+.... +..++||.... ... ....+...|...|+.+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998864 45689996441 111 23455556677776664 247788888776 446789
Q ss_pred EEccCC--CCHHHHH
Q 042371 158 YEFISN--GTLFQYL 170 (400)
Q Consensus 158 ~e~~~~--g~L~~~l 170 (400)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3444443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0097 Score=56.29 Aligned_cols=139 Identities=18% Similarity=0.198 Sum_probs=92.4
Q ss_pred ccceeeecCcEEEEEEEecCCcEEEEEEccccC-----ch---------------------hHHHHHHHHHHHHhCCCCc
Q 042371 87 VNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH-----EG---------------------KLEEFINEVVILSQINHRN 140 (400)
Q Consensus 87 ~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~-----~~---------------------~~~~~~~E~~~l~~l~h~~ 140 (400)
+-..|..|--+.||.|...+|..+|||+.+... .+ ..-+...|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345788999999999999899999999544210 00 1223456888888886554
Q ss_pred ceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 042371 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE 220 (400)
Q Consensus 141 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~ 220 (400)
|+-.--... ....|||+|+.. +=+-. ..-....++...+..+-.+++.-|.-|-+... +||.||.--|+|+-+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGr-dgw~a--PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGR-DGWAA--PKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCceee--ecceEeeeeccC-CCCcC--cccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC
Confidence 432111111 123689999853 21111 11112246777788888888888888766553 999999999999876
Q ss_pred CCcEEEEecCCcc
Q 042371 221 KYTAKVADFGTSK 233 (400)
Q Consensus 221 ~~~~kl~Dfgla~ 233 (400)
+ .+.|+|-+-+.
T Consensus 301 G-~lyiIDVSQSV 312 (520)
T KOG2270|consen 301 G-KLYIIDVSQSV 312 (520)
T ss_pred C-EEEEEEccccc
Confidence 4 89999988764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.029 Score=52.81 Aligned_cols=29 Identities=31% Similarity=0.399 Sum_probs=25.3
Q ss_pred CCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 204 ~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999998 578999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.024 Score=53.42 Aligned_cols=31 Identities=16% Similarity=0.331 Sum_probs=27.9
Q ss_pred CCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 204 ~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
.+++|+|+.++|||++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3599999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.019 Score=54.68 Aligned_cols=140 Identities=20% Similarity=0.224 Sum_probs=75.9
Q ss_pred ceeeecCcEEEEEEEecC----CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcc-eeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLAD----GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.|..|=...+|+....+ +..|++|........ .-.-.+|..+++.+...++ +++++++. .+ +|.+|++|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345557777888886433 237888865433222 2223568888888864444 34555542 22 58888877
Q ss_pred CCHHH--------------HHhh-cCCC-----CCCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 042371 164 GTLFQ--------------YLHD-QNEE-----FPLTWEMRLRIATEV----------------------AGSLSYLH-- 199 (400)
Q Consensus 164 g~L~~--------------~l~~-~~~~-----~~l~~~~~~~i~~~i----------------------~~~l~~LH-- 199 (400)
.+|.. .+.+ +... .+-.+....++..++ ..-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65421 0111 1111 011122222222221 11111111
Q ss_pred --hcC-CCCeEecCCCCCCeEEcC-CCcEEEEecCCcc
Q 042371 200 --SAA-SMPIYHRDIKSTNILLNE-KYTAKVADFGTSK 233 (400)
Q Consensus 200 --~~~-~~~iiHrDikp~NIll~~-~~~~kl~Dfgla~ 233 (400)
..+ +.-++|.|+.+.|||+++ ++.++++||..|-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 111 223799999999999975 5689999999885
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.014 Score=56.45 Aligned_cols=74 Identities=18% Similarity=0.112 Sum_probs=49.9
Q ss_pred cceeeecCcEEEEEEEec-CCcEEEEEEccc---cC---chhHHHHHHHHHHHHhCC--CC-cceeeeeEEeeCCcceEE
Q 042371 88 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VH---EGKLEEFINEVVILSQIN--HR-NVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~---~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv 157 (400)
.+.||.|.-..||++... +++.++||.... .. +-..++..-|..+|+... .| .++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 467899999999999974 356799995321 11 234567777888888764 34 45556644 34455688
Q ss_pred EEccCC
Q 042371 158 YEFISN 163 (400)
Q Consensus 158 ~e~~~~ 163 (400)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.0061 Score=54.04 Aligned_cols=30 Identities=30% Similarity=0.523 Sum_probs=21.1
Q ss_pred CeEecCCCCCCeEE-cCCCcEEEEecCCccc
Q 042371 205 PIYHRDIKSTNILL-NEKYTAKVADFGTSKF 234 (400)
Q Consensus 205 ~iiHrDikp~NIll-~~~~~~kl~Dfgla~~ 234 (400)
.++|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 38999999999999 7888999999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.017 Score=56.99 Aligned_cols=51 Identities=20% Similarity=0.244 Sum_probs=40.0
Q ss_pred HHHHHHHHHHHHhCCCCcceeeeeEEeeC-CcceEEEEccCCCCHHHHHhhcC
Q 042371 123 LEEFINEVVILSQINHRNVVKLLGCCLET-EVPLLVYEFISNGTLFQYLHDQN 174 (400)
Q Consensus 123 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~ 174 (400)
...++..+.+++.+.|+|+..++++.... ....+|||++ +.+|++++..+.
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 35667778899999999999998876543 3467899999 569999887654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.037 Score=52.42 Aligned_cols=104 Identities=18% Similarity=0.208 Sum_probs=69.2
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..|++|++. |++|.- +. ...+.++..++.+.+..+.-+...- +.-|||+...||||+ +|++-|+||-++
T Consensus 300 y~yl~~kdh-gt~is~-ik------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-IK------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-ee------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 456777765 445431 21 1457788889999888888887765 389999999999999 899999999999
Q ss_pred cccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHH
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGV 274 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 274 (400)
+.- .+..... ....-.|-.+. +.-+..-+||-+--
T Consensus 369 Rl~-~~q~~is-----y~rldhp~lF~-G~dd~QFeIYrlMr 403 (488)
T COG5072 369 RLS-YSQGIIS-----YNRLDHPDLFN-GVDDYQFEIYRLMR 403 (488)
T ss_pred ecc-cCCceee-----ccccCchhhhc-CccceeeeHHHHHH
Confidence 842 2222211 12233455555 33366677776543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.23 Score=47.18 Aligned_cols=140 Identities=19% Similarity=0.286 Sum_probs=78.9
Q ss_pred eeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCC---Cc---ceeeeeEE--eeCC--cceEEEE
Q 042371 90 ILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH---RN---VVKLLGCC--LETE--VPLLVYE 159 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~~---iv~~~~~~--~~~~--~~~lv~e 159 (400)
.|.+ .-..+|+....+|+. ++|..... ....++..|+..|..+.- += +..+=|-. .-.+ ..+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 4444 566789888777666 88876543 345566677777777731 11 22221211 1123 6678999
Q ss_pred ccCCCCHHH-H--------------HhhcCCCC---------CCCHHH-------------HHHHHHHHHHHHHHHHhc-
Q 042371 160 FISNGTLFQ-Y--------------LHDQNEEF---------PLTWEM-------------RLRIATEVAGSLSYLHSA- 201 (400)
Q Consensus 160 ~~~~g~L~~-~--------------l~~~~~~~---------~l~~~~-------------~~~i~~~i~~~l~~LH~~- 201 (400)
|++|..+.. . ++....++ ...|.. ......++...+..+...
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887772 0 11111111 112220 001222333333333321
Q ss_pred ---CCCC---eEecCCCCCCeEEcCCCc-EEEEecCCcc
Q 042371 202 ---ASMP---IYHRDIKSTNILLNEKYT-AKVADFGTSK 233 (400)
Q Consensus 202 ---~~~~---iiHrDikp~NIll~~~~~-~kl~Dfgla~ 233 (400)
-... +||+|+.|+||+++.+.. +-++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1122 899999999999999875 8999999875
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.63 Score=44.19 Aligned_cols=93 Identities=16% Similarity=0.130 Sum_probs=51.4
Q ss_pred ccChHHHHHHhcCCccc---c-eeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCc--ceeee
Q 042371 72 LFTTKELDKATDHFNVN---R-ILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN--VVKLL 145 (400)
Q Consensus 72 ~~~~~~~~~~~~~y~~~---~-~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~ 145 (400)
.++.+.+......+-+. + ..=.+.-..||+....++..+++|..... ......+..|...+..+.... ++...
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 34555554444444331 1 22234557799988777888999976422 234456667777776663211 22211
Q ss_pred ---e--EEeeCCcceEEEEccCCCC
Q 042371 146 ---G--CCLETEVPLLVYEFISNGT 165 (400)
Q Consensus 146 ---~--~~~~~~~~~lv~e~~~~g~ 165 (400)
+ ....++..+.++++++|..
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCC
Confidence 1 1223455678999988764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.13 Score=49.92 Aligned_cols=74 Identities=22% Similarity=0.287 Sum_probs=43.6
Q ss_pred ceeeecCcEEEEEEEecCC--cE-----EEEEEccccCchhHHHHHHHHHHHHhCCCCcc-eeeeeEEeeCCcceEEEEc
Q 042371 89 RILGQGGQGTVYKGMLADG--RI-----VAVKKSKIVHEGKLEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~--~~-----vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~ 160 (400)
+.|..|-...+|++...++ .. |.++... ......-.-.+|+.+++.+...++ +++++.+. -+++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4566688889999875432 22 4443321 111111223568889988865444 45566553 2689999
Q ss_pred cCCCCHH
Q 042371 161 ISNGTLF 167 (400)
Q Consensus 161 ~~~g~L~ 167 (400)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987654
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.19 Score=44.80 Aligned_cols=75 Identities=19% Similarity=0.193 Sum_probs=53.2
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC---CCcceeeeeEEeeCCcceEEEEccCCCC
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVYEFISNGT 165 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 165 (400)
+.+.-|..-..|...+ +..++.+|.- .......|..|+.-|..|. .-.+.+.+.+..+.+..|+||||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3455555556666544 4567888843 3445577888888777773 4568888988888999999999998765
Q ss_pred HH
Q 042371 166 LF 167 (400)
Q Consensus 166 L~ 167 (400)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.51 Score=51.90 Aligned_cols=31 Identities=26% Similarity=0.456 Sum_probs=26.0
Q ss_pred CCeEecCCCCCCeEEcCCC--cEE-EEecCCccc
Q 042371 204 MPIYHRDIKSTNILLNEKY--TAK-VADFGTSKF 234 (400)
Q Consensus 204 ~~iiHrDikp~NIll~~~~--~~k-l~Dfgla~~ 234 (400)
..+||+|+.+.|||++.++ ++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3499999999999999875 555 999998854
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.19 Score=45.85 Aligned_cols=80 Identities=23% Similarity=0.155 Sum_probs=53.8
Q ss_pred ccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc-CCCC
Q 042371 87 VNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI-SNGT 165 (400)
Q Consensus 87 ~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~g~ 165 (400)
....+..|..+.|+.+...+|.+.++|......... .+ ......|+..+-...|++++.-.+ .-.|++|.+ ++.+
T Consensus 6 ~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E-~~g~~~L~~w~G~GaVrll~~d~~--~~AlLLErl~~g~~ 81 (253)
T PF04655_consen 6 PDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HE-ARGEAALRWWNGRGAVRLLAADPE--RGALLLERLDPGRS 81 (253)
T ss_pred cCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hh-hhHHhHhheeCCCCceeeeccccc--cchhhhhhccCCCc
Confidence 344567899999999999999999999765322211 11 112245777777788899886533 346788888 4557
Q ss_pred HHHHH
Q 042371 166 LFQYL 170 (400)
Q Consensus 166 L~~~l 170 (400)
|.++.
T Consensus 82 L~~~~ 86 (253)
T PF04655_consen 82 LASLP 86 (253)
T ss_pred hhhcc
Confidence 76554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 400 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-33 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-30 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-29 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-28 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-28 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-28 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-27 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-25 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-25 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-25 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-23 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-22 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-22 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-22 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-22 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-22 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-22 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-21 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-21 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-21 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-21 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-21 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-21 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-21 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-21 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-20 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-20 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-20 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-19 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-19 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-19 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-19 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-18 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-18 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-18 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-18 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-18 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-18 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-17 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-17 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-16 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-123
Identities = 115/308 (37%), Positives = 175/308 (56%), Gaps = 5/308 (1%)
Query: 60 LTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH 119
L+SS +L++AT++F+ ++G G G VYKG+L DG VA+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 120 EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEE-FP 178
+EEF E+ LS H ++V L+G C E +L+Y+++ NG L ++L+ +
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 179 LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK-FIVI 237
++WE RL I A L YLH+ I HRD+KS NILL+E + K+ DFG SK +
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGL 297
DQTH++T V+GT GY+DPEYF G+ T+KSDVYSFGVVL E+L + I+ + +E L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 298 AAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357
A + + S +L +D + + E + A +CL L+ + RP+M +V +LE
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
Query: 358 IQALQKDI 365
LQ+ +
Sbjct: 313 ALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-112
Identities = 116/309 (37%), Positives = 179/309 (57%), Gaps = 10/309 (3%)
Query: 71 KLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKK-SKIVHEGKLEEFINE 129
K F+ +EL A+D+F+ ILG+GG G VYKG LADG +VAVK+ + +G +F E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 130 VVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNE-EFPLTWEMRLRIA 188
V ++S HRN+++L G C+ LLVY +++NG++ L ++ E + PL W R RIA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG 248
A L+YLH I HRD+K+ NILL+E++ A V DFG +K + THVTT V+G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 249 TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSK--EATGLAAYFILSME 306
T G++ PEY +G+ ++K+DV+ +GV+L+EL+TGQ+ L + L + ++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 307 ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV--AME----LERIQA 360
E +L +D + + EE+ + +A C + RP M EV +E ER +
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEE 317
Query: 361 LQKDINVKQ 369
QK+ +Q
Sbjct: 318 WQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-111
Identities = 99/310 (31%), Positives = 166/310 (53%), Gaps = 18/310 (5%)
Query: 62 SSDGSIDRCKLFTTKELDKATDHFN------VNRILGQGGQGTVYKGMLADGRIVAVKK- 114
S + S R F+ EL T++F+ +G+GG G VYKG + + VAVKK
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
Query: 115 -SKIVHEGK--LEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLH 171
+ + + ++F E+ ++++ H N+V+LLG + + LVY ++ NG+L L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 172 DQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231
+ PL+W MR +IA A +++LH HRDIKS NILL+E +TAK++DFG
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 232 SK-FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTG 290
++ QT +T+++ GT Y+ PE R G+ T KSD+YSFGVVL+E++TG +
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 291 SKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKE 350
+ L +E + + D+ + + + ++A++CL+ +RP +K+
Sbjct: 239 EPQL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 351 VAMELERIQA 360
V L+ + A
Sbjct: 297 VQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 3e-77
Identities = 73/318 (22%), Positives = 120/318 (37%), Gaps = 32/318 (10%)
Query: 73 FTTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVI 132
T+ L + + + +G G V+K L VAVK + + + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFP-IQDKQSWQNEYEVYS 71
Query: 133 LSQINHRNVVKLLGCCLETEVP----LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
L + H N+++ +G L+ F G+L +L ++W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIA 127
Query: 189 TEVAGSLSYLHSAASM-------PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241
+A L+YLH I HRDIKS N+LL TA +ADFG + ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 242 VTTKVQ-GTFGYLDPEYFRSG-----QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEAT 295
T Q GT Y+ PE + D+Y+ G+VL EL + +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 296 GLAAYF-----ILSMEENRLYDFLDDQVLKVGQKEEIM-TIATLATRCLNLNGKRRPTMK 349
+ M+E ++ + QK M + C + + + R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 350 EVAMELERIQALQKDINV 367
V ERI +Q+ N+
Sbjct: 308 CV---GERITQMQRLTNI 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 9e-76
Identities = 86/289 (29%), Positives = 134/289 (46%), Gaps = 40/289 (13%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRN 140
N+ +G G GTV++ G VAVK H ++ EF+ EV I+ ++ H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+V +G + +V E++S G+L++ LH L RL +A +VA ++YLH+
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
+ PI HR++KS N+L+++KYT KV DFG S+ + GT ++ PE R
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRD 213
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD-DQVL 319
+KSDVYSFGV+L EL T Q+P + L+ QV+
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP-------------------------WGNLNPAQVV 248
Query: 320 -KVGQKEEIMTI--------ATLATRCLNLNGKRRPTMKEVAMELERIQ 359
VG K + + I A + C +RP+ + L +
Sbjct: 249 AAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-74
Identities = 75/287 (26%), Positives = 129/287 (44%), Gaps = 42/287 (14%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
V ++G+G G V K + VA+K+ I E + + FI E+ LS++NH N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIV 64
Query: 143 KLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
KL G CL P+ LV E+ G+L+ LH T + + + ++YLHS
Sbjct: 65 KLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 202 ASMPIYHRDIKSTNILLNEKYT-AKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
+ HRD+K N+LL T K+ DFGT+ D T +G+ ++ PE F
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320
+++K DV+S+G++L E++T +KP + +++
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP--------------F--------DEIGGPAFRIMW 215
Query: 321 VGQKEEIMTI--------ATLATRCLNLNGKRRPTMKEVAMELERIQ 359
+ +L TRC + + +RP+M+E+ + +
Sbjct: 216 AVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-72
Identities = 83/296 (28%), Positives = 136/296 (45%), Gaps = 47/296 (15%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-------SKIVHEGKLEEFINEVVILS 134
+ + +G+GG G V+KG + D +VA+K + K +EF EV I+S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 135 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
+NH N+VKL G P +V EF+ G L+ L D+ P+ W ++LR+ ++A
Sbjct: 79 NLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALG 134
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEK-----YTAKVADFGTSKFIVIDQTHVTTKVQGT 249
+ Y+ + + PI HRD++S NI L AKVADFG S+ H + + G
Sbjct: 135 IEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGN 189
Query: 250 FGYLDPEYF--RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307
F ++ PE +T+K+D YSF ++L +LTG+ P E + FI
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-----FDEYSYGKIKFI----- 239
Query: 308 NRLYDFLDDQVLKVGQKEEI-----MTIATLATRCLNLNGKRRPTMKEVAMELERI 358
+ + + G + I + + C + + K+RP + EL +
Sbjct: 240 --------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-72
Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 51/290 (17%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHE----GKLEEFINEVVILSQINHRNVVKL 144
I+G GG G VY+ G VAVK ++ + +E E + + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASM 204
G CL+ LV EF G L + L + + ++ + A ++A ++YLH A +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 205 PIYHRDIKSTNILLNEKY--------TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
PI HRD+KS+NIL+ +K K+ DFG ++ +T + G + ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAA-GAYAWMAPE 184
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316
R+ F+ SDV+S+GV+L ELLTG+ P + GLA
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP-----FRGIDGLAV----------------- 222
Query: 317 QVLKVGQKEEIMTI--------ATLATRCLNLNGKRRPTMKEVAMELERI 358
V + + I A L C N + RP+ + +L I
Sbjct: 223 -AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-68
Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 51/294 (17%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRN 140
N L + G ++KG G + VK K+ K +F E L +H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 141 VVKLLGCCLETEVPLL--VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
V+ +LG C P + ++ G+L+ LH+ F + ++ A ++A +++L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFL 127
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
H+ I + S +++++E TA+++ + ++ PE
Sbjct: 128 HTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEAL 180
Query: 259 R---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315
+ +D++SF V+L EL+T + P + L
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP-------------------------FADLS 215
Query: 316 --DQVLKVGQKEEIMTI--------ATLATRCLNLNGKRRPTMKEVAMELERIQ 359
+ +KV + TI + L C+N + +RP + LE++Q
Sbjct: 216 NMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-64
Identities = 64/292 (21%), Positives = 109/292 (37%), Gaps = 38/292 (13%)
Query: 87 VNRILGQGGQGTVYKGMLADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRNVVKL 144
+ ++G+G G VY G G VA++ I +E +L+ F EV+ Q H NVV
Sbjct: 37 IGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASM 204
+G C+ ++ TL+ + D L +IA E+ + YLH +
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLH---AK 149
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI----DQTHVTTKVQGTFGYLDPEYFRS 260
I H+D+KS N+ + + DFG + + G +L PE R
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 261 GQ---------FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311
F+ SDV++ G + EL + P K A + +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-----KTQPAEAIIWQM--GTGMKP 261
Query: 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363
+ + K I+ + C + RPT ++ LE++ +
Sbjct: 262 NLSQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-64
Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 29/285 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHRN 140
V + +G G GTVYKG VAVK + +L+ F NEV +L + H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 141 VVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
++ +G T L +V ++ +L+ +LH +F + + IA + A + YLH
Sbjct: 82 ILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHASETKFE--MKKLIDIARQTARGMDYLH 137
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTTKVQGTFGYLDPEYF 258
+ I HRD+KS NI L+E T K+ DFG + +H ++ G+ ++ PE
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 259 R---SGQFTDKSDVYSFGVVLVELLTGQKPII-LTGSKEATGLAAYFILSMEENRLYDFL 314
R S ++ +SDVY+FG+VL EL+TGQ P + + + LS + +++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254
Query: 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359
+ + L CL RP+ + E+E +
Sbjct: 255 PKR------------MKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-64
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 45/291 (15%)
Query: 89 RILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
+LG+G G K G ++ +K+ E F+ EV ++ + H NV+K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
+ + + E+I GTL + + W R+ A ++A ++YLH SM I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT-------------TKVQGTFGYLD 254
HRD+ S N L+ E VADFG ++ +V ++T V G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 255 PEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN-RLYDF 313
PE + +K DV+SFG+VL E++ + F L++
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----DPDYLPRTMDFGLNVRGFLDR--- 242
Query: 314 LDDQVLKVGQKEEI-----MTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359
+ + RC +L+ ++RP+ ++ LE ++
Sbjct: 243 ------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-61
Identities = 67/330 (20%), Positives = 115/330 (34%), Gaps = 46/330 (13%)
Query: 73 FTTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVI 132
E D+ + ++G+G G VYKG L D R VAVK + + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 133 --LSQINHRNVVKLLGCCLETEVP-----LLVYEFISNGTLFQYLHDQNEEFPLTWEMRL 185
+ + H N+ + + LLV E+ NG+L +YL W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSC 114
Query: 186 RIATEVAGSLSYLHSAAS------MPIYHRDIKSTNILLNEKYTAKVADFGTSKFI---- 235
R+A V L+YLH+ I HRD+ S N+L+ T ++DFG S +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 236 ---VIDQTHVTTKVQGTFGYLDPEYFRS-------GQFTDKSDVYSFGVVLVELLTGQKP 285
++ + GT Y+ PE + D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 286 IILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK----------VGQKEEIMTIATLAT 335
+ S A+ D + + ++
Sbjct: 235 LFPGESVPEY-QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 336 RCLNLNGKRRPTMKEVAMELERIQALQKDI 365
C + + + R T + + + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-57
Identities = 67/313 (21%), Positives = 113/313 (36%), Gaps = 52/313 (16%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINE--VVILSQINHRNVVKLLG 146
+ +G+G G V+ G G VAVK E + E + + H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98
Query: 147 CCLETEVP----LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-- 200
++ L+ ++ NG+L+ YL L + L++A L +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 201 ---AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV---TTKVQGTFGYLD 254
I HRD+KS NIL+ + T +AD G + + D V GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 255 PE------YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308
PE Q +D+YSFG++L E+ + Y + +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS--------GGIVEEYQLPYHDLV 266
Query: 309 RLYDFLDDQVLKVGQK-------------EEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355
+D V K E + + L T C N R T V
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV---K 323
Query: 356 ERIQALQKDINVK 368
+ + + + ++K
Sbjct: 324 KTLAKMSESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-55
Identities = 61/304 (20%), Positives = 105/304 (34%), Gaps = 51/304 (16%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVI--LSQINHRNVVKLLG 146
+G+G G V++G G VAVK I + + E + + H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 147 CCLETEVP----LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-- 200
+ + L+ + G+L+ YL L LRI +A L++LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 201 ---AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI----VIDQTHVTTKVQGTFGYL 253
I HRD+KS NIL+ + +AD G + +V GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 254 DPE------YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307
PE + D+++FG+VL E+ + + ++ +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP----PFY----DV 236
Query: 308 NRLYDFLDDQVLKVGQK-------------EEIMTIATLATRCLNLNGKRRPTMKEVAME 354
+D V + ++A L C N R T +
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 355 LERI 358
L +I
Sbjct: 297 LTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-54
Identities = 62/312 (19%), Positives = 115/312 (36%), Gaps = 52/312 (16%)
Query: 90 ILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINE--VVILSQINHRNVVKLLGC 147
+G+G G V++G G VAVK I + + E + + H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 148 CLETEVP----LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
+ LV ++ +G+LF YL+ +T E +++A A L++LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 204 -----MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT---TKVQGTFGYLDP 255
I HRD+KS NIL+ + T +AD G + + GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 256 E------YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309
E + + ++D+Y+ G+V E+ Y + +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--------GGIHEDYQLPYYDLVP 272
Query: 310 LYDFLDDQVLKVGQK-------------EEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356
+++ V ++ E + +A + C NG R T + +
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI---KK 329
Query: 357 RIQALQKDINVK 368
+ L + +K
Sbjct: 330 TLSQLSQQEGIK 341
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 77/346 (22%), Positives = 141/346 (40%), Gaps = 51/346 (14%)
Query: 34 YIIKRED--IKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKAT-----DHFN 86
+II+ D +L+ + F L+ L++ + + + + K +
Sbjct: 59 FIIQSLDNLYRLEGEGFPSIPLLI-DHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLV 117
Query: 87 VNRILGQGGQGTVYKGMLADGRI-VAVKKSK-IVHEGKLEEFINEVVILSQINHRNVVKL 144
+ +G+G G V+ G L VAVK + + +F+ E IL Q +H N+V+L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASM 204
+G C + + +V E + G +L + + + L++ + A + YL S
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLE---SK 232
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY--LDPEYFRSGQ 262
HRD+ + N L+ EK K++DFG S+ D + + PE G+
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 263 FTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321
++ +SDV+SFG++L E + G P Y LS N+ Q +
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP--------------YPNLS---NQ-------QTREF 327
Query: 322 GQKEEIM--------TIATLATRCLNLNGKRRPTMKEVAMELERIQ 359
+K + + L +C +RP+ + EL+ I+
Sbjct: 328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 83/338 (24%), Positives = 137/338 (40%), Gaps = 68/338 (20%)
Query: 62 SSDGSIDRCKLFTTKELDK---ATDHFNVNRILGQGGQGTVYKGMLADGR----IVAVK- 113
S G + R +L+ + + +ILG+G G+V +G L VAVK
Sbjct: 10 HSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKT 69
Query: 114 -KSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE-----VPLLVYEFISNGTLF 167
K + ++EEF++E + +H NV++LLG C+E P+++ F+ G L
Sbjct: 70 MKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLH 129
Query: 168 QYL---HDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTA 224
YL + + + L+ ++A + YL ++ HRD+ + N +L + T
Sbjct: 130 TYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTV 186
Query: 225 KVADFGTSKFIVIDQTHVTTKVQGTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVEL 279
VADFG SK I + G + E +T KSDV++FGV + E+
Sbjct: 187 CVADFGLSK--KIYSGDYYRQ--GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242
Query: 280 LT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQK-----------EEI 327
T G P Y + E +YD+L G + EI
Sbjct: 243 ATRGMTP--------------YPGVQNHE--MYDYLLH-----GHRLKQPEDCLDELYEI 281
Query: 328 MTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365
M C + RPT + ++LE++ D+
Sbjct: 282 M------YSCWRTDPLDRPTFSVLRLQLEKLLESLPDV 313
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-44
Identities = 81/308 (26%), Positives = 133/308 (43%), Gaps = 66/308 (21%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADG----RIVAVK--KSKIVHEGKLEEFINEVVILSQI 136
F + R+LG+G G+V + L VAVK K+ I+ +EEF+ E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 137 NHRNVVKLLGCCLETE------VPLLVYEFISNGTLFQYL---HDQNEEFPLTWEMRLRI 187
+H +V KL+G L + +P+++ F+ +G L +L F L + +R
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 188 ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ 247
++A + YL +S HRD+ + N +L E T VADFG S+ I + Q
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQ 195
Query: 248 GTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYF 301
G L E +T SDV++FGV + E++T GQ P Y
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--------------YA 241
Query: 302 ILSMEENRLYDFLDDQVLKVGQK-----------EEIMTIATLATRCLNLNGKRRPTMKE 350
+ E +Y++L G + ++M +C + + K+RP+
Sbjct: 242 GIENAE--IYNYLIG-----GNRLKQPPECMEEVYDLM------YQCWSADPKQRPSFTC 288
Query: 351 VAMELERI 358
+ MELE I
Sbjct: 289 LRMELENI 296
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-44
Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 57/293 (19%)
Query: 89 RILGQGGQGTVYKGMLADGR----IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVK 143
++G+G G VY G L D AVK + G++ +F+ E +I+ +H NV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 144 LLGCCLETEVPLL-VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
LLG CL +E L V ++ +G L ++ +NE T + + +VA + +L A
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL-----DPEY 257
S HRD+ + N +L+EK+T KVADFG ++ + + T L E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALES 267
Query: 258 FRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316
++ +FT KSDV+SFGV+L EL+T G P Y ++ + + +L
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPP--------------YPDVNTFD--ITVYLLQ 311
Query: 317 QVLKVGQKEE-----------IMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
G++ +M +C + + RP+ E+ + I
Sbjct: 312 -----GRRLLQPEYCPDPLYEVM------LKCWHPKAEMRPSFSELVSRISAI 353
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 75/297 (25%), Positives = 124/297 (41%), Gaps = 39/297 (13%)
Query: 83 DHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN 137
H LG+G G+V G +VAVK+ + + +F E+ IL ++
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 138 HRNVVKLLGCCLET-EVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
+VK G L LV E++ +G L +L Q L L ++++ +
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GYL 253
YL S HRD+ + NIL+ + K+ADFG +K + +D+ + + G +
Sbjct: 141 EYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYD 312
PE F+ +SDV+SFGVVL EL T K + S E + +RL +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLE 255
Query: 313 FLDDQVLKVGQ---------KE--EIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
L++ GQ E E+M C + + RP+ + +L+ +
Sbjct: 256 LLEE-----GQRLPAPPACPAEVHELM------KLCWAPSPQDRPSFSALGPQLDML 301
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-43
Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 57/293 (19%)
Query: 89 RILGQGGQGTVYKGMLADGR----IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVK 143
++G+G G VY G L D AVK + G++ +F+ E +I+ +H NV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 144 LLGCCLETEVPLL-VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
LLG CL +E L V ++ +G L ++ +NE T + + +VA + YL A
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL-----DPEY 257
S HRD+ + N +L+EK+T KVADFG ++ + + T L E
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 258 FRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316
++ +FT KSDV+SFGV+L EL+T G P Y ++ + + +L
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPP--------------YPDVNTFD--ITVYLLQ 247
Query: 317 QVLKVGQKEE-----------IMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
G++ +M +C + + RP+ E+ + I
Sbjct: 248 -----GRRLLQPEYCPDPLYEVM------LKCWHPKAEMRPSFSELVSRISAI 289
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 55/303 (18%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGR------IVAVKKSK-IVHEGKLEEFINEVVILSQ 135
+ ++R LGQG G VY+G+ VA+K + EF+NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYL-------HDQNEEFPLTWEMRLRIA 188
N +VV+LLG + + L++ E ++ G L YL + P + +++A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG 248
E+A ++YL + HRD+ + N ++ E +T K+ DFG ++ I +T K G
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK--G 197
Query: 249 TFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFI 302
G L PE + G FT SDV+SFGVVL E+ T ++P Y
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--------------YQG 243
Query: 303 LSMEENRLYDFLDD-QVLKV-----GQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356
LS E+ + F+ + +L E+M C N K RP+ E+ ++
Sbjct: 244 LSNEQ--VLRFVMEGGLLDKPDNCPDMLFELM------RMCWQYNPKMRPSFLEIISSIK 295
Query: 357 RIQ 359
Sbjct: 296 EEM 298
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGR-----IVAVKKSKIVHEGK-LEEFINEVVILSQI 136
F ++LG G GTVYKG+ VA+K+ + K +E ++E +++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 137 NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
++ +V +LLG CL + V L+ + + G L Y+ + + + L ++A ++
Sbjct: 75 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMN 131
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT---FGYL 253
YL + HRD+ + N+L+ K+ DFG +K + ++ +G ++
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWM 186
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
E +T +SDV+S+GV + EL+T G KP
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 84/373 (22%), Positives = 144/373 (38%), Gaps = 61/373 (16%)
Query: 17 CENYEGGYR---CITPKRKVYIIKRED-----IKLKEKF--------FKRNGGLVLQQQL 60
E+ G + Y I + + +F L L
Sbjct: 134 SESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTL 193
Query: 61 TSSDGSIDRCKLFTTKELDKA----TDHFNVNRILGQGGQGTVYKGMLADGRI-VAVKKS 115
++ ++ + LG G G VY+G+ + VAVK
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 253
Query: 116 KIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNE 175
K ++EEF+ E ++ +I H N+V+LLG C ++ EF++ G L YL + N
Sbjct: 254 K-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 312
Query: 176 EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235
+ ++ + L +AT+++ ++ YL HR++ + N L+ E + KVADFG S+ +
Sbjct: 313 Q-EVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368
Query: 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEA 294
D + + PE +F+ KSDV++FGV+L E+ T G P
Sbjct: 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--------- 419
Query: 295 TGLAAYFILSMEENRLYDFLDD-QVLKVGQKEEIM--------TIATLATRCLNLNGKRR 345
Y +D QV ++ +K+ M + L C N R
Sbjct: 420 ----------------YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 463
Query: 346 PTMKEVAMELERI 358
P+ E+ E +
Sbjct: 464 PSFAEIHQAFETM 476
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 77/300 (25%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 89 RILGQGGQGTVYKGMLADGR------IVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
LG+G G V+ + +VAVK K E ++F E +L+ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYL------------HDQNEEFPLTWEMRLRIATE 190
+ G C E L+V+E++ +G L ++L + PL L +A++
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF 250
VA + YL A + HRD+ + N L+ + K+ DFG S+ I + +V G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVGGR- 219
Query: 251 GYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILS 304
L PE +FT +SDV+SFGVVL E+ T G++P ++ LS
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WYQLS 265
Query: 305 MEENRLYDFLDD-QVLKV-----GQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
E D + + L+ + IM C ++R ++K+V L+ +
Sbjct: 266 NTE--AIDCITQGRELERPRACPPEVYAIM------RGCWQREPQQRHSIKDVHARLQAL 317
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-43
Identities = 74/300 (24%), Positives = 136/300 (45%), Gaps = 32/300 (10%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVHEGKLEEFINEVV 131
+ ++ H + LG+G G+V G +VAVKK + E L +F E+
Sbjct: 6 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 132 ILSQINHRNVVKLLGCCLET-EVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT 189
IL + H N+VK G C L L+ E++ G+L YL Q + + L+ +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 121
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT 249
++ + YL + HRD+ + NIL+ + K+ DFG +K + D+ K G
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 250 F--GYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307
+ PE +F+ SDV+SFGVVL E + T +++ A F+ +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYE--------LFTYIEKSKSPPAEFMRMIGN 230
Query: 308 NRLYDFLDDQVLKVGQKEEIM--------TIATLATRCLNLNGKRRPTMKEVAMELERIQ 359
++ + ++++ + + I + T C N N +RP+ +++A+ +++I+
Sbjct: 231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-43
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 17/214 (7%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG--KLEEFINEVVILS 134
EL + + + + LG G G V G VAVK ++ EG +EF E +
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSEDEFFQEAQTMM 58
Query: 135 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
+++H +VK G C + +V E+ISNG L YL ++ L L + +V
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEG 116
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY-- 252
+++L S HRD+ + N L++ KV+DFG +++++ DQ + V F
Sbjct: 117 MAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKW 171
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE F +++ KSDV++FG+++ E+ + G+ P
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-43
Identities = 74/299 (24%), Positives = 134/299 (44%), Gaps = 32/299 (10%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVHEGKLEEFINEVV 131
+ ++ H + LG+G G+V G +VAVKK + E L +F E+
Sbjct: 37 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 132 ILSQINHRNVVKLLGCCLET-EVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT 189
IL + H N+VK G C L L+ E++ G+L YL E L+ +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTS 152
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT 249
++ + YL + HRD+ + NIL+ + K+ DFG +K + D+ + K G
Sbjct: 153 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209
Query: 250 F--GYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307
+ PE +F+ SDV+SFGVVL E + T +++ A F+ +
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYE--------LFTYIEKSKSPPAEFMRMIGN 261
Query: 308 NRLYDFLDDQVLKVGQKEEIM--------TIATLATRCLNLNGKRRPTMKEVAMELERI 358
++ + ++++ + + I + T C N N +RP+ +++A+ +++I
Sbjct: 262 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-42
Identities = 72/299 (24%), Positives = 113/299 (37%), Gaps = 42/299 (14%)
Query: 83 DHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVH-EGKLEEFINEVVILSQI 136
+ R LG+G G V G +VAVK K + E+ IL +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 137 NHRNVVKLLGCCLETEVP--LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
H +++K GCC + LV E++ G+L YL + + L A ++
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEG 146
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GY 252
++YLH+ HRD+ + N+LL+ K+ DFG +K + + + G +
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLY 311
PE + +F SDV+SFGV L ELLT A M RL
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG--QMTVLRLT 261
Query: 312 DFLDDQVLKVGQ---------KE--EIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359
+ L+ G+ E +M C RPT + + L+ +
Sbjct: 262 ELLER-----GERLPRPDKCPAEVYHLM------KNCWETEASFRPTFENLIPILKTVH 309
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQI 136
E+ + + + LG G G V+ G VAVK K + F+ E ++ Q+
Sbjct: 9 EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 65
Query: 137 NHRNVVKLLGCCLETEVPLL-VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
H+ +V+L T+ P+ + E++ NG+L +L LT L +A ++A +
Sbjct: 66 QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGM 122
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY--L 253
+++ HRD+++ NIL+++ + K+ADFG ++ I ++ T + F
Sbjct: 123 AFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWT 177
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE G FT KSDV+SFG++L E++T G+ P
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 89 RILGQGGQGTVYKGMLADGR----IVAVKKSKIVHEGK-LEEFINEVVILSQINHRNVVK 143
R++G+G G VY G D A+K + E + +E F+ E +++ +NH NV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 144 LLGCCLETE-VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
L+G L E +P ++ ++ +G L Q++ ++ + T + + +VA + YL A
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL---A 141
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL-----DPEY 257
HRD+ + N +L+E +T KVADFG ++ I + Q L E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPVKWTALES 199
Query: 258 FRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
++ +FT KSDV+SFGV+L ELLT G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 72/298 (24%), Positives = 118/298 (39%), Gaps = 40/298 (13%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA-----DGRIVAVKKSKIVHEGK-LEEFINEVVILSQI 136
R LG+G G V G VAVK K G + + E+ IL +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 137 NHRNVVKLLGCCLETEVP--LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
H N+VK G C E L+ EF+ +G+L +YL + + + +L+ A ++
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GY 252
+ YL S HRD+ + N+L+ ++ K+ DFG +K I D+ + T K +
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLY 311
PE +F SDV+SFGV L ELLT + +++ L
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR--LV 253
Query: 312 DFLDDQVLKVGQ---------KE--EIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
+ L + G+ E ++M +C R + + + E +
Sbjct: 254 NTLKE-----GKRLPCPPNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRI-VAVKKSKIVHEG--KLEEFINEVVIL 133
E+++ + LG G G VY+G+ + VAVK K E ++EEF+ E ++
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVM 63
Query: 134 SQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
+I H N+V+LLG C ++ EF++ G L YL + N + ++ + L +AT+++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISS 122
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK----VQGT 249
++ YL HRD+ + N L+ E + KVADFG S+ + D ++ T
Sbjct: 123 AMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE +F+ KSDV++FGV+L E+ T G P
Sbjct: 180 ----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-42
Identities = 62/273 (22%), Positives = 111/273 (40%), Gaps = 34/273 (12%)
Query: 88 NRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGK--LEEFINEVVILSQINHRNVVKL 144
+ +G+G TVYKG+ VA + + K + F E +L + H N+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 145 LGCCLETEVP----LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
T +LV E +++GTL YL + ++ ++ L +LH+
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 147
Query: 201 AASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
+ PI HRD+K NI + + K+ D G + + + V GT ++ PE +
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT--LKRASFAKA-VIGTPEFMAPEMYE 203
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE--NRLYDFLDDQ 317
+ + DVY+FG+ ++E+ T + P S+ Y ++ +
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFDKVAIPE 258
Query: 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKE 350
V KE I C+ N R ++K+
Sbjct: 259 V-----KEIIE-------GCIRQNKDERYSIKD 279
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-42
Identities = 88/336 (26%), Positives = 139/336 (41%), Gaps = 60/336 (17%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYKGMLADGR------IVAVKKSKIVH-EGKLEEFIN 128
KE+ + + + R LG G G VY+G ++ VAVK V E +F+
Sbjct: 25 KEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYL----HDQNEEFPLTWEMR 184
E +I+S+ NH+N+V+ +G L++ ++ E ++ G L +L ++ L
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN---EKYTAKVADFGTSKFIVIDQTH 241
L +A ++A YL HRDI + N LL AK+ DFG ++ I +
Sbjct: 143 LHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAS 197
Query: 242 VTTKVQGTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEAT 295
K G L PE F G FT K+D +SFGV+L E+ + G P
Sbjct: 198 YYRK--GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---------- 245
Query: 296 GLAAYFILSMEENRLYDFLDD-QVLK-----VGQKEEIMTIATLATRCLNLNGKRRPTMK 349
Y S +E + +F+ + G IM T+C + RP
Sbjct: 246 ----YPSKSNQE--VLEFVTSGGRMDPPKNCPGPVYRIM------TQCWQHQPEDRPNFA 293
Query: 350 EVAMELERIQALQKDINVKQICDEIESCDIVSTSTE 385
+ LERI+ +D +V IE +V +
Sbjct: 294 II---LERIEYCTQDPDVINTALPIEYGPLVEEEEK 326
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-42
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 26/276 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK---SKIVHEGKLEEFINEVVILSQINH 138
+F + + +G+G VY+ L DG VA+KK ++ + I E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMR-LRIATEVAGSLSY 197
NV+K +E +V E G L + + ++ L E + ++ +L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
+HS + HRDIK N+ + K+ D G +F T + V GT Y+ PE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF--ILSMEENRLYDFLD 315
+ KSD++S G +L E+ Q P + L + I + L
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ L+ L C+N + ++RP + V
Sbjct: 264 SEELR-----------QLVNMCINPDPEKRPDVTYV 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 30/287 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHR 139
+ + V +G G G K +DG+I+ K+ E + + ++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 140 NVVKLLGCCLETEVPLL--VYEFISNGTLFQYLHDQNEE-FPLTWEMRLRIATEVAGSLS 196
N+V+ ++ L V E+ G L + +E L E LR+ T++ +L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 197 YLHS--AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
H + HRD+K N+ L+ K K+ DFG ++ + D + T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 255 PEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF--ILSMEENRLYD 312
PE + +KSD++S G +L EL P A I + R+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKELAGKIREGKFRRIPY 238
Query: 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359
D+ + + TR LNL RP+++E+ +E I
Sbjct: 239 RYSDE------------LNEIITRMLNLKDYHRPSVEEI-LENPLIL 272
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 17/214 (7%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG--KLEEFINEVVILS 134
E+D + LG G G V G VA+K K EG +EFI E ++
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMM 74
Query: 135 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
++H +V+L G C + ++ E+++NG L YL + + L + +V +
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEA 132
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY-- 252
+ YL S HRD+ + N L+N++ KV+DFG S++++ D+ T+ V F
Sbjct: 133 MEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRW 187
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE +F+ KSD+++FGV++ E+ + G+ P
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-42
Identities = 49/221 (22%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 75 TKELDKATDHFNVNRILGQGGQGTVYKGMLADGR-----IVAVKKSKIVHEGK-LEEFIN 128
+ + ++LG G GTV+KG+ V +K + + + +
Sbjct: 7 ARIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 64
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
++ + ++H ++V+LLG C LV +++ G+L ++ ++ L
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWG 121
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG 248
++A + YL + HR++ + N+LL +VADFG + + D +
Sbjct: 122 VQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SE 176
Query: 249 T---FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
++ E G++T +SDV+S+GV + EL+T G +P
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-42
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 8/206 (3%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHR 139
+ + + +G+G G DGR +K+ I + EE EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
N+V+ E +V ++ G LF+ ++ Q + L ++ +L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-LFQEDQILDWFVQICLALKHVH 142
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
I HRDIKS NI L + T ++ DFG ++ + + GT YL PE
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKP 285
+ + +KSD+++ G VL EL T +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 80/293 (27%), Positives = 136/293 (46%), Gaps = 39/293 (13%)
Query: 17 CENYEGGYR-CITPKRKV--YIIKREDIKL---KEKFF-----------KRNGGLV--LQ 57
NY G Y C++ + KV Y I KL +E +F GL L
Sbjct: 109 STNYPGDYTLCVSCEGKVEHYRIMYHASKLSIDEEVYFENLMQLVEHYTTDADGLCTRLI 168
Query: 58 QQLTSSDGSIDRCKLFTTK-ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSK 116
+ + + + + L+ + + +G+G G V G G VAVK K
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK 225
Query: 117 IVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNE 175
++ + F+ E +++Q+ H N+V+LLG +E + L +V E+++ G+L YL +
Sbjct: 226 --NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 283
Query: 176 EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235
L + L+ + +V ++ YL HRD+ + N+L++E AKV+DFG +K
Sbjct: 284 S-VLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 236 VIDQTHVTTKVQGTFGY--LDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
+T+ G PE R +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 340 ------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 11/213 (5%)
Query: 75 TKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILS 134
E+ + + + LGQG G V+ G VA+K K E F+ E ++
Sbjct: 261 AWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMK 317
Query: 135 QINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
++ H +V+L +E P+ +V E++S G+L +L + ++ L + +A ++A
Sbjct: 318 KLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIAS 374
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
++Y+ M HRD+++ NIL+ E KVADFG ++ I ++ + +
Sbjct: 375 GMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 431
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE G+FT KSDV+SFG++L EL T G+ P
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-41
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG--KLEEFINEVVILS 134
+D + +G G G V+ G + VA+K + EG E+FI E ++
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMM 58
Query: 135 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
+++H +V+L G CLE LV EF+ +G L YL Q F E L + +V
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEG 116
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY-- 252
++YL + HRD+ + N L+ E KV+DFG ++F++ DQ T+ F
Sbjct: 117 MAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKW 171
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE F +++ KSDV+SFGV++ E+ + G+ P
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 75 TKELDKATDHFNVNRILGQGGQGTVYKGMLADGR----IVAVKKSKI-VHEGKLEEFINE 129
T+E++ ++ +I+G G G V G L VA+K K E + +F++E
Sbjct: 43 TREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSE 100
Query: 130 VVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT 189
I+ Q +H N+++L G + ++V E++ NG+L +L + + T + +
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLR 158
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT 249
V + YL + + HRD+ + N+L++ KV+DFG S+ + D T G
Sbjct: 159 GVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 250 FGYL--DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE F+ SDV+SFGVV+ E+L G++P
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 22/223 (9%)
Query: 75 TKELDKATDHFNVNRILGQGGQGTVYKGMLADGRI-----VAVKKSKIVHEGKLE----E 125
T E+ +++G G G VYKGML VA+K + G E +
Sbjct: 38 TTEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK---TLKAGYTEKQRVD 92
Query: 126 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL 185
F+ E I+ Q +H N+++L G + + +++ E++ NG L ++L + ++ + +
Sbjct: 93 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLV 150
Query: 186 RIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK 245
+ +A + YL A+M HRD+ + NIL+N KV+DFG S+ + D T
Sbjct: 151 GMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 246 VQGTFGY--LDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
G PE +FT SDV+SFG+V+ E++T G++P
Sbjct: 208 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-41
Identities = 86/323 (26%), Positives = 133/323 (41%), Gaps = 58/323 (17%)
Query: 89 RILGQGGQGTVYKGMLADGR------IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNV 141
R LG G G VY+G ++ VAVK V E +F+ E +I+S+ NH+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYL----HDQNEEFPLTWEMRLRIATEVAGSLSY 197
V+ +G L++ ++ E ++ G L +L ++ L L +A ++A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 198 LHSAASMPIYHRDIKSTNILLN---EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL- 253
L HRDI + N LL AK+ DFG ++ I + K G L
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRK--GGCAMLP 249
Query: 254 ----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEEN 308
PE F G FT K+D +SFGV+L E+ + G P Y S +E
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--------------YPSKSNQE- 294
Query: 309 RLYDFLDD-QVLK-----VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362
+ +F+ + G IM T+C + RP + LERI+
Sbjct: 295 -VLEFVTSGGRMDPPKNCPGPVYRIM------TQCWQHQPEDRPNFAII---LERIEYCT 344
Query: 363 KDINVKQICDEIESCDIVSTSTE 385
+D +V IE +V +
Sbjct: 345 QDPDVINTALPIEYGPLVEEEEK 367
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 15/207 (7%)
Query: 87 VNRILGQGGQGTVYKGMLADGRI---VAVK--KSKIVHEGKLEEFINEVVILSQINHRNV 141
++ LG G GTV KG ++ VAVK K++ +E + E ++ Q+++ +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
V+++G C E +LV E G L +YL + + + + +V+ + YL
Sbjct: 81 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL--- 133
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GYLDPEYFR 259
HRD+ + N+LL ++ AK++DFG SK + D+ + + G + + PE
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 260 SGQFTDKSDVYSFGVVLVELLT-GQKP 285
+F+ KSDV+SFGV++ E + GQKP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-41
Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 15/219 (6%)
Query: 75 TKELDKATDHFNVNRILGQGGQGTVYKGML----ADGRIVAVKKSKI-VHEGKLEEFINE 129
KELD + ++++++G G G V G L VA+K K+ E + +F+ E
Sbjct: 39 AKELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 130 VVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT 189
I+ Q +H N+++L G +++ ++V E++ NG+L +L + + T + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLR 154
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT 249
+A + YL + M HRD+ + NIL+N KV+DFG + + D T G
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 250 FGYL--DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE +FT SDV+S+G+VL E+++ G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 70/306 (22%)
Query: 89 RILGQGGQGTVYKGMLADGR------IVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
R LG+G G V+ + +VAVK K ++F E +L+ + H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYL-------------HDQNEEFPLTWEMRLRIAT 189
K G C + + ++V+E++ +G L ++L + + L L IA+
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT 249
++A + YL AS HRD+ + N L+ K+ DFG S+ + + +V G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYYRVGGH 194
Query: 250 FGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFIL 303
L PE +FT +SDV+SFGV+L E+ T G++P +F L
Sbjct: 195 -TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------WFQL 239
Query: 304 SMEENRLYDFLDDQVLKVGQK-----------EEIMTIATLATRCLNLNGKRRPTMKEVA 352
S E + + + G+ ++M C ++R +KE+
Sbjct: 240 SNTE--VIECITQ-----GRVLERPRVCPKEVYDVM------LGCWQREPQQRLNIKEIY 286
Query: 353 MELERI 358
L +
Sbjct: 287 KILHAL 292
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 11/213 (5%)
Query: 75 TKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILS 134
E+ + + + LGQG G V+ G VA+K K E F+ E ++
Sbjct: 178 AWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMK 234
Query: 135 QINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
++ H +V+L +E P+ +V E++S G+L +L + ++ L + +A ++A
Sbjct: 235 KLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIAS 291
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
++Y+ M HRD+++ NIL+ E KVADFG ++ I ++ + +
Sbjct: 292 GMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 348
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE G+FT KSDV+SFG++L EL T G+ P
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 83 DHFNVNRILGQGGQGTVYKGML--ADGRI--VAVKKSK---IVHEGKLEEFINEVVILSQ 135
+ LG G G V +G G+ VAVK K + +++FI EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
++HRN+++L G L P+ +V E G+L L F L R A +VA
Sbjct: 78 LDHRNLIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEG 133
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY-- 252
+ YL S HRD+ + N+LL + K+ DFG + + + H + +
Sbjct: 134 MGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE ++ F+ SD + FGV L E+ T GQ+P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-41
Identities = 54/213 (25%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGR-----IVAVKKSKIVH-EGKLEEFINEVVILSQI 136
F ++LG G GTVYKG+ VA+K+ + +E ++E +++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 137 NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
++ +V +LLG CL L+ + + G L Y+ + + + L ++A ++
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMN 131
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT---FGYL 253
YL + HRD+ + N+L+ K+ DFG +K + ++ +G ++
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWM 186
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
E +T +SDV+S+GV + EL+T G KP
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-41
Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 21/214 (9%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG-KLEEFINEVVILSQ 135
L+ + + +G+G G V G G VAVK K + F+ E +++Q
Sbjct: 17 ALNM--KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK---NDATAQAFLAEASVMTQ 70
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
+ H N+V+LLG +E + L +V E+++ G+L YL + L + L+ + +V +
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEA 129
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK--VQGTFGY 252
+ YL HRD+ + N+L++E AKV+DFG +K T T K V+ T
Sbjct: 130 MEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT--- 181
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE R +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 182 -APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-41
Identities = 65/284 (22%), Positives = 114/284 (40%), Gaps = 48/284 (16%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVK 143
F ++G GG G V+K DG+ +K+ K E+ EV L++++H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVH 68
Query: 144 LLGCCLETEVPL----------------LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI 187
GC + + EF GTL Q++ + E L + L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALEL 127
Query: 188 ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ 247
++ + Y+HS + +RD+K +NI L + K+ DFG + T+ +
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKRTRSK 182
Query: 248 GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307
GT Y+ PE S + + D+Y+ G++L ELL + E + + +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKF----FTDLRD 233
Query: 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ D D + TL + L+ + RP E+
Sbjct: 234 GIISDIFDKK------------EKTLLQKLLSKKPEDRPNTSEI 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-41
Identities = 67/270 (24%), Positives = 120/270 (44%), Gaps = 18/270 (6%)
Query: 24 YR-CITPKRKVYIIKR---EDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELD 79
Y+ YI R ++ +K+ L Q+L+ S K + +
Sbjct: 126 YKIRTLDNGGFYISPRSTFSTLQELVDHYKKGND-GLCQKLSVPCMSSKPQKPWEKDAWE 184
Query: 80 KATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHR 139
+ + + LG G G V+ VAVK K E F+ E ++ + H
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHD 243
Query: 140 NVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+VKL T+ P+ ++ EF++ G+L +L +E + + ++A ++++
Sbjct: 244 KLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY--LDPE 256
HRD+++ NIL++ K+ADFG ++ I ++ T + F PE
Sbjct: 301 ---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPE 355
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
G FT KSDV+SFG++L+E++T G+ P
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 76/321 (23%), Positives = 133/321 (41%), Gaps = 79/321 (24%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGR------IVAVKKSKIVH-EGKLEEFINEVVILSQ 135
+ + + LG+G G V K + VAVK K +L + ++E +L Q
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYL---------------------HDQN 174
+NH +V+KL G C + LL+ E+ G+L +L D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 175 EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234
+E LT + A +++ + YL A M + HRD+ + NIL+ E K++DFG S+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 235 IVIDQTHVTTKVQGTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIIL 288
+ + ++ V+ + G + E +T +SDV+SFGV+L E++T G P
Sbjct: 200 VYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--- 252
Query: 289 TGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQK-----------EEIMTIATLATRC 337
Y + E L++ L G + +M +C
Sbjct: 253 -----------YPGIPPER--LFNLLKT-----GHRMERPDNCSEEMYRLM------LQC 288
Query: 338 LNLNGKRRPTMKEVAMELERI 358
+RP +++ +LE++
Sbjct: 289 WKQEPDKRPVFADISKDLEKM 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-40
Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 87 VNRILGQGGQGTVYKGML--ADGRI-VAVKKSKIVHEGK-LEEFINEVVILSQINHRNVV 142
+ LG G G+V +G+ +I VA+K K E EE + E I+ Q+++ +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+L+G C + +LV E G L ++L + EE P+ + +V+ + YL
Sbjct: 74 RLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYL---E 127
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF--GYLDPEYFRS 260
HRD+ + N+LL ++ AK++DFG SK + D ++ T + G + + PE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 261 GQFTDKSDVYSFGVVLVELLT-GQKP 285
+F+ +SDV+S+GV + E L+ GQKP
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGR----IVAVKKSKIVHEG----KLEEFIN 128
E+ + + + R +G+G G V++G+ VA+K E+F+
Sbjct: 11 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK---TCKNCTSDSVREKFLQ 65
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
E + + Q +H ++VKL+G E ++ E + G L +L Q ++ L + A
Sbjct: 66 EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYA 122
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG 248
+++ +L+YL S HRDI + N+L++ K+ DFG S+++ + +K +
Sbjct: 123 YQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 249 TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
++ PE +FT SDV+ FGV + E+L G KP
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 87 VNRILGQGGQGTVYKGM-LADGRIVAVK--KSKIVHEGK-LEEFINEVVILSQINHRNVV 142
+ LG GG TVY VA+K + + L+ F EV SQ++H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
++ E + LV E+I TL +Y+ PL+ + + ++ + + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT--KVQGTFGYLDPEYFRS 260
I HRDIK NIL++ T K+ DFG +K + +T +T V GT Y PE +
Sbjct: 132 ---IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKP 285
+ +D+YS G+VL E+L G+ P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-40
Identities = 79/322 (24%), Positives = 133/322 (41%), Gaps = 74/322 (22%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGR--------IVAVKKSK-IVHEGKLEEFINEVVIL 133
D + + LG+G G V VAVK K E L + ++E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 134 SQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYL-------------HDQNEEFPL 179
I H+N++ LLG C + ++ E+ S G L +YL ++ E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 180 TWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239
T++ + ++A + YL AS HRD+ + N+L+ E K+ADFG ++ I
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 240 THVTTKVQGTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKE 293
+ + T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 212 YY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-------- 259
Query: 294 ATGLAAYFILSMEENRLYDFLDDQVLKVGQK-----------EEIMTIATLATRCLNLNG 342
Y + +EE L+ L + G + +M C +
Sbjct: 260 ------YPGIPVEE--LFKLLKE-----GHRMDKPANCTNELYMMM------RDCWHAVP 300
Query: 343 KRRPTMKEVAMELERIQALQKD 364
+RPT K++ +L+RI L +
Sbjct: 301 SQRPTFKQLVEDLDRILTLTTN 322
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-40
Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 15/208 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGK--LEEFINEVVILSQI-NH 138
F LG G G V+K DGR+ AVK+S G + EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLR-IATEVAGSLSY 197
V+L E + L E +L Q+ P E ++ + +L++
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLP---EAQVWGYLRDTLLALAH 172
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
LHS + H D+K NI L + K+ DFG + +G Y+ PE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEVQEGDPRYMAPEL 227
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ G + +DV+S G+ ++E+ +
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNMEL 254
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-40
Identities = 59/294 (20%), Positives = 109/294 (37%), Gaps = 46/294 (15%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGK-LEEFINEVVILSQINHRN 140
F + LG+GG G V++ D A+K+ ++ + E+ + EV L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 141 VVKLLGCCLE---------TEVPLLVY---EFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
+V+ LE + + +Y + L +++ + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ- 247
++A ++ +LHS + HRD+K +NI KV DFG + D+ T
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 248 ----------GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGL 297
GT Y+ PE ++ K D++S G++L ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------------- 225
Query: 298 AAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
F ME R + + ++ + L+ + RP +
Sbjct: 226 --PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-40
Identities = 80/309 (25%), Positives = 137/309 (44%), Gaps = 58/309 (18%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRI----VAVKKSKIVHEG----KLEEFIN 128
+ + + +NRILG+G G VY+G+ + + VAVK + E+F++
Sbjct: 8 GIAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFMS 62
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
E VI+ ++H ++VKL+G E E ++ E G L YL + + +
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYS 119
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG 248
++ +++YL S+ HRDI NIL+ K+ DFG S++I + K
Sbjct: 120 LQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASV 173
Query: 249 T---FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILS 304
T ++ PE +FT SDV+ F V + E+L+ G++P +F L
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP--------------FFWLE 219
Query: 305 MEENRLYDFLDDQVLKVGQKEEIM--------TIATLATRCLNLNGKRRPTMKEVAMELE 356
N+ V+ V +K + + + TL TRC + + RP E+ L
Sbjct: 220 ---NK-------DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
Query: 357 RIQALQKDI 365
+ ++KDI
Sbjct: 270 DVYQMEKDI 278
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 71/320 (22%), Positives = 131/320 (40%), Gaps = 70/320 (21%)
Query: 89 RILGQGGQGTVYKGMLADGR------IVAVKKSKIVHEGK-LEEFINEVVILSQINHRNV 141
R +G+G G V++ +VAVK K +F E ++++ ++ N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYL---------------------HDQNEEFPLT 180
VKLLG C + L++E+++ G L ++L PL+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 181 WEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240
+L IA +VA ++YL + HRD+ + N L+ E K+ADFG S+ I
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 241 HVTTKVQGTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEA 294
+ + PE ++T +SDV+++GVVL E+ + G +P
Sbjct: 230 YK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--------- 276
Query: 295 TGLAAYFILSMEENRLYDFLDD-QVLKV-----GQKEEIMTIATLATRCLNLNGKRRPTM 348
Y+ ++ EE + ++ D +L + +M C + RP+
Sbjct: 277 -----YYGMAHEE--VIYYVRDGNILACPENCPLELYNLM------RLCWSKLPADRPSF 323
Query: 349 KEVAMELERI-QALQKDINV 367
+ L+R+ + + + V
Sbjct: 324 CSIHRILQRMCERAEGTVGV 343
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 34/304 (11%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
H+ + LG+GG V L DG A+K+ + EE E + NH N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 143 KLLGCCLETEVP----LLVYEFISNGTLFQYL-HDQNEEFPLTWEMRLRIATEVAGSLSY 197
+L+ CL L+ F GTL+ + +++ LT + L + + L
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ--------GT 249
+H+ HRD+K TNILL ++ + D G+ I + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 250 FGYLDPEYF--RSGQFTD-KSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306
Y PE F +S D ++DV+S G VL ++ G+ P + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------DMVFQKGDSVALAV 260
Query: 307 ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDIN 366
+N+L + + L + ++ +RP + + +LE +Q +
Sbjct: 261 QNQLSIPQSPRHSS--------ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312
Query: 367 VKQI 370
QI
Sbjct: 313 TTQI 316
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 91 LGQGGQGTVYKGML--ADGRI-VAVKKSKIVHEGK-LEEFINEVVILSQINHRNVVKLLG 146
LG G G+V +G+ +I VA+K K E EE + E I+ Q+++ +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
C + +LV E G L ++L + EE P+ + +V+ + YL
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYL---EEKNF 457
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY--LDPEYFRSGQFT 264
HR++ + N+LL ++ AK++DFG SK + D ++ T + G + PE +F+
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 265 DKSDVYSFGVVLVELLT-GQKP 285
+SDV+S+GV + E L+ GQKP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-39
Identities = 77/310 (24%), Positives = 129/310 (41%), Gaps = 74/310 (23%)
Query: 89 RILGQGGQGTVYKGMLADGR--------IVAVKKSK-IVHEGKLEEFINEVVILSQI-NH 138
+ LG+G G V VAVK K E L + ++E+ ++ I H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYL-------------HDQNEEFPLTWEMRL 185
+N++ LLG C + ++ E+ S G L +YL ++ E +T++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 186 RIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK 245
++A + YL AS HRD+ + N+L+ E K+ADFG ++ I +
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 259
Query: 246 VQGTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAA 299
+ T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-------------- 305
Query: 300 YFILSMEENRLYDFLDDQVLKVGQK-----------EEIMTIATLATRCLNLNGKRRPTM 348
Y + +EE L+ L + G + +M C + +RPT
Sbjct: 306 YPGIPVEE--LFKLLKE-----GHRMDKPANCTNELYMMM------RDCWHAVPSQRPTF 352
Query: 349 KEVAMELERI 358
K++ +L+RI
Sbjct: 353 KQLVEDLDRI 362
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 49/216 (22%), Positives = 83/216 (38%), Gaps = 33/216 (15%)
Query: 83 DHFNVNRILGQGGQGTVYKG--MLADGRIVAVKKSKIVHEGKLEE----FINEVVILSQI 136
+ V + GG G +Y +GR V +K + E + E L+++
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK---GLVHSGDAEAQAMAMAERQFLAEV 136
Query: 137 NHRNVVKLL-----GCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEV 191
H ++V++ V +V E++ +L + L + E+
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEI 191
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV--IDQTHVTTKVQGT 249
+LSYLHS + + D+K NI+L E+ K+ D G V I+ + GT
Sbjct: 192 LPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG----AVSRINSFGY---LYGT 240
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
G+ PE R T +D+Y+ G L L
Sbjct: 241 PGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPT 275
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-39
Identities = 72/326 (22%), Positives = 127/326 (38%), Gaps = 70/326 (21%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
F +LGQG G V K D R A+KK + E KL ++EV++L+ +NH+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 141 VVKLLGCCLETEVPL-------------LVYEFISNGTLFQYLHDQNEEFPLTWEMR-LR 186
VV+ LE + + E+ NGTL+ +H +N R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ---RDEYWR 120
Query: 187 IATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI----------- 235
+ ++ +LSY+HS I HRD+K NI ++E K+ DFG +K +
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 236 ---VIDQTHVTTKVQGTFGYLDPEYFR-SGQFTDKSDVYSFGVVLVELLTGQKPIILTGS 291
++T+ + GT Y+ E +G + +K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------- 227
Query: 292 KEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT--------LATRCLNLNGK 343
F ME + + L+ E + ++ +
Sbjct: 228 ---------FSTGMERVNIL-----KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273
Query: 344 RRPTMKEVAMELERIQALQKDINVKQ 369
+RP + + + +D +K+
Sbjct: 274 KRPGART-LLNSGWLPVKHQDEVIKE 298
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-39
Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 89 RILGQGGQGTVYKGMLADGR------IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNV 141
LG+ G VYKG L VA+K K EEF +E ++ +++ H NV
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLH-------------DQNEEFPLTWEMRLRIA 188
V LLG + + +++ + S+G L ++L D+ + L + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQG 248
++A + YL +S + H+D+ + N+L+ +K K++D G + + K+ G
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV---YAADYYKLLG 188
Query: 249 TFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
L PE G+F+ SD++S+GVVL E+ + G +P
Sbjct: 189 N-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-39
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 14/205 (6%)
Query: 87 VNRILGQGGQGTVYKGM-LADGRIVAVK--KSKIVHEGK-LEEFINEVVILSQINHRNVV 142
+ R++G+GG G VY+ RIVA+K + + E ++ +VV
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+ + I+ L L + PL + I ++ +L H+A
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT--KVQGTFGYLDPEYFRS 260
HRD+K NIL++ A + DFG + +T GT Y+ PE F
Sbjct: 155 ---ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKP 285
T ++D+Y+ VL E LTG P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 87/383 (22%), Positives = 140/383 (36%), Gaps = 90/383 (23%)
Query: 32 KVYIIKRED-----IKLKEKF--------FKRNGGLVLQQQLTSSDGSIDRCKLFTTKEL 78
Y F + + + G + + E
Sbjct: 2 GYYHHHHHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPED 61
Query: 79 DK---ATDHFNVNRILGQGGQGTVYKGMLAD--------GRIVAVKKSK-IVHEGKLEEF 126
+ D + + LG+G G V VAVK K E L +
Sbjct: 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 121
Query: 127 INEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYL-------------HD 172
I+E+ ++ I H+N++ LLG C + ++ E+ S G L +YL
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 173 QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232
N E L+ + + A +VA + YL AS HRD+ + N+L+ E K+ADFG +
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 233 KFIVIDQTHVTTKVQGTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPI 286
+ I + + T G L PE +T +SDV+SFGV+L E+ T G P
Sbjct: 239 RDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP- 293
Query: 287 ILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQK-----------EEIMTIATLAT 335
Y + +EE L+ L + G + +M
Sbjct: 294 -------------YPGVPVEE--LFKLLKE-----GHRMDKPSNCTNELYMMM------R 327
Query: 336 RCLNLNGKRRPTMKEVAMELERI 358
C + +RPT K++ +L+RI
Sbjct: 328 DCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 82/316 (25%), Positives = 123/316 (38%), Gaps = 74/316 (23%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD------GRIVAVKKSKIVH-EGKLEEFINEVVILSQ 135
D + + LG+G G V + R VAVK K + ++E+ IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 136 I-NHRNVVKLLGCCLETEVPLLV-YEFISNGTLFQYL-------------HDQNEEFPLT 180
I +H NVV LLG C + PL+V EF G L YL + + LT
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 181 WEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240
E + + +VA + +L AS HRD+ + NILL+EK K+ DFG ++ I D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 241 HVTTKVQGTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEA 294
+ V+ L PE +T +SDV+SFGV+L E+ + G P
Sbjct: 204 Y----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------- 250
Query: 295 TGLAAYFILSMEENR-LYDFLDDQVLKVGQKEE-----------IMTIATLATRCLNLNG 342
Y ++ + L + G + M C +
Sbjct: 251 -----YP--GVKIDEEFCRRLKE-----GTRMRAPDYTTPEMYQTM------LDCWHGEP 292
Query: 343 KRRPTMKEVAMELERI 358
+RPT E+ L +
Sbjct: 293 SQRPTFSELVEHLGNL 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 66/282 (23%), Positives = 109/282 (38%), Gaps = 48/282 (17%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
+LG+G G VY G L++ +A+K+ + E+ + + H+N+V+ LG
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT-EVAGSLSYLHSAASMPI 206
E + E + G+L L + E + T ++ L YLH I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYTKQILEGLKYLHDNQ---I 143
Query: 207 YHRDIKSTNILLNEKY-TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ--F 263
HRDIK N+L+N K++DFGTSK + T GT Y+ PE G +
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202
Query: 264 TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR----------LYDF 313
+D++S G ++E+ TG+ P + AA F + M + F
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF----YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355
+ +C + +R A +L
Sbjct: 259 IL--------------------KCFEPDPDKRAC----ANDL 276
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 57/315 (18%), Positives = 115/315 (36%), Gaps = 76/315 (24%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRI--------VAVKKSKIVHEGKLEEFIN 128
++ + N LGQG ++KG+ + V +K H E F
Sbjct: 4 KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
++S+++H+++V G C+ + +LV EF+ G+L YL + W+ L +A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT--------AKVADFGTSKFIVIDQT 240
++A ++ +L + H ++ + NILL + K++D G S ++
Sbjct: 120 KQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD- 175
Query: 241 HVTTKVQGTFGYLDP---------EYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTG 290
+ E + +D +SFG L E+ + G KP
Sbjct: 176 ----------ILQERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP----- 218
Query: 291 SKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIM------TIATLATRCLNLNGKR 344
L ++ + L+ + + +A L C++
Sbjct: 219 ---------LSALD---SQ-------RKLQFYEDRHQLPAPKAAELANLINNCMDYEPDH 259
Query: 345 RPTMKEVAMELERIQ 359
RP+ + + +L +
Sbjct: 260 RPSFRAIIRDLNSLF 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 71/297 (23%), Positives = 130/297 (43%), Gaps = 46/297 (15%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYKGMLADGR----IVAVKKSKIVH-EGKLEEFINEV 130
E+ + + + R +G+G G V++G+ VA+K K + E+F+ E
Sbjct: 385 YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 131 VILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATE 190
+ + Q +H ++VKL+G E V ++ E + G L +L + L + A +
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQ 499
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF 250
++ +L+YL S HRDI + N+L++ K+ DFG S+++ + +K +
Sbjct: 500 LSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 251 GYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENR 309
++ PE +FT SDV+ FGV + E+L G KP + + +
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP--------------FQGVKNND-- 600
Query: 310 LYDFLDDQVLKVGQKEEIM--------TIATLATRCLNLNGKRRPTMKEVAMELERI 358
V+ + E + T+ +L T+C + RRP E+ +L I
Sbjct: 601 --------VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-38
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 87 VNRILGQGGQGTVYKGM-LADGRIVAVK--KSKIVHEGK-LEEFINEVVILSQINHRNVV 142
+ ILG GG V+ L D R VAVK ++ + + F E + +NH +V
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 143 KLL--GC--CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+ G +P +V E++ TL +H E P+T + + + + +L++
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFS 132
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT--KVQGTFGYLDPE 256
H I HRD+K NI+++ KV DFG ++ I VT V GT YL PE
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
R +SDVYS G VL E+LTG+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 75/334 (22%), Positives = 130/334 (38%), Gaps = 72/334 (21%)
Query: 89 RILGQGGQGTVYKGMLADG---RIVAVKKSK-IVHEGKLEEFINEVVILSQI-NHRNVVK 143
++G+G G V K + A+K+ K + +F E+ +L ++ +H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYL-------------HDQNEEFPLTWEMRLRIATE 190
LLG C L E+ +G L +L + L+ + L A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF 250
VA + YL + HRD+ + NIL+ E Y AK+ADFG S+ + T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTM----- 200
Query: 251 GYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILS 304
G L E +T SDV+S+GV+L E+++ G P Y ++
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------------YCGMT 246
Query: 305 MEENRLYDFLDDQVLKVGQ---------KE--EIMTIATLATRCLNLNGKRRPTMKEVAM 353
E LY+ L G E ++M +C RP+ ++ +
Sbjct: 247 CAE--LYEKLPQ-----GYRLEKPLNCDDEVYDLM------RQCWREKPYERPSFAQILV 293
Query: 354 ELERIQALQKDINVKQICDEIESCDIVSTSTETS 387
L R+ +K + ++ I ++ E +
Sbjct: 294 SLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA 327
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 74/316 (23%), Positives = 122/316 (38%), Gaps = 73/316 (23%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGR------IVAVKKSK-IVHEGKLEEFINEVVILSQ 135
+ + + LG G G V + VAVK K H + E ++E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 136 I-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYL---------------HDQNEEFPL 179
+ NH N+V LLG C L++ E+ G L +L +++E L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 180 TWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239
E L + +VA +++L AS HRD+ + NILL K+ DFG ++ I
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKN 197
Query: 240 THVTTKVQGTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKE 293
L PE + +T +SDV+S+G+ L EL + G P
Sbjct: 198 DSNYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-------- 247
Query: 294 ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEE-----------IMTIATLATRCLNLNG 342
Y + ++ Y + + G + IM C + +
Sbjct: 248 ------YPGMPVDSK-FYKMIKE-----GFRMLSPEHAPAEMYDIM------KTCWDADP 289
Query: 343 KRRPTMKEVAMELERI 358
+RPT K++ +E+
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 62/300 (20%), Positives = 115/300 (38%), Gaps = 39/300 (13%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVILSQINHRN 140
+ ++ ILGQG V++G G + A+K + I ++ + E +L ++NH+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 141 VVKLLGC--CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+VKL T +L+ EF G+L+ L + + + L L + +V G +++L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 199 HSAASMPIYHRDIKSTNILL----NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
I HR+IK NI+ + + K+ DFG ++ + D + GT YL
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183
Query: 255 PEYFRSG--------QFTDKSDVYSFGVVLVELLTGQKP---------------IILTGS 291
P+ + ++ D++S GV TG P I+TG
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 292 KEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ + D L G + + + L + ++ +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQEKCWGFDQF 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-36
Identities = 73/307 (23%), Positives = 120/307 (39%), Gaps = 71/307 (23%)
Query: 89 RILGQGGQGTVYKGMLADGR------IVAVKKSK-IVHEGKLEEFINEVVILSQI-NHRN 140
+ LG G G V + VAVK K H + E ++E+ I+S + H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEF-----------PLTWEMRLRIAT 189
+V LLG C L++ E+ G L +L ++ + L ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT 249
+VA +++L AS HRD+ + N+LL + AK+ DFG ++ I+ D + +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKG 224
Query: 250 FGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYF-I 302
L PE +T +SDV+S+G++L E+ + G P Y I
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--------------YPGI 270
Query: 303 LSMEENRLYDFLDDQVLKVGQK-----------EEIMTIATLATRCLNLNGKRRPTMKEV 351
L + Y + D G + IM C L RPT +++
Sbjct: 271 LVNSK--FYKLVKD-----GYQMAQPAFAPKNIYSIM------QACWALEPTHRPTFQQI 317
Query: 352 AMELERI 358
L+
Sbjct: 318 CSFLQEQ 324
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-36
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
+ F + R LG+G G VY I+A+K K+++ G + EV I S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
N+++L G + L+ E+ GT+++ L + + TE+A +LSY
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSY 124
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
HS + HRDIK N+LL K+ADFG S GT YL PE
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDYLPPEM 178
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+K D++S GV+ E L G+ P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 66/319 (20%), Positives = 122/319 (38%), Gaps = 40/319 (12%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVILSQINHRN 140
+ ++ ILGQG V++G G + A+K + I ++ + E +L ++NH+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 141 VVKLLGC--CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+VKL T +L+ EF G+L+ L + + + L L + +V G +++L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 199 HSAASMPIYHRDIKSTNILL----NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
I HR+IK NI+ + + K+ DFG ++ + D + GT YL
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183
Query: 255 PEYFRSG--------QFTDKSDVYSFGVVLVELLTGQKP---------------IILTGS 291
P+ + ++ D++S GV TG P I+TG
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 292 KEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ + D L G + + + L + ++ +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL---LTPVLANILEADQEKCWGFDQF 300
Query: 352 AMELERIQALQKDINVKQI 370
E I + I+V +
Sbjct: 301 FAETSDILH-RMVIHVFSL 318
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-35
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
+ F V +LG+G VY+ + G VA+K K + G ++ NEV I Q+ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
++++L E + LV E NG + +YL ++ + F E R ++ + Y
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEAR-HFMHQIITGMLY 127
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
LHS I HRD+ +N+LL K+ADFG + + + T + GT Y+ PE
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEI 183
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+SDV+S G + LL G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 70/315 (22%), Positives = 119/315 (37%), Gaps = 78/315 (24%)
Query: 89 RILGQGGQGTVYKGMLADGR------IVAVKKSK-IVHEGKLEEFINEVVILSQI-NHRN 140
++LG G G V VAVK K + E ++E+ +++Q+ +H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYL--------------------HDQNEEFPLT 180
+V LLG C + L++E+ G L YL ++ + LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 181 WEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240
+E L A +VA + +L HRD+ + N+L+ K+ DFG ++ I+
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM--SD 225
Query: 241 HVTTKVQGTFGYL-----DPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEA 294
L PE G +T KSDV+S+G++L E+ + G P
Sbjct: 226 SNYVV--RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--------- 274
Query: 295 TGLAAYFILSMEENRLYDFLDDQVLKVGQKEE-----------IMTIATLATRCLNLNGK 343
Y + ++ N Y + + G K + IM C + +
Sbjct: 275 -----YPGIPVDAN-FYKLIQN-----GFKMDQPFYATEEIYIIM------QSCWAFDSR 317
Query: 344 RRPTMKEVAMELERI 358
+RP+ + L
Sbjct: 318 KRPSFPNLTSFLGCQ 332
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 77/309 (24%), Positives = 126/309 (40%), Gaps = 39/309 (12%)
Query: 52 GGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKG-MLADGRIV 110
G + L ++ G F +D + R+LG+G G V G+
Sbjct: 1 GPGSMMDHLHATPGM------FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC 54
Query: 111 AVK---KSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLF 167
AVK K ++ + E + EV +L Q++H N++KL + LV E + G LF
Sbjct: 55 AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 168 QYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTA 224
+ + + RI +V ++Y+H I HRD+K N+LL ++
Sbjct: 115 DEIISRK---RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI 168
Query: 225 KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQK 284
++ DFG S + + GT Y+ PE G + +K DV+S GV+L LL+G
Sbjct: 169 RIIDFGLSTH--FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP 225
Query: 285 PIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ--KEEIMTIATLATRCLNLNG 342
P G+ E L + + Y F Q KV + K+ L + L
Sbjct: 226 P--FNGANEYDILKK--VEKGK----YTFELPQWKKVSESAKD-------LIRKMLTYVP 270
Query: 343 KRRPTMKEV 351
R + ++
Sbjct: 271 SMRISARDA 279
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 56/238 (23%), Positives = 95/238 (39%), Gaps = 20/238 (8%)
Query: 56 LQQQLTSSDGSIDRCKLFTTK-ELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK 113
L + ++G + KL E + +G+G G V++ G AVK
Sbjct: 30 LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89
Query: 114 KSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQ 173
K ++ E E E+V + ++ +V L G E + E + G+L Q + Q
Sbjct: 90 KVRL--EVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQ 143
Query: 174 NEEFPLTWEMRLRIAT-EVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGT 231
P E R + L YLH+ I H D+K+ N+LL+ A + DFG
Sbjct: 144 MGCLP---EDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGH 197
Query: 232 SKFIVIDQTHVTTK----VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ + D + + GT ++ PE K D++S +++ +L G P
Sbjct: 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 57/315 (18%), Positives = 118/315 (37%), Gaps = 44/315 (13%)
Query: 56 LQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVK-- 113
+ S G + + + +++ + +G GG V++ + +I A+K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60
Query: 114 -KSKIVHEGKLEEFINEVVILSQINHRN--VVKLLGCCLETEVPLLVYEFISNGTLFQYL 170
+ ++ L+ + NE+ L+++ + +++L + + +V E N L +L
Sbjct: 61 NLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL 118
Query: 171 HDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230
+ + R + ++ +H I H D+K N L+ + K+ DFG
Sbjct: 119 KKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFG 171
Query: 231 TSKFIVIDQTHVTTKVQ-GTFGYLDPE-----------YFRSGQFTDKSDVYSFGVVLVE 278
+ + D T V Q GT Y+ PE + + KSDV+S G +L
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 279 LLTGQKPIILTGSKEATGLAAYF--ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATR 336
+ G+ P + ++ I E D + + +
Sbjct: 232 MTYGKTPF----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD------------VLKC 275
Query: 337 CLNLNGKRRPTMKEV 351
CL + K+R ++ E+
Sbjct: 276 CLKRDPKQRISIPEL 290
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 59/288 (20%), Positives = 111/288 (38%), Gaps = 53/288 (18%)
Query: 85 FNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVK 143
F +LG G +GT+ + D R VAV K + EV +L + + H NV++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAV---KRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 144 LLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS 203
+ + + E + TL +Y+ + ++F + + + L++LH S
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLH---S 136
Query: 204 MPIYHRDIKSTNILLNEK-----YTAKVADFGTSKFIVIDQ--THVTTKVQGTFGYLDPE 256
+ I HRD+K NIL++ A ++DFG K + + + + V GT G++ PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 257 YFRS---GQFTDKSDVYSFGVVLVELLTGQKP----------IILTGSKEATGLAAYFIL 303
T D++S G V +++ IL G+ L
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ + + + + ++ ++RP+ K V
Sbjct: 257 DVI---ARELI--------------------EKMIAMDPQKRPSAKHV 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 6e-34
Identities = 34/310 (10%), Positives = 69/310 (22%), Gaps = 50/310 (16%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVI 132
L + + L G + V+ + A+K +LE
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 133 LSQINHRNVVKLLGCCLETEVP--------------------------LLVYEFI--SNG 164
+++ + + LL+
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 165 TLFQYLHD-QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223
LF L + ++ + L S + H N+ +
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGR 232
Query: 224 AKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG--QFTDKSDVYSFGVVLVELLT 281
+ D Y E+ + FT + + G+ + +
Sbjct: 233 LMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 282 GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLN 341
P G ++ S+ + + TL R LN +
Sbjct: 289 LFLPF---GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD-----FVKTLIGRFLNFD 340
Query: 342 GKRRPTMKEV 351
+RR E
Sbjct: 341 RRRRLLPLEA 350
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-34
Identities = 55/287 (19%), Positives = 111/287 (38%), Gaps = 44/287 (15%)
Query: 84 HFNVNRILGQGGQGTVYKGMLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH-- 138
+++ + +G GG V++ + +I A+K + ++ L+ + NE+ L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHS 68
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+++L + + +V E N L +L + + R + ++ +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 124
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ-GTFGYLDPE- 256
H I H D+K N L+ + K+ DFG + + D T V Q GT Y+ PE
Sbjct: 125 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 257 ----------YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF--ILS 304
+ + KSDV+S G +L + G+ P + ++ I
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDP 236
Query: 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
E D + + + CL + K+R ++ E+
Sbjct: 237 NHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISIPEL 271
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
D F++ R LG+G G VY LA + I+A+K KS++ EG + E+ I S
Sbjct: 14 DDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLR-IATEVAG 193
+ H N++++ + L+ EF G L++ L ++ F E R E+A
Sbjct: 71 LRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQ-KHGRFD---EQRSATFMEELAD 125
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
+L Y H + HRDIK N+L+ K K+ADFG S + GT YL
Sbjct: 126 ALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYL 179
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE +K D++ GV+ E L G P
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 54/287 (18%), Positives = 110/287 (38%), Gaps = 44/287 (15%)
Query: 84 HFNVNRILGQGGQGTVYKGMLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH-- 138
+++ + +G GG V++ + +I A+K + ++ L+ + NE+ L+++
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHS 115
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+++L + + +V E N L +L + + R + ++ +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 171
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ-GTFGYLDPE- 256
H I H D+K N L+ + K+ DFG + + D T V Q G Y+ PE
Sbjct: 172 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 257 ----------YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF--ILS 304
+ + KSDV+S G +L + G+ P + ++ I
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDP 283
Query: 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
E D + + + CL + K+R ++ E+
Sbjct: 284 NHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISIPEL 318
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 80 KATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVILSQIN 137
+ + + LG GG G V + + G VA+K+ + + E + E+ I+ ++N
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 138 HRNVVKLLGCCLETE-------VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATE 190
H NVV + +PLL E+ G L +YL+ L + ++
Sbjct: 71 HPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQ 247
++ +L YLH I HRD+K NI+L ++ K+ D G +K + DQ + T+
Sbjct: 130 ISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFV 184
Query: 248 GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
GT YL PE ++T D +SFG + E +TG +P
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 70/288 (24%), Positives = 113/288 (39%), Gaps = 34/288 (11%)
Query: 73 FTTKELDKATDHFNVNRILGQGGQGTVYKG-MLADGRIVAVK---KSKIVHEGKLEEFIN 128
F T + ++ + + LG G G V A+K K+ + + +
Sbjct: 27 FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLE 85
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
EV +L ++H N++KL + LV E G LF + + I
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVII 142
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTK 245
+V ++YLH I HRD+K N+LL + K+ DFG S + +
Sbjct: 143 KQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKE 197
Query: 246 VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305
GT Y+ PE R ++ +K DV+S GV+L LL G P +E IL
Sbjct: 198 RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--------ILRK 248
Query: 306 EENRLYDFLDDQVLKVGQ--KEEIMTIATLATRCLNLNGKRRPTMKEV 351
E Y F + V + K+ L + L + +RR + ++
Sbjct: 249 VEKGKYTFDSPEWKNVSEGAKD-------LIKQMLQFDSQRRISAQQA 289
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 15/209 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
+ R LG+GG ++ + A K KS ++ + E+ E+ I + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLT-WEMRLRIATEVAGSLS 196
++VV G E + +V E +L + + LT E R ++
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEAR-YYLRQIVLGCQ 155
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
YLH + HRD+K N+ LNE K+ DFG + + D + GT Y+ PE
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 211
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ + DV+S G ++ LL G+ P
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-33
Identities = 68/303 (22%), Positives = 118/303 (38%), Gaps = 43/303 (14%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNV 141
V R+L +GG VY+ + GR A+K+ E K I EV + ++ H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 142 VKLLGCCLETEVP-------LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
V+ + L+ + G L ++L PL+ + L+I + +
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ------- 247
+ ++H PI HRD+K N+LL+ + T K+ DFG++ I + + +
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 248 ----GTFGYLDPE---YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAY 300
T Y PE + + +K D+++ G +L L Q P E
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF------EDGAKLR- 260
Query: 301 FILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360
I+ N Y Q +L L +N + R ++ EV +L+ I A
Sbjct: 261 -IV----NGKYSIPPHDT----QYTV---FHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 361 LQK 363
+
Sbjct: 309 ARN 311
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 41/279 (14%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
+ +GQG GTVY M +A G+ VA+++ + + K E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+V L L + +V E+++ G+L D E + + E +L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLH- 133
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
S + HRDIKS NILL + K+ DFG I +Q+ +T V GT ++ PE
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKP---------IILTGSKEATGLAAYFILSMEENRLY 311
+ K D++S G++ +E++ G+ P + L + L LS
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI---FR 247
Query: 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKE 350
DFL+ RCL ++ ++R + KE
Sbjct: 248 DFLN--------------------RCLEMDVEKRGSAKE 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-33
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 15/209 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
+ R LG+GG ++ + A K KS ++ + E+ E+ I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLT-WEMRLRIATEVAGSLS 196
++VV G E + +V E +L + + LT E R ++
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEAR-YYLRQIVLGCQ 129
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
YLH + HRD+K N+ LNE K+ DFG + + D + GT Y+ PE
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 185
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ + DV+S G ++ LL G+ P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 9/205 (4%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
+ +G+G G V GR VAVK + + + E NEVVI+ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
VV++ L E ++ EF+ G L D + L E + V +L+YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLH- 158
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
+ + HRDIKS +ILL K++DFG I D + V GT ++ PE
Sbjct: 159 --AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKP 285
+ + D++S G++++E++ G+ P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 56/239 (23%), Positives = 107/239 (44%), Gaps = 36/239 (15%)
Query: 74 TTKELDKATDHFNVNRILGQGGQGTVYKGMLA--DGRIVAVK-----------------K 114
KE DK + + + R L QG + L D + A+K
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNN 78
Query: 115 SKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLH-- 171
KI + K ++F NE+ I++ I + + G + + ++YE++ N ++ ++
Sbjct: 79 DKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYF 137
Query: 172 ---DQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVAD 228
D+N + ++ I V S SY+H+ I HRD+K +NIL+++ K++D
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSD 195
Query: 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTD--KSDVYSFGVVLVELLTGQKP 285
FG S+++ +GT+ ++ PE+F + + K D++S G+ L + P
Sbjct: 196 FGESEYM---VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 33/229 (14%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGK--LEEFINEVVILSQI-N 137
T F+ +G G G+V+K + DG I A+K+SK G + + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLR-IATEVAGSLS 196
H +VV+ E + L+ E+ + G+L + + E L+ + +V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 197 YLHSAASMPIYHRDIKSTNILLNE-------------------KYTAKVADFGTSKFIVI 237
Y+HS M + H DIK +NI ++ K K+ D G I
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 238 DQTHVTTKVQGTFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKP 285
Q G +L E + K+D+++ + +V +
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-32
Identities = 41/254 (16%), Positives = 82/254 (32%), Gaps = 27/254 (10%)
Query: 56 LQQQLTSSDGSIDRC----KLFTTKELDKATDHFNVNRILGQGGQGTVYKGM------LA 105
L + ++S + + + E + V+ +LG+G VY+
Sbjct: 34 LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93
Query: 106 DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 165
+ + +K K + + + L +K L +LV E S GT
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 166 LFQYLHD--QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223
L ++ E + + + A + + +H I H DIK N +L +
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210
Query: 224 A-----------KVADFGTSKFI-VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYS 271
+ D G S + + + + T T G+ E + + + D +
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270
Query: 272 FGVVLVELLTGQKP 285
+ +L G
Sbjct: 271 VAATVYCMLFGTYM 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 75/299 (25%), Positives = 118/299 (39%), Gaps = 43/299 (14%)
Query: 72 LFTTKELDKATDHFNVNRILGQGGQGTVYKG-MLADGRIVAVK---KSKIV--------- 118
++ K+ K + + R LG G G V A+K KS+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 119 -HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEF 177
E EE NE+ +L ++H N++KL + + LV EF G LF+ + +++
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--- 141
Query: 178 PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKF 234
I ++ + YLH I HRDIK NILL N K+ DFG S F
Sbjct: 142 KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA 294
+ + GT Y+ PE + ++ +K DV+S GV++ LL G P G +
Sbjct: 199 --FSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP--FGGQNDQ 253
Query: 295 TGLAAYFILSMEENRLYDFLDDQVLKVGQ--KEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ + + Y F + + KE L L + +R T +E
Sbjct: 254 DIIKK--VEKGK----YYFDFNDWKNISDEAKE-------LIKLMLTYDYNKRCTAEEA 299
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
+ + + LG G G VYK G + A K + E +LE++I E+ IL+ +H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT---EVAGSLSY 197
+VKLLG ++ EF G + + + + I ++ +L++
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNF 132
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE- 256
LH S I HRD+K+ N+L+ + ++ADFG S + + + GT ++ PE
Sbjct: 133 LH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 257 ----YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ + K+D++S G+ L+E+ + P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 73/280 (26%), Positives = 115/280 (41%), Gaps = 36/280 (12%)
Query: 82 TDHFNVNRILGQGGQGTVYKG-MLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQIN 137
+ +N+ +LG+G G V K + AVK K+ ++ + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD 79
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
H N++KL E +V E + G LF + + + RI +V ++
Sbjct: 80 HPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGIT 135
Query: 197 YLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
Y+H I HRD+K NILL + K+ DFG S Q GT Y+
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYI 190
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313
PE R G + +K DV+S GV+L LL+G P G E L + + + Y F
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSGTPP--FYGKNEYDILKR--VETGK----YAF 241
Query: 314 LDDQVLKVGQ--KEEIMTIATLATRCLNLNGKRRPTMKEV 351
Q + K+ L + L + R T +
Sbjct: 242 DLPQWRTISDDAKD-------LIRKMLTFHPSLRITATQC 274
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI-VHEGKLEEFINEVVILSQINHR 139
+ F +G+G G V+KG+ ++VA+K + E ++E+ E+ +LSQ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
V K G L+ ++ E++ G+ L PL I E+ L YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH 136
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
S HRDIK+ N+LL+E K+ADFG + + Q T V GT ++ PE +
Sbjct: 137 S---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 192
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKP 285
+ K+D++S G+ +EL G+ P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPP 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
+ F+V LG+G G+VYK + G+IVA+K+ + E L+E I E+ I+ Q + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT---EVAGSLSY 197
VVK G + +V E+ G++ + +N+ IAT L Y
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKGLEY 140
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
LH M HRDIK+ NILLN + AK+ADFG + + T + GT ++ PE
Sbjct: 141 LHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ + +D++S G+ +E+ G+ P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 71/300 (23%), Positives = 120/300 (40%), Gaps = 52/300 (17%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNV 141
+ +ILG G GTV GR VAV K + + + E+ +L++ +H NV
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAV---KRMLIDFCDIALMEIKLLTESDDHPNV 71
Query: 142 VKLLGCCLETEVPL-LVYEFISNGTLFQYL---HDQNEEFPLTWEMRLR-IATEVAGSLS 196
++ C T+ L + E N L + + +E L E + ++A ++
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 197 YLHSAASMPIYHRDIKSTNILLNEK-------------YTAKVADFGTSKFIVIDQTHVT 243
+LH S+ I HRD+K NIL++ ++DFG K + Q+
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 244 TKVQ---GTFGYLDPEYFRSGQF-------TDKSDVYSFGVVLVELLT-GQKPIILTGSK 292
T + GT G+ PE T D++S G V +L+ G+ P G K
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP---FGDK 243
Query: 293 EATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT-LATRCLNLNGKRRPTMKEV 351
S E N + +K ++ AT L ++ ++ + +RPT +V
Sbjct: 244 ----------YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 30/236 (12%), Positives = 66/236 (27%), Gaps = 42/236 (17%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQ--------- 135
+LGQ + G V ++ +++ EV+ L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 136 -------------INHRNVVKLLGCCLETEVPLLVYEFI-------SNGTLFQYLHDQNE 175
+ K++ L+ ++ F + T + L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 176 EF-PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234
L RL++ +V L+ LH + H ++ +I+L+++ + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQ-----FTDKSDVYSFGVVLVELLTGQKP 285
+ GQ T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 66/242 (27%), Positives = 107/242 (44%), Gaps = 15/242 (6%)
Query: 58 QQLTSSDGSIDRCKLFTT---KELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVK 113
++L + R + F T K + D F LG G G V+K G ++A K
Sbjct: 5 EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 114 KSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHD 172
+ + I E+ +L + N +V G + E + G+L Q L
Sbjct: 65 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124
Query: 173 QNEEFPLTWEMRL-RIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231
P E L +++ V L+YL I HRD+K +NIL+N + K+ DFG
Sbjct: 125 AGR-IP---EQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGS 291
S ++ + + V GT Y+ PE + ++ +SD++S G+ LVE+ G+ PI +
Sbjct: 179 SGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 292 KE 293
KE
Sbjct: 236 KE 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
+ F +ILG+G TV +LA R A+K K I+ E K+ E ++S+
Sbjct: 30 EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAG 193
++H VKL + + L + NG L +Y+ + F E R E+
Sbjct: 87 LDHPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIR-KIGSFD---ETCTRFYTAEIVS 141
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK-VQGTFGY 252
+L YLH I HRD+K NILLNE ++ DFGT+K + + GT Y
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ PE SD+++ G ++ +L+ G P
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 41/281 (14%), Positives = 86/281 (30%), Gaps = 65/281 (23%)
Query: 91 LGQGGQGTVYKGMLAD---GRIVAVKKSKIVH------EGKLEEFINEVVILSQINHRNV 141
G ++ + D R VA+ V + L+E ++ + LS+I+ V
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALT---FVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
++L L+V E+I G+L + + +R +A + H A
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA 148
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
+ + + ++ +A +
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA----- 179
Query: 262 QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321
+ D+ G L LL + P L + +GLA Q ++
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAP----------AERDTAGQPIEP 225
Query: 322 GQKEEIM--TIATLATRCLNLNGKRRPTMKEVAMELERIQA 360
+ + I+ +A R + +G R + +++ A
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIRSAS-TLLNLMQQATA 265
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 49/208 (23%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
D++++ LG G G V++ + A GR+ K + NE+ I++Q++H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 141 VVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
++ L E + + L+ EF+S G LF + E++ ++ + + L ++H
Sbjct: 110 LINLHDAF-EDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH 166
Query: 200 SAASMPIYHRDIKSTNILLNEKYTA--KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
I H DIK NI+ K + K+ DFG + ++ + T + PE
Sbjct: 167 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAPEI 221
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+D+++ GV+ LL+G P
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-29
Identities = 40/328 (12%), Positives = 86/328 (26%), Gaps = 90/328 (27%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVI 132
EL + +LGQ + G V ++ +++ EV+
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 133 LSQI-------------------------NHRNVVKLLGCCLETEVP--LLVYEFI--SN 163
L + + ++++ + V +Y + +
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 164 GTLFQYLHDQNEE-FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY 222
T + L + L RL++ +V L+ LH + H ++ +I+L+++
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRG 243
Query: 223 TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF-----------RSGQFTDKSDVYS 271
+ F + + G+ PE R T D ++
Sbjct: 244 GVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 272 FGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMT-- 329
G+V+ + P D L + I
Sbjct: 299 LGLVIYWIWCADLP---------------------------ITKDAALGGSEW--IFRSC 329
Query: 330 ------IATLATRCLNLNGKRRPTMKEV 351
+ L L + R +
Sbjct: 330 KNIPQPVRALLEGFLRYPKEDRLLPLQA 357
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 12/262 (4%)
Query: 28 TPKRKVYIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNV 87
P + + D+ + K + G + D + D DH+++
Sbjct: 102 IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDI 161
Query: 88 NRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLG 146
+ LG G G V++ A G A K HE E E+ +S + H +V L
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 147 CCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
E + + ++YEF+S G LF+ + D++ + + + + +V L ++H
Sbjct: 222 AF-EDDNEMVMIYEFMSGGELFEKVADEHNKM--SEDEAVEYMRQVCKGLCHMH---ENN 275
Query: 206 IYHRDIKSTNILLNEKYTA--KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF 263
H D+K NI+ K + K+ DFG + +D GT + PE
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAPEVAEGKPV 333
Query: 264 TDKSDVYSFGVVLVELLTGQKP 285
+D++S GV+ LL+G P
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSP 355
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 72/279 (25%), Positives = 116/279 (41%), Gaps = 34/279 (12%)
Query: 82 TDHFNVNRILGQGGQGTVYKG-MLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQIN 137
+ +N+ +LG+G G V K + AVK K+ ++ + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD 79
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
H N++KL ++ +V E + G LF + + + RI +V ++Y
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITY 136
Query: 198 LHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
+H I HRD+K NILL + K+ DFG S Q GT Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIA 191
Query: 255 PEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314
PE R G + +K DV+S GV+L LL+G P G E L + + + Y F
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPP--FYGKNEYDILKR--VETGK----YAFD 242
Query: 315 DDQVLKVGQ--KEEIMTIATLATRCLNLNGKRRPTMKEV 351
Q + K+ L + L + R T +
Sbjct: 243 LPQWRTISDDAKD-------LIRKMLTFHPSLRITATQC 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 82 TDHFNVNRILGQGGQGTVYKG-MLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQIN 137
D F R LG G G V+ + G +K K + + +E+ E+ +L ++
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD 78
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEF-PLTWEMRLRIATEVAGSL 195
H N++K+ E + +V E G L + + L+ + ++ +L
Sbjct: 79 HPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 196 SYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
+Y H S + H+D+K NIL + K+ DFG ++ +T GT Y
Sbjct: 138 AYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAGTALY 192
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ PE F+ T K D++S GVV+ LLTG P
Sbjct: 193 MAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI-VHEGKLEEFINEVVILSQINHRN 140
D + + ++G G V VA+K+ + + ++E + E+ +SQ +H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTL-----FQYLHDQNEEFPLTWEMRLRIAT---EVA 192
+V + + LV + +S G++ +++ L E IAT EV
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-E--STIATILREVL 131
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF-G 251
L YLH + HRD+K+ NILL E + ++ADFG S F+ KV+ TF G
Sbjct: 132 EGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 252 ---YLDPEYFRSGQFTD-KSDVYSFGVVLVELLTGQKP 285
++ PE + D K+D++SFG+ +EL TG P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 24/219 (10%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEG-----KLEEFINEVVI 132
D + +++ LG G G V + VA++ K K E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 133 LSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVA 192
L ++NH ++K+ + E +V E + G LF + L ++
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQML 249
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEK---YTAKVADFGTSKFIVIDQTHVTTKVQGT 249
++ YLH I HRD+K N+LL+ + K+ DFG SK + +T + + GT
Sbjct: 250 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGT 304
Query: 250 FGYLDPEYFRSGQF---TDKSDVYSFGVVLVELLTGQKP 285
YL PE S D +S GV+L L+G P
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGK---LEEFINEVVILSQIN 137
F+ R +G G G VY + + +VA+KK + ++ I EV L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT---EVAGS 194
H N ++ GC L LV E+ G+ L + IA
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE-----IAAVTHGALQG 166
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
L+YLHS + HRD+K+ NILL+E K+ DFG++ + + V GT ++
Sbjct: 167 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMA 218
Query: 255 PE---YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE GQ+ K DV+S G+ +EL + P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 21/212 (9%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQIN 137
F +LG G V+ G++ A+K KS + LE NE+ +L +I
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIK 64
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
H N+V L E+ LV + +S G LF + ++ T + + +V ++
Sbjct: 65 HENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVK 120
Query: 197 YLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
YLH I HRD+K N+L E + DFG SK Q + + GT GY+
Sbjct: 121 YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYV 174
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE ++ D +S GV+ LL G P
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 58/280 (20%), Positives = 105/280 (37%), Gaps = 38/280 (13%)
Query: 82 TDHFNVNRILGQGGQGTVYKG-MLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQIN 137
++ + +G+G G V A K K + + F E+ I+ ++
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSLD 64
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
H N+++L E + LV E + G LF+ + + RI +V +++
Sbjct: 65 HPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVA 120
Query: 197 YLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
Y H + + HRD+K N L + K+ DFG + + GT Y+
Sbjct: 121 YCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTPYYV 175
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313
P+ G + + D +S GV++ LL G P + ++ + I + F
Sbjct: 176 SPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP--FSAPTDSEVMLK--IREGT----FTF 226
Query: 314 LDDQVLKVGQ--KEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ L V + L R L + K+R T +
Sbjct: 227 PEKDWLNVSPQAES-------LIRRLLTKSPKQRITSLQA 259
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
D F + +++G+G V + G++ A+K K ++ G++ F E +L
Sbjct: 61 DDFEILKVIGRGAFSEV---AVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAG 193
+ R + +L + E L LV E+ G L L E P R E+
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP---AEMARFYLAEIVM 173
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
++ +H + HRDIK NILL+ ++ADFG+ + D T + GT YL
Sbjct: 174 AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 254 DPEYFRSGQFTDKSDVY-------SFGVVLVELLTGQKP 285
PE ++ + Y + GV E+ GQ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 14/219 (6%)
Query: 73 FTTKELDKATDHFNVNR--ILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINE 129
T + + V++ ILG G G V+K A G +A K K EE NE
Sbjct: 77 IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE 136
Query: 130 VVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
+ +++Q++H N+++L E++ + LV E++ G LF + D++ T +
Sbjct: 137 ISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNL--TELDTILFM 193
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTA--KVADFGTSKFIVIDQTHVTTKV 246
++ + ++H M I H D+K NIL + K+ DFG ++
Sbjct: 194 KQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVN 248
Query: 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
GT +L PE + +D++S GV+ LL+G P
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 16/215 (7%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKL--EEFINEVVILSQ 135
D + + ++G+G V + + G+ AVK +K L E+ E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAG 193
+ H ++V+LL ++ L +V+EF+ L + + + F + + ++
Sbjct: 83 LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 194 SLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF 250
+L Y H I HRD+K +LL K+ FG + + +V GT
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTP 197
Query: 251 GYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
++ PE + + DV+ GV+L LL+G P
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 40/221 (18%), Positives = 79/221 (35%), Gaps = 25/221 (11%)
Query: 82 TDHFNVNRILGQGGQ--GTVYKGM-LADGRIVAVKKSKIVHEGK--LEEFINEVVILSQI 136
+ + ++G+G + TV G V V++ + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 137 NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYL-HDQNEEFPLTWEMRLRIAT---EVA 192
NH N+V + +V F++ G+ + + IA V
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ----- 247
+L Y+H M HR +K+++IL++ ++ ++ ++
Sbjct: 139 KALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 248 -GTFGYLDPEYFR--SGQFTDKSDVYSFGVVLVELLTGQKP 285
+L PE + + KSD+YS G+ EL G P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 46/211 (21%), Positives = 90/211 (42%), Gaps = 19/211 (9%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQIN 137
+ + + LG+G G V++ + + + K E+ IL+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIAR 59
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
HRN++ L E+ L +++EFIS +F+ ++ F L + +V +L
Sbjct: 60 HRNILHLHESF-ESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQ 116
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTA--KVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
+LH S I H DI+ NI+ + ++ K+ +FG ++ + + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLFTAPEYYA 171
Query: 255 PEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE + + +D++S G ++ LL+G P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 83 DHFNVNRILGQGGQGTVYK-GMLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
+ + V +++G+G G V + ++ A+K K +++ F E I++ N
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLS 196
VV+L + + L +V E++ G L + N + P E R EV +L
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVP---EKWARFYTAEVVLALD 182
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
+HS M HRD+K N+LL++ K+ADFGT + + GT Y+ PE
Sbjct: 183 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 257 YFRS----GQFTDKSDVYSFGVVLVELLTGQKP 285
+S G + + D +S GV L E+L G P
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQIN 137
+D+++V LG+G V + + G A K K+ ++ E I ++
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ 63
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
H N+V+L + E LV++ ++ G LF+ + + + ++ S++
Sbjct: 64 HPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIA 119
Query: 197 YLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
Y HS I HR++K N+LL + K+ADFG + + + + GT GYL
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYL 174
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE + ++ D+++ GV+L LL G P
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 9e-27
Identities = 54/209 (25%), Positives = 101/209 (48%), Gaps = 11/209 (5%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
D F R+LG+GG G V+ + G++ A K K ++ + + E IL++++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLS 196
R +V L ET+ L LV ++ G + ++++ +E+ P E R ++ L
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
+LH I +RD+K N+LL++ +++D G + + QT GT G++ PE
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
++ D ++ GV L E++ + P
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKL---EEFINEVVILS 134
D +++ LG G V K + G A K K + + EE EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 135 QINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
Q+ H NV+ L E + L+ E +S G LF +L ++ L+ E ++
Sbjct: 71 QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILD 126
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTA----KVADFGTSKFIVIDQTHVTTKVQGT 249
++YLH + I H D+K NI+L +K K+ DFG + I+ + GT
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIFGT 181
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309
++ PE ++D++S GV+ LL+G P G + LA I S+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLAN--ITSVS--- 234
Query: 310 LYDFLDDQVLKVGQ--KEEIMTIATLATRCLNLNGKRRPTMKEV 351
YDF ++ + K+ I + L ++R T++E
Sbjct: 235 -YDFDEEFFSHTSELAKDFI-------RKLLVKETRKRLTIQEA 270
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
DHF + R +G+G G V D ++ A+K K K V ++ E+ I+ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAGSLS 196
+V L + E + +V + + G L +L QN F E +++ E+ +L
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFK---EETVKLFICELVMALD 129
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
YL + I HRD+K NILL+E + DF + + + T + GT Y+ PE
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPE 184
Query: 257 YFRSGQFT--DKS-DVYSFGVVLVELLTGQKP 285
F S + + D +S GV ELL G++P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 50/217 (23%), Positives = 95/217 (43%), Gaps = 24/217 (11%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
+ F + +++G+G G V + ++ A+K K +++ + F E +L
Sbjct: 74 EDFEILKVIGRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAG 193
+ + + L + + L LV ++ G L L + P E R E+
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP---EEMARFYLAEMVI 186
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
++ +H + HRDIK NIL++ ++ADFG+ ++ D T ++ GT Y+
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 254 DPEYFRSGQFTDKS-----DVYSFGVVLVELLTGQKP 285
PE ++ + D +S GV + E+L G+ P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 18/233 (7%)
Query: 61 TSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSK 116
+ + R F K +D+++V LG+G V + + G A K K
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 117 IVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNE 175
+ ++ E I ++ H N+V+L + E LV++ ++ G LF+ + +
Sbjct: 67 LSAR-DFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 176 EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY---TAKVADFGTS 232
+ ++ S++Y HS I HR++K N+LL K K+ADFG +
Sbjct: 125 ---YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ + + GT GYL PE + ++ D+++ GV+L LL G P
Sbjct: 179 IEV--NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 65 GSIDRCKLFTTKELDKAT-DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVH 119
+R + E T + F R+LG+GG G V + G++ A K K +I
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224
Query: 120 EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEE-F 177
+NE IL ++N R VV L ET+ L LV ++ G L +++ + F
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF 283
Query: 178 PLTWEMRLRI-ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236
P E R A E+ L LH I +RD+K NILL++ +++D G + +
Sbjct: 284 P---EARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
QT + +V GT GY+ PE ++ ++T D ++ G +L E++ GQ P
Sbjct: 338 EGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 21/216 (9%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIV---HEGKLEEFINEVVILS 134
D +++ LG G V K + G A K K + EE EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 135 QINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
Q+ H N++ L E + L+ E +S G LF +L + L+ E ++
Sbjct: 71 QVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTA----KVADFGTSKFIVIDQTHVTTKVQGT 249
++YLH + I H D+K NI+L +K K+ DFG + I+ + GT
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIFGT 181
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
++ PE ++D++S GV+ LL+G P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIV---HEGKLEEFINEVVILS 134
DH+ + LG G V K G+ A K K ++ EE EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 135 QINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
+I H N++ L E + + L+ E +S G LF +L ++ LT + + ++
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILD 119
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTA----KVADFGTSKFIVIDQTHVTTKVQGT 249
+ YLH S I H D+K NI+L +K K+ DFG + I+ + + GT
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIFGT 174
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
++ PE ++D++S GV+ LL+G P
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 56/335 (16%), Positives = 107/335 (31%), Gaps = 56/335 (16%)
Query: 31 RKVYIIKREDIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRI 90
Y IKR I+L + R K+ + +H + R
Sbjct: 31 DCNYAIKR--IRLPNRELARE-------------------KVMREVKALAKLEHPGIVRY 69
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSK---IVHEGKLEEFINEVVILSQINHRNVVKLLGC 147
+ K I +S + ++ ++ + + +N V L
Sbjct: 70 FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
+ + L +++ + + L I ++A ++ +LHS +
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLM 186
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ-----------GTFGYLDPE 256
HRD+K +NI KV DFG + D+ T GT Y+ PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316
++ K D++S G++L ELL F ME R+ + +
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYS------------------FSTQMERVRIITDVRN 288
Query: 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ ++ + L+ + RP ++
Sbjct: 289 LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKL---EEFINEVVILS 134
D+++ LG G V K + G A K K + + E+ EV IL
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 135 QINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
+I H NV+ L E + + L+ E ++ G LF +L ++ LT E ++
Sbjct: 70 EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILN 125
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTA----KVADFGTSKFIVIDQTHVTTKVQGT 249
+ YLH S+ I H D+K NI+L ++ K+ DFG + ID + + GT
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIFGT 180
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
++ PE ++D++S GV+ LL+G P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 78 LDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEV-VILS 134
++ D LG+G G V K + G+I+AVK+ V+ + + + ++ + +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 135 QINHRNVVKLLGCCL-ETEVPLLVYEF--ISNGTLFQYLHDQNEEFPLTWEMRL-RIATE 190
++ V G E +V + E S ++ + D+ + P E L +IA
Sbjct: 62 TVDCPFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIP---EDILGKIAVS 117
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF 250
+ +L +LHS S + HRD+K +N+L+N K+ DFG S ++V G
Sbjct: 118 IVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCK 173
Query: 251 GYLDPE----YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y+ PE ++ KSD++S G+ ++EL + P
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVVILSQIN- 137
+ F+V+RI+G+GG G VY AD G++ A+K K +I + +NE ++LS ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 138 --HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAG 193
+V + T L + + ++ G L +L Q+ F E +R A E+
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS---EADMRFYAAEIIL 303
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
L ++H+ + +RD+K NILL+E +++D G + + H V GT GY+
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYM 357
Query: 254 DPEYFRSGQFTDKS-DVYSFGVVLVELLTGQKP 285
PE + G D S D +S G +L +LL G P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 24/219 (10%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEE-----FINEVVI 132
D + +++ LG G G V + VA+K K K E E+ I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 133 LSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVA 192
L ++NH ++K+ + E +V E + G LF + L ++
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQML 124
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGT 249
++ YLH I HRD+K N+LL E K+ DFG SK + +T + + GT
Sbjct: 125 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGT 179
Query: 250 FGYLDPEYFRSGQ---FTDKSDVYSFGVVLVELLTGQKP 285
YL PE S + D +S GV+L L+G P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVH------EGKLEEFINEVV 131
+++ ILG+G V + + + AVK + + E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 132 ILSQIN-HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQ---NEEFPLTWEMRLR 186
IL +++ H N+++L ET LV++ + G LF YL ++ +E+ E R +
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETR-K 128
Query: 187 IATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV 246
I + + LH + I HRD+K NILL++ K+ DFG S +D +V
Sbjct: 129 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREV 183
Query: 247 QGTFGYLDPEYFRSGQFTDKS------DVYSFGVVLVELLTGQKP 285
GT YL PE + D++S GV++ LL G P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 76/311 (24%), Positives = 128/311 (41%), Gaps = 60/311 (19%)
Query: 61 TSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSK 116
+ + KL KE + + V +LG GG G+VY G+ ++D VA+K K +
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 117 IVHEGKLEEFIN---EVVILSQINHR--NVVKLLGCCLETEVPL-LVYEFISN-GTLFQY 169
I G+L EVV+L +++ V++LL E L+ E LF +
Sbjct: 81 ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDF 139
Query: 170 LHDQ---NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYTAK 225
+ ++ EE R +V ++ + H+ + HRDIK NIL++ + K
Sbjct: 140 ITERGALQEE-----LAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190
Query: 226 VADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT-DKSDVYSFGVVLVELLTGQK 284
+ DFG+ + T T GT Y PE+ R ++ + V+S G++L +++ G
Sbjct: 191 LIDFGSGAL--LKDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247
Query: 285 PIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT----LATRCLNL 340
P F D+ + GQ +++ L CL L
Sbjct: 248 P---------------------------FEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 280
Query: 341 NGKRRPTMKEV 351
RPT +E+
Sbjct: 281 RPSDRPTFEEI 291
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 61/263 (23%), Positives = 100/263 (38%), Gaps = 53/263 (20%)
Query: 73 FTTKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKI--VHEGKLEEF 126
F L + +++ +GQG G V + I A+K K+KI ++ +E
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 127 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL- 185
EV ++ +++H N+ +L + + LV E G L L+ ++ M +
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 186 ------------------------------------RIATEVAGSLSYLHSAASMPIYHR 209
I ++ +L YLH+ I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHR 192
Query: 210 DIKSTNILL--NEKYTAKVADFGTSKFIVI---DQTHVTTKVQGTFGYLDPEYFRSGQ-- 262
DIK N L N+ + K+ DFG SK + + T GT ++ PE +
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 263 FTDKSDVYSFGVVLVELLTGQKP 285
+ K D +S GV+L LL G P
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHR 139
F + ++G G G VYKG + G++ A+K + + + EE E+ +L + +HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHR 81
Query: 140 NVVKLLGCCLETEVPL------LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIAT---E 190
N+ G ++ P LV EF G++ L + L E IA E
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEW---IAYICRE 137
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF 250
+ LS+LH + HRDIK N+LL E K+ DFG S + T + GT
Sbjct: 138 ILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 193
Query: 251 GYLDPEYFRSGQFTD-----KSDVYSFGVVLVELLTGQKP 285
++ PE + D KSD++S G+ +E+ G P
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 14/219 (6%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI-VHEGKLEEFINEV-VI 132
+ D + +G+G G+V K + G+I+AVK+ + V E + ++ + ++ V+
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 133 LSQINHRNVVKLLGCCL-ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL-RIATE 190
+ + +V+ G E + + E +S Y + + + E L +I
Sbjct: 75 MRSSDCPYIVQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF 250
+L++L I HRDIK +NILL+ K+ DFG S +V + T+ G
Sbjct: 134 TVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCR 189
Query: 251 GYLDPE----YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y+ PE + +SDV+S G+ L EL TG+ P
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKI-----VHEGKLEEFINEVVI 132
++ ++G+G V + + A G AVK + E E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 133 LSQI-NHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQ---NEEFPLTWEMRLRI 187
L Q+ H +++ L+ E+ + LV++ + G LF YL ++ +E+ E R I
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEK-----ETR-SI 205
Query: 188 ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQ 247
+ ++S+LH+ I HRD+K NILL++ +++DFG S ++ ++
Sbjct: 206 MRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELC 260
Query: 248 GTFGYLDPEYFRSGQFTD------KSDVYSFGVVLVELLTG 282
GT GYL PE + + D+++ GV+L LL G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 31/229 (13%)
Query: 75 TKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFIN-- 128
K+ + + + +LG+GG GTV+ G L D VA+K +++++ L + +
Sbjct: 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 129 -EVVILSQIN----HRNVVKLLGCCLETEVPL-LVYEFISNGT-LFQYLHDQ---NEEFP 178
EV +L ++ H V++LL ET+ LV E LF Y+ ++ E
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-- 139
Query: 179 LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKFIVI 237
R +V ++ + HS + HRDIK NIL++ + AK+ DFG+ +
Sbjct: 140 ---PSR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL--L 190
Query: 238 DQTHVTTKVQGTFGYLDPEYFRSGQFT-DKSDVYSFGVVLVELLTGQKP 285
T GT Y PE+ Q+ + V+S G++L +++ G P
Sbjct: 191 HDEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK--KSKIVHEGKLEEFINEVVILSQINH 138
T+ + + LG+G V + + + G+ A +K + ++ E I + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
N+V+L E L+++ ++ G LF+ + + + ++ ++ +
Sbjct: 70 PNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLH 125
Query: 198 LHSAASMPIYHRDIKSTNILLNEKY---TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
H M + HR++K N+LL K K+ADFG + + +Q GT GYL
Sbjct: 126 CHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLS 181
Query: 255 PEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE R + D+++ GV+L LL G P
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 19/220 (8%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI-VHEGKLEEFINEV-VI 132
+ + +G G G V+K G ++AVK+ + ++ + + + ++ V+
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 133 LSQINHRNVVKLLGCCL-ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRL-RIATE 190
L + +V+ G + T+V + E + P E L ++
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKR-MQGPIP---ERILGKMTVA 132
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF 250
+ +L YL + HRD+K +NILL+E+ K+ DFG S +V + G
Sbjct: 133 IVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCA 188
Query: 251 GYLDPE-----YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y+ PE + ++DV+S G+ LVEL TGQ P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 50/225 (22%), Positives = 95/225 (42%), Gaps = 18/225 (8%)
Query: 71 KLFTTKELDKATDHFNVN-RILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEE 125
+ + ++ + + + + LG+G V + + + G+ A K K + + + E
Sbjct: 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR-AE 74
Query: 126 FINEVVILSQINHR-NVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEM 183
++E+ +L V+ L E + L+ E+ + G +F + E ++
Sbjct: 75 ILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEM-VSEND 132
Query: 184 RLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQT 240
+R+ ++ + YLH I H D+K NILL K+ DFG S+ I
Sbjct: 133 VIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHA 187
Query: 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
++ GT YL PE T +D+++ G++ LLT P
Sbjct: 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 88 NRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLL 145
++ LG+G K + + AVK I+ + E+ L H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
+ LV E ++ G LF+ + + + I ++ ++S++H +
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHD---VG 126
Query: 206 IYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
+ HRD+K N+L N+ K+ DFG ++ D + T T Y PE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185
Query: 263 FTDKSDVYSFGVVLVELLTGQKP 285
+ + D++S GV+L +L+GQ P
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVP 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVIL 133
D +D F V LG+G VY+ + A+K K V + + E+ +L
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVL 102
Query: 134 SQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVA 192
+++H N++KL ET + LV E ++ G LF + ++ + ++
Sbjct: 103 LRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQIL 158
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGT 249
+++YLH I HRD+K N+L K+ADFG SK + + + V GT
Sbjct: 159 EAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGT 213
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
GY PE R + + D++S G++ LL G +P
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 21/234 (8%)
Query: 62 SSDGSIDRCKLFTTKELDKAT-DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK--- 113
S + + ++ K + T + F ++LG+G G V +L GR A+K
Sbjct: 126 SDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILK 182
Query: 114 KSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHD 172
K IV + ++ + E +L H + L +T L V E+ + G LF +L
Sbjct: 183 KEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS- 240
Query: 173 QNEEFPLTWEMRLRI-ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231
+ F E R R E+ +L YLHS + +RD+K N++L++ K+ DFG
Sbjct: 241 RERVFS---EDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGL 295
Query: 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
K I GT YL PE + D + GVV+ E++ G+ P
Sbjct: 296 CK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-24
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHR 139
H+ + LG G G V G G VAVK + KI + + E+ L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 140 NVVKLLGCCLETEVPL-LVYEFISNGTLFQYL--HDQNEEFPLTWEMRLRIATEVAGSLS 196
+++KL + T +V E++S G LF Y+ H + EE E R R+ ++ ++
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQILSAVD 125
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
Y H + HRD+K N+LL+ AK+ADFG S + + T+ G+ Y PE
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE 180
Query: 257 YFRSGQFTD--KSDVYSFGVVLVELLTGQKP 285
SG+ + D++S GV+L LL G P
Sbjct: 181 VI-SGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHR 139
++ + + +G+G V + GR VA+K K+++ L++ EV I+ +NH
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKILNHP 74
Query: 140 NVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQ---NEEFPLTWEMRLRIATEVAGSL 195
N+VKL +ETE L L+ E+ S G +F YL E+ E R ++ ++
Sbjct: 75 NIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EAR-SKFRQIVSAV 127
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
Y H I HRD+K+ N+LL+ K+ADFG S + G Y P
Sbjct: 128 QYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAP 182
Query: 256 EYFRSGQFTD--KSDVYSFGVVLVELLTGQKP 285
E F G+ D + DV+S GV+L L++G P
Sbjct: 183 ELF-QGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 23/232 (9%)
Query: 63 SDGSIDRCKLFTTKELDKAT-DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---K 114
+ D K + T + A D F+ + LG G G V ML G A+K K
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDK 76
Query: 115 SKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQN 174
K+V ++E +NE IL +N +VKL + +V E+++ G +F +L
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136
Query: 175 EEFPLTWEMRLRI-ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233
F E R A ++ + YLHS + + +RD+K N+L++++ +V DFG +K
Sbjct: 137 R-FS---EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ T + GT L PE S + D ++ GV++ E+ G P
Sbjct: 190 RV----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 59/278 (21%), Positives = 110/278 (39%), Gaps = 31/278 (11%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQ-INHR 139
TD + V +G G + + A AVK I+ + K + E+ IL + H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPT-EEIEILLRYGQHP 76
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
N++ L + + +V E + G L + Q + + + ++ YLH
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLH 133
Query: 200 SAASMPIYHRDIKSTNILLNEK----YTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
+ + HRD+K +NIL ++ + ++ DFG +K + + + T T ++ P
Sbjct: 134 A---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAP 189
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315
E + D++S GV+L +LTG P + A I S + +
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR-IGSGK----FSLSG 244
Query: 316 DQVLKVGQ--KEEIMTIATLATRCLNLNGKRRPTMKEV 351
V K+ L ++ L+++ +R T V
Sbjct: 245 GYWNSVSDTAKD-------LVSKMLHVDPHQRLTAALV 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFIN-EVVILSQINH 138
+ + +LG+G G V + + AVK K K+ E + E+ +L ++ H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 139 RNVVKLLG-CCLETEVPL-LVYEFISNGT--LFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
+NV++L+ E + + +V E+ G + + + FP + ++
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFP-VCQAH-GYFCQLIDG 121
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS---KFIVIDQTHVTTKVQGTFG 251
L YLHS I H+DIK N+LL T K++ G + D T T+ QG+
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPA 176
Query: 252 YLDPEYFRSGQFTD--KSDVYSFGVVLVELLTGQKP 285
+ PE K D++S GV L + TG P
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFIN-----EVVILS 134
++ LG G G V+ + + V VK K K++ + +E+ E+ ILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 135 QINHRNVVKLLGCCLETEVPL-LVYEFISNGT-LFQYL--HDQNEEFPLTWEMRLRIATE 190
++ H N++K+L E + LV E +G LF ++ H + +E I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LAS-YIFRQ 138
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF 250
+ ++ YL I HRDIK NI++ E +T K+ DFG++ ++ + T GT
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTI 193
Query: 251 GYLDPEYFRSGQFTD--KSDVYSFGVVLVELLTGQKP 285
Y PE G + +++S GV L L+ + P
Sbjct: 194 EYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 75/238 (31%), Positives = 112/238 (47%), Gaps = 24/238 (10%)
Query: 63 SDGSIDRCKLFTTKELDKAT-DHFNVNRILGQGGQGTVY---KGMLAD-GRIVAVK---K 114
+ T +K ++F + ++LG G G V+ K D G++ A+K K
Sbjct: 33 LTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK 92
Query: 115 SKIVHEGKLEEFI-NEVVILSQINHRN-VVKLLGCCLETEVPL-LVYEFISNGTLFQYLH 171
+ IV + K E E +L I +V L +TE L L+ ++I+ G LF +L
Sbjct: 93 ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL- 150
Query: 172 DQNEE-FPLTWEMRLRI-ATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADF 229
E F E ++I E+ +L +LH + I +RDIK NILL+ + DF
Sbjct: 151 -SQRERFT---EHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDF 203
Query: 230 GTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF-TDKS-DVYSFGVVLVELLTGQKP 285
G SK V D+T GT Y+ P+ R G DK+ D +S GV++ ELLTG P
Sbjct: 204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 37/226 (16%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFIN-EVVILS 134
K ++ + +++G G G V++ L + VA+K K++ + + F N E+ I+
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQD---KRFKNRELQIMR 87
Query: 135 QINHRNVVKLLGCCLET-----EVPL-LVYEFISNGTLFQYLHD---QNEEFPL------ 179
+ H NVV L EV L LV E++ T+++ + P+
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLY 146
Query: 180 TWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIVID 238
+++ LR SL+Y+HS I HRDIK N+LL+ K+ DFG++K ++
Sbjct: 147 MYQL-LR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195
Query: 239 QTHVTTKVQGTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQ 283
+ +V+ + Y PE F + +T D++S G V+ EL+ GQ
Sbjct: 196 EPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 9e-23
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN----EVVILSQIN 137
+ +++ + LG+G G V + VAVK IV + + E+ I +N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYL--HDQNEEFPLTWEMRLRIATEVAGS 194
H NVVK G L E+ S G LF + E + + R ++
Sbjct: 64 HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAG 117
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK-FIVIDQTHVTTKVQGTFGYL 253
+ YLH + I HRDIK N+LL+E+ K++DFG + F ++ + K+ GT Y+
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 254 DPEYFRSGQFTD--KSDVYSFGVVLVELLTGQKP 285
PE + DV+S G+VL +L G+ P
Sbjct: 175 APELL-KRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHR 139
H+ + LG G G V G G VAVK + KI + + E+ L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 140 NVVKLLGCCLETEVPL-LVYEFISNGTLFQYL--HDQNEEFPLTWEMRLRIATEVAGSLS 196
+++KL + T + +V E++S G LF Y+ + + +E E R R+ ++ +
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESR-RLFQQILSGVD 130
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
Y H + HRD+K N+LL+ AK+ADFG S + + T+ G+ Y PE
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE 185
Query: 257 YFRSGQFTD--KSDVYSFGVVLVELLTGQKP 285
SG+ + D++S GV+L LL G P
Sbjct: 186 VI-SGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 68/212 (32%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 83 DHFNVNRILGQGGQGTVY----KGMLADGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
F + ++LGQG G V+ ++ A+K K+ + E IL +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVE 82
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAG 193
+NH +VKL +TE L L+ +F+ G LF L + F E ++ E+A
Sbjct: 83 VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFT---EEDVKFYLAELAL 137
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
+L +LHS + I +RD+K NILL+E+ K+ DFG SK ID GT Y+
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 193
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE T +D +SFGV++ E+LTG P
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
+ F+ ++LG+G G V +L GR A+K K I+ + ++ + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAG 193
H + L +T L V E+ + G LF +L + F E R R E+
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFT---EERARFYGAEIVS 116
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
+L YLHS + +RDIK N++L++ K+ DFG K I GT YL
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYL 172
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE + D + GVV+ E++ G+ P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA-------DGRIVAVK---KSKIVHEGK-LEEFINEVV 131
+ F + R+LG+GG G V G+I A+K K+ IV K E
Sbjct: 17 ECFELLRVLGKGGYGKV---FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 132 ILSQINHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-AT 189
IL ++ H +V L+ +T L L+ E++S G LF L + F E
Sbjct: 74 ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFM---EDTACFYLA 128
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT 249
E++ +L +LH I +RD+K NI+LN + K+ DFG K I VT GT
Sbjct: 129 EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGT 184
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y+ PE D +S G ++ ++LTG P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN----EVVILSQIN 137
+ +++ + LG+G G V + VAVK IV + + E+ I +N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 138 HRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYL--HDQNEEFPLTWEMRLRIATEVAGS 194
H NVVK G L E+ S G LF + E + + R ++
Sbjct: 64 HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAG 117
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK-FIVIDQTHVTTKVQGTFGYL 253
+ YLH + I HRDIK N+LL+E+ K++DFG + F ++ + K+ GT Y+
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 254 DPEYFRSGQFTD--KSDVYSFGVVLVELLTGQKP 285
PE + DV+S G+VL +L G+ P
Sbjct: 175 APELL-KRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 82 TDHFNVNR-ILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQI 136
D + + +LG+G V + L + AVK K EV +L Q
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQC 67
Query: 137 -NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQ---NEEFPLTWEMRLRIATEVA 192
HRNV++L+ E + LV+E + G++ ++H + NE E + +VA
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVA 121
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFI-------VIDQTHV 242
+L +LH+ I HRD+K NIL N+ K+ DF I I +
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 243 TTKVQGTFGYLDPEYFRSGQFTDKS-----DVYSFGVVLVELLTGQKP 285
T G+ Y+ PE + D++S GV+L LL+G P
Sbjct: 179 LTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-22
Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 42/230 (18%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVK---KSKIV-----------------------HEG 121
+G+G G V D A+K K K++ G
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 122 KLEEFINEVVILSQINHRNVVKL---LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFP 178
+E+ E+ IL +++H NVVKL L E + +V+E ++ G + + + P
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLK----P 133
Query: 179 LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238
L+ + ++ + YLH I HRDIK +N+L+ E K+ADFG S
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 239 QTHVTTKVQGTFGYLDPEYFRSGQFT---DKSDVYSFGVVLVELLTGQKP 285
++ V GT ++ PE + DV++ GV L + GQ P
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 69/224 (30%), Positives = 112/224 (50%), Gaps = 39/224 (17%)
Query: 82 TDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFIN-EVVILSQINHR 139
+ +++G G G VY+ L D G +VA+KK V + K F N E+ I+ +++H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDK--RFKNRELQIMRKLDHC 107
Query: 140 NVVKLLGCCLET-----EVPL-LVYEFISNGTLFQYLHD---QNEEFPL------TWEMR 184
N+V+L + EV L LV +++ T+++ + P+ +++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL- 165
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIVIDQTHVT 243
R SL+Y+HS I HRDIK N+LL+ + K+ DFG++K +V + +V+
Sbjct: 166 FR-------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 244 TKVQGTFGYLDPEY-FRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
+ Y PE F + +T DV+S G VL ELL GQ PI
Sbjct: 216 YIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 5e-22
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 34/217 (15%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
F + R LG G G V L +GR A+K K +V ++E +E ++LS
Sbjct: 6 QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEE-FPLTWEMRLRI-ATEVA 192
+ H ++++ G + + ++ ++I G LF L + + FP + A EV
Sbjct: 63 VTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLL--RKSQRFP---NPVAKFYAAEVC 116
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTF-G 251
+L YLHS I +RD+K NILL++ K+ DFG +K V D T+ T G
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTY-------TLCG 165
Query: 252 ---YLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y+ PE + + D +SFG+++ E+L G P
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 8e-22
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
F++ R++G+G V +L RI A+K K + + ++ E + Q
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 136 I-NHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVA 192
NH +V L C +TE L V E+++ G L ++ + + P E R + E++
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEIS 120
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
+L+YLH I +RD+K N+LL+ + K+ D+G K + T+ GT Y
Sbjct: 121 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNY 176
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ PE R + D ++ GV++ E++ G+ P
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
F++ R++G+G V +L RI A++ K + + ++ E + Q
Sbjct: 52 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 136 I-NHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVA 192
NH +V L C +TE L V E+++ G L ++ + + P E R + E++
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEIS 163
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK-FIVIDQTHVTTKVQGTFG 251
+L+YLH I +RD+K N+LL+ + K+ D+G K + T T+ GT
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPN 218
Query: 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y+ PE R + D ++ GV++ E++ G+ P
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 39/284 (13%)
Query: 82 TDHFNVNR-ILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NH 138
TD + +++ +LG G G V + G+ A+K +++ + EV Q
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLY--DSPKARQEVDHHWQASGG 81
Query: 139 RNVVKLLGCCLETEVP----LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
++V +L L++ E + G LF + ++ ++ T I ++ +
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTA 140
Query: 195 LSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFG 251
+ +LHS I HRD+K N+L + K+ DFG +K Q + T T
Sbjct: 141 IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPY 194
Query: 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF--ILSMEENR 309
Y+ PE ++ D++S GV++ LL G P + I +
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP--FYSNTGQAISPGMKRRIRLGQ--- 249
Query: 310 LYDFLDDQVLKVGQ--KEEIMTIATLATRCLNLNGKRRPTMKEV 351
Y F + + +V + K+ L L + R T+ +
Sbjct: 250 -YGFPNPEWSEVSEDAKQ-------LIRLLLKTDPTERLTITQF 285
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
F+ +++G+G G V +LA + AVK K I+ + + + ++E +L +
Sbjct: 38 SDFHFLKVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 136 -INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVA 192
+ H +V L +T L V ++I+ G LF +L + F E R R A E+A
Sbjct: 95 NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ-RERCFL---EPRARFYAAEIA 149
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
+L YLHS + I +RD+K NILL+ + + DFG K I+ T+ GT Y
Sbjct: 150 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEY 205
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
L PE + D + G VL E+L G P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 39/220 (17%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
D ++ + +G G G +VAVK + + E ++ E++ + H
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQ---REIINHRSLRH 75
Query: 139 RNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVA----- 192
N+V+ + T L ++ E+ S G L++ + + R + + A
Sbjct: 76 PNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAG-----------RFSEDEARFFFQ 123
Query: 193 ---GSLSYLHSAASMPIYHRDIKSTNILLNEKYTA--KVADFGTSKFIVIDQTHVTTKVQ 247
+SY HS M I HRD+K N LL+ K+ DFG SK V+ +T
Sbjct: 124 QLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--V 178
Query: 248 GTFGYLDPEYFRSGQFTD--KSDVYSFGVVLVELLTGQKP 285
GT Y+ PE Q D +DV+S GV L +L G P
Sbjct: 179 GTPAYIAPEVL-LRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-21
Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
D+F R+LG+G G V MLA G + AVK K I+ + +E + E ILS
Sbjct: 23 DNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 136 I-NHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVA 192
NH + +L CC +T L V EF++ G L ++ ++ F E R R A E+
Sbjct: 80 ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEII 134
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
+L +LH I +RD+K N+LL+ + K+ADFG K I T GT Y
Sbjct: 135 SALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDY 190
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ PE + + D ++ GV+L E+L G P
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 18/217 (8%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFIN-----EVVILSQIN 137
+ + +G+G G VYK + GRIVA+K+ ++ E +E I E+ +L +++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKELH 77
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
H N+V L+ LV+EF+ L + L + + ++++ + + G +++
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIKIYLYQLLRG-VAH 134
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
H I HRD+K N+L+N K+ADFG ++ I T +V T Y P+
Sbjct: 135 CHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDV 190
Query: 258 -FRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
S +++ D++S G + E++TG KP + G +
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITG-KP-LFPGVTD 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 22/213 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRN 140
D+ +++LG G G V + A+K ++ + EV + + +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARREVELHWRASQCPH 116
Query: 141 VVKLLGCCLETEVP-----LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
+V+++ E L+V E + G LF + D+ ++ T I + ++
Sbjct: 117 IVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAI 174
Query: 196 SYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
YLHS + I HRD+K N+L K+ DFG +K + +TT T Y
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYY 229
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ PE ++ D++S GV++ LL G P
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINHR 139
+ + LG+G G V + VA+K + + E+ L + H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 140 NVVKLLGCCLETEVPL-LVYEFISNGTLFQYL--HDQNEEFPLTWEMRLRIATEVAGSLS 196
+++KL + T + +V E+ G LF Y+ + E E R R ++ ++
Sbjct: 70 HIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED----EGR-RFFQQIICAIE 122
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
Y H I HRD+K N+LL++ K+ADFG S + T+ G+ Y PE
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177
Query: 257 YFRSGQFTD--KSDVYSFGVVLVELLTGQKP 285
+G+ + DV+S G+VL +L G+ P
Sbjct: 178 VI-NGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN-----EVVILSQINHRNVVKL 144
+G+G GTV+K IVA+K+ ++ + +E + E+ +L ++ H+N+V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRL 66
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASM 204
+ LV+EF L +Y N + ++ + + G L + HS
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE-IVKSFLFQLLKG-LGFCHS---R 120
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY-FRSGQF 263
+ HRD+K N+L+N K+A+FG ++ I + +V T Y P+ F + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 179
Query: 264 TDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
+ D++S G + EL +P + G+
Sbjct: 180 STSIDMWSAGCIFAELANAGRP-LFPGNDV 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
+ F ++++LG+G G V LA + A+K K ++ + +E + E +LS
Sbjct: 17 EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 136 -INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVA 192
H + + C +T+ L V E+++ G L ++ +F R A E+
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFD---LSRATFYAAEII 128
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
L +LHS I +RD+K NILL++ K+ADFG K + T GT Y
Sbjct: 129 LGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDY 184
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ PE ++ D +SFGV+L E+L GQ P
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
FN +LG+G G V ML+ + AVK K ++ + +E + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 136 INHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVAG 193
+ L C +T L V E+++ G L ++ Q F E A E+A
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIAI 453
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
L +L S I +RD+K N++L+ + K+ADFG K I T GT Y+
Sbjct: 454 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 509
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
PE + D ++FGV+L E+L GQ P
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
FN +LG+G G V ML+ + AVK K ++ + +E + E +L+
Sbjct: 20 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 136 I-NHRNVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRI-ATEVA 192
+ +L C +T L V E+++ G L ++ Q F E A E+A
Sbjct: 77 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIA 131
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
L +L S I +RD+K N++L+ + K+ADFG K I T GT Y
Sbjct: 132 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDY 187
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ PE + D ++FGV+L E+L GQ P
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 6e-20
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF----INEVVILSQINHRNVVKLL 145
LG+G TVYKG +VA+K+ ++ HE E I EV +L + H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
+ LV+E++ L QYL D + ++L + + G L+Y H
Sbjct: 67 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH-NVKLFLFQLLRG-LAYCHRQK--- 120
Query: 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY-FRSGQFT 264
+ HRD+K N+L+NE+ K+ADFG ++ I +V T Y P+ S ++
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYS 179
Query: 265 DKSDVYSFGVVLVELLTGQKPIILTGSKE 293
+ D++ G + E+ TG +P + GS
Sbjct: 180 TQIDMWGVGCIFYEMATG-RP-LFPGSTV 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 8e-20
Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN--EVVILSQINHRNVVKLLGC 147
+G+G G V K GRIVA+KK + K+ + I E+ +L Q+ H N+V LL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIY 207
C + + LV+EF+ + T+ L ++ + + G + + HS I
Sbjct: 93 CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQ-VVQKYLFQIING-IGFCHSHN---II 146
Query: 208 HRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY-FRSGQFTDK 266
HRDIK NIL+++ K+ DFG ++ + +V T Y PE ++
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKA 205
Query: 267 SDVYSFGVVLVELLTGQ 283
DV++ G ++ E+ G+
Sbjct: 206 VDVWAIGCLVTEMFMGE 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 9e-20
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 91 LGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEF----INEVVILSQINHRNVVKLLG 146
+G+G G VYK G A+KK ++ E E I E+ IL ++ H N+VKL
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYD 67
Query: 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206
+ +LV+E + L + L + + + G ++Y H +
Sbjct: 68 VIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESV-TAKSFLLQLLNG-IAYCHD---RRV 121
Query: 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY-FRSGQFTD 265
HRD+K N+L+N + K+ADFG ++ I T ++ T Y P+ S +++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYST 180
Query: 266 KSDVYSFGVVLVELLTGQKPIILTGSKE 293
D++S G + E++ G P + G E
Sbjct: 181 TIDIWSVGCIFAEMVNG-TP-LFPGVSE 206
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN--EVVILSQINHRNVVKLLGC 147
+G+G G V+K G+IVA+KK + + + I E+ +L Q+ H N+V LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 148 CLETEVPLLVYEFISNGTLFQYLHDQNEEFP------LTWEMRLRIATEVAGSLSYLHSA 201
LV+E+ + T+ L P +TW L+ ++++ H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITW-QTLQ-------AVNFCHKH 121
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY-FRS 260
HRD+K NIL+ + K+ DFG ++ + + +V T Y PE
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGD 177
Query: 261 GQFTDKSDVYSFGVVLVELLTGQ 283
Q+ DV++ G V ELL+G
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGV 200
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 66/278 (23%), Positives = 95/278 (34%), Gaps = 79/278 (28%)
Query: 83 DHFNVNRILGQGGQGTVYKGML------ADGRIVAVKKSK-IVHEGKLEEFINEVVILSQ 135
D + + LG+G G V + A R VAVK K + ++E+ IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 136 I-NHRNVVKLLGCCLETEVPLLV-YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEV-- 191
I +H NVV LLG C + PL+V EF G L YL + EF R
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 192 ----------------------------AGSLSYLHSAASMPIYHRDIKSTNILLN---- 219
SLS + + ++D + L+
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 220 --------------------------EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
EK K+ DFG ++ I D + V+ L
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARL 257
Query: 254 D-----PEYFRSGQFTDKSDVYSFGVVLVELLT-GQKP 285
PE +T +SDV+SFGV+L E+ + G P
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 3e-19
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN-----EVVILSQINHRNVVKL 144
LG+G TVYK +IVA+KK K+ H + ++ IN E+ +L +++H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFP------LTWEMRLRIATEVAGSLSYL 198
L LV++F+ L + D + M L+ L YL
Sbjct: 78 LDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYML-MTLQ-------GLEYL 128
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY- 257
H I HRD+K N+LL+E K+ADFG +K T +V T Y PE
Sbjct: 129 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELL 184
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
F + + D+++ G +L ELL P L G +
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLR-VP-FLPGDSD 218
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 35/227 (15%)
Query: 80 KATDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEF--INEVVILSQI 136
K D F V R+ GQG GTV G G VA+KK V + + + L+ +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPRFRNRELQIMQDLAVL 76
Query: 137 NHRNVVKLL------GCCLETEVPL-LVYEFISNGTLFQYL-HDQNEEFPLTWEMR---- 184
+H N+V+L G ++ L +V E++ + TL + + + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 185 ---LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSKFIVIDQT 240
+R S+ LH S+ + HRDIK N+L+NE T K+ DFG++K + +
Sbjct: 136 FQLIR-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 241 HVTTKVQGTFGYLDPEY-FRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
+V + Y PE F + +T D++S G + E++ G+ PI
Sbjct: 188 NVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHR 139
D + + R LG+G V++ + + + V VK K V + ++ E+ IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGP 91
Query: 140 NVVKLLGCCL--ETEVPLLVYEFISNG---TLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
N++ L + P LV+E ++N L+Q L D + F +E+ L+ +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-YMYEI-LK-------A 142
Query: 195 LSYLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIVIDQT---HVTTKVQGTF 250
L Y HS I HRD+K N++++ E ++ D+G ++F Q V ++
Sbjct: 143 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY---- 195
Query: 251 GYLDPEYFRSGQFTDKS-DVYSFGVVLVELLTGQKPI 286
+ PE Q D S D++S G +L ++ ++P
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF----INEVVILSQINHRNVVKLL 145
LG G TVYKG+ G VA+K+ K+ E E I E+ ++ ++ H N+V+L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLY 69
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNEEF---PLTWEMRLRIATEVAGSLSYLHSAA 202
LV+EF+ N L +Y+ + L + ++ L++ H
Sbjct: 70 DVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY-FRSG 261
I HRD+K N+L+N++ K+ DFG ++ I +++V T Y P+ S
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSR 184
Query: 262 QFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
++ D++S G +L E++TG KP + G+ +
Sbjct: 185 TYSTSIDIWSCGCILAEMITG-KP-LFPGTND 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 32/239 (13%)
Query: 69 RCKLFTTKELDKATDHFNVNRI-LGQGGQGTVYKGM---LADGRIVAVKKSKIVHEGKLE 124
+ KL + +E + D F +G+G G VYK D + A+K+ + G
Sbjct: 8 KVKLSSERE--RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISM 63
Query: 125 EFINEVVILSQINHRNVVKLLGCCLE-TEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWE 182
E+ +L ++ H NV+ L L + + L++++ + L+ +
Sbjct: 64 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 183 MRLRIATE-------VAGSLSYLHSAASMPIYHRDIKSTNILL----NEKYTAKVADFGT 231
++L + G + YLH+ + HRD+K NIL+ E+ K+AD G
Sbjct: 123 VQLPRGMVKSLLYQILDG-IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 232 SKFIVI---DQTHVTTKVQGTFGYLDPEY-FRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
++ + V TF Y PE + +T D+++ G + ELLT +PI
Sbjct: 179 ARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 39/234 (16%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF----INEVVILSQIN 137
+ +GQG G V+K G+ VA+KK + +E E F + E+ IL +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 138 HRNVVKLLGCCLETEVPL--------LVYEFISNGTLFQYLHD-----QNEEFPLTWEMR 184
H NVV L+ C P LV++F HD N T
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTLSEI 126
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV-- 242
R+ + L Y+H I HRD+K+ N+L+ K+ADFG ++ + +
Sbjct: 127 KRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 243 --TTKVQGTFGYLDPEY-FRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
T +V T Y PE + D++ G ++ E+ T P I+ G+ E
Sbjct: 184 RYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SP-IMQGNTE 234
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 91 LGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEF----INEVVILSQINHRNVVKLL 145
LG+G G VYK + VA+K+ ++ HE E I EV +L ++ HRN+++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQHRNIIELK 99
Query: 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMP 205
L++E+ N L +Y+ D+N + + ++ + + G +++ HS
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMR-VIKSFLYQLING-VNFCHSRR--- 152
Query: 206 IYHRDIKSTNILLNEKYTA-----KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY-FR 259
HRD+K N+LL+ + K+ DFG ++ I T ++ T Y PE
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLG 211
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
S ++ D++S + E+L P + G E
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMK-TP-LFPGDSE 243
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 28/223 (12%)
Query: 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKK--SKIVHEGKLEEFIN---------EV 130
+ V R + G G V G+ ++G VA+K+ + + + + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 131 VILSQINHRNVVKLLGCCLETEVPL-----LVYEFISNGT-LFQYLHDQNEEFPLTWEMR 184
+L+ +H N++ L + E P LV E + T L Q +HDQ ++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRI--VISPQHI 136
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT 244
+ L LH A + HRD+ NILL + + DF ++ T
Sbjct: 137 QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKT 191
Query: 245 KVQGTFGYLDPEY-FRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
Y PE + FT D++S G V+ E+ K +
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 24/221 (10%)
Query: 87 VNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN-----EVVILSQIN--- 137
V I G G GTVYK G VA+K ++ + G + EV +L ++
Sbjct: 14 VAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 138 HRNVVKLLGCCLETEVPL-----LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVA 192
H NVV+L+ C + LV+E + L YL L E + +
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG-LPAETIKDLMRQFL 130
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
L +LH+ I HRD+K NIL+ T K+ADFG ++ T V T Y
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV-TLWY 185
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
PE + D++S G + E+ KP + G+ E
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KP-LFCGNSE 224
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 64/243 (26%), Positives = 99/243 (40%), Gaps = 53/243 (21%)
Query: 83 DHFN----VNRILGQGGQGTVYKGM-LADGRIVAVK----KSKIVHEGKLEEFINEVVIL 133
DH V +++G+G G V K + VA+K + + + E + IL
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-----IRIL 147
Query: 134 SQINHR------NVVKLLGC-------CLETEVPLL---VYEFISNGTLFQYLHDQNEEF 177
+ + NV+ +L C+ E LL +YE I +N+
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIK----------KNKFQ 195
Query: 178 PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE--KYTAKVADFGTSKFI 235
+ + + A + L LH I H D+K NILL + + KV DFG+S +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY- 251
Query: 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEAT 295
+ V T +Q F Y PE ++ D++S G +L ELLTG +L G E
Sbjct: 252 --EHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY--PLLPGEDEGD 306
Query: 296 GLA 298
LA
Sbjct: 307 QLA 309
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 56/243 (23%), Positives = 103/243 (42%), Gaps = 47/243 (19%)
Query: 79 DKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK----KSKIVHEGKLEEFINEVVIL 133
+K D + ++ ++G+G G V K + VA+K K +++ ++E V +L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-----VRLL 104
Query: 134 SQINHR------NVVKLLGC-------CLETEVPLL---VYEFISNGTLFQYLHDQNEEF 177
+N +V L CL E +L +Y+ +
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLL----------RNTNFR 152
Query: 178 PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL-NEKYTA-KVADFGTSKFI 235
++ + + A ++ +L +L + + I H D+K NILL N K +A K+ DFG+S
Sbjct: 153 GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ- 210
Query: 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEAT 295
+ +Q F Y PE + D++S G +LVE+ TG+ + +G+ E
Sbjct: 211 --LGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE--PLFSGANEVD 265
Query: 296 GLA 298
+
Sbjct: 266 QMN 268
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 4e-16
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 87 VNRILGQGGQGTVYKG--MLADGRIVAVKKSKIVHEGKLEEF----INEVVILSQIN--- 137
V I G+G G V+K + GR VA+K+ ++ E I EV +L +
Sbjct: 16 VAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFE 72
Query: 138 HRNVVKLLGCCLETEVPL-----LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVA 192
H NVV+L C + LV+E + L YL E + E + ++
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-VPTETIKDMMFQLL 130
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
L +LHS + HRD+K NIL+ K+ADFG ++ T+ V T Y
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TLWY 185
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293
PE + D++S G + E+ KP + GS +
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KP-LFRGSSD 224
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 50/248 (20%), Positives = 102/248 (41%), Gaps = 52/248 (20%)
Query: 78 LDKATDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFIN-EVVILSQ 135
L+ ++ +++ + LG G G V + + G+ A+KK ++ + + + N E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--VLQDPR---YKNRELDIMKV 56
Query: 136 INHRNVVKLLGC-------CLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
++H N++KL+ + P + + H ++ + L +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 189 TE-------------------------------VAGSLSYLHSAASMPIYHRDIKSTNIL 217
E + ++ ++HS I HRDIK N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLL 173
Query: 218 LN-EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE-YFRSGQFTDKSDVYSFGVV 275
+N + T K+ DFG++K ++ + V + Y PE + ++T D++S G V
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 276 LVELLTGQ 283
EL+ G+
Sbjct: 232 FGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 41/224 (18%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN---------EVV 131
+ + +G G QG V R VA+KK F N E+V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 132 ILSQINHRNVVKLLGCCLETEVPL------LVYEFIS---NGTLFQYLHDQNEEFPLTWE 182
++ +NH+N++ LL + +V E + + L + + L ++
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQ 135
Query: 183 MRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242
M L + +LHSA I HRD+K +NI++ T K+ DFG ++ + +
Sbjct: 136 M-LC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 182
Query: 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
T T Y PE + + D++S G ++ E++ G +
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 47/231 (20%), Positives = 85/231 (36%), Gaps = 55/231 (23%)
Query: 87 VNRILGQGGQGTVYKGM-LADGRIVAVK--KSKIVHEGKLEEFINEVVILSQIN------ 137
+ R LG G TV+ + + VA+K + + E +E+ +L ++N
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTK 79
Query: 138 -----HRNVVKLLGC-----------CLETEVPLL---VYEFISNGTLFQYLHDQNEEFP 178
+++KLL + E +L + I + E
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIK----------KYEHRG 127
Query: 179 LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE------KYTAKVADFGTS 232
+ +I+ ++ L Y+H I H DIK N+L+ K+AD G +
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQ 283
+ H T +Q Y PE + +D++S ++ EL+TG
Sbjct: 186 CW---YDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 41/224 (18%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN---------EVV 131
+ + +G G QG V R VA+KK F N E+V
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 132 ILSQINHRNVVKLL-----GCCLETEVPL-LVYEFIS---NGTLFQYLHDQNEEFPLTWE 182
++ +NH+N++ LL LE + LV E + + L + + L ++
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQ 172
Query: 183 MRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV 242
M L + +LHSA I HRD+K +NI++ T K+ DFG ++ + +
Sbjct: 173 M-LC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 219
Query: 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
T T Y PE + + D++S G ++ E++ K +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 41/224 (18%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFIN---------EV 130
+ + +G G G V + G VA+KK + F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--------FQSELFAKRAYREL 75
Query: 131 VILSQINHRNVVKLLGCCLETEVPL------LVYEFISNGTLFQYLHDQNEEFPLTWEMR 184
+L + H NV+ LL E LV F+ L + + + L +
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRI 130
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT-HVT 243
+ ++ L Y+H+A I HRD+K N+ +NE K+ DFG ++ + T +V
Sbjct: 131 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187
Query: 244 TKVQGTFGYLDPEY-FRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
T+ Y PE ++T D++S G ++ E++TG K +
Sbjct: 188 TRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFIN---------EV 130
+ +G G G+V + G VA+KK S+ F + E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP--------FQSEIFAKRAYREL 74
Query: 131 VILSQINHRNVVKLLGCCLETEVPL------LVYEFIS---NGTLFQYLHDQNEEFPLTW 181
++L + H NV+ LL LV F+ + ++ ++ L +
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-LVY 133
Query: 182 EMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241
+M L+ L Y+HSA + HRD+K N+ +NE K+ DFG ++ + T
Sbjct: 134 QM-LK-------GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 242 -VTTKVQGTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
V T+ Y PE + D++S G ++ E+LTG K +
Sbjct: 183 YVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 57/242 (23%), Positives = 86/242 (35%), Gaps = 66/242 (27%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN---------EVV 131
+ F + +LG+G G V G IVA+KK +E F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 132 ILSQINHRNVVKLLGCCLETEVPL-----LVYEF--------ISNGTL----FQYLHDQN 174
IL H N++ + ++ E IS L QY Q
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ- 120
Query: 175 EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234
LR ++ LH + + HRD+K +N+L+N KV DFG ++
Sbjct: 121 ---------TLR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 235 IVIDQTHVTTKVQGTFG---------YLDPEY-FRSGQFTDKSDVYSFGVVLVELLTGQK 284
I + G Y PE S +++ DV+S G +L EL +
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-R 220
Query: 285 PI 286
PI
Sbjct: 221 PI 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 56/257 (21%), Positives = 98/257 (38%), Gaps = 55/257 (21%)
Query: 57 QQQLTSSDGSIDRCKLFTTK-ELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK 114
++ + + ++ + +G+G G V + VA+KK
Sbjct: 3 HHHHMAAAAAAGPEMVRGQVFDVG---PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK 59
Query: 115 SKIVHEGKLEEFIN---------EVVILSQINHRNVVKLLGCCLETEVPL-----LVYEF 160
+ F + E+ IL + H N++ + + +V +
Sbjct: 60 --------ISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111
Query: 161 ISNGT-LFQYLHDQNEEFPLTWEMR-------LRIATEVAGSLSYLHSAASMPIYHRDIK 212
+ T L++ L Q L+ + LR L Y+HSA + HRD+K
Sbjct: 112 M--ETDLYKLLKTQ----HLSNDHICYFLYQILR-------GLKYIHSAN---VLHRDLK 155
Query: 213 STNILLNEKYTAKVADFGTSKFIVIDQTHVT--TKVQGTFGYLDPEY-FRSGQFTDKSDV 269
+N+LLN K+ DFG ++ D H T+ T Y PE S +T D+
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 270 YSFGVVLVELLTGQKPI 286
+S G +L E+L+ +PI
Sbjct: 216 WSVGCILAEMLSN-RPI 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 41/224 (18%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFIN---------EVV 131
+ + +G G G+V G VAVKK F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 132 ILSQINHRNVVKLLGCCLETEVPL------LVYEFISNGT-LFQYLHDQNEEFPLTWEMR 184
+L + H NV+ LL LV + G L + Q LT +
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQ----KLTDDHV 134
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT-HVT 243
+ ++ L Y+HSA I HRD+K +N+ +NE K+ DFG ++ + T +V
Sbjct: 135 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA 191
Query: 244 TKVQGTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
T+ Y PE + D++S G ++ ELLTG + +
Sbjct: 192 TRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 48/223 (21%), Positives = 84/223 (37%), Gaps = 43/223 (19%)
Query: 73 FTTKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVV 131
K+ D+ +++LG G G V + A+K ++ + EV
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARREVE 62
Query: 132 ILSQI-NHRNVVKLLGCCLETEVP-----LLVYEFISNGTLFQYLHDQNEEFPLTWEMRL 185
+ + ++V+++ E L+V E + G LF + D+ ++ T
Sbjct: 63 LHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREAS 120
Query: 186 RIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIVIDQTHV 242
I + ++ YLHS + I HRD+K N+L K+ DFG +K +
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTGE--- 173
Query: 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y D D++S GV++ LL G P
Sbjct: 174 --------KY-DKS----------CDMWSLGVIMYILLCGYPP 197
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 55/241 (22%), Positives = 95/241 (39%), Gaps = 62/241 (25%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN 140
+ + LG GG G V+ + + VA+KK + ++ + E+ I+ +++H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 141 VVKLL------GCCLETEVPL--------LVYEF--------ISNGTL----FQYLHDQN 174
+VK+ G L +V +V E+ + G L + Q
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ- 128
Query: 175 EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSK 233
LR L Y+HSA + HRD+K N+ +N E K+ DFG ++
Sbjct: 129 ---------LLR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 234 FIVIDQTH-------VTTKVQGTFGYLDPE-YFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
+ +H + TK Y P +T D+++ G + E+LTG K
Sbjct: 170 IMDPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KT 223
Query: 286 I 286
+
Sbjct: 224 L 224
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 8e-13
Identities = 71/348 (20%), Positives = 113/348 (32%), Gaps = 102/348 (29%)
Query: 79 DKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK----KSKIVHEGKLEEFINEVVIL 133
+ F V R +G G G V + + + AVK K K+ E IL
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-----EADIL 85
Query: 134 SQINHR-----NVVKLLGC-------CLETEVPLL---VYEFISNGTLFQYLHDQNEEFP 178
+I + N+VK G CL E L +YE I+ +N
Sbjct: 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIIT----------RNNYNG 133
Query: 179 LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTA-------------- 224
E E+ +L+YL M + H D+K NILL++ Y
Sbjct: 134 FHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190
Query: 225 -----------KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFG 273
K+ DFG + F + + + Y PE + + SD++SFG
Sbjct: 191 IQIYRTKSTGIKLIDFGCATF---KSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFG 246
Query: 274 VVLVELLTGQKPIILTGSKEATGLA----------AYFILSMEENRLYDFLDDQVLKVGQ 323
VL EL TG ++ + LA + + +++ LK+
Sbjct: 247 CVLAELYTGS--LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAW 304
Query: 324 KEEIMTIAT---------------------LATRCLNLNGKRRPTMKE 350
E +I + L ++ RP+ E
Sbjct: 305 PENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 34/190 (17%)
Query: 57 QQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKS 115
++Q SS + + + ++ D + + ++G G G V + + R+VA+KK
Sbjct: 30 RKQHHSSKPTASMPRPHSDWQIP---DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 116 KIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL-----LVYEFISNGT-LF 167
V + + E+ IL+++NH +VVK+L + +V +V E +
Sbjct: 87 LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFK 144
Query: 168 QYLHDQNEEFPLTWEMR-------LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE 220
+ LT L + Y+HSA I HRD+K N L+N+
Sbjct: 145 KLFRTPV---YLTELHIKTLLYNLLV-------GVKYVHSAG---ILHRDLKPANCLVNQ 191
Query: 221 KYTAKVADFG 230
+ KV DFG
Sbjct: 192 DCSVKVCDFG 201
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 43/251 (17%), Positives = 91/251 (36%), Gaps = 71/251 (28%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFIN---------EV 130
D++ + ++G+G G VY + VA+KK +++ F + E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREI 76
Query: 131 VILSQINHRNVVKLLGCCLETEVPL-----LVYEFI---------SNGTLFQYLHDQNEE 176
IL+++ +++L + ++ +V E + +L +++ +
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP----IFLTEEHIK 132
Query: 177 FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236
+ + + L +++H + I HRD+K N LLN+ + KV DFG ++ I
Sbjct: 133 T-ILYNL-LL-------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 237 IDQTHVTTKVQGTFGYLDPEYFRSGQF----------------------TDKSDVYSFGV 274
++ P + T D++S G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240
Query: 275 VLVELLTGQKP 285
+ ELL +
Sbjct: 241 IFAELLNMLQS 251
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 53/243 (21%), Positives = 83/243 (34%), Gaps = 65/243 (26%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM--LADGRIVAVK----KSKIVHEGKLEEFINEVVILSQ 135
+ + + LG+G G V + + VA+K K +LE + +L +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-----INVLKK 72
Query: 136 INHR------NVVKLLGC-------CLETEVPLL---VYEFISNGTLFQYLHDQNEEFPL 179
I + V + C+ E LL +EF+ +N P
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLK----------ENNFQPY 120
Query: 180 TWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTA--------------- 224
+A ++ +L +LH + H D+K NIL
Sbjct: 121 PLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 225 ----KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELL 280
+VADFG++ F D H TT V Y PE + DV+S G +L E
Sbjct: 178 NTSIRVADFGSATF---DHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 281 TGQ 283
G
Sbjct: 234 RGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 57/246 (23%), Positives = 93/246 (37%), Gaps = 65/246 (26%)
Query: 79 DKATDHFNVNRILGQGGQGTVYKG--MLADGRIVAVK----KSKIVHEGKLEEFINEVVI 132
D + + + LG+G G V + A GR VAVK + + E + +
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQV 64
Query: 133 LSQINHR------NVVKLLGC-------CLETEVPLL---VYEFISNGTLFQYLHDQNEE 176
L +N V++L C+ E LL Y+FI +N
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIK----------ENGF 112
Query: 177 FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTA------------ 224
P + ++A ++ S+++LHS + H D+K NIL +
Sbjct: 113 LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDER 169
Query: 225 -------KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLV 277
KV DFG++ + D H +T V Y PE + ++ DV+S G +L+
Sbjct: 170 TLINPDIKVVDFGSATY---DDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILI 225
Query: 278 ELLTGQ 283
E G
Sbjct: 226 EYYLGF 231
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 61/254 (24%), Positives = 95/254 (37%), Gaps = 80/254 (31%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFIN---------EV 130
+ + + LG+G G V+K + G +VAVKK F N E+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--------FQNSTDAQRTFREI 59
Query: 131 VILSQIN-HRNVVKLLGCCLETEVPL--------LVYEFISNGT-LFQYLHDQNEEFPLT 180
+IL++++ H N+V LL V LV++++ T L + L
Sbjct: 60 MILTELSGHENIVNLL------NVLRADNDRDVYLVFDYM--ETDLHAVIRAN----ILE 107
Query: 181 WEMR-------LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233
+ ++ + YLHS + HRD+K +NILLN + KVADFG S+
Sbjct: 108 PVHKQYVVYQLIK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157
Query: 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTD---------------------KSDVYSF 272
V + + TD D++S
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217
Query: 273 GVVLVELLTGQKPI 286
G +L E+L G KPI
Sbjct: 218 GCILGEILCG-KPI 230
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 31/220 (14%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRN 140
+ F + R +G G G +Y G + VA+K + + K + + E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+ + +E + +LV + + +L + + + L + L +A ++ + ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVH- 120
Query: 201 AASMPIYHRDIKSTNILLNEKYTAK---VADFGTSKFIVIDQTHV------TTKVQGTFG 251
S HRDIK N L+ A + DFG +K TH + GT
Sbjct: 121 --SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 252 Y------LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y L E R + D+ S G VL+ L G P
Sbjct: 179 YASVNTHLGIEQSR------RDDLESLGYVLMYFLRGSLP 212
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 47/239 (19%), Positives = 76/239 (31%), Gaps = 54/239 (22%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI--------VHEGKLEEFINEVVILS 134
+ + + +G GG G +Y A K+ E K + + + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 135 QINHRNVVKLLGCCLETEVPLLVY--EFISNGTLF------------QYLHDQNEEFPLT 180
+ R + LG +PL G + Q + QN F
Sbjct: 98 KWIERKQLDYLG------IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK- 150
Query: 181 WEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV--ADFGTSKFIVID 238
L++ + L Y+H H DIK+ N+LL K +V AD+G S +
Sbjct: 151 -STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 239 QTHV------TTKVQGTFGY------LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
H GT + R +SDV G ++ L G+ P
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR------RSDVEILGYCMLRWLCGKLP 259
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 58/276 (21%), Positives = 89/276 (32%), Gaps = 89/276 (32%)
Query: 79 DKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI- 136
D ++V R LG G TV+ + + VA+K K E ++E+ +L +
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVR 91
Query: 137 -------NHRNVVKLLGC-----------CLETEVPLL--VYEFISNGTLFQYLHDQNEE 176
N VV+LL C+ E L + ++I ++
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWI----------IKSNY 140
Query: 177 FPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN----------------- 219
L +I +V L YLH+ I H DIK NILL+
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 220 --------------------------------EKYTAKVADFGTSKFIVIDQTHVTTKVQ 247
EK K+AD G + + H T +Q
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ 255
Query: 248 GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQ 283
T Y E + +D++S + EL TG
Sbjct: 256 -TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 45/222 (20%), Positives = 79/222 (35%), Gaps = 33/222 (14%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRN 140
H+ V R +G+G G +++G L + + VA+K + E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTG 67
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+ + E +LV + + +L L +F + + A ++ + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIHE 124
Query: 201 AASMPIYHRDIKSTNILLNEKYTAK-----VADFGTSKFIVIDQTHV------TTKVQGT 249
+ + +RDIK N L+ + V DFG KF T + GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 250 FGY------LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y L E R + D+ + G V + L G P
Sbjct: 182 ARYMSINTHLGREQSR------RDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 31/220 (14%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH-RN 140
+ + + R +G G G +Y G +A G VA+K + + K + E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+ + C E + ++V E + +L + + +F L + L +A ++ + Y+HS
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHS 123
Query: 201 AASMPIYHRDIKSTNILLNEKYTAK---VADFGTSKFIVIDQTHV------TTKVQGTFG 251
HRD+K N L+ + DFG +K +TH + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 252 Y------LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y L E R + D+ S G VL+ G P
Sbjct: 181 YASINTHLGIEQSR------RDDLESLGYVLMYFNLGSLP 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 1e-09
Identities = 43/252 (17%), Positives = 78/252 (30%), Gaps = 67/252 (26%)
Query: 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKI--------VHEGKLEEFINEVVI 132
T+ +G+G G V++ + AD VA+K I H+ EE + E++I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 133 LSQI---------NHRNVVKLLGCCL----------------------ETEVPL------ 155
++ + L + P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 156 --LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKS 213
+V EF G + + + + I ++ SL+ + S+ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 214 TNILLNEKYTAKVAD--------FGTSKFIV--IDQTHVTTKVQGTFGYLD---PEYFRS 260
N+LL + K+ + V ID T + G + D E +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250
Query: 261 GQFTDKSDVYSF 272
G + D+Y
Sbjct: 251 GDGDYQFDIYRL 262
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 43/221 (19%), Positives = 81/221 (36%), Gaps = 33/221 (14%)
Query: 84 HFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNV 141
+F V + +G G G + G L VA+K + + + + E Q+ + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
++ + +V E + +L + F L + L IA ++ + Y+HS
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHSK 124
Query: 202 ASMPIYHRDIKSTNILLNEKYTAK-----VADFGTSKFIVIDQTHV------TTKVQGTF 250
+ +RD+K N L+ + DF +K + +T + GT
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 251 GY------LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP 285
Y L E R + D+ + G + + L G P
Sbjct: 182 RYMSINTHLGKEQSR------RDDLEALGHMFMYFLRGSLP 216
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 38/241 (15%), Positives = 81/241 (33%), Gaps = 45/241 (18%)
Query: 79 DKATDHFNVNRILGQGGQGTVYKGM---------LADGRIVAVK----KSKIVHEGKL-- 123
DK+ + + + QG +Y+ + ++K ++ +E
Sbjct: 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 124 ----EEFINEVVILSQINHRNVVKLLGC-CLETEVPLLVYEFISNGTLFQYLHDQNEEFP 178
+N+ L + +G + + LV + G Q D + +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHV 155
Query: 179 LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV--ADFGTSKFIV 236
L+ L++A + +L +LH H ++ + NI ++ + ++V A +G +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 237 IDQTHVTTKVQ------GTFGY------LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQK 284
HV G + R +SD+ S G +++ L G
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR------RSDLQSLGYCMLKWLYGFL 266
Query: 285 P 285
P
Sbjct: 267 P 267
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 44/242 (18%), Positives = 76/242 (31%), Gaps = 57/242 (23%)
Query: 84 HFNVNRILGQGGQGTVYKGM------LADGRIVAVKKSKIVH-----EGKLEEFINEVVI 132
+ V +GQGG G +Y + VK + E K + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 133 LSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQY---------------LHDQNEEF 177
+ + +K LG VP + + Y + F
Sbjct: 96 IQKWIRTRKLKYLG------VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149
Query: 178 PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV--ADFGTSKFI 235
+ L+++ + L Y+H H DIK++N+LLN K +V D+G +
Sbjct: 150 SR--KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
Query: 236 VIDQTHV------TTKVQGTFGY------LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQ 283
+ H GT + R + D+ G +++ LTG
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR------RGDLEILGYCMIQWLTGH 258
Query: 284 KP 285
P
Sbjct: 259 LP 260
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-06
Identities = 10/26 (38%), Positives = 13/26 (50%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRC 26
+DEC G C + +C N G Y C
Sbjct: 96 VDECSSGQHQCDSSTVCFNTVGSYSC 121
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Length = 86 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-05
Identities = 9/26 (34%), Positives = 11/26 (42%), Gaps = 1/26 (3%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRC 26
IDEC+ C C N G + C
Sbjct: 3 IDECRISPDLCGRG-QCVNTPGDFEC 27
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Length = 86 | Back alignment and structure |
|---|
Score = 38.4 bits (90), Expect = 3e-04
Identities = 12/26 (46%), Positives = 14/26 (53%), Gaps = 1/26 (3%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRC 26
IDEC+ C +C N EG YRC
Sbjct: 46 IDECQRDPLLC-RGGVCHNTEGSYRC 70
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} Length = 87 | Back alignment and structure |
|---|
Score = 37.6 bits (88), Expect = 5e-04
Identities = 8/26 (30%), Positives = 13/26 (50%), Gaps = 1/26 (3%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRC 26
+DEC + C + C+N G + C
Sbjct: 3 VDECSLKPSICGTAV-CKNIPGDFEC 27
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Length = 82 | Back alignment and structure |
|---|
Score = 37.6 bits (88), Expect = 6e-04
Identities = 10/26 (38%), Positives = 16/26 (61%), Gaps = 2/26 (7%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRC 26
+DECK+ + ++ C N +G YRC
Sbjct: 5 MDECKEP--DVCKHGQCINTDGSYRC 28
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 400 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.81 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.59 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.96 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.66 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.4 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.4 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.39 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.34 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.01 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.8 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.93 | |
| 2kl7_A | 71 | Fibulin-4; secreted, calcium, disease mutation, di | 94.84 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 93.32 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 91.79 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.72 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 89.54 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.24 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 87.21 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 85.98 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 85.23 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 83.97 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 81.66 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-59 Score=433.69 Aligned_cols=261 Identities=27% Similarity=0.448 Sum_probs=216.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
.++|.+.+.||+|+||.||+|.+. ++..||||.++.......+.|.+|+.+|++++|||||++++++.+.+..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357899999999999999999853 46789999988776777788999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEE
Q 042371 156 LVYEFISNGTLFQYLHDQN----------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAK 225 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~k 225 (400)
||||||++|+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997642 2346999999999999999999999999 99999999999999999999
Q ss_pred EEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHH
Q 042371 226 VADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 226 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 303 (400)
|+|||+|+........ ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||......+ + ..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~----~~ 241 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V----IE 241 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H----HH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HH
Confidence 9999999865433322 2233568999999999999999999999999999999999 899995433211 1 11
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
....+.. ...+...++.+.+|+.+||+.||++|||+++|++.|+.+.+.
T Consensus 242 ~i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 CITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111111 112334556799999999999999999999999999988754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-58 Score=434.01 Aligned_cols=260 Identities=27% Similarity=0.452 Sum_probs=210.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
.++|.+.++||+|+||.||+|.+. ++..||||.++.......+.|.+|+.+|++++|||||++++++.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356888899999999999999864 47889999998777777889999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 042371 156 LVYEFISNGTLFQYLHDQNE------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 223 (400)
||||||++|+|.++++.... ..++++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999976432 236999999999999999999999999 999999999999999999
Q ss_pred EEEEecCCccccccCC-ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHH
Q 042371 224 AKVADFGTSKFIVIDQ-THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYF 301 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 301 (400)
+||+|||+++...... ........||+.|+|||++.+..|+.++|||||||++|||+| |+.||......+ .
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~---- 269 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---A---- 269 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---H----
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---H----
Confidence 9999999998654332 223345679999999999999999999999999999999999 899995433211 1
Q ss_pred HHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 302 ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
......+. ....+...++.+.+|+.+||+.||++|||+.||+++|+.+..
T Consensus 270 ~~~i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 270 IDCITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11111111 111233455679999999999999999999999999998865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-58 Score=427.68 Aligned_cols=267 Identities=28% Similarity=0.432 Sum_probs=210.0
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
|+...+++++.+.||+|+||+||+|.+++ .||||.++.. .....+.|.+|+.+|++++|||||++++++.+ +.++
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 34556789999999999999999998754 5999987643 34456789999999999999999999998764 5689
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
||||||+||+|.+++..... ++++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+..
T Consensus 108 iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999976543 5999999999999999999999999 999999999999999999999999999865
Q ss_pred ccC-CceeeecccccCCCCCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 236 VID-QTHVTTKVQGTFGYLDPEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 236 ~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
... .........||+.|||||++.+ ++|+.++|||||||++|||+||+.||....... ........+...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~ 256 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYAS 256 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCC
Confidence 432 2233455679999999999864 469999999999999999999999995433211 111111111100
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
+ .....+...++.+.+|+.+||+.||.+|||+.+|++.|+.++....
T Consensus 257 ----p-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 257 ----P-DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ----C-CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred ----C-CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 0 0112233455679999999999999999999999999998876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=432.52 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=204.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.++|++.+.||+|+||.||+|... +|+.||||.+... .....+.+.+|+.+|++++|||||++++++.+.+.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999964 6899999987643 3445678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
|||+||+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999976543 25899999999999999999999999 999999999999999999999999999875321
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... .. .........
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~-~~i~~~~~~------- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LV-LKIISGSFP------- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HH-HHHHHTCCC-------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HH-HHHHcCCCC-------
Confidence 222345679999999999999999999999999999999999999995432211 11 111111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+||.+||+.||.+|||+.|++++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122345678999999999999999999999885
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=425.95 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=211.2
Q ss_pred cCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
.++++.+.||+|+||.||+|.+. +++.||||.++... ....+.|.+|+.++++++|||||++++++.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45778899999999999999863 46789999986533 344678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 042371 156 LVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY 222 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 222 (400)
||||||++|+|.++|..... ...+++..++.++.||+.||.|||+.+ ||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975421 235899999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCccccccCC-ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHH
Q 042371 223 TAKVADFGTSKFIVIDQ-THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAY 300 (400)
Q Consensus 223 ~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 300 (400)
.+||+|||+++...... ........||+.|+|||++.++.|+.++|||||||++|||+| |..||......+ +
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~--- 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V--- 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H---
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H---
Confidence 99999999998764332 223345679999999999999999999999999999999998 899995433211 1
Q ss_pred HHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 301 FILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
......+.. ...+...+..+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus 257 -~~~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 -VEMIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HHHHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111111 122344567799999999999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=429.17 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=209.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
..|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 68999999987666666677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
+||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.+... ..
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VP 225 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SC
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC-CC
Confidence 999999999753 3899999999999999999999999 999999999999999999999999999876432 23
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||....... .. ..+....... ..
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~-~~i~~~~~~~-------~~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AM-KMIRDNLPPR-------LK 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH-HHHHHSSCCC-------CS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HH-HHHHcCCCCC-------CC
Confidence 3456789999999999999999999999999999999999999995432211 11 1111110000 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....++.+.+||.+||+.||.+|||+.|++++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 122345678999999999999999999998874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-56 Score=421.39 Aligned_cols=257 Identities=20% Similarity=0.219 Sum_probs=209.3
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.+.|++.++||+|+||.||+|... +|+.||||+++.... ..+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888999999999999999965 689999998864322 24699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-cEEEEecCCccccccCC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~Dfgla~~~~~~~ 239 (400)
|+||+|.+++...+ ++++..++.++.||+.||.|||+++ |+||||||+|||++.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999998765 5999999999999999999999999 99999999999999987 69999999998764322
Q ss_pred ce----eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 240 TH----VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 240 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.. .....+||+.|||||++.+..|+.++|||||||++|+|++|++||....... +.... .....
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i----~~~~~----- 273 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKI----ASEPP----- 273 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHH----HHSCC-----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHH----HcCCC-----
Confidence 11 1233579999999999999999999999999999999999999996433221 11110 01100
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
.....+...++.+.+||.+||+.||.+|||+.||+++|........
T Consensus 274 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 274 --PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp --GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 0111233456678999999999999999999999999988776543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=417.39 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=209.9
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||+||+|... +++.||||.+... .....+.+.+|+.+|++++||||+++++++.+.+.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357999999999999999999964 6899999987632 344567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||++||+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999998765 5999999999999999999999999 99999999999999999999999999987653
Q ss_pred CC-ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 238 DQ-THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 238 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
.. .....+.+||+.|+|||++.+..|+.++||||+||++|+|++|++||....... .. ..+..... .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~-~~i~~~~~-~---- 252 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IF-AKIIKLEY-D---- 252 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHTCC-C----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHcCCC-C----
Confidence 32 233456789999999999999999999999999999999999999995432111 11 11111111 1
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...++.+.+||.+||+.||.+|||++|++.+
T Consensus 253 -----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 -----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -----CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 122334568999999999999999999987653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-56 Score=412.22 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=199.0
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEee----CCcceEE
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLE----TEVPLLV 157 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 157 (400)
|++.++||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+|++++|||||++++++.+ ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 467788999999999999965 5889999987543 34456789999999999999999999999865 3457999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCcEEEEecCCccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-KYTAKVADFGTSKFIV 236 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~Dfgla~~~~ 236 (400)
||||+||+|.+++.... .+++..+..++.||+.||.|||+++ .+|+||||||+|||++. +|.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999998754 5899999999999999999999976 45999999999999985 7899999999997542
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
.....+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||....... .. ......+... .
T Consensus 184 ---~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~-~~~i~~~~~~----~ 249 (290)
T 3fpq_A 184 ---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QI-YRRVTSGVKP----A 249 (290)
T ss_dssp ---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HH-HHHHTTTCCC----G
T ss_pred ---CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HH-HHHHHcCCCC----C
Confidence 223445789999999999864 69999999999999999999999995322211 11 1111111110 0
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. +...++.+.+||.+||+.||.+|||+.+++++
T Consensus 250 ~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 11123458899999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=430.95 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=210.2
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
+.|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999965 68999999987666666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
+||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|+.+... ..
T Consensus 231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VP 302 (423)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CC
T ss_pred CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC-Cc
Confidence 999999999754 3899999999999999999999999 999999999999999999999999999876432 23
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||....... .. ..+....... ..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~-~~i~~~~~~~-------~~ 368 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AM-KMIRDNLPPR-------LK 368 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH-HHHHHSCCCC-------CS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HH-HHHHcCCCCC-------Cc
Confidence 3456789999999999999999999999999999999999999995332211 11 1111110000 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....++.+.+||.+||+.||.+|||+.|++++
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 122345678999999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=427.93 Aligned_cols=272 Identities=28% Similarity=0.389 Sum_probs=221.1
Q ss_pred cChHHHHHHhcCCcccceeeecCcEEEEEEEecC------CcEEEEEEccccC-chhHHHHHHHHHHHHhCCC-Ccceee
Q 042371 73 FTTKELDKATDHFNVNRILGQGGQGTVYKGMLAD------GRIVAVKKSKIVH-EGKLEEFINEVVILSQINH-RNVVKL 144 (400)
Q Consensus 73 ~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h-~~iv~~ 144 (400)
+..+.|+...++|++.+.||+|+||.||+|.+.+ ++.||||.+.... ....+.+.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4556788888999999999999999999998542 3579999886533 3456789999999999965 899999
Q ss_pred eeEEeeC-CcceEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 042371 145 LGCCLET-EVPLLVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRD 210 (400)
Q Consensus 145 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrD 210 (400)
+++|.+. +.++||||||++|+|.++|+.... ...+++..++.++.||+.||.|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 568999999999999999976421 235899999999999999999999999 99999
Q ss_pred CCCCCeEEcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCc
Q 042371 211 IKSTNILLNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIIL 288 (400)
Q Consensus 211 ikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~ 288 (400)
|||+|||++.++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876543332 3445678999999999999999999999999999999998 9999954
Q ss_pred CCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 289 TGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
..... ........+. ....+...++.+.+++.+||+.||.+|||+.+|+++|+.+....
T Consensus 291 ~~~~~------~~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKIDE------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCSH------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHH------HHHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 33221 1111111111 11122334567899999999999999999999999999987644
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=403.88 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=192.0
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.+|+.++||||+++++++.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 6899999987542 2344677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+ +|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 999 679999998754 5999999999999999999999999 99999999999999999999999999986532
Q ss_pred CceeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.....+..||+.|+|||++.+..| +.++||||+||++|+|++|+.||...... ... ........
T Consensus 165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~-~~i~~~~~------- 229 (275)
T 3hyh_A 165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLF-KNISNGVY------- 229 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHTCC-------
T ss_pred -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHH-HHHHcCCC-------
Confidence 233445779999999999998886 57999999999999999999999543211 111 11111110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...++.+.+|+.+||+.||.+|||++|++++
T Consensus 230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1122345668999999999999999999999885
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=408.49 Aligned_cols=248 Identities=28% Similarity=0.316 Sum_probs=197.3
Q ss_pred cCCcccceeeecCcEEEEEEEec----CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
++|++.+.||+|+||.||+|+.. .++.||+|.+... .......+.+|+.+|++++|||||++++++.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 4678999987542 22234467889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
|||||+||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998765 5999999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
.. .....+.+||+.|+|||++.+..|+.++||||+||++|+|++|+.||......+ .. ..+.....
T Consensus 178 ~~-~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~-~~i~~~~~------ 243 (304)
T 3ubd_A 178 DH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TM-TMILKAKL------ 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCCC------
T ss_pred CC-CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HH-HHHHcCCC------
Confidence 32 233445789999999999999999999999999999999999999995432211 11 11111111
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTM-----KEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~~ 354 (400)
..+...++.+.+||.+||+.||.+|||+ +|++++
T Consensus 244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1122345678999999999999999985 566553
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-55 Score=409.14 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=199.9
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC----cceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE----VPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 158 (400)
++|.+.+.||+|+||.||+|.+ +|+.||||++..... .......|+..+.+++||||+++++++.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4688899999999999999998 588999998764322 1122234555567789999999999998764 468999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA-----SMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
|||++|+|.++++.. ++++..++.++.|++.||.|||+.. .++|+||||||+|||++.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999764 3899999999999999999999871 2239999999999999999999999999998
Q ss_pred ccccCCcee---eecccccCCCCCccccccC------CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccc--------cc
Q 042371 234 FIVIDQTHV---TTKVQGTFGYLDPEYFRSG------QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA--------TG 296 (400)
Q Consensus 234 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~--------~~ 296 (400)
......... .....||+.|+|||++.+. .|+.++|||||||++|||+||.+||........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 764433222 2345799999999998754 467899999999999999999888743322110 00
Q ss_pred hHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 297 LAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.................++. .....+.+..+.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 01111111111111100111 11123456778999999999999999999999999998875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=404.67 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=190.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc-------
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEV------- 153 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------- 153 (400)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45999999999999999999964 68999999886544 3345778999999999999999999999876543
Q ss_pred -----ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEe
Q 042371 154 -----PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVAD 228 (400)
Q Consensus 154 -----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D 228 (400)
+|||||||++|+|.+++.........++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999987654334567778999999999999999999 99999999999999999999999
Q ss_pred cCCccccccCCce-----------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccch
Q 042371 229 FGTSKFIVIDQTH-----------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGL 297 (400)
Q Consensus 229 fgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 297 (400)
||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence 9999876432211 1234579999999999999999999999999999999996 763110 000
Q ss_pred HHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 298 AAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..........+.. .....++.+.+|+.+||+.||.+|||+.+++++
T Consensus 235 --~~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 235 --RTLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp --HHHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011111111110 112233457789999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=401.73 Aligned_cols=265 Identities=22% Similarity=0.291 Sum_probs=201.7
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEee------CCc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLE------TEV 153 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~ 153 (400)
++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999964 6899999988643 23446778899999999999999999998764 356
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
+|||||||+ |+|.+++.... ++++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 68999997644 5999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccC---CceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 234 FIVID---QTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 234 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
.+... ........+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.......................
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 76432 12234567899999999998875 569999999999999999999999954332211111100000000000
Q ss_pred ccc------------ccch--hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 LYD------------FLDD--QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ~~~------------~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+.. +... .......+..+..+.+||.+||+.||.+|||+.|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0000 00000011234568899999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=392.48 Aligned_cols=199 Identities=21% Similarity=0.346 Sum_probs=170.2
Q ss_pred HhcCCcccceeeecCcEEEEEEEec----CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 155 (400)
..++|++.+.||+|+||.||+|+.+ .++.||+|.+... .....+.+|+.+|+.+ +||||+++++++.+.+.+|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999853 4678999987543 3346788999999998 6999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CcEEEEecCCccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSKF 234 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~Dfgla~~ 234 (400)
|||||++||+|.+++. .+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999984 3899999999999999999999999 9999999999999876 7999999999975
Q ss_pred cccCC---------------------------ceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCC
Q 042371 235 IVIDQ---------------------------THVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 235 ~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf 286 (400)
..... .......+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 43211 1122345799999999999875 5899999999999999999999999
Q ss_pred CcCC
Q 042371 287 ILTG 290 (400)
Q Consensus 287 ~~~~ 290 (400)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 5443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=380.00 Aligned_cols=287 Identities=39% Similarity=0.640 Sum_probs=245.2
Q ss_pred ChHHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 74 TTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 74 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
+..++....++|++.+.||+|+||.||+|..++++.||+|+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 33344556789999999999999999999988899999998877666677889999999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNE-EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999876432 235899999999999999999999999 999999999999999999999999999
Q ss_pred cccccC-CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 233 KFIVID-QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 233 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
...... .........||+.|+|||++.+..++.++||||||+++|+|++|+.||.............+.........+.
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 764322 2222334568999999999999999999999999999999999999997666655555555555555555666
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
..++...........+..+.+++.+||+.||.+|||+.+++++|+.+.+..+
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 6666666666778889999999999999999999999999999999887544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=410.93 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=210.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|++.+.||+|+||.||+|..+ +|+.||+|.+........+.+.+|+.+|+.++||||+++++++.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999965 6899999998776666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC--CcEEEEecCCccccccC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK--YTAKVADFGTSKFIVID 238 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~--~~~kl~Dfgla~~~~~~ 238 (400)
|+||+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~- 309 (573)
T 3uto_A 236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 309 (573)
T ss_dssp CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence 999999999865432 5899999999999999999999999 9999999999999854 8999999999987643
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... .. ..+..... .+.+ .
T Consensus 310 -~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~-~~i~~~~~-~~~~-~- 378 (573)
T 3uto_A 310 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TL-RNVKSCDW-NMDD-S- 378 (573)
T ss_dssp -TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHTTCC-CCCS-G-
T ss_pred -CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HH-HHHHhCCC-CCCc-c-
Confidence 334455679999999999999999999999999999999999999995433211 11 11111110 0111 1
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.....++.+.+||.+||+.||.+|||+.|+++|
T Consensus 379 ---~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 ---AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ---GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112234568899999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=406.30 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=200.9
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHH---HHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFIN---EVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|++.+.||+|+||.||+|... +|+.||||.+... .........+ ++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999965 6899999987532 1222233334 45666778999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
||||||++||+|.+++.... .+++..+..++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999998765 5999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.... ...+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||........ ........ ...
T Consensus 342 ~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~-~~~---- 410 (689)
T 3v5w_A 342 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTL-TMA---- 410 (689)
T ss_dssp CSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHH-HCC----
T ss_pred cCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhc-CCC----
Confidence 5322 2345689999999999974 5799999999999999999999999954332211 11111111 110
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
...+...++.+.+||.+||+.||.+|++ ++||++|
T Consensus 411 ------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1112334567899999999999999998 6888775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=373.01 Aligned_cols=286 Identities=39% Similarity=0.647 Sum_probs=239.4
Q ss_pred cccccChHHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCc-hhHHHHHHHHHHHHhCCCCcceeeeeE
Q 042371 69 RCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHE-GKLEEFINEVVILSQINHRNVVKLLGC 147 (400)
Q Consensus 69 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~ 147 (400)
....++..++....++|++.+.||+|+||.||+|...+++.||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4467888999999999999999999999999999988899999998765332 223368899999999999999999999
Q ss_pred EeeCCcceEEEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhc---CCCCeEecCCCCCCeEEcCCCc
Q 042371 148 CLETEVPLLVYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSA---ASMPIYHRDIKSTNILLNEKYT 223 (400)
Q Consensus 148 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~---~~~~iiHrDikp~NIll~~~~~ 223 (400)
+...+..++||||+++|+|.+++.... ...++++..++.++.|++.||.|||+. + |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence 999999999999999999999998754 234589999999999999999999999 7 999999999999999999
Q ss_pred EEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCC--CccccchHHHH
Q 042371 224 AKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTG--SKEATGLAAYF 301 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~ 301 (400)
+||+|||++...............||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .........+.
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999999998765445555556679999999999998999999999999999999999999995321 11122223333
Q ss_pred HHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 302 ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
.............+...........+..+.+++.+||+.||.+|||+.+|+++|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 33333445555556666666778888999999999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=361.53 Aligned_cols=265 Identities=24% Similarity=0.394 Sum_probs=217.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367999999999999999999975 5889999988766677788899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999987543 4899999999999999999999999 99999999999999999999999999986543221
Q ss_pred ee-------------eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh
Q 042371 241 HV-------------TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307 (400)
Q Consensus 241 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 307 (400)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|..||..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~------- 236 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV------- 236 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-------
Confidence 11 1145699999999999999999999999999999999999999854332211100000
Q ss_pred cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhcc
Q 042371 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~ 365 (400)
........+...+..+.+++.+||+.||.+|||+.++++.|+.++......
T Consensus 237 -------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 237 -------RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp -------HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred -------hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence 000011112233455889999999999999999999999999998765543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=357.55 Aligned_cols=251 Identities=26% Similarity=0.437 Sum_probs=209.2
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999995 46899999988766666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence 9999999999764 3899999999999999999999999 9999999999999999999999999997654322
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ....... .....
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~-~~~~~------- 236 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATN-GTPEL------- 236 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHH-CSCCC-------
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC-CCCCC-------
Confidence 233446799999999999999999999999999999999999999954322110 0000000 00000
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122344568999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=379.43 Aligned_cols=324 Identities=26% Similarity=0.414 Sum_probs=239.4
Q ss_pred CCCCceeEeccCc---eeeecCCchhhhhhHHH----HHHHHHHHhhcCCccchhhhccC-CCCCCcccccChHHHHHHh
Q 042371 11 CSENLLCENYEGG---YRCITPKRKVYIIKRED----IKLKEKFFKRNGGLVLQQQLTSS-DGSIDRCKLFTTKELDKAT 82 (400)
Q Consensus 11 ~~~~~~c~~~~~~---y~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 82 (400)
-|...+|+.+.+. |++....+..++..+.. ..+.+.+.....++......... .+.......+....+....
T Consensus 113 ~g~~~Lsv~~~~~v~H~~I~~~~~~~~i~~~~~F~sl~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~ 192 (450)
T 1k9a_A 113 PGDYTLCVSCEGKVEHYRIMYHASKLSIDEEVYFENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNM 192 (450)
T ss_dssp TTSEEEEEECSSSEEEEEEEEETTEEESSSSSCBSSHHHHHHHHHHCCTTSSSCCCEECCCTTCEEHHHHHHHTTCBCCG
T ss_pred CCceEEEEEeCCeeeEEEEEecCCceEeccccccccHHHHHhhhcccccchhhhccccccccCcccchhhhcccccccCh
Confidence 4667889888664 77755555555543221 34455555544444322111100 0000000111122334456
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC-cceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE-VPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~ 161 (400)
++|++.+.||+|+||.||+|... ++.||||.++... ..+.+.+|+.+|++++||||+++++++.... ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 78999999999999999999985 7799999886533 4578999999999999999999999987765 689999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++|+|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TTCBHHHHHHHHCTT-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999876432 4799999999999999999999999 999999999999999999999999999754221
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... .. .....+ ...
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~---------~~~ 405 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKG---------YKM 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH----HHHHTT---------CCC
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcC---------CCC
Confidence 122357889999999999999999999999999999998 999996443221 11 111111 111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
..+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 22334456799999999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=349.05 Aligned_cols=284 Identities=34% Similarity=0.578 Sum_probs=228.7
Q ss_pred cccccChHHHHHHhcCCccc------ceeeecCcEEEEEEEecCCcEEEEEEcccc----CchhHHHHHHHHHHHHhCCC
Q 042371 69 RCKLFTTKELDKATDHFNVN------RILGQGGQGTVYKGMLADGRIVAVKKSKIV----HEGKLEEFINEVVILSQINH 138 (400)
Q Consensus 69 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h 138 (400)
....|+..++...+++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678888999988888776 8999999999999987 5789999987542 23446788999999999999
Q ss_pred CcceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 042371 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL 218 (400)
Q Consensus 139 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 218 (400)
|||+++++++.+.+..++||||+++++|.+++.......++++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976544456999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccch
Q 042371 219 NEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGL 297 (400)
Q Consensus 219 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 297 (400)
+.++.+||+|||++........ .......||+.|+|||++.+ .++.++||||||+++|+|++|..||........ .
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 9999999999999976543222 22334568999999998875 589999999999999999999999965433221 1
Q ss_pred HHHHHH-HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 298 AAYFIL-SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 298 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
...... ......+..+++.. ....+...+..+.+++.+||+.||.+|||+.+++++|+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111111 11112222333222 233456778889999999999999999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=353.87 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=214.2
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 467999999999999999999988888999998865432 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 88 ~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999976443 5899999999999999999999999 999999999999999999999999999865433333
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... . ....... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~-~~~~~~~---------~~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------V-VEDISTG---------FRL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-HHHHHTT---------CCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------H-HHHHhcC---------ccC
Confidence 3344556788999999999999999999999999999999 999995432211 1 1111111 011
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
..+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11222345689999999999999999999999999998763
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=366.68 Aligned_cols=265 Identities=28% Similarity=0.425 Sum_probs=214.8
Q ss_pred HhcCCcccceeeecCcEEEEEEEec--------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEee
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA--------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLE 150 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 150 (400)
..++|++.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3478999999999999999999852 3457999988654 334567899999999999 89999999999999
Q ss_pred CCcceEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNIL 217 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 217 (400)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999987532 124889999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCcccc
Q 042371 218 LNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEAT 295 (400)
Q Consensus 218 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~ 295 (400)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999986543221 12233456889999999999999999999999999999999 999995433221
Q ss_pred chHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 296 GLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
.. ...... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.....+
T Consensus 314 -~~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 -LF----KLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp -HH----HHHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -HH----HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 11 011111 11112233456799999999999999999999999999999875543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=353.60 Aligned_cols=260 Identities=26% Similarity=0.422 Sum_probs=214.3
Q ss_pred HhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3467999999999999999999988888999998865433 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999987543 4899999999999999999999999 99999999999999999999999999987654444
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||........ ........ .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~---------~ 223 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-------VLKVSQGH---------R 223 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHTTC---------C
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-------HHHHHcCC---------C
Confidence 44444556788999999999899999999999999999999 9999954332210 11111110 0
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
...+...+..+.+++.+||+.||.+|||+.+++++|+.+++..
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1112223456899999999999999999999999999876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=362.71 Aligned_cols=267 Identities=30% Similarity=0.432 Sum_probs=207.2
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
++...++|++.+.||+|+||.||+|.. .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 334457899999999999999999987 57889999876433 344578899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+++|+|.+++........+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999986543234899999999999999999999976 35999999999999999999999999999754
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .. ........
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~---~~~~~~~~------ 256 (309)
T 3p86_A 190 AST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VV---AAVGFKCK------ 256 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HH---HHHHHSCC------
T ss_pred ccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhcCC------
Confidence 322 222344568999999999999999999999999999999999999995432211 00 00000000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 257 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 ---RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 01122334566899999999999999999999999999887643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=372.77 Aligned_cols=265 Identities=25% Similarity=0.415 Sum_probs=214.4
Q ss_pred HHHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 76 KELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 76 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
..+....++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 344455678999999999999999999976 68999999876432 3345678899999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999999999986543 4899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceee-ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 234 FIVIDQTHVT-TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 234 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
.......... ....+++.|+|||++.+..++.++||||||+++|||++ |..||........ ........
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~-- 332 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REFVEKGG-- 332 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHHHHTTC--
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC--
Confidence 5432211111 11235778999999999999999999999999999998 9999954332110 11111111
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 333 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 -------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1112223456789999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=360.64 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=211.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEec----CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
..++|++.+.||+|+||.||+|... .+..||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3467999999999999999999964 3456999988754 3445678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 127 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999976533 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce--eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 236 VIDQTH--VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 236 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... . .......
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~-~~~~~~~---- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------V-ISSVEEG---- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------H-HHHHHTT----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------H-HHHHHcC----
Confidence 433222 2223346778999999999999999999999999999999 999995433221 0 1111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 271 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 271 -----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 111122334567999999999999999999999999999987643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=382.43 Aligned_cols=313 Identities=24% Similarity=0.387 Sum_probs=234.4
Q ss_pred eeeec-CCchhhhhhHH----HHHHHHHHHhhcCCccchhhhccCCCCCCcccccChHHHHHHhcCCcccceeeecCcEE
Q 042371 24 YRCIT-PKRKVYIIKRE----DIKLKEKFFKRNGGLVLQQQLTSSDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGT 98 (400)
Q Consensus 24 y~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~ 98 (400)
|++.. ..+..++..+. -..+.+.+.+.+.++..+...... +......+....++...++|++.+.||+|+||.
T Consensus 126 ~~I~~~~~g~~~i~~~~~F~sl~eLv~~y~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~ 203 (454)
T 1qcf_A 126 YKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCM--SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGE 203 (454)
T ss_dssp EEEEECTTSCEESSSSSCBSSHHHHHHHHTSSCTTSSSCCCSBCC--CCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEE
T ss_pred EEEEEcCCCcEEEeCccccCCHHHHHHHHHhccCCcccccccccc--ccCccccccccceeechHHeEEEEEcccCCceE
Confidence 55533 34444443321 234556666555555432211111 111112233455666778999999999999999
Q ss_pred EEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCC
Q 042371 99 VYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFP 178 (400)
Q Consensus 99 V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 178 (400)
||+|..+++..||||.+.... ...+.+.+|+.+|++++||||+++++++. ....++||||+++|+|.+++..... ..
T Consensus 204 V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-~~ 280 (454)
T 1qcf_A 204 VWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEG-SK 280 (454)
T ss_dssp EEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHH-HT
T ss_pred EEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccC-CC
Confidence 999999888899999887543 35688999999999999999999999986 5678999999999999999975422 14
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCCCCcccc
Q 042371 179 LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258 (400)
Q Consensus 179 l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~ 258 (400)
+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..............+++.|+|||++
T Consensus 281 ~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~ 357 (454)
T 1qcf_A 281 QPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 357 (454)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHh
Confidence 789999999999999999999999 99999999999999999999999999986543222222334467889999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHh
Q 042371 259 RSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRC 337 (400)
Q Consensus 259 ~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 337 (400)
....++.++||||||+++|+|++ |+.||....... . ......+ .....+...++.+.+++.+|
T Consensus 358 ~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~----~~~i~~~---------~~~~~~~~~~~~l~~li~~c 421 (454)
T 1qcf_A 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V----IRALERG---------YRMPRPENCPEELYNIMMRC 421 (454)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H----HHHHHHT---------CCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcC---------CCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999999999999 999995432211 0 1111111 11112233456799999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHH
Q 042371 338 LNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 338 l~~dP~~RPt~~ell~~L~~~~~ 360 (400)
|+.||.+|||+.+|++.|+.+..
T Consensus 422 l~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 422 WKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp TCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ccCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=356.61 Aligned_cols=249 Identities=26% Similarity=0.383 Sum_probs=207.6
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
..++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 357899999999999999999996 57899999987643 344567888999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999997764 4899999999999999999999999 99999999999999999999999999976532
Q ss_pred CCceeeecccccCCCCCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFT-DKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
........||+.|+|||++.+..++ .++||||+||++|+|++|+.||....... .. .....+..
T Consensus 167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~-~~i~~~~~------ 231 (328)
T 3fe3_A 167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LR-ERVLRGKY------ 231 (328)
T ss_dssp --SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCCC------
T ss_pred --CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCCC------
Confidence 2234456799999999999988875 78999999999999999999995432211 11 11111110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1112234568899999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=360.31 Aligned_cols=267 Identities=28% Similarity=0.459 Sum_probs=209.9
Q ss_pred hcCCcccceeeecCcEEEEEEEe-----cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--Ccc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 154 (400)
.++|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999983 35789999998876677778899999999999999999999998653 458
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999987543 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCc--eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc----
Q 042371 235 IVIDQT--HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN---- 308 (400)
Q Consensus 235 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---- 308 (400)
...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~ 235 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQ 235 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHHHHCTTCCTH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHhhhcCccccc
Confidence 643222 1223344677899999999999999999999999999999999997432110 00000000
Q ss_pred ----ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 309 ----RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 309 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
.....+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00000111111122334557799999999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=350.59 Aligned_cols=272 Identities=23% Similarity=0.352 Sum_probs=216.0
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC--cceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETE--VPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 157 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367999999999999999999975 48899999876433 344677889999999999999999999988765 67899
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCcEEEEecCCcc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL----NEKYTAKVADFGTSK 233 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll----~~~~~~kl~Dfgla~ 233 (400)
|||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655445999999999999999999999999 9999999999999 788889999999998
Q ss_pred ccccCCceeeecccccCCCCCccccc--------cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFR--------SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 305 (400)
..... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||...................
T Consensus 165 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 65432 2233456899999999986 5788999999999999999999999996544332222222211111
Q ss_pred -hhccccccc-----------chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 306 -EENRLYDFL-----------DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 306 -~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
....+..+. ............+..+.+++.+||+.||++|||++|++++..+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111110000 00111234577888899999999999999999999999988764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=361.02 Aligned_cols=270 Identities=24% Similarity=0.322 Sum_probs=210.1
Q ss_pred HhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc----ceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV----PLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~l 156 (400)
..++|++.+.||+|+||.||+|... ++.||||++.... ........|+.+++.++||||+++++++..... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4578999999999999999999875 7899999886433 334455668888999999999999999987554 599
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCCCCeEEcCCCcEEE
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA----------ASMPIYHRDIKSTNILLNEKYTAKV 226 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~iiHrDikp~NIll~~~~~~kl 226 (400)
||||+++|+|.+++... .+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 99999999999999764 389999999999999999999998 8 999999999999999999999
Q ss_pred EecCCccccccCCce-eeecccccCCCCCccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHH
Q 042371 227 ADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSG-----QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAY 300 (400)
Q Consensus 227 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 300 (400)
+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999765433222 23335689999999998863 456788999999999999999999965443222111111
Q ss_pred ---------HHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 301 ---------FILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 301 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.............+.. .......+..+.+|+.+||+.||.+|||+.++++.|+++++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hccCCchhhhhhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0000111111111110 0112345667999999999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=355.25 Aligned_cols=261 Identities=24% Similarity=0.410 Sum_probs=212.3
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
....++|++.+.||+|+||.||++...++..||+|.+..... ..+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 345678999999999999999999988888999998875432 3467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999976433 4899999999999999999999999 999999999999999999999999999865433
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ .......
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~--------- 237 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQG--------- 237 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHTT---------
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-------HHHHhcc---------
Confidence 3233334456788999999999999999999999999999998 9999954332110 0111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
.....+...++.+.+++.+||+.||.+|||+.+++++|..+...
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 01111222345689999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=381.54 Aligned_cols=327 Identities=25% Similarity=0.402 Sum_probs=240.7
Q ss_pred CCCceeEeccCc---eeeec-CCchhhhhhHHH----HHHHHHHHhhcCCccchhhhccCCCCCCcc--cccChHHHHHH
Q 042371 12 SENLLCENYEGG---YRCIT-PKRKVYIIKRED----IKLKEKFFKRNGGLVLQQQLTSSDGSIDRC--KLFTTKELDKA 81 (400)
Q Consensus 12 ~~~~~c~~~~~~---y~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 81 (400)
|...+++...+. |++.. ..+++|+..... ..+.+.+.....++...-............ .......++..
T Consensus 139 ~~~~lsv~~~~~v~h~~I~~~~~g~~~~~~~~~F~sl~eLv~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (495)
T 1opk_A 139 GQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEME 218 (495)
T ss_dssp TCEEEEEEETTEEEEEECEECTTSCEESSTTSCBSSHHHHHHHHTTCCTTSSSCCCEECCCCSCCCCSSSCSSSSCCBCC
T ss_pred CceEEEEeeCCeEEEEEEEecCCCceEeccCccchhHHHHhhhhcccccccchhccccccccccccccccCccccccccC
Confidence 456666666555 66643 355555443322 344455544444443221111110000000 00112334455
Q ss_pred hcCCcccceeeecCcEEEEEEEecC-CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..+|++.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.+|++++||||+++++++......+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 6789999999999999999999764 7899999886543 3467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++|+|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999875432 5899999999999999999999999 99999999999999999999999999987643333
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||....... .. .... ....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~----~~~~---------~~~~ 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY----ELLE---------KDYR 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----HHHH---------TTCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHH---------cCCC
Confidence 33334456788999999999999999999999999999999 999995443221 11 0111 1111
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1223344567999999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=350.59 Aligned_cols=261 Identities=28% Similarity=0.412 Sum_probs=207.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999964 6889999987542 234457888999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++++|.+++.... ++++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999998764 5899999999999999999999999 99999999999999999999999999987644
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
..........||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ...... ......
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~-~~~~~~----- 231 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHI-QDSVPN----- 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHH-SSCCCC-----
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHh-hccCCC-----
Confidence 33333445679999999999999999999999999999999999999995432211 011111 111110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRP-TMKEVAMELERIQA 360 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ell~~L~~~~~ 360 (400)
.........+..+.+++.+||+.||.+|| +++++.+.|+.+..
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 11112233456789999999999999998 89999888876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=365.00 Aligned_cols=273 Identities=28% Similarity=0.394 Sum_probs=218.6
Q ss_pred ccChHHHHHHhcCCcccceeeecCcEEEEEEEe------cCCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCccee
Q 042371 72 LFTTKELDKATDHFNVNRILGQGGQGTVYKGML------ADGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVK 143 (400)
Q Consensus 72 ~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~ 143 (400)
.+....++...++|++.+.||+|+||.||+|.+ .+++.||||.+... .....+.+.+|+.++..+ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 445567777889999999999999999999973 24578999988653 334457789999999999 7999999
Q ss_pred eeeEEeeCCc-ceEEEEccCCCCHHHHHhhcCC-----------------------------------------------
Q 042371 144 LLGCCLETEV-PLLVYEFISNGTLFQYLHDQNE----------------------------------------------- 175 (400)
Q Consensus 144 ~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 175 (400)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887654 8999999999999999976532
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 176 ----------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 176 ----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 112889999999999999999999999 9999999999999999999999999998654332
Q ss_pred c-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 240 T-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 240 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. .......||+.|+|||++.+..++.++||||||+++|+|++ |..||........ ..........
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~------- 314 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTR------- 314 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCC-------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCC-------
Confidence 2 23344568899999999999999999999999999999998 9999954332210 1111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
...+...++.+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 315 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 315 --MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1112223456899999999999999999999999999988653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=378.06 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=209.8
Q ss_pred hHHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 75 TKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 75 ~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
...++...++|++.+.||+|+||.||+|.+.++..||||.+.... ...+.+.+|+.+|++++||||+++++++.+ +..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 444556678899999999999999999999888889999887543 345789999999999999999999999876 678
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 999999999999999975322 24899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.............+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+ .......+
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~----- 397 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERG----- 397 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT-----
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC-----
Confidence 64333333334456889999999999999999999999999999999 999995432211 01111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.....+...++.+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 398 ----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 398 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 1111223445678999999999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=351.56 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=201.8
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecC----CcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
...++|++.+.||+|+||.||+|.... +..||+|..... .....+.+.+|+.+++.++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345789999999999999999998642 457999987653 3445678899999999999999999999974 5678
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999976543 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.............+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... .. ........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~----~~i~~~~~--- 235 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI----GRIENGER--- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCC---
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH----HHHHcCCC---
Confidence 64433333334456789999999999999999999999999999997 999996443221 11 11111110
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+....+
T Consensus 236 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 236 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11223345678999999999999999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=362.89 Aligned_cols=261 Identities=25% Similarity=0.443 Sum_probs=202.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec----CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.++|++.+.||+|+||.||+|... ++..||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999864 4678999988754 34456789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999976543 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCcee--eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 237 IDQTHV--TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 237 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
...... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... . ......
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~------~-~~~i~~------ 265 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------V-IKAVDE------ 265 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH------H-HHHHHT------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------H-HHHHHc------
Confidence 332221 122335778999999999999999999999999999998 999995433211 0 111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
......+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 266 ---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 266 ---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp ---TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred ---CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 11111223345679999999999999999999999999999876443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=351.72 Aligned_cols=267 Identities=21% Similarity=0.304 Sum_probs=204.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
..++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457899999999999999999998889999999876432 334577889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++ +|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 88888876443 4899999999999999999999999 999999999999999999999999999865322
Q ss_pred CceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc----
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF---- 313 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 313 (400)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......................+...
T Consensus 173 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 173 -VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp -CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred -cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 223344568999999999876 56899999999999999999999999654433211111100000000011000
Q ss_pred ---------cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 ---------LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000001112234568899999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=358.70 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=205.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc------hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE------GKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999965 589999998765322 1357889999999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----cEEEEecC
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY----TAKVADFG 230 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~Dfg 230 (400)
++||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999997643 5899999999999999999999999 99999999999998876 79999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ..+....
T Consensus 165 ~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~-~~i~~~~- 234 (361)
T 2yab_A 165 LAHEIED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANITAVS- 234 (361)
T ss_dssp SCEECCT--TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHTTC-
T ss_pred CceEcCC--CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcC-
Confidence 9986543 223345679999999999999999999999999999999999999995432211 00 1111110
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+ +.... ...+..+.+||.+||..||.+|||+.+++++
T Consensus 235 ~~~-~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 YDF-DEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCC-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCC-Cchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 11111 1234568899999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=351.34 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=207.3
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999965 6899999987642 344567888999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999998654 4899999999999999999999999 99999999999999999999999999975432
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ... .......
T Consensus 158 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~-~i~~~~~------- 222 (337)
T 1o6l_A 158 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFE-LILMEEI------- 222 (337)
T ss_dssp -TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH-HHHHCCC-------
T ss_pred -CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHH-HHHcCCC-------
Confidence 2223345679999999999999999999999999999999999999995432111 111 1111110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11223456689999999999999999 89999886
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=361.66 Aligned_cols=274 Identities=28% Similarity=0.405 Sum_probs=219.2
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEec--------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeE
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLA--------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGC 147 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 147 (400)
++...++|.+.+.||+|+||.||+|... .+..||+|++... .......+.+|+.+++.+ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3445678999999999999999999852 2357999987653 344567889999999999 89999999999
Q ss_pred EeeCCcceEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 042371 148 CLETEVPLLVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKST 214 (400)
Q Consensus 148 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~ 214 (400)
+...+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence 9999999999999999999999987542 235899999999999999999999999 999999999
Q ss_pred CeEEcCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCc
Q 042371 215 NILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSK 292 (400)
Q Consensus 215 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~ 292 (400)
|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986543221 22333457889999999999999999999999999999999 99998543221
Q ss_pred cccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhccccccc
Q 042371 293 EATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQI 370 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~ 370 (400)
. . ........ ....+...+..+.+++.+||+.||.+|||+.+|+++|+.+.+..........
T Consensus 301 ~------~-~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 301 E------L-FKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp H------H-HHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred H------H-HHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 1 1 11111111 1111223445689999999999999999999999999999987766554443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=347.52 Aligned_cols=262 Identities=25% Similarity=0.374 Sum_probs=212.9
Q ss_pred cccChHHHHHHhcC----------CcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCC
Q 042371 71 KLFTTKELDKATDH----------FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHR 139 (400)
Q Consensus 71 ~~~~~~~~~~~~~~----------y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ 139 (400)
..++..++....+. |...+.||+|+||.||+|... +|+.||||.+........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34566666555543 777889999999999999976 6899999998776666778899999999999999
Q ss_pred cceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 042371 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN 219 (400)
Q Consensus 140 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 219 (400)
||+++++++...+..++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 9999999999999999999999999999998643 4899999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHH
Q 042371 220 EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAA 299 (400)
Q Consensus 220 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 299 (400)
.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~------ 248 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------ 248 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------
T ss_pred CCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence 99999999999997654322 22344679999999999999999999999999999999999999995432211
Q ss_pred HHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 300 YFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ...........+ ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 249 ~-~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 A-MKRLRDSPPPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H-HHHHHHSSCCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H-HHHHhcCCCCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 111111110000 0111234568899999999999999999999885
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=344.27 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=213.3
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467999999999999999999988888999998875433 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999976543 4899999999999999999999999 999999999999999999999999999865432222
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... . ........ ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~-~~~i~~~~---------~~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------V-VEDISTGF---------RL 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-HHHHHTTC---------CC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------H-HHHHhcCC---------cC
Confidence 2333456788999999999999999999999999999999 899985432211 1 11111110 01
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
..+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11223345689999999999999999999999999998763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=353.51 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=206.9
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|++.+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999965 5889999987643 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCcEEEEecCCccccccC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE--KYTAKVADFGTSKFIVID 238 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~--~~~~kl~Dfgla~~~~~~ 238 (400)
+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~- 156 (321)
T 1tki_A 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC-
Confidence 999999999976432 5899999999999999999999999 999999999999997 78999999999987643
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
........||+.|+|||++.+..++.++||||||+++|+|++|..||....... . ......... .+ +...
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~-~~~i~~~~~-~~-~~~~ 226 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------I-IENIMNAEY-TF-DEEA 226 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHHHHHTCC-CC-CHHH
T ss_pred -CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------H-HHHHHcCCC-CC-Chhh
Confidence 233345668999999999998889999999999999999999999995432211 1 111111110 00 0111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
. ...+..+.+++.+||..||.+|||+.+++++-
T Consensus 227 ~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred h----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 1 12345689999999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=353.85 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=215.3
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEe------cCCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEee
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGML------ADGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLE 150 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 150 (400)
+....++|.+.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 344567899999999999999999985 23578999988653 34456788999999999999999999999999
Q ss_pred CCcceEEEEccCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQNE---------------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHR 209 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHr 209 (400)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence 9999999999999999999987542 124889999999999999999999999 9999
Q ss_pred CCCCCCeEEcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 042371 210 DIKSTNILLNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPII 287 (400)
Q Consensus 210 Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~ 287 (400)
||||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999865433222 2233456888999999999999999999999999999999 999995
Q ss_pred cCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 288 LTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
...... .. ....... ....+...++.+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 255 ~~~~~~---~~----~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPER---LF----NLLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGGG---HH----HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHH---HH----HHhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 433221 11 1111111 1112233456799999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=348.34 Aligned_cols=267 Identities=26% Similarity=0.415 Sum_probs=214.9
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
++....++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3445567899999999999999999998888899999876433 34578899999999999999999999876 456899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 9999999999999975421 14899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
...........+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... . .......
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~-~~~~~~~------- 226 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------V-IQNLERG------- 226 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------H-HHHHHTT-------
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------H-HHHHhcc-------
Confidence 433333344557889999999998899999999999999999999 999985432211 0 1111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhcc
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~ 365 (400)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus 227 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 227 --YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred --cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 011112234567899999999999999999999999999988755443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=344.25 Aligned_cols=254 Identities=29% Similarity=0.488 Sum_probs=197.3
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCc----hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHE----GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|... ++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999975 78899998764322 3357788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--------CCcEEEEec
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE--------KYTAKVADF 229 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~--------~~~~kl~Df 229 (400)
|||+++++|.+++... .+++..++.++.|++.||.|||+.+..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999998643 4899999999999999999999988556889999999999986 678999999
Q ss_pred CCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 230 GTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 230 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
|++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... . ........
T Consensus 161 g~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~-~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------V-AYGVAMNK 230 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------H-HHHHHTSC
T ss_pred Ccccccccc---cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHhhhcCC
Confidence 999765322 2224568999999999999999999999999999999999999995432111 0 01111111
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
.....+...++.+.+++.+||+.||.+|||+.+++++|+++
T Consensus 231 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 --------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 01112233456799999999999999999999999999754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=341.72 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=202.3
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHh--CCCCcceeeeeEEeeC----Ccce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQ--INHRNVVKLLGCCLET----EVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~----~~~~ 155 (400)
.++|++.+.||+|+||.||+|.. +++.||+|.+.. .....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999988 688999998753 334556667777766 7899999999986543 4578
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeEEcCCCcEEEE
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH--------SAASMPIYHRDIKSTNILLNEKYTAKVA 227 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiHrDikp~NIll~~~~~~kl~ 227 (400)
+||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999543 4899999999999999999999 777 9999999999999999999999
Q ss_pred ecCCccccccCCcee---eecccccCCCCCccccccC------CCCCcchhHHHHHHHHHHHhC----------CCCCCc
Q 042371 228 DFGTSKFIVIDQTHV---TTKVQGTFGYLDPEYFRSG------QFTDKSDVYSFGVVLVELLTG----------QKPIIL 288 (400)
Q Consensus 228 Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg----------~~pf~~ 288 (400)
|||++.......... .....||+.|+|||++.+. .++.++||||||+++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997654333322 2234689999999999876 455799999999999999999 778754
Q ss_pred CCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 289 TGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
....... ................+.. .......+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPS-FEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCC-HHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcc-hhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3322211 1111111111111111110 112235677899999999999999999999999999886
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=349.20 Aligned_cols=265 Identities=28% Similarity=0.440 Sum_probs=220.0
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
++...++|++.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3445678999999999999999999976 4788999987643 4456788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++...... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTT-TSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhcccC-CccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999875433 5899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
...........+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ... ....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~----~~~~-------- 227 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEK-------- 227 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHT--------
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhc--------
Confidence 444444455567889999999999999999999999999999999 999985433221 110 0111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
......+...++.+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 228 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 228 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11111223345678999999999999999999999999999876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=351.97 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=201.0
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEV------ 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------ 153 (400)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999975 78999999886533 3456789999999999999999999999866442
Q ss_pred ---------------------------------------------------ceEEEEccCCCCHHHHHhhcCCCCCCCHH
Q 042371 154 ---------------------------------------------------PLLVYEFISNGTLFQYLHDQNEEFPLTWE 182 (400)
Q Consensus 154 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~ 182 (400)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999876654456777
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc-----------eeeecccccCC
Q 042371 183 MRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT-----------HVTTKVQGTFG 251 (400)
Q Consensus 183 ~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~ 251 (400)
.++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 99999999999999999999999999987643321 12234568999
Q ss_pred CCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHH
Q 042371 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIA 331 (400)
Q Consensus 252 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 331 (400)
|+|||++.+..++.++||||||+++|+|++|..|+.. ... .......... .......++.+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~-~~~~~~~~~~---------~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVR-IITDVRNLKF---------PLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHH-HHHHHHTTCC---------CHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHH-HHHHhhccCC---------CcccccCChhHH
Confidence 9999999999999999999999999999999877510 000 0000111110 011123445678
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 042371 332 TLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 332 ~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+++.+||+.||.+|||+.+++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=350.50 Aligned_cols=267 Identities=26% Similarity=0.409 Sum_probs=216.2
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEe------cCCcEEEEEEccccC-chhHHHHHHHHHHHHhC-CCCcceeeeeEEe
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGML------ADGRIVAVKKSKIVH-EGKLEEFINEVVILSQI-NHRNVVKLLGCCL 149 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 149 (400)
+....++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 344557899999999999999999984 246789999876543 34567889999999999 8999999999999
Q ss_pred eCCcceEEEEccCCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 042371 150 ETEVPLLVYEFISNGTLFQYLHDQNE---------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKST 214 (400)
Q Consensus 150 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~ 214 (400)
..+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999987542 124899999999999999999999999 999999999
Q ss_pred CeEEcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCc
Q 042371 215 NILLNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSK 292 (400)
Q Consensus 215 NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~ 292 (400)
|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999876433322 2233457889999999999999999999999999999999 99999544322
Q ss_pred cccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 293 EATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.. . ....... .....+...+..+.+++.+||+.||.+|||+.+++++|+++....
T Consensus 255 ~~--~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 255 SK--F----YKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HH--H----HHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hH--H----HHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11 0 0111110 111112234566899999999999999999999999999987754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=357.62 Aligned_cols=269 Identities=25% Similarity=0.412 Sum_probs=212.7
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEe------cCCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEE
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGML------ADGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCC 148 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 148 (400)
+++...++|.+.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3455668899999999999999999985 23568999987643 233457889999999999 899999999999
Q ss_pred eeCCcceEEEEccCCCCHHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 042371 149 LETEVPLLVYEFISNGTLFQYLHDQNEE--------------------FPLTWEMRLRIATEVAGSLSYLHSAASMPIYH 208 (400)
Q Consensus 149 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 208 (400)
...+..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+.+ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999999999999999999999865421 23789999999999999999999999 999
Q ss_pred cCCCCCCeEEcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCC
Q 042371 209 RDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPI 286 (400)
Q Consensus 209 rDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf 286 (400)
|||||+|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999866433322 2334557889999999999999999999999999999998 99999
Q ss_pred CcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 287 ILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
........ ........ .....+...+..+.+++.+||+.||.+|||+.+++++|+.+.+...
T Consensus 276 ~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 276 PGIPVDAN------FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTCCCSHH------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ccCCcHHH------HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 54432211 01111111 1111122335668999999999999999999999999999876544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=340.37 Aligned_cols=266 Identities=17% Similarity=0.175 Sum_probs=213.5
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... .....+.+|+.++..+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999995 56899999987533 2334577899999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-----EEEEecCCccc
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT-----AKVADFGTSKF 234 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-----~kl~Dfgla~~ 234 (400)
|+ +++|.+++..... ++++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 87 ~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 9999999987543 4899999999999999999999999 999999999999987765 99999999987
Q ss_pred cccCCc------eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 235 IVIDQT------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 235 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 653322 12344669999999999999999999999999999999999999996544322211111111111111
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
... . .....++.+.+++.+||+.||.+|||+.+|++.|+++......
T Consensus 241 ~~~-----~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 241 PLR-----E----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp CHH-----H----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cHH-----H----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 100 0 0112345689999999999999999999999999999876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=350.25 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=205.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc------hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE------GKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456999999999999999999975 588999998764322 1367889999999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----cEEEEecC
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY----TAKVADFG 230 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~Dfg 230 (400)
++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997543 5899999999999999999999999 99999999999999887 89999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .. .......
T Consensus 164 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~-~~~~~~~- 233 (326)
T 2y0a_A 164 LAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANVSAVN- 233 (326)
T ss_dssp TCEECCTT--SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHHTC-
T ss_pred CCeECCCC--CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HH-HHHHhcC-
Confidence 99865322 22344569999999999999999999999999999999999999995432211 00 0000000
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+ ..... ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 234 ~~~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YEF-EDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCC-CHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCc-Ccccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 01111 1224568899999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.76 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=201.7
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcc
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 154 (400)
...++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999965 5889999987642 334567788999999988 799999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999998764 4899999999999999999999999 99999999999999999999999999975
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
... .........||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... .. ..+.....
T Consensus 174 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~-~~i~~~~~---- 241 (353)
T 3txo_A 174 GIC-NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LF-EAILNDEV---- 241 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCCC----
T ss_pred ccc-CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HH-HHHHcCCC----
Confidence 322 2233445679999999999999999999999999999999999999995433211 11 11111110
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTM------KEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+||++ .+++++
T Consensus 242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1112234568899999999999999998 777764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=360.75 Aligned_cols=265 Identities=26% Similarity=0.381 Sum_probs=213.2
Q ss_pred HhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
..++|++.+.||+|+||.||+|... ++..||||.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3478999999999999999999843 4678999988643 34455678899999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---cEEE
Q 042371 154 PLLVYEFISNGTLFQYLHDQNE----EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY---TAKV 226 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl 226 (400)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999987532 235899999999999999999999999 99999999999999555 5999
Q ss_pred EecCCccccccCC-ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHH
Q 042371 227 ADFGTSKFIVIDQ-THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILS 304 (400)
Q Consensus 227 ~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 304 (400)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||....... . ...
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~-~~~ 298 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------V-LEF 298 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------H-HHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------H-HHH
Confidence 9999997553221 122334557899999999999999999999999999999998 999995432211 1 111
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
..... ....+...+..+.+|+.+||+.||.+|||+.+|+++|+.+......
T Consensus 299 i~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 299 VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred HHcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 11111 1111223445689999999999999999999999999998875443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=343.17 Aligned_cols=263 Identities=29% Similarity=0.460 Sum_probs=209.9
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC----CcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
..++|.+.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35689999999999999999998543 346999987654 34456788999999999999999999999765 4578
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999977543 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
............+++.|+|||++.+..++.++||||||+++|+|++ |+.||........ .. .......
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~----~~~~~~~---- 232 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IG----VLEKGDR---- 232 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HH----HHHHTCC----
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HH----HHhcCCC----
Confidence 4433333344557889999999999999999999999999999998 9999954333221 10 1111100
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhcc
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~ 365 (400)
...+...++.+.+++.+||+.||.+|||+.+++++|+.+....+.+
T Consensus 233 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~i 278 (281)
T 3cc6_A 233 -----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278 (281)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhhh
Confidence 1112223456899999999999999999999999999998876553
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=346.50 Aligned_cols=265 Identities=16% Similarity=0.177 Sum_probs=211.4
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 4689999998764322 34578899999999 89999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-----EEEEecCCccc
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT-----AKVADFGTSKF 234 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-----~kl~Dfgla~~ 234 (400)
|+ +++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 8999999986532 5999999999999999999999999 999999999999998887 99999999986
Q ss_pred cccCCce------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 235 IVIDQTH------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 235 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 5433221 1245679999999999999999999999999999999999999996543222111111110000000
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
...... ...+ .+.+++.+||+.||.+||++.+|++.|+++......
T Consensus 240 ------~~~~~~---~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 240 ------PIEVLC---ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp ------CHHHHT---TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ------CHHHHh---ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 000000 1122 699999999999999999999999999988876544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=362.87 Aligned_cols=254 Identities=21% Similarity=0.312 Sum_probs=205.7
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
..++|++.+.||+|+||.||+|... +|+.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567999999999999999999864 68899999876433 34456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCcEEEEecCCccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN---EKYTAKVADFGTSKF 234 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~---~~~~~kl~Dfgla~~ 234 (400)
|||++||+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999998754 4899999999999999999999999 99999999999998 457899999999976
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
.... ........||+.|+|||++.+..|+.++||||+||++|+|++|..||....... . ......+.. .+.
T Consensus 163 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~------~-~~~i~~~~~-~~~ 233 (444)
T 3soa_A 163 VEGE-QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR------L-YQQIKAGAY-DFP 233 (444)
T ss_dssp CCTT-CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------H-HHHHHHTCC-CCC
T ss_pred ecCC-CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH------H-HHHHHhCCC-CCC
Confidence 5432 223345679999999999999999999999999999999999999995432111 0 111111111 111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ......++.+.+|+.+||+.||.+|||+.+++++
T Consensus 234 ~-----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 S-----PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp T-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred c-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 1112334668999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=344.60 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=200.7
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998779999999876433 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++ +|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-V 154 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc-c
Confidence 975 99998876433 4899999999999999999999999 999999999999999999999999999765322 2
Q ss_pred eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh---cccccc---
Q 042371 241 HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE---NRLYDF--- 313 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 313 (400)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ..... ...... ..+...
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRI-FRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHH-HHHHCCCCTTTSTTGGGS
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HHHHCCCChhhchhhhcc
Confidence 223345689999999998764 58999999999999999999999995433211 11111 110000 000000
Q ss_pred --cc-------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 --LD-------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 --~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+ +..........++.+.+|+.+||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 000011112345678899999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=352.34 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=202.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999965 68899999875432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999987543 4899999999999999999999999 9999999999999999999999999998654322
Q ss_pred -ceeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 240 -THVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 240 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ .+..... ...
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~~~~~-~~~-------- 226 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----EYSDWKE-KKT-------- 226 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH----HHHHHHT-TCT--------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH----HHHHHhc-ccc--------
Confidence 222345679999999999987775 7789999999999999999999964432211 1111110 000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 227 -~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000112234568899999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=354.86 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=206.0
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
..++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999965 5889999987643 334567888999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---cEEEEecCCccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY---TAKVADFGTSKF 234 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl~Dfgla~~ 234 (400)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999987643 5899999999999999999999999 99999999999998654 599999999986
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... . ......... .+.
T Consensus 181 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------~-~~~i~~~~~-~~~ 250 (362)
T 2bdw_A 181 VND--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------L-YAQIKAGAY-DYP 250 (362)
T ss_dssp CTT--CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHTCC-CCC
T ss_pred ecC--CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------H-HHHHHhCCC-CCC
Confidence 542 222344679999999999999999999999999999999999999995432111 1 111111111 111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 251 ~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 012234568999999999999999999999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=362.90 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=206.8
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
....++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++..++||||+++++++.+....
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 344678999999999999999999975 5889999987531 122334578899999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||++||+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.
T Consensus 145 ~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 9999999999999999754 3899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccCCCCCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQ----FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
.............||+.|+|||++.+.. |+.++|||||||++|+|++|+.||....... ...........
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~ 291 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHKNS 291 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHHHH
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HHHHHHhcccc
Confidence 6544333445678999999999998665 8899999999999999999999995432211 11111110000
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKR--RPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~ 354 (400)
..+ ......+..+.+||.+||..+|.+ ||++.+++++
T Consensus 292 ~~~-------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 LTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCC-------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccC-------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000 011123456899999999999988 9999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=353.53 Aligned_cols=264 Identities=25% Similarity=0.422 Sum_probs=213.2
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLET 151 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 151 (400)
....++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345688999999999999999999974 2478999988754 334467889999999999999999999999999
Q ss_pred CcceEEEEccCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNE---------------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRD 210 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrD 210 (400)
+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999987431 136899999999999999999999999 99999
Q ss_pred CCCCCeEEcCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCc
Q 042371 211 IKSTNILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIIL 288 (400)
Q Consensus 211 ikp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~ 288 (400)
|||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999976532221 22334557899999999999999999999999999999999 9999954
Q ss_pred CCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 289 TGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
..... ........... ..+...+..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 280 ~~~~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MAHEE-------VIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SCHHH-------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CChHH-------HHHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 32211 11111111111 11223445689999999999999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=349.71 Aligned_cols=263 Identities=28% Similarity=0.440 Sum_probs=197.8
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC-C---cEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD-G---RIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~-~---~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
..++|++.+.||+|+||.||+|.... + ..||+|.+... .....+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34689999999999999999999653 3 27999987653 445578899999999999999999999999877655
Q ss_pred ------eEEEEccCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEE
Q 042371 155 ------LLVYEFISNGTLFQYLHDQN---EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAK 225 (400)
Q Consensus 155 ------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~k 225 (400)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 89999999999999986532 2225899999999999999999999999 99999999999999999999
Q ss_pred EEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHH
Q 042371 226 VADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 226 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 303 (400)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ . ..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~---~~ 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---Y---NY 251 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H---HH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---H---HH
Confidence 999999986543221 12233456789999999999999999999999999999999 9999954332211 0 00
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.. ... ....+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 252 ~~-~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 252 LI-GGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HH-TTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred Hh-cCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00 100 11122334467899999999999999999999999999987743
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=355.01 Aligned_cols=279 Identities=24% Similarity=0.339 Sum_probs=212.6
Q ss_pred hcCCcccceeeecCcEEEEEEEe-----cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEe--eCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL--ETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 154 (400)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+........+.+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36799999999999999999983 357899999988776677788999999999999999999999887 44568
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 899999999999999986433 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCce--eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 235 IVIDQTH--VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 235 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............ ..........+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHHHH
Confidence 6433222 223345788899999999999999999999999999999999998432111000000 0000000000011
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhccc
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDIN 366 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~ 366 (400)
.+........+...++.+.+++.+||+.||.+|||+.+++++|+.+........
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 111111122334456779999999999999999999999999999877554433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=379.73 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=214.3
Q ss_pred hHHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 75 TKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 75 ~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
...|+...++|++.+.||+|+||.||+|.+.++..||||.+.... ...+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 445566678899999999999999999999888889999887543 345789999999999999999999999876 678
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
+|||||+++|+|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eEeeehhcCCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999999753221 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.............++..|+|||++.+..++.++||||||+++|+|++ |+.||......+ .......+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~----- 480 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERG----- 480 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTT-----
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC-----
Confidence 54322222233446788999999999999999999999999999999 999995432211 01111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 481 ----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 481 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 0111223445678999999999999999999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=354.98 Aligned_cols=257 Identities=24% Similarity=0.371 Sum_probs=204.3
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 155 (400)
..++|++.+.||+|+||.||+|..+ +++.||+|.+... .......+..|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467999999999999999999965 5789999987643 233345678899999887 8999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||++||+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999998754 4899999999999999999999999 999999999999999999999999999753
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccc--cchHHHHHHHhhhcccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA--TGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 313 (400)
.. .........||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.... ...............
T Consensus 204 ~~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 278 (396)
T 4dc2_A 204 LR-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 278 (396)
T ss_dssp CC-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred cc-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence 22 23334557799999999999999999999999999999999999999964432211 111111111111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTM------KEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~ell~~ 354 (400)
...+...+..+.+||.+||+.||.+||++ .+++++
T Consensus 279 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 ------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 01122345668999999999999999996 566554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=363.64 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=208.2
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
+....++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|..++..++||||+++++++.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3445678999999999999999999976 4789999987532 12223447889999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||++||+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 9999999999999999986432 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
..............||+.|+|||++. ...|+.++|||||||++|+|++|+.||........ ........
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~ 297 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK 297 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHH
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHhhhhcc
Confidence 76544444455578999999999987 45789999999999999999999999954332111 11111000
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKR--RPTMKEVAME 354 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~ 354 (400)
....+. ......++.+.+||.+||..+|++ ||++++++++
T Consensus 298 ~~~~~p------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 ERFQFP------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHCCCC------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCC------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 000000 011123456889999999988888 9999999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=350.73 Aligned_cols=259 Identities=24% Similarity=0.455 Sum_probs=203.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCc----EEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGR----IVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
.++|++.+.||+|+||.||+|.+. +++ +||+|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357999999999999999999954 343 4688876532 3345678999999999999999999999998754 78
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+|++|+.+|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999987543 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 236 VIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 236 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ . .....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----~~~~~------ 234 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEK------ 234 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHT------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---H----HHHHc------
Confidence 433222 2233456889999999999999999999999999999999 9999954332211 1 01111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
......+...+..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 235 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 235 ---GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ---TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ---CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 1111122334456899999999999999999999999999887543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.79 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=204.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999965 5889999987532 234567888999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||++||+|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.+|.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~- 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP- 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc-
Confidence 99999999999998643 5899999999999999999999999 9999999999999999999999999998653
Q ss_pred CCceeeecccccCCCCCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
.........||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||............. .....
T Consensus 167 -~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~~~~~------ 235 (384)
T 4fr4_A 167 -RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH----TFETT------ 235 (384)
T ss_dssp -TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH----HHHHC------
T ss_pred -CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH----HHhhc------
Confidence 2233455679999999999864 458999999999999999999999996443322111111 11110
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT-MKEVAM 353 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ell~ 353 (400)
....+...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01112234567899999999999999998 666654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=343.53 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=205.3
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||++... +|+.||+|.+... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999965 6899999987642 223467788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999998654 4899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ... .......
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~-~i~~~~~------- 220 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYE-KILNAEL------- 220 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-HHHHCCC-------
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHH-HHHhCCC-------
Confidence 2334679999999999999999999999999999999999999995432211 111 1111110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11223345689999999999999999 88998875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=351.09 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=204.5
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999996 56899999987532 122345788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+ +|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 679999887654 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCceeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ...+..
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~ 222 (336)
T 3h4j_B 161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNS 222 (336)
T ss_dssp --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCS
T ss_pred --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHc
Confidence 223344679999999999988776 6899999999999999999999954332211 000100
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
. ....+...+..+.+|+.+||+.||.+|||+.+++++-
T Consensus 223 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 223 C-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp S-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred C-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 0 0112233456689999999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=356.52 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=207.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999965 6889999988766555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCcEEEEecCCccccccC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE--KYTAKVADFGTSKFIVID 238 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~--~~~~kl~Dfgla~~~~~~ 238 (400)
+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999875432 5899999999999999999999999 999999999999974 468999999999865432
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... . ......... .+ +
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~-~~~i~~~~~-~~-~--- 270 (387)
T 1kob_A 205 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------T-LQNVKRCDW-EF-D--- 270 (387)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------H-HHHHHHCCC-CC-C---
T ss_pred --cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------H-HHHHHhCCC-CC-C---
Confidence 22334569999999999999999999999999999999999999995432211 0 011111110 00 0
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+..+.+||.+||+.||.+|||+.+++++
T Consensus 271 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11112345668999999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=344.11 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=195.6
Q ss_pred hcCCcccceeeecCcEEEEEEEe----cCCcEEEEEEccccC----chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML----ADGRIVAVKKSKIVH----EGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
.++|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999986 468899999876432 2345667889999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999998654 4899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .. .......
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~-~~i~~~~---- 237 (327)
T 3a62_A 170 ESIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TI-DKILKCK---- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HH-HHHHHTC----
T ss_pred ccccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHhCC----
Confidence 54322 223345679999999999999999999999999999999999999995432211 00 1111110
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
...+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011223345689999999999999999 77788775
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=353.27 Aligned_cols=268 Identities=24% Similarity=0.342 Sum_probs=197.2
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEee----
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLE---- 150 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---- 150 (400)
.++....+|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++.++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 33445568999999999999999999964 68899999886666666788899999999996 9999999999842
Q ss_pred ----CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEE
Q 042371 151 ----TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV 226 (400)
Q Consensus 151 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl 226 (400)
....++||||++ |+|.+++.......++++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence 334789999996 699998876433446999999999999999999999976 35999999999999999999999
Q ss_pred EecCCccccccCCce-----------eeecccccCCCCCcccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCc
Q 042371 227 ADFGTSKFIVIDQTH-----------VTTKVQGTFGYLDPEYF---RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSK 292 (400)
Q Consensus 227 ~Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 292 (400)
+|||++......... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876432211 11134589999999998 5677899999999999999999999999432211
Q ss_pred cccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhcc
Q 042371 293 EATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~ 365 (400)
. ..............+..+.+++.+||+.||.+|||+.+++++|+.+.......
T Consensus 260 ~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 260 R-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred H-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 0 00000000111112234789999999999999999999999999998765443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=347.47 Aligned_cols=266 Identities=26% Similarity=0.386 Sum_probs=207.8
Q ss_pred hcCCcccceeeecCcEEEEEEEe-----cCCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--Cc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLET--EV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 153 (400)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35689999999999999999983 35889999987643 334567889999999999999999999999876 56
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999999999999966543 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc--eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH------h
Q 042371 234 FIVIDQT--HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS------M 305 (400)
Q Consensus 234 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~ 305 (400)
....... .......||..|+|||++.+..++.++||||||+++|+|++|..|+..... ...... .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA-------LFLKMIGPTHGQM 247 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-------HHHHHHCSCCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh-------HHhhccCCccccc
Confidence 7654332 223345678889999999999999999999999999999999998632110 000000 0
Q ss_pred hhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 306 EENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
....+...+........+...++.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000000001111111223345567999999999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=348.60 Aligned_cols=272 Identities=26% Similarity=0.363 Sum_probs=210.8
Q ss_pred CcccceeeecCcEEEEEEEec-----CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--CcceE
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-----DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 156 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 156 (400)
|++.+.||+|+||.||++.+. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 499999999999999988642 57899999887543 34467789999999999999999999999874 56789
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++.... +++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999997643 899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCce--eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 237 IDQTH--VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 237 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||........ ..............+...+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence 33221 22345578889999999998999999999999999999999999843211000 0000000000000111111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+....
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 11122223344566799999999999999999999999999999876554
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=341.09 Aligned_cols=263 Identities=22% Similarity=0.331 Sum_probs=202.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 5889999987643 33445788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++ +|.+.+..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp CCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence 9976 66666655332 5899999999999999999999999 999999999999999999999999999865322
Q ss_pred ceeeecccccCCCCCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh---ccccccc-
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE---NRLYDFL- 314 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 314 (400)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ..... ...... ..+....
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i-~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRI-FRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHH-HHHHCCCCTTTCTTGGG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHH-HHHhCCCChhhhhhhcc
Confidence 22334456899999999998765 89999999999999999999888643322211 11111 111100 0000000
Q ss_pred -----------chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 315 -----------DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 315 -----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
............+..+.+|+.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000111122345678999999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=346.15 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=205.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 156 (400)
.++|++.+.||+|+||.||+|..+ +++.||+|.+... .......+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999975 5889999987643 334466788999999988 89999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999998654 4899999999999999999999999 9999999999999999999999999997532
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCcccc--chHHHHHHHhhhccccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEAT--GLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 314 (400)
. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... ...............
T Consensus 162 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 162 R-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp C-TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred C-CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 2 223344567999999999999999999999999999999999999999654322111 111111111111110
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTM------KEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+||++ .+++++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1122345668999999999999999996 566654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=350.18 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=205.2
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCc
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEV 153 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 153 (400)
....++|.+.+.||+|+||.||+|..+ +++.||+|.+... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345688999999999999999999975 5889999987642 234566788899999877 89999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999998754 4899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. ..+....
T Consensus 167 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~-~~i~~~~---- 234 (345)
T 1xjd_A 167 ENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LF-HSIRMDN---- 234 (345)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCC----
T ss_pred hcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HH-HHHHhCC----
Confidence 54322 223445679999999999999999999999999999999999999995432211 10 1111110
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMK-EVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ell~~ 354 (400)
...+...+..+.+++.+||+.||.+||++. +++++
T Consensus 235 ------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 235 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 011122345689999999999999999997 76643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=343.12 Aligned_cols=261 Identities=29% Similarity=0.461 Sum_probs=202.8
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.++|++.+.||+|+||.||+|... ++.||+|.+.. ....+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 357999999999999999999875 78899998753 345678899999999999999999999876 4589999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-EEEEecCCccccccCCc
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT-AKVADFGTSKFIVIDQT 240 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-~kl~Dfgla~~~~~~~~ 240 (400)
++++|.+++........+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++. +||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~--- 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--- 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc---
Confidence 99999999987554334789999999999999999999932222999999999999998886 79999999975432
Q ss_pred eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .. ..........
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~-~~~~~~~~~~--------- 223 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RI-MWAVHNGTRP--------- 223 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HH-HHHHHTTCCC---------
T ss_pred -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HH-HHHHhcCCCC---------
Confidence 12334589999999999999999999999999999999999999964332211 00 0011111111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhcc
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~ 365 (400)
......+..+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 111223456889999999999999999999999999987655443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=348.01 Aligned_cols=267 Identities=27% Similarity=0.423 Sum_probs=214.3
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec--------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEE
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA--------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCC 148 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 148 (400)
....++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 344578999999999999999999853 4678999988654 334567889999999999 899999999999
Q ss_pred eeCCcceEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042371 149 LETEVPLLVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTN 215 (400)
Q Consensus 149 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~N 215 (400)
...+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999986532 124899999999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCcc
Q 042371 216 ILLNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKE 293 (400)
Q Consensus 216 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 293 (400)
||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 99999999999999999865433221 2233456889999999998899999999999999999999 999995432211
Q ss_pred ccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 294 ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
. ........ ....+...+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 268 ------~-~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 ------L-FKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ------H-HHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ------H-HHHHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1 11111111 1112223445689999999999999999999999999999876554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=347.66 Aligned_cols=273 Identities=28% Similarity=0.398 Sum_probs=217.7
Q ss_pred cChHHHHHHhcCCcccceeeecCcEEEEEEEe------cCCcEEEEEEccccC-chhHHHHHHHHHHHHhC-CCCcceee
Q 042371 73 FTTKELDKATDHFNVNRILGQGGQGTVYKGML------ADGRIVAVKKSKIVH-EGKLEEFINEVVILSQI-NHRNVVKL 144 (400)
Q Consensus 73 ~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~ 144 (400)
+....+....++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455666678999999999999999999984 246789999876533 33456789999999999 69999999
Q ss_pred eeEEeeCC-cceEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 042371 145 LGCCLETE-VPLLVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRD 210 (400)
Q Consensus 145 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrD 210 (400)
++++...+ ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987755 48999999999999999986542 123789999999999999999999999 99999
Q ss_pred CCCCCeEEcCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCc
Q 042371 211 IKSTNILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIIL 288 (400)
Q Consensus 211 ikp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~ 288 (400)
|||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986543322 22334557889999999999999999999999999999998 9999954
Q ss_pred CCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 289 TGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
...... .......... ...+...+..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 254 ~~~~~~------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 254 VKIDEE------FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCCSHH------HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cchhHH------HHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 332210 1111111111 11122234568999999999999999999999999999886543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=341.25 Aligned_cols=269 Identities=25% Similarity=0.373 Sum_probs=205.1
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhC--CCCcceeeeeEEeeC----C
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQI--NHRNVVKLLGCCLET----E 152 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~----~ 152 (400)
....++|++.+.||+|+||.||+|... ++.||+|.+... .......|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 445678999999999999999999885 889999987532 234455566666554 899999999999887 6
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEecCCCCCCeEEcCCCcE
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA--------ASMPIYHRDIKSTNILLNEKYTA 224 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~~~~iiHrDikp~NIll~~~~~~ 224 (400)
..++||||+++|+|.+++... .+++..++.++.|++.||.|||.. + |+||||||+|||++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 789999999999999999764 389999999999999999999998 7 9999999999999999999
Q ss_pred EEEecCCccccccCCcee---eecccccCCCCCccccccCCCCCc------chhHHHHHHHHHHHhC----------CCC
Q 042371 225 KVADFGTSKFIVIDQTHV---TTKVQGTFGYLDPEYFRSGQFTDK------SDVYSFGVVLVELLTG----------QKP 285 (400)
Q Consensus 225 kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~il~elltg----------~~p 285 (400)
||+|||++.......... .....||+.|+|||++.+..++.. +|||||||++|+|++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997654322221 124568999999999988776665 9999999999999999 556
Q ss_pred CCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 286 IILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 286 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
|......... .... ............... .......+..+.+++.+||+.||.+|||+.+++++|+.+....+
T Consensus 262 ~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 262 YHDLVPSDPS-YEDM-REIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTTTSCSSCC-HHHH-HHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred HhhhcCCCCc-hhhh-HHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 5432221111 1111 111111111111110 11123677889999999999999999999999999999987553
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=349.60 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=204.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-----chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-----EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999964 68999999875321 224678899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---EEEEecCC
Q 042371 156 LVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT---AKVADFGT 231 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~Dfgl 231 (400)
+||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887653 22335899999999999999999999999 999999999999987654 99999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
+...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .. ..........
T Consensus 180 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~-~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGES-GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RL-FEGIIKGKYK 250 (351)
T ss_dssp CEECCTT-SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HH-HHHHHHTCCC
T ss_pred eeEecCC-CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HH-HHHHHcCCCC
Confidence 9865432 2223445799999999999999999999999999999999999999954210 00 1111111100
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...... ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 251 --~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001111 1234568999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=353.84 Aligned_cols=275 Identities=23% Similarity=0.344 Sum_probs=216.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC--cceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETE--VPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 157 (400)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999975 48999999876432 344677889999999999999999999988765 67999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCcEEEEecCCcc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL----NEKYTAKVADFGTSK 233 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll----~~~~~~kl~Dfgla~ 233 (400)
|||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999987654445999999999999999999999999 9999999999999 778889999999998
Q ss_pred ccccCCceeeecccccCCCCCcccccc--------CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRS--------GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 305 (400)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...................
T Consensus 165 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 65332 22334569999999999865 567889999999999999999999996543322221111111111
Q ss_pred h-hccccccc-----------chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 306 E-ENRLYDFL-----------DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 306 ~-~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
. ...+..+. ............+..+.+++.+||+.||++|||+.++++.++.+...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1 10000000 00111234577888899999999999999999999999999887653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=352.75 Aligned_cols=274 Identities=17% Similarity=0.201 Sum_probs=208.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC------CcEEEEEEccccCchh-----------HHHHHHHHHHHHhCCCCccee
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD------GRIVAVKKSKIVHEGK-----------LEEFINEVVILSQINHRNVVK 143 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~------~~~vaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~ 143 (400)
..++|++.+.||+|+||.||+|.+.. ++.||+|.+....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 4789999876433211 122345666777888999999
Q ss_pred eeeEEeeC----CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 042371 144 LLGCCLET----EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN 219 (400)
Q Consensus 144 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 219 (400)
+++++... ...+|||||+ +++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998765 4479999999 9999999987533 5999999999999999999999999 99999999999999
Q ss_pred --CCCcEEEEecCCccccccCCce------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCC
Q 042371 220 --EKYTAKVADFGTSKFIVIDQTH------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGS 291 (400)
Q Consensus 220 --~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 291 (400)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999765432211 11334599999999999999999999999999999999999999964322
Q ss_pred ccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhccc
Q 042371 292 KEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDIN 366 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~ 366 (400)
... ........ ....+..+++..+. ....+..+.+++.+||+.||.+|||+.+|++.|+.+........
T Consensus 267 ~~~--~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 267 DPK--YVRDSKIR-YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp CHH--HHHHHHHH-HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred CHH--HHHHHHHH-hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 211 11111111 11122222222111 12234568999999999999999999999999999987655443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=351.55 Aligned_cols=267 Identities=18% Similarity=0.256 Sum_probs=205.2
Q ss_pred hcCCcccceeeec--CcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQG--GQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G--~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.++|++.+.||+| +||.||+|... +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999975 6899999987643 24456778889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999875333 4899999999999999999999999 9999999999999999999999999986543
Q ss_pred cCCc------eeeecccccCCCCCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh--
Q 042371 237 IDQT------HVTTKVQGTFGYLDPEYFRS--GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME-- 306 (400)
Q Consensus 237 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-- 306 (400)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCcc
Confidence 2211 11122468899999999987 67999999999999999999999999643322110 000000000
Q ss_pred -------hc-------------ccccccc---------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 307 -------EN-------------RLYDFLD---------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 307 -------~~-------------~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. ....... ...........++.+.+|+.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0000000 000001123345679999999999999999999999976
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=339.65 Aligned_cols=264 Identities=26% Similarity=0.389 Sum_probs=213.5
Q ss_pred hcCCcccc-eeeecCcEEEEEEEec---CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNR-ILGQGGQGTVYKGMLA---DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~-~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.++|.+.+ .||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35677766 9999999999999853 5778999988754 344567899999999999999999999998 5566899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999975432 5899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCcee--eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 237 IDQTHV--TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 237 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ ........
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~i~~~~---- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGK---- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTC----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHhcCC----
Confidence 333222 223346889999999998899999999999999999998 9999954432210 01111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhcccc
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDINV 367 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 367 (400)
....+...+..+.+++.+||+.||.+|||+.+++++|+.+..+......
T Consensus 231 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 231 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred -----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 1112234456799999999999999999999999999999887765443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=359.30 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=206.9
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE 152 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 152 (400)
++....++|++.+.||+|+||.||++..+ +++.||+|.+... .......+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 34445688999999999999999999975 6899999987532 2233455788999999999999999999999999
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..|+||||++||+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999987543 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCccccc-------cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFR-------SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 305 (400)
+..............||+.|+|||++. ...|+.++|||||||++|+|++|+.||........ + ....
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~-~~i~ 283 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-----Y-GKIV 283 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----H-HHHH
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-----H-HHHH
Confidence 876544333344567999999999987 35789999999999999999999999954332111 0 0111
Q ss_pred hhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 042371 306 EENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRR---PTMKEVAME 354 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ell~~ 354 (400)
.......+ .......+..+.+||.+||. +|.+| |++++++++
T Consensus 284 ~~~~~~~~------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 284 HYKEHLSL------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp THHHHCCC------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred hcccCcCC------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00000000 00112345678999999999 99998 689998876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=350.36 Aligned_cols=268 Identities=27% Similarity=0.445 Sum_probs=213.0
Q ss_pred hcCCcccceeeecCcEEEEEEEe-----cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC--cc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-----ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE--VP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 154 (400)
.++|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999983 358899999987766677788999999999999999999999987654 78
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999987543 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcee--eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc----
Q 042371 235 IVIDQTHV--TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN---- 308 (400)
Q Consensus 235 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---- 308 (400)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... . .......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-------~-~~~~~~~~~~~ 266 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-------F-MRMIGNDKQGQ 266 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-------H-HHHHCTTCCTH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-------H-HHhhccccchh
Confidence 64333221 22344677899999999888999999999999999999999997422100 0 0000000
Q ss_pred ----ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 309 ----RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 309 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.+...+........+...+..+.+++.+||+.||.+|||+.+|++.|+++++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 000111111111223345567999999999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=351.33 Aligned_cols=270 Identities=27% Similarity=0.431 Sum_probs=216.4
Q ss_pred ccChHHHHHHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceee
Q 042371 72 LFTTKELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKL 144 (400)
Q Consensus 72 ~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~ 144 (400)
.+...++....++|++.+.||+|+||.||+|... .++.||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3455566677789999999999999999999854 36789999876433 3345678899999999999999999
Q ss_pred eeEEeeCCcceEEEEccCCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 042371 145 LGCCLETEVPLLVYEFISNGTLFQYLHDQN-------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNIL 217 (400)
Q Consensus 145 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 217 (400)
++++.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence 999999999999999999999999987532 1135789999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCcccc
Q 042371 218 LNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEAT 295 (400)
Q Consensus 218 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~ 295 (400)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 248 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 248 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--
Confidence 999999999999999865432221 1223346889999999999999999999999999999999 899985432211
Q ss_pred chHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 296 GLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
. ......... ...+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 249 ----~-~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 ----V-LRFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ----H-HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----H-HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0 111111111 11122345668999999999999999999999999987644
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=345.38 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=206.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEee----CCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE----TEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 155 (400)
..++|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999996 5689999998876666777889999999999999999999999873 34678
Q ss_pred EEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 156 LVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
+||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999998763 22336899999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCce--------eeecccccCCCCCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH
Q 042371 235 IVIDQTH--------VTTKVQGTFGYLDPEYFRSGQ---FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 235 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 303 (400)
....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~-~--- 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVA-L--- 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHH-H---
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhh-H---
Confidence 4311110 012245799999999987554 78999999999999999999999842110000 000 0
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.. ............+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 259 ~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 259 AV---------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HH---------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred Hh---------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00 0000111122345679999999999999999999999999988754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=345.63 Aligned_cols=263 Identities=26% Similarity=0.439 Sum_probs=206.3
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC-----CcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD-----GRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
...+|++.+.||+|+||.||+|.... +..||+|.+... .......+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34678899999999999999998642 246999987653 334456788999999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999976533 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcee--eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 235 IVIDQTHV--TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 235 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... . ........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~-~~~~~~~~-- 267 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------V-MKAINDGF-- 267 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-HHHHHTTC--
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------H-HHHHHCCC--
Confidence 64322211 222345788999999999999999999999999999999 999995432211 0 11111110
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
....+...+..+.+++.+||+.||.+|||+.++++.|+++......
T Consensus 268 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 268 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 1111223456789999999999999999999999999998875444
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=350.85 Aligned_cols=269 Identities=24% Similarity=0.383 Sum_probs=215.4
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEecC------CcEEEEEEccccC-chhHHHHHHHHHHHHhC-CCCcceeeeeEE
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLAD------GRIVAVKKSKIVH-EGKLEEFINEVVILSQI-NHRNVVKLLGCC 148 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 148 (400)
.++...++|.+.+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345566889999999999999999999642 2479999876543 34567889999999999 899999999999
Q ss_pred eeCCcceEEEEccCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 042371 149 LETEVPLLVYEFISNGTLFQYLHDQNE-----------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNIL 217 (400)
Q Consensus 149 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIl 217 (400)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 999999999999999999999976421 235899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCcccc
Q 042371 218 LNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEAT 295 (400)
Q Consensus 218 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~ 295 (400)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 999999999999999865433222 2233456889999999999999999999999999999998 9999854332211
Q ss_pred chHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 296 GLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
. ....... .....+...+..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 276 -~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 276 -F----YKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp -H----HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -H----HHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 0 0111110 0011122234568999999999999999999999999999876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=343.40 Aligned_cols=268 Identities=24% Similarity=0.353 Sum_probs=190.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999965 58899999876533 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 160 FISNGTLFQYLHDQN---EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999887542 1235899999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc--
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF-- 313 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 313 (400)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......................+...
T Consensus 160 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IP-VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SC-CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CC-cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 22 222334568999999999876 46899999999999999999999999644322111100000000000000000
Q ss_pred ---------------cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 ---------------LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ---------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+............+..+.+|+.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000011111234578999999999999999999998874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=345.03 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=196.0
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc--------------------------hhHHHHHHHHHHHH
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE--------------------------GKLEEFINEVVILS 134 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~--------------------------~~~~~~~~E~~~l~ 134 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999964 688999998754321 12356889999999
Q ss_pred hCCCCcceeeeeEEee--CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 042371 135 QINHRNVVKLLGCCLE--TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIK 212 (400)
Q Consensus 135 ~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik 212 (400)
.++||||+++++++.+ ....++||||+++++|.+++.. .++++..++.++.||+.||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 5678999999999999876532 25899999999999999999999999 9999999
Q ss_pred CCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCCCCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCcC
Q 042371 213 STNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ---FTDKSDVYSFGVVLVELLTGQKPIILT 289 (400)
Q Consensus 213 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~ 289 (400)
|+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999998654322 2334467999999999998765 377899999999999999999999543
Q ss_pred CCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 290 GSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... .. ......... .+ ......++.+.+++.+||+.||.+|||+.+++++
T Consensus 244 ~~~------~~-~~~~~~~~~-~~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 RIM------CL-HSKIKSQAL-EF-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SHH------HH-HHHHHHCCC-CC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred cHH------HH-HHHHhcccC-CC-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 211 11 111111110 00 0112234568999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=345.48 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=205.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999965 6899999987542 234567888999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999998754 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... . ...+.....
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~-~~~i~~~~~------- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------I-YEKIVSGKV------- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHCCC-------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------H-HHHHHcCCC-------
Confidence 2 234568999999999999999999999999999999999999995432111 1 111111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+||+ +.+++++
T Consensus 256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 112234566899999999999999998 8888875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=337.14 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=206.4
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC--CcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 157 (400)
.++|++.+.||+|+||.||+|... ++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467999999999999999999985 888999987653 334567889999999999999999999999877 678999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999986543 25899999999999999999999876 4599999999999999999999999998764321
Q ss_pred CCceeeecccccCCCCCccccccCCCCC---cchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTD---KSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
....||+.|+|||++.+..++. ++||||||+++|+|++|+.||....... .........
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~------ 227 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEG------ 227 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSC------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcC------
Confidence 2345799999999998765544 7999999999999999999995432211 001111111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 ---LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111223345669999999999999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=337.57 Aligned_cols=252 Identities=22% Similarity=0.413 Sum_probs=204.1
Q ss_pred hcCCcccceeeecCcEEEEEEEecC-C-------cEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD-G-------RIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
.++|.+.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999998643 3 4799998877666777889999999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--------EE
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT--------AK 225 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~--------~k 225 (400)
.++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999987543 3899999999999999999999999 999999999999998887 99
Q ss_pred EEecCCccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH
Q 042371 226 VADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS 304 (400)
Q Consensus 226 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 304 (400)
|+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+....... ......
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----RKLQFY 231 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHH
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----HHHHHh
Confidence 999999975422 123457899999999987 679999999999999999999654442221111 000111
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
...... +...+..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 232 ~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111 11113448899999999999999999999999988754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=335.32 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=206.1
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
..++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467999999999999999999975 477899998876666667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCcEEEEecCCccccc
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~Dfgla~~~~ 236 (400)
|+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999987654 4899999999999999999999999 9999999999999 788899999999997654
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
. ........||+.|+|||++.+ .++.++||||||+++|+|++|+.||....... .......... ... .
T Consensus 161 ~--~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-~~~-~ 228 (277)
T 3f3z_A 161 P--GKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTF-TFP-E 228 (277)
T ss_dssp T--TSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-CCC-H
T ss_pred C--ccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCC-CCC-c
Confidence 2 223344568999999999875 49999999999999999999999995432211 0111111110 000 0
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... ...+..+.+++.+||+.||.+|||+.+++++
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 KDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0234568999999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=342.82 Aligned_cols=268 Identities=25% Similarity=0.332 Sum_probs=199.5
Q ss_pred HHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC-----chhHHHHHHHHHHHHhC---CCCcceeeeeEEee
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH-----EGKLEEFINEVVILSQI---NHRNVVKLLGCCLE 150 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~ 150 (400)
...++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999996 468999999876432 11234556677776666 59999999999987
Q ss_pred CC-----cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEE
Q 042371 151 TE-----VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAK 225 (400)
Q Consensus 151 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~k 225 (400)
.. ..++||||+. ++|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 4789999997 5999999875433 4899999999999999999999999 99999999999999999999
Q ss_pred EEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh
Q 042371 226 VADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305 (400)
Q Consensus 226 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 305 (400)
|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...................
T Consensus 161 l~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 161 LADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp ECSCSCTTTSTT--CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCccccccCC--CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999986532 223345678999999999999999999999999999999999999995433221111000000000
Q ss_pred hhcccccccc---hh-------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 EENRLYDFLD---DQ-------VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 ~~~~~~~~~~---~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+..... .. .........++.+.+|+.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000000 00 0000112334678999999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=344.90 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=205.2
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC-CcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 155 (400)
..++|++.+.||+|+||.||+|.... ++.||+|.+... .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45789999999999999999999764 788999987642 234567788999999988 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999998754 4899999999999999999999999 999999999999999999999999999753
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. ..+.....
T Consensus 172 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~-~~i~~~~~----- 238 (353)
T 2i0e_A 172 IW-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LF-QSIMEHNV----- 238 (353)
T ss_dssp CC-TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCCC-----
T ss_pred cc-CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HH-HHHHhCCC-----
Confidence 22 2223445679999999999999999999999999999999999999995432211 11 11111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+||+ +.+++++
T Consensus 239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112234566899999999999999995 5777765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=345.39 Aligned_cols=259 Identities=24% Similarity=0.453 Sum_probs=202.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCc----EEEEEEccc-cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGR----IVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~----~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
.++|++.+.||+|+||.||+|... +++ +||+|.+.. ........+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999964 344 357776643 23455788999999999999999999999998754 78
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+|++|+.+|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999987543 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 236 VIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 236 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ . ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~----~~~~~~----- 235 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKG----- 235 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTT-----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---H----HHHHcC-----
Confidence 43222 12233446788999999999999999999999999999999 9999954433221 1 011111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 236 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 236 ----ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 111122234456899999999999999999999999999988544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=342.60 Aligned_cols=247 Identities=21% Similarity=0.239 Sum_probs=194.1
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|++.+.||+|+||+||+|... +++.||||++.... .........|+..+..+ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999976 68999999865432 23344555666665555 89999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+ +++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 6799998877543 5999999999999999999999999 9999999999999999999999999987653
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
. ........||+.|+|||++.+ .++.++|||||||++|+|++|..|+.... . ........ ...
T Consensus 209 ~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~--~~~~~~~~----~~~ 271 (311)
T 3p1a_A 209 T--AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------G--WQQLRQGY----LPP 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------H--HHHHTTTC----CCH
T ss_pred c--CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------H--HHHHhccC----CCc
Confidence 2 223344568999999999875 79999999999999999999976652210 0 01111111 111
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... ...++.+.+++.+||+.||.+|||+.+++++
T Consensus 272 ~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 EFT----AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111 1234568999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=351.17 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=195.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|++.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999975 68899999876432 2235678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--EEEEecCCccccccC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT--AKVADFGTSKFIVID 238 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~--~kl~Dfgla~~~~~~ 238 (400)
+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 99999999997654 4899999999999999999999999 999999999999987765 99999999974322
Q ss_pred CceeeecccccCCCCCccccccCCCCCc-chhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDK-SDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ........... .. .+
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~-~~-~~---- 241 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSV-KY-SI---- 241 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTT-CC-CC----
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcC-CC-CC----
Confidence 222334569999999999988888766 8999999999999999999954332211 11111111100 00 00
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
......+..+.+|+.+||+.||.+|||+.+++++=
T Consensus 242 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 242 ---PDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp ---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred ---CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 01112345688999999999999999999999873
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=350.91 Aligned_cols=273 Identities=23% Similarity=0.264 Sum_probs=207.8
Q ss_pred ccChHHHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCC-----CCcceeee
Q 042371 72 LFTTKELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-----HRNVVKLL 145 (400)
Q Consensus 72 ~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~ 145 (400)
.++..+.....++|.+.+.||+|+||.||+|... +++.||+|.+.. .......+..|+.+++.+. ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3444444556789999999999999999999974 688999998763 2344566778999999986 99999999
Q ss_pred eEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----
Q 042371 146 GCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE----- 220 (400)
Q Consensus 146 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~----- 220 (400)
+++...+..++||||+ +++|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999999999 89999999875433 4899999999999999999999999 999999999999975
Q ss_pred --------------------CCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHH
Q 042371 221 --------------------KYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELL 280 (400)
Q Consensus 221 --------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 280 (400)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 78999999999976432 223456899999999999999999999999999999999
Q ss_pred hCCCCCCcCCCccccchHHHHHHHhhh--------cccccccchh-hhcc-----------------CC---HHHHHHHH
Q 042371 281 TGQKPIILTGSKEATGLAAYFILSMEE--------NRLYDFLDDQ-VLKV-----------------GQ---KEEIMTIA 331 (400)
Q Consensus 281 tg~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~-~~~~-----------------~~---~~~~~~l~ 331 (400)
+|+.||..................... ......+... .... .+ ....+.+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 999999654322111111000000000 0000000000 0000 00 00125678
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 042371 332 TLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 332 ~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+|+.+||+.||.+|||+.+++++
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhcCChhhCCCHHHHhcC
Confidence 99999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=348.34 Aligned_cols=254 Identities=20% Similarity=0.318 Sum_probs=198.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEecCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCC--CcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINH--RNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~l 156 (400)
..++|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++..++| |||+++++++...+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 34679999999999999999999888999999987643 33445788999999999976 999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
|||+ .+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++....
T Consensus 87 v~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 9995 5789999998754 5899999999999999999999999 99999999999997 5789999999998764
Q ss_pred cCCce-eeecccccCCCCCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH
Q 042371 237 IDQTH-VTTKVQGTFGYLDPEYFRS-----------GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS 304 (400)
Q Consensus 237 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 304 (400)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .......
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~ 233 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAI 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHH
Confidence 33222 2335679999999999865 67899999999999999999999999532211 1111111
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.. .......+...+..+.+|+.+||+.||.+|||+.+++++-.
T Consensus 234 ~~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 234 ID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred hc---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 11 11111111222346889999999999999999999998743
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=330.32 Aligned_cols=267 Identities=19% Similarity=0.244 Sum_probs=210.4
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEE-eeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCC-LETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+|+.+++.++|++++..+..+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999996 5789999998754332 24688999999999988876666555 56667899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCcEEEEecCCccccc
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~Dfgla~~~~ 236 (400)
|+ +++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 8999999975443 5899999999999999999999999 9999999999999 478899999999998765
Q ss_pred cCCce------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 237 IDQTH------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 237 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 33221 124457899999999999999999999999999999999999999754433222222211111111000
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhcc
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~ 365 (400)
... ....++.+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus 240 -----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 240 -----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp -----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -----HHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 000 1123456899999999999999999999999999998766543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.58 Aligned_cols=266 Identities=22% Similarity=0.304 Sum_probs=199.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999975 58999999875433 233567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998876543 4899999999999999999999999 999999999999999999999999999765422
Q ss_pred CceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH--------HHhhhcc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI--------LSMEENR 309 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~~ 309 (400)
........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||................ .......
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 -SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred -ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 222334568999999999876 678999999999999999999999995443322111110000 0000000
Q ss_pred ccc---ccchh---hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 LYD---FLDDQ---VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ~~~---~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... ..+.. .........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000 0000012345568999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=336.19 Aligned_cols=262 Identities=29% Similarity=0.475 Sum_probs=198.2
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
+...++|++.+.||+|+||.||+|...+ .+|+|.+... .....+.+.+|+.+++.++||||++++++. .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 3456789999999999999999998643 5999987653 344567889999999999999999999965 4566899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999975443 5899999999999999999999999 9999999999999999999999999997653
Q ss_pred cC-CceeeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 237 ID-QTHVTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 237 ~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.. .........||+.|+|||++. +..++.++||||||+++|+|++|+.||....... .............
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~ 245 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSP 245 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCc
Confidence 21 122234456899999999986 6678999999999999999999999995433221 1111111111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
. ........+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 246 ~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 D-----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C-----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred c-----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0 01112234567999999999999999999999999998764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=341.27 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=202.8
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC-CcceEEE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLET-EVPLLVY 158 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 158 (400)
...++|++.+.||+|+||.||++... ++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+. +..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 34578999999999999999999874 789999987643 3567889999999999999999999987654 4789999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++...... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHH-HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhcccc-cCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999764321 3789999999999999999999999 999999999999999999999999998754322
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... .. ......
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~--------- 230 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKG--------- 230 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTT---------
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcC---------
Confidence 223357889999999999999999999999999999998 999995433211 10 011111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.++...
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 111122334567999999999999999999999999999988754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=331.38 Aligned_cols=267 Identities=19% Similarity=0.242 Sum_probs=207.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEE-eeCCcceEEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCC-LETEVPLLVY 158 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 158 (400)
..++|++.+.||+|+||.||+|.. .+++.||+|...... ....+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 568899999754322 223577899999999988777766655 5667789999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCcEEEEecCCcccc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFI 235 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~Dfgla~~~ 235 (400)
||+ +++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 8999999975443 4899999999999999999999999 9999999999999 78899999999999876
Q ss_pred ccCCc------eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 236 VIDQT------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 236 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 43322 122345689999999999999999999999999999999999999976544333222222111111110
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
. ... ....+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 239 ~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 I-----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp H-----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred h-----hhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 0 000 112245689999999999999999999999999999887654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=337.78 Aligned_cols=254 Identities=31% Similarity=0.548 Sum_probs=202.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchh-------HHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGK-------LEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+....... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468999999999999999999964 68999999875432211 167889999999999999999999986544
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-----EEEEe
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT-----AKVAD 228 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~-----~kl~D 228 (400)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999998876443 5899999999999999999999976 45999999999999988776 99999
Q ss_pred cCCccccccCCceeeecccccCCCCCccccc--cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR--SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
||++.... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||......... ... ...
T Consensus 173 fg~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~-~~~ 243 (287)
T 4f0f_A 173 FGLSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FIN-MIR 243 (287)
T ss_dssp CTTCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHH-HHH
T ss_pred CCcccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHH-HHh
Confidence 99997532 2234466899999999984 456789999999999999999999999644322110 001 111
Q ss_pred hcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 307 ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
... .....+...++.+.+++.+||+.||.+|||+.++++.|++
T Consensus 244 ~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEG--------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSC--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccC--------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111 1111223345679999999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=349.13 Aligned_cols=258 Identities=24% Similarity=0.426 Sum_probs=202.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCc----EEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGR----IVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
.++|++.+.||+|+||.||+|.+. ++. +||+|.+.... ......+.+|+.+++.++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357999999999999999999964 344 37888664322 333456778999999999999999999886 45688
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999976432 4888999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 236 VIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 236 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
..... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||......... ........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~--- 235 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DLLEKGER--- 235 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HHHHTTCB---
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCCC---
Confidence 43322 22344567889999999999999999999999999999999 99999644322110 11111100
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
...+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 236 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 236 ------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111112234578999999999999999999999999988653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=344.58 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=208.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcE--EEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRI--VAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~--vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 157 (400)
++|++.+.||+|+||.||+|... ++.. +|+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999964 4554 488877642 334556788999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcE
Q 042371 158 YEFISNGTLFQYLHDQN-------------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTA 224 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~ 224 (400)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 1235899999999999999999999999 9999999999999999999
Q ss_pred EEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHH
Q 042371 225 KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 225 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 303 (400)
||+|||++..... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 252 (327)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHH
Confidence 9999999874321 112233456889999999998899999999999999999998 999995432211 011
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhccc
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDIN 366 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~ 366 (400)
..... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+....+...
T Consensus 253 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 253 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred HhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 11111 1111222345678999999999999999999999999999988766543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=337.44 Aligned_cols=261 Identities=26% Similarity=0.389 Sum_probs=206.3
Q ss_pred CCcccceeeecCcEEEEEEEecC----CcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc-eEE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP-LLV 157 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~lv 157 (400)
.|.+.+.||+|+||.||+|...+ +..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677999999999999998532 2379999876533 34567889999999999999999999999876655 999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999976433 5899999999999999999999999 99999999999999999999999999976533
Q ss_pred CC---ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 238 DQ---THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 238 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
.. ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+....... .... .....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~----~~~~~------ 244 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTH----FLAQG------ 244 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHH----HHHTT------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHH----HhhcC------
Confidence 21 122234557889999999999999999999999999999999655543222111 1110 00010
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
.....+...+..+.+++.+||+.||.+|||+.++++.|+++......
T Consensus 245 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 245 ---RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ---CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 01111223345689999999999999999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=353.49 Aligned_cols=264 Identities=24% Similarity=0.357 Sum_probs=193.6
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc--cCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCC--c
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI--VHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETE--V 153 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--~ 153 (400)
...++|++.+.||+|+||.||+|... +++.||||++.. ........+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34678999999999999999999964 689999998753 23455677889999999997 999999999997654 6
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999997 5899998763 4899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccC--------------------CceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCc
Q 042371 234 FIVID--------------------QTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSK 292 (400)
Q Consensus 234 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 292 (400)
..... .........||+.|+|||++.+ ..|+.++|||||||++|+|++|++||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 64321 1122344679999999999876 67999999999999999999999999644322
Q ss_pred cccchHHHHHHHhhhcc-----------------------------cccccc---h-hhhccCCHHHHHHHHHHHHHhcc
Q 042371 293 EATGLAAYFILSMEENR-----------------------------LYDFLD---D-QVLKVGQKEEIMTIATLATRCLN 339 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~---~-~~~~~~~~~~~~~l~~li~~cl~ 339 (400)
.. +.... ....... ....+. . ..........++.+.+|+.+||+
T Consensus 238 ~~--~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQ--LERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HH--HHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HH--HHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 11 11100 0000000 000000 0 00000011234568999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042371 340 LNGKRRPTMKEVAME 354 (400)
Q Consensus 340 ~dP~~RPt~~ell~~ 354 (400)
.||.+|||+.+++++
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=338.57 Aligned_cols=267 Identities=24% Similarity=0.376 Sum_probs=203.6
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999996 46899999987642 34456788899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 157 VYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999987521 2235899999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .... ...........
T Consensus 187 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~~~--- 257 (310)
T 2wqm_A 187 SSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEQCDYPP--- 257 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHH-HHHHHTTCSCC---
T ss_pred cCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHH-HHHhhcccCCC---
Confidence 4322 2223456899999999999999999999999999999999999998533211 1111 11111111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
......+..+.+++.+||+.||.+|||+.++++.|+++.+..+.
T Consensus 258 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 258 -----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 01123445689999999999999999999999999999986554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=337.53 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=204.9
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEee---------
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE--------- 150 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 150 (400)
...+|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999975 68999999876543 346689999999999999999998754
Q ss_pred -------CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 042371 151 -------TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223 (400)
Q Consensus 151 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~ 223 (400)
....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 3457899999999999999976532 25899999999999999999999999 999999999999999999
Q ss_pred EEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH
Q 042371 224 AKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 303 (400)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+... ... ..
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~-~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKF-FT 229 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHH-HH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHH-HH
Confidence 9999999997654322 233456899999999999999999999999999999999999987210 000 01
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
...... .+...+..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 230 ~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 DLRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred Hhhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 111111 11223455889999999999999999999999999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=333.84 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=205.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999965 5889999987543 3345677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---EEEEecCCcccc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT---AKVADFGTSKFI 235 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~Dfgla~~~ 235 (400)
||+++++|.+.+.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999999887654 4899999999999999999999999 999999999999987655 999999999765
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.. ........||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .......... ....
T Consensus 159 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~-~~~~ 228 (284)
T 3kk8_A 159 ND--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAY-DYPS 228 (284)
T ss_dssp CS--SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC-CCCT
T ss_pred cc--CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccc-cCCc
Confidence 32 222344668999999999999999999999999999999999999995432211 0111111111 0000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......++.+.+++.+||+.||.+|||+.+++++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 -----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0112334568999999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=343.73 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=180.6
Q ss_pred cceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEEEccCCCC
Q 042371 88 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFISNGT 165 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 165 (400)
.+.||+|+||.||+|... +++.||+|.+.. .....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 689999998753 34466778999999997 9999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---cEEEEecCCccccccCCcee
Q 042371 166 LFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY---TAKVADFGTSKFIVIDQTHV 242 (400)
Q Consensus 166 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~ 242 (400)
|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++...... ...
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~ 165 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQP 165 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCc
Confidence 999998754 5899999999999999999999999 99999999999998765 8999999999765322 223
Q ss_pred eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccC
Q 042371 243 TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322 (400)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (400)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....................+... +... .
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~-----~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-FEGE-----A 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-CCSH-----H
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-CCcc-----c
Confidence 344568999999999999999999999999999999999999996543321111111111112111110 0000 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....++.+.+|+.+||+.||.+|||+.+++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12245678999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=346.83 Aligned_cols=262 Identities=24% Similarity=0.298 Sum_probs=202.5
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-----CchhHHHHHHHHHHHHhCCCCcceeeeeEEee
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-----HEGKLEEFINEVVILSQINHRNVVKLLGCCLE 150 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 150 (400)
.+....++|++.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34566788999999999999999999964 5789999976532 34556789999999999999999999999999
Q ss_pred CCcceEEEEccCCCCHHHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQN-------------------------------------EEFPLTWEMRLRIATEVAG 193 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~ 193 (400)
.+..++||||+++|+|.+++.... ....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999985210 0112467778899999999
Q ss_pred HHHHHHhcCCCCeEecCCCCCCeEEcCCC--cEEEEecCCccccccCC---ceeeecccccCCCCCcccccc--CCCCCc
Q 042371 194 SLSYLHSAASMPIYHRDIKSTNILLNEKY--TAKVADFGTSKFIVIDQ---THVTTKVQGTFGYLDPEYFRS--GQFTDK 266 (400)
Q Consensus 194 ~l~~LH~~~~~~iiHrDikp~NIll~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 266 (400)
||.|||+.+ |+||||||+|||++.++ .+||+|||++....... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998776 89999999998654322 112345668999999999875 678999
Q ss_pred chhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCC
Q 042371 267 SDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP 346 (400)
Q Consensus 267 ~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 346 (400)
+||||||+++|+|++|+.||....... ...... .... .+..+ .....+..+.+++.+||+.||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~-~~~~-~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVL-NKKL-CFENP-----NYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCC-CTTSG-----GGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHH-hccc-ccCCc-----ccccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999995433211 111111 1110 00000 1112345689999999999999999
Q ss_pred CHHHHHHH
Q 042371 347 TMKEVAME 354 (400)
Q Consensus 347 t~~ell~~ 354 (400)
|+.+++++
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999885
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=351.08 Aligned_cols=247 Identities=24% Similarity=0.309 Sum_probs=197.2
Q ss_pred cceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 88 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999964 6899999998776666678899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE--cCCCcEEEEecCCccccccCCceeee
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL--NEKYTAKVADFGTSKFIVIDQTHVTT 244 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~~ 244 (400)
.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...... ....
T Consensus 174 ~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~~~ 246 (373)
T 2x4f_A 174 FDRIIDESY--NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLK 246 (373)
T ss_dssp HHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CBCC
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--cccc
Confidence 998876432 4899999999999999999999999 9999999999999 56789999999999865422 2233
Q ss_pred cccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCH
Q 042371 245 KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQK 324 (400)
Q Consensus 245 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (400)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ... ......+ .+... ...
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~-~i~~~~~-~~~~~-----~~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLN-NILACRW-DLEDE-----EFQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-HHHHTCC-CSCSG-----GGT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHHhccC-CCChh-----hhc
Confidence 4569999999999999999999999999999999999999995432211 001 1111110 00000 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 325 EEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 325 ~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..++.+.+|+.+||+.||.+|||+.+++++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 234568999999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=342.67 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=197.4
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc---
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP--- 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--- 154 (400)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 568999999876532 33456788999999999999999999998876544
Q ss_pred -eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 155 -LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 155 -~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999998654 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc--eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 234 FIVIDQT--HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 234 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ...........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~- 237 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI- 237 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC-
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC-
Confidence 6543222 12234568999999999999999999999999999999999999995432211 11111111100
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH-HHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAM-ELERI 358 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~-~L~~~ 358 (400)
.... .....+..+.+++.+||+.||.+||++.+++. .|..+
T Consensus 238 ---~~~~---~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 ---PPSA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---CHHH---HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---Cccc---ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000 01123456889999999999999997766654 34443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=339.17 Aligned_cols=263 Identities=27% Similarity=0.376 Sum_probs=210.5
Q ss_pred HhcCCcccc-eeeecCcEEEEEEEec---CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 81 ATDHFNVNR-ILGQGGQGTVYKGMLA---DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 81 ~~~~y~~~~-~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
..++|.+.+ .||+|+||.||+|.+. .++.||+|.+.... ....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788888 9999999999999642 46789999876532 33467899999999999999999999998 56678
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999998754 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcee--eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 235 IVIDQTHV--TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 235 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
........ .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... .........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~-- 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE-- 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC--
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC--
Confidence 64333322 222346788999999998889999999999999999999 999995433211 011111111
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhccc
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDIN 366 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~ 366 (400)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+-......+
T Consensus 238 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 238 -------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 111223345679999999999999999999999999999987665544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=337.78 Aligned_cols=261 Identities=29% Similarity=0.482 Sum_probs=205.1
Q ss_pred hcCCcccceeeecCcEEEEEEEecC----CcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEe-eCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCL-ETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~ 155 (400)
..+|++.+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568999999999999999998542 235899987643 3445678899999999999999999999864 456789
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999976433 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCc---eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 236 VIDQT---HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 236 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||....... .... .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~----~~~~~-- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGR-- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH----HHTTC--
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH----HhcCC--
Confidence 43221 22334557889999999999999999999999999999999 556664332211 1100 00100
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 250 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 011122234568999999999999999999999999999887543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=342.97 Aligned_cols=274 Identities=24% Similarity=0.387 Sum_probs=201.8
Q ss_pred HhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHH--HHhCCCCcceeeeeEEee-----CCc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVI--LSQINHRNVVKLLGCCLE-----TEV 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~~~~~~~~-----~~~ 153 (400)
..++|++.+.||+|+||.||+|.. +++.||+|.+... ....+..|..+ +..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 347899999999999999999977 6789999987643 23344445555 445899999999986543 225
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEecCCCCCCeEEcCCCcE
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA---------ASMPIYHRDIKSTNILLNEKYTA 224 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~iiHrDikp~NIll~~~~~~ 224 (400)
.++||||+++|+|.+++.... .++..++.++.||+.||.|||+. + |+||||||+|||++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 689999999999999997654 58899999999999999999998 7 9999999999999999999
Q ss_pred EEEecCCccccccCC-------ceeeecccccCCCCCcccccc-------CCCCCcchhHHHHHHHHHHHhCCCCCCcCC
Q 042371 225 KVADFGTSKFIVIDQ-------THVTTKVQGTFGYLDPEYFRS-------GQFTDKSDVYSFGVVLVELLTGQKPIILTG 290 (400)
Q Consensus 225 kl~Dfgla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~pf~~~~ 290 (400)
||+|||++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999998654321 122234569999999999986 456778999999999999999987764433
Q ss_pred CccccchHHH-----------HHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 291 SKEATGLAAY-----------FILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 291 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
.......... .............+.. ........+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 2211111000 0000000000000000 11123346678999999999999999999999999999999
Q ss_pred HHhhcccc
Q 042371 360 ALQKDINV 367 (400)
Q Consensus 360 ~~~~~~~~ 367 (400)
....+-+.
T Consensus 318 ~~~~~~~~ 325 (336)
T 3g2f_A 318 MIWERNKS 325 (336)
T ss_dssp HCCCC---
T ss_pred HHHHhccc
Confidence 86665443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=340.10 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=201.2
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec----CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
...++|.+.+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34578999999999999999999854 2458999987653 34456788999999999999999999999887553
Q ss_pred -----ceEEEEccCCCCHHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEE
Q 042371 154 -----PLLVYEFISNGTLFQYLHDQ---NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAK 225 (400)
Q Consensus 154 -----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~k 225 (400)
.++||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 48999999999999998542 22346999999999999999999999999 99999999999999999999
Q ss_pred EEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHH
Q 042371 226 VADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 226 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 303 (400)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---- 260 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD---- 260 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH----
Confidence 999999976543221 12233457889999999999999999999999999999999 899985433221 110
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
...... ....+...+..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 261 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 YLLHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 011110 011122344568999999999999999999999999999887543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=356.71 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=196.4
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3477999999999999999999964 6889999987642 33445677889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999997654 58999999999999999999998 88 999999999999999999999999999754
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.. .........||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... ...... ....
T Consensus 300 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~-~~~~----- 366 (446)
T 4ejn_A 300 IK-DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELIL-MEEI----- 366 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCC-----
T ss_pred cC-CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHH-hCCC-----
Confidence 32 2233445679999999999999999999999999999999999999995432211 111111 1100
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
..+...+..+.+|+.+||+.||.+|| |+.+++++
T Consensus 367 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 -----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 01222345689999999999999999 99999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.77 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=191.3
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
...++|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 44678999999999999999999976 57899999876432 3466788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCcEEEEecCCcccc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE---KYTAKVADFGTSKFI 235 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~Dfgla~~~ 235 (400)
||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++...
T Consensus 128 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999997643 4899999999999999999999999 999999999999975 889999999999865
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........... ...
T Consensus 202 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~-~~~- 271 (349)
T 2w4o_A 202 EH--QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY-YFI- 271 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC-CCC-
T ss_pred Cc--ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC-ccC-
Confidence 32 222344668999999999999999999999999999999999999995433221 01111111111 000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+..+.+|+.+||+.||.+|||+.+++++
T Consensus 272 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 ----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112345668999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=336.24 Aligned_cols=271 Identities=24% Similarity=0.342 Sum_probs=211.3
Q ss_pred HHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHh--CCCCcceeeeeEEeeCC-
Q 042371 76 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQ--INHRNVVKLLGCCLETE- 152 (400)
Q Consensus 76 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~- 152 (400)
.......++|.+.+.||+|+||.||+|.. +++.||+|.+.. .....+.+|..++.. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33455678899999999999999999998 488999998753 334667788888887 68999999999998776
Q ss_pred ---cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeEEcCC
Q 042371 153 ---VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH--------SAASMPIYHRDIKSTNILLNEK 221 (400)
Q Consensus 153 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiHrDikp~NIll~~~ 221 (400)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+|||++.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN 183 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred ccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence 789999999999999999764 3899999999999999999999 777 9999999999999999
Q ss_pred CcEEEEecCCccccccCCce---eeecccccCCCCCccccccCC------CCCcchhHHHHHHHHHHHhC----------
Q 042371 222 YTAKVADFGTSKFIVIDQTH---VTTKVQGTFGYLDPEYFRSGQ------FTDKSDVYSFGVVLVELLTG---------- 282 (400)
Q Consensus 222 ~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltg---------- 282 (400)
+.+||+|||++......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999999766443322 223456899999999987652 34689999999999999999
Q ss_pred CCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 283 QKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 283 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
..||........ ...... ...........+... ......+..+.+++.+||+.||.+|||+.+++++|+++....
T Consensus 264 ~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 264 QLPYYDLVPSDP-SVEEMR-KVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CCTTTTTSCSSC-CHHHHH-HHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccCccccCcCcc-cHHHHH-HHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 778754332211 111111 111111111111110 122356678999999999999999999999999999987643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=341.35 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=200.2
Q ss_pred hcCCccc-ceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEE
Q 042371 82 TDHFNVN-RILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 82 ~~~y~~~-~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.+.|.+. +.||+|+||.||+|... +++.||||.+..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578884 78999999999999954 6899999998766666678899999999985 7999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---EEEEecCCcccc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT---AKVADFGTSKFI 235 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~Dfgla~~~ 235 (400)
||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999998754 4899999999999999999999999 999999999999998765 999999999765
Q ss_pred ccCCc------eeeecccccCCCCCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccch-------
Q 042371 236 VIDQT------HVTTKVQGTFGYLDPEYFRS-----GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGL------- 297 (400)
Q Consensus 236 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~------- 297 (400)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 11223458999999999875 5689999999999999999999999965432210000
Q ss_pred -HHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 298 -AAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 298 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
............ ..+... .. ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~~i~~~~-~~~~~~-~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGK-YEFPDK-DW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCC-CCCCHH-HH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccC-cccCch-hc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000011111111 011100 00 1134568999999999999999999999884
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=355.12 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=196.4
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE------ 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 152 (400)
.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999864 5889999987643 3445678889999999999999999999997654
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 46999999976 56666642 3889999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH--------
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS-------- 304 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------- 304 (400)
+.... ........||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... .+.......
T Consensus 212 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 212 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred eecCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHH
Confidence 86532 233455679999999999999999999999999999999999999995433211 111000000
Q ss_pred ----------hhh------cccccccchhhhccC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 305 ----------MEE------NRLYDFLDDQVLKVG---QKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 305 ----------~~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... ..+...+........ ....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000111000000 12235678999999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=350.92 Aligned_cols=252 Identities=20% Similarity=0.320 Sum_probs=198.0
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCC--CCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIV--HEGKLEEFINEVVILSQIN--HRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv 157 (400)
..+|++.+.||+|+||.||++...+++.||||.+... .....+.+.+|+.++..++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999878999999987643 3445678899999999996 59999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|| +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 56789999998754 5889999999999999999999999 99999999999996 57999999999987643
Q ss_pred CCce-eeecccccCCCCCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh
Q 042371 238 DQTH-VTTKVQGTFGYLDPEYFRS-----------GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305 (400)
Q Consensus 238 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 305 (400)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHh
Confidence 2221 2345679999999999865 46899999999999999999999999533211 11111111
Q ss_pred hhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 306 EENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
.. ......+...+..+.+|+.+||+.||.+|||+.+++++-
T Consensus 282 ~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 282 DP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Cc---------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11 111111111235688999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=347.29 Aligned_cols=265 Identities=17% Similarity=0.213 Sum_probs=199.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec----CCcEEEEEEccccCch-----------hHHHHHHHHHHHHhCCCCcceeeee
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIVHEG-----------KLEEFINEVVILSQINHRNVVKLLG 146 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~ 146 (400)
.++|.+.+.||+|+||.||+|... .+..+|+|........ ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999975 5678999987643321 1234667888999999999999999
Q ss_pred EEee----CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 042371 147 CCLE----TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY 222 (400)
Q Consensus 147 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~ 222 (400)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 67889999999 999999997654 5899999999999999999999999 99999999999999877
Q ss_pred --cEEEEecCCccccccCCce------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccc
Q 042371 223 --TAKVADFGTSKFIVIDQTH------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA 294 (400)
Q Consensus 223 --~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 294 (400)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999765432111 11345689999999999999999999999999999999999999953222111
Q ss_pred cchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 295 TGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
. ........ ...+...+. ........+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 269 ~--~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 269 A--VQTAKTNL-LDELPQSVL---KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp H--HHHHHHHH-HHTTTHHHH---HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred H--HHHHHHhh-cccccHHHH---hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 0 00000000 000110000 00011134457999999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=330.27 Aligned_cols=249 Identities=29% Similarity=0.392 Sum_probs=202.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999865 5778999987532 223356788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999998754 4899999999999999999999999 99999999999999999999999999865422
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.......||+.|+|||.+.+..++.++||||||+++|+|++|..||....... .. ......
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~--------- 222 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TY-KRISRV--------- 222 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHHT---------
T ss_pred ---ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HH-HHHHhC---------
Confidence 22334568999999999999999999999999999999999999995432211 00 011110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
....+...+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 223 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 223 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp -CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred -CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 01112223456889999999999999999999999743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=354.43 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=205.9
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|.+.+.||+|+||.||+|... +|+.||||.+... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999965 6899999987542 223456889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999997543 5899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCceeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... . ......+..
T Consensus 169 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~-~~~i~~~~~------ 233 (476)
T 2y94_A 169 --GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------L-FKKICDGIF------ 233 (476)
T ss_dssp --TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------H-HHHHHTTCC------
T ss_pred --cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------H-HHHHhcCCc------
Confidence 223345679999999999998776 689999999999999999999995433211 1 111111110
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1112234568899999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=348.35 Aligned_cols=267 Identities=25% Similarity=0.388 Sum_probs=207.0
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999975 6889999987654 34456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
|+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998754 489999999999999999999996 8 999999999999999999999999999755321
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH---------------
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL--------------- 303 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------------- 303 (400)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.................
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 22345689999999999999999999999999999999999999965432211000000000
Q ss_pred --------Hhhhcccccccc----hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 304 --------SMEENRLYDFLD----DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 304 --------~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
...........+ ...........+..+.+|+.+||+.||.+|||+.+++++-.-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 000000000000 000001112235578999999999999999999999997443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=336.19 Aligned_cols=262 Identities=22% Similarity=0.264 Sum_probs=200.6
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4578999999999999999999965 68899999876532 2335778899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999998754 4899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
...........|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ........ ... .
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~-~~~---~- 253 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQ-AIP---R- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHS-CCC---C-
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhcc-CCC---C-
Confidence 43333334556899999999999999999999999999999999999999532211 00111111 000 0
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHHHh
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRP-TMKEVAMELERIQALQ 362 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ell~~L~~~~~~~ 362 (400)
....+...+..+.+++.+||+.||.+|| |++++++.|+.+.+..
T Consensus 254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0111223445688999999999999999 9999999998765433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=345.54 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=196.4
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCch-hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEG-KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|.+.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999975 6889999987643322 112445799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
++ ++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-T 154 (324)
T ss_dssp CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-c
Confidence 97 589998876543 5899999999999999999999999 999999999999999999999999999754322 2
Q ss_pred eeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh--
Q 042371 241 HVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ-- 317 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 317 (400)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......................+.......
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 22334568999999999876 568999999999999999999999996543322111111100000111111111100
Q ss_pred -----------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 -----------VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000112234568899999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=340.40 Aligned_cols=252 Identities=26% Similarity=0.370 Sum_probs=205.3
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc------hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE------GKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999965 588999998764322 1367889999999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----cEEEEecC
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY----TAKVADFG 230 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~Dfg 230 (400)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997643 5899999999999999999999999 99999999999999887 79999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .. .......
T Consensus 165 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~~i~~~~- 234 (321)
T 2a2a_A 165 LAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANITSVS- 234 (321)
T ss_dssp TCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHTTC-
T ss_pred cceecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHhcc-
Confidence 99865432 22344568999999999999999999999999999999999999995432211 00 0111100
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. .+.... ...+..+.+++.+||+.||.+|||+.+++++
T Consensus 235 ~~-~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YD-FDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC-CCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc-cChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 011111 1223568899999999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=360.47 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=208.0
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 6899999987542 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||++||+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999976543 24899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......... .... ......
T Consensus 339 ~--~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~-~i~~~~-------- 405 (576)
T 2acx_A 339 G--QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVER-LVKEVP-------- 405 (576)
T ss_dssp T--CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHH-HHHHCC--------
T ss_pred C--ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHH-Hhhccc--------
Confidence 2 23344579999999999999899999999999999999999999996543221111 1111 111100
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
...+...+..+.+||.+||+.||.+|| ++.+++++
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111223456689999999999999999 78888876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=347.97 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=193.2
Q ss_pred hcCCccc-ceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHH-hCCCCcceeeeeEEee----CCcc
Q 042371 82 TDHFNVN-RILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILS-QINHRNVVKLLGCCLE----TEVP 154 (400)
Q Consensus 82 ~~~y~~~-~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~----~~~~ 154 (400)
.++|.+. +.||+|+||.||++... +++.||||.+... ..+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567766 68999999999999965 6889999987532 35667888874 4589999999999875 5578
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCcEEEEecCC
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE---KYTAKVADFGT 231 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~Dfgl 231 (400)
+|||||++||+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999986532 25899999999999999999999999 999999999999997 78999999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
++.... ........||+.|+|||++.+..|+.++|||||||++|+|++|+.||............... ......
T Consensus 211 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~~~~~- 284 (400)
T 1nxk_A 211 AKETTS--HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IRMGQY- 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HHHTCC-
T ss_pred ccccCC--CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HHcCcc-
Confidence 986532 22234567899999999999999999999999999999999999999654332211111110 001110
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.+.. ......+..+.+||.+||+.||.+|||+.+++++-.
T Consensus 285 ~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 285 EFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp CCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0000 011234566899999999999999999999998743
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=349.12 Aligned_cols=261 Identities=28% Similarity=0.480 Sum_probs=199.3
Q ss_pred cCCcccceeeecCcEEEEEEEec--CC--cEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEee-CCcceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA--DG--RIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~--~~--~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 156 (400)
..|.+.+.||+|+||.||+|... ++ ..||+|.+... .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999853 22 36899987643 34567889999999999999999999998754 557899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999976443 4889999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCce---eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 237 IDQTH---VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 237 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||....... .... .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~~~~--- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGR--- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HHTTC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HHcCC---
Confidence 32211 1233457889999999999999999999999999999999 677875433221 1111 11111
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 0111223445689999999999999999999999999998875543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=342.07 Aligned_cols=267 Identities=14% Similarity=0.192 Sum_probs=207.1
Q ss_pred hcCCcccceeeecCcEEEEEEEecC---------CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCccee---------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD---------GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVK--------- 143 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~--------- 143 (400)
.++|++.+.||+|+||.||+|.... ++.||+|.+... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999753 789999987643 45778999999999999987
Q ss_pred ------eeeEEee-CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042371 144 ------LLGCCLE-TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216 (400)
Q Consensus 144 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NI 216 (400)
+++++.. ....++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5667665 66789999999 9999999987521 25999999999999999999999999 99999999999
Q ss_pred EEcCCC--cEEEEecCCccccccCCce------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCc
Q 042371 217 LLNEKY--TAKVADFGTSKFIVIDQTH------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIIL 288 (400)
Q Consensus 217 ll~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 288 (400)
|++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999865432211 12335789999999999999999999999999999999999999965
Q ss_pred CCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 289 TGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
....... .... .... ......+.+.... ....+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 271 ~~~~~~~-~~~~-~~~~-~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 271 CLPNTED-IMKQ-KQKF-VDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp GTTCHHH-HHHH-HHHH-HHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCcCHHH-HHHH-HHhc-cCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 4322111 1111 1111 1111111111100 012245689999999999999999999999999998876553
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.57 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=201.3
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
..|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999996 578999999876432 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+. |+|.+++..... ++++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 588888865433 5899999999999999999999999 99999999999999999999999999976432
Q ss_pred CceeeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||....... ... .........
T Consensus 207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~-~~~~~~~~~--- 272 (348)
T 1u5q_A 207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY-HIAQNESPA--- 272 (348)
T ss_dssp ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HHHHSCCCC---
T ss_pred ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHH-HHHhcCCCC---
Confidence 22356899999999984 5678999999999999999999999985432211 001 111111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
......+..+.+++.+||+.||.+|||+.+++++..
T Consensus 273 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 273 -----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 111223456889999999999999999999997643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=366.75 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=202.5
Q ss_pred eeeecCcEEEEEEEec---CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCCCC
Q 042371 90 ILGQGGQGTVYKGMLA---DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGT 165 (400)
Q Consensus 90 ~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 165 (400)
.||+|+||.||+|.+. ++..||||.++.. .....+.+.+|+.+|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 4567999988754 34467889999999999999999999999876 56899999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee--e
Q 042371 166 LFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV--T 243 (400)
Q Consensus 166 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~ 243 (400)
|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......... .
T Consensus 422 L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999975432 5899999999999999999999999 9999999999999999999999999998764332221 1
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccC
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (400)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+. ......+. ....
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~---------~~~~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGK---------RMEC 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH-------HHHHHTTC---------CCCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCC---------CCCC
Confidence 22335689999999999999999999999999999998 9999965433211 11111111 1112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
+...+..+.+++.+||+.||.+|||+.+|++.|+.+......
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 234556799999999999999999999999999998765433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=344.72 Aligned_cols=255 Identities=27% Similarity=0.349 Sum_probs=204.9
Q ss_pred hcCCcccceeeecCcEEEEEEEe----cCCcEEEEEEccccC----chhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCC
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML----ADGRIVAVKKSKIVH----EGKLEEFINEVVILSQI-NHRNVVKLLGCCLETE 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 152 (400)
.++|++.+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999986 368899999876422 23345677899999999 6999999999999999
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999998754 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRS--GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
+..............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~--- 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS--- 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC---
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhcc---
Confidence 8654433334445679999999999986 357899999999999999999999996544322111 111111100
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAMEL 355 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~L 355 (400)
....+...+..+.+|+.+||+.||.+|| |+.+++++.
T Consensus 282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0111223445688999999999999999 999998874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=344.25 Aligned_cols=243 Identities=24% Similarity=0.374 Sum_probs=202.1
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC--------chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH--------EGKLEEFINEVVILSQINHRNVVKLLGCCLET 151 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 151 (400)
..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999995 468899999876432 11334567899999999999999999999999
Q ss_pred CcceEEEEccCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 152 EVPLLVYEFISNG-TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 152 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
+..++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999766 9999987654 4899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
++...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 176 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------ 235 (335)
T 3dls_A 176 SAAYLERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------ 235 (335)
T ss_dssp TCEECCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred cceECCCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence 99865432 22344669999999999988877 7899999999999999999999943110
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..... ...+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 236 ---~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---TVEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---GTTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HHhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01111234568999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=336.36 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=207.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.+.|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 357999999999999999999864 68899999876433 4456889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999998643 4899999999999999999999999 9999999999999999999999999997654322
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... . .........
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~~~--------- 236 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------V-LFLIPKNNP--------- 236 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------H-HHHHHHSCC---------
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------H-HHHhhcCCC---------
Confidence 22334568999999999999999999999999999999999999995432211 0 011111110
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
.......+..+.+++.+||+.||.+|||+.+++++..-
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 11112234568999999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.07 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=194.4
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
...++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44578999999999999999999854 68899999886533 2335667899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-----CCCcEEEEecCC
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-----EKYTAKVADFGT 231 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-----~~~~~kl~Dfgl 231 (400)
||||+++ +|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999975 9999998754 4899999999999999999999999 99999999999994 455699999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH-Hhh-hc
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL-SME-EN 308 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~-~~ 308 (400)
+...... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ....... ... ..
T Consensus 184 a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 184 ARAFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTT
T ss_pred ccccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCchh
Confidence 9765322 2223445689999999999874 589999999999999999999999954332111 1110000 000 00
Q ss_pred cccc-------------ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 309 RLYD-------------FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 309 ~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+.. +....+........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 000000000011134668899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=341.75 Aligned_cols=258 Identities=17% Similarity=0.227 Sum_probs=208.7
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEE------ecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC---CCcceeeeeEE
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGM------LADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN---HRNVVKLLGCC 148 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~ 148 (400)
+....++|.+.+.||+|+||.||+|. ...++.||+|.+... ....+..|+.++..++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34456789999999999999999994 346889999987643 3456777888888886 99999999999
Q ss_pred eeCCcceEEEEccCCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC------
Q 042371 149 LETEVPLLVYEFISNGTLFQYLHDQN--EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE------ 220 (400)
Q Consensus 149 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~------ 220 (400)
...+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 99999999999999999999997532 2335999999999999999999999999 999999999999998
Q ss_pred -----CCcEEEEecCCcccccc-CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccc
Q 042371 221 -----KYTAKVADFGTSKFIVI-DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA 294 (400)
Q Consensus 221 -----~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 294 (400)
++.+||+|||+++.... ..........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 89999999999976532 23344556779999999999999999999999999999999999999984322111
Q ss_pred cchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHHHh
Q 042371 295 TGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRR-PTMKEVAMELERIQALQ 362 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~ell~~L~~~~~~~ 362 (400)
...... .... ...+.+.+++..||+.+|.+| |+++++.+.|+.+....
T Consensus 293 -------------~~~~~~----~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 -------------CKPEGL----FRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -------------EEECSC----CTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------eeechh----cccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 000000 0011 124457899999999999999 78899998888877643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=335.60 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=203.6
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
..++|.+.+.||+|+||.||++... +++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3567999999999999999999965 689999998876555555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCcEEEEecCCccccc
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~Dfgla~~~~ 236 (400)
|+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999987654 4899999999999999999999999 9999999999999 778899999999997542
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... . ......... .+.
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~-~~~i~~~~~-~~~-- 227 (304)
T 2jam_A 161 N---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------L-FEKIKEGYY-EFE-- 227 (304)
T ss_dssp C---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------H-HHHHHHCCC-CCC--
T ss_pred C---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------H-HHHHHcCCC-CCC--
Confidence 2 22233568999999999999999999999999999999999999995432211 0 111111110 000
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+..+.+++.+||+.||.+|||+.+++++
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 ---SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01112344668999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=343.99 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=193.0
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHH-HHhCCCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVI-LSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
..++|++.+.||+|+||.||+|..+ +++.||+|.+.... ......+..|..+ ++.++||||+++++++.+.+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3468999999999999999999975 57899999876432 2344566777776 46689999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999998754 4899999999999999999999999 999999999999999999999999999753
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+.....
T Consensus 190 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~-~i~~~~~----- 256 (373)
T 2r5t_A 190 IE-HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYD-NILNKPL----- 256 (373)
T ss_dssp BC-CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHH-HHHHSCC-----
T ss_pred cc-CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHH-HHHhccc-----
Confidence 32 2233445679999999999999999999999999999999999999995332111 111 1111110
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~el 351 (400)
..+...+..+.+|+.+||+.||.+||++.+.
T Consensus 257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 0112234568999999999999999998543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=344.28 Aligned_cols=258 Identities=23% Similarity=0.278 Sum_probs=196.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE------ 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 152 (400)
.++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 478999999999999999999964 6899999987543 3344677889999999999999999999987653
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..++||||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 78999998763 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh-hhcc-
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM-EENR- 309 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~- 309 (400)
+.... ......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... .+........ ....
T Consensus 176 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 176 RQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEF 249 (367)
T ss_dssp EECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHH
T ss_pred ccccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHH
Confidence 86432 2344678999999999887 689999999999999999999999995433211 1110000000 0000
Q ss_pred ---------------cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 ---------------LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+..... ..........++.+.+|+.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEK-KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCC-CCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCC-CCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000 00011122345678999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=329.95 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=184.7
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999996 468999999875422 23357788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++++|.+++..... ++++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999976432 5899999999999999999999999 99999999999999999999999999976532
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.. .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... .......
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~ 228 (278)
T 3cok_A 165 PH-EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CC-CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhcc
Confidence 22 2223456899999999999989999999999999999999999999644322110 0000000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 01122334568899999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=342.88 Aligned_cols=255 Identities=20% Similarity=0.285 Sum_probs=202.1
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
..++|++.+.||+|+||.||++..+ +++.||+|.+...... ..+|+.++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999975 5889999987644322 34678888887 7999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC----CcEEEEecCCccc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK----YTAKVADFGTSKF 234 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~----~~~kl~Dfgla~~ 234 (400)
||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+..+ +.+||+|||++..
T Consensus 96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999997654 5899999999999999999999999 9999999999998543 3599999999986
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
..... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||........... ......+... +
T Consensus 170 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~----~~~i~~~~~~-~- 242 (342)
T 2qr7_A 170 LRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI----LARIGSGKFS-L- 242 (342)
T ss_dssp CBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH----HHHHHHCCCC-C-
T ss_pred CcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH----HHHHccCCcc-c-
Confidence 54322 233456789999999999988899999999999999999999999964322111111 1111111110 0
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
........+..+.+|+.+||..||.+|||+.+++++-.
T Consensus 243 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 243 ----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp ----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 01112234566899999999999999999999998633
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=330.08 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=204.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999975 68899999876432 3446788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999886543 5899999999999999999999999 9999999999999999999999999997654322
Q ss_pred c-eeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 240 T-HVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 240 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ .+..... ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~-~~~~------- 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----EYSDWKE-KKTY------- 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH----HHHHHHT-TCTT-------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH----HHHHhhh-cccc-------
Confidence 1 22344568999999999987765 7789999999999999999999965432211 1111110 0000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+..+.+++.+||+.||.+|||+.+++++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00112234568899999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=340.79 Aligned_cols=265 Identities=26% Similarity=0.384 Sum_probs=208.9
Q ss_pred HhcCCcccceeeecCcEEEEEEEe------cCCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML------ADGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
..++|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999984 24678999988643 34456788899999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCcEEE
Q 042371 154 PLLVYEFISNGTLFQYLHDQNE----EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE---KYTAKV 226 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl 226 (400)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999987542 134899999999999999999999999 999999999999994 446999
Q ss_pred EecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHH
Q 042371 227 ADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILS 304 (400)
Q Consensus 227 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 304 (400)
+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||....... . ...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~-~~~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------V-LEF 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------H-HHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------H-HHH
Confidence 99999875432221 22234557899999999999999999999999999999998 999985432211 1 111
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhc
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 364 (400)
...... ...+...+..+.+++.+||+.||.+|||+.+++++|+.+......
T Consensus 258 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 258 VTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred HhcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 111110 111223445689999999999999999999999999998765443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=329.41 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=197.9
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357999999999999999999964 58899999876533 3456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCcEEEEecCCcccc
Q 042371 160 FISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFI 235 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~Dfgla~~~ 235 (400)
|+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986531 1235899999999999999999999999 9999999999999 45678999999999765
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.. ........||+.|+|||++. ..++.++||||||+++|+|++|+.||....... .............
T Consensus 178 ~~--~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~--- 245 (285)
T 3is5_A 178 KS--DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKEPNYA--- 245 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCC---
T ss_pred CC--cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCCcccc---
Confidence 32 22234456899999999986 578999999999999999999999995432211 1000000000000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......++.+.+++.+||+.||.+|||+.+++++
T Consensus 246 -----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 246 -----VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -----C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -----cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001124568899999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=331.46 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=201.9
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
+.|.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455556999999999999996 468899999887666666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCcEEEEecCCccccccCCc
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-KYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~Dfgla~~~~~~~~ 240 (400)
++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++...... .
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-N 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC-C
Confidence 99999999987655456789999999999999999999999 999999999999987 889999999999765322 2
Q ss_pred eeeecccccCCCCCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 241 HVTTKVQGTFGYLDPEYFRSGQ--FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ....... .. .
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~--~~---------~ 243 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGM--FK---------V 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHH--HC---------C
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhcc--cc---------c
Confidence 2233456899999999987654 88999999999999999999999954322111 0000000 00 0
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011223345668999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=355.27 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=203.2
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
..++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999965 6899999987532 234567889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCcEEEEecCCccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN---EKYTAKVADFGTSKF 234 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~---~~~~~kl~Dfgla~~ 234 (400)
|||+++++|.+.+.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999987654 4899999999999999999999999 99999999999995 456799999999986
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
... ........||+.|+|||++.+ .|+.++||||+||++|+|++|+.||....... . .......... +.
T Consensus 174 ~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~-~~~i~~~~~~-~~ 242 (486)
T 3mwu_A 174 FQQ--NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------I-LKRVETGKYA-FD 242 (486)
T ss_dssp BCC--C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHTCCC-SC
T ss_pred CCC--CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhCCCC-CC
Confidence 532 223344679999999999875 69999999999999999999999995432211 1 1111111110 00
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ......++.+.+|+.+||+.||.+|||+.+++++
T Consensus 243 ~-----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 L-----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp S-----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0112234568899999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=341.03 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=204.4
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc--------hhHHHHHHHHHHHHhC-CCCcceeeeeEE
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE--------GKLEEFINEVVILSQI-NHRNVVKLLGCC 148 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 148 (400)
....++|.+.+.||+|+||.||+|... +|+.||||.+..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 455678999999999999999999975 689999998764321 1245678999999999 799999999999
Q ss_pred eeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEe
Q 042371 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVAD 228 (400)
Q Consensus 149 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D 228 (400)
...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998654 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccccCCceeeecccccCCCCCcccccc------CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS------GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 302 (400)
||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... . .
T Consensus 244 fG~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~----~ 314 (365)
T 2y7j_A 244 FGFSCHLEP--GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---M----L 314 (365)
T ss_dssp CTTCEECCT--TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----H
T ss_pred cCcccccCC--CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---H----H
Confidence 999976542 223345679999999999863 358899999999999999999999995432111 0 0
Q ss_pred HHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 303 LSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........ .+. .... ...+..+.+++.+||+.||.+|||+.+++++
T Consensus 315 ~~i~~~~~-~~~-~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 RMIMEGQY-QFS-SPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHTCC-CCC-HHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhCCC-CCC-Cccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111110 000 0000 1123568899999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=349.33 Aligned_cols=249 Identities=15% Similarity=0.168 Sum_probs=194.1
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccc---cCchhHHHHHHHHH---HHHhCCCCcceeee-------eE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKI---VHEGKLEEFINEVV---ILSQINHRNVVKLL-------GC 147 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~---~~~~~~~~~~~E~~---~l~~l~h~~iv~~~-------~~ 147 (400)
.++|++.+.||+|+||.||+|.. .+++.||||.+.. ......+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999996 4689999998763 33455678889995 45555799999998 65
Q ss_pred EeeCC-----------------cceEEEEccCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 042371 148 CLETE-----------------VPLLVYEFISNGTLFQYLHDQNE----EFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206 (400)
Q Consensus 148 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 206 (400)
+.+.+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 55443 278999999 6799999986431 112345888899999999999999999 9
Q ss_pred EecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCCCCccccccC-----------CCCCcchhHHHHHH
Q 042371 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-----------QFTDKSDVYSFGVV 275 (400)
Q Consensus 207 iHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~i 275 (400)
+||||||+|||++.++.+||+|||+++.. ........| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRD----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEET----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheec----CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 99999999999999999999999999753 223345567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH-
Q 042371 276 LVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME- 354 (400)
Q Consensus 276 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~- 354 (400)
+|+|++|+.||........ ...+.. .....++.+.+|+.+||+.||.+|||+.+++++
T Consensus 303 l~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 361 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 361 (377)
T ss_dssp HHHHHHSSCCC------CC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred HHHHHHCCCCCcccccccc---------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence 9999999999943322110 011110 012234568999999999999999999999974
Q ss_pred -HHHHHH
Q 042371 355 -LERIQA 360 (400)
Q Consensus 355 -L~~~~~ 360 (400)
++.+..
T Consensus 362 ~f~~~~~ 368 (377)
T 3byv_A 362 EYEQLRT 368 (377)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 555544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=329.78 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=203.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc------hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE------GKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999976 689999998764321 2367889999999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----cEEEEecC
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY----TAKVADFG 230 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~Dfg 230 (400)
++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999997654 4899999999999999999999999 99999999999998877 89999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
++...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....... . ........
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~~- 227 (283)
T 3bhy_A 158 IAHKIEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------T-LTNISAVN- 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHHHHTTC-
T ss_pred cceeccCC--CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------H-HHHhHhcc-
Confidence 99765322 22334568999999999999999999999999999999999999995432211 0 00010100
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERI 358 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~ 358 (400)
.. ...... ...+..+.+++.+||+.||.+|||+.+++++ ++.+
T Consensus 228 ~~-~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 228 YD-FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CC-CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cC-Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 00 011111 1224568899999999999999999999985 4444
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=340.75 Aligned_cols=265 Identities=24% Similarity=0.258 Sum_probs=197.6
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCch-----hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEG-----KLEEFINEVVILSQINHRNVVKLLGCCLETEV 153 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 153 (400)
...++|++.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44578999999999999999999975 5899999987643221 12467899999999999999999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||+++ +|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 88888876443 4888899999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh---cc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE---NR 309 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~ 309 (400)
..... ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||....... .+... ...... ..
T Consensus 161 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i-~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSP-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRI-FETLGTPTEEQ 236 (346)
T ss_dssp TTTSC-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-HHHHCCCCTTT
T ss_pred eccCC-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHH-HHHcCCCChhh
Confidence 65422 2233446689999999998754 58999999999999999999999985433211 11111 111100 00
Q ss_pred ccccc------chhhhcc-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 LYDFL------DDQVLKV-----GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ~~~~~------~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+.... ....... .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 10000 0000000 012334679999999999999999999999886
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=350.86 Aligned_cols=198 Identities=25% Similarity=0.368 Sum_probs=167.4
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC-----Cc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET-----EV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 153 (400)
.++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999965 5889999988643 334567889999999999999999999998766 56
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||++ ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999996 59999997643 5899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc---------------------eeeecccccCCCCCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 042371 234 FIVIDQT---------------------HVTTKVQGTFGYLDPEYF-RSGQFTDKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 234 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~pf 286 (400)
....... ...+...||+.|+|||++ ....|+.++|||||||++|+|++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 7643221 123557799999999986 5667999999999999999999865554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=341.07 Aligned_cols=267 Identities=23% Similarity=0.305 Sum_probs=200.7
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC-------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLET------- 151 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------- 151 (400)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999997 468999999875432 23356778999999999999999999998873
Q ss_pred -CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 152 -EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 152 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
+..++||||+++ +|.+.+..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999975 77777765433 4899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccC---CceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh
Q 042371 231 TSKFIVID---QTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 231 la~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
++...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....................
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99765422 1222344568999999999876 4689999999999999999999999964432221111111000001
Q ss_pred hcccccccchhhhc--------cCC-H------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 307 ENRLYDFLDDQVLK--------VGQ-K------EEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 307 ~~~~~~~~~~~~~~--------~~~-~------~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+.......... ... . ..++.+.+|+.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11110000000000 000 0 013458899999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=354.04 Aligned_cols=194 Identities=28% Similarity=0.421 Sum_probs=154.9
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC-----Cc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET-----EV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 153 (400)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999865 6889999987543 334567889999999999999999999998543 46
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 469999987643 5899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc--------------------------eeeecccccCCCCCcccc-ccCCCCCcchhHHHHHHHHHHHhC
Q 042371 234 FIVIDQT--------------------------HVTTKVQGTFGYLDPEYF-RSGQFTDKSDVYSFGVVLVELLTG 282 (400)
Q Consensus 234 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg 282 (400)
....... ......+||+.|+|||++ .+..|+.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7542211 123446789999999986 566799999999999999999993
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=329.96 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=199.5
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999975 6899999987643 344567788999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC--------------
Q 042371 157 VYEFISNGTLFQYLHDQNE-EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-------------- 221 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-------------- 221 (400)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976421 125899999999999999999999999 9999999999999844
Q ss_pred -----CcEEEEecCCccccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCcccc
Q 042371 222 -----YTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEAT 295 (400)
Q Consensus 222 -----~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 295 (400)
..+||+|||++...... ....||+.|+|||++.+. .++.++||||||+++|+|++|.+|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 47999999999765332 223489999999999866 56789999999999999999988763211
Q ss_pred chHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 296 GLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. .......... ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 236 ---~--~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ---Q--WHEIRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---H--HHHHHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---H--HHHHHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 0111111111 1122334568999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=326.64 Aligned_cols=247 Identities=26% Similarity=0.347 Sum_probs=204.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999975 5788999987542 223356788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999998754 4899999999999999999999999 99999999999999999999999999865432
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||....... . ........
T Consensus 167 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~-~~~~~~~~-------- 228 (284)
T 2vgo_A 167 ---LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------T-HRRIVNVD-------- 228 (284)
T ss_dssp ---SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHHHHTTC--------
T ss_pred ---cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------H-HHHHhccc--------
Confidence 22234568999999999999999999999999999999999999995432211 0 01111100
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 --LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 01122334568899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=341.07 Aligned_cols=266 Identities=24% Similarity=0.359 Sum_probs=200.9
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999975 58899999875433 233566789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999998888766443 4899999999999999999999999 999999999999999999999999999765432
Q ss_pred CceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH--------HHHhhhc-
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF--------ILSMEEN- 308 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~- 308 (400)
........||+.|+|||++.+. .++.++||||||+++|+|++|+.||............... .......
T Consensus 178 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 -GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred -ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 2223345689999999998875 7899999999999999999999999654322111100000 0000000
Q ss_pred -----ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 309 -----RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 309 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+................++.+.+|+.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000011112345679999999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=355.48 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=200.0
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
..++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999975 68899999876432 33457788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CcEEEEecCCccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK---YTAKVADFGTSKF 234 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~Dfgla~~ 234 (400)
|||+++|+|.+.+.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999887654 4899999999999999999999999 9999999999999764 4599999999986
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
.... .......||+.|+|||++. ..|+.++||||+||++|+|++|+.||....... . ......... .+.
T Consensus 189 ~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~-~~~i~~~~~-~~~ 257 (494)
T 3lij_A 189 FENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------I-LRKVEKGKY-TFD 257 (494)
T ss_dssp CBTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHTCC-CCC
T ss_pred CCCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhCCC-CCC
Confidence 5432 2334467999999999986 579999999999999999999999995433211 1 111111111 011
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+ .....++.+.+|+.+||+.||.+|||+.+++++
T Consensus 258 ~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SP-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SG-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ch-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11 011234568899999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=353.65 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=206.4
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|.+.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67899999999999999999975 6899999987542 2234577889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 159 EFISNGTLFQYLHDQNE-EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
||++||+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999876432 335899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.. .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ ......... ...
T Consensus 342 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~-~~~-------- 409 (543)
T 3c4z_A 342 GQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVL-EQA-------- 409 (543)
T ss_dssp TC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHH-HCC--------
T ss_pred CC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHh-hcc--------
Confidence 22 223345799999999999999999999999999999999999999965432111 111111111 110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTM-----KEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~~ 354 (400)
...+...+..+.+|+.+||+.||.+||++ .+++++
T Consensus 410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 --VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred --cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 01123345678999999999999999975 566653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=343.11 Aligned_cols=269 Identities=21% Similarity=0.268 Sum_probs=198.9
Q ss_pred hHHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccC-----------chhHHHHHHHHHHHHhCCCCccee
Q 042371 75 TKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH-----------EGKLEEFINEVVILSQINHRNVVK 143 (400)
Q Consensus 75 ~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~ 143 (400)
..++....++|++.+.||+|+||.||+|...++..||||++.... ....+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456677789999999999999999999998889999999875422 122478899999999999999999
Q ss_pred eeeEEeeC-----CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 042371 144 LLGCCLET-----EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL 218 (400)
Q Consensus 144 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll 218 (400)
+++++... ...++||||++ |+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99998543 35799999997 58888887543 25899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccch
Q 042371 219 NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGL 297 (400)
Q Consensus 219 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 297 (400)
+.++.+||+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~- 244 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTA--DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN- 244 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-
T ss_pred cCCCCEEEEecCccccccc--ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 9999999999999975432 223344568999999999877 679999999999999999999999995433211100
Q ss_pred HHHHHHHhhhccc-----------ccccc-------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 298 AAYFILSMEENRL-----------YDFLD-------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 298 ~~~~~~~~~~~~~-----------~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........... ..... ...........++.+.+|+.+||+.||.+|||+.+++++
T Consensus 245 --~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 --KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp --HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00000000000 00000 000001112234568999999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=326.68 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=206.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|.+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999975 5788999986543 234567788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999987654 4899999999999999999999999 99999999999999999999999999976532
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. ........||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .. ........
T Consensus 168 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~-~~~~~~~~------- 232 (294)
T 2rku_A 168 D-GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TY-LRIKKNEY------- 232 (294)
T ss_dssp T-TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTCC-------
T ss_pred C-ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhhccC-------
Confidence 2 222334568999999999999999999999999999999999999995433211 00 11111100
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
..+...+..+.+++.+||+.||.+|||+.+++++-
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11122345688999999999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=340.87 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=204.9
Q ss_pred HHHHHHhcCCccc-ceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCC-CCcceeeeeEEee
Q 042371 76 KELDKATDHFNVN-RILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQIN-HRNVVKLLGCCLE 150 (400)
Q Consensus 76 ~~~~~~~~~y~~~-~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 150 (400)
...+...++|.+. +.||+|+||.||+|... +++.||+|.+... .......+.+|+.++..+. ||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3345566778887 89999999999999965 5899999987643 2344678899999999995 6999999999999
Q ss_pred CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCcEEEE
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE---KYTAKVA 227 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~ 227 (400)
.+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999999865432 25899999999999999999999999 999999999999998 7899999
Q ss_pred ecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh
Q 042371 228 DFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307 (400)
Q Consensus 228 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 307 (400)
|||++..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||........ . .....
T Consensus 177 Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~--~~i~~ 247 (327)
T 3lm5_A 177 DFGMSRKIGH--ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-----Y--LNISQ 247 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----H--HHHHH
T ss_pred eCccccccCC--ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----H--HHHHh
Confidence 9999986532 2223345699999999999999999999999999999999999999954332110 0 00101
Q ss_pred cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... .. ........+..+.+++.+||+.||.+|||+.+++++
T Consensus 248 ~~~-~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 VNV-DY-----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TCC-CC-----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccc-cc-----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000 00 011112344568899999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=356.94 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=205.5
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999975 6899999987542 24457789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCcEEEEecCCcc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSK 233 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~Dfgla~ 233 (400)
||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999987654 4899999999999999999999999 9999999999999 467899999999997
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
..... .......||+.|+|||++.+ .|+.++||||+||++|+|++|++||....... ........... +
T Consensus 178 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~-~ 246 (484)
T 3nyv_A 178 HFEAS--KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYT-F 246 (484)
T ss_dssp HBCCC--CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-C
T ss_pred Ecccc--cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC-C
Confidence 65322 23344569999999999875 79999999999999999999999995432211 01111111110 0
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. ......++.+.+|+.+||+.||.+|||+.+++++
T Consensus 247 ~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 EL-----PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CS-----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00 0112334668999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=333.56 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=206.9
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|.+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3578999999999999999999975 4788999987543 33456788899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999987654 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .. ........
T Consensus 193 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~~~~~~~~------ 258 (335)
T 2owb_A 193 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TY-LRIKKNEY------ 258 (335)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHHTCC------
T ss_pred cCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HH-HHHhcCCC------
Confidence 222 22344568999999999999999999999999999999999999995432211 00 11111100
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 259 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112234568899999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=328.45 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=199.0
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEee----CCcce
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLE----TEVPL 155 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 155 (400)
..|++.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45889999999999999999964 5788999987643 34556788999999999999999999999875 34578
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCcEEEEecCCccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKF 234 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~~kl~Dfgla~~ 234 (400)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999998754 4899999999999999999999976 3499999999999998 788999999999975
Q ss_pred cccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
... .......||+.|+|||++. +.++.++||||||+++|+|++|+.||....... .. ..........
T Consensus 182 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~-~~~~~~~~~~--- 248 (290)
T 1t4h_A 182 KRA---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QI-YRRVTSGVKP--- 248 (290)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HH-HHHHTTTCCC---
T ss_pred ccc---cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HH-HHHHhccCCc---
Confidence 432 2233456899999999887 469999999999999999999999995432211 11 1111111110
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... +...++.+.+++.+||+.||.+|||+.+++++
T Consensus 249 -~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 -ASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -GGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -ccc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001 11123458999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=354.51 Aligned_cols=252 Identities=29% Similarity=0.391 Sum_probs=202.1
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc-------------hhHHHHHHHHHHHHhCCCCcceeeee
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE-------------GKLEEFINEVVILSQINHRNVVKLLG 146 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 146 (400)
..++|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999965 578999998764321 33577889999999999999999999
Q ss_pred EEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---c
Q 042371 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY---T 223 (400)
Q Consensus 147 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~ 223 (400)
++.+....++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999987654 4899999999999999999999999 99999999999999776 6
Q ss_pred EEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH
Q 042371 224 AKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 303 (400)
+||+|||++...... .......||+.|+|||++. +.++.++||||+||++|+|++|..||....... ...
T Consensus 188 ~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~ 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIK 257 (504)
T ss_dssp EEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred EEEEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH
Confidence 999999999865432 2334466999999999987 569999999999999999999999995433211 111
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........ .+.... ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 258 ~i~~~~~~--~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKYY--FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCC--CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111110 000000 1234568999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=333.23 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=200.4
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEee--CCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLE--TEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.. .....+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999985 4689999998763 33567889999999997 9999999999987 5678999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-cEEEEecCCccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKFIV 236 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~Dfgla~~~~ 236 (400)
|||+++++|.+++.. +++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++....
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999998852 788999999999999999999999 99999999999999776 89999999998653
Q ss_pred cCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.. .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +... ............++
T Consensus 183 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~-~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PG--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRI-AKVLGTEDLYDYID 258 (330)
T ss_dssp TT--CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHH-HHHHCHHHHHHHHH
T ss_pred CC--CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHH-HHhcCCchhhhHHH
Confidence 22 22344568999999999877 67999999999999999999999999544332111 1110 00000000000000
Q ss_pred -----------------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 -----------------------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 -----------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000001112245679999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.56 Aligned_cols=250 Identities=28% Similarity=0.396 Sum_probs=199.9
Q ss_pred ceeeecCcEEEEEEEec---CCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLA---DGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
+.||+|+||.||+|.+. .++.||||.++... ....+.+.+|+.+|+.++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999887532 3446889999999999999999999999864 557899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc--e
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT--H 241 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~--~ 241 (400)
|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997654 4899999999999999999999999 99999999999999999999999999986643322 1
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||....... ......... ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~---------~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE---------RM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---------CC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------CC
Confidence 2233446788999999999999999999999999999998 999995433221 111111111 11
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
..+...+..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 12234456799999999999999999999999999987653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=345.73 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=194.9
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc------ce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV------PL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~ 155 (400)
..+|++.+.||+|+||.||+|....+..+|+|++..... ...+|+.+++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457999999999999999999987777799997653322 12369999999999999999999865443 78
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCcEEEEecCCccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKF 234 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~~kl~Dfgla~~ 234 (400)
+||||++++.+..+.........+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987544433332222336999999999999999999999999 99999999999999 789999999999986
Q ss_pred cccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH----------
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL---------- 303 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------- 303 (400)
... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+......
T Consensus 192 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 192 LIA--GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CCT--TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred ccC--CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 532 2233446689999999998765 59999999999999999999999996443221 11111100
Q ss_pred Hhhh----cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 304 SMEE----NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 304 ~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.... ..+................++.+.+|+.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 00000000111111122345679999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.74 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=192.7
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--------chhHHHHHHHHHHHHhCCCCcceeeeeEEe
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--------EGKLEEFINEVVILSQINHRNVVKLLGCCL 149 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 149 (400)
....++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345789999999999999999999965 57899999875421 112235789999999999999999999975
Q ss_pred eCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---cEEE
Q 042371 150 ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY---TAKV 226 (400)
Q Consensus 150 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl 226 (400)
. ...++||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 4 55799999999999999886543 5899999999999999999999999 99999999999997544 5999
Q ss_pred EecCCccccccCCceeeecccccCCCCCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH
Q 042371 227 ADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 227 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 303 (400)
+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....
T Consensus 284 ~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~---- 355 (419)
T 3i6u_A 284 TDFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD---- 355 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH----
T ss_pred eecccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH----
Confidence 99999987532 233345679999999999853 678899999999999999999999996433221 1111
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....... .+. +... ...++.+.+|+.+||+.||.+|||+.+++++
T Consensus 356 ~i~~~~~-~~~-~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 QITSGKY-NFI-PEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTCC-CCC-HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCC-CCC-chhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111110 000 0000 1234568999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=334.01 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=198.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec--CCc--EEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA--DGR--IVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~--~~~--~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|++.+.||+|+||.||+|.+. ++. .||+|.+... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999853 233 6899977643 3445678899999999999999999999988765 8
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 899999999999999986532 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcee--eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 235 IVIDQTHV--TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 235 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ..........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~-- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGE-- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCC--
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccCC--
Confidence 64332221 223457888999999998889999999999999999999 999995432211 1111111100
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
....+...+..+.+++.+||+.||.+|||+.++++.|++++.
T Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 011122345679999999999999999999999999988764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=339.22 Aligned_cols=265 Identities=21% Similarity=0.286 Sum_probs=201.4
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC-----Ccc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLET-----EVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 154 (400)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999965 68899999876433 34457888999999999999999999998765 357
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||++ ++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 5999998764 3899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCcee--eecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 235 IVIDQTHV--TTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 235 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......................+.
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 54322211 234579999999998754 458999999999999999999999995543322111111000000000000
Q ss_pred cccc------------hh--hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 312 DFLD------------DQ--VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 312 ~~~~------------~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.... .. .........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00 0000011234568999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=322.63 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=197.2
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
..++|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3478999999999999999999975 6899999987543 22345688899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999997754 4899999999999999999999999 9999999999999999999999999997653
Q ss_pred cCCceeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.. .......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... . ........ .
T Consensus 163 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~-~~~~~~~~-~---- 228 (276)
T 2h6d_A 163 DG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------L-FKKIRGGV-F---- 228 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHCC-C----
T ss_pred CC--cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------H-HHHhhcCc-c----
Confidence 22 22334568999999999988766 689999999999999999999995432111 0 11111110 0
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0112234568899999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.10 Aligned_cols=270 Identities=21% Similarity=0.299 Sum_probs=199.9
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC-----
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLET----- 151 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 151 (400)
++...++|++.+.||+|+||.||+|.. .+++.||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345567899999999999999999986 46899999987543222 23699999999999999999998543
Q ss_pred ---------------------------------CcceEEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHH
Q 042371 152 ---------------------------------EVPLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSY 197 (400)
Q Consensus 152 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~ 197 (400)
...++||||++ ++|.+.+... .....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 23789999998 4888777642 122359999999999999999999
Q ss_pred HHhcCCCCeEecCCCCCCeEEc-CCCcEEEEecCCccccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHH
Q 042371 198 LHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVV 275 (400)
Q Consensus 198 LH~~~~~~iiHrDikp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~i 275 (400)
||+.+ |+||||||+|||++ .++.+||+|||+++.... ........||+.|+|||++.+. .++.++||||+||+
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP--SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCT--TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCC--CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 99999999999998 688999999999986532 2233445689999999998765 59999999999999
Q ss_pred HHHHHhCCCCCCcCCCccccchHHHHHHHhhh---------------cccccccchhhhccCCHHHHHHHHHHHHHhccc
Q 042371 276 LVELLTGQKPIILTGSKEATGLAAYFILSMEE---------------NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNL 340 (400)
Q Consensus 276 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 340 (400)
+|+|++|+.||......+. +.... ..... ..+............+...+..+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~--~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ--LVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHH--HHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999964332211 11110 00000 000111111111112233456689999999999
Q ss_pred CCCCCCCHHHHHHH--HHHHHH
Q 042371 341 NGKRRPTMKEVAME--LERIQA 360 (400)
Q Consensus 341 dP~~RPt~~ell~~--L~~~~~ 360 (400)
||.+|||+.|++++ ++.++.
T Consensus 309 dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SGGGSCCHHHHHTSGGGHHHHH
T ss_pred ChhhCCCHHHHhcCHHHHHHHh
Confidence 99999999999976 665554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=365.60 Aligned_cols=264 Identities=26% Similarity=0.420 Sum_probs=209.5
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEecC----CcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLET 151 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 151 (400)
.++...++|++.+.||+|+||.||+|.+.. +..||+|..... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 344556789999999999999999998642 467999987653 3344578899999999999999999999985 4
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
+..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 568999999999999999986542 5899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
+...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... . .........
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~----~~~i~~~~~ 610 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V----IGRIENGER 610 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HHHHHHTCC
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---H----HHHHHcCCC
Confidence 98764433333334557789999999999999999999999999999997 999995432211 0 111111111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus 611 ---------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 611 ---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1122234567899999999999999999999999999987654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=333.97 Aligned_cols=266 Identities=25% Similarity=0.397 Sum_probs=187.9
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
....++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 445688999999999999999999964 68899999876432 3345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 157 VYEFISNGTLFQYLHDQ-----NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998741 12235899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCC----ceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh
Q 042371 232 SKFIVIDQ----THVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 232 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
+....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ . .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L---MLTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H---HHHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H---HHHhc
Confidence 87653221 112234568999999999876 5789999999999999999999999964432211 0 00111
Q ss_pred hcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 307 ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ..................+..+.+++.+||+.||.+|||+.+++++
T Consensus 242 ~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 N-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp S-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred c-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0000000000011112234568999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=321.83 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=198.5
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC----chhHHHHHHHHHHHHhCCCCcceeeeeEEe--eCCc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH----EGKLEEFINEVVILSQINHRNVVKLLGCCL--ETEV 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~ 153 (400)
..++|.+.+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999964 68899999876432 334678899999999999999999999984 4457
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.++||||++++ |.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999876 7777766433 25899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccC-CceeeecccccCCCCCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 234 FIVID-QTHVTTKVQGTFGYLDPEYFRSGQ--FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 234 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
..... .........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... . .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~-~~~i~~~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK------L-FENIGKGSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------H-HHHHHHCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH------H-HHHHhcCCC
Confidence 65422 222334556899999999988654 3779999999999999999999995432111 1 111111110
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112234568899999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=330.95 Aligned_cols=258 Identities=25% Similarity=0.390 Sum_probs=203.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEee--CCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 156 (400)
.++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999975 6899999987643 34456788999999999999999999998854 567899
Q ss_pred EEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 157 VYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAA--SMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997642 2335899999999999999999999976 2349999999999999999999999999997
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ...........
T Consensus 165 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~~-- 234 (279)
T 2w5a_A 165 ILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFR-- 234 (279)
T ss_dssp HC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC--
T ss_pred eecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHHhhcccc--
Confidence 653221 12233568999999999999999999999999999999999999995432111 11111111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
..+...+..+.+++.+||+.||.+|||+.++++++.
T Consensus 235 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 112234566899999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=330.59 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=187.8
Q ss_pred HhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCc--hhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHE--GKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
..++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+..+...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999996 4689999998765322 2233344555557888999999999999999999999
Q ss_pred EEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 158 YEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
|||+++ +|.+++... .....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999974 888877642 2223699999999999999999999998 8 999999999999999999999999999765
Q ss_pred ccCCceeeecccccCCCCCcccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYF----RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
... .......||+.|+|||++ .+..++.++||||||+++|+|++|+.||........ ...... .....
T Consensus 161 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~-~~~~~ 232 (290)
T 3fme_A 161 VDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQVV-EEPSP 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----HHHHHH-HSCCC
T ss_pred ccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----HHHHHh-ccCCC
Confidence 332 222334689999999996 566789999999999999999999999954322110 001111 11111
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+..+.+++.+||+.||.+|||+.+++++
T Consensus 233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 233 --------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11112334568999999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=344.50 Aligned_cols=200 Identities=25% Similarity=0.335 Sum_probs=172.7
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC------CCCcceeeeeEEeeCCc
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI------NHRNVVKLLGCCLETEV 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~ 153 (400)
...+|++.+.||+|+||.||+|... +++.||||.+... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4567999999999999999999865 5889999988643 33446677888888776 57799999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--EEEEecCC
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT--AKVADFGT 231 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~--~kl~Dfgl 231 (400)
.++||||+. ++|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 6999998875433 4899999999999999999999999 999999999999999887 99999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCC
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTG 290 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 290 (400)
+.... .......||+.|+|||++.+..++.++|||||||++|+|++|++||....
T Consensus 249 a~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEH----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETT----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecC----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 97542 22334578999999999999999999999999999999999999996543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=328.78 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=200.5
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467999999999999999999975 5889999988776666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 98 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-L 171 (302)
T ss_dssp CTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-H
T ss_pred CCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-c
Confidence 999999999876443 4899999999999999999999999 999999999999999999999999987543211 1
Q ss_pred eeeecccccCCCCCcccc-----ccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 241 HVTTKVQGTFGYLDPEYF-----RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.......||+.|+|||++ .+..++.++||||||+++|+|++|..||....... .. ...........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~~-- 242 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VL-LKIAKSDPPTL-- 242 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH-HHHHHSCCCCC--
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HH-HHHhccCCccc--
Confidence 122335689999999998 46678999999999999999999999995433211 00 11111111000
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 243 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 -----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -----CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1122334568999999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=339.29 Aligned_cols=263 Identities=24% Similarity=0.272 Sum_probs=202.3
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCC--------CCcceeeeeEEe---
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQIN--------HRNVVKLLGCCL--- 149 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~~~~~~--- 149 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 6889999987632 344677889999999985 788999999987
Q ss_pred -eCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCC-----
Q 042371 150 -ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLNEKY----- 222 (400)
Q Consensus 150 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~----- 222 (400)
.....++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 455789999999 5577676655432 2589999999999999999999998 8 99999999999999775
Q ss_pred --------------------------------------------cEEEEecCCccccccCCceeeecccccCCCCCcccc
Q 042371 223 --------------------------------------------TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258 (400)
Q Consensus 223 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~ 258 (400)
.+||+|||++..... ......||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----CSCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----cCccCCCCCcccCChhh
Confidence 799999999976532 23345689999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH---HHhhh--------cc-cccccch----------
Q 042371 259 RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI---LSMEE--------NR-LYDFLDD---------- 316 (400)
Q Consensus 259 ~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~--------~~-~~~~~~~---------- 316 (400)
.+..++.++|||||||++|+|++|+.||................ ..... .. ...+...
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999996544332111111100 00000 00 0000000
Q ss_pred ---------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 ---------QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00112356777889999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=330.58 Aligned_cols=263 Identities=23% Similarity=0.356 Sum_probs=203.9
Q ss_pred hcCCcccceeeecCcEEEEEEEe--cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCC------cceeeeeEEeeCCc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML--ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHR------NVVKLLGCCLETEV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~ 153 (400)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+.+|+.+++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 36889999987643 34457788999999988765 49999999999999
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-------------
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE------------- 220 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~------------- 220 (400)
.++||||+ +++|.+++..... .++++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 8899999977543 25899999999999999999999999 999999999999987
Q ss_pred ------CCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccc
Q 042371 221 ------KYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA 294 (400)
Q Consensus 221 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 294 (400)
++.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 66899999999976422 22345689999999999999999999999999999999999999965433221
Q ss_pred cchHHHHHHHhhhcc-----ccccc---------------------c-hhhhccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 042371 295 TGLAAYFILSMEENR-----LYDFL---------------------D-DQVLKVGQKEEIMTIATLATRCLNLNGKRRPT 347 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~-----~~~~~---------------------~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 347 (400)
............... ..... . ...........++.+.+|+.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 111110000000000 00000 0 00001123455678999999999999999999
Q ss_pred HHHHHHH
Q 042371 348 MKEVAME 354 (400)
Q Consensus 348 ~~ell~~ 354 (400)
+.+++++
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=361.08 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=206.0
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 155 (400)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999965 5788999987642 334567788999999988 6999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
|||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999998764 4899999999999999999999999 999999999999999999999999999854
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
... ........||+.|+|||++.+..|+.++|||||||++|||++|+.||....... .... +....
T Consensus 493 ~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~------~~~~-i~~~~------ 558 (674)
T 3pfq_A 493 IWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQS-IMEHN------ 558 (674)
T ss_dssp CCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHSSC------
T ss_pred ccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH------HHHH-HHhCC------
Confidence 322 233455779999999999999999999999999999999999999995432211 1111 11111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTM-----KEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~~ 354 (400)
...+...+..+.+||.+||+.||.+||++ ++|+++
T Consensus 559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 01122345678999999999999999998 666654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=326.82 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=204.1
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---------chhHHHHHHHHHHHHhCC-CCcceeeeeEE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---------EGKLEEFINEVVILSQIN-HRNVVKLLGCC 148 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 148 (400)
...++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999975 68899999876432 123467789999999995 99999999999
Q ss_pred eeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEe
Q 042371 149 LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVAD 228 (400)
Q Consensus 149 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D 228 (400)
...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999998754 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccccCCceeeecccccCCCCCccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR------SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 302 (400)
||++..... ........|++.|+|||++. ...++.++||||||+++|+|++|..||....... . .
T Consensus 168 fg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~-~ 238 (298)
T 1phk_A 168 FGFSCQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------M-L 238 (298)
T ss_dssp CTTCEECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-H
T ss_pred ccchhhcCC--CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------H-H
Confidence 999976532 22334456899999999985 4568899999999999999999999995432111 0 1
Q ss_pred HHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 303 LSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........ .+.. ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~-~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 239 RMIMSGNY-QFGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHHTCC-CCCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhcCCc-ccCc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11111111 0000 0112345668999999999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=342.28 Aligned_cols=265 Identities=18% Similarity=0.261 Sum_probs=208.4
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCC-CcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|.. .+++.||||.+..... ...+..|+.+++.+.| +++..+..++......+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 4689999997654322 2357889999999986 556666666777788899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCcEEEEecCCccccc
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL---NEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~Dfgla~~~~ 236 (400)
|+ +++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 8999999986443 4899999999999999999999999 9999999999999 688899999999998765
Q ss_pred cCCce------eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 237 IDQTH------VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 237 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................. .+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----KV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----HH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----cc
Confidence 33221 123567999999999999999999999999999999999999999654432221111111111 11
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
...++ .+. ...+..+.+++.+||+.+|.+||++.+|++.|+++.....
T Consensus 234 ~~~~~-~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 234 ATSIE-ALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HSCHH-HHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccHH-HHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 10000 011 1224568999999999999999999999999999987554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=333.89 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=193.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE------ 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 152 (400)
.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999864 6889999987642 3445677889999999999999999999987665
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..++||||+++ +|.+++.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 78888752 3889999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHH-------------
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAA------------- 299 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~------------- 299 (400)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 175 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccc--ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 76532 222344678999999999999999999999999999999999999995433211000000
Q ss_pred ---HHHHHhhh-cc-----cccccchhhhcc---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 300 ---YFILSMEE-NR-----LYDFLDDQVLKV---GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 300 ---~~~~~~~~-~~-----~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........ .. +........... .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 00 000000000000 112346779999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=342.49 Aligned_cols=261 Identities=23% Similarity=0.275 Sum_probs=183.7
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC------C
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET------E 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 152 (400)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999985 46899999987643 334567888999999999999999999998654 5
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..++|+|++ +++|.+++... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 68999988652 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......................+.
T Consensus 180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 180 RHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 76432 2344678999999999877 679999999999999999999999995433211110000000000000000
Q ss_pred cccchh--------------hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 312 DFLDDQ--------------VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 312 ~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+.... .........++.+.+|+.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 0000011224568999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=336.76 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=198.0
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEee-----
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLE----- 150 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----- 150 (400)
+....++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3345688999999999999999999964 68899999876433 3446788999999998 79999999999987
Q ss_pred -CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEec
Q 042371 151 -TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADF 229 (400)
Q Consensus 151 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Df 229 (400)
.+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeC
Confidence 4578999999999999999986532 25899999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCceeeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH
Q 042371 230 GTSKFIVIDQTHVTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS 304 (400)
Q Consensus 230 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 304 (400)
|++...... ........||+.|+|||++. +..++.++||||||+++|+|++|..||....... . ...
T Consensus 174 g~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~--~~~ 245 (326)
T 2x7f_A 174 GVSAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----A--LFL 245 (326)
T ss_dssp TTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----H--HHH
T ss_pred cCceecCcC-ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----H--HHH
Confidence 999765322 12223456899999999987 5678999999999999999999999995332111 0 011
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......... .....+..+.+++.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 246 IPRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHSCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhcCccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111111 112234568999999999999999999999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=342.90 Aligned_cols=255 Identities=13% Similarity=0.074 Sum_probs=183.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc---hhHHHHHHHHHHHHhC--CCCcceeee-------eEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE---GKLEEFINEVVILSQI--NHRNVVKLL-------GCC 148 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~~ 148 (400)
..+|.+.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999965 689999998876432 3456677785544444 699988755 444
Q ss_pred eeCC-----------------cceEEEEccCCCCHHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 042371 149 LETE-----------------VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMR------LRIATEVAGSLSYLHSAASMP 205 (400)
Q Consensus 149 ~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ 205 (400)
...+ ..+|||||++ |+|.+++..... .+++..+ +.++.||+.||.|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 4332 3799999998 899999987532 2455555 677899999999999999
Q ss_pred eEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCCCCcccccc--CCCCCcchhHHHHHHHHHHHhCC
Q 042371 206 IYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS--GQFTDKSDVYSFGVVLVELLTGQ 283 (400)
Q Consensus 206 iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~ 283 (400)
|+||||||+|||++.++.+||+|||+++... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETT----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecC----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998642 12224557799999999987 68999999999999999999999
Q ss_pred CCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 284 KPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 284 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.||........... .....................+..+.+|+.+||+.||.+|||+.+++++
T Consensus 291 ~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 291 LPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99965432211000 0000000000111111112445679999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=325.12 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=200.5
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
...++|++.+.||+|+||.||+|... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 45678999999999999999999975 5899999987643 23467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999975433 5899999999999999999999999 999999999999999999999999999765432
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .. ..........+
T Consensus 179 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~--~~~~~~~~~~~----- 245 (314)
T 3com_A 179 M-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AI--FMIPTNPPPTF----- 245 (314)
T ss_dssp B-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HH--HHHHHSCCCCC-----
T ss_pred c-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HH--HHHhcCCCccc-----
Confidence 2 22334568999999999999999999999999999999999999995432211 00 11111110000
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0112234568999999999999999999999885
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=337.49 Aligned_cols=272 Identities=22% Similarity=0.261 Sum_probs=190.8
Q ss_pred HHHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc-
Q 042371 76 KELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV- 153 (400)
Q Consensus 76 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 153 (400)
.......++|++.+.||+|+||.||+|... +++.||||++... ........+++..+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445677789999999999999999999974 6899999987543 2233456778888899999999999999876443
Q ss_pred ------ceEEEEccCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCeEEcC-CCc
Q 042371 154 ------PLLVYEFISNGTLFQYLHD-QNEEFPLTWEMRLRIATEVAGSLSYLH--SAASMPIYHRDIKSTNILLNE-KYT 223 (400)
Q Consensus 154 ------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~iiHrDikp~NIll~~-~~~ 223 (400)
.++||||+++ +|...+.. ......+++..++.++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999986 55544432 233346899999999999999999999 888 999999999999996 899
Q ss_pred EEEEecCCccccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH
Q 042371 224 AKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 302 (400)
+||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||................
T Consensus 171 ~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEECCCTTCBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 999999999865432 233445689999999998655 48999999999999999999999996543221111100000
Q ss_pred --------HHh-hhcccccccc------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 303 --------LSM-EENRLYDFLD------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 303 --------~~~-~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... .......... ...........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 0000000000 000111122246779999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=330.23 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=196.7
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC--------chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH--------EGKLEEFINEVVILSQINHRNVVKLLGCCLET 151 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 151 (400)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999965 57899999875421 12234578999999999999999999998765
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---EEEEe
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT---AKVAD 228 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~D 228 (400)
. .++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 799999999999999887543 5899999999999999999999999 999999999999987664 99999
Q ss_pred cCCccccccCCceeeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 305 (400)
||++..... ........||+.|+|||++. ...++.++||||||+++|+|++|..||........ .... .
T Consensus 161 fg~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~----~ 232 (322)
T 2ycf_A 161 FGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ----I 232 (322)
T ss_dssp CTTCEECCC--CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHH----H
T ss_pred Cccceeccc--ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHH----H
Confidence 999976532 22223456899999999974 56789999999999999999999999964432211 1111 1
Q ss_pred hhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 EENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..... ... +... ...+..+.+++.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~-~~~-~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 TSGKY-NFI-PEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHTCC-CCC-HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhCcc-ccC-chhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11110 000 0010 1234568999999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=329.69 Aligned_cols=264 Identities=25% Similarity=0.366 Sum_probs=200.0
Q ss_pred HhcCCcccceeeecCcEEEEEEEe--cCCcEEEEEEccccC--chhHHHHHHHHHHHHhC---CCCcceeeeeEEe----
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGML--ADGRIVAVKKSKIVH--EGKLEEFINEVVILSQI---NHRNVVKLLGCCL---- 149 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~---- 149 (400)
..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347899999999999999999997 367899999876432 22223455677776665 8999999999987
Q ss_pred -eCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEe
Q 042371 150 -ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVAD 228 (400)
Q Consensus 150 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D 228 (400)
.....++||||++ |+|.+++...... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 5999999875432 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh--
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME-- 306 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-- 306 (400)
||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ . ........
T Consensus 164 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~-~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--L-GKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCC
T ss_pred CcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--H-HHHHHHcCCC
Confidence 9999765322 223345689999999999999999999999999999999999999964332111 1 11111000
Q ss_pred -hccccccc----------chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 307 -ENRLYDFL----------DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 307 -~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+.... ............+..+.+|+.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 0000111122345678999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=336.01 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=204.1
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCch-----------------hHHHHHHHHHHHHhCCCCcceee
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEG-----------------KLEEFINEVVILSQINHRNVVKL 144 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~~iv~~ 144 (400)
.++|++.+.||+|+||.||+|.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 8999999987643211 12788999999999999999999
Q ss_pred eeEEeeCCcceEEEEccCCCCHHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeE
Q 042371 145 LGCCLETEVPLLVYEFISNGTLFQY------LHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNIL 217 (400)
Q Consensus 145 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIl 217 (400)
++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 54321 2369999999999999999999999 88 999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCceeeecccccCCCCCccccccC-CCCC-cchhHHHHHHHHHHHhCCCCCCcCCCcccc
Q 042371 218 LNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTD-KSDVYSFGVVLVELLTGQKPIILTGSKEAT 295 (400)
Q Consensus 218 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il~elltg~~pf~~~~~~~~~ 295 (400)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|+.||.......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-- 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence 999999999999999865322 33456689999999999887 6766 9999999999999999999996443211
Q ss_pred chHHHHHHHhhhcccccccch----------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 296 GLAAYFILSMEENRLYDFLDD----------QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. ......... .+... ..........+..+.+++.+||+.||.+|||+.+++++
T Consensus 260 ---~~-~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ---EL-FNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ---HH-HHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HH-HHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 111111111 00000 00000113345678999999999999999999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=331.59 Aligned_cols=262 Identities=22% Similarity=0.318 Sum_probs=194.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEe-----------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCL----------- 149 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----------- 149 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999976 48999999887766677788999999999999999999999873
Q ss_pred ---eCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCcEE
Q 042371 150 ---ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYTAK 225 (400)
Q Consensus 150 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~~k 225 (400)
+....++||||++ |+|.+++... ++++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3456789999997 5999998642 4899999999999999999999999 99999999999997 567999
Q ss_pred EEecCCccccccCC--ceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH
Q 042371 226 VADFGTSKFIVIDQ--THVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 226 l~Dfgla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 302 (400)
|+|||++....... ........+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence 99999998653221 112233457999999998865 67899999999999999999999999644321110 0000
Q ss_pred HHhhh------cc----cccccchhhh------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 303 LSMEE------NR----LYDFLDDQVL------KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 303 ~~~~~------~~----~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..... .. +......... .......+..+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000 00 0000000000 00112235678999999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=342.73 Aligned_cols=260 Identities=25% Similarity=0.327 Sum_probs=193.0
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC------cce
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETE------VPL 155 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~ 155 (400)
.+|++.+.||+|+||.||+|... +++.||||++..... ...+|+.+++.++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999975 589999998754322 2346999999999999999999885422 357
Q ss_pred EEEEccCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CcEEEEecCCcc
Q 042371 156 LVYEFISNGTLFQYLHDQ-NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSK 233 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~Dfgla~ 233 (400)
+||||+++ +|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999976 676666531 12235999999999999999999999999 9999999999999965 578999999998
Q ss_pred ccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH-------h
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS-------M 305 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~ 305 (400)
..... .......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||....... .+....... +
T Consensus 206 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred hcccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence 65322 223446789999999998764 79999999999999999999999996433211 111111100 0
Q ss_pred --hhcccccc-----cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 --EENRLYDF-----LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 --~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......+ .............+..+.+|+.+||+.||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000000 00000001112334678999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=330.34 Aligned_cols=258 Identities=20% Similarity=0.319 Sum_probs=199.7
Q ss_pred HHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCC--CCcceeeeeEEeeC
Q 042371 76 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIV--HEGKLEEFINEVVILSQIN--HRNVVKLLGCCLET 151 (400)
Q Consensus 76 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 151 (400)
..+....++|++.+.||+|+||.||++...+++.||+|.+... .....+.+.+|+.++..++ |+||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3344556789999999999999999999888999999987643 3445678899999999997 59999999999999
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
+..++||| +.+++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++ +.+||+|||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 99999999 55789999998754 5899999999999999999999999 999999999999975 7999999999
Q ss_pred ccccccCCce-eeecccccCCCCCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHH
Q 042371 232 SKFIVIDQTH-VTTKVQGTFGYLDPEYFRS-----------GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAA 299 (400)
Q Consensus 232 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 299 (400)
+......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... .
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~ 247 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S 247 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----H
Confidence 9865432221 2234568999999999875 478889999999999999999999995432211 0
Q ss_pred HHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 300 YFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
........ ......+...+..+.+++.+||+.||.+|||+.+++++-
T Consensus 248 ~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 248 KLHAIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHHHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHhc---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11111111 111111112245688999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=340.31 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=183.1
Q ss_pred cCCcc-cceeeecCcEEEEEEEec---CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEee--CCcceE
Q 042371 83 DHFNV-NRILGQGGQGTVYKGMLA---DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLL 156 (400)
Q Consensus 83 ~~y~~-~~~lg~G~fg~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 156 (400)
+.|.+ .++||+|+||.||+|... +++.||+|.+.... ....+.+|+.+|+.++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44666 558999999999999965 47889999886432 23567899999999999999999999965 567899
Q ss_pred EEEccCCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCcEEE
Q 042371 157 VYEFISNGTLFQYLHDQN------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL----NEKYTAKV 226 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll----~~~~~~kl 226 (400)
||||+++ +|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999974 8888775321 1224899999999999999999999999 9999999999999 67789999
Q ss_pred EecCCccccccCCc--eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccc------cch
Q 042371 227 ADFGTSKFIVIDQT--HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA------TGL 297 (400)
Q Consensus 227 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~------~~~ 297 (400)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987643211 223446789999999998874 589999999999999999999999954432100 000
Q ss_pred HHHHHHHhhh---cccccc---cc---------hhhhcc---------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042371 298 AAYFILSMEE---NRLYDF---LD---------DQVLKV---------GQKEEIMTIATLATRCLNLNGKRRPTMKEVAM 353 (400)
Q Consensus 298 ~~~~~~~~~~---~~~~~~---~~---------~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 353 (400)
.......... ..+..+ .+ ...... .....+..+.+||.+||+.||.+|||+.++++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 000000 00 000000 00011346889999999999999999999998
Q ss_pred H
Q 042371 354 E 354 (400)
Q Consensus 354 ~ 354 (400)
+
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=323.23 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=192.8
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEee---------
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE--------- 150 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 150 (400)
..++|++.+.||+|+||.||+|... +++.||+|.+.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3467999999999999999999964 689999998754 33456788999999999999999999998865
Q ss_pred ----CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEE
Q 042371 151 ----TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV 226 (400)
Q Consensus 151 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl 226 (400)
.+..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 3467899999999999999986442 4788999999999999999999999 999999999999999999999
Q ss_pred EecCCccccccCC-------------ceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCc
Q 042371 227 ADFGTSKFIVIDQ-------------THVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSK 292 (400)
Q Consensus 227 ~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 292 (400)
+|||++....... ........||+.|+|||++.+. .++.++||||||+++|+|++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999997653211 1122345689999999998764 78999999999999999998 442110
Q ss_pred cccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 293 EATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. .... ....... ... .........+..+.+++.+||+.||.+|||+.+++++
T Consensus 233 ~---~~~~-~~~~~~~-~~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 E---RVNI-LKKLRSV-SIE-----FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H---HHHH-HHHHHST-TCC-----CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h---HHHH-HHhcccc-ccc-----cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0 0000 0111110 000 0111223344568899999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=338.49 Aligned_cols=269 Identities=25% Similarity=0.396 Sum_probs=204.1
Q ss_pred ChHHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC
Q 042371 74 TTKELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLET 151 (400)
Q Consensus 74 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 151 (400)
...+++...++|++.+.||+|+||.||+|...+ .+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345556667899999999999999999998754 48999876432 33345677899999999999999999999999
Q ss_pred CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 152 EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 152 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
+..++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999976442 5899999999999999999999999 99999999999998 67999999999
Q ss_pred ccccccCC----ceeeecccccCCCCCcccccc---------CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchH
Q 042371 232 SKFIVIDQ----THVTTKVQGTFGYLDPEYFRS---------GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLA 298 (400)
Q Consensus 232 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 298 (400)
+....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----- 250 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----- 250 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 87543211 122233458999999999864 457899999999999999999999995433211
Q ss_pred HHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhhcc
Q 042371 299 AYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~ 365 (400)
.............. ....+..+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus 251 --~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 251 --IIWQMGTGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp --HHHHHHTTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred --HHHHhccCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 11111111111111 1122345889999999999999999999999999988765543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.99 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=199.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC-----Ccc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLET-----EVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 154 (400)
.++|.+.+.||+|+||.||+|... +|+.||||.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999965 68899999886433 34456788999999999999999999987654 568
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
++||||++ ++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 5999988763 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce---------eeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH
Q 042371 235 IVIDQTH---------VTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS 304 (400)
Q Consensus 235 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 304 (400)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~-~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LLLIF-GI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH-HH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHH-HH
Confidence 5422111 1223568999999998764 6789999999999999999999999964432111 10000 00
Q ss_pred hhhcc---cccccc---------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 305 MEENR---LYDFLD---------------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 305 ~~~~~---~~~~~~---------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..... ...... ...........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000000 000000112345678999999999999999999999884
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.81 Aligned_cols=259 Identities=23% Similarity=0.311 Sum_probs=196.8
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc---
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP--- 154 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--- 154 (400)
..++|.+.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999964 6899999987653 333467888999999999999999999999877655
Q ss_pred ---eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 155 ---LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 155 ---~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
++||||+. ++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 588887732 3899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH-hhhcc
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS-MEENR 309 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~ 309 (400)
+.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ........ .....
T Consensus 191 a~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 191 ARHAD----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTE 264 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred ccccc----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCcHH
Confidence 97543 22344568999999999887 6899999999999999999999999954332111 00000000 00000
Q ss_pred cccccchh--------h-------hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 LYDFLDDQ--------V-------LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ~~~~~~~~--------~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
+...+... . ........++.+.+|+.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 0 000011235678999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=321.03 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=203.7
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
....++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999975 6889999987543 2345678899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CcEEEEecCCc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK---YTAKVADFGTS 232 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~Dfgla 232 (400)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999887654 4899999999999999999999999 9999999999999764 47999999999
Q ss_pred cccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... . ..........
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~-~~~~~~~~~~- 240 (287)
T 2wei_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------I-LKRVETGKYA- 240 (287)
T ss_dssp GTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHCCCC-
T ss_pred eeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHcCCCC-
Confidence 7653222 2233458999999999875 58999999999999999999999995432211 1 1111111110
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. +.. .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~-~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 F-DLP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp C-CSG----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred C-Cch----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 000 011234568999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=331.39 Aligned_cols=201 Identities=26% Similarity=0.365 Sum_probs=170.9
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CC-----cceeeeeEEeeCC
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HR-----NVVKLLGCCLETE 152 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~ 152 (400)
...++|++.+.||+|+||.||+|... +++.||||.+... ......+..|+.++..++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 44678999999999999999999965 6889999988632 334566778888888874 44 4999999999999
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCCeEecCCCCCCeEEc--CCCcEEEEe
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS--AASMPIYHRDIKSTNILLN--EKYTAKVAD 228 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~~~~iiHrDikp~NIll~--~~~~~kl~D 228 (400)
..++||||++ ++|.+++...... .+++..++.++.|++.||.|||. .+ |+||||||+|||++ .++.+||+|
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999996 5999999875432 48999999999999999999994 56 99999999999995 477899999
Q ss_pred cCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCC
Q 042371 229 FGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTG 290 (400)
Q Consensus 229 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 290 (400)
||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 205 FG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 205 FGSSCQLGQ----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CTTCEETTC----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCceeccc----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999986532 2334568999999999999999999999999999999999999996443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=326.04 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=200.6
Q ss_pred HhcCCcccceeeecCcEEEEEEEec-CC-cEEEEEEccccCchhHHHHHHHHHHHHhCCCCc------ceeeeeEEeeCC
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA-DG-RIVAVKKSKIVHEGKLEEFINEVVILSQINHRN------VVKLLGCCLETE 152 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~ 152 (400)
..++|++.+.||+|+||.||+|... ++ ..||+|.+... ....+.+.+|+.+++.++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3578999999999999999999964 34 68999987643 344567888999999987665 899999999999
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE--------------
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILL-------------- 218 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll-------------- 218 (400)
..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 5677777765432 25899999999999999999999999 9999999999999
Q ss_pred -----cCCCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCcc
Q 042371 219 -----NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE 293 (400)
Q Consensus 219 -----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 293 (400)
+.++.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5678999999999975422 2234568999999999999999999999999999999999999996443221
Q ss_pred ccchHHHHHHHhhhc-----ccccc-cc---------------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCC
Q 042371 294 ATGLAAYFILSMEEN-----RLYDF-LD---------------------DQVLKVGQKEEIMTIATLATRCLNLNGKRRP 346 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~-----~~~~~-~~---------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 346 (400)
............... ..... .. ...........+..+.+|+.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 111110000000000 00000 00 0000112234566799999999999999999
Q ss_pred CHHHHHHH
Q 042371 347 TMKEVAME 354 (400)
Q Consensus 347 t~~ell~~ 354 (400)
|+.+++++
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=326.81 Aligned_cols=263 Identities=21% Similarity=0.263 Sum_probs=199.8
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-----------CCcceeeeeEEe
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-----------HRNVVKLLGCCL 149 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~~ 149 (400)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.. .......+.+|+.+++.++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999996 4688999998763 2334567788999988876 899999999988
Q ss_pred eCC----cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEc-----
Q 042371 150 ETE----VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLN----- 219 (400)
Q Consensus 150 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~----- 219 (400)
..+ ..++||||+ +++|.+++...... .+++..++.++.||+.||.|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 678999999 88999999875433 489999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchH
Q 042371 220 -EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLA 298 (400)
Q Consensus 220 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 298 (400)
..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCC----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 344899999999976532 223456899999999999999999999999999999999999999644322111000
Q ss_pred HHHHHHhh-hccccc--------------------cc--------ch--hhhccCCHHHHHHHHHHHHHhcccCCCCCCC
Q 042371 299 AYFILSME-ENRLYD--------------------FL--------DD--QVLKVGQKEEIMTIATLATRCLNLNGKRRPT 347 (400)
Q Consensus 299 ~~~~~~~~-~~~~~~--------------------~~--------~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 347 (400)
........ -+.... .+ .. ......+...+..+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 00000000 000000 00 00 0011234677888999999999999999999
Q ss_pred HHHHHHH
Q 042371 348 MKEVAME 354 (400)
Q Consensus 348 ~~ell~~ 354 (400)
+.+++++
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=328.34 Aligned_cols=258 Identities=23% Similarity=0.302 Sum_probs=196.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc-----
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV----- 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 153 (400)
.++|.+.+.||+|+||.||+|... +|+.||||.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999964 6899999987643 23345778899999999999999999999987654
Q ss_pred -ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 154 -PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 154 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
.++||||++ ++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 588777632 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH-hhhccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS-MEENRL 310 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~ 310 (400)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ +....... .....+
T Consensus 174 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 174 RHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEF 247 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHHH
T ss_pred cCCCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 76432 2334568999999999877 6789999999999999999999999964432111 00000000 000000
Q ss_pred cccc-c--------------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFL-D--------------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~-~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+ + ...........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0 000011122345679999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=326.33 Aligned_cols=254 Identities=21% Similarity=0.293 Sum_probs=174.3
Q ss_pred HhcCCcccc-eeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHH-HHHHhCCCCcceeeeeEEee----CCc
Q 042371 81 ATDHFNVNR-ILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEV-VILSQINHRNVVKLLGCCLE----TEV 153 (400)
Q Consensus 81 ~~~~y~~~~-~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~----~~~ 153 (400)
..++|.+.+ .||+|+||.||+|... +++.||+|.+.... ...+|+ ..++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 357899855 6999999999999975 68999999875321 122233 34566799999999999876 445
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCcEEEEecC
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE---KYTAKVADFG 230 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~Dfg 230 (400)
.++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 7999999999999999987543 25999999999999999999999999 999999999999986 4459999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
++..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||............ ........
T Consensus 177 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~- 249 (336)
T 3fhr_A 177 FAKETTQ---NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLGQ- 249 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceeccc---cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhccc-
Confidence 9976432 2233456899999999998888999999999999999999999999543322110000 00000000
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
.. .........+..+.+|+.+||+.||.+|||+.+++++-
T Consensus 250 ~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 250 YG-----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp -C-----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred cc-----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 00011123456689999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=324.01 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=181.6
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHH-HHHhCCCCcceeeeeEEeeCCcceE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
...++|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|+. +++.++||||+++++++...+..++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 34578999999999999999999975 68999999876542 333455566666 6677899999999999999999999
Q ss_pred EEEccCCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 157 VYEFISNGTLFQYLHDQ--NEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
||||+++ +|.+++... .....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999985 888877641 1123589999999999999999999998 8 9999999999999999999999999997
Q ss_pred ccccCCceeeecccccCCCCCcccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYF----RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++ .+..++.++||||||+++|+|++|+.||........ ... .
T Consensus 175 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~~--~ 241 (327)
T 3aln_A 175 QLVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QLT--Q 241 (327)
T ss_dssp C--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--C
T ss_pred ecccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HHH--H
Confidence 65322 222334689999999998 456789999999999999999999999954321100 000 0
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
.................+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 00000000111111234566899999999999999999999998633
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.40 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=188.8
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
+.|.+.+.||+|+||+||.+...+|+.||||.+... ..+.+.+|+.++..+ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456667899999999998776667999999987532 345678899999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-------------CcE
Q 042371 162 SNGTLFQYLHDQNEEF----PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK-------------YTA 224 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~-------------~~~ 224 (400)
+ |+|.+++....... ..++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 59999997654211 0123345779999999999999999 9999999999999754 489
Q ss_pred EEEecCCccccccCCce---eeecccccCCCCCcccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCcc
Q 042371 225 KVADFGTSKFIVIDQTH---VTTKVQGTFGYLDPEYFRS-------GQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKE 293 (400)
Q Consensus 225 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 293 (400)
||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876433221 1234579999999999875 578999999999999999999 999995432211
Q ss_pred ccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 294 ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ... ... ... ...........+..+.+++.+||+.||.+|||+.+++++
T Consensus 248 -----~---~i~-~~~-~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 -----S---NII-RGI-FSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -----H---HHH-HTC-CCC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----H---HHh-cCC-CCc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0 000 000 000 111122345677889999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=322.12 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=191.1
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCc------hhHHHHHHHHHHHHhC----CCCcceeee
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHE------GKLEEFINEVVILSQI----NHRNVVKLL 145 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l----~h~~iv~~~ 145 (400)
+.+...++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455678899999999999999999986 4688999998764322 1233455788999888 899999999
Q ss_pred eEEeeCCcceEEEEc-cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCc
Q 042371 146 GCCLETEVPLLVYEF-ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYT 223 (400)
Q Consensus 146 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~ 223 (400)
+++...+..++|||+ +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 999999999999999 78999999998754 4899999999999999999999999 99999999999999 8899
Q ss_pred EEEEecCCccccccCCceeeecccccCCCCCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHH
Q 042371 224 AKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFT-DKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFI 302 (400)
Q Consensus 224 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 302 (400)
+||+|||++...... ......||+.|+|||++.+..+. .++||||||+++|+|++|+.||.... .
T Consensus 179 ~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~--- 244 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E--- 244 (312)
T ss_dssp EEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H---
T ss_pred EEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H---
Confidence 999999999865432 23345689999999999877764 58999999999999999999984210 0
Q ss_pred HHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 303 LSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..... ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 245 --~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 --ILEAE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --HHHTC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --Hhhhc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01122334568899999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=323.73 Aligned_cols=254 Identities=22% Similarity=0.355 Sum_probs=181.7
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc-hh-HHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE-GK-LEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~-~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
...++|++.+.||+|+||.||+|... +++.||+|.+..... .. .+.+..+..+++.++||||+++++++.+.+..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34578999999999999999999975 689999998765432 22 2334445556788899999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
||||+ ++.+..+...... .+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 102 v~e~~-~~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EECCC-SEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecc-CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 99999 5566666554332 589999999999999999999995 8 999999999999999999999999999765
Q ss_pred ccCCceeeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||....... ....... ....
T Consensus 176 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~~~~ 247 (318)
T 2dyl_A 176 VDD--KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVL-QEEP 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHH-HSCC
T ss_pred cCC--ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHh-ccCC
Confidence 322 2233456899999999984 5578999999999999999999999995432211 0111111 1110
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+ ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 248 ~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 PLL-------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCC-------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 0011234568899999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=328.37 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=199.4
Q ss_pred ChHHHHHHhcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCch------hHHHHHHHHHHHHhCC--CCcceee
Q 042371 74 TTKELDKATDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEG------KLEEFINEVVILSQIN--HRNVVKL 144 (400)
Q Consensus 74 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~--h~~iv~~ 144 (400)
+..+.+...++|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++ |+||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3344556678999999999999999999985 46889999987643211 2245667999999996 5999999
Q ss_pred eeEEeeCCcceEEEEccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCC
Q 042371 145 LGCCLETEVPLLVYEFISN-GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKY 222 (400)
Q Consensus 145 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~ 222 (400)
++++...+..++|||++.+ ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 9999999999999999976 89999998754 4899999999999999999999999 99999999999999 778
Q ss_pred cEEEEecCCccccccCCceeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH
Q 042371 223 TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF 301 (400)
Q Consensus 223 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 301 (400)
.+||+|||++..... .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....
T Consensus 188 ~~kL~Dfg~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------- 253 (320)
T 3a99_A 188 ELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------- 253 (320)
T ss_dssp EEEECCCTTCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred CEEEeeCcccccccc---ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------
Confidence 999999999986532 22334568999999999987776 678999999999999999999994211
Q ss_pred HHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 302 ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....... ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 254 --~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 --EIIRGQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --HHHHCCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --hhhcccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0111234568899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=330.16 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=187.6
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
..+|.+.+.||+|+||.|+.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 356899999999999997655556789999998754322 2356799999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----CCcEEEEecCCcccc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-----KYTAKVADFGTSKFI 235 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-----~~~~kl~Dfgla~~~ 235 (400)
++ |+|.+++..... .+.+..++.++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 599999976543 2444556789999999999999999 999999999999953 236889999999866
Q ss_pred ccCCc--eeeecccccCCCCCccccc---cCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 236 VIDQT--HVTTKVQGTFGYLDPEYFR---SGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 236 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||....... .........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCC
Confidence 43221 2234467999999999997 4567889999999999999999 999984322111 011111101
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. .. .......+..+.+|+.+||+.||.+|||+.+++++
T Consensus 247 ~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 L-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp C-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 00 11122345668899999999999999999999954
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=343.10 Aligned_cols=274 Identities=24% Similarity=0.316 Sum_probs=203.6
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEee------CCc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLE------TEV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~ 153 (400)
.++|++.+.||+|+||.||+|... +|+.||+|.+... .....+.+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999964 6889999987643 34456788999999999999999999998765 667
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---EEEEecC
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT---AKVADFG 230 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~Dfg 230 (400)
.++||||+++|+|.+++........+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999987655446899999999999999999999999 999999999999997764 9999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccc--hHHHHHHH-hhh
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATG--LAAYFILS-MEE 307 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~-~~~ 307 (400)
++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.......... ........ ...
T Consensus 170 ~a~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQ--GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTS--CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccc--ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 9986532 223344678999999999999999999999999999999999999995432110000 00000000 000
Q ss_pred cccc---cccch-hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHH-----HHHHHHHHH
Q 042371 308 NRLY---DFLDD-QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV-----AMELERIQA 360 (400)
Q Consensus 308 ~~~~---~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~el-----l~~L~~~~~ 360 (400)
.... .+... ..........+..+.+++.+||..||.+|||+.++ .+.++.+..
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000 00000 01112344567889999999999999999999884 444554443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=340.22 Aligned_cols=242 Identities=22% Similarity=0.305 Sum_probs=194.7
Q ss_pred HhcCCcccceeeecCcEEEEEEEec--CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc----
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLA--DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV---- 153 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 153 (400)
..++|++.+.||+|+||.||+|.+. +++.||||.+... .......+.+|+.++..++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999975 5899999987643 33445678899999999999999999999987765
Q ss_pred -ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 154 -PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 154 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
.||||||++|++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999887643 4899999999999999999999999 9999999999999986 9999999999
Q ss_pred cccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
+..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.......
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------- 283 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------- 283 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-------------------
Confidence 865322 345699999999998765 4899999999999999999998874211100
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT-MKEVAMELERIQA 360 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ell~~L~~~~~ 360 (400)
+.. .......+..+.+++.+||+.||.+||+ ++++...|..+..
T Consensus 284 ~~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 LPE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CCT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 000 0001123456889999999999999995 6666666766654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=303.57 Aligned_cols=235 Identities=16% Similarity=0.145 Sum_probs=184.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999975 48999999886543 33457889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||++|++|.+++... .....+..++.||+.||.|||+.| |+||||||+|||++.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999998532 345568889999999999999999 9999999999999999999998543
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
|++ +++.++|||||||++|+|++|+.||............ .........
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~-- 223 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQPI-- 223 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSCBC--
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccCCC--
Confidence 333 3688999999999999999999999654332100000 000000000
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
.........+..+.+++.+||+.||.+| |+.++++.|+++.....
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0001112344668999999999999999 99999999999876543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=322.53 Aligned_cols=250 Identities=14% Similarity=0.155 Sum_probs=184.8
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCc---hhHHHHHHHHHHHHhCCC-Ccce---------e----
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHE---GKLEEFINEVVILSQINH-RNVV---------K---- 143 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h-~~iv---------~---- 143 (400)
..+|...+.||+|+||.||+|.+ .+|+.||||++..... ...+.+.+|+.+++.+.| +|.. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 45588889999999999999995 4689999998763322 235778899999999976 2211 1
Q ss_pred --------eeeEEee-----CCcceEEEEccCCCCHHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 042371 144 --------LLGCCLE-----TEVPLLVYEFISNGTLFQYLHDQ----NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPI 206 (400)
Q Consensus 144 --------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 206 (400)
+..++.. ....+++|+++ +++|.+++... .....+++..++.++.||+.||.|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 1111111 12346777766 67999998521 12235788899999999999999999999 9
Q ss_pred EecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecccccCCCCCcccc----------ccCCCCCcchhHHHHHHH
Q 042371 207 YHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF----------RSGQFTDKSDVYSFGVVL 276 (400)
Q Consensus 207 iHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwSlG~il 276 (400)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999876432 2445567 999999998 555688999999999999
Q ss_pred HHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--
Q 042371 277 VELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME-- 354 (400)
Q Consensus 277 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~-- 354 (400)
|+|++|+.||........ ....+. .....++.+.+|+.+||+.||.+|||+.+++++
T Consensus 308 ~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~ 366 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHCCCCCCCcchhhh---------------HHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 999999999954322111 011111 011234669999999999999999999999875
Q ss_pred HHHHHHH
Q 042371 355 LERIQAL 361 (400)
Q Consensus 355 L~~~~~~ 361 (400)
++.+...
T Consensus 367 ~~~~~~~ 373 (413)
T 3dzo_A 367 YEQLRTE 373 (413)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 5555443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=301.59 Aligned_cols=229 Identities=22% Similarity=0.313 Sum_probs=179.3
Q ss_pred hcCCccc-ceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHH-HhCCCCcceeeeeEEee----CCcc
Q 042371 82 TDHFNVN-RILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVIL-SQINHRNVVKLLGCCLE----TEVP 154 (400)
Q Consensus 82 ~~~y~~~-~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~~~ 154 (400)
.++|.+. +.||+|+||.||++.. .+++.||+|.+.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567777 7899999999999996 4688999998753 24566788887 55689999999999877 6678
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCcEEEEecCC
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE---KYTAKVADFGT 231 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~Dfgl 231 (400)
++||||+++++|.+++...... .+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999875432 5899999999999999999999999 999999999999998 78999999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
+.... +..++.++|||||||++|+|++|+.||........ . ....
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~-~~~~ 211 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------S-PGMK 211 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------h-HHHH
Confidence 86431 24567899999999999999999999954322110 0 0000
Q ss_pred cccchhhhccCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042371 312 DFLDDQVLKVGQ----KEEIMTIATLATRCLNLNGKRRPTMKEVAMEL 355 (400)
Q Consensus 312 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 355 (400)
..+.... ...+ ...+..+.+++.+||+.||.+|||+.+++++-
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 212 TRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp CSSCTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHhhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 0000000 0011 12356789999999999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=312.67 Aligned_cols=243 Identities=18% Similarity=0.193 Sum_probs=183.8
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccC--------chhHHHHHHHHHHHHhCC---------CCcceee
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH--------EGKLEEFINEVVILSQIN---------HRNVVKL 144 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~~iv~~ 144 (400)
.++|++.+.||+|+||.||+|.. +++.||||.+.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 67999999876542 233578889999998885 6666666
Q ss_pred eeEE-----------------ee-------------CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 042371 145 LGCC-----------------LE-------------TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194 (400)
Q Consensus 145 ~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 194 (400)
.+.+ .+ .+..+|||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 5553 32 6788999999999977666643 248999999999999999
Q ss_pred HHHHH-hcCCCCeEecCCCCCCeEEcCCC--------------------cEEEEecCCccccccCCceeeecccccCCCC
Q 042371 195 LSYLH-SAASMPIYHRDIKSTNILLNEKY--------------------TAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253 (400)
Q Consensus 195 l~~LH-~~~~~~iiHrDikp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ 253 (400)
|.||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 899 99999999999999887 8999999999865321 246899999
Q ss_pred CccccccCCCCCcchhHHHHHH-HHHHHhCCCCCCcCCCccccchHHHHHHHhh-hcccccccchhhhccCCHHHHHHHH
Q 042371 254 DPEYFRSGQFTDKSDVYSFGVV-LVELLTGQKPIILTGSKEATGLAAYFILSME-ENRLYDFLDDQVLKVGQKEEIMTIA 331 (400)
Q Consensus 254 aPE~~~~~~~~~~~DiwSlG~i-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~ 331 (400)
|||++.+.. +.++||||+|++ .+++++|..||.. ............ ..... ...........++.+.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhccC----cccchhhhhhcCHHHH
Confidence 999998766 889999998777 7788889999821 000000111111 00000 0001112345778899
Q ss_pred HHHHHhcccCCCCCCCHHHHH-HH
Q 042371 332 TLATRCLNLNGKRRPTMKEVA-ME 354 (400)
Q Consensus 332 ~li~~cl~~dP~~RPt~~ell-~~ 354 (400)
+|+.+||+.| |+.+++ ++
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999976 898888 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=279.26 Aligned_cols=184 Identities=18% Similarity=0.118 Sum_probs=128.8
Q ss_pred eecCcEEEEEEE-ecCCcEEEEEEccccC----------chhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEEEE
Q 042371 92 GQGGQGTVYKGM-LADGRIVAVKKSKIVH----------EGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 92 g~G~fg~V~~~~-~~~~~~vaiK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
+.|++|.+..++ .--|+.+|+|.+.... +...+++.+|+.+|+++ .|+||+++++++.+++..|||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 344444443333 1236778999765321 23456799999999999 69999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|++|++|.++|...+ +++.. .|+.||+.||.|+|++| ||||||||+|||++.+|.+||+|||+|+......
T Consensus 323 yv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 323 KLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp CCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred cCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999998654 46654 58899999999999999 9999999999999999999999999998654332
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 286 (400)
....+.+||+.|+|||++.+ .+..++|+||+|++++++.++..|+
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 23345679999999999875 5677899999999988877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=247.55 Aligned_cols=184 Identities=14% Similarity=0.196 Sum_probs=144.6
Q ss_pred cccceeeecCcEEEEEEEecCCcEEEEEEccccC--------chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 86 NVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH--------EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 86 ~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
...+.||+|+||.||++.. .+..+++|+..... ....+.+.+|+.++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 46788888643211 11245688999999999999999666666677888999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999875 4478999999999999999 999999999999999 999999999987643
Q ss_pred CCcee------eecccccCCCCCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCC
Q 042371 238 DQTHV------TTKVQGTFGYLDPEYFRS--GQFTDKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 238 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf 286 (400)
..... .....||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22211 235679999999999987 56888899999999999988887765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=206.09 Aligned_cols=160 Identities=16% Similarity=0.177 Sum_probs=126.3
Q ss_pred HHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCc------------------hhHHHHHHHHHHHHhCCCCcc
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHE------------------GKLEEFINEVVILSQINHRNV 141 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~~i 141 (400)
.....|.+.+.||+|+||.||+|...+|+.||+|.+..... .....+.+|+.+++.++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 34566778899999999999999997799999998754221 13467889999999999 4
Q ss_pred eeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 042371 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK 221 (400)
Q Consensus 142 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~ 221 (400)
+++.+++. .+..++||||++|++|.+ +.. .....++.|++.||.|||+.| |+||||||+|||++ +
T Consensus 164 ~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 164 LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E 228 (282)
T ss_dssp SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence 66666543 356799999999999988 421 124469999999999999999 99999999999999 9
Q ss_pred CcEEEEecCCccccccCCceeeecccccCCCCCcccccc----------CCCCCcchhHH
Q 042371 222 YTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS----------GQFTDKSDVYS 271 (400)
Q Consensus 222 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DiwS 271 (400)
+.+||+|||+++. +..+.|||++.. ..|...+|+|.
T Consensus 229 ~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 229 EGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999999999862 456789998753 33455566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=172.57 Aligned_cols=137 Identities=20% Similarity=0.204 Sum_probs=106.5
Q ss_pred CCcccceeeecCcEEEEEEEe-cCCcE--EEEEEccccCch------------------------hHHHHHHHHHHHHhC
Q 042371 84 HFNVNRILGQGGQGTVYKGML-ADGRI--VAVKKSKIVHEG------------------------KLEEFINEVVILSQI 136 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~-~~~~~--vaiK~~~~~~~~------------------------~~~~~~~E~~~l~~l 136 (400)
-|.+.+.||+|+||.||+|.. .+|+. ||||..+..... ....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999997 67888 999975432111 123678899999999
Q ss_pred CCCcc--eeeeeEEeeCCcceEEEEccCC-C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEe
Q 042371 137 NHRNV--VKLLGCCLETEVPLLVYEFISN-G----TLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH-SAASMPIYH 208 (400)
Q Consensus 137 ~h~~i--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH 208 (400)
.|+++ +.++.. +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| ..+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88754 444432 357899999942 3 67766432 123456789999999999999 988 999
Q ss_pred cCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 209 RDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 209 rDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6.8e-19 Score=167.77 Aligned_cols=135 Identities=13% Similarity=0.165 Sum_probs=98.8
Q ss_pred CCcccceeeecCcEEEEEEEecCCcEEEEEEccccCc--------------hhHH--------HHHHHHHHHHhCCCCcc
Q 042371 84 HFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHE--------------GKLE--------EFINEVVILSQINHRNV 141 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~~i 141 (400)
-|.+.+.||+|+||.||+|...+|+.||||..+.... .... ....|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3899999999999999999988899999997543110 0011 12345666666644433
Q ss_pred e--eeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 042371 142 V--KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN 219 (400)
Q Consensus 142 v--~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~ 219 (400)
. ..++. ...+|||||++|++|..+.. .+ ....++.||+.+|.+||..| ||||||||.|||++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------VP--DPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC-------CS--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc-------cH--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 2 22221 23479999999988865432 11 24568899999999999999 99999999999998
Q ss_pred CCC----------cEEEEecCCccc
Q 042371 220 EKY----------TAKVADFGTSKF 234 (400)
Q Consensus 220 ~~~----------~~kl~Dfgla~~ 234 (400)
.++ .+.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 776 489999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=3.6e-13 Score=122.59 Aligned_cols=146 Identities=16% Similarity=0.122 Sum_probs=113.3
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEE
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 157 (400)
......|++...++.|+++.||++... +..+++|............+.+|+.+++.+. +..++++++++.+.+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567999999999999999998764 6789999876422223345788999999884 67788999999888889999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA----------------------------------- 202 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 202 (400)
|||++|.+|.+.+.. ......++.+++.+|..||...
T Consensus 89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999998876321 1123467889999999999811
Q ss_pred ---------------------CCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 203 ---------------------SMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 203 ---------------------~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
...++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1338999999999999876566799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=6.7e-12 Score=113.66 Aligned_cols=137 Identities=16% Similarity=0.159 Sum_probs=99.6
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCc--ceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN--VVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~ 160 (400)
..+.+....+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +++++.+....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 445554444466679999998777788999976533 2245678899988885434 56688888877788999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA-------------------------------------- 202 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 202 (400)
++|.+|. ... .. ...++.+++..|..||...
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998873 211 12 2246677778888888643
Q ss_pred -----------------CCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 203 -----------------SMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 203 -----------------~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
...++|+|++|.|||++.++.+.|+|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.9e-10 Score=109.50 Aligned_cols=142 Identities=15% Similarity=0.210 Sum_probs=104.8
Q ss_pred ccceeeecCcEEEEEEEecCCcEEEEEEcc--ccC-chhHHHHHHHHHHHHhCC--CCcceeeeeEEeeC---CcceEEE
Q 042371 87 VNRILGQGGQGTVYKGMLADGRIVAVKKSK--IVH-EGKLEEFINEVVILSQIN--HRNVVKLLGCCLET---EVPLLVY 158 (400)
Q Consensus 87 ~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~ 158 (400)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988754 578888654 221 122356778999999986 45678888888766 4579999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA------------------------------------ 202 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 202 (400)
||++|..+.+.. ...++......++.+++..|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999988764311 113677888889999999999999831
Q ss_pred -------------------CCCeEecCCCCCCeEEcCCCc--EEEEecCCccc
Q 042371 203 -------------------SMPIYHRDIKSTNILLNEKYT--AKVADFGTSKF 234 (400)
Q Consensus 203 -------------------~~~iiHrDikp~NIll~~~~~--~kl~Dfgla~~ 234 (400)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.3e-10 Score=108.18 Aligned_cols=183 Identities=21% Similarity=0.215 Sum_probs=121.0
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCc--ceeeeeEEeeCC---cceEEEEcc
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRN--VVKLLGCCLETE---VPLLVYEFI 161 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~~ 161 (400)
.+.++.|....||+.. ..+++|.... ......+.+|+.+|+.+. +.. +++.+......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 4588886432 234567889999998873 332 444554433332 458999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA--------------------------------------- 202 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 202 (400)
+|.+|.+.... .++......++.+++..+..||...
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99888654321 2677777788888888888888621
Q ss_pred ----------------CCCeEecCCCCCCeEEcC--CCcEEEEecCCccccccCCceeeecccccCCC---CCccccc--
Q 042371 203 ----------------SMPIYHRDIKSTNILLNE--KYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY---LDPEYFR-- 259 (400)
Q Consensus 203 ----------------~~~iiHrDikp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y---~aPE~~~-- 259 (400)
...++|+|++|.||+++. .+.+.|+||+.+..-. .... ......+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~-~~~D----l~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD-PDND----FISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC-TTHH----HHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC-hHHH----HHHHHhhccccCHHHHHHH
Confidence 134799999999999998 5568899999886421 1100 0001111 2333211
Q ss_pred --c-CCC---------CCcchhHHHHHHHHHHHhCCCCC
Q 042371 260 --S-GQF---------TDKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 260 --~-~~~---------~~~~DiwSlG~il~elltg~~pf 286 (400)
. +.. ..-.+.|+++.++|.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 111 11268999999999999999886
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=4.3e-07 Score=84.28 Aligned_cols=136 Identities=17% Similarity=0.171 Sum_probs=93.2
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCC---cceeeeeEEe-eCCcceEEEEccCC
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHR---NVVKLLGCCL-ETEVPLLVYEFISN 163 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~ 163 (400)
.+.++.|....||+. +..+++|... .......+.+|..+|+.+.+. .+++.+.+.. ..+..++||+|++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356889999999987 4668888642 233456788999999998642 3556666654 34567899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA----------------------------------------- 202 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------- 202 (400)
.+|.+..-. .++......++.++...|..||...
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 1344444455555555555555422
Q ss_pred ----------------CCCeEecCCCCCCeEEcC---CCc-EEEEecCCccc
Q 042371 203 ----------------SMPIYHRDIKSTNILLNE---KYT-AKVADFGTSKF 234 (400)
Q Consensus 203 ----------------~~~iiHrDikp~NIll~~---~~~-~kl~Dfgla~~ 234 (400)
...++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224799999999999997 455 48999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=5.4e-07 Score=81.76 Aligned_cols=143 Identities=19% Similarity=0.187 Sum_probs=101.5
Q ss_pred HHhcCCcccceeeecCcE-EEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceE
Q 042371 80 KATDHFNVNRILGQGGQG-TVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg-~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 156 (400)
.....|+.. .+..|..| .||+.... ++..+++|... ......+.+|..+|+.+. +--+++++.++.+.+..++
T Consensus 22 ~~l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~---~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~l 97 (272)
T 4gkh_A 22 ADLYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGK---GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWL 97 (272)
T ss_dssp HHHTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEE---THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred ccccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECC---CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEE
Confidence 333445443 44556555 68987754 46678898654 334566788999998884 3347788899888899999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS--------------------------------- 203 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--------------------------------- 203 (400)
|||+++|.++.+...... .....+..++...|..||....
T Consensus 98 vme~l~G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE 170 (272)
T ss_dssp EEECCCSEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred EEEeeCCccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence 999999988877654321 1233466777777777775320
Q ss_pred ----------------------CCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 204 ----------------------MPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 204 ----------------------~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127999999999999987777799999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=5.4e-07 Score=85.33 Aligned_cols=80 Identities=4% Similarity=-0.044 Sum_probs=53.9
Q ss_pred ccee-eecCcEEEEEEEec-------CCcEEEEEEccccC---chhHHHHHHHHHHHHhCC-C--CcceeeeeEEeeC--
Q 042371 88 NRIL-GQGGQGTVYKGMLA-------DGRIVAVKKSKIVH---EGKLEEFINEVVILSQIN-H--RNVVKLLGCCLET-- 151 (400)
Q Consensus 88 ~~~l-g~G~fg~V~~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~-- 151 (400)
.+.| +.|..+.+|+.... ++..+++|...... ......+.+|+.+++.+. + -.+++++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999988754 25678888654321 001245667888888774 2 3567788776654
Q ss_pred -CcceEEEEccCCCCHH
Q 042371 152 -EVPLLVYEFISNGTLF 167 (400)
Q Consensus 152 -~~~~lv~e~~~~g~L~ 167 (400)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.23 E-value=5.9e-06 Score=77.34 Aligned_cols=140 Identities=18% Similarity=0.210 Sum_probs=77.2
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCC--Ccceeeee------EEeeCCcceEEEEc
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH--RNVVKLLG------CCLETEVPLLVYEF 160 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~------~~~~~~~~~lv~e~ 160 (400)
+.|+.|..+.||+....++ .+++|..... ...+..|..+++.+.. -.+++++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999887554 4888976541 1333345555554421 12333332 12345667899999
Q ss_pred cCCCCHH--------------HHHhhcCCCC--C---------CCHHHH-------------------------------
Q 042371 161 ISNGTLF--------------QYLHDQNEEF--P---------LTWEMR------------------------------- 184 (400)
Q Consensus 161 ~~~g~L~--------------~~l~~~~~~~--~---------l~~~~~------------------------------- 184 (400)
++|..+. ..++...... + -.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1111111100 0 122110
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 185 LRIATEVAGSLSYLHS----------AASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 185 ~~i~~~i~~~l~~LH~----------~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
..+...+..++.+|+. .....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223345666653 123459999999999999888899999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=6.9e-06 Score=78.92 Aligned_cols=75 Identities=17% Similarity=0.152 Sum_probs=49.2
Q ss_pred cceeeecCcEEEEEEEec-CCcEEEEEEccccCc-------hhHHHHHHHHHHHHhCCC--C-cceeeeeEEeeCCcceE
Q 042371 88 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE-------GKLEEFINEVVILSQINH--R-NVVKLLGCCLETEVPLL 156 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-~iv~~~~~~~~~~~~~l 156 (400)
.+.||.|.++.||++... +++.+++|....... .....+..|..+++.+.. + .+++++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 467899996542111 123456778888887732 3 34455543 4456789
Q ss_pred EEEccCCC
Q 042371 157 VYEFISNG 164 (400)
Q Consensus 157 v~e~~~~g 164 (400)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.96 E-value=6.2e-05 Score=68.86 Aligned_cols=79 Identities=19% Similarity=0.148 Sum_probs=57.2
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-C--CcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-H--RNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~lv~e 159 (400)
....-...+|.|..+.||+....+|+.+++|............+..|+..|+.+. . -.+++.+.. +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 3455567899999999999999999999999765433333456778999998884 2 234455543 23579999
Q ss_pred ccCCCC
Q 042371 160 FISNGT 165 (400)
Q Consensus 160 ~~~~g~ 165 (400)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.88 E-value=9e-05 Score=71.69 Aligned_cols=78 Identities=9% Similarity=0.089 Sum_probs=46.4
Q ss_pred CCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceeeecc-cccCCCCCccccccCC---CCCcchhHHHHHHHHHH
Q 042371 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKV-QGTFGYLDPEYFRSGQ---FTDKSDVYSFGVVLVEL 279 (400)
Q Consensus 204 ~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~el 279 (400)
..++|+|++|.|||++.++ +.|+||+.+..-.. ........ .-...|++|+...... -....++.+....+|..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECH-HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCch-HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4499999999999999876 99999998864211 00000000 0123456665543111 11234555778888887
Q ss_pred HhCC
Q 042371 280 LTGQ 283 (400)
Q Consensus 280 ltg~ 283 (400)
+.+.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00014 Score=67.26 Aligned_cols=75 Identities=17% Similarity=0.090 Sum_probs=58.9
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC---CCcceeeeeEEeeCCcceEEEEccCCC
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~g 164 (400)
.+.|+.|.+..+|+... ++..+++|.... .....+..|+..|+.+. ...+++.+.+....+..++||||++|.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45789999999999886 466788886542 23567888999888884 356888888887778899999999987
Q ss_pred CH
Q 042371 165 TL 166 (400)
Q Consensus 165 ~L 166 (400)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00016 Score=62.53 Aligned_cols=99 Identities=17% Similarity=0.152 Sum_probs=66.0
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCceee
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT 243 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 243 (400)
-+|.++|...+. ++++.++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|+|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 389999988765 79999999999999999877632110 11233457899999999887764 1110
Q ss_pred ecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh
Q 042371 244 TKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT 281 (400)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 281 (400)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1133466888763 345678899999999999986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00058 Score=63.64 Aligned_cols=140 Identities=14% Similarity=0.096 Sum_probs=70.6
Q ss_pred eeeecCcEE-EEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCC--CcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 90 ILGQGGQGT-VYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH--RNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 90 ~lg~G~fg~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
.|+.|+... +|+....++..+++|....... ..+..|+.++..+.. -.+++++.+.. ...+++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcch
Confidence 455555554 6676654466777775433211 223446666666532 23556666533 233789999977666
Q ss_pred HHHHhhcC---------------------C-CC-CCCHHHHH-------HHH-------------HHHHHHHHHHH---h
Q 042371 167 FQYLHDQN---------------------E-EF-PLTWEMRL-------RIA-------------TEVAGSLSYLH---S 200 (400)
Q Consensus 167 ~~~l~~~~---------------------~-~~-~l~~~~~~-------~i~-------------~~i~~~l~~LH---~ 200 (400)
.+.+.... . .. .+...... .+. ..+...+..+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 54432110 0 00 11111110 000 01111222221 1
Q ss_pred cCCCCeEecCCCCCCeEEcCC----CcEEEEecCCccc
Q 042371 201 AASMPIYHRDIKSTNILLNEK----YTAKVADFGTSKF 234 (400)
Q Consensus 201 ~~~~~iiHrDikp~NIll~~~----~~~kl~Dfgla~~ 234 (400)
.....++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123459999999999999874 6899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0032 Score=58.06 Aligned_cols=158 Identities=14% Similarity=0.187 Sum_probs=84.4
Q ss_pred cChHHHHHHhcCCcc-----cceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCc--ceeee
Q 042371 73 FTTKELDKATDHFNV-----NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN--VVKLL 145 (400)
Q Consensus 73 ~~~~~~~~~~~~y~~-----~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~ 145 (400)
++..++.....+|.+ .+.|+.|....+|+....++ .+++|..... .....+..|..++..+.... +++++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444555555555655 23566788899999887555 6788876531 11234455677766663211 33333
Q ss_pred eE------EeeCCcceEEEEccCCCCHHH--------------HHhhcCCCCC------CC---HHHHHH----------
Q 042371 146 GC------CLETEVPLLVYEFISNGTLFQ--------------YLHDQNEEFP------LT---WEMRLR---------- 186 (400)
Q Consensus 146 ~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~~~------l~---~~~~~~---------- 186 (400)
.. ....+..+++|+|++|..+.. .++....... .. |...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 123456789999998865311 0111111100 11 111100
Q ss_pred --HHHHHHHHHHHHHhc----CCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 187 --IATEVAGSLSYLHSA----ASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 187 --i~~~i~~~l~~LH~~----~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
+...+...+..++.. ....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001134445555432 12348999999999999987556899999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00023 Score=69.08 Aligned_cols=72 Identities=17% Similarity=0.152 Sum_probs=48.1
Q ss_pred cceeeecCcEEEEEEEecC--------CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCc-ceeeeeEEeeCCcceEEE
Q 042371 88 NRILGQGGQGTVYKGMLAD--------GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN-VVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 158 (400)
.+.|+.|....||++...+ +..+++|+.... .....+..|..+++.+...+ .+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4578888899999998653 478888876321 11245567888888885333 3566665432 3899
Q ss_pred EccCCCC
Q 042371 159 EFISNGT 165 (400)
Q Consensus 159 e~~~~g~ 165 (400)
+|++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00032 Score=66.73 Aligned_cols=141 Identities=18% Similarity=0.231 Sum_probs=81.2
Q ss_pred ceeeecCcEEEEEEEec--------CCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEEE
Q 042371 89 RILGQGGQGTVYKGMLA--------DGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 159 (400)
+.|..|-...+|+.... ++..+++|+.... ........+|..+++.+. +.-.+++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888889998864 2468899874321 123455668999988874 3333566666543 38999
Q ss_pred ccCCCCHHH--------------HH---hhcCC--CCCC--CHHHHHHHHHHHHH-------------------HHHH--
Q 042371 160 FISNGTLFQ--------------YL---HDQNE--EFPL--TWEMRLRIATEVAG-------------------SLSY-- 197 (400)
Q Consensus 160 ~~~~g~L~~--------------~l---~~~~~--~~~l--~~~~~~~i~~~i~~-------------------~l~~-- 197 (400)
|++|.+|.. .+ +.... .... -+..+.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998765431 11 11110 1111 23444555544322 1222
Q ss_pred --HHhc-CCCCeEecCCCCCCeEEcCC----CcEEEEecCCccc
Q 042371 198 --LHSA-ASMPIYHRDIKSTNILLNEK----YTAKVADFGTSKF 234 (400)
Q Consensus 198 --LH~~-~~~~iiHrDikp~NIll~~~----~~~kl~Dfgla~~ 234 (400)
|... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 22358999999999999876 7899999998853
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00068 Score=62.23 Aligned_cols=71 Identities=15% Similarity=0.134 Sum_probs=43.0
Q ss_pred cceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcc-eeeeeEEeeCCcceEEEEcc-CCCC
Q 042371 88 NRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFI-SNGT 165 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~g~ 165 (400)
.+.|+.|....+|+. ..+++|........ .....+|+.+++.+....+ ++++.. +...-+++++|+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 45888865432111 1112457777776642222 455544 333457899999 6654
Q ss_pred H
Q 042371 166 L 166 (400)
Q Consensus 166 L 166 (400)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0019 Score=59.83 Aligned_cols=142 Identities=14% Similarity=0.134 Sum_probs=78.8
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCC--cceeeeeE-----EeeCCcceEEEEcc
Q 042371 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHR--NVVKLLGC-----CLETEVPLLVYEFI 161 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~-----~~~~~~~~lv~e~~ 161 (400)
..|+ |....||+....+|+.+++|..... ......+..|..++..+... .+++++.. ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 8888999987767778999976522 12345566787777776421 23444432 12244567899999
Q ss_pred CCCCHH-----H------H---HhhcCC------CCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 042371 162 SNGTLF-----Q------Y---LHDQNE------EFPLTWEMR----LRI---------------ATEVAGSLSYLHSA- 201 (400)
Q Consensus 162 ~~g~L~-----~------~---l~~~~~------~~~l~~~~~----~~i---------------~~~i~~~l~~LH~~- 201 (400)
+|..+. . . ++.... ......... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 1 1 111100 001222111 001 01111122222221
Q ss_pred ---CCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 202 ---ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 202 ---~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223489999999999999 4 899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00095 Score=65.16 Aligned_cols=74 Identities=14% Similarity=0.046 Sum_probs=46.5
Q ss_pred cceeeecCcEEEEEEEecC-CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcc-eeeeeEEeeCCcceEEEEccCCCC
Q 042371 88 NRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFISNGT 165 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g~ 165 (400)
.+.|+.|-...+|+....+ +..+++|.......... ...+|+.++..+...++ +++++.+. + .+||+|++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4578888889999998764 47788886532211111 12478888888864444 56776652 2 36999998754
Q ss_pred H
Q 042371 166 L 166 (400)
Q Consensus 166 L 166 (400)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0011 Score=62.79 Aligned_cols=74 Identities=14% Similarity=0.122 Sum_probs=42.8
Q ss_pred cceeeecCcEEEEEEEecC---------CcEEEEEEccccCchhHHHHHHHHHHHHhCCCCc-ceeeeeEEeeCCcceEE
Q 042371 88 NRILGQGGQGTVYKGMLAD---------GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRN-VVKLLGCCLETEVPLLV 157 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv 157 (400)
.+.|+.|....+|+....+ +..+++|....... .......|..+++.+...+ .+++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3467788888999988643 26788886543211 1112356777777774323 44666543 2 3789
Q ss_pred EEccCCCCH
Q 042371 158 YEFISNGTL 166 (400)
Q Consensus 158 ~e~~~~g~L 166 (400)
|+|++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0029 Score=59.13 Aligned_cols=31 Identities=19% Similarity=0.411 Sum_probs=27.3
Q ss_pred CCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 204 MPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 204 ~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.031 Score=53.80 Aligned_cols=74 Identities=8% Similarity=0.023 Sum_probs=46.7
Q ss_pred cceeeecCcEEEEEEEecC--------CcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEE
Q 042371 88 NRILGQGGQGTVYKGMLAD--------GRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 158 (400)
.+.|..|-...+|+....+ +..++++........ .-...+|..+++.+. +.-.+++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4567778888999988653 578898875432211 112346778877774 33345566533 2 37899
Q ss_pred EccCCCCH
Q 042371 159 EFISNGTL 166 (400)
Q Consensus 159 e~~~~g~L 166 (400)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.93 E-value=0.085 Score=50.31 Aligned_cols=29 Identities=38% Similarity=0.549 Sum_probs=25.0
Q ss_pred eEecCCCCCCeEE------cCCCcEEEEecCCccc
Q 042371 206 IYHRDIKSTNILL------NEKYTAKVADFGTSKF 234 (400)
Q Consensus 206 iiHrDikp~NIll------~~~~~~kl~Dfgla~~ 234 (400)
++|+|+.+.|||+ +.+..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4566899999998854
|
| >2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.84 E-value=0.019 Score=40.18 Aligned_cols=28 Identities=32% Similarity=0.796 Sum_probs=25.8
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeec
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCIT 28 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~ 28 (400)
||||......|.....|++..|+|+|..
T Consensus 3 idEC~~~~~~C~~~~~C~Nt~Gsy~C~~ 30 (71)
T 2kl7_A 3 VNECLTIPEACKGEMKCINHYGGYLCLP 30 (71)
T ss_dssp SCCTTCCCCSCTTEEEEEETTCCEEEEE
T ss_pred cccccCCCCCCCCCCEeECCCCCeEecc
Confidence 7999998889999999999999999963
|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=93.32 E-value=0.083 Score=34.27 Aligned_cols=30 Identities=40% Similarity=0.894 Sum_probs=24.6
Q ss_pred CCcCCCC--------CCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDG--------TANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~--------~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||... ...|. +.|++..|+|+|..+.+.
T Consensus 4 idEC~~~~~~~~~~~~~~C~--~~C~n~~Gsy~C~C~~Gy 41 (53)
T 1apq_A 4 LDECASRSKSGEEDPQPQCQ--HLCHNYVGGYFCSCRPGY 41 (53)
T ss_dssp CCTTTCSTTTCCCSSSCTTS--SEEEEETTEEEEECSTTC
T ss_pred cccccCcccccccccCCCCC--CEeECCCCCeEEECCCCC
Confidence 7999875 35686 589999999999887765
|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
Probab=91.79 E-value=0.036 Score=49.71 Aligned_cols=32 Identities=22% Similarity=0.586 Sum_probs=28.1
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||..+.-.|..+..|+++.|+|.|.++.+.
T Consensus 5 iDEC~~~~~~C~~~a~C~Nt~Gsy~C~C~~Gy 36 (285)
T 1gl4_A 5 QQTCANNRHQCSVHAECRDYATGFCCRCVANY 36 (285)
T ss_dssp --CHHHHGGGSCTTEEEEECSSCEEEEECTTE
T ss_pred chhccCCCCCCCCCCEeEcCCCCeEEEcCCCC
Confidence 79999999999999999999999999888776
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.72 E-value=0.45 Score=40.82 Aligned_cols=115 Identities=7% Similarity=0.095 Sum_probs=76.8
Q ss_pred CCCcceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042371 137 NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNI 216 (400)
Q Consensus 137 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NI 216 (400)
.||++++. .+....+.+.+.++.-+ +...+-.-. .++...+++++.+|+....+++. -+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57888766 45555555555555433 222222211 27788999999999988866554 46889999999
Q ss_pred EEcCCCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 042371 217 LLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 217 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 286 (400)
+++.++.+++.-.|+-..+ +|. .++...=.-.+=+++..+++++.+|
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999999877754322 221 1222333456788999999999998
|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
Probab=89.54 E-value=0.22 Score=32.65 Aligned_cols=30 Identities=13% Similarity=0.415 Sum_probs=25.0
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
.|||......|. +.|++..|+|+|..+.+.
T Consensus 1 ~dEC~~~~~~C~--~~C~nt~Gsy~C~C~~Gy 30 (55)
T 2jkh_L 1 RKLCSLDNGDCD--QFCHEEQNSVVCSCARGY 30 (55)
T ss_dssp -CCTTTGGGGCS--SEEEEETTEEEEECCTTE
T ss_pred CccccCCCCCcC--cEeEcCCCCeEEeCCCCC
Confidence 499988777886 489999999999887765
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.24 E-value=0.94 Score=38.97 Aligned_cols=114 Identities=13% Similarity=0.111 Sum_probs=75.1
Q ss_pred CCCcceeeeeEEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCC
Q 042371 137 NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS-YLHSAASMPIYHRDIKSTN 215 (400)
Q Consensus 137 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~iiHrDikp~N 215 (400)
.||++ --.+-.+++.+.+.++.-+++.=...++ .++...+++++.+|+.... +++. -+|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 2333355566666666543332222332 2788889999999888766 5544 5788899999
Q ss_pred eEEcCCCcEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 042371 216 ILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286 (400)
Q Consensus 216 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 286 (400)
|+++.++.+++.-.|+-.. ++|.- .+..-=.-++=+++..++.++..|
T Consensus 115 L~f~~~~~p~i~hRGi~~~------------------lpP~e-----~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES------------------LPPDE-----WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp EEECTTCCEEESCCEETTT------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred EEEeCCCcEEEEEcCCccc------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999999987775432 22221 122222346778899999998887
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=87.21 E-value=0.48 Score=34.12 Aligned_cols=31 Identities=29% Similarity=0.599 Sum_probs=26.8
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||...+..|.. ..|++..|+|+|..+.+.
T Consensus 3 ideC~~~~~~C~~-g~C~n~~g~y~C~C~~Gy 33 (86)
T 1lmj_A 3 IDECRISPDLCGR-GQCVNTPGDFECKCDEGY 33 (86)
T ss_dssp CCTTTTCSSTTTT-SCEEEETTEEEECCCSSE
T ss_pred cccccCCCCCCCC-CEEECCCCCEEeeCCCCc
Confidence 7999998888964 589999999999888775
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=85.98 E-value=0.9 Score=27.04 Aligned_cols=30 Identities=23% Similarity=0.516 Sum_probs=24.5
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||.+. .|...-.|++..++|.|..+.+.
T Consensus 3 ~d~C~~~--pC~ngg~C~~~~~~~~C~C~~G~ 32 (39)
T 1edm_B 3 GDQCESN--PCLNGGSCKDDINSYECWCPFGF 32 (39)
T ss_dssp CCTTTTC--CCCTTCEEEEETTEEEEECCTTC
T ss_pred cccCCCC--CCCCCCEeEcCCCceEeECCCCC
Confidence 6899854 58877899999999999877654
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=85.23 E-value=0.33 Score=34.99 Aligned_cols=31 Identities=42% Similarity=0.880 Sum_probs=26.2
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||...+..|. +..|++..|+|+|..+.+.
T Consensus 46 ideC~~~~~~C~-~~~C~n~~g~y~C~C~~G~ 76 (86)
T 1lmj_A 46 IDECQRDPLLCR-GGVCHNTEGSYRCECPPGH 76 (86)
T ss_dssp CCHHHHCSSTTT-TSEEEEETTEEEEESCTTS
T ss_pred cccccCCCCcCC-CCEeEcCCCCEEEECcCCc
Confidence 799988877785 5799999999999887764
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.97 E-value=0.42 Score=34.54 Aligned_cols=31 Identities=29% Similarity=0.748 Sum_probs=27.3
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||...+..| ....|++..|+|+|..+.+.
T Consensus 3 ideC~~~~~~C-~~~~C~n~~g~y~C~C~~G~ 33 (87)
T 1z6c_A 3 VDECSLKPSIC-GTAVCKNIPGDFECECPEGY 33 (87)
T ss_dssp SCSSSSSSSSB-TTSSCCCBTTBCCCSSSTTC
T ss_pred cccccCCCCCC-CCCEeECCCCCEEEECCCCc
Confidence 79999998889 67899999999999887775
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
Probab=81.66 E-value=0.6 Score=37.17 Aligned_cols=33 Identities=30% Similarity=0.674 Sum_probs=29.0
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCchh
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRKV 33 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~~ 33 (400)
||||......|.....|++..|+|+|..+.+..
T Consensus 96 ideC~~~~~~C~~~~~C~n~~g~y~C~C~~Gy~ 128 (143)
T 2bou_A 96 VDECSSGQHQCDSSTVCFNTVGSYSCRCRPGWK 128 (143)
T ss_dssp CCHHHHTCCCCCTTSEEEECSSCEEEECCSSSC
T ss_pred ccCccCcCCCCCCCCEEECCCCCEEeeCCCCcc
Confidence 789998888999999999999999998877653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 400 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-68 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-63 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-61 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 | |
| d1gl4a2 | 40 | g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 | 7e-05 | |
| d1lmja2 | 42 | g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapien | 1e-04 | |
| d1lmja1 | 44 | g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens | 2e-04 | |
| d2vj3a1 | 42 | g.3.11.1 (A:411-452) Neurogenic locus notch homolo | 5e-04 | |
| d1uzka2 | 43 | g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sa | 6e-04 | |
| d1apqa_ | 53 | g.3.11.1 (A:) Complement protease C1R {Human (Homo | 0.001 | |
| d1uzka1 | 43 | g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sa | 0.002 | |
| d1emoa1 | 43 | g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sa | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-72
Identities = 72/282 (25%), Positives = 115/282 (40%), Gaps = 21/282 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
V + +G G GTVYKG V + +L+ F NEV +L + H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+G +V ++ +L+ +LH + IA + A + YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH--- 121
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI-VIDQTHVTTKVQGTFGYLDPEYFR-- 259
+ I HRD+KS NI L+E T K+ DFG + +H ++ G+ ++ PE R
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 260 -SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318
++ +SDVY+FG+VL EL+TGQ P I + L L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360
+ + L CL RP ++ +E +
Sbjct: 236 SNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 2e-69
Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 21/276 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
+ + LG G G V+ G VAVK K + F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+L + + ++ E++ NG+L +L + LT L +A ++A ++++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEE-- 127
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
HRD+++ NIL+++ + K+ADFG ++ I ++ + + PE G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 263 FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322
FT KSDV+SFG++L E++T + M + L+ V
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVR 231
Query: 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
+ L C + RPT + LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-68
Identities = 66/277 (23%), Positives = 119/277 (42%), Gaps = 21/277 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
+ +G G G V+ G + VA+K + + E+FI E ++ +++H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+L G CLE LV+EF+ +G L YL Q E L + +V ++YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
+ HRD+ + N L+ E KV+DFG ++F++ DQ +T + + PE F +
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 263 FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322
++ KSDV+SFGV++ E+ + K + + + + +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVEDISTGFRLYK 223
Query: 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359
+ + + C + RP + +L I
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 1e-67
Identities = 68/278 (24%), Positives = 126/278 (45%), Gaps = 27/278 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
+ + +G+G G V G G VAVK I ++ + F+ E +++Q+ H N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 143 KLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
+LLG +E + L +V E+++ G+L YL + L + L+ + +V ++ YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 202 ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSG 261
HRD+ + N+L++E AKV+DFG +K + + + PE R
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREK 175
Query: 262 QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321
+F+ KSDV+SFG++L E+ + + + + + D V +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKGYKMDAPDGCPPAVYE- 231
Query: 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359
+ C +L+ RP+ ++ +LE I+
Sbjct: 232 -----------VMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-66
Identities = 69/303 (22%), Positives = 120/303 (39%), Gaps = 37/303 (12%)
Query: 78 LDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVILSQ 135
++ D F LG G G V+K G ++A K + + I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
N +V G + E + G+L Q L + ++ +++ V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
+YL I HRD+K +NIL+N + K+ DFG S + + GT Y+ P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKE---------------------- 293
E + ++ +SD++S G+ LVE+ G+ PI +KE
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 294 -ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT----LATRCLNLNGKRRPTM 348
L++Y + S +++ LD V + K + +CL N R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 349 KEV 351
K++
Sbjct: 293 KQL 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 9e-66
Identities = 68/276 (24%), Positives = 119/276 (43%), Gaps = 21/276 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
+ + LGQG G V+ G VA+K K E F+ E ++ ++ H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+L E + +V E++S G+L +L + ++ + +A ++A ++Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
M HRD+++ NIL+ E KVADFG ++ I ++ + + PE G+
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 263 FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322
FT KSDV+SFG++L EL T + M + D ++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPC 235
Query: 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
E ++ L +C + RPT + + LE
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (531), Expect = 1e-65
Identities = 77/300 (25%), Positives = 133/300 (44%), Gaps = 29/300 (9%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQ 135
E+++ + LG G G VY+G+ VAVK K ++EEF+ E ++ +
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
I H N+V+LLG C ++ EF++ G L YL + N + ++ + L +AT+++ ++
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAM 128
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
YL HRD+ + N L+ E + KVADFG S+ + D + + P
Sbjct: 129 EYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 256 EYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315
E +F+ KSDV++FGV+L E+ T ++ +++Y+ L+
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230
Query: 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDINVKQICDEIE 375
+ + L C N RP+ E+ E + I DE+E
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQESSISDEVE 284
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-64
Identities = 63/276 (22%), Positives = 116/276 (42%), Gaps = 21/276 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV 142
+ LG G G V G VA+K K + +EFI E ++ ++H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+L G C + ++ E+++NG L YL + + L + +V ++ YL S
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
HRD+ + N L+N++ KV+DFG S++++ D+ + + + PE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 263 FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVG 322
F+ KSD+++FGV++ E+ + K + T A I ++V
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---AEHIAQGLRLYRPHLASEKVYT-- 232
Query: 323 QKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
+ C + RPT K + + +
Sbjct: 233 ----------IMYSCWHEKADERPTFKILLSNILDV 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-64
Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 30/273 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
+ F + R LG+G G VY I+A+K K+++ G + EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
N+++L G + L+ E+ GT+++ L + + TE+A +LSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
H S + HRDIK N+LL K+ADFG S + + GT YL PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMI 176
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318
+K D++S GV+ E L G+ P + T Y +S E DF+ +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFTFPDFVTEGA 231
Query: 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
L +R L N +RP ++EV
Sbjct: 232 RD------------LISRLLKHNPSQRPMLREV 252
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 6e-64
Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 25/277 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKI--VHEGKLEEFINEVVILSQINHR 139
+ + V +G G G K +DG+I+ K+ + E + + ++EV +L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 140 NVVKLLGCCLETE--VPLLVYEFISNGTLFQYLHDQNEEF-PLTWEMRLRIATEVAGSLS 196
N+V+ ++ +V E+ G L + +E L E LR+ T++ +L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 197 YLH--SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
H S + HRD+K N+ L+ K K+ DFG ++ + D + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182
Query: 255 PEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314
PE + +KSD++S G +L EL P KE A I + R+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFRRIPYRY 238
Query: 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
D++ + + TR LNL RP+++E+
Sbjct: 239 SDELNE------------IITRMLNLKDYHRPSVEEI 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 2e-63
Identities = 66/312 (21%), Positives = 124/312 (39%), Gaps = 47/312 (15%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYKGML------ADGRIVAVKK-SKIVHEGKLEEFIN 128
L+ ++ R +G+G G V++ +VAVK + +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEF----------- 177
E ++++ ++ N+VKLLG C + L++E+++ G L ++L +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 178 ----------PLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVA 227
PL+ +L IA +VA ++YL HRD+ + N L+ E K+A
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182
Query: 228 DFGTSKFIV-IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPI 286
DFG S+ I D ++ PE ++T +SDV+++GVVL E+ +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ- 241
Query: 287 ILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP 346
M + ++ D + + + + L C + RP
Sbjct: 242 --------------PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 287
Query: 347 TMKEVAMELERI 358
+ + L+R+
Sbjct: 288 SFCSIHRILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (516), Expect = 3e-63
Identities = 67/304 (22%), Positives = 127/304 (41%), Gaps = 38/304 (12%)
Query: 73 FTTKELDKATDHFN---------VNRILGQGGQGTVYKGMLA----DGRIVAVKK-SKIV 118
FT ++ ++A F + +++G G G V G L VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 119 HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFP 178
E + +F++E I+ Q +H NV+ L G ++ +++ EF+ NG+L +L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124
Query: 179 LTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238
T + + +A + YL M HRD+ + NIL+N KV+DFG S+F+ D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 239 QTHVTTK----VQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEA 294
+ T + + PE + +FT SDV+S+G+V+ E+++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--------- 232
Query: 295 TGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354
M + + ++ + + L C + RP ++
Sbjct: 233 ------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 355 LERI 358
L+++
Sbjct: 287 LDKM 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 6e-63
Identities = 71/292 (24%), Positives = 130/292 (44%), Gaps = 30/292 (10%)
Query: 75 TKELDKATDHFNVNRILGQGGQGTVYKGMLADG-----RIVAVKK-SKIVHEGKLEEFIN 128
T E+ +++G G G VYKGML VA+K E + +F+
Sbjct: 1 TTEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG 58
Query: 129 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIA 188
E I+ Q +H N+++L G + + +++ E++ NG L ++L +++ EF + +
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGML 116
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ--THVTTKV 246
+A + YL + M HRD+ + NIL+N KV+DFG S+ + D T+ T+
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 247 QGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306
+ + PE +FT SDV+SFG+V+ E++T + +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELS 218
Query: 307 ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
+ + ++D + I L +C RRP ++ L+++
Sbjct: 219 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-62
Identities = 70/316 (22%), Positives = 129/316 (40%), Gaps = 41/316 (12%)
Query: 67 IDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKK-SKIVH 119
ID +L + + + + + LG G G V + VAVK H
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 120 EGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHD------ 172
+ E ++E+ +LS + NH N+V LLG C L++ E+ G L +L
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 173 ---------QNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYT 223
+++E L E L + +VA +++L S HRD+ + NILL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRI 183
Query: 224 AKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTG 282
K+ DFG ++ I D + V + ++ PE + +T +SDV+S+G+ L EL +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 283 QKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNG 342
+ +++ Y + + + + + + C + +
Sbjct: 244 GSS--------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 343 KRRPTMKEVAMELERI 358
+RPT K++ +E+
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 5e-62
Identities = 75/291 (25%), Positives = 133/291 (45%), Gaps = 31/291 (10%)
Query: 79 DKATDHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKK-SKIVHEGKLEEFINEVVIL 133
HFN ++G+G G VY G L D AVK ++I G++ +F+ E +I+
Sbjct: 25 SSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 134 SQINHRNVVKLLGCCLETE-VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVA 192
+H NV+ LLG CL +E PL+V ++ +G L ++ ++ + + +
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 193 GSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV---IDQTHVTTKVQGT 249
+ AS HRD+ + N +L+EK+T KVADFG ++ + D H T +
Sbjct: 143 -----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309
++ E ++ +FT KSDV+SFGV+L EL+T P + ++L
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQGRRLL 254
Query: 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360
++ D + + + +C + + RP+ E+ + I +
Sbjct: 255 QPEYCPDPLYE------------VMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 7e-62
Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 28/290 (9%)
Query: 76 KELDKATDHFNV-NRILGQGGQGTVYKGMLA---DGRIVAVKK-SKIVHEGKLEEFINEV 130
K+L D+ + + LG G G+V +G+ VA+K + + EE + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 131 VILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATE 190
I+ Q+++ +V+L+G C + E +LV E G L ++L + EE P + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQ 117
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK--VQG 248
V+ + YL HRD+ + N+LL ++ AK++DFG SK + D ++ T + +
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 249 TFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308
+ PE +F+ +SDV+S+GV + E L+ + FI +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQGKRM 231
Query: 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
++ L + C + RP V +
Sbjct: 232 ECPPECPPELYA------------LMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-61
Identities = 74/291 (25%), Positives = 135/291 (46%), Gaps = 26/291 (8%)
Query: 63 SDGSIDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEG 121
SD I KL + + + +GQG GTVY M +A G+ VA+++ + +
Sbjct: 1 SDEEILE-KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 122 KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTW 181
K E INE++++ + + N+V L L + +V E+++ G+L + + +
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDE 115
Query: 182 EMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241
+ E +L +LH S + HRDIKS NILL + K+ DFG I +Q+
Sbjct: 116 GQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF 301
+T V GT ++ PE + K D++S G++ +E++ G+ P +
Sbjct: 173 RSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---------------Y 216
Query: 302 ILSMEENRLYDFLDDQVLKVGQKEEIMTIA-TLATRCLNLNGKRRPTMKEV 351
+ LY + ++ E++ I RCL+++ ++R + KE+
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 6e-61
Identities = 66/286 (23%), Positives = 120/286 (41%), Gaps = 26/286 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKK-SKIVHEGKLEEFINEVVILSQIN 137
+ + R +G+G G V++G+ VA+K + E+F+ E + + Q +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
H ++VKL+G E V ++ E + G L +L + + L + A +++ +L+Y
Sbjct: 67 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 123
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
L S HRDI + N+L++ K+ DFG S+++ + +K + ++ PE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317
+FT SDV+ FGV + E+L I + E +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGERLPMPPNCPPT 237
Query: 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363
+ L T+C + RRP E+ +L I +K
Sbjct: 238 LYS------------LMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 7e-61
Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 31/279 (11%)
Query: 88 NRILGQGGQGTVYKGMLAD---GRIVAVK--KSKIVHEGKLEEFINEVVILSQINHRNVV 142
++ LG G GTV KG + VAVK K++ +E + E ++ Q+++ +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
+++G C E E +LV E G L +YL + + + + +V+ + YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTK--VQGTFGYLDPEYFRS 260
HRD+ + N+LL ++ AK++DFG SK + D+ + + + + PE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 261 GQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319
+F+ KSDV+SFGV++ E + GQKP G+ + +M E
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPY--------RGMKGSEVTAMLEKGERMGCPAGCP 236
Query: 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
+ + L C + + RP V + L
Sbjct: 237 R--------EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-60
Identities = 64/302 (21%), Positives = 115/302 (38%), Gaps = 30/302 (9%)
Query: 89 RILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCC 148
+G+G G V++G G VAVK E + E+ + H N++ +
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 149 LETE----VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA-- 202
+ LV ++ +G+LF YL+ + +T E +++A A L++LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 203 ---SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV---TTKVQGTFGYLDPE 256
I HRD+KS NIL+ + T +AD G + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 257 YFRS------GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATG----LAAYFILSME 306
+ ++D+Y+ G+V E+ + + + + M
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 307 ENRLYDFLDDQVLKVGQKEEIM-TIATLATRCLNLNGKRRPTMKEVAMELERIQALQKDI 365
+ L + Q E + +A + C NG R T + L ++ Q+ I
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ-QEGI 301
Query: 366 NV 367
+
Sbjct: 302 KM 303
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-59
Identities = 57/276 (20%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 85 FNVNRILGQGGQGTVYKGMLAD-GRIVAVKK--SKIVHEGKLEEFINEVVILSQINHRNV 141
+ +G+G TVYKG+ + VA + + + + + + F E +L + H N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 142 VKLLGCCLET----EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
V+ T + +LV E +++GTL YL + ++ ++ L +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQF 127
Query: 198 LHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
LH+ + PI HRD+K NI + + K+ D G + + V GT ++ PE
Sbjct: 128 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPE 183
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316
+ ++ + DVY+FG+ ++E+ T + P + ++Y +
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVTS 227
Query: 317 QVLKVGQKEEIMT-IATLATRCLNLNGKRRPTMKEV 351
V + + + + C+ N R ++K++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-59
Identities = 67/284 (23%), Positives = 111/284 (39%), Gaps = 29/284 (10%)
Query: 75 TKELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVIL 133
T++L+ D + + LG G G VYK + A K E +LE+++ E+ IL
Sbjct: 5 TRDLN-PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 134 SQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
+ +H N+VKLL ++ EF + G + + + PLT + +
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLD 121
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
+L+YLH I HRD+K+ NIL K+ADFG S + + GT ++
Sbjct: 122 ALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWM 177
Query: 254 DPEYF-----RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308
PE + + K+DV+S G+ L+E+ + P
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP---------------HHELNPMR 222
Query: 309 RLYDFLDDQVLKVGQKEEI-MTIATLATRCLNLNGKRRPTMKEV 351
L + + Q +CL N R T ++
Sbjct: 223 VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (492), Expect = 2e-59
Identities = 69/280 (24%), Positives = 108/280 (38%), Gaps = 33/280 (11%)
Query: 79 DKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILS 134
D F+ R +G G G VY + + +VA+K S K ++ I EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 135 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
++ H N ++ GC L LV E+ + PL +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQG 127
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLD 254
L+YLH S + HRD+K+ NILL+E K+ DFG++ + GT ++
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMA 179
Query: 255 PEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311
PE + GQ+ K DV+S G+ +EL + P+ + A Y I E L
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQNESPALQ 235
Query: 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ + CL + RPT + +
Sbjct: 236 SGHWSEYFR-----------NFVDSCLQKIPQDRPTSEVL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-59
Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 24/273 (8%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRN 140
+ +++ + LG+G G V + VAVK + E E+ I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
VVK G E + L E+ S G LF + + R ++ + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH- 120
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID-QTHVTTKVQGTFGYLDPEYFR 259
+ I HRDIK N+LL+E+ K++DFG + + + + K+ GT Y+ PE +
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 260 SGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318
+F + DV+S G+VL +L G+ P ++ + + + +D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
L L + L N R T+ ++
Sbjct: 237 LA------------LLHKILVENPSARITIPDI 257
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 194 bits (493), Expect = 4e-59
Identities = 60/272 (22%), Positives = 108/272 (39%), Gaps = 23/272 (8%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV 141
DH++++ LG G G V++ A G A K HE E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
V L + +++YEF+S G LF+ + D++ ++ + + +V L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 202 ASMPIYHRDIKSTNILLNEKY--TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
H D+K NI+ K K+ DFG + + Q+ T GT + PE
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319
+D++S GV+ LL+G P E L ++ ++ D
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCDWNMDDSAFS 250
Query: 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ + + L + R T+ +
Sbjct: 251 GISED-----GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-58
Identities = 71/333 (21%), Positives = 132/333 (39%), Gaps = 50/333 (15%)
Query: 57 QQQLTSSDGS----IDRCKLFTTKELDKATDHFNVNRILGQGGQGTVYKGML------AD 106
Q+T S + +D + + + ++ ++LG G G V
Sbjct: 7 MVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGV 66
Query: 107 GRIVAVKK-SKIVHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNG 164
VAVK + + E ++E+ +++Q+ +H N+V LLG C + L++E+ G
Sbjct: 67 SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126
Query: 165 TLFQYLHDQNEEF--------------------PLTWEMRLRIATEVAGSLSYLHSAASM 204
L YL + E+F LT+E L A +VA + +L
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FK 183
Query: 205 PIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT-TKVQGTFGYLDPEYFRSGQF 263
HRD+ + N+L+ K+ DFG ++ I+ D +V + ++ PE G +
Sbjct: 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
Query: 264 TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQ 323
T KSDV+S+G++L E+ + Y + ++ N Y + +
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVN-------------PYPGIPVDAN-FYKLIQNGFKMDQP 289
Query: 324 KEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356
I + C + ++RP+ + L
Sbjct: 290 FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-58
Identities = 69/321 (21%), Positives = 120/321 (37%), Gaps = 39/321 (12%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADG---RIVAVKK-SKIVHEGKLEEFINEVVILSQI-N 137
+ ++G+G G V K + A+K+ + + +F E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEF-------------PLTWEMR 184
H N++ LLG C L E+ +G L +L L+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT 244
L A +VA + YL HRD+ + NIL+ E Y AK+ADFG S+ + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ--EVYVKKT 184
Query: 245 KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS 304
+ ++ E +T SDV+S+GV+L E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQKD 364
M LY+ L + L +C RP+ ++ + L R+ +K
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 365 INVKQICDEIESCDIVSTSTE 385
V E + + S E
Sbjct: 290 -YVNTTLYEKFTYAGIDCSAE 309
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 8e-58
Identities = 59/286 (20%), Positives = 124/286 (43%), Gaps = 29/286 (10%)
Query: 80 KATDHFNVNRILGQGGQGTVYKGMLAD-----GRIVAVKK-SKIVHEGKLEEFINEVVIL 133
K T+ F ++LG G GTVYKG+ VA+K+ + +E ++E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 134 SQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
+ +++ +V +LLG CL + V L+ + + G L Y+ + + + L ++A
Sbjct: 66 ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAK 122
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI-VIDQTHVTTKVQGTFGY 252
++YL + HRD+ + N+L+ K+ DFG +K + ++ + + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312
+ E +T +SDV+S+GV + EL+T + + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISS 224
Query: 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
L+ + + + +C ++ RP +E+ +E ++
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 2e-57
Identities = 69/277 (24%), Positives = 109/277 (39%), Gaps = 28/277 (10%)
Query: 80 KATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
K + F +ILG+G TV LA R A+K K I+ E K+ E ++S+
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
++H VKL + E + NG L +Y+ E+ +L
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSAL 121
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID-QTHVTTKVQGTFGYLD 254
YLH I HRD+K NILLNE ++ DFGT+K + + + GT Y+
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 255 PEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314
PE SD+++ G ++ +L+ G P E I+ +E + F
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQK--IIKLEYDFPEKFF 234
Query: 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
L + L L+ +R +E+
Sbjct: 235 PK-------------ARDLVEKLLVLDATKRLGCEEM 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-56
Identities = 64/287 (22%), Positives = 113/287 (39%), Gaps = 31/287 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGML----ADGRIVAVK---KSKIVHEGKLEEFINEVVILSQ 135
+ LG G G V +G VAVK + +++FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
++HRN+++L G L + +V E G+L L R A +VA +
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGM 124
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH--VTTKVQGTFGYL 253
YL S HRD+ + N+LL + K+ DFG + + + H + + F +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313
PE ++ F+ SD + FGV L E+ T + + + +++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILHK 226
Query: 314 LDDQVLKVGQKEEIMT-IATLATRCLNLNGKRRPTMKEVAMELERIQ 359
+D + ++ + E+ I + +C + RPT + L Q
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 182 bits (463), Expect = 1e-55
Identities = 73/289 (25%), Positives = 115/289 (39%), Gaps = 30/289 (10%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQIN 137
+D + + ILG GG V+ L R VAVK F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 138 HRNVVKLLGCCLETE----VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
H +V + +P +V E++ TL +H + P+T + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV--TTKVQGTFG 251
+L++ H I HRD+K NI+++ KV DFG ++ I V T V GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311
YL PE R +SDVYS G VL E+LTG+ P TG + +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--------TGDSPVSVAYQHVREDP 231
Query: 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP-TMKEVAMELERIQ 359
+ + + + + L N + R T E+ +L R+
Sbjct: 232 IPPSARHEGLSAD-----LDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 184 bits (468), Expect = 2e-55
Identities = 54/272 (19%), Positives = 108/272 (39%), Gaps = 23/272 (8%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV 141
D++++ LG G G V++ + A GR+ K + NE+ I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
+ L + +L+ EF+S G LF + ++ + ++ + + L ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH-- 144
Query: 202 ASMPIYHRDIKSTNILL--NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
I H DIK NI+ + + K+ DFG + ++ + T + PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAPEIVD 201
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319
+D+++ GV+ LL+G P E L + ++F +D
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDWEFDEDAFS 253
Query: 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
V + L ++R T+ +
Sbjct: 254 SVSPE-----AKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-55
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 33/291 (11%)
Query: 83 DHFNVNRILGQGGQGTVYKGML------ADGRIVAVKK-SKIVHEGKLEEFINEVVILSQ 135
+ ++R LGQG G VY+G+ VA+K ++ + EF+NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEF-------PLTWEMRLRIA 188
N +VV+LLG + + L++ E ++ G L YL P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 189 TEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV-IDQTHVTTKVQ 247
E+A ++YL+ + HRD+ + N ++ E +T K+ DFG ++ I D K
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 248 GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE 307
++ PE + G FT SDV+SFGVVL E+ T + S E + + E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVME 250
Query: 308 NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
L D D+ + L C N K RP+ E+ ++
Sbjct: 251 GGLLDKPDNCPDML---------FELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-54
Identities = 76/309 (24%), Positives = 125/309 (40%), Gaps = 44/309 (14%)
Query: 77 ELDKATDHFNVNRILGQGGQGTVYKGML--------ADGRIVAVKK-SKIVHEGKLEEFI 127
EL + D + + LG+G G V VAVK E L + I
Sbjct: 9 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 128 NEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQ------------- 173
+E+ ++ I H+N++ LLG C + ++ E+ S G L +YL +
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 174 NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233
N E L+ + + A +VA + YL S HRD+ + N+L+ E K+ADFG ++
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 234 FIVIDQTHVTTKVQ-GTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSK 292
I + T ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------- 236
Query: 293 EATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVA 352
+ L+ L + + + C + +RPT K++
Sbjct: 237 --------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 353 MELERIQAL 361
+L+RI AL
Sbjct: 289 EDLDRIVAL 297
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 6e-54
Identities = 59/278 (21%), Positives = 103/278 (37%), Gaps = 20/278 (7%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVIL 133
K+ + D ++ +LG G V ++VA+K +K EGK NE+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 134 SQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
+I H N+V L L+ + +S G LF + ++ T R+ +V
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLD 118
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
++ YLH + + L+E ++DFG SK D V + GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYV 176
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313
PE ++ D +S GV+ LL G P + + Y+F
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--------LFEQILKAEYEF 228
Query: 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ + + ++R T ++
Sbjct: 229 DSPYWDDISDS-----AKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-54
Identities = 78/299 (26%), Positives = 121/299 (40%), Gaps = 40/299 (13%)
Query: 83 DHFNVNRILGQGGQGTVYKGM------LADGRIVAVKK-SKIVHEGKLEEFINEVVILSQ 135
D + + LG+G G V + A R VAVK + + ++E+ IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 136 INHR-NVVKLLGCCLETEVPL-LVYEFISNGTLFQYLHDQNEEF-------------PLT 180
I H NVV LLG C + PL ++ EF G L YL + EF LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 181 WEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240
E + + +VA + +L S HRD+ + NILL+EK K+ DFG ++ I D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 241 HV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAA 299
+V + ++ PE +T +SDV+SFGV+L E+ + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDE 244
Query: 300 YFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
F ++E D ++ C + +RPT E+ L +
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEM---------YQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 8e-53
Identities = 60/279 (21%), Positives = 114/279 (40%), Gaps = 27/279 (9%)
Query: 76 KELDKATDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILS 134
KEL + + + LG+G G V++ + + + K K+ + E+ IL+
Sbjct: 1 KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILN 56
Query: 135 QINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGS 194
HRN++ L E ++++EFIS +F+ ++ F L + +V +
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEA 114
Query: 195 LSYLHSAASMPIYHRDIKSTNILLNEK--YTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
L +LH S I H DI+ NI+ + T K+ +FG ++ + + Y
Sbjct: 115 LQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLFTAPEY 169
Query: 253 LDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312
PE + + +D++S G ++ LL+G P + +++ I+ N Y
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--------IIENIMNAEYT 221
Query: 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
F ++ ++ + R L K R T E
Sbjct: 222 FDEEAFKEISIE-----AMDFVDRLLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (439), Expect = 5e-52
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 38/286 (13%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK---------SKIVHEGKLEEFINEVVI 132
+++ ILG+G V + + + AVK S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 133 LSQIN-HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEV 191
L +++ H N+++L LV++ + G LF YL ++ L+ + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFG 251
+ LH + I HRD+K NILL++ K+ DFG S +D +V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPS 174
Query: 252 YLDPEYFRSGQ------FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM 305
YL PE + + D++S GV++ LL G P +L M
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------WHRKQMLMLRM 226
Query: 306 EENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ Y F + + L +R L + ++R T +E
Sbjct: 227 IMSGNYQFGSPEWDDYSDT-----VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-49
Identities = 60/277 (21%), Positives = 110/277 (39%), Gaps = 29/277 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILS-QIN 137
+ F ++++LG+G G V+ + A+K K ++ + +E + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 138 HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
H + + E V E+++ G L ++ + A E+ L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118
Query: 198 LHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
LHS I +RD+K NILL++ K+ADFG K ++ T GT Y+ PE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317
++ D +SFGV+L E+L GQ P + + M+ +L+ +
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPF-----HGQDEEELFHSIRMDNPFYPRWLEKE 229
Query: 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354
L + ++R ++ +
Sbjct: 230 AKD------------LLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (414), Expect = 6e-48
Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 39/296 (13%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
F + R LG G G V+ +GR A+K K +V ++E +E ++LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
++++ G + + ++ ++I G LF L + A EV +L YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
H S I +RD+K NILL++ K+ DFG +K++ VT + GT Y+ PE
Sbjct: 121 H---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318
+ + D +SFG+++ E+L G P ++ + Y + E R F ++ V
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPF-----YDSNTMKTYEKILNAELRFPPFFNEDV 228
Query: 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ----KDINVKQI 370
L +R + + +R + E K++ +++
Sbjct: 229 KD------------LLSRLITRDLSQRLGNLQNGTE----DVKNHPWFKEVVWEKL 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 9e-47
Identities = 59/286 (20%), Positives = 111/286 (38%), Gaps = 24/286 (8%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK--KSKIVHEGKLEEFINEVVILSQINHR 139
++F +G+G G VYK G +VA+K + EG I E+ +L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
N+VKLL LV+EF+ D + + + ++ L++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
S + HRD+K N+L+N + K+ADFG ++ + T +V +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF----------ILSMEENR 309
++ D++S G + E++T + G E L F +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRAL--FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 310 LYDFLDDQVLKVGQKEEIMTIAT----LATRCLNLNGKRRPTMKEV 351
Y + + + + + L ++ L+ + +R + K
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-46
Identities = 69/280 (24%), Positives = 114/280 (40%), Gaps = 32/280 (11%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGK---LEEFINEVVILSQ 135
D+++ LG G V K + G A K K + + E+ EV IL +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
I H NV+ L +L+ E ++ G LF +L ++ LT E ++ +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 126
Query: 196 SYLHSAASMPIYHRDIKSTNILLNE----KYTAKVADFGTSKFIVIDQTHVTTKVQGTFG 251
YLHS + I H D+K NI+L + K K+ DFG + I D + + GT
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPE 181
Query: 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311
++ PE ++D++S GV+ LL+G P + +E L+ Y
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSAVNY 233
Query: 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+F D+ R L + K+R T+++
Sbjct: 234 EFEDEYFSNTSAL-----AKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 65/292 (22%), Positives = 104/292 (35%), Gaps = 25/292 (8%)
Query: 80 KATDHFNVNRILGQGGQGTVYKG--MLADGRIVAVK--KSKIVHEGKLEEFINEVVILSQ 135
+A + +G+G G V+K + GR VA+K + + EG I EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 136 I---NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQ---YLHDQNEEFPLTWEMRLRIAT 189
+ H NVV+L C + + + Q D+ E + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 190 EVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGT 249
++ L +LHS + HRD+K NIL+ K+ADFG ++ T V T
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVT 178
Query: 250 FGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309
Y PE + D++S G + E+ + + + G I E
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 310 LYDF--LDDQVLKVGQKEEIMTIAT--------LATRCLNLNGKRRPTMKEV 351
L Q + I T L +CL N +R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (401), Expect = 2e-46
Identities = 55/283 (19%), Positives = 107/283 (37%), Gaps = 20/283 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRN 140
+ ++ +G+G G VYK G A+KK ++ EG I E+ IL ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 141 VVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+VKL + +LV+E + + L ++ ++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118
Query: 201 AASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRS 260
+ HRD+K N+L+N + K+ADFG ++ I T ++ + S
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 261 GQFTDKSDVYSFGVVLVELLTGQKP------------IILTGSKEATGLAAYFILSMEEN 308
+++ D++S G + E++ G I + + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ + + K + L ++ L L+ +R T K+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-46
Identities = 54/289 (18%), Positives = 106/289 (36%), Gaps = 22/289 (7%)
Query: 82 TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK-SKIVHEGKLEEFINEVVILSQINHR 139
+ +G+G G V + VA+KK S H+ + + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
N++ + + + ++ + L+ + L+ + ++ L Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVT--TKVQGTFGYLDPEY 257
S + HRD+K +N+LLN K+ DFG ++ D H T+ T Y PE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 258 FRSGQFTDKS-DVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316
+ + KS D++S G +L E+L+ + + + S + L ++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 317 QVLKVGQKEEIMTIAT--------------LATRCLNLNGKRRPTMKEV 351
+ L + L N +R +++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 160 bits (405), Expect = 4e-46
Identities = 61/274 (22%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLAD-GRIVAVK---KSKIVHEGKLEEFINEVV---ILSQ 135
+ F+V+RI+G+GG G VY AD G++ A+K K +I + +NE + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 136 INHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSL 195
+ +V + + + + ++ G L +L + A E+ L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGL 120
Query: 196 SYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDP 255
++H + + +RD+K NILL+E +++D G + + H + GT GY+ P
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 256 EYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314
E + G + +D +S G +L +LL G P K + L D
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTM 348
++ +L L + RR
Sbjct: 233 SPEL------------RSLLEGLLQRDVNRRLGC 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-45
Identities = 65/281 (23%), Positives = 100/281 (35%), Gaps = 25/281 (8%)
Query: 89 RILGQGGQGTVYKGM-LADGRIVAVKKSKIVH-----EGKLEEFINEVVILSQINHRNVV 142
LG+G TVYK +IVA+KK K+ H +G + E+ +L +++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 143 KLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA 202
LL LV++F+ + LT L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ-- 118
Query: 203 SMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQ 262
I HRD+K N+LL+E K+ADFG +K T +V T Y PE +
Sbjct: 119 -HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 263 FTD-KSDVYSFGVVLVELLTGQKPI-----------ILTGSKEATGLAAYFILSMEENRL 310
D+++ G +L ELL + I T + S+ +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+ L + L N R T +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 2e-45
Identities = 51/287 (17%), Positives = 98/287 (34%), Gaps = 28/287 (9%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV 141
+ + + R +G G G +Y G +A G VA+K + + K + E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 142 VKLLG-CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+ + C E + ++V E + + + + L +A ++ + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS 121
Query: 201 AASMPIYHRDIKSTNILLNEK---YTAKVADFGTSKFIVIDQTHV------TTKVQGTFG 251
HRD+K N L+ + DFG +K +TH + GT
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 252 YLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311
Y + + + D+ S G VL+ G P + + E ++
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEKKMS 234
Query: 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
++ + AT C +L +P + +
Sbjct: 235 TPIEVLCKGYPSE-----FATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-45
Identities = 67/287 (23%), Positives = 108/287 (37%), Gaps = 28/287 (9%)
Query: 85 FNVNRILGQGGQGTVYKGMLAD-GRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVK 143
+ +++G G G VY+ L D G +VA+KK E+ I+ +++H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVR 77
Query: 144 LLGCCLETEVP------LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSY 197
L + LV +++ H + L ++ SL+Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 198 LHSAASMPIYHRDIKSTNILLNEK-YTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPE 256
+HS I HRDIK N+LL+ K+ DFG++K +V + +V+ + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPEL 193
Query: 257 YFRSGQFTDKSDVYSFGVVLVELLTGQKP------------IILTGSKEATGLAAYFILS 304
F + +T DV+S G VL ELL GQ II +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
E + KV + L +R L R T E
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 6e-45
Identities = 57/274 (20%), Positives = 105/274 (38%), Gaps = 29/274 (10%)
Query: 87 VNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQI-NHRNVVKL 144
+++LG G G V + A+K + + EV + + ++V++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRI 70
Query: 145 LGCC----LETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS 200
+ + L+V E + G LF + D+ ++ T I + ++ YLHS
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS 129
Query: 201 AASMPIYHRDIKSTNILLN---EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
+ I HRD+K N+L K+ DFG +K + T T Y+ PE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEV 184
Query: 258 FRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317
++ D++S GV++ LL G P + I + Y+F + +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----YEFPNPE 240
Query: 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
+V ++ + L L +R T+ E
Sbjct: 241 WSEVSEE-----VKMLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-44
Identities = 71/280 (25%), Positives = 117/280 (41%), Gaps = 42/280 (15%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLE---EFINEVVILSQ 135
+ V +LG GG G+VY G+ ++D VA+K K +I G+L EVV+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 136 IN--HRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
++ V++LL + +L+ E + L E+ +V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLE 121
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGY 252
++ + H + + HRDIK NIL++ + K+ DFG+ + + V T GT Y
Sbjct: 122 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVY 175
Query: 253 LDPEYFRSGQFTDKS-DVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311
PE+ R ++ +S V+S G++L +++ G P F E R
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---------------FEHDEEIIRGQ 220
Query: 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEV 351
F +V Q L CL L RPT +E+
Sbjct: 221 VFFRQRVSSECQH--------LIRWCLALRPSDRPTFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (383), Expect = 9e-44
Identities = 55/285 (19%), Positives = 107/285 (37%), Gaps = 22/285 (7%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHR 139
+ +G+G GTV+K IVA+K+ ++ EG + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 140 NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLH 199
N+V+L + LV+EF + + E+ ++ L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 200 SAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFR 259
S + HRD+K N+L+N K+A+FG ++ I + +V + F
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 260 SGQFTDKSDVYSFGVVLVELLTGQKPI------------ILTGSKEATGLAAYFILSMEE 307
+ ++ D++S G + EL +P+ I T + + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 308 NRLYDFLDDQVLKVGQKEEIMTIAT-LATRCLNLNGKRRPTMKEV 351
+ Y V ++ L L N +R + +E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-43
Identities = 66/296 (22%), Positives = 111/296 (37%), Gaps = 36/296 (12%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
+ F+ ++LG+G G V A GR A+K K I+ + ++ + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+ L + V E+ + G LF +L E T E E+ +S L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEI---VSAL 118
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
S + +RDIK N++L++ K+ DFG K + D GT YL PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVL 177
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318
+ D + GVV+ E++ G+ P + ++ MEE R L +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ----KDINVKQI 370
L L + K+R + + ++ IN + +
Sbjct: 233 KS------------LLAGLLKKDPKQRLGGGPSDAK----EVMEHRFFLSINWQDV 272
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 6e-43
Identities = 61/299 (20%), Positives = 108/299 (36%), Gaps = 36/299 (12%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHR 139
+ +GQG G V+K G+ VA+KK + + EG + E+ IL + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 140 NVVKLLGCCLETEVP--------LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEV 191
NVV L+ C P LV++F + + T R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQML 126
Query: 192 AGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT---HVTTKVQG 248
L+ L+ I HRD+K+ N+L+ K+ADFG ++ + + + T
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 249 TFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKP-----------IILTGSKEATG 296
T Y PE + + D++ G ++ E+ T +I T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 297 LAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLA----TRCLNLNGKRRPTMKEV 351
+ + E + + Q KV + + A + L L+ +R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (371), Expect = 2e-41
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK---KSKIVHEGKLEEFINEVVILSQINH 138
D F+ + LG G G V G A+K K K+V ++E +NE IL +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 139 RNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
+VKL + +V E+++ G +F +L + A ++ + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157
Query: 199 HSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYF 258
H S+ + +RD+K N+L++++ +V DFG +K T + GT L PE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEII 210
Query: 259 RSGQFTDKSDVYSFGVVLVELLTGQKP 285
S + D ++ GV++ E+ G P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 8e-41
Identities = 55/302 (18%), Positives = 103/302 (34%), Gaps = 30/302 (9%)
Query: 73 FTTKELDKAT----DHFNVNRILGQGGQGTVYKGM-LADGRIVAVK--KSKIVHEGKLEE 125
F +E+ K + + +G G G V + G VA+K E +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 126 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQ-NEEFPLTWEMR 184
E+ +L + H NV+ LL E +F + + L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 185 LRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTT 244
+ ++ L Y+H + I HRD+K N+ +NE K+ DFG ++ + +T
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 245 KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP---------------IILT 289
V + ++T D++S G ++ E++TG+ + T
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 290 GSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMK 349
E L + + + + L + L L+ ++R T
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVN-LLEKMLVLDAEQRVTAG 296
Query: 350 EV 351
E
Sbjct: 297 EA 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (358), Expect = 5e-40
Identities = 48/289 (16%), Positives = 93/289 (32%), Gaps = 30/289 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV 141
H+ V R +G+G G +++G L + + VA+K + +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 142 VKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA 201
+ + + + ++ + +L L + + A ++ + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE- 119
Query: 202 ASMPIYHRDIKSTNILLNEKYT-----AKVADFGTSKFIVIDQTHV------TTKVQGTF 250
+ +RDIK N L+ + V DFG KF T + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 251 GYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF-ILSMEENR 309
Y+ + + + D+ + G V + L G P G K AT Y I +++
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP--WQGLKAATNKQKYERIGEKKQST 235
Query: 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358
L + NL P + ++
Sbjct: 236 PLRELCAGFPE--------EFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (345), Expect = 8e-38
Identities = 59/296 (19%), Positives = 112/296 (37%), Gaps = 41/296 (13%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRN 140
D + + R LG+G V++ + + + V VK I+ K ++ E+ IL + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK---ILKPVKKKKIKREIKILENLRGGPN 91
Query: 141 VVKLLGCCLE--TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYL 198
++ L + + P LV+E ++N Q LT E+ +L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 199 HSAASMPIYHRDIKSTNILL-NEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEY 257
HS M I HRD+K N+++ +E ++ D+G ++F Q + + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 258 FRSGQFTD-KSDVYSFGVVLVELLTGQKPI--------ILTGSKEATGLAAYFILSMEEN 308
Q D D++S G +L ++ ++P L + G + + N
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 309 RLYDFLDDQVLKVGQKEEIMTIAT-------------LATRCLNLNGKRRPTMKEV 351
D + +L ++ + L + + R T +E
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-37
Identities = 73/283 (25%), Positives = 112/283 (39%), Gaps = 30/283 (10%)
Query: 83 DHFNVNRILGQGGQGTVYKGMLA----DGRIVAVK---KSKIVHEGK-LEEFINEVVILS 134
++F + ++LG G G V+ G++ A+K K+ IV + K E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 135 QINHR-NVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
I +V L L+ ++I+ G LF +L + T E+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVL 140
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
+L +LH + I +RDIK NILL+ + DFG SK V D+T GT Y+
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 254 DPEYFRSGQ--FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311
P+ R G D +S GV++ ELLTG P + G K + + IL E
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354
+ L R L + K+R +
Sbjct: 258 EMSAL-------------AKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-36
Identities = 66/307 (21%), Positives = 110/307 (35%), Gaps = 40/307 (13%)
Query: 73 FTTKELDKA----TDHFNVNRILGQGGQGTVYKGM-LADGRIVAVK--KSKIVHEGKLEE 125
F +EL+K + + +G G G+V G VAVK +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 126 FINEVVILSQINHRNVVKLLGCC-----LETEVPLLVYEFISNGTLFQYLHDQNEEFPLT 180
E+ +L + H NV+ LL LE + + + L + Q LT
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLT 119
Query: 181 WEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240
+ + ++ L Y+H S I HRD+K +N+ +NE K+ DFG ++
Sbjct: 120 DDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DD 173
Query: 241 HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAY 300
+T V + + D++S G ++ ELLTG+ G+ L
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 231
Query: 301 F------------ILSMEENRLYDFLDDQVLKVGQKEEIMTIATLA----TRCLNLNGKR 344
+S E R Y Q+ K+ + LA + L L+ +
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
Query: 345 RPTMKEV 351
R T +
Sbjct: 292 RITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-34
Identities = 55/303 (18%), Positives = 109/303 (35%), Gaps = 45/303 (14%)
Query: 83 DHFNVNRILGQGGQGTVYKGM-LADGRIVAVKK--SKIVHEGKLEEFINEVVILSQINHR 139
+ + +G G QG V R VA+KK ++ + E+V++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 140 NVVKLLGCCL------ETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAG 193
N++ LL E + LV E + + E + ++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 194 SLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHVTTKVQGTFGYL 253
+ +LH S I HRD+K +NI++ T K+ DFG ++ + + T T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 185
Query: 254 DPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP-------------------IILTGSKEA 294
PE + + D++S G ++ E++ + K+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 295 TGLAAYFILSMEENRLYDF--LDDQVLKVGQKEEIMTIATLA----TRCLNLNGKRRPTM 348
++ + + F L L E A+ A ++ L ++ +R ++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 349 KEV 351
+
Sbjct: 306 DDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (284), Expect = 5e-29
Identities = 55/318 (17%), Positives = 104/318 (32%), Gaps = 58/318 (18%)
Query: 85 FNVNRILGQGGQGTVYKGM-LADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVK 143
+ + R LG G TV+ + + VA+K + + E +E+ +L ++N + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 144 LLGCCLETEVPLLVY-------------EFISNGTLFQYLHDQNEEFPLTWEMRLRIATE 190
+ LL + F G L + E + +I+ +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 191 VAGSLSYLHSAASMPIYHRDIKSTNILLNEK------YTAKVADFGTSKFIVIDQTHVTT 244
+ L Y+H I H DIK N+L+ K+AD G + + T+
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS-- 189
Query: 245 KVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKP-------------IILTGS 291
T Y PE + +D++S ++ EL+TG +
Sbjct: 190 --IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 292 KEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIAT------------------L 333
E G ++L + F +L+ K + +
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 334 ATRCLNLNGKRRPTMKEV 351
+ L L+ ++R +
Sbjct: 308 LSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 3e-19
Identities = 27/159 (16%), Positives = 55/159 (34%), Gaps = 20/159 (12%)
Query: 87 VNRILGQGGQGTVYKGMLADGRIVAVK----------KSKIVHEGKLEEFINEVVILSQI 136
+ +++G+G + V+ VK K K + F + ++
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 137 NHRNVVKLLGCCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLS 196
R + KL G + Y + N + L D E + + E + + ++
Sbjct: 64 EFRALQKLQGLAVPKV-----YAWEGNA-VLMELIDAKELYRVRVENPDEVLDMILEEVA 117
Query: 197 YLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235
+ I H D+ N+L++E + DF S +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEV 152
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 40 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 37.5 bits (87), Expect = 7e-05
Identities = 7/23 (30%), Positives = 11/23 (47%)
Query: 4 CKDGTANCSENLLCENYEGGYRC 26
C + CS + C +Y G+ C
Sbjct: 2 CANNRHQCSVHAECRDYATGFCC 24
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (85), Expect = 1e-04
Identities = 13/29 (44%), Positives = 15/29 (51%), Gaps = 1/29 (3%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRCITP 29
IDEC+ C +C N EG YRC P
Sbjct: 2 IDECQRDPLLCR-GGVCHNTEGSYRCECP 29
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 44 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.3 bits (84), Expect = 2e-04
Identities = 9/29 (31%), Positives = 11/29 (37%), Gaps = 1/29 (3%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRCITP 29
IDEC+ C C N G + C
Sbjct: 3 IDECRISPDLCG-RGQCVNTPGDFECKCD 30
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.5 bits (82), Expect = 5e-04
Identities = 9/29 (31%), Positives = 11/29 (37%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRCITP 29
+DEC G C C N G + C
Sbjct: 3 VDECSLGANPCEHAGKCINTLGSFECQCL 31
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.1 bits (81), Expect = 6e-04
Identities = 9/26 (34%), Positives = 13/26 (50%), Gaps = 1/26 (3%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRC 26
IDEC++ C C N G ++C
Sbjct: 3 IDECQELPGLCQ-GGKCINTFGSFQC 27
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} Length = 53 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Score = 34.9 bits (80), Expect = 0.001
Identities = 12/32 (37%), Positives = 16/32 (50%), Gaps = 6/32 (18%)
Query: 1 IDECKDGTANCSENL------LCENYEGGYRC 26
+DEC + + E+ LC NY GGY C
Sbjct: 4 LDECASRSKSGEEDPQPQCQHLCHNYVGGYFC 35
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 33.7 bits (77), Expect = 0.002
Identities = 11/29 (37%), Positives = 13/29 (44%), Gaps = 2/29 (6%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRCITP 29
++EC D T S C N G Y C P
Sbjct: 3 VNECLDPTTCISG--NCVNTPGSYICDCP 29
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 33.2 bits (76), Expect = 0.003
Identities = 10/26 (38%), Positives = 16/26 (61%), Gaps = 2/26 (7%)
Query: 1 IDECKDGTANCSENLLCENYEGGYRC 26
+DECK+ + ++ C N +G YRC
Sbjct: 5 MDECKEP--DVCKHGQCINTDGSYRC 28
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 400 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.79 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.76 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.67 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.65 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 96.35 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 96.35 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.33 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 96.12 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.91 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 95.82 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.53 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 95.21 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 94.86 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 92.42 | |
| d1nzia2 | 42 | Complement C1S component {Human (Homo sapiens) [Ta | 91.73 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.27 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 86.19 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 82.15 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 80.92 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-57 Score=411.55 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=203.3
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.++|++.+.||+|+||.||+|.+.+++.||||++... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 3579999999999999999999988889999998753 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999876543 5899999999999999999999999 999999999999999999999999999876544444
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTG-QKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||....... . ......+ ...
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~----~~~i~~~---------~~~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---V----VEDISTG---------FRL 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---H----HHHHHHT---------CCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHhc---------CCC
Confidence 44456789999999999999999999999999999999995 55553221111 1 1111111 111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
..+...++.+.+|+.+||+.||++|||+++|+++|+++.++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 12233456789999999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-56 Score=409.13 Aligned_cols=264 Identities=28% Similarity=0.459 Sum_probs=207.9
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
+...++|++.+.||+|+||.||+|..++ .||||.+... .....+.+.+|+.+|++++||||+++++++.+ +..+|
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 3446789999999999999999998753 5999987643 34567889999999999999999999998754 56899
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 v~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999976543 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCC-ceeeecccccCCCCCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 237 IDQ-THVTTKVQGTFGYLDPEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 237 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
... ........||+.|+|||++.+ ..|+.++|||||||++|||+||+.||........ . ......+....
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~----~~~~~~~~~~p 229 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--I----IFMVGRGYLSP 229 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H----HHHHHHTSCCC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--H----HHHHhcCCCCC
Confidence 322 223445679999999999864 3589999999999999999999999954332211 1 11111111100
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
.....+...++.+.+|+.+||+.||.+|||+++|+++|+.+++.
T Consensus 230 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 230 -----DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -----CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 01112334456799999999999999999999999999998864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=411.38 Aligned_cols=263 Identities=25% Similarity=0.400 Sum_probs=213.7
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
+|+...++|++.+.||+|+||.||+|.++++..||||++... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 344556789999999999999999999988899999988653 3345789999999999999999999998754 56799
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~-~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 99999999999987654322 4899999999999999999999999 9999999999999999999999999998775
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
...........||+.|+|||++.++.++.++|||||||++|||+||..|+....... . .......+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-----~-~~~~i~~~-------- 226 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----E-VIQNLERG-------- 226 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H-HHHHHHTT--------
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-----H-HHHHHHhc--------
Confidence 544444555678999999999999999999999999999999999655543222111 0 01111111
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.....+...++.+.+|+.+||+.||++|||+++|++.|+.+-.
T Consensus 227 -~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1111223445678999999999999999999999999988643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-56 Score=415.70 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=218.1
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
+|+...++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|+.+|++++||||+++++++.+.+..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34555678999999999999999999975 5889999988643 344678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
|||||+++|+|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~-~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhcccc-chHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999999765433 5899999999999999999999999 999999999999999999999999999877
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
............|++.|+|||++.+..|+.++|||||||++|||++|..||....... .. ......
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-----~~-~~~i~~-------- 231 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QV-YELLEK-------- 231 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HH-HHHHHT--------
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-----HH-HHHHhc--------
Confidence 6555555555678999999999999999999999999999999999777663322211 10 111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQ 359 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~ 359 (400)
......+...++.+.+|+.+||+.||.+|||+++|++.|+.+.
T Consensus 232 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 232 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1112223344567999999999999999999999999887753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=404.65 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=209.2
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999996 468999999987666666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
+||+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.+... ..
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QS 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST-TC
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc-cc
Confidence 999999988654 4899999999999999999999999 999999999999999999999999999876432 23
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhcc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLKV 321 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (400)
......||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... ......... ...+ .
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~-~~~~-------~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TPEL-------Q 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC-SCCC-------S
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC-CCCC-------C
Confidence 3445679999999999999999999999999999999999999995332211 011111111 0111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 322 GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...++.+.+|+.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122345678999999999999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=408.06 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=204.3
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|..+ +|+.||||.+.... ....+.+.+|+.+|++++||||+++++++.+.+..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 467999999999999999999975 68999999876433 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999987543 5999999999999999999999999 9999999999999999999999999998765433
Q ss_pred c-eeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 240 T-HVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 240 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. ......+||+.|+|||++.+..+ +.++||||+||++|+|++|++||....... ..+.... ....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~~~~-~~~~-------- 224 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QEYSDWK-EKKT-------- 224 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS----HHHHHHH-TTCT--------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH----HHHHHHh-cCCC--------
Confidence 2 23455779999999999988876 578999999999999999999995433211 1111111 1100
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........++.+.+|+.+||+.||.+|||++|++++
T Consensus 225 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011112334568899999999999999999998763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=400.03 Aligned_cols=246 Identities=29% Similarity=0.409 Sum_probs=207.2
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|..+ +++.||+|.+.. ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 688999998753 22344677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 9999999999998755 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.......||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... .. .......
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~-~~i~~~~--------- 220 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TY-KRISRVE--------- 220 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTC---------
T ss_pred --CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HH-HHHHcCC---------
Confidence 22345679999999999999999999999999999999999999995432211 11 1111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...++.+.+|+.+||+.||.+|||++|++++
T Consensus 221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 01122345678999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-55 Score=398.20 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=214.0
Q ss_pred hcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
.++|++.+.||+|+||.||+|+.++++.||||.++.... ..+.+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 368999999999999999999998888999998875433 4578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++|+|..++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999776543 4899999999999999999999999 999999999999999999999999999876554444
Q ss_pred eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 242 VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+. ......+ ...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~~~i~~~---------~~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQG---------LRL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTT---------CCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------HHHHHhC---------CCC
Confidence 4455678999999999999999999999999999999998 8999954432211 1111111 111
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELER 357 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 357 (400)
..+...++.+.+|+.+||+.||++|||+++++++|.+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1223344679999999999999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-55 Score=405.21 Aligned_cols=258 Identities=26% Similarity=0.455 Sum_probs=201.3
Q ss_pred hcCCcccceeeecCcEEEEEEEecC-C---cEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLAD-G---RIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~-~---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.++|++.+.||+|+||.||+|..+. + ..||||.+... .....+.+.+|+.+|++++||||+++++++.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568899999999999999999642 3 35889987643 34456789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998876443 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCcee----eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 237 IDQTHV----TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 237 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
...... .....||+.|+|||++.++.|+.++|||||||++|||+| |+.||....... . ......+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~----~~~i~~~--- 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---V----INAIEQD--- 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HHHHHTT---
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcC---
Confidence 332221 222457899999999999999999999999999999998 899995433211 1 1111111
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.....+...++.+.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus 250 ------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 ------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111233455679999999999999999999999999998765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-55 Score=403.03 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=208.1
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
+.|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+|++++||||+++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999965 68899999987766677788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++|+|.+++..... ++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQ 165 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HH
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC-cc
Confidence 99999999876443 5999999999999999999999999 999999999999999999999999999765322 12
Q ss_pred eeecccccCCCCCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 242 VTTKVQGTFGYLDPEYFR-----SGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
......||+.|+|||++. +..|+.++|||||||++|+|++|+.||........ . . .........
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~--~--~i~~~~~~~---- 234 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---L--L--KIAKSEPPT---- 234 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H--H--HHHHSCCCC----
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---H--H--HHHcCCCCC----
Confidence 233467999999999984 45689999999999999999999999954432211 1 0 011111100
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+...++.+.+|+.+||+.||.+|||++|++++
T Consensus 235 ---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 ---LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01122345678999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=404.51 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=196.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEee--CCcceE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLL 156 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 156 (400)
.++|++.+.||+|+||.||+|... +|+.||+|.+... .+...+.+.+|+.++++++||||+++++++.+ .+.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999964 6899999987653 34456778999999999999999999999865 456799
Q ss_pred EEEccCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 157 VYEFISNGTLFQYLHDQN-EEFPLTWEMRLRIATEVAGSLSYLHSAA--SMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999987532 2236999999999999999999999865 2349999999999999999999999999998
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
..... ........||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... ...........
T Consensus 163 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~-- 232 (269)
T d2java1 163 ILNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFR-- 232 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCC--
T ss_pred ecccC-CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCC--
Confidence 76432 223345679999999999999999999999999999999999999995432211 11111111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...++.+.+|+.+||+.||.+|||++|++++
T Consensus 233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1122345679999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-55 Score=410.08 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=206.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||+||+|... +|+.||+|.+... .......+.+|+.+|++++||||+++++++.+.+..+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 568999999999999999999964 6899999987653 34446788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSA-ASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
|++||+|.+++.+.+ .+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999998765 489999999999999999999974 8 999999999999999999999999999865422
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHh-------------
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSM------------- 305 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------- 305 (400)
......||+.|+|||++.+..|+.++||||+||++|||++|+.||...................
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2335679999999999999999999999999999999999999996543321100000000000
Q ss_pred ----------hhcccccccchhh----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 306 ----------EENRLYDFLDDQV----LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 306 ----------~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......+..+... ........+..+.+|+.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000000000 000011234568999999999999999999999996
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-54 Score=396.95 Aligned_cols=260 Identities=26% Similarity=0.419 Sum_probs=204.3
Q ss_pred hcCCcccceeeecCcEEEEEEEecCC-----cEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLADG-----RIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
.+.|++.++||+|+||.||+|.+++. ..||||++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35789999999999999999986532 47999987643 3344567899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+.++++.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999998876543 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce--eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 236 VIDQTH--VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 236 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
...... ......||+.|+|||++.++.++.++|||||||++|||++|..|+....... .. .....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~----~~~i~------- 227 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EV----MKAIN------- 227 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH----HHHHH-------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HH----HHHHh-------
Confidence 433222 2234568999999999999999999999999999999999766653322211 01 11111
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
.......+...+..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 228 --~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 228 --DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111222334556799999999999999999999999999988763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=408.42 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=208.3
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecC-C-----cEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEEee
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLAD-G-----RIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCCLE 150 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 150 (400)
+...++|++.+.||+|+||+||+|+... + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3445789999999999999999998643 2 36899987543 344456788999999998 89999999999999
Q ss_pred CCcceEEEEccCCCCHHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQNE--------------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRD 210 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrD 210 (400)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 9999999999999999999976532 125899999999999999999999999 99999
Q ss_pred CCCCCeEEcCCCcEEEEecCCccccccCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCc
Q 042371 211 IKSTNILLNEKYTAKVADFGTSKFIVIDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIIL 288 (400)
Q Consensus 211 ikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~ 288 (400)
|||+|||++.++.+||+|||+|+........ ......||+.|+|||++.++.|+.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876543332 3345668999999999999999999999999999999998 8999954
Q ss_pred CCCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042371 289 TGSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELE 356 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 356 (400)
...... + ......+ .....+...++.+.+|+.+||+.||++|||++||+++|.
T Consensus 270 ~~~~~~--~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDAN--F----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSHH--H----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHH--H----HHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 332211 1 1111111 111223344567999999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=392.43 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=198.2
Q ss_pred CcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEee----CCcceEE
Q 042371 85 FNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLE----TEVPLLV 157 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 157 (400)
|++.+.||+|+||+||+|... ++..||+|.+... .....+.+.+|+.+|++++||||+++++++.+ ...+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 467788999999999999965 5889999987643 34456788999999999999999999999865 3457899
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCcEEEEecCCccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN-EKYTAKVADFGTSKFIV 236 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~-~~~~~kl~Dfgla~~~~ 236 (400)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999998754 5899999999999999999999976 4599999999999997 47899999999997643
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
. .......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||....... .. ......+.. ..
T Consensus 167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~-~~~i~~~~~----~~ 232 (270)
T d1t4ha_ 167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QI-YRRVTSGVK----PA 232 (270)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HH-HHHHTTTCC----CG
T ss_pred C---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HH-HHHHHcCCC----Cc
Confidence 2 23345679999999999875 69999999999999999999999995332211 11 111111111 01
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.. +...++.+.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 11223458899999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=395.70 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=209.2
Q ss_pred cCCcccce-eeecCcEEEEEEEec---CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 83 DHFNVNRI-LGQGGQGTVYKGMLA---DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 83 ~~y~~~~~-lg~G~fg~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
++|.+.+. ||+|+||.||+|.++ ++..||||.++.. .....+.+.+|+.+|++++||||+++++++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 56777774 999999999999854 3557999987653 34556789999999999999999999999865 467999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999865433 5899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcee--eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 238 DQTHV--TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 238 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
..... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ . ......+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~----~~~i~~~~~---- 230 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGKR---- 230 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H----HHHHHTTCC----
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCC----
Confidence 33222 234568999999999999999999999999999999998 999996443221 1 111111111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
...+...++.+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 231 -----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 122334556789999999999999999999999999877653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-53 Score=405.24 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=209.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++||||+++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999964 6899999998776667778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCcEEEEecCCccccccC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE--KYTAKVADFGTSKFIVID 238 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~--~~~~kl~Dfgla~~~~~~ 238 (400)
++||+|.+++..... .+++..++.++.||+.||.|||+.| |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 105 ~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~- 178 (350)
T d1koaa2 105 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 178 (350)
T ss_dssp CCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT-
T ss_pred CCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc-
Confidence 999999999865432 5999999999999999999999999 999999999999964 57899999999987643
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
........||+.|+|||++.+..|+.++|||||||++|+|++|+.||......+ .. ..+..... .+ +.
T Consensus 179 -~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~-~~i~~~~~-~~-~~-- 246 (350)
T d1koaa2 179 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TL-RNVKSCDW-NM-DD-- 246 (350)
T ss_dssp -TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHTCC-CS-CC--
T ss_pred -ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCCC-CC-Cc--
Confidence 333445679999999999999999999999999999999999999995332211 11 11111100 00 00
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
......++.+.+||.+||+.||.+|||+.|++++
T Consensus 247 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 --SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234568999999999999999999999885
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=393.30 Aligned_cols=249 Identities=28% Similarity=0.399 Sum_probs=200.6
Q ss_pred ceeeecCcEEEEEEEecC---CcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEccCC
Q 042371 89 RILGQGGQGTVYKGMLAD---GRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFISN 163 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 163 (400)
++||+|+||.||+|.+++ ++.||||.++.. .....+.+.+|+.+|++++||||+++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 468999987642 33446789999999999999999999999865 457899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCcee-
Q 042371 164 GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTHV- 242 (400)
Q Consensus 164 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 242 (400)
|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999998654 5999999999999999999999999 9999999999999999999999999998765433322
Q ss_pred -eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhhhc
Q 042371 243 -TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVLK 320 (400)
Q Consensus 243 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (400)
.....||+.|+|||++.+..++.++|||||||++|||++ |+.||....... .......+. ..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~---------~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE---------RM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---------CC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCC---------CC
Confidence 234568999999999999999999999999999999998 899995432211 111111111 11
Q ss_pred cCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 321 VGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
..+...+..+.+|+.+||+.||.+|||+++|++.|+..-.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 2233445679999999999999999999999998887643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-55 Score=401.72 Aligned_cols=262 Identities=26% Similarity=0.384 Sum_probs=206.1
Q ss_pred HHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 78 LDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 78 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
|+...++|++.+.||+|+||.||+|.++++..||||++... ....+.+.+|+.++++++|||||++++++.+ +..++|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 34445789999999999999999999988889999998654 3345789999999999999999999999854 568999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++|+|..++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999999998764322 4899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
..........||+.|+|||++.++.++.++|||||||++|||++|..|+....... .. .......
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~~-~~~i~~~--------- 230 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EV-LDQVERG--------- 230 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HH-HHHHHTT---------
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----HH-HHHHHhc---------
Confidence 44444455678999999999999999999999999999999999766653332211 00 1111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQA 360 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~ 360 (400)
.....+...++.+.+++.+||+.||++|||+++|+++|+..-.
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1112233445679999999999999999999999998877543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-54 Score=396.00 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=205.4
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999974 6899999987532 3445678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||++||+|.+++...+ .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999988765 5999999999999999999999999 999999999999999999999999999876433
Q ss_pred C-ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 239 Q-THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 239 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. ........||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... .. ........
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~-~~i~~~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IF-QKIIKLEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHTTCC-------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HH-HHHHcCCC-------
Confidence 2 223345679999999999999999999999999999999999999995432111 11 11111110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+...++.+.+||.+||+.||.+|||++|++++
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1122345668999999999999999999998764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=396.00 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=201.7
Q ss_pred HhcCCcccceeeecCcEEEEEEEecC----CcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLAD----GRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
..++|++.+.||+|+||.||+|.+.. +..||||.+... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 35689999999999999999998642 356899987653 3444678999999999999999999999986 46789
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999998876543 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
............||+.|+|||++.+..|+.++|||||||++|||++ |.+||....... .. .....+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~----~~i~~~~~---- 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI----GRIENGER---- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCC----
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCCC----
Confidence 5444444555678999999999999999999999999999999998 899986543322 11 11111111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
...+...++.+.+|+.+||+.||.+|||+.+|+++|+.+....
T Consensus 228 -----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 228 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1123344567999999999999999999999999999887643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-54 Score=400.73 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=201.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC---chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH---EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
..|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34999999999999999999964 68899999876433 334567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
|||++|+|..++.... ++++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999977665543 5999999999999999999999999 99999999999999999999999999986432
Q ss_pred CceeeecccccCCCCCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccc
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRS---GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLD 315 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (400)
.....||+.|+|||++.+ +.|+.++|||||||++|+|++|..||....... . ...........+
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~-~~~i~~~~~~~~-- 234 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A-LYHIAQNESPAL-- 234 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------H-HHHHHHSCCCCC--
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------H-HHHHHhCCCCCC--
Confidence 234569999999999864 468999999999999999999999995332111 0 111111111111
Q ss_pred hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+...++.+.+|+.+||+.||.+|||+++++++
T Consensus 235 ------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 235 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 122335679999999999999999999999873
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-54 Score=400.01 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=191.4
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
.+.|++.+.||+|+||+||+|... +++.||||.+.... ......+.+|+.+|++++||||+++++++.+.+..|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999965 68999999876432 2334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCcEEEEecCCccccc
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN---EKYTAKVADFGTSKFIV 236 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~---~~~~~kl~Dfgla~~~~ 236 (400)
|++||+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+. .++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999997644 5999999999999999999999999 99999999999995 57899999999998653
Q ss_pred cCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccch
Q 042371 237 IDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDD 316 (400)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (400)
. ........||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... . ......... .
T Consensus 162 ~--~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~-~~~i~~~~~-~---- 227 (307)
T d1a06a_ 162 P--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------L-FEQILKAEY-E---- 227 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------H-HHHHHTTCC-C----
T ss_pred C--CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------H-HHHHhccCC-C----
Confidence 2 233345679999999999999999999999999999999999999995432211 1 111111110 0
Q ss_pred hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 317 QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.........++.+.+|+.+||+.||.+|||+.|++++
T Consensus 228 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 -FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0011123345678999999999999999999999885
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-53 Score=402.88 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=209.4
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEcc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 161 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 161 (400)
++|++.+.||+|+||.||+|... +|+.||||.+..........+.+|+.+|++++||||+++++++.+.+.+||||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999964 68999999987666566678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCCcEEEEecCCccccccCC
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLN--EKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~--~~~~~kl~Dfgla~~~~~~~ 239 (400)
+||+|.+++..... ++++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||+|.....
T Consensus 109 ~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-- 181 (352)
T d1koba_ 109 SGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 181 (352)
T ss_dssp CCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred CCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC--
Confidence 99999998765433 5999999999999999999999999 99999999999998 568999999999987643
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQVL 319 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
........||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... . ...+..... .+ .
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~-~~~i~~~~~-~~-----~ 248 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------T-LQNVKRCDW-EF-----D 248 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------H-HHHHHHCCC-CC-----C
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhCCC-CC-----C
Confidence 333445679999999999999999999999999999999999999995332211 0 111111110 00 1
Q ss_pred ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 320 KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......++.+.+||.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122345668999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=389.35 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=205.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccC------chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVH------EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|++.+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999974 68999999875321 22467899999999999999999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----cEEEEecC
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY----TAKVADFG 230 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~Dfg 230 (400)
+|||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999998764 5999999999999999999999999 99999999999998776 59999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
++..... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||....... . .........
T Consensus 163 ~a~~~~~--~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~-~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------T-LANVSAVNY 233 (293)
T ss_dssp TCEECTT--SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHTTCC
T ss_pred hhhhcCC--CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------H-HHHHHhcCC
Confidence 9986532 233345678999999999999999999999999999999999999995432211 0 011111100
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+ .... +...+..+.+||.+||+.||.+|||+++++++
T Consensus 234 -~~-~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 -EF-EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -CC-CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CC-Cchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0111 11234568899999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=389.44 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=208.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
.++|++.+.||+|+||.||+|..+ +|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357999999999999999999964 6899999987632 344567889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||++||+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999998765 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. .......+||+.|+|||++.+..|+.++||||+||++|+|++|++||....... .. ........
T Consensus 158 ~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~-~~i~~~~~------- 222 (337)
T d1o6la_ 158 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LF-ELILMEEI------- 222 (337)
T ss_dssp T-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCCC-------
T ss_pred C-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HH-HHHhcCCC-------
Confidence 2 233445779999999999999999999999999999999999999996443211 11 11111111
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
..+...++.+.+||.+||+.||.+||+ +++++++
T Consensus 223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 112234566899999999999999995 8888875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=385.93 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=201.7
Q ss_pred HhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEee-CCcceEEEE
Q 042371 81 ATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLVYE 159 (400)
Q Consensus 81 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 159 (400)
..++|++.+.||+|+||.||+|..+ |..||||+++. ....+.+.+|+.++++++||||+++++++.+ .+.+++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 3467899999999999999999985 77899998864 3455789999999999999999999999865 456899999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+++|+|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~~-~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp CCTTEEHHHHHHHHHHH-HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ccCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC--
Confidence 99999999999764321 4899999999999999999999999 99999999999999999999999999986432
Q ss_pred ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
......+|+.|+|||++.++.++.++|||||||++|||+| |++||....... .. .....+ .
T Consensus 156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~----~~i~~~---------~ 217 (262)
T d1byga_ 156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKG---------Y 217 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTT---------C
T ss_pred --CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcC---------C
Confidence 2233457899999999999999999999999999999998 788875433221 11 111111 1
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
....+...++.+.+|+.+||+.||.+|||+.+|+++|++++..
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 1122333456789999999999999999999999999998653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=392.90 Aligned_cols=257 Identities=24% Similarity=0.470 Sum_probs=204.6
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCc----EEEEEEccc-cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGR----IVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~----~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 156 (400)
.+|++.+.||+|+||.||+|.+. +|+ +||+|++.. ......+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 343 689998754 3344567899999999999999999999999865 5678
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIV 236 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~ 236 (400)
+++|+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998877543 5899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCce-eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccccc
Q 042371 237 IDQTH-VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYDFL 314 (400)
Q Consensus 237 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (400)
..... ......||+.|+|||++.++.|+.++|||||||++|||+| |.+||....... +.. ....+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~------ 229 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKG------ 229 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHT------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcC------
Confidence 43332 2334568999999999999999999999999999999998 788985443221 111 11111
Q ss_pred chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 315 DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
.....+...++.+.+|+.+||+.||.+|||+.+|+++|.++...
T Consensus 230 ---~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11122334456789999999999999999999999999987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=389.97 Aligned_cols=270 Identities=27% Similarity=0.373 Sum_probs=205.5
Q ss_pred ChHHHHHHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeee
Q 042371 74 TTKELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLL 145 (400)
Q Consensus 74 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 145 (400)
....|+...++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34556666688999999999999999999853 2468999988643 334466788888888777 689999999
Q ss_pred eEEeeCC-cceEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 042371 146 GCCLETE-VPLLVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDI 211 (400)
Q Consensus 146 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi 211 (400)
+++...+ ..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 9887654 68999999999999999975421 234889999999999999999999999 999999
Q ss_pred CCCCeEEcCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCcC
Q 042371 212 KSTNILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTG-QKPIILT 289 (400)
Q Consensus 212 kp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~ 289 (400)
||+|||++.++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++| .+||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986543322 233446799999999999999999999999999999999996 5677433
Q ss_pred CCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 290 GSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
.... ........+.. ...+...++.+.+++.+||+.||.+|||+.+++++|+.+..+
T Consensus 241 ~~~~------~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 241 KIDE------EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCSH------HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH------HHHHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 2211 01111111111 112223455689999999999999999999999999998654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-51 Score=384.74 Aligned_cols=245 Identities=27% Similarity=0.395 Sum_probs=205.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|..+ +|+.||||++.. ......+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999964 689999998753 23445678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||++||+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 9999999999988765 4789999999999999999999999 99999999999999999999999999987532
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
......||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... .... ......
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~-i~~~~~-------- 218 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEK-ILNAEL-------- 218 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHHCCC--------
T ss_pred ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHH-HHcCCC--------
Confidence 2335679999999999999999999999999999999999999995432211 1111 111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
..+...++.+.+++.+||+.||.+|+ |+++++++
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11223345689999999999999996 89999876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-51 Score=380.82 Aligned_cols=259 Identities=27% Similarity=0.387 Sum_probs=203.5
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCc----
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEV---- 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 153 (400)
.++|++.+.||+|+||.||+|.. .+|+.||||.+... .......+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 46899999987643 23445678999999999999999999999886543
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.||||||++|++|.+++.... ++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999987765 5899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCC--ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 234 FIVIDQ--THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 234 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
...... ........||+.|+|||++.+..|+.++|||||||++|+|++|++||...... .............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCC
Confidence 653222 22344567999999999999999999999999999999999999999533211 1111111111110
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRP-TMKEVAMELERIQ 359 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ell~~L~~~~ 359 (400)
........++.+.++|.+||+.||.+|| |++++++.|.+++
T Consensus 234 -------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0111223456789999999999999998 8999998888765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-52 Score=389.37 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=210.4
Q ss_pred HHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEccccC-chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC
Q 042371 80 KATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIVH-EGKLEEFINEVVILSQINHRNVVKLLGCCLETE 152 (400)
Q Consensus 80 ~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 152 (400)
...++|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|+.+|++++||||+++++++...+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 34578999999999999999999864 35789999886543 334577999999999999999999999999999
Q ss_pred cceEEEEccCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNE---------------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDI 211 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi 211 (400)
..+++|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEE
Confidence 99999999999999999975321 124889999999999999999999999 999999
Q ss_pred CCCCeEEcCCCcEEEEecCCccccccCC-ceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCC-CCCCcC
Q 042371 212 KSTNILLNEKYTAKVADFGTSKFIVIDQ-THVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQ-KPIILT 289 (400)
Q Consensus 212 kp~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~pf~~~ 289 (400)
||+|||++.++.+||+|||+++...... ........||+.|+|||.+.+..|+.++|||||||++|||++|. +||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999998654322 22334567899999999999999999999999999999999985 566433
Q ss_pred CCccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 290 GSKEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
...+. ......+... ..+...++.+.+|+.+||+.||.+||||.+|+++|+++
T Consensus 247 ~~~e~-------~~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 247 AHEEV-------IYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp CHHHH-------HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CHHHH-------HHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22211 1111222111 12233456789999999999999999999999999886
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=382.93 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=198.1
Q ss_pred cCCcccceeeecCcEEEEEEEecC--C--cEEEEEEcccc---CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcce
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLAD--G--RIVAVKKSKIV---HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPL 155 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~--~--~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 155 (400)
++|++.+.||+|+||.||+|.... + ..||||++... .....+.+.+|+.+|++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 569999999999999999998532 2 36899987542 34456789999999999999999999999965 4678
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
+||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998876543 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcee--eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCccccchHHHHHHHhhhccccc
Q 042371 236 VIDQTHV--TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKEATGLAAYFILSMEENRLYD 312 (400)
Q Consensus 236 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
....... .....|++.|+|||++.+..++.++||||||+++|||+| |+.||......+ ........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~---- 231 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEG---- 231 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSC----
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCC----
Confidence 5433322 233557889999999999999999999999999999998 899995332221 111111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 313 FLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
.....+...+..+.+|+.+||+.||++|||+.+|++.|.+.
T Consensus 232 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 -----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112234456799999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-52 Score=386.76 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=205.8
Q ss_pred cCCcccceeeecCcEEEEEEEecC-Cc--EEEEEEccc-cCchhHHHHHHHHHHHHhC-CCCcceeeeeEEeeCCcceEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLAD-GR--IVAVKKSKI-VHEGKLEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~-~~--~vaiK~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 157 (400)
++|++.++||+|+||.||+|.+++ +. .||||++.. ......+.+.+|+.+|.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 679999999999999999999753 43 478887653 3344567899999999998 799999999999999999999
Q ss_pred EEccCCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcE
Q 042371 158 YEFISNGTLFQYLHDQ-------------NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTA 224 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~ 224 (400)
|||+++|+|.++++.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754 12346999999999999999999999999 9999999999999999999
Q ss_pred EEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCC-CCCCcCCCccccchHHHHHH
Q 042371 225 KVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQ-KPIILTGSKEATGLAAYFIL 303 (400)
Q Consensus 225 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~~ 303 (400)
||+|||+++..... .......||+.|+|||.+.++.|+.++|||||||++|||++|. +||....... ...
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 237 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred EEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHH
Confidence 99999999764322 2223456899999999999999999999999999999999975 5663322111 111
Q ss_pred HhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 304 SMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
....+ .....+...++.+.+||.+||+.||++|||+.+|+++|+++....+
T Consensus 238 ~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 238 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 11111 1122233445679999999999999999999999999999876443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-51 Score=377.08 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=205.1
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCc---------hhHHHHHHHHHHHHhCC-CCcceeeeeEEee
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHE---------GKLEEFINEVVILSQIN-HRNVVKLLGCCLE 150 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 150 (400)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999996 4689999998764321 12356889999999997 9999999999999
Q ss_pred CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
.+.+||||||+++|+|.+++.... ++++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999998755 5999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeecccccCCCCCcccccc------CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRS------GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS 304 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 304 (400)
+++.... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ....
T Consensus 156 ~a~~~~~--~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~ 226 (277)
T d1phka_ 156 FSCQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRM 226 (277)
T ss_dssp TCEECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH
T ss_pred heeEccC--CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHH
Confidence 9987643 223345679999999999853 347889999999999999999999995432211 1111
Q ss_pred hhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 305 MEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
...+.. ... .......++.+.+|+.+||+.||.+|||++|++++
T Consensus 227 i~~~~~-~~~-----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGNY-QFG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTCC-CCC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCCC-CCC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111 000 11122345679999999999999999999999764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=384.01 Aligned_cols=267 Identities=26% Similarity=0.423 Sum_probs=215.6
Q ss_pred HHHHHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhC-CCCcceeeeeEE
Q 042371 77 ELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQI-NHRNVVKLLGCC 148 (400)
Q Consensus 77 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 148 (400)
.|+...++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 45555689999999999999999999852 3568999988653 344566889999999999 699999999999
Q ss_pred eeCCcceEEEEccCCCCHHHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 042371 149 LETEVPLLVYEFISNGTLFQYLHDQN---------------EEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKS 213 (400)
Q Consensus 149 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp 213 (400)
.+....++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 99999999999999999999997643 1235899999999999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCC
Q 042371 214 TNILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGS 291 (400)
Q Consensus 214 ~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~ 291 (400)
+|||++.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654333 33345678999999999999999999999999999999999 5555533222
Q ss_pred ccccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 292 KEATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
.+. ... ++........+...+..+.+||.+||+.||.+|||+.+|+++|+++...
T Consensus 254 ~~~------~~~---------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DSK------FYK---------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SHH------HHH---------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH------HHH---------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 110 011 1111111222333456799999999999999999999999999887554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=384.44 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=205.8
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.++|++.+.||+|+||+||+|... +++.||+|.+.... .....+.+|+.+|+.++||||+++++++.+.+.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999975 68899999887543 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC--CcEEEEecCCccccccC
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEK--YTAKVADFGTSKFIVID 238 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~--~~~kl~Dfgla~~~~~~ 238 (400)
|+||+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~- 156 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence 999999999976542 5899999999999999999999999 9999999999999854 4899999999986532
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
........+|+.|+|||.+.+..|+.++||||+||++|+|++|..||....... . ...+..... . ++...
T Consensus 157 -~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~-~~~i~~~~~-~-~~~~~ 226 (321)
T d1tkia_ 157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------I-IENIMNAEY-T-FDEEA 226 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHHHHHTCC-C-CCHHH
T ss_pred -CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhCCC-C-CChhh
Confidence 333445668999999999999999999999999999999999999995433211 1 111111110 0 01111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ...+..+.+|+.+||..||.+|||+.|++++
T Consensus 227 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1234568899999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.3e-51 Score=388.40 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=200.1
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHH---HHHHHHHhCCCCcceeeeeEEeeCCcc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFI---NEVVILSQINHRNVVKLLGCCLETEVP 154 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~ 154 (400)
.++|++.+.||+|+||.||+|... +|+.||||.+... .......+. .++.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999965 6899999987531 112223333 446677778899999999999999999
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccc
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKF 234 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~ 234 (400)
|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999998765 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccc
Q 042371 235 IVIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDF 313 (400)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.... ......||+.|+|||++.. ..|+.++|||||||++|+|++|+.||........ ... ........
T Consensus 157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~-~~~~~~~~---- 225 (364)
T d1omwa3 157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEI-DRMTLTMA---- 225 (364)
T ss_dssp CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHH-HHHSSSCC----
T ss_pred cCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHH-HHhcccCC----
Confidence 5432 2344679999999999875 5689999999999999999999999965433221 111 01100000
Q ss_pred cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 314 LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
...+...++.+.+||.+||+.||.+||| +++++++
T Consensus 226 ------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1112234566899999999999999999 6888875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-50 Score=384.99 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=205.9
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccc---cCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKI---VHEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 158 (400)
++|++.+.||+|+||.||+|..+ +|+.||||.+.. ......+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999964 689999998753 22345678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccC
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVID 238 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~ 238 (400)
||+.+|+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 9999999999998765 4899999999999999999999999 99999999999999999999999999987532
Q ss_pred CceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 239 QTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
......||+.|+|||++.+..|+.++|||||||++|+|++|+.||...... .. .........
T Consensus 194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~-~~~i~~~~~-------- 255 (350)
T d1rdqe_ 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QI-YEKIVSGKV-------- 255 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHCCC--------
T ss_pred ---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HH-HHHHhcCCC--------
Confidence 233467999999999999999999999999999999999999999533211 11 111111110
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRP-----TMKEVAME 354 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 354 (400)
..+...++.+.+||.+||+.||.+|+ |+++++++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 11223456689999999999999994 89999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=380.55 Aligned_cols=255 Identities=28% Similarity=0.469 Sum_probs=204.1
Q ss_pred cceeeecCcEEEEEEEecCC----cEEEEEEccc-cCchhHHHHHHHHHHHHhCCCCcceeeeeEEee-CCcceEEEEcc
Q 042371 88 NRILGQGGQGTVYKGMLADG----RIVAVKKSKI-VHEGKLEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLVYEFI 161 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~~~----~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 161 (400)
.++||+|+||+||+|.+.++ ..||||++.. ......+.+.+|+.+|++++||||+++++++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999996432 2589998764 455567889999999999999999999999876 45789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCce
Q 042371 162 SNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQTH 241 (400)
Q Consensus 162 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 241 (400)
++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999876543 4788899999999999999999999 999999999999999999999999999876433222
Q ss_pred ---eeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchhh
Q 042371 242 ---VTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQV 318 (400)
Q Consensus 242 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
......||+.|+|||.+.+..++.++||||||+++|||++|..||....... ..... ...+..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~----i~~g~~-------- 252 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY----LLQGRR-------- 252 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCC--------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCCC--------
Confidence 2233568999999999999999999999999999999999888874332211 11111 111111
Q ss_pred hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 319 LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
...+...++.+.+|+.+||+.||++|||+.||+++|+.+....
T Consensus 253 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 253 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 1112233456899999999999999999999999999997643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=383.12 Aligned_cols=264 Identities=29% Similarity=0.424 Sum_probs=209.7
Q ss_pred HHHhcCCcccceeeecCcEEEEEEEecC--------CcEEEEEEccccC-chhHHHHHHHHHHHHhC-CCCcceeeeeEE
Q 042371 79 DKATDHFNVNRILGQGGQGTVYKGMLAD--------GRIVAVKKSKIVH-EGKLEEFINEVVILSQI-NHRNVVKLLGCC 148 (400)
Q Consensus 79 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~--------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 148 (400)
+...++|++.+.||+|+||.||+|+... +..||||++.... ......+.+|...+.++ +||||+++++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3445789999999999999999998532 2479999886543 34567888999999888 799999999999
Q ss_pred eeCCcceEEEEccCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042371 149 LETEVPLLVYEFISNGTLFQYLHDQNE-------------EFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTN 215 (400)
Q Consensus 149 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~N 215 (400)
.+++..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence 999999999999999999999976531 235899999999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEEecCCccccccCCc-eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCcCCCcc
Q 042371 216 ILLNEKYTAKVADFGTSKFIVIDQT-HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLT-GQKPIILTGSKE 293 (400)
Q Consensus 216 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 293 (400)
||++.++.+||+|||+++....... .......||+.|+|||.+.++.|+.++||||||+++|||++ |.+||.......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 9999999999999999987654332 22344668999999999999999999999999999999998 788885332211
Q ss_pred ccchHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042371 294 ATGLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQAL 361 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~ 361 (400)
.......+. ....+...++.+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 246 -------~~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 -------LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -------HHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 111111111 1112223456799999999999999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=379.96 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=204.5
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc---CchhHHHHHHHHHHHH-hCCCCcceeeeeEEeeCCcceEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV---HEGKLEEFINEVVILS-QINHRNVVKLLGCCLETEVPLLV 157 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 157 (400)
++|++.+.||+|+||+||+|... +++.||||.+... .....+.+..|..++. .++||||+++++++.+.+..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999965 6899999987632 2344567777777765 68999999999999999999999
Q ss_pred EEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccccc
Q 042371 158 YEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVI 237 (400)
Q Consensus 158 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~ 237 (400)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999998755 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccccccchh
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLYDFLDDQ 317 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
. ........||+.|+|||++.+..|+.++||||+||++|+|++|+.||....... . .........
T Consensus 156 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~-~~~i~~~~~------- 220 (320)
T d1xjda_ 156 G-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------L-FHSIRMDNP------- 220 (320)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHCCC-------
T ss_pred c-cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------H-HHHHHcCCC-------
Confidence 2 333445679999999999999999999999999999999999999995432211 0 111111110
Q ss_pred hhccCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 042371 318 VLKVGQKEEIMTIATLATRCLNLNGKRRPTMK-EVAME 354 (400)
Q Consensus 318 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ell~~ 354 (400)
..+...++.+.+|+.+||+.||.+|||+. +++++
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 11223356689999999999999999995 77653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=383.61 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=198.8
Q ss_pred hcCCcccc-eeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHh-CCCCcceeeeeEEee----CCcc
Q 042371 82 TDHFNVNR-ILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQ-INHRNVVKLLGCCLE----TEVP 154 (400)
Q Consensus 82 ~~~y~~~~-~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~----~~~~ 154 (400)
.++|.+.. .||+|+||.||+|.. .+++.||||++.. ...+.+|+.++.+ .+||||+++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46798875 699999999999996 4689999998753 2456789988765 489999999999875 3568
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCcEEEEecCC
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE---KYTAKVADFGT 231 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~Dfgl 231 (400)
|||||||+||+|.+++...+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 999999999999999986533 25999999999999999999999999 999999999999985 46799999999
Q ss_pred ccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 232 SKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 232 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
++.... ........||+.|+|||++.+..|+.++|||||||++|+|++|+.||............ ........ .
T Consensus 161 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~-~ 234 (335)
T d2ozaa1 161 AKETTS--HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQ-Y 234 (335)
T ss_dssp CEECCC--CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS-S
T ss_pred eeeccC--CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCC-C
Confidence 986543 23334567999999999999999999999999999999999999999544322110000 00000000 0
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.+. .......++.+.+||.+||+.||.+|||+.|++++
T Consensus 235 ~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCC-----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 01112456679999999999999999999999885
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=377.85 Aligned_cols=258 Identities=24% Similarity=0.245 Sum_probs=193.9
Q ss_pred ccceeeecCcEEEEEEEec-CCcEEEEEEccccCch-----hHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 87 VNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEG-----KLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 87 ~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
.+++||+|+||+||+|... +|+.||||++...... ..+.+.+|+.+|++++||||+++++++.+.+..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 6899999987653322 134688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+.++++..+..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-N 154 (299)
T ss_dssp CSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-C
T ss_pred hcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC-c
Confidence 99877766654332 5888999999999999999999999 999999999999999999999999999865432 2
Q ss_pred eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh---cccccccc-
Q 042371 241 HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE---NRLYDFLD- 315 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~- 315 (400)
.......||+.|+|||++.+. .|+.++|||||||++|+|++|.+||......+ .+... ...... ..+.....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i-~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRI-FETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-HHHHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHH-HHhcCCCChhhccchhcc
Confidence 233446799999999998654 68999999999999999999999995433221 11111 111000 00000000
Q ss_pred -----hhh-----hccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 -----DQV-----LKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 -----~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
... ........++.+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 000011234678999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=371.37 Aligned_cols=269 Identities=22% Similarity=0.307 Sum_probs=200.9
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHH--HHHhCCCCcceeeeeEEeeCC----cceE
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVV--ILSQINHRNVVKLLGCCLETE----VPLL 156 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~--~l~~l~h~~iv~~~~~~~~~~----~~~l 156 (400)
++|.+.+.||+|+||.||+|+. +|+.||||++... ....+..|.+ .+.+++||||+++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5688999999999999999997 5789999987643 2334444444 455779999999999998764 4689
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeEEcCCCcEEEEecCC
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA-----SMPIYHRDIKSTNILLNEKYTAKVADFGT 231 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiHrDikp~NIll~~~~~~kl~Dfgl 231 (400)
||||+++|+|.++++.. .+++..++.++.|++.||.|||... ..+|+||||||+|||++.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999864 3899999999999999999999741 12399999999999999999999999999
Q ss_pred ccccccCCce---eeecccccCCCCCccccccCC------CCCcchhHHHHHHHHHHHhCCCCCCcCCCcccc-------
Q 042371 232 SKFIVIDQTH---VTTKVQGTFGYLDPEYFRSGQ------FTDKSDVYSFGVVLVELLTGQKPIILTGSKEAT------- 295 (400)
Q Consensus 232 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~------- 295 (400)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9876543322 223467999999999987643 577899999999999999999887443321110
Q ss_pred -chHHHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 296 -GLAAYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 296 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.................-+.. ..........+.+|+.+||+.||.+|||+.||++.|+++....
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 011111111111111100000 1112345567899999999999999999999999999988643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=375.37 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=199.5
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999996 468999999886432 2345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
|+.+ ++.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~- 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155 (298)
T ss_dssp CCSE-EHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-
T ss_pred ecCC-chhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC-
Confidence 9976 45555544332 25999999999999999999999999 999999999999999999999999999865432
Q ss_pred ceeeecccccCCCCCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH-hhhc-ccccccc-
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS-MEEN-RLYDFLD- 315 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~- 315 (400)
........||+.|+|||.+.... ++.++||||+||++|+|++|+.||....... .+....... .... .......
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccccccc
Confidence 23334457999999999877665 5789999999999999999999995432211 111110000 0000 0000000
Q ss_pred -----hhhh------ccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 316 -----DQVL------KVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 316 -----~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.... .......+..+.+|+.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 00011234668999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-51 Score=380.30 Aligned_cols=265 Identities=28% Similarity=0.421 Sum_probs=213.3
Q ss_pred hHHHHHHhcCCcccceeeecCcEEEEEEEec------CCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeE
Q 042371 75 TKELDKATDHFNVNRILGQGGQGTVYKGMLA------DGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGC 147 (400)
Q Consensus 75 ~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 147 (400)
.++|+...++|++.+.||+|+||.||+|.+. ++..||||++... .......+.+|+.++++++||||++++++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 3455666789999999999999999999863 2578999988643 33445678999999999999999999999
Q ss_pred EeeCCcceEEEEccCCCCHHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 042371 148 CLETEVPLLVYEFISNGTLFQYLHDQ-------NEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE 220 (400)
Q Consensus 148 ~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~ 220 (400)
+...+..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 168 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecC
Confidence 99999999999999999999998653 12234789999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCccccccCCcee-eecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCC-CCCCcCCCccccchH
Q 042371 221 KYTAKVADFGTSKFIVIDQTHV-TTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQ-KPIILTGSKEATGLA 298 (400)
Q Consensus 221 ~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~ 298 (400)
++++||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||.......
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~----- 243 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----- 243 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 9999999999998765433322 23346899999999999999999999999999999999985 6664322111
Q ss_pred HHHHHHhhhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042371 299 AYFILSMEENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERI 358 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~ 358 (400)
.. .....+.. ...+...++.+.+++.+||+.||.+|||+.+|+++|++.
T Consensus 244 -~~-~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 244 -VL-RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp -HH-HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -HH-HHHHhCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11 11111111 112233456799999999999999999999999998664
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6e-50 Score=370.73 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=200.7
Q ss_pred cCCcccceeeecCcEEEEEEEecCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 160 (400)
++|++.+.||+|+||+||+|..++|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..+++|+|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999889999999876532 33467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCCc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQT 240 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~ 240 (400)
+.++.+..+..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-V 154 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC-c
Confidence 98876666654433 5999999999999999999999999 999999999999999999999999999865432 2
Q ss_pred eeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc---cccccc--
Q 042371 241 HVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN---RLYDFL-- 314 (400)
Q Consensus 241 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 314 (400)
.......|++.|+|||.+.+. .++.++||||+||++|+|++|+.||....... ....... ..... .+....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~-~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFR-ILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHCCCCTTTSTTGGGS
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHH-hhCCCChhhccchhhh
Confidence 233445689999999998754 57999999999999999999999995433211 1111110 00000 000000
Q ss_pred ----------chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 315 ----------DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 315 ----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
............++.+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000011122334678999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=370.77 Aligned_cols=241 Identities=26% Similarity=0.428 Sum_probs=196.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCc------hhHHHHHHHHHHHHhCC--CCcceeeeeEEeeCC
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHE------GKLEEFINEVVILSQIN--HRNVVKLLGCCLETE 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 152 (400)
.++|++.+.||+|+||.||+|... +|+.||||.+..... .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999964 689999998753211 12234668999999986 899999999999999
Q ss_pred cceEEEEccCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCcEEEEecC
Q 042371 153 VPLLVYEFISN-GTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-KYTAKVADFG 230 (400)
Q Consensus 153 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~Dfg 230 (400)
..++||||+.+ +++.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 68888887654 4899999999999999999999999 999999999999985 4799999999
Q ss_pred CccccccCCceeeecccccCCCCCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc
Q 042371 231 TSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQF-TDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR 309 (400)
Q Consensus 231 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
+++... ........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.... ......
T Consensus 157 ~a~~~~---~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~ 220 (273)
T d1xwsa_ 157 SGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ 220 (273)
T ss_dssp TCEECC---SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC
T ss_pred cceecc---cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcc
Confidence 997643 223345679999999999988776 567899999999999999999994210 000110
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 LYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ..+...++.+.+|+.+||+.||++|||++|++++
T Consensus 221 ~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 V----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 0112234668999999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-50 Score=372.76 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=196.9
Q ss_pred hcCCcccceeeecCcEEEEEEEec-C-CcEEEEEEccccC--chhHHHHHHHHHHHHhC---CCCcceeeeeEEee----
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-D-GRIVAVKKSKIVH--EGKLEEFINEVVILSQI---NHRNVVKLLGCCLE---- 150 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~-~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~---- 150 (400)
.++|++.+.||+|+||+||+|... + ++.||||++.... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999963 3 6779999875432 22234456777776665 79999999999853
Q ss_pred -CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEec
Q 042371 151 -TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADF 229 (400)
Q Consensus 151 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Df 229 (400)
....+++|||++++++......... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2467899999988776554443332 5899999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHH--hhh
Q 042371 230 GTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILS--MEE 307 (400)
Q Consensus 230 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~ 307 (400)
|++.... .........||+.|+|||++.+.+|+.++||||+||++|+|++|++||........ +....... ...
T Consensus 161 g~~~~~~--~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 161 GLARIYS--FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGE 236 (305)
T ss_dssp CSCCCCC--GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCG
T ss_pred hhhhhhc--ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCch
Confidence 9997653 22334556799999999999999999999999999999999999999964432211 11110000 000
Q ss_pred cccccc----------cchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 NRLYDF----------LDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 ~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
..+... .............++.+.+|+.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00000111122345668899999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=368.87 Aligned_cols=265 Identities=25% Similarity=0.315 Sum_probs=196.9
Q ss_pred CCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC------CcceE
Q 042371 84 HFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVVKLLGCCLET------EVPLL 156 (400)
Q Consensus 84 ~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~l 156 (400)
+|+..++||+|+||+||+|+.. +|+.||||++...... ..+|+.+|++++||||+++++++... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5899999999999999999975 6899999987653322 24799999999999999999998643 24689
Q ss_pred EEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-cEEEEecCCcccc
Q 042371 157 VYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKFI 235 (400)
Q Consensus 157 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~Dfgla~~~ 235 (400)
||||++++.+..+.........+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654444433223336999999999999999999999999 99999999999999775 8999999999866
Q ss_pred ccCCceeeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH----------H
Q 042371 236 VIDQTHVTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL----------S 304 (400)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------~ 304 (400)
.. ........||+.|+|||.+.+ ..|+.++||||+||++|+|++|+.||........ +...... .
T Consensus 174 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CT--TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHH
T ss_pred cC--CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhhh
Confidence 43 233344679999999998765 5789999999999999999999999954432211 1111000 0
Q ss_pred h----hhcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 042371 305 M----EENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERIQ 359 (400)
Q Consensus 305 ~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~~ 359 (400)
. ....+................++.+.+|+.+||+.||.+|||+.|++++ ++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0 0000111111111111223345678999999999999999999999975 54443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=363.21 Aligned_cols=267 Identities=21% Similarity=0.262 Sum_probs=195.7
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEee--------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLE-------- 150 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 150 (400)
.++|++.+.||+|+||+||+|.. .+|+.||||++... .......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999996 47899999987543 33445778899999999999999999998755
Q ss_pred CCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecC
Q 042371 151 TEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFG 230 (400)
Q Consensus 151 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfg 230 (400)
.+..++||||+.++++........ .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 345789999998766654443322 5899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCC---ceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh
Q 042371 231 TSKFIVIDQ---THVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME 306 (400)
Q Consensus 231 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 306 (400)
+++...... ........||+.|+|||++.+. .|+.++||||+||++|+|++|+.||....................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 997654322 1222335689999999998765 689999999999999999999999954322111111111100000
Q ss_pred hcccccccch--------hhhccCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 307 ENRLYDFLDD--------QVLKVGQ-------KEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 307 ~~~~~~~~~~--------~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
.......... ....... ...++.+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000000 0000000 1113457899999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=366.25 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=196.7
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc-CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC----cce
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV-HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE----VPL 155 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~ 155 (400)
..+|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999986 47899999988643 3445678899999999999999999999987654 234
Q ss_pred EEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 042371 156 LVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFI 235 (400)
Q Consensus 156 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~ 235 (400)
++++|+.+|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 555667799999999754 3899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCce--eeecccccCCCCCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcc---
Q 042371 236 VIDQTH--VTTKVQGTFGYLDPEYFRS-GQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENR--- 309 (400)
Q Consensus 236 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 309 (400)
...... ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||.......................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 432221 2344668999999999854 5678999999999999999999999954432211111000000000000
Q ss_pred ---------cccccch--hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 310 ---------LYDFLDD--QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 310 ---------~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....... ..........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00000011223568899999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=365.53 Aligned_cols=263 Identities=23% Similarity=0.283 Sum_probs=197.2
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCC------
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETE------ 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 152 (400)
.++|++.+.||+|+||+||+|... +|+.||||++... .....+.+.+|+.+|++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999964 6899999998643 3345678899999999999999999999997654
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
.+++||||+ +.+|..++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 66888877643 4999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh-----
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME----- 306 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----- 306 (400)
+.... ..+...||+.|+|||++.+. .++.++||||+||++|+|++|++||........ +.........
T Consensus 169 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred eccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcHHH
Confidence 86532 23456799999999998764 578999999999999999999999954432111 1100000000
Q ss_pred ------------hcccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 042371 307 ------------ENRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME--LERIQ 359 (400)
Q Consensus 307 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~~~ 359 (400)
...+..... ..........++.+.+|+.+||..||.+|||+.|++++ |+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEK-KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCC-CCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhcchhhhhhhccCCcccc-cchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000000000 00011122334568899999999999999999999986 55443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=350.64 Aligned_cols=263 Identities=19% Similarity=0.221 Sum_probs=200.3
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcce-eeeeEEeeCCcceEEEEc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNVV-KLLGCCLETEVPLLVYEF 160 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~ 160 (400)
++|++.+.||+|+||.||+|.+. +|+.||||.+..... ...+..|+.+++.++|+|++ .+..++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999964 689999997664322 24577899999999876654 555666777888999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCcEEEEecCCcccccc
Q 042371 161 ISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE---KYTAKVADFGTSKFIVI 237 (400)
Q Consensus 161 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~Dfgla~~~~~ 237 (400)
+ +++|...+..... .+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+....
T Consensus 85 ~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5577776655443 4899999999999999999999999 999999999999864 45799999999987653
Q ss_pred CCc------eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhcccc
Q 042371 238 DQT------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRLY 311 (400)
Q Consensus 238 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC--
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC--
Confidence 322 123456799999999999999999999999999999999999999965443322221111111100000
Q ss_pred cccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042371 312 DFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQ 362 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~ 362 (400)
.+. .....++++.+++.+||+.||.+||+++++.+.|+++....
T Consensus 237 ---~~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 237 ---IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ---HHH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---hhH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 000 11223456899999999999999999999999999876543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=352.68 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=205.4
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeCCcceEEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 159 (400)
++|++.+.||+|+||+||+|++ .+++.||||+++.. .......+.+|+.+|+.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 46889999987543 34457889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCccccccCC
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSKFIVIDQ 239 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~ 239 (400)
++.+++|..++.... .+++..++.++.|++.||+|||.++ |+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~- 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC-
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC-
Confidence 999999888876543 5899999999999999999999999 999999999999999999999999999875432
Q ss_pred ceeeecccccCCCCCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhh--hcccc---cc
Q 042371 240 THVTTKVQGTFGYLDPEYFRSGQ-FTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSME--ENRLY---DF 313 (400)
Q Consensus 240 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~---~~ 313 (400)
........+++.|+|||.+.+.. ++.++||||+||++|+|++|+.||....... ............ ...+. ..
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-HHHHHHHhhcCCCChhhhhhhhhc
Confidence 22333445788999999987665 6899999999999999999999974433221 111111111000 00000 00
Q ss_pred c---------chhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 314 L---------DDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 314 ~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ............++.+.+|+.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0001111223345678999999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.4e-46 Score=346.33 Aligned_cols=265 Identities=17% Similarity=0.182 Sum_probs=208.7
Q ss_pred hcCCcccceeeecCcEEEEEEEec-CCcEEEEEEccccCchhHHHHHHHHHHHHhCCC-CcceeeeeEEeeCCcceEEEE
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIVHEGKLEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 159 (400)
.++|++.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+|+++++.+.| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999965 68899999765432 22456788999999965 899999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----CCcEEEEecCCccc
Q 042371 160 FISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNE-----KYTAKVADFGTSKF 234 (400)
Q Consensus 160 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~-----~~~~kl~Dfgla~~ 234 (400)
|+ +++|.+++..... .++...+..++.|++.||.|||+.| |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 6899999876543 4899999999999999999999999 999999999999974 56899999999987
Q ss_pred cccCCc------eeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhc
Q 042371 235 IVIDQT------HVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEEN 308 (400)
Q Consensus 235 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 643221 12334679999999999999999999999999999999999999996544332211111111100000
Q ss_pred ccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhh
Q 042371 309 RLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAMELERIQALQK 363 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 363 (400)
.. ..+ ....++++.+++..|++.+|++||+++.+.+.|+++....+
T Consensus 236 ~~-----~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 236 PL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp CH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred Ch-----HHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 00 111 11234568999999999999999999999999988765443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.9e-47 Score=357.89 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=197.3
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeC--CcceEEE
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLET--EVPLLVY 158 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~ 158 (400)
++|++.+.||+|+||+||+|+. .+|+.||||+++. ...+.+.+|+.+|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 4689999998763 33567889999999995 99999999998754 4688999
Q ss_pred EccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-cEEEEecCCcccccc
Q 042371 159 EFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKY-TAKVADFGTSKFIVI 237 (400)
Q Consensus 159 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~Dfgla~~~~~ 237 (400)
||+++++|..+.+ .+++..++.++.||+.||.|||+.| |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999876532 4899999999999999999999999 99999999999998655 699999999986543
Q ss_pred CCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHH-------Hhhh--
Q 042371 238 DQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFIL-------SMEE-- 307 (400)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------~~~~-- 307 (400)
........+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||................. ....
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2334456789999999998765 579999999999999999999999965543321111110000 0000
Q ss_pred -c---ccccccc--------hhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 -N---RLYDFLD--------DQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 -~---~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
. ....... ...........++.+.+||.+||+.||.+|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000 000011112344678999999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=358.62 Aligned_cols=254 Identities=27% Similarity=0.356 Sum_probs=205.3
Q ss_pred hcCCcccceeeecCcEEEEEEEec----CCcEEEEEEcccc----CchhHHHHHHHHHHHHhCCC-CcceeeeeEEeeCC
Q 042371 82 TDHFNVNRILGQGGQGTVYKGMLA----DGRIVAVKKSKIV----HEGKLEEFINEVVILSQINH-RNVVKLLGCCLETE 152 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 152 (400)
.++|++.+.||+|+||+||+|... +|+.||||.+... .....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 367999999999999999999842 4789999987532 22345678899999999976 89999999999999
Q ss_pred cceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCc
Q 042371 153 VPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTS 232 (400)
Q Consensus 153 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla 232 (400)
..+++|||+.+|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999998765 3788999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccCCCCCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhhccc
Q 042371 233 KFIVIDQTHVTTKVQGTFGYLDPEYFRSG--QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEENRL 310 (400)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
+..............|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.............. ... ..
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~--~~~-~~-- 251 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RIL-KS-- 251 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHH-HC--
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hcc-cC--
Confidence 87655555555567799999999998754 468899999999999999999999965544332111111 110 00
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 042371 311 YDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPT-----MKEVAME 354 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 354 (400)
....+...++.+.+|+.+||++||.+||| ++|++++
T Consensus 252 --------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 01122345567999999999999999994 7888764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=357.44 Aligned_cols=261 Identities=21% Similarity=0.282 Sum_probs=191.0
Q ss_pred cCCcccceeeecCcEEEEEEEec-CCcEEEEEEcccc--CchhHHHHHHHHHHHHhCCCCcceeeeeEEeeC------Cc
Q 042371 83 DHFNVNRILGQGGQGTVYKGMLA-DGRIVAVKKSKIV--HEGKLEEFINEVVILSQINHRNVVKLLGCCLET------EV 153 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~ 153 (400)
++|++.+.||+|+||+||+|.+. +|+.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999965 6899999987643 344566789999999999999999999998643 56
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.|+||||+.++ +.+.+.. .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 79999999765 4444431 4899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH------------
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF------------ 301 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~------------ 301 (400)
.... ........+|+.|+|||++.+..++.++||||+||++|+|++|+.||...............
T Consensus 168 ~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 6532 33344567899999999999999999999999999999999999999543321110000000
Q ss_pred ----HHHhhhc------ccccccchhhhcc---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 302 ----ILSMEEN------RLYDFLDDQVLKV---GQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 302 ----~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
....... ............. .....++.+.+|+.+||..||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0000111111111 123456789999999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=356.73 Aligned_cols=261 Identities=23% Similarity=0.261 Sum_probs=195.0
Q ss_pred hcCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccC--chhHHHHHHHHHHHHhCCCCcceeeeeEEeeC-----Cc
Q 042371 82 TDHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVH--EGKLEEFINEVVILSQINHRNVVKLLGCCLET-----EV 153 (400)
Q Consensus 82 ~~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 153 (400)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999996 469999999886432 34456788999999999999999999998643 33
Q ss_pred ceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 154 PLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 154 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
.+++|+|+.+|+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 46777788899999998643 4999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceeeecccccCCCCCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHHHHHhhh-----
Q 042371 234 FIVIDQTHVTTKVQGTFGYLDPEYFRSG-QFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYFILSMEE----- 307 (400)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----- 307 (400)
... .......||+.|+|||.+.+. .++.++||||+||++|+|++|++||.....................
T Consensus 170 ~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 542 223445689999999987665 4689999999999999999999999543322111110000000000
Q ss_pred ----------cccccccchhhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042371 308 ----------NRLYDFLDDQVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKEVAME 354 (400)
Q Consensus 308 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 354 (400)
........... .......++.+.+||.+||+.||.+|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000 00011234568899999999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-41 Score=320.50 Aligned_cols=264 Identities=22% Similarity=0.229 Sum_probs=190.7
Q ss_pred cCCcccceeeecCcEEEEEEEe-cCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-----------CCcceeeeeEEee
Q 042371 83 DHFNVNRILGQGGQGTVYKGML-ADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-----------HRNVVKLLGCCLE 150 (400)
Q Consensus 83 ~~y~~~~~lg~G~fg~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~ 150 (400)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4599999999999999999996 46899999988643 233467788888888775 5789999988765
Q ss_pred C--CcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCC-----
Q 042371 151 T--EVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHS-AASMPIYHRDIKSTNILLNEKY----- 222 (400)
Q Consensus 151 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDikp~NIll~~~~----- 222 (400)
. ...+++|.++..+..............+++..+..++.||+.||.|||+ .| |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4556677766555443333333334468999999999999999999998 77 99999999999998665
Q ss_pred -cEEEEecCCccccccCCceeeecccccCCCCCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCcCCCccccchHHHH
Q 042371 223 -TAKVADFGTSKFIVIDQTHVTTKVQGTFGYLDPEYFRSGQFTDKSDVYSFGVVLVELLTGQKPIILTGSKEATGLAAYF 301 (400)
Q Consensus 223 -~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 301 (400)
.++++|||.+.... .......||+.|+|||++.+..|+.++||||+||++++|++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETT----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeecccccccc----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 49999999997543 2234466999999999999999999999999999999999999999654332211111111
Q ss_pred HHHhh---h------------------cccccccch----------hhhccCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 042371 302 ILSME---E------------------NRLYDFLDD----------QVLKVGQKEEIMTIATLATRCLNLNGKRRPTMKE 350 (400)
Q Consensus 302 ~~~~~---~------------------~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 350 (400)
...+. . ......+.. ..........++.+.+|+.+||..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 10000 0 000000000 0111234677888999999999999999999999
Q ss_pred HHHH
Q 042371 351 VAME 354 (400)
Q Consensus 351 ll~~ 354 (400)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=3.4e-25 Score=191.19 Aligned_cols=165 Identities=18% Similarity=0.203 Sum_probs=120.9
Q ss_pred CcccceeeecCcEEEEEEEecCCcEEEEEEccccCc------------------hhHHHHHHHHHHHHhCCCCcceeeee
Q 042371 85 FNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHE------------------GKLEEFINEVVILSQINHRNVVKLLG 146 (400)
Q Consensus 85 y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 146 (400)
+.+.+.||+|+||.||+|...+|+.||||.++.... ........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 457889999999999999988899999997542110 01234456888999999999998876
Q ss_pred EEeeCCcceEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCcEEE
Q 042371 147 CCLETEVPLLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAASMPIYHRDIKSTNILLNEKYTAKV 226 (400)
Q Consensus 147 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDikp~NIll~~~~~~kl 226 (400)
+. ..+++|||+++..+.. ++...+..++.|++.+|.|||..| |+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 53 3479999998765432 333445678999999999999999 9999999999999976 5899
Q ss_pred EecCCccccccCCceeeecccccCCCCCcc-----ccccCCCCCcchhHHHHHHH
Q 042371 227 ADFGTSKFIVIDQTHVTTKVQGTFGYLDPE-----YFRSGQFTDKSDVYSFGVVL 276 (400)
Q Consensus 227 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DiwSlG~il 276 (400)
+|||+|.....+... .|.... .+....|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999999764322111 111110 01235788999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.79 E-value=3.1e-08 Score=87.45 Aligned_cols=149 Identities=17% Similarity=0.154 Sum_probs=104.8
Q ss_pred HHHHHHhcCCcccceeeecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcc
Q 042371 76 KELDKATDHFNVNRILGQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVP 154 (400)
Q Consensus 76 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 154 (400)
.++......|++.+..+.++.+.||+... ++..+++|+...........+.+|...+..+. +--+++++.+..+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666677888777655555678998765 45567788765544444455677888887774 43467788888888889
Q ss_pred eEEEEccCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 042371 155 LLVYEFISNGTLFQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAAS------------------------------- 203 (400)
Q Consensus 155 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~------------------------------- 203 (400)
++||++++|.++.+...... . ...++.+++..+..||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEecccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999988866543211 1 22345666666777775321
Q ss_pred -------------------------CCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 204 -------------------------MPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 204 -------------------------~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127999999999999987666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.24 E-value=1e-06 Score=76.94 Aligned_cols=130 Identities=18% Similarity=0.168 Sum_probs=85.2
Q ss_pred eeeecC-cEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCC--CCcceeeeeEEeeCCcceEEEEccCCCCH
Q 042371 90 ILGQGG-QGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQIN--HRNVVKLLGCCLETEVPLLVYEFISNGTL 166 (400)
Q Consensus 90 ~lg~G~-fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 166 (400)
.+..|. -+.||+....++..+++|...... ...+..|...++.+. .-.+++++.+..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344444 367999988778888999654332 234566777777663 23367788888888888999999988665
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 042371 167 FQYLHDQNEEFPLTWEMRLRIATEVAGSLSYLHSAA-------------------------------------------- 202 (400)
Q Consensus 167 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------- 202 (400)
.+. ..... ..+.++...|..||...
T Consensus 94 ~~~--------~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSS--------HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTS--------CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccc--------cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 321 01111 12233444444444311
Q ss_pred -----------CCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 203 -----------SMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 203 -----------~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
...++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1127999999999999987667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.87 E-value=3.7e-05 Score=71.45 Aligned_cols=76 Identities=21% Similarity=0.209 Sum_probs=48.7
Q ss_pred cceeeecCcEEEEEEEec-CCcEEEEEEccc----cCc---hhHHHHHHHHHHHHhCC-C--CcceeeeeEEeeCCcceE
Q 042371 88 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKI----VHE---GKLEEFINEVVILSQIN-H--RNVVKLLGCCLETEVPLL 156 (400)
Q Consensus 88 ~~~lg~G~fg~V~~~~~~-~~~~vaiK~~~~----~~~---~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~l 156 (400)
.+.||.|....||+.... +++.+++|.... ..+ ....+...|...|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 357899999999999865 467899995332 111 12345566888887663 2 345566644 4556789
Q ss_pred EEEccCCCC
Q 042371 157 VYEFISNGT 165 (400)
Q Consensus 157 v~e~~~~g~ 165 (400)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.11 E-value=0.00048 Score=63.69 Aligned_cols=72 Identities=18% Similarity=0.170 Sum_probs=48.0
Q ss_pred ceeeecCcEEEEEEEecC--------CcEEEEEEccccCchhHHHHHHHHHHHHhCC-CCcceeeeeEEeeCCcceEEEE
Q 042371 89 RILGQGGQGTVYKGMLAD--------GRIVAVKKSKIVHEGKLEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYE 159 (400)
Q Consensus 89 ~~lg~G~fg~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 159 (400)
+.|+.|-.-.+|++...+ .+.|+++.... .. ......+|..+++.+. +.-.+++++++.+ .+|++
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 578889999999988543 34577765442 22 2334567888888885 4334567776642 68999
Q ss_pred ccCCCCH
Q 042371 160 FISNGTL 166 (400)
Q Consensus 160 ~~~~g~L 166 (400)
|++|..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.76 E-value=0.0065 Score=53.67 Aligned_cols=158 Identities=12% Similarity=0.085 Sum_probs=79.4
Q ss_pred cChHHHHHHhcCCccccee-----eecCcEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCC-----Ccce
Q 042371 73 FTTKELDKATDHFNVNRIL-----GQGGQGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINH-----RNVV 142 (400)
Q Consensus 73 ~~~~~~~~~~~~y~~~~~l-----g~G~fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-----~~iv 142 (400)
.+.+++.....+|.+.+.. ..|---+.|+....+| .+++|+..... ....+..|+.++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4567777778888875543 3566678899887655 48888764321 22334445556665532 2222
Q ss_pred eee-e--EEeeCCcceEEEEccCCCCHHH--------------HHhhcCCCC------CCCH------------------
Q 042371 143 KLL-G--CCLETEVPLLVYEFISNGTLFQ--------------YLHDQNEEF------PLTW------------------ 181 (400)
Q Consensus 143 ~~~-~--~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~~------~l~~------------------ 181 (400)
... + ..........++.+..+..... .++...... ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 111 0 1122334455666655432211 001000000 0000
Q ss_pred HHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCCeEEcCCCcEEEEecCCcc
Q 042371 182 EMRLRIATEVAGSLSYLHSAA-SMPIYHRDIKSTNILLNEKYTAKVADFGTSK 233 (400)
Q Consensus 182 ~~~~~i~~~i~~~l~~LH~~~-~~~iiHrDikp~NIll~~~~~~kl~Dfgla~ 233 (400)
......+..+...+...+..+ ..++||+|+.++||+++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011112222222222222211 2349999999999999988777899999885
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.67 E-value=0.0007 Score=40.99 Aligned_cols=31 Identities=29% Similarity=0.598 Sum_probs=27.4
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||......|. +..|++..|+|+|..+.+-
T Consensus 3 idEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy 33 (44)
T d1lmja1 3 IDECRISPDLCG-RGQCVNTPGDFECKCDEGY 33 (44)
T ss_dssp CCTTTTCSSTTT-TSCEEEETTEEEECCCSSE
T ss_pred ccccCCCCCCCC-CCEeEcCCCCeEEeCCCCC
Confidence 899999999996 5689999999999888774
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.67 E-value=0.0003 Score=42.36 Aligned_cols=32 Identities=41% Similarity=0.837 Sum_probs=28.4
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCchh
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRKV 33 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~~ 33 (400)
||||...+..|. +..|++..|+|+|..+.+..
T Consensus 2 idEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~ 33 (42)
T d1lmja2 2 IDECQRDPLLCR-GGVCHNTEGSYRCECPPGHQ 33 (42)
T ss_dssp CCHHHHCSSTTT-TSEEEEETTEEEEESCTTSC
T ss_pred ccccCCCCCCCC-CCEeECCCCCeEEeCCCCCe
Confidence 899999999995 67999999999999887753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.65 E-value=0.0033 Score=56.15 Aligned_cols=68 Identities=15% Similarity=0.093 Sum_probs=43.9
Q ss_pred cEEEEEEEecCCcEEEEEEccccCchhHHHHHHHHHHHHhCCCCcc--eeee-----eEEeeCCcceEEEEccCCC
Q 042371 96 QGTVYKGMLADGRIVAVKKSKIVHEGKLEEFINEVVILSQINHRNV--VKLL-----GCCLETEVPLLVYEFISNG 164 (400)
Q Consensus 96 fg~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~g 164 (400)
-..||++...+|..+++|..... ....+++..|...+..|....+ +... ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 46899999989999999976532 2345667778888777642221 1111 1233455677889988764
|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.35 E-value=0.0012 Score=40.20 Aligned_cols=32 Identities=31% Similarity=0.726 Sum_probs=21.9
Q ss_pred CCcCCCCCCCCCC-CceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSE-NLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~-~~~c~~~~~~y~~~~~~~~ 32 (400)
||||......+.. .+.|+++.|+|+|..+.+.
T Consensus 1 IdEC~~~~~~~~~C~~~C~Nt~gsy~C~C~~Gy 33 (45)
T d1nt0a3 1 VDECRTSLGDSVPCDHYCHNYLGGYYCSCRVGY 33 (45)
T ss_dssp CCTTC-------CCSSEEEEETTEEEEECCTTE
T ss_pred CcCCccCCCCcCCCCCEeecCCCCEEEeCCCCC
Confidence 8999987665444 5699999999999888775
|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.35 E-value=0.0019 Score=39.30 Aligned_cols=32 Identities=28% Similarity=0.561 Sum_probs=27.0
Q ss_pred CCcCCCCCCCC-CCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANC-SENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~-~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||......+ +-.+.|++..|+|+|..+.+.
T Consensus 1 IdEC~~~~~~~~~C~~~C~Nt~Gsy~C~C~~Gy 33 (45)
T d1szba2 1 IDECQVAPGEAPTCDHHCHNHLGGFYCSCRAGY 33 (45)
T ss_dssp CCTTCCCTTSCCSSSSEEEEETTEEEEECCTTE
T ss_pred CcCCcCCCCCCCCCCCCCccCCCCeEEECCCCC
Confidence 89999888765 446799999999999888875
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.33 E-value=0.00041 Score=41.93 Aligned_cols=31 Identities=32% Similarity=0.650 Sum_probs=27.6
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||...+..|. ++.|++..|+|+|..+.+.
T Consensus 3 inEC~~~~~~c~-~~~C~Nt~Gsy~C~C~~Gy 33 (43)
T d1uzka2 3 IDECQELPGLCQ-GGKCINTFGSFQCRCPTGY 33 (43)
T ss_dssp CCHHHHCGGGGB-TSEEEECSSCEEEECCTTC
T ss_pred cccccCCCCCcC-CCEEECCCCCeEeECCCCC
Confidence 899999888886 5789999999999988874
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.12 E-value=0.0028 Score=40.10 Aligned_cols=32 Identities=38% Similarity=0.769 Sum_probs=27.2
Q ss_pred CCcCCCCCCCCCCC------ceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSEN------LLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~------~~c~~~~~~y~~~~~~~~ 32 (400)
||||......|... +.|+++-|+|+|..+.+.
T Consensus 4 idEC~~~~~~c~~~~~~~c~~~C~Nt~GsY~C~C~~Gy 41 (53)
T d1apqa_ 4 LDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGY 41 (53)
T ss_dssp CCTTTCSTTTCCCSSSCTTSSEEEEETTEEEEECSTTC
T ss_pred cccccCCCCCcccCCCCCccCEeEcCCCCeEeECCCCC
Confidence 89999888877544 489999999999988775
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.91 E-value=0.0029 Score=38.03 Aligned_cols=30 Identities=33% Similarity=0.549 Sum_probs=24.5
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||..... +-++.|++..|+|+|..+.+.
T Consensus 3 idEC~~~~~--~c~~~C~Nt~G~y~C~C~~Gy 32 (43)
T d1uzka1 3 VNECLDPTT--CISGNCVNTPGSYICDCPPDF 32 (43)
T ss_dssp CCGGGSTTS--SBTSEEEEETTEEEEECCTTC
T ss_pred ccccCCCCc--CcCCEeECCCCCEEEecCCCC
Confidence 899987543 346899999999999988775
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.82 E-value=0.0029 Score=37.61 Aligned_cols=29 Identities=45% Similarity=0.996 Sum_probs=23.9
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||. ....| .+.|++..|+|+|..+.+.
T Consensus 1 idEC~-~~~~C--~~~C~n~~Gsy~C~C~~Gy 29 (41)
T d1i0ua2 1 IDECQ-DPDTC--SQLCVNLEGGYKCQCEEGF 29 (41)
T ss_dssp CCTTT-TTTSC--SSCEECSSSCCEECCCTTE
T ss_pred CccCC-CCCCC--CCEeECCCCCEEeECCCCC
Confidence 89996 35566 4799999999999888875
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.53 E-value=0.0027 Score=38.16 Aligned_cols=30 Identities=37% Similarity=0.728 Sum_probs=24.6
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||.... |+-++.|++..|+|+|..+.+.
T Consensus 5 idEC~~~~--~~~~~~C~Nt~Gsy~C~C~~Gy 34 (43)
T d1emoa1 5 MDECKEPD--VCKHGQCINTDGSYRCECPFGY 34 (43)
T ss_dssp CCSSSSTT--SCSSSCCCCCSSCCCCCCCTTE
T ss_pred eeccCCcC--CCCCCEeECCCCCeEeECCCCc
Confidence 79997654 4457889999999999888774
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.21 E-value=0.011 Score=35.08 Aligned_cols=32 Identities=28% Similarity=0.583 Sum_probs=29.1
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||......|..+..|++.-|+|.|..+.+.
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~ 34 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGY 34 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTE
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCC
Confidence 89999888999999999999999999887764
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.86 E-value=0.0048 Score=36.20 Aligned_cols=29 Identities=38% Similarity=0.843 Sum_probs=23.6
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||.. ...|. +.|++..|+|+|..+.+.
T Consensus 2 idEC~~-~~~C~--~~C~N~~Gsy~C~C~~Gy 30 (40)
T d1dx5i3 2 IDECEN-GGFCS--GVCHNLPGTFECICGPDS 30 (40)
T ss_dssp CCHHHH-CSSCS--SEEEECSSSEEEEECSSS
T ss_pred ccccCC-CcCcc--CEeeCCCCCeEeECCCCC
Confidence 899964 35564 799999999999888765
|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.42 E-value=0.038 Score=32.25 Aligned_cols=31 Identities=32% Similarity=0.827 Sum_probs=26.4
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCchh
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRKV 33 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~~ 33 (400)
+|||-....-|. ++|++..|+|+|..+.+..
T Consensus 2 ~neC~~~nggC~--h~C~n~~g~~~C~C~~Gy~ 32 (40)
T d3bpse1 2 TNECLDNNGGCS--HVCNDLKIGYECLCPDGFQ 32 (40)
T ss_dssp SCGGGTGGGGCS--SEEEECSSSEEEECCTTCC
T ss_pred cccCCCCCCCCc--CEEEcCCCCEEEECCCCCE
Confidence 699988877775 6999999999999888763
|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement C1S component species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.73 E-value=0.09 Score=30.93 Aligned_cols=29 Identities=41% Similarity=0.928 Sum_probs=23.2
Q ss_pred CcCCCC-CCCCCCCceeEeccCceeeecCCch
Q 042371 2 DECKDG-TANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 2 ~~~~~~-~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
|||... ...|. +.|++..|+|+|..+.+.
T Consensus 1 dEC~~~~~~~C~--~~C~n~~Gsy~C~C~~Gy 30 (42)
T d1nzia2 1 NECTDFVDVPCS--HFCNNFIGGYFCSCPPEY 30 (42)
T ss_dssp CTTTC-CCCCSS--SEEEEETTEEEEECCTTC
T ss_pred CCCCCCCCcCCC--CEeecCCCCEEEeCCCCC
Confidence 899754 35675 689999999999988875
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.27 E-value=0.18 Score=29.03 Aligned_cols=30 Identities=23% Similarity=0.665 Sum_probs=26.0
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||||.+.+ |...-.|+...++|.|..+.+.
T Consensus 1 Id~C~~~P--C~n~g~C~~~~~~y~C~C~~G~ 30 (39)
T d2vj3a2 1 VNECVSNP--CQNDATCLDQIGEFQCICMPGY 30 (39)
T ss_dssp CCTTTTCC--CCSSCEEEECSSCEEEECCTTE
T ss_pred CcCCcCCC--CCCCCEEECCCCCEEEeCCCCC
Confidence 89998865 9999999999999999887663
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=86.19 E-value=0.077 Score=30.86 Aligned_cols=29 Identities=24% Similarity=0.659 Sum_probs=24.2
Q ss_pred CCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 4 CKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 4 ~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
|..+.-.|..+..|++..|+|.|..+.+.
T Consensus 2 C~~~~~~C~~~A~C~Nt~Gsy~C~C~~Gy 30 (40)
T d1gl4a2 2 CANNRHQCSVHAECRDYATGFCCRCVANY 30 (40)
T ss_dssp HHHHGGGSCTTEEEEECSSCEEEEECTTE
T ss_pred ccCCCCCCCCCCEeecCCCCeEeECCCCC
Confidence 44566789999999999999999887664
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.15 E-value=0.81 Score=26.07 Aligned_cols=30 Identities=23% Similarity=0.527 Sum_probs=25.4
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
+|+|.+.+ |...-.|+...++|.|..+.+.
T Consensus 3 ~d~C~~~P--C~ngg~C~~~~~~y~C~C~~g~ 32 (39)
T d1edmb_ 3 GDQCESNP--CLNGGSCKDDINSYECWCPFGF 32 (39)
T ss_dssp CCTTTTCC--CCTTCEEEEETTEEEEECCTTC
T ss_pred cccCCCCC--CCCCcEEEcCCCCEEEECCCCC
Confidence 68998755 9999999999999999887653
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=80.92 E-value=0.7 Score=26.03 Aligned_cols=30 Identities=20% Similarity=0.455 Sum_probs=25.3
Q ss_pred CCcCCCCCCCCCCCceeEeccCceeeecCCch
Q 042371 1 IDECKDGTANCSENLLCENYEGGYRCITPKRK 32 (400)
Q Consensus 1 ~~~~~~~~~~~~~~~~c~~~~~~y~~~~~~~~ 32 (400)
||+|.+-+ |...-.|+...++|.|..+.+.
T Consensus 2 ~d~C~~~P--C~ngg~C~~~~~~y~C~C~~g~ 31 (37)
T d2c4fl1 2 GDQCASSP--CQNGGSCKDQLQSYICFCLPAF 31 (37)
T ss_dssp CCGGGGCC--CCTTCEEEEETTEEEEECCTTE
T ss_pred cccCCCCC--CCCCCEEECCCCCeEEECCCCC
Confidence 79998655 9889999999999999887653
|